gene	reactome
A0A075B6P5	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A0A075B6S6	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A0A0A6YYK7	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
A0A0C4DH25	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A0A0C4DH73	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A0A183	Developmental Biology;Keratinization;Formation of the cornified envelope
A0AVF1	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
A0AVI4	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
A0AVK6	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription)
A0AVT1	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
A0FGR8	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
A0FGR9	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
A0JLT2	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
A0M8Q6	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A0MZ66	Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Nervous system development
A0PJK1	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
A1A4S6	Apoptosis;Signal Transduction;Regulation of Apoptosis;Signaling by Rho GTPases;Rho GTPase cycle;Regulation of PAK-2p34 activity by PS-GAP/RHG10;Programmed Cell Death
A1A580	Developmental Biology;Keratinization
A1A5B4	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
A1E959	Metabolism of proteins;Amyloid fiber formation
A1IGU5	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
A1L190	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
A1L3X0	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
A1L4H1	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class B Receptors;Vesicle-mediated transport
A2KUC3	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A2NJV5	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A2NXD2	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
A2RRD8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A2RRP1	Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
A2RU49	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives
A2RUC4	tRNA modification in the nucleus and cytosol;Synthesis of wybutosine at G37 of tRNA(Phe);tRNA processing;Metabolism of RNA
A2RUS2	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
A2VDF0	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;GDP-fucose biosynthesis
A2VEC9	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
A3KFT3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A4D1E1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A4D1S5	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
A4D2G3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A4GXA9	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Fanconi Anemia Pathway;DNA Repair
A5D6W6	Metabolism;Metabolism of lipids;Lipid particle organization
A5D8V6	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
A5LHX3	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
A5PL33	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A5PLK6	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events
A5PLN9	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
A5X5Y0	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
A5YKK6	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
A5YM69	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
A5YM72	Metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
A6H8Y1	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
A6NCV1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NCW0	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
A6NCW7	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
A6ND01	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
A6ND48	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NDG6	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
A6NDH6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NDL8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NDX5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A6NET4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NF89	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NFC9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NFH5	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
A6NGB9	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
A6NGU5	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations;Aflatoxin activation and detoxification
A6NGY5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NH00	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NH21	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
A6NHA9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NHC0	Degradation of the extracellular matrix;Extracellular matrix organization
A6NHG9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NHJ4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A6NHL2	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
A6NHX0	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
A6NI28	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
A6NI73	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
A6NIH7	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;Trafficking of myristoylated proteins to the cilium
A6NIJ9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NIX2	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cellular responses to stress;Cellular responses to external stimuli
A6NJZ3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NK53	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A6NK58	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives
A6NK59	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
A6NKK0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NL08	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NL26	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NLF2	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
A6NM03	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NM76	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NMB1	Innate Immune System;Immune System;DAP12 interactions
A6NMS3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NMU1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NMZ5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NMZ7	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
A6NN14	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A6NND4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
A6NNF4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A6NNM8	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
A6NNZ2	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
A6NP11	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A6PVC2	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
A7E2V4	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of expression of SLITs and ROBOs;Nervous system development
A7KAX9	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
A7MBM2	Signal Transduction;Hedgehog ligand biogenesis;Signaling by Hedgehog;Release of Hh-Np from the secreting cell
A8CG34	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
A8K0R7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8K4G0	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions
A8K7I4	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
A8K855	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO
A8K8P3	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
A8K8V0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8MPY1	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
A8MQ27	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus
A8MT69	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Fanconi Anemia Pathway;Chromosome Maintenance;DNA Repair;Nucleosome assembly
A8MTJ3	Hemostasis;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signal Transduction;Disease;Adenylate cyclase inhibitory pathway;G-protein activation;Peptide hormone metabolism;Signaling by GPCR;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;Metabolism of proteins;Signal amplification;Incretin synthesis, secretion, and inactivation;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
A8MTY0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8MTY7	Developmental Biology;Keratinization
A8MTZ0	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
A8MUK1	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
A8MUV8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8MUX0	Developmental Biology;Keratinization
A8MUZ8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8MVA2	Developmental Biology;Keratinization
A8MVS1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8MVX0	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
A8MWA4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8MX34	Developmental Biology;Keratinization
A8MX76	Degradation of the extracellular matrix;Extracellular matrix organization
A8MXU0	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
A8MXV4	Metabolism;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
A8MXY4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
A8MXZ3	Developmental Biology;Keratinization
A8MYU2	Fertilization;Sperm Motility And Taxes;Reproduction
A8MYZ6	PIP3 activates AKT signaling;Signal Transduction;Disease;AKT phosphorylates targets in the nucleus;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
A8TX70	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
A9QM74	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Disease;Influenza Infection;Immune System;NS1 Mediated Effects on Host Pathways;Infectious disease;Interferon Signaling
A9YTQ3	Metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Xenobiotics;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Aryl hydrocarbon receptor signalling
B0YJ81	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
B1NKT1	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;OAS antiviral response;Interferon Signaling
B2RTY4	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
B4DX44	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
B4DXR9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
B6A8C7	Innate Immune System;Immune System;Neutrophil degranulation
B7ZC32	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
C9J2P7	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
C9JJH3	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
C9JLJ4	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
C9JPN9	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
C9JR72	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
C9JRZ8	Metabolism;Estrogen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
C9JVI0	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
D6R901	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
D6R9N7	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
D6RA61	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
D6RBQ6	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
D6RCP7	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
D6RJB6	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
F5H8Q3	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5H8R0	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5H8R6	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5H8S6	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5H991	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5H9F9	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5H9I4	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5H9N4	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5H9N9	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5H9T4	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HA06	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HA10	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HA93	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HAC7	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HAE6	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HAM0	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HAR3	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HAS7	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HAY6	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HAZ3	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HB40	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HB41	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HB52	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HB53	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HBC6	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HBR4	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HBX1	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HC14	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HC16	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HC33	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HC71	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HC79	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HC97	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HCH8	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HCM1	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HCP3	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HCU8	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HD03	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HD27	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HD92	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HDC7	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HDK1	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HDM3	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HDQ6	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HE05	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HE12	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HE44	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HE69	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HEA3	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HEF3	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HEN7	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HEN8	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HET1	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HET4	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HEU0	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HF49	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HF62	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HF90	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HFA5	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HFB4	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HFG3	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HFJ7	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HFJ8	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HFZ4	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HG51	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HG68	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HG98	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HGG3	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HGH8	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HGI9	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F5HGJ4	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HGP1	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HGQ8	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HGT1	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HGU6	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HH39	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HHQ0	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HHS3	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HHT4	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HI32	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HI85	Disease;Infectious disease;HCMV Infection;HCMV Early Events
F5HI87	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HIG1	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F5HIN9	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
F7V995	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F7V996	Disease;Infectious disease;HCMV Infection;HCMV Late Events
F7V999	Disease;Infectious disease;HCMV Infection;HCMV Early Events
O00115	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Vesicle-mediated transport
O00116	Metabolism;Metabolism of lipids;Plasmalogen biosynthesis;Wax and plasmalogen biosynthesis;Peroxisomal protein import;TYSND1 cleaves peroxisomal proteins;Protein localization
O00139	Hemostasis;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Vesicle-mediated transport;RHO GTPases Activate Formins;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;EML4 and NUDC in mitotic spindle formation;Kinesins;Factors involved in megakaryocyte development and platelet production
O00141	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Generic Transcription Pathway;Stimuli-sensing channels;Transcriptional Regulation by TP53;Transport of small molecules;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;Ion channel transport
O00142	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage
O00144	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
O00148	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
O00154	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
O00155	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O00159-3	Epigenetic regulation of gene expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Gene expression (Transcription)
O00159	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Disease;Innate Immune System;Immune System;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
O00161	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Neutrophil degranulation;Class I MHC mediated antigen processing & presentation
O00167	DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair
O00168	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
O00170	Cytokine Signaling in Immune system;Metabolism;Immune System;Biological oxidations;Phase I - Functionalization of compounds;Interleukin-12 family signaling;Signaling by Interleukins;Aryl hydrocarbon receptor signalling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
O00180	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
O00182	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling
O00186	Hemostasis;Disinhibition of SNARE formation;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O00187-1	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Ficolins bind to repetitive carbohydrate structures on the target cell surface
O00189	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Vesicle-mediated transport
O00194	Hemostasis;Platelet degranulation ;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
O00203	Disease;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
O00204-1	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O00204-2	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O00206	Apoptosis;ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Caspase activation via Death Receptors in the presence of ligand;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF-mediated programmed cell death;Diseases of Immune System;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Regulation of TLR by endogenous ligand;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Class I MHC mediated antigen processing & presentation
O00212	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;RHO GTPases Activate Formins
O00213	DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair
O00217	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O00219	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan biosynthesis and export;Metabolism of carbohydrates
O00220	Apoptosis;Hemostasis;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Regulation by c-FLIP;Transcriptional Regulation by TP53;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;Regulation of necroptotic cell death;TP53 Regulates Transcription of Death Receptors and Ligands;Dimerization of procaspase-8;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);TRAIL  signaling
O00221	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Adaptive Immune System;Immune System;Signaling by the B Cell Receptor (BCR)
O00222	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
O00230	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O00231	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O00232	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O00233	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O00237	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
O00238	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
O00241	Cell-Cell communication;Innate Immune System;Immune System;DAP12 interactions;Signal regulatory protein family interactions;Neutrophil degranulation
O00244	Innate Immune System;Immune System;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Antimicrobial peptides;Ion influx/efflux at host-pathogen interface;Cellular responses to external stimuli
O00253	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
O00254	Hemostasis;Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;Thrombin signalling through proteinase activated receptors (PARs);GPCR ligand binding;Platelet activation, signaling and aggregation
O00255	Signal Transduction;Signaling by TGF-beta Receptor Complex;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Deactivation of the beta-catenin transactivating complex;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;RHO GTPases activate IQGAPs;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein phosphorylation;Signaling by TGF-beta family members
O00257	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers
O00258	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
O00264	Innate Immune System;Immune System;Neutrophil degranulation
O00267	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;mRNA Capping;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
O00268	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
O00270	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Free fatty acid receptors;GPCR ligand binding
O00273	Apoptosis;Apoptosis induced DNA fragmentation;Programmed Cell Death;Apoptotic execution phase
O00291	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
O00292	Hemostasis;Platelet degranulation ;Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O00300	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
O00303	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
O00305	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;NCAM signaling for neurite out-growth;Muscle contraction;NCAM1 interactions;Axon guidance;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Nervous system development
O00308	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus
O00311	Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Mitotic G1 phase and G1/S transition;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
O00327	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids
O00329	PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Disease;Synthesis of PIPs at the plasma membrane;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Axon guidance;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RET signaling;Signaling by Erythropoietin;Intracellular signaling by second messengers;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Interleukin receptor SHC signaling;Regulation of signaling by CBL;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
O00330	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Glyoxylate metabolism and glycine degradation;Signaling by Retinoic Acid;Pyruvate metabolism;Metabolism of amino acids and derivatives;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
O00337	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
O00338	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O00341	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Glutamate Neurotransmitter Release Cycle;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
O00391	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
O00398	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;GPCR ligand binding
O00399	Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
O00400	Disease;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Defective SLC33A1 causes spastic paraplegia 42 (SPG42);SLC transporter disorders;Disorders of transmembrane transporters
O00401	Developmental Biology;Metabolism;Cell-Cell communication;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Metabolism of nitric oxide: eNOS activation and regulation;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;NOSTRIN mediated eNOS trafficking;EPH-Ephrin signaling;Netrin-1 signaling;Nephrin family interactions;EPHB-mediated forward signaling;DCC mediated attractive signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
O00408	Hemostasis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects;G alpha (s) signalling events
O00410	Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;vRNP Assembly;Infectious disease
O00411	Mitochondrial biogenesis;Mitochondrial transcription initiation;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Gene expression (Transcription);Transcription from mitochondrial promoters
O00418	Signal Transduction;mTOR signalling;mTORC1-mediated signalling
O00421	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR ligand binding
O00422	Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
O00425	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA;Metabolism of RNA
O00429	Apoptosis;Programmed Cell Death;Apoptotic execution phase
O00443	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Metabolism of lipids;Vesicle-mediated transport;Clathrin-mediated endocytosis
O00444	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O00445	Metabolism;Integration of energy metabolism;Regulation of insulin secretion
O00451	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
O00459	Hemostasis;PI3K Cascade;IRS-mediated signalling;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by SCF-KIT;PI Metabolism;Phospholipid metabolism;Cell-Cell communication;Signal Transduction;Disease;Synthesis of PIPs at the plasma membrane;Signaling by NTRKs;Innate Immune System;Immune System;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signaling by VEGF;Signaling by Rho GTPases;Rho GTPase cycle;PI3K/AKT activation;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Tie2 Signaling;DAP12 interactions;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;Signaling by GPCR;Nephrin family interactions;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;G alpha (q) signalling events;Axon guidance;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;RET signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Interleukin receptor SHC signaling;Regulation of signaling by CBL;FLT3 Signaling;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development
O00461	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
O00462	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Metabolism of carbohydrates;Lysosomal oligosaccharide catabolism
O00468	Developmental Biology;Metabolism;Extracellular matrix organization;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Integrin cell surface interactions;Visual phototransduction;Non-integrin membrane-ECM interactions;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;NCAM signaling for neurite out-growth;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;NCAM1 interactions;Axon guidance;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Nervous system development;Retinoid metabolism and transport
O00469	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
O00470	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
O00471	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
O00472	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
O00476	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
O00478	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
O00481	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
O00482-1	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in early pancreatic precursor cells;Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O00482-2	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
O00482-3	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O00482	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
O00483	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
O00487	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O00499	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
O00501	Cell-Cell communication;Generic Transcription Pathway;Tight junction interactions;Cell-cell junction organization;Cell junction organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates expression of components of tight junctions
O00505	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Disease;Influenza Infection;Immune System;NS1 Mediated Effects on Host Pathways;Infectious disease;Interferon Signaling
O00512	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Deactivation of the beta-catenin transactivating complex
O00519	Metabolism;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
O00533	Developmental Biology;L1CAM interactions;Axon guidance;CHL1 interactions;Nervous system development
O00541	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O00548	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;MECP2 regulates transcription of neuronal ligands
O00555	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Metabolism;Integration of energy metabolism;Regulation of insulin secretion
O00559	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
O00560	Developmental Biology;Innate Immune System;Immune System;EPH-Ephrin signaling;L1CAM interactions;Ephrin signaling;Axon guidance;Neurofascin interactions;Neutrophil degranulation;Nervous system development
O00562	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PI;Phospholipid metabolism;Metabolism of lipids
O00566	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O00567	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O00571	Innate Immune System;Immune System;Neutrophil degranulation
O00574	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O00584	Innate Immune System;Immune System;Neutrophil degranulation
O00585	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O00587	Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing
O00590	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR ligand binding
O00602	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Ficolins bind to repetitive carbohydrate structures on the target cell surface;Neutrophil degranulation
O00622	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
O00623	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Peroxisomal protein import;Class I peroxisomal membrane protein import;Protein localization
O00625	Digestion;Digestion and absorption
O00626	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling
O00628	Peroxisomal protein import;Protein localization
O00629	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Disease;Influenza Infection;Immune System;NS1 Mediated Effects on Host Pathways;Infectious disease;Interferon Signaling
O00631	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
O00634	Developmental Biology;Myogenesis
O00635	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
O00712	RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation
O00716	Signaling by NOTCH;Signal Transduction;Cell Cycle;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;CDC6 association with the ORC:origin complex;Assembly of the pre-replicative complex;G2 Phase;DNA Replication Pre-Initiation;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;DNA Replication;Cellular responses to external stimuli
O00743	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
O00744	Developmental Biology;Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Transcriptional regulation of white adipocyte differentiation;GPCR ligand binding
O00746	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
O00748	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
O00750	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
O00754	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Metabolism of carbohydrates;Lysosomal oligosaccharide catabolism
O00755	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
O00757	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
O00762	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Metabolism of proteins;Regulation of mitotic cell cycle;Post-translational protein modification;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Protein ubiquitination;Transcriptional Regulation by VENTX;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O00763	Metabolism;Integration of energy metabolism;ChREBP activates metabolic gene expression;Regulation of cholesterol biosynthesis by SREBP (SREBF);Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Carnitine metabolism;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism
O00764	Metabolism;Innate Immune System;Immune System;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Neutrophil degranulation;Vitamins B6 activation to pyridoxal phosphate
O00767	Metabolism;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism of steroids;Fatty acid metabolism;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
O05442	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Escape of Mtb from the phagocyte;Phagocyte cell death caused by cytosolic Mtb
O14490	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
O14492	Hemostasis;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Signaling by Receptor Tyrosine Kinases;Factors involved in megakaryocyte development and platelet production
O14493	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
O14494	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O14495	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O14497	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
O14498	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O14503	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
O14508	Interleukin-7 signaling;Cytokine Signaling in Immune system;Immune System;Metabolism of proteins;Signaling by Interleukins;Post-translational protein modification;Neddylation;Growth hormone receptor signaling
O14511	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;GRB7 events in ERBB2 signaling;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
O14520	Transport of small molecules;Transport of glycerol from adipocytes to the liver by Aquaporins;Passive transport by Aquaporins;Aquaporin-mediated transport
O14521	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
O14526	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
O14531	Developmental Biology;Semaphorin interactions;CRMPs in Sema3A signaling;Axon guidance;Nervous system development
O14543	Interleukin-6 signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Immune System;Generic Transcription Pathway;Signaling by Leptin;Metabolism of proteins;Signaling by Interleukins;Post-translational protein modification;Interleukin-6 family signaling;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon gamma signaling;Regulation of IFNG signaling;Signaling by PTK6;PTK6 Activates STAT3;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes;Neddylation;Signaling by Non-Receptor Tyrosine Kinases;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;Growth hormone receptor signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O14544	Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Metabolism of proteins;Post-translational protein modification;Neddylation;Signaling by Receptor Tyrosine Kinases
O14548	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
O14556	Metabolism;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
O14559	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
O14561	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Glyoxylate metabolism and glycine degradation;Metabolism of lipids;Respiratory electron transport;Complex I biogenesis;Metabolism of amino acids and derivatives;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
O14576	Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Autophagy;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy
O14578-3	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate CIT
O14578	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate CIT
O14579	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
O14581	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O14594	Developmental Biology;Metabolism;Extracellular matrix organization;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;CS/DS degradation;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective CHST3 causes SEDCJD;Defective CHST14 causes EDS, musculocontractural type;Defective CHSY1 causes TPBS;L1CAM interactions;NCAM signaling for neurite out-growth;Diseases of glycosylation;NCAM1 interactions;Axon guidance;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of carbohydrates;Nervous system development
O14595	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
O14607	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
O14610	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
O14613	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
O14618	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
O14625	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O14628	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O14633	Developmental Biology;Keratinization;Formation of the cornified envelope
O14638	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
O14639	Developmental Biology;Netrin-1 signaling;DCC mediated attractive signaling;Axon guidance;Nervous system development
O14640	Signal Transduction;Disease;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Beta-catenin independent WNT signaling;PCP/CE pathway;Degradation of DVL;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Negative regulation of TCF-dependent signaling by DVL-interacting proteins;Infectious disease;RHO GTPases Activate Formins;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
O14641	Signal Transduction;Disease;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;Membrane Trafficking;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Signaling by Hippo;Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins;Degradation of DVL;Disassembly of the destruction complex and recruitment of AXIN to the membrane;WNT5A-dependent internalization of FZD4;Negative regulation of TCF-dependent signaling by DVL-interacting proteins;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
O14646	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
O14649	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK-releated acid-sensitive K+ channel (TASK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
O14653	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
O14654	Signal Transduction;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Signaling by Receptor Tyrosine Kinases
O14656	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
O14657	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
O14662	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
O14672	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Signaling by NOTCH;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by EGFR;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;EPH-Ephrin signaling;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;EPH-ephrin mediated repulsion of cells;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Neutrophil degranulation;Post-translational protein phosphorylation;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Nervous system development;Amyloid fiber formation
O14678	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of metabolism;Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)
O14684	Metabolism;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism
O14686	Developmental Biology;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Deactivation of the beta-catenin transactivating complex;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
O14709	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O14717	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
O14718	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding
O14727	Apoptosis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Activation of caspases through apoptosome-mediated cleavage;Cytochrome c-mediated apoptotic response;SMAC (DIABLO) binds to IAPs ;SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;Innate Immune System;Immune System;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;Neutrophil degranulation;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6;Regulation of the apoptosome activity
O14730	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O14732	Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
O14733	Cytokine Signaling in Immune system;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Cellular Senescence;FCERI mediated MAPK activation;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease;Cellular responses to external stimuli;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
O14734	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;alpha-linolenic acid (ALA) metabolism;Beta-oxidation of pristanoyl-CoA;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
O14735	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PI;Phospholipid metabolism;Metabolism of lipids
O14744	snRNP Assembly;Metabolism of non-coding RNA;Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
O14746	Telomere Maintenance;Signal Transduction;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Chromosome Maintenance
O14756	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O14757	Signaling by SCF-KIT;Signal Transduction;Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;TP53 Regulates Transcription of DNA Repair Genes;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;Transcriptional Regulation by E2F6;Signaling by Receptor Tyrosine Kinases
O14763	Apoptosis;Hemostasis;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Regulation by c-FLIP;Transcriptional Regulation by TP53;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;Regulation of necroptotic cell death;TP53 Regulates Transcription of Death Receptors and Ligands;Dimerization of procaspase-8;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);TRAIL  signaling
O14771	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O14772	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;GDP-fucose biosynthesis
O14773	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
O14775-1	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O14775	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
O14777	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
O14782	Hemostasis;Adaptive Immune System;Immune System;Organelle biogenesis and maintenance;Membrane Trafficking;MHC class II antigen presentation;Cilium Assembly;Intraflagellar transport;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
O14786	Developmental Biology;Signal Transduction;Signaling by VEGF;Neurophilin interactions with VEGF and VEGFR;Semaphorin interactions;L1CAM interactions;Signaling by ROBO receptors;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Axon guidance;Signal transduction by L1;CHL1 interactions;Signaling by Receptor Tyrosine Kinases;Nervous system development
O14788	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
O14791	Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Post-translational protein phosphorylation
O14792	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
O14793	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
O14795	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle
O14796	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O14798	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Death Receptors and Ligands;RNA Polymerase II Transcription;Gene expression (Transcription)
O14802	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
O14804	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O14810	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;GABA synthesis, release, reuptake and degradation
O14815	Degradation of the extracellular matrix;Extracellular matrix organization
O14818	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O14827	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Death Receptor Signalling;FLT3 Signaling
O14829	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O14832	Metabolism;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;TYSND1 cleaves peroxisomal proteins;Protein localization
O14836	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
O14841	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Disease;Glutathione synthesis and recycling;Biological oxidations;Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
O14842	Metabolism;Signal Transduction;Integration of energy metabolism;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);GPCR downstream signalling;Metabolism of proteins;Free fatty acids regulate insulin secretion;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);G alpha (q) signalling events;Regulation of insulin secretion;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Free fatty acid receptors;GPCR ligand binding
O14843	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;Free fatty acid receptors;GPCR ligand binding
O14862	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The AIM2 inflammasome
O14874	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
O14879	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
O14880	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations;Aflatoxin activation and detoxification
O14893	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
O14896	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
O14904	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Negative regulation of TCF-dependent signaling by WNT ligand antagonists;GPCR ligand binding
O14905	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
O14907	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Rhotekin and Rhophilins
O14910	Neurotransmitter release cycle;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Dopamine Neurotransmitter Release Cycle;Activation of NMDA receptors and postsynaptic events;Neurexins and neuroligins;Protein-protein interactions at synapses;Assembly and cell surface presentation of NMDA receptors
O14920	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;TCR signaling;Downstream TCR signaling;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;Diseases of Immune System;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Diseases associated with the TLR signaling cascade;IKBKB deficiency causes SCID;IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR);IkBA variant leads to EDA-ID;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);MAP3K8 (TPL2)-dependent MAPK1/3 activation;Death Receptor Signalling;TNF signaling;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O14921	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events
O14924	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O14925	Mitochondrial protein import;Protein localization
O14929	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
O14931	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O14933	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Termination of translesion DNA synthesis;DNA Damage Bypass;DNA Repair;Interferon Signaling;Negative regulators of DDX58/IFIH1 signaling;Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O14936	Neurotransmitter release cycle;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Extracellular matrix organization;Cell-Cell communication;Dopamine Neurotransmitter Release Cycle;Syndecan interactions;Non-integrin membrane-ECM interactions;Nephrin family interactions;Activation of NMDA receptors and postsynaptic events;Neurexins and neuroligins;Protein-protein interactions at synapses;Assembly and cell surface presentation of NMDA receptors
O14939	Metabolism;Synthesis of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism of lipids
O14944	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;Membrane Trafficking;EGFR interacts with phospholipase C-gamma;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Downregulation of ERBB2 signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
O14949	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
O14950	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Semaphorin interactions;EPHA-mediated growth cone collapse;Muscle contraction;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Smooth Muscle Contraction;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Nervous system development
O14957	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
O14958	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
O14964	Signal Transduction;Disease;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Metabolism of proteins;Lysosome Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases;Endosomal Sorting Complex Required For Transport (ESCRT);Infection with Mycobacterium tuberculosis;Inhibition of membrane repair;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
O14965	Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Generic Transcription Pathway;Regulation of PLK1 Activity at G2/M Transition;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;SUMOylation of DNA replication proteins;Regulation of TP53 Activity;Post-translational protein modification;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Regulation of TP53 Activity through Phosphorylation;G2/M Transition;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;AURKA Activation by TPX2;Interaction between PHLDA1 and AURKA
O14966	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
O14974	Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Regulation of PLK1 Activity at G2/M Transition;Mitotic G2-G2/M phases;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;G2/M Transition;Cell Cycle, Mitotic
O14975	Metabolism;Innate Immune System;Immune System;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Bile acid and bile salt metabolism;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism of lipids;Neutrophil degranulation;Metabolism of steroids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
O14976	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Clathrin-mediated endocytosis
O14977	Metabolism;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Metabolism of amino acids and derivatives
O14978	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O14979	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
O14980	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Export of Viral Ribonucleoproteins from Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Signaling by TGF-beta Receptor Complex;Interactions of Rev with host cellular proteins;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Deactivation of the beta-catenin transactivating complex;HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Infectious disease;RHO GTPases Activate Formins;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by TGF-beta family members;Extra-nuclear estrogen signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;EML4 and NUDC in mitotic spindle formation
O14983	Hemostasis;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
O14986	PIP3 activates AKT signaling;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Signaling by WNT;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Metabolism of lipids;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
O14994	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle
O15013	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
O15020	Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;L1CAM interactions;NCAM signaling for neurite out-growth;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;FLT3 Signaling;Nervous system development
O15027	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
O15033	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O15041	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
O15042	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O15047	Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
O15054	Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;Cellular responses to external stimuli
O15055	Circadian Clock
O15056	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Membrane Trafficking;Metabolism of lipids;Vesicle-mediated transport;Clathrin-mediated endocytosis
O15066	Hemostasis;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Immune System;Organelle biogenesis and maintenance;Membrane Trafficking;MHC class II antigen presentation;Cilium Assembly;Intraflagellar transport;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
O15067	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
O15068	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
O15072	Extracellular matrix organization;Collagen formation;Disease;Collagen biosynthesis and modifying enzymes;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
O15078	Cell Cycle;Innate Immune System;Immune System;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Neutrophil degranulation;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O15084	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
O15085	Developmental Biology;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;Sema4D in semaphorin signaling;G alpha (12/13) signalling events;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Death Receptor Signalling;Nervous system development
O15091	tRNA processing in the mitochondrion;tRNA modification in the mitochondrion;tRNA processing;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
O15105	Signal Transduction;Signaling by TGF-beta Receptor Complex;Signaling by BMP;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Metabolism of proteins;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
O15111	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;ER-Phagosome pathway;Antigen processing-Cross presentation;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;AKT phosphorylates targets in the cytosol;TCR signaling;Downstream TCR signaling;PI3K/AKT Signaling in Cancer;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;Diseases of Immune System;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Diseases associated with the TLR signaling cascade;IKBKB deficiency causes SCID;IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR);IkBA variant leads to EDA-ID;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Diseases of signal transduction by growth factor receptors and second messengers;TNFR2 non-canonical NF-kB pathway;Constitutive Signaling by AKT1 E17K in Cancer;NIK-->noncanonical NF-kB signaling;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Death Receptor Signalling;TNF signaling;Intracellular signaling by second messengers;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O15116	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Metabolism of RNA
O15117	Adaptive Immune System;Cell-Cell communication;Immune System;TCR signaling;Generation of second messenger molecules;Signal regulatory protein family interactions
O15118	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;LDL clearance;Plasma lipoprotein clearance
O15120	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Metabolism of lipids;Neutrophil degranulation
O15121	Metabolism;Sphingolipid de novo biosynthesis;Innate Immune System;Immune System;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation
O15123	Hemostasis;Cell surface interactions at the vascular wall;Tie2 Signaling
O15126	Innate Immune System;Immune System;Neutrophil degranulation
O15130	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
O15131	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Disease;Influenza Infection;Immune System;NS1 Mediated Effects on Host Pathways;Infectious disease;Interferon Signaling
O15143	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
O15144	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
O15145	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
O15146	Extracellular matrix organization;ECM proteoglycans
O15151	Cell Cycle;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli
O15155	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification
O15160	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase III Chain Elongation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
O15164	Signaling by FGFR in disease;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
O15169	Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT;Generic Transcription Pathway;Metabolism of proteins;Degradation of AXIN;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates estrogen receptor mediated transcription;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in WNT signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
O15181	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O15197	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
O15198	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
O15205	Metabolism of proteins;Post-translational protein modification;Neddylation
O15212	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins
O15213	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O15217	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
O15228	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids;Plasmalogen biosynthesis;Wax and plasmalogen biosynthesis;Peroxisomal protein import;Protein localization
O15229	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
O15230	Cytokine Signaling in Immune system;Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Immune System;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
O15232	Extracellular matrix organization;ECM proteoglycans;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
O15234	Developmental Biology;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signaling by ROBO receptors;Axon guidance;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
O15235	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
O15239	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O15240	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
O15244	Neurotransmitter release cycle;Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Metabolism;Norepinephrine Neurotransmitter Release Cycle;Abacavir transmembrane transport;Abacavir transport and metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Organic cation transport;Organic cation/anion/zwitterion transport
O15245	Neurotransmitter release cycle;Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Metabolism;Norepinephrine Neurotransmitter Release Cycle;Abacavir transmembrane transport;Abacavir transport and metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Organic cation transport;Organic cation/anion/zwitterion transport
O15247	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
O15254	Metabolism;Beta-oxidation of pristanoyl-CoA;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
O15259	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
O15260	Innate Immune System;Immune System;Membrane Trafficking;Vesicle-mediated transport;Neutrophil degranulation;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
O15263	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
O15264	Developmental Biology;Signal Transduction;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;p38MAPK events;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;Netrin-1 signaling;DSCAM interactions;Axon guidance;VEGFA-VEGFR2 Pathway;Signaling by Receptor Tyrosine Kinases;Nervous system development
O15265	HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
O15269	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O15270	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O15273	Striated Muscle Contraction;Muscle contraction
O15287	Fanconi Anemia Pathway;DNA Repair
O15294	HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;UCH proteinases;Post-translational protein modification
O15296	Metabolism;Arachidonic acid metabolism;Synthesis of 15-eicosatetraenoic acid derivatives;Metabolism of lipids;Fatty acid metabolism
O15297	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2
O15303	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
O15305	Disease;Diseases of glycosylation;Metabolism of proteins;Defective PMM2 causes PMM2-CDG (CDG-1a);Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of GDP-mannose;Synthesis of substrates in N-glycan biosythesis;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
O15315	Hemostasis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;DNA Repair;Factors involved in megakaryocyte development and platelet production
O15318	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
O15327	Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of IP2, IP, and Ins in the cytosol;Metabolism of lipids
O15342	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
O15344	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
O15350	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;TP53 Regulates Transcription of Caspase Activators and Caspases;TP53 Regulates Transcription of Death Receptors and Ligands;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs
O15354	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O15357	Cytokine Signaling in Immune system;Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Immune System;Synthesis of IP3 and IP4 in the cytosol;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Interleukin receptor SHC signaling
O15360	Fanconi Anemia Pathway;DNA Repair
O15371	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
O15372	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
O15379	PIP3 activates AKT signaling;Developmental Biology;NR1D1 (REV-ERBA) represses gene expression;Metabolism;Signaling by NOTCH;Mitochondrial biogenesis;Signal Transduction;Disease;Organelle biogenesis and maintenance;p75NTR negatively regulates cell cycle via SC1;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;PPARA activates gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Transcriptional regulation of white adipocyte differentiation;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;PTEN Regulation;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Regulation of PTEN gene transcription;Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Loss of MECP2 binding ability to the NCoR/SMRT complex;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;HCMV Infection;HCMV Early Events;Disorders of developmental biology
O15382	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
O15389	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
O15392	Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Generic Transcription Pathway;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Signaling by Interleukins;SUMOylation of DNA replication proteins;TP53 Regulates Transcription of Cell Death Genes;RHO GTPases Activate Formins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Neddylation;EML4 and NUDC in mitotic spindle formation
O15397	Gene Silencing by RNA;Transcriptional regulation by small RNAs;Gene expression (Transcription)
O15399	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation
O15427	Hemostasis;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Cell surface interactions at the vascular wall;Basigin interactions;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Proton-coupled monocarboxylate transport;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
O15431	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters
O15438	Metabolism;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of lipids;Metabolism of steroids
O15439	Hemostasis;Platelet degranulation ;Transport of small molecules;ABC-family proteins mediated transport;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O15440	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan biosynthesis and export;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of carbohydrates
O15444	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O15446	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
O15455	ZBP1(DAI) mediated induction of type I IFNs;Disease;Trafficking and processing of endosomal TLR;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;RIP-mediated NFkB activation via ZBP1;Cytosolic sensors of pathogen-associated DNA ;Diseases of Immune System;Diseases associated with the TLR signaling cascade;TLR3 deficiency - HSE;UNC93B1 deficiency - HSE;TICAM1 deficiency - HSE;TRAF3 deficiency - HSE;TLR3-mediated TICAM1-dependent programmed cell death;TICAM1-dependent activation of IRF3/IRF7;TICAM1,TRAF6-dependent induction of TAK1 complex
O15457	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
O15460	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
O15466	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
O15467	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O15484	Degradation of the extracellular matrix;Extracellular matrix organization
O15488	Metabolism;Disease;Glycogen storage diseases;Glycogen synthesis;Glycogen storage disease type 0 (liver GYS2);Glycogen storage disease type IV (GBE1);Diseases of carbohydrate metabolism;Diseases of metabolism;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
O15492	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events
O15496	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
O15498	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
O15503	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Metabolism of lipids;Metabolism of steroids
O15504	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
O15511	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Neutrophil degranulation;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
O15514	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
O15516	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;PPARA activates gene expression;HATs acetylate histones;Chromatin modifying enzymes;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids
O15519-1	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Regulation by c-FLIP;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Regulation of necroptotic cell death
O15519-2	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Regulation of necroptotic cell death;Dimerization of procaspase-8
O15519	Signal Transduction;Death Receptor Signalling;TRAIL  signaling
O15520	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Regulation of beta-cell development;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR1b ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;Activated point mutants of FGFR2;Regulation of gene expression in early pancreatic precursor cells;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR2 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
O15524	Interleukin-7 signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Interferon gamma signaling;Regulation of IFNG signaling;Signaling by Receptor Tyrosine Kinases;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;Growth hormone receptor signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O15525	Hemostasis;Factors involved in megakaryocyte development and platelet production
O15527-4	Recognition and association of DNA glycosylase with site containing an affected purine;Disease;Base Excision Repair;DNA Repair;Depurination;Base-Excision Repair, AP Site Formation;Diseases of Base Excision Repair;Defective Base Excision Repair Associated with OGG1;Defective OGG1 Localization;Diseases of DNA repair
O15527	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Displacement of DNA glycosylase by APEX1;Disease;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;Base Excision Repair;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Diseases of Base Excision Repair;Defective Base Excision Repair Associated with OGG1;Defective OGG1 Substrate Binding;Defective OGG1 Substrate Processing;Diseases of DNA repair
O15528	Metabolism;Disease;Vitamin D (calciferol) metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Vitamins;Phase I - Functionalization of compounds;Metabolism of lipids;Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
O15530	Hemostasis;PI3K Cascade;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;IRS-mediated signalling;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Activation of AKT2;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;TCR signaling;Downstream TCR signaling;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated NF-kB activation;Integrin signaling;Transcriptional Regulation by TP53;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;RSK activation;VEGFR2 mediated vascular permeability;VEGFR2 mediated cell proliferation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);RHO GTPases activate PKNs;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription);Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;FLT3 Signaling;Estrogen-stimulated signaling through PRKCZ
O15533	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
O15534	Circadian Clock
O15539	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events
O15540	Metabolism;Signaling by NOTCH;Signal Transduction;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
O15547	Hemostasis;Elevation of cytosolic Ca2+ levels;Platelet homeostasis;Platelet calcium homeostasis
O15550	Developmental Biology;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
O15551	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
O15552	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;Free fatty acid receptors;GPCR ligand binding
O15553	Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Infectious disease;Inflammasomes;The NLRP3 inflammasome;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
O15554	Neuronal System;Ca2+ activated K+ channels;Potassium Channels
O33321	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Modulation by Mtb of host immune system
O43143	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O43148	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;Transcription of the HIV genome;Infectious disease;mRNA Capping;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
O43151	Epigenetic regulation of gene expression;TET1,2,3 and TDG demethylate DNA;Gene expression (Transcription)
O43155	Signal Transduction;Signaling by FGFR;Downstream signaling of activated FGFR1;Signaling by FGFR1;Signaling by Receptor Tyrosine Kinases
O43157	Developmental Biology;Signal Transduction;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;Sema4D in semaphorin signaling;G alpha (12/13) signalling events;Sema4D mediated inhibition of cell attachment and migration;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Nervous system development
O43159	Epigenetic regulation of gene expression;SIRT1 negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
O43164	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O43166	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
O43169	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
O43172	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O43173	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
O43174	Metabolism;Signal Transduction;Biological oxidations;Cytochrome P450 - arranged by substrate type;Vitamins;Phase I - Functionalization of compounds;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
O43175	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
O43181	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O43182	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
O43184	Extracellular matrix organization;Signal Transduction;Signaling by EGFR;Invadopodia formation;Signaling by Receptor Tyrosine Kinases
O43187	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Interleukin-1 signaling;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane
O43189	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Gene expression (Transcription)
O43193	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
O43194	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O43196	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
O43236-6	Apoptosis;Intrinsic Pathway for Apoptosis;Release of apoptotic factors from the mitochondria;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;Programmed Cell Death
O43237	Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Autophagy;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy
O43242	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O43251	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases
O43252	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Glycosaminoglycan metabolism;Disease;Transport and synthesis of PAPS;Biological oxidations;Selenoamino acid metabolism;Metabolism of ingested H2SeO4 and H2SeO3 into H2Se;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Metabolism of amino acids and derivatives;Metabolism of carbohydrates
O43255	Developmental Biology;Adaptive Immune System;Immune System;Netrin-1 signaling;Metabolism of proteins;Axon guidance;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Nervous system development;Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O43264	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Vesicle-mediated transport;RHO GTPases Activate Formins;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;EML4 and NUDC in mitotic spindle formation
O43272	Metabolism;Proline catabolism;Metabolism of amino acids and derivatives
O43278	Signal Transduction;Signaling by MET;MET Receptor Activation;Signaling by MST1;Signaling by Receptor Tyrosine Kinases
O43280	Digestion of dietary carbohydrate;Digestion;Digestion and absorption
O43286	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;Asparagine N-linked glycosylation;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
O43290	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O43291	Signal Transduction;Signaling by MET;MET Receptor Activation;Signaling by MST1;Signaling by Receptor Tyrosine Kinases
O43292	Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O43293	Apoptosis;Caspase activation via Dependence Receptors in the absence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death
O43295	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by ROBO receptors;Axon guidance;Inactivation of CDC42 and RAC1;Nervous system development
O43296	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O43300	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
O43301	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
O43303	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O43306	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;Adrenaline,noradrenaline inhibits insulin secretion;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
O43307	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling;GABA receptor activation
O43314	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol
O43315	Transport of small molecules;Transport of glycerol from adipocytes to the liver by Aquaporins;Passive transport by Aquaporins;Aquaporin-mediated transport
O43316	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
O43318	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by WNT;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Beta-catenin independent WNT signaling;Metabolism of proteins;Ca2+ pathway;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;TNFR1-induced NFkappaB signaling pathway;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Alpha-protein kinase 1 signaling pathway;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane;Signaling by the B Cell Receptor (BCR)
O43320	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
O43323	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding;Hedgehog ligand biogenesis;Signaling by Hedgehog;Release of Hh-Np from the secreting cell;Hh mutants abrogate ligand secretion;Ligand-receptor interactions;Hedgehog 'on' state;Activation of SMO;HHAT G278V abrogates palmitoylation of Hh-Np;Diseases of signal transduction by growth factor receptors and second messengers
O43324	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
O43345	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O43347	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of expression of SLITs and ROBOs;Nervous system development
O43353	Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;TCR signaling;Downstream TCR signaling;p75NTR recruits signalling complexes;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Death Receptor Signalling;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
O43361	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O43364	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Regulation of expression of SLITs and ROBOs;Nervous system development
O43365	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
O43374	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
O43390	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O43395	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O43426	Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of IP2, IP, and Ins in the cytosol;Synthesis of IP3 and IP4 in the cytosol;Membrane Trafficking;Metabolism of lipids;Vesicle-mediated transport;Clathrin-mediated endocytosis
O43432	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
O43447	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O43448	Neuronal System;Potassium Channels;Voltage gated Potassium channels
O43451	Innate Immune System;Immune System;Digestion of dietary carbohydrate;Neutrophil degranulation;Digestion;Digestion and absorption
O43462	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Plasma lipoprotein assembly, remodeling, and clearance;ATF6 (ATF6-alpha) activates chaperones;Unfolded Protein Response (UPR);Transport of small molecules;Metabolism of proteins;Metabolism of lipids;CREB3 factors activate genes;Metabolism of steroids;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
O43463	Epigenetic regulation of gene expression;PKMTs methylate histone lysines;Chromatin modifying enzymes;SIRT1 negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
O43474	Developmental Biology;Generic Transcription Pathway;Peptide hormone metabolism;Transcriptional regulation of white adipocyte differentiation;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin;Transcriptional regulation of pluripotent stem cells;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
O43482	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
O43488	Metabolism;Biological oxidations;Aflatoxin activation and detoxification
O43491	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
O43493	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Post-translational protein modification;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Post-translational protein phosphorylation
O43497	Developmental Biology;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Nervous system development
O43502	Hemostasis;Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;DNA Repair;Meiotic recombination;Factors involved in megakaryocyte development and platelet production
O43504	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
O43505	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective LARGE causes MDDGA6 and MDDGB6;O-linked glycosylation;Diseases of metabolism;Post-translational protein modification;Metabolism of carbohydrates
O43506	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
O43508	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
O43511	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers;Defective SLC26A4 causes Pendred syndrome (PDS);SLC transporter disorders;Disorders of transmembrane transporters
O43513	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
O43516	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
O43520	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
O43521	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BIM and translocation to mitochondria ;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation of BH3-only proteins;Signal Transduction;Disease;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Generic Transcription Pathway;Programmed Cell Death;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Transcriptional regulation by RUNX3;RUNX3 regulates BCL2L11 (BIM) transcription;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes;Diseases of programmed cell death
O43524	Signaling by NODAL;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;AKT phosphorylates targets in the nucleus;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Transcriptional regulation by RUNX3;ESR-mediated signaling;RUNX3 regulates BCL2L11 (BIM) transcription;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;FOXO-mediated transcription of cell death genes;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Regulation of FOXO transcriptional activity by acetylation;FOXO-mediated transcription of cell cycle genes;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Diseases of programmed cell death
O43525	Neuronal System;Developmental Biology;Potassium Channels;Voltage gated Potassium channels;L1CAM interactions;Axon guidance;Interaction between L1 and Ankyrins;Nervous system development
O43526	Neuronal System;Developmental Biology;Potassium Channels;Voltage gated Potassium channels;L1CAM interactions;Axon guidance;Interaction between L1 and Ankyrins;Nervous system development
O43529	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
O43541	Signal Transduction;Signaling by BMP;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates bone development;Signaling by TGF-beta family members
O43542	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;DNA Repair
O43543	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;DNA Repair
O43548	Developmental Biology;Keratinization;Formation of the cornified envelope
O43555	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
O43557	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
O43559	Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Immune System;Signaling by FGFR;Downstream signaling of activated FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;FRS-mediated FGFR2 signaling;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through FRS2 and FRS3;FLT3 Signaling
O43561-2	Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
O43561	Hemostasis;GPVI-mediated activation cascade;Adaptive Immune System;Immune System;TCR signaling;Generation of second messenger molecules;Platelet activation, signaling and aggregation
O43566	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O43570	Metabolism;Reversible hydration of carbon dioxide
O43572	Hemostasis;Factors involved in megakaryocyte development and platelet production
O43581	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
O43586	Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Infectious disease;Inflammasomes;The NLRP3 inflammasome;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
O43592	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
O43597	Spry regulation of FGF signaling;Signal Transduction;Signaling by EGFR;EGFR downregulation;Signaling by FGFR;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by Receptor Tyrosine Kinases
O43598	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism
O43602	Developmental Biology;L1CAM interactions;Axon guidance;Neurofascin interactions;Nervous system development
O43603	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O43609	Signal Transduction;Signaling by EGFR;EGFR downregulation;Signaling by Receptor Tyrosine Kinases
O43612	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
O43613	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
O43614	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
O43615	Mitochondrial protein import;Protein localization
O43617	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
O43623	PIP3 activates AKT signaling;Signal Transduction;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers
O43633	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Lysosome Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
O43639	Developmental Biology;Cell-Cell communication;Signal Transduction;Downstream signal transduction;Signaling by PDGF;Signaling by VEGF;EPH-Ephrin signaling;Nephrin family interactions;Signaling by ROBO receptors;Ephrin signaling;Axon guidance;Activation of RAC1;VEGFA-VEGFR2 Pathway;Regulation of cortical dendrite branching;Signaling by Receptor Tyrosine Kinases;Nervous system development
O43653	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O43660	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O43663	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate CIT
O43665	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O43674	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O43676	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O43677	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O43678	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O43681	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
O43683	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
O43684	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Amplification of signal from the kinetochores;Inactivation of APC/C via direct inhibition of the APC/C complex;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
O43688	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O43699	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O43704	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O43707	Hemostasis;Platelet degranulation ;Cell-Cell communication;Nephrin family interactions;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O43708	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Regulation of pyruvate dehydrogenase (PDH) complex;Biological oxidations;Pyruvate metabolism;Metabolism of amino acids and derivatives;Pyruvate metabolism and Citric Acid (TCA) cycle;Tyrosine catabolism;Phenylalanine and tyrosine metabolism
O43709	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O43715	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
O43731	ER to Golgi Anterograde Transport;Membrane Trafficking;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
O43739	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
O43741	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Mitochondrial biogenesis;Signal Transduction;Macroautophagy;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism;mTOR signalling;Organelle biogenesis and maintenance;Membrane Trafficking;Carnitine metabolism;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Metabolism of lipids;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Fatty acid metabolism;Autophagy;Lipophagy;Activation of AMPK downstream of NMDARs;Selective autophagy
O43747	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease
O43749	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O43752	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
O43759	Innate Immune System;Immune System;Neutrophil degranulation
O43765	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
O43766	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives
O43768	Cell Cycle;MASTL Facilitates Mitotic Progression;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
O43772	Metabolism;Carnitine metabolism;Metabolism of lipids;Fatty acid metabolism
O43776	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
O43790	Developmental Biology;Keratinization;Formation of the cornified envelope
O43791	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state
O43805	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O43808	Metabolism;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Class I peroxisomal membrane protein import;Protein localization
O43809	mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
O43815	PIP3 activates AKT signaling;Signal Transduction;Disease;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Signaling by PDGFR in disease;Signaling by cytosolic PDGFRA and PDGFRB fusion proteins
O43818	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O43819	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
O43820	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;CS/DS degradation;Hyaluronan metabolism;Hyaluronan uptake and degradation;Metabolism of carbohydrates
O43825	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
O43826	Metabolism;Disease;Glycogen storage diseases;Glycogen storage disease type Ib (SLC37A4);Diseases of carbohydrate metabolism;Diseases of metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
O43837	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
O43852	Hemostasis;Platelet degranulation ;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
O43861	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
O43865	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Adaptive Immune System;Metabolism;DAG and IP3 signaling;Signal Transduction;Integration of energy metabolism;Disease;Innate Immune System;Immune System;Signaling by VEGF;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;GPCR downstream signalling;Muscle contraction;G alpha (i) signalling events;Regulation of insulin secretion;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Cardiac conduction;Ion homeostasis;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Infectious disease;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
O43868	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
O43869	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O43889	Unfolded Protein Response (UPR);Metabolism of proteins;CREB3 factors activate genes
O43895	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O43896	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
O43897	Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Anchoring fibril formation;Crosslinking of collagen fibrils
O43903	Apoptosis;Apoptotic cleavage of cellular proteins;Caspase-mediated cleavage of cytoskeletal proteins;Programmed Cell Death;Apoptotic execution phase
O43909	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
O43913	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Assembly of the ORC complex at the origin of replication;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
O43914	Developmental Biology;Adaptive Immune System;Cell-Cell communication;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;DAP12 signaling;Semaphorin interactions;Signal regulatory protein family interactions;Other semaphorin interactions;Axon guidance;Neutrophil degranulation;Nervous system development
O43915	Hemostasis;Platelet degranulation ;Signal Transduction;Signaling by VEGF;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by Receptor Tyrosine Kinases
O43916	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of carbohydrates
O43920	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O43921	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
O43924	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;ARL13B-mediated ciliary trafficking of INPP5E
O43927	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O43929	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Assembly of the ORC complex at the origin of replication;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
O43933	Peroxisomal protein import;Protein localization
O50393	Disease;Infectious disease;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis
O53361	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of autophagy;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
O53533	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
O53692	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Inhibition of membrane repair;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
O53971	Disease;Infectious disease;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis
O60216	Meiotic synapsis;Reproduction;Meiosis;Signal Transduction;Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
O60218	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
O60220	Mitochondrial protein import;Protein localization
O60229	Developmental Biology;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;EPH-Ephrin signaling;Signaling by GPCR;GPCR downstream signalling;EPHB-mediated forward signaling;G alpha (q) signalling events;G alpha (12/13) signalling events;Axon guidance;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Death Receptor Signalling;Nervous system development
O60231	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O60234	Innate Immune System;Immune System;Neutrophil degranulation
O60237-4	Cell Cycle;Regulation of PLK1 Activity at G2/M Transition;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic
O60237	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs
O60238	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
O60240	Developmental Biology;Metabolism;Signal Transduction;Triglyceride catabolism;Transcriptional regulation of white adipocyte differentiation;Metabolism of lipids;Triglyceride metabolism;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose
O60243	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
O60244	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
O60245	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O60258-1	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3b ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
O60259	Developmental Biology;Keratinization;Formation of the cornified envelope
O60260	Adaptive Immune System;Macroautophagy;Immune System;Metabolism of proteins;Mitophagy;Pink/Parkin Mediated Mitophagy;Deubiquitination;Josephin domain DUBs;Post-translational protein modification;Autophagy;Aggrephagy;Selective autophagy;Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O60262	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
O60264	Cell Cycle;Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;DNA Repair;Gene expression (Transcription);Nucleosome assembly
O60266	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
O60271	Developmental Biology;Myogenesis
O60282	Insulin processing;Peptide hormone metabolism;Metabolism of proteins
O60285	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription)
O60291	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O60294	tRNA modification in the nucleus and cytosol;Synthesis of wybutosine at G37 of tRNA(Phe);tRNA processing;Metabolism of RNA
O60304	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O60306	Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;DNA Repair;Metabolism of RNA
O60312	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
O60313	Apoptosis;Regulation of Apoptosis;Programmed Cell Death
O60331	PIP3 activates AKT signaling;Developmental Biology;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Negative regulation of the PI3K/AKT network;Membrane Trafficking;Semaphorin interactions;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Axon guidance;Metabolism of lipids;Vesicle-mediated transport;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Clathrin-mediated endocytosis;Intracellular signaling by second messengers;Nervous system development
O60333	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
O60337	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
O60341	Hemostasis;PIP3 activates AKT signaling;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;HDACs deacetylate histones;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;PTEN Regulation;ESR-mediated signaling;Regulation of PTEN gene transcription;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;Factors involved in megakaryocyte development and platelet production
O60343	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport
O60346	PIP3 activates AKT signaling;Signal Transduction;Negative regulation of the PI3K/AKT network;Intracellular signaling by second messengers
O60353	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;Ca2+ pathway;PCP/CE pathway;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;GPCR ligand binding;RNF mutants show enhanced WNT signaling and proliferation;Diseases of signal transduction by growth factor receptors and second messengers
O60359	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;LGI-ADAM interactions
O60361	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
O60391	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of NMDA receptors and postsynaptic events;Assembly and cell surface presentation of NMDA receptors
O60403	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O60404	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O60412	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O60422	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;Regulation of gene expression in early pancreatic precursor cells
O60423	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
O60427	Metabolism;PPARA activates gene expression;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Fatty acid metabolism
O60431	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O60437	Developmental Biology;Adaptive Immune System;Immune System;Keratinization;Formation of the cornified envelope;Butyrophilin (BTN) family interactions
O60462	Developmental Biology;Signal Transduction;Signaling by VEGF;Neurophilin interactions with VEGF and VEGFR;L1CAM interactions;Axon guidance;NrCAM interactions;Signaling by Receptor Tyrosine Kinases;Nervous system development
O60469	Developmental Biology;Netrin-1 signaling;DSCAM interactions;Axon guidance;Nervous system development
O60476	Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification;N-glycan trimming and elongation in the cis-Golgi;Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2
O60481	Developmental Biology;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Transcriptional regulation of pluripotent stem cells
O60486	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
O60488	Metabolism;Integration of energy metabolism;Free fatty acids regulate insulin secretion;Regulation of insulin secretion;Intracellular metabolism of fatty acids regulates insulin secretion;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
O60493	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
O60494	Metabolism;Disease;Plasma lipoprotein assembly, remodeling, and clearance;Cobalamin (Cbl, vitamin B12) transport and metabolism;Vitamin D (calciferol) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective AMN causes hereditary megaloblastic anemia 1;Defective CUBN causes hereditary megaloblastic anemia 1;Transport of small molecules;Metabolism of lipids;Diseases of metabolism;Metabolism of steroids;HDL clearance;Plasma lipoprotein clearance
O60496	Hemostasis;Developmental Biology;Cell surface interactions at the vascular wall;Tie2 Signaling;Axon guidance;RET signaling;Nervous system development
O60499	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
O60500	Cell-Cell communication;Nephrin family interactions
O60503	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
O60504	Muscle contraction;Smooth Muscle Contraction
O60507	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O60508	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
O60512	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
O60513	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
O60522	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
O60542	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
O60543	Metabolism;Metabolism of lipids;Lipid particle organization
O60547	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;GDP-fucose biosynthesis
O60551	Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Infectious disease
O60563	Formation of RNA Pol II elongation complex ;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Signaling by TGF-beta Receptor Complex;Interactions of Tat with host cellular proteins;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by TGF-beta family members;Estrogen-dependent gene expression
O60566	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Amplification of signal from the kinetochores;Inactivation of APC/C via direct inhibition of the APC/C complex;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
O60568	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
O60573	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
O60583	Formation of RNA Pol II elongation complex ;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Transcription of the HIV genome;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Signaling by TGF-beta family members
O60602	Disease;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR5);IRAK4 deficiency (TLR5);MyD88 cascade initiated on plasma membrane
O60603	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Beta defensins;Defensins;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Infectious disease;Regulation of TLR by endogenous ligand;Neutrophil degranulation;Antimicrobial peptides;Infection with Mycobacterium tuberculosis;Modulation by Mtb of host immune system;Class I MHC mediated antigen processing & presentation
O60609	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
O60610	Signaling by ERBB2;Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins;ERBB2 Regulates Cell Motility;Neutrophil degranulation;Signaling by Receptor Tyrosine Kinases
O60641	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
O60645	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
O60656	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;PPARA activates gene expression;Biological oxidations;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
O60658	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events
O60662	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O60664	Metabolism;Macroautophagy;Triglyceride catabolism;Membrane Trafficking;Metabolism of lipids;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Triglyceride metabolism;Autophagy;Lipophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Selective autophagy
O60669	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Proton-coupled monocarboxylate transport
O60671	Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
O60673	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA Damage Bypass;DNA Repair
O60674	Interleukin-6 signaling;Hemostasis;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;Prolactin receptor signaling;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signal Transduction;Cell Cycle;Disease;Immune System;Signaling by Leptin;RMTs methylate histone arginines;Chromatin modifying enzymes;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-2 family signaling;Mitotic G1 phase and G1/S transition;Chromatin organization;Interleukin-3, Interleukin-5 and GM-CSF signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-6 family signaling;Interleukin-4 and Interleukin-13 signaling;IL-6-type cytokine receptor ligand interactions;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;Interferon gamma signaling;Regulation of IFNG signaling;Interleukin-20 family signaling;Interleukin-35 Signalling;Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Interleukin-12 signaling;Interleukin-23 signaling;Interleukin-27 signaling;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Erythropoietin activates Phospholipase C gamma (PLCG);Erythropoietin activates STAT5;Erythropoietin activates RAS;Interleukin receptor SHC signaling;Interferon Signaling;FLT3 Signaling;Signaling downstream of RAS mutants;Growth hormone receptor signaling;Factors involved in megakaryocyte development and platelet production
O60675	Hemostasis;Factors involved in megakaryocyte development and platelet production
O60678	RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Post-translational protein modification;Protein methylation
O60683	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Peroxisomal protein import;Protein localization
O60701	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Formation of the active cofactor, UDP-glucuronate;Biological oxidations
O60704	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O60706	Neuronal System;ATP sensitive Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Disease;Transport of small molecules;ABC-family proteins mediated transport;Muscle contraction;Cardiac conduction;Ion homeostasis;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia
O60716	Cell-Cell communication;Signal Transduction;Disease;Signaling by VEGF;Adherens junctions interactions;Cell-cell junction organization;VEGFA-VEGFR2 Pathway;Cell junction organization;VEGFR2 mediated vascular permeability;Infectious disease;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells;Signaling by Receptor Tyrosine Kinases
O60721	Signal Transduction;Disease;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D);SLC transporter disorders;Disorders of transmembrane transporters
O60725	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Post-translational protein modification
O60729	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
O60733	Metabolism;Acyl chain remodelling of PC;Acyl chain remodeling of CL;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism of lipids;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
O60741	Neuronal System;HCN channels;Potassium Channels
O60749	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
O60755	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O60760	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism
O60762	Synthesis of dolichyl-phosphate mannose;Post-translational modification: synthesis of GPI-anchored proteins;Disease;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective DPM1 causes DPM1-CDG (CDG-1e);Defective DPM3 causes DPM3-CDG (CDG-1o);Defective DPM2 causes DPM2-CDG (CDG-1u);Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
O60763	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Transport to the Golgi and subsequent modification
O60765	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O60779	Metabolism;Vitamin B1 (thiamin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
O60783	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
O60784	Innate Immune System;Immune System;Neutrophil degranulation
O60814	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
O60825	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
O60826	Metabolism of proteins;Post-translational protein modification;Neddylation
O60828	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O60830	Mitochondrial protein import;Protein localization
O60832	Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;rRNA modification in the nucleus and cytosol;rRNA processing;Chromosome Maintenance;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O60840	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
O60841	Metabolism of proteins;Eukaryotic Translation Initiation;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
O60858	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
O60870	Metabolism of proteins;Post-translational protein modification;Protein methylation
O60879-2	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins
O60879-3	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins
O60880	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O60882	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures
O60883	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
O60884	Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular responses to external stimuli
O60890	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
O60894	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O60895	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O60896	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O60906	Metabolism;Signal Transduction;Glycosphingolipid metabolism;Ceramide signalling;p75 NTR receptor-mediated signalling;Sphingolipid metabolism;Metabolism of lipids;TNFR1-mediated ceramide production;Death Receptor Signalling;TNF signaling
O60907	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Signaling by NOTCH;Mitochondrial biogenesis;Signal Transduction;Disease;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;Signaling by NOTCH1;PPARA activates gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Signaling by Nuclear Receptors;Loss of MECP2 binding ability to the NCoR/SMRT complex;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;HCMV Infection;HCMV Early Events;Disorders of developmental biology
O60909	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
O60911	Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Adaptive Immune System;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Activation of Matrix Metalloproteinases;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Assembly of collagen fibrils and other multimeric structures;Generic Transcription Pathway;MHC class II antigen presentation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes;Class I MHC mediated antigen processing & presentation
O60921	Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
O60925	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins
O60931	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Miscellaneous transport and binding events
O60934	Reproduction;Meiosis;Cell Cycle;Generic Transcription Pathway;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through MMEJ (alt-NHEJ);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Sensing of DNA Double Strand Breaks;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Nonhomologous End-Joining (NHEJ);Homologous DNA Pairing and Strand Exchange;DNA Double Strand Break Response;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Cellular responses to external stimuli;Meiotic recombination
O60938	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Keratan sulfate degradation;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Defective ST3GAL3 causes MCT12 and EIEE15;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
O60939	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
O60942	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;Transcription of the HIV genome;Infectious disease;mRNA Capping;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
O69622	Disease;Infectious disease;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis
O69623	Disease;Infectious disease;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis
O75015	Post-translational modification: synthesis of GPI-anchored proteins;Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation
O75019	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O75022	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
O75023	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O75027	Mitochondrial ABC transporters;Metabolism;Cytosolic iron-sulfur cluster assembly;Transport of small molecules;ABC-family proteins mediated transport
O75030	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;Post-translational protein modification
O75037	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
O75038	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
O75044	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Signaling by ROBO receptors;Axon guidance;Inactivation of CDC42 and RAC1;RHO GTPases Activate Formins;Nervous system development
O75051	Developmental Biology;Semaphorin interactions;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Other semaphorin interactions;Axon guidance;Nervous system development
O75056	Hemostasis;Metabolism;Extracellular matrix organization;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Cell surface interactions at the vascular wall;Visual phototransduction;Syndecan interactions;Non-integrin membrane-ECM interactions;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport
O75061	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Clathrin-mediated endocytosis
O75064	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
O75077	Developmental Biology;LGI-ADAM interactions
O75078	Developmental Biology;LGI-ADAM interactions
O75083	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O75084	Signal Transduction;Disease;Signaling by WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins;GPCR ligand binding;Infectious disease;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
O75093	Developmental Biology;Netrin-1 signaling;Signaling by ROBO receptors;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Regulation of cortical dendrite branching;Regulation of expression of SLITs and ROBOs;Nervous system development
O75094	Developmental Biology;Netrin-1 signaling;Signaling by ROBO receptors;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Nervous system development
O75096	Extracellular matrix organization;ECM proteoglycans
O75106	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
O75110	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
O75116	Developmental Biology;Signal Transduction;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;EPHB-mediated forward signaling;EPHA-mediated growth cone collapse;Sema4D in semaphorin signaling;G alpha (12/13) signalling events;Sema4D induced cell migration and growth-cone collapse;Axon guidance;VEGFA-VEGFR2 Pathway;RHO GTPases Activate ROCKs;Signaling by Receptor Tyrosine Kinases;Nervous system development
O75122	Developmental Biology;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Signaling by ROBO receptors;Axon guidance;Role of ABL in ROBO-SLIT signaling;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation;Nervous system development
O75131	Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Metabolism of lipids;Neutrophil degranulation
O75140	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
O75143	Macroautophagy;Autophagy
O75144	Adaptive Immune System;Immune System;Costimulation by the CD28 family
O75145	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
O75146	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Clathrin-mediated endocytosis
O75147	Metabolism of proteins;Post-translational protein modification;Neddylation
O75150	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
O75151	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
O75152	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
O75154	Organelle biogenesis and maintenance;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
O75159	Cytokine Signaling in Immune system;Immune System;Metabolism of proteins;Signaling by Interleukins;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Neddylation
O75161	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hippo;Cilium Assembly;Anchoring of the basal body to the plasma membrane
O75164	Signal Transduction;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
O75165	Innate Immune System;Immune System;Neutrophil degranulation
O75167	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O75173	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
O75175	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
O75182-1	Metabolism;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
O75182	Epigenetic regulation of gene expression;Generic Transcription Pathway;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
O75185	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
O75190	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
O75191	Metabolism;Formation of xylulose-5-phosphate;Metabolism of carbohydrates
O75192	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
O75197	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling;RNF mutants show enhanced WNT signaling and proliferation;Diseases of signal transduction by growth factor receptors and second messengers
O75208	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
O75223	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations
O75251	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O75306	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O75310	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
O75311	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
O75317	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
O75326	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
O75330	Metabolism;Glycosaminoglycan metabolism;Cell Cycle;Hyaluronan metabolism;Hyaluronan uptake and degradation;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;Metabolism of carbohydrates;AURKA Activation by TPX2
O75334	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
O75335	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
O75339	Signal Transduction;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);Signaling by Receptor Tyrosine Kinases
O75342	Metabolism;Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
O75343	Hemostasis;Nitric oxide stimulates guanylate cyclase;Muscle contraction;Platelet homeostasis;Smooth Muscle Contraction
O75344	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
O75346	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75347	Post-chaperonin tubulin folding pathway;Protein folding;Metabolism of proteins
O75348	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
O75351	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT)
O75352	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective MPDU1 causes MPDU1-CDG (CDG-1f);Diseases of metabolism;Post-translational protein modification
O75354	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism
O75355	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism
O75356	Metabolism;Metabolism of nucleotides;Disease;Infectious disease;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
O75362	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
O75369	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
O75373	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75376	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;NR1D1 (REV-ERBA) represses gene expression;Metabolism;Signaling by NOTCH;Mitochondrial biogenesis;Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Organelle biogenesis and maintenance;Signaling by NOTCH1;PPARA activates gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Transcriptional regulation of white adipocyte differentiation;Nuclear Receptor transcription pathway;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;Loss of MECP2 binding ability to the NCoR/SMRT complex;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;HCMV Infection;HCMV Early Events;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis;Disorders of developmental biology
O75379	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
O75380	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O75381	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Peroxisomal protein import;Class I peroxisomal membrane protein import;Protein localization
O75382	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
O75385	Macroautophagy;Membrane Trafficking;Mitophagy;Vesicle-mediated transport;TBC/RABGAPs;RAB GEFs exchange GTP for GDP on RABs;Receptor Mediated Mitophagy;Rab regulation of trafficking;Autophagy;Selective autophagy
O75386	Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
O75387	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
O75388	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O75390	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;Protein localization
O75394	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
O75396	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation
O75400	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O75417	HDR through MMEJ (alt-NHEJ);DNA Double-Strand Break Repair;Homology Directed Repair;DNA Repair
O75419	Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;DNA strand elongation;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
O75431	Mitochondrial protein import;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation;Protein localization
O75436	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking
O75437	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75438	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O75439	Mitochondrial protein import;Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1;Protein localization
O75443	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O75444	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development
O75446	Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
O75448	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
O75452	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
O75460	IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
O75461	Cell Cycle;Generic Transcription Pathway;Mitotic G1 phase and G1/S transition;G1/S-Specific Transcription;G1/S Transition;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
O75462	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions;Interleukin-27 signaling
O75467	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75469-1	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
O75469-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75469-3	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75469-4	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75469-5	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75469-6	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75469-7	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75473	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination
O75474	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT;Disassembly of the destruction complex and recruitment of AXIN to the membrane
O75475	HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;2-LTR circle formation;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated nuclear import of PICs;Infectious disease
O75477	Disease;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective CFTR causes cystic fibrosis
O75478	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
O75486	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
O75487	Metabolism;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Visual phototransduction;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport
O75489	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O75494	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O75496	Cell Cycle;Mitotic G1 phase and G1/S transition;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Cell Cycle, Mitotic;DNA Replication
O75506	Cellular responses to stress;HSF1 activation;Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Cellular responses to external stimuli
O75508	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
O75509	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
O75521-2	Metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
O75525	Signal Transduction;Signaling by PTK6;PTK6 Regulates Proteins Involved in RNA Processing;Signaling by Non-Receptor Tyrosine Kinases
O75528	HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
O75529	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
O75530	PIP3 activates AKT signaling;Developmental Biology;Signal Transduction;Disease;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Infectious disease;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers;HCMV Infection;HCMV Early Events
O75531	HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;2-LTR circle formation;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated nuclear import of PICs;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Infectious disease;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
O75533	Epigenetic regulation of gene expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Gene expression (Transcription);Metabolism of RNA
O75553	Developmental Biology;Axon guidance;Reelin signalling pathway;Nervous system development
O75554	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O75563	Cell-Cell communication;Signal regulatory protein family interactions
O75569	MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Small interfering RNA (siRNA) biogenesis;Gene expression (Transcription)
O75575	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
O75578	Hemostasis;Developmental Biology;Extracellular matrix organization;Integrin cell surface interactions;L1CAM interactions;Axon guidance;CHL1 interactions;Platelet Adhesion to exposed collagen;Nervous system development
O75581	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;RNF mutants show enhanced WNT signaling and proliferation;Diseases of signal transduction by growth factor receptors and second messengers
O75582	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;CREB phosphorylation;L1CAM interactions;NCAM signaling for neurite out-growth;Axon guidance;Recycling pathway of L1;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
O75586	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
O75593	Signaling by NODAL;Developmental Biology;Signaling by Activin;Signal Transduction;Signaling by TGF-beta family members
O75594	Innate Immune System;Immune System;Neutrophil degranulation;Antimicrobial peptides
O75600	Metabolism;Metabolism of amino acids and derivatives;Threonine catabolism
O75604	Signal Transduction;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Regulation of TP53 Activity;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);TNF signaling
O75608	Metabolism;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation
O75610	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL
O75616	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
O75626	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Expression;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription)
O75629	Innate Immune System;Immune System;Neutrophil degranulation
O75636	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Ficolins bind to repetitive carbohydrate structures on the target cell surface
O75643	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O75648	tRNA modification in the mitochondrion;tRNA processing;Metabolism of RNA
O75665	Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O75676	Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Nervous system development
O75688	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
O75689	Signaling by ERBB4;Nuclear signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases
O75690	Developmental Biology;Keratinization
O75691	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O75694	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
O75695	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;Trafficking of myristoylated proteins to the cilium
O75712	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
O75715	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
O75718	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
O75746	Mitochondrial protein import;Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of amino acids and derivatives;Metabolism of carbohydrates;Aspartate and asparagine metabolism;Protein localization
O75747	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the Golgi membrane;Metabolism of lipids
O75751	Metabolism;Abacavir transmembrane transport;Abacavir transport and metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport
O75752	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
O75762	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
O75771	Generic Transcription Pathway;Transcriptional Regulation by TP53;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
O75787	Innate Immune System;Immune System;Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins;Neutrophil degranulation
O75791	Adaptive Immune System;Signaling by SCF-KIT;Signal Transduction;Innate Immune System;Immune System;TCR signaling;Generation of second messenger molecules;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Costimulation by the CD28 family;CD28 co-stimulation;Signaling by Receptor Tyrosine Kinases
O75795	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
O75807	Signal Transduction;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Cellular responses to stress;Cellular responses to external stimuli;Signaling by TGF-beta family members;Response of EIF2AK1 (HRI) to heme deficiency
O75808	Degradation of the extracellular matrix;Extracellular matrix organization
O75817	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
O75818	tRNA processing in the nucleus;Major pathway of rRNA processing in the nucleolus and cytosol;tRNA processing;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O75820	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O75821	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
O75822	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
O75828	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
O75832	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
O75843	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Vesicle-mediated transport
O75845	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Cholesterol biosynthesis via desmosterol;Cholesterol biosynthesis via lathosterol;Metabolism of steroids
O75865	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
O75874	Metabolism;Disease;Innate Immune System;Immune System;Metabolism of vitamins and cofactors;Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate;NADPH regeneration;Diseases of metabolism;Neutrophil degranulation;Metabolism of cofactors;Peroxisomal protein import;Protein localization
O75880	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
O75881	Metabolism;Disease;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
O75886	Signal Transduction;Disease;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Infectious disease;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases;Endosomal Sorting Complex Required For Transport (ESCRT)
O75888	Cytokine Signaling in Immune system;Immune System;HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;Metabolism of RNA
O75891	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
O75897	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O75899	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
O75907	Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Metabolism of lipids;Neutrophil degranulation;Triglyceride biosynthesis;Triglyceride metabolism
O75908	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;LDL clearance;Plasma lipoprotein clearance
O75909	Formation of RNA Pol II elongation complex ;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Transcription of the HIV genome;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Signaling by TGF-beta family members
O75911	Signal Transduction;The retinoid cycle in cones (daylight vision);Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
O75912	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
O75914	Developmental Biology;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;TCR signaling;Generation of second messenger molecules;EPH-Ephrin signaling;Semaphorin interactions;Signaling by ROBO receptors;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent Vav1 pathway;Ephrin signaling;Sema3A PAK dependent Axon repulsion;Axon guidance;Activation of RAC1;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;RHO GTPases activate PAKs;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Signaling by Receptor Tyrosine Kinases;Nervous system development
O75915	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Glutamate Neurotransmitter Release Cycle
O75916-3	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O75916	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;G alpha (i) signalling events;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
O75923	Muscle contraction;Smooth Muscle Contraction
O75925	Cytokine Signaling in Immune system;Immune System;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;SUMOylation of ubiquitinylation proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of intracellular receptors;SUMOylation of chromatin organization proteins;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair;Interferon gamma signaling;Regulation of IFNG signaling;Interferon Signaling
O75928-1	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;SUMOylation of ubiquitinylation proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification
O75928-2	SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of intracellular receptors;SUMOylation of chromatin organization proteins;Post-translational protein modification
O75928	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
O75934	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O75935	Adaptive Immune System;Cell Cycle;Immune System;Organelle biogenesis and maintenance;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Regulation of PLK1 Activity at G2/M Transition;HSP90 chaperone cycle for steroid hormone receptors (SHR);Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
O75936	Metabolism;Carnitine synthesis;Metabolism of amino acids and derivatives
O75937	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O75940	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O75943	Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
O75947	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
O75955	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
O75962	Developmental Biology;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;Netrin-1 signaling;GPCR downstream signalling;G alpha (q) signalling events;G alpha (12/13) signalling events;DCC mediated attractive signaling;Axon guidance;Death Receptor Signalling;Nervous system development
O75964	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
O75971	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter
O75976	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
O76000	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O76001	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O76002	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O76003	Transport of small molecules;Iron uptake and transport
O76009	Developmental Biology;Keratinization;Formation of the cornified envelope
O76011	Developmental Biology;Keratinization;Formation of the cornified envelope
O76013	Developmental Biology;Keratinization;Formation of the cornified envelope
O76014	Developmental Biology;Keratinization;Formation of the cornified envelope
O76015	Developmental Biology;Keratinization;Formation of the cornified envelope
O76024	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
O76036	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O76050	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus
O76061	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
O76062	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
O76064	Cell Cycle;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
O76071	Metabolism;Cytosolic iron-sulfur cluster assembly
O76074	Hemostasis;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
O76075	Apoptosis;Apoptosis induced DNA fragmentation;Programmed Cell Death;Apoptotic execution phase
O76081	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;G alpha (z) signalling events
O76082	Metabolism;Disease;Carnitine metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport;Metabolism of lipids;Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP);SLC transporter disorders;Disorders of transmembrane transporters;Fatty acid metabolism
O76083	Hemostasis;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
O76090	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
O76093	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3b ligand binding and activation;FGFR3c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR3 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
O76094	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
O76099	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O76100	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O94759	Innate Immune System;Immune System;Stimuli-sensing channels;TRP channels;Transport of small molecules;Neutrophil degranulation;Ion channel transport
O94760	Metabolism;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation
O94766	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Diseases associated with glycosaminoglycan metabolism;Defective B3GAT3 causes JDSSDHD;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
O94772	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O94776	PIP3 activates AKT signaling;Signal Transduction;Epigenetic regulation of gene expression;Generic Transcription Pathway;HDACs deacetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
O94777	Synthesis of dolichyl-phosphate mannose;Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Disease;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective DPM1 causes DPM1-CDG (CDG-1e);Defective DPM3 causes DPM3-CDG (CDG-1o);Defective DPM2 causes DPM2-CDG (CDG-1u);Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
O94778	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Transport of small molecules;Passive transport by Aquaporins;Aquaporin-mediated transport;Cellular responses to external stimuli
O94779	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O94782	Recognition of DNA damage by PCNA-containing replication complex;Fanconi Anemia Pathway;DNA Damage Bypass;DNA Repair
O94788	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
O94804	Innate Immune System;Immune System;Neutrophil degranulation
O94805	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
O94806	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O94808	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
O94810	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;G alpha (i) signalling events;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
O94813	Developmental Biology;Netrin-1 signaling;Signaling by ROBO receptors;Axon guidance;Activation of RAC1;Regulation of commissural axon pathfinding by SLIT and ROBO;Inactivation of CDC42 and RAC1;Role of ABL in ROBO-SLIT signaling;SLIT2:ROBO1 increases RHOA activity;Regulation of expression of SLITs and ROBOs;Nervous system development
O94817	Macroautophagy;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Mitophagy;Pink/Parkin Mediated Mitophagy;Receptor Mediated Mitophagy;Negative regulators of DDX58/IFIH1 signaling;Autophagy;Selective autophagy
O94822	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O94823	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
O94826	Mitochondrial protein import;Macroautophagy;Metabolism of proteins;Mitophagy;Pink/Parkin Mediated Mitophagy;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Protein localization;Autophagy;Selective autophagy
O94827	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
O94830	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
O94844	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
O94855	Adaptive Immune System;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;Metabolism of proteins;Asparagine N-linked glycosylation;Metabolism of lipids;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Metabolism of steroids;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
O94856	Developmental Biology;Innate Immune System;Immune System;L1CAM interactions;Axon guidance;Interaction between L1 and Ankyrins;Neurofascin interactions;Neutrophil degranulation;Nervous system development
O94864	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
O94874	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O94886	Innate Immune System;Immune System;Neutrophil degranulation
O94887	Developmental Biology;Semaphorin interactions;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Axon guidance;Nervous system development
O94888	Metabolism of proteins;Post-translational protein modification;Neddylation
O94892	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O94901	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
O94905	Signaling by FGFR in disease;Disease;FGFR1 mutant receptor activation;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Defective CFTR causes cystic fibrosis;Signaling by plasma membrane FGFR1 fusions
O94906	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O94907	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Signaling by WNT in cancer;Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling;Diseases of signal transduction by growth factor receptors and second messengers
O94911	Transport of small molecules;ABC-family proteins mediated transport
O94913	RNA polymerase II transcribes snRNA genes;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
O94919	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
O94923	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
O94925	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Metabolism;Glutamate Neurotransmitter Release Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Glutamate and glutamine metabolism
O94927	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O94929	Developmental Biology;Netrin-1 signaling;DCC mediated attractive signaling;Axon guidance;Nervous system development
O94933	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
O94941	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O94952	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O94953	Signal Transduction;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
O94955	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
O94956-3	Metabolism;Metabolism of porphyrins;Heme degradation
O94956	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of organic anions
O94966	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
O94972	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O94973-3	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
O94973	Developmental Biology;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Signaling by NTRKs;Nef Mediated CD4 Down-regulation;Innate Immune System;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;Signaling by NTRK1 (TRKA);Signaling by WNT;Membrane Trafficking;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;Transport of small molecules;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;PCP/CE pathway;Axon guidance;Recycling pathway of L1;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Neutrophil degranulation;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDLR internalisation and degradation;LDL clearance;Plasma lipoprotein clearance;Signaling by Receptor Tyrosine Kinases;Nervous system development
O94979	Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
O94986	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O94988	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
O94989	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
O94991	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
O95006	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95007	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95013	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95045	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Pyrimidine catabolism;Nucleobase catabolism;Nucleotide salvage
O95047	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95050	Metabolism;Selenoamino acid metabolism;Methylation of MeSeH for excretion;Metabolism of amino acids and derivatives
O95059	tRNA processing in the nucleus;Major pathway of rRNA processing in the nucleolus and cytosol;tRNA processing;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
O95067	Polo-like kinase mediated events;Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Resolution of Sister Chromatid Cohesion;Condensation of Prometaphase Chromosomes;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope Breakdown;Activation of NIMA Kinases NEK9, NEK6, NEK7;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Nuclear Pore Complex (NPC) Disassembly;Mitotic G2-G2/M phases;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA replication checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint
O95069	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK related potassium channel (TREK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
O95070	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
O95072	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
O95084	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
O95096	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
O95125	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O95136	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding
O95139	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O95140	Hemostasis;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Autophagy;Selective autophagy;Factors involved in megakaryocyte development and platelet production
O95149	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
O95150	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
O95153	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Metabolism;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Metabolism of steroid hormones;Pregnenolone biosynthesis;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Metabolism of lipids;Metabolism of steroids
O95154	Metabolism;Biological oxidations;Aflatoxin activation and detoxification
O95163	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
O95166	Macroautophagy;Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking;Autophagy
O95167	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O95168	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O95169	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis;Protein localization
O95178	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O95180	Developmental Biology;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Nervous system development
O95182	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O95185	Developmental Biology;Netrin-1 signaling;Netrin mediated repulsion signals;Axon guidance;Nervous system development
O95190	Metabolism;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Metabolism of amino acids and derivatives
O95196	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;CS/DS degradation;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective CHST3 causes SEDCJD;Defective CHST14 causes EDS, musculocontractural type;Defective CHSY1 causes TPBS;Diseases of glycosylation;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of carbohydrates
O95197	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
O95198	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O95201	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O95202	Transport of small molecules;Mitochondrial calcium ion transport
O95208	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
O95210	Innate Immune System;Immune System;Neutrophil degranulation
O95221	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95222	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95229	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
O95231	Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli
O95235	Hemostasis;Adaptive Immune System;Cell Cycle;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Telophase/Cytokinesis;M Phase;Cell Cycle, Mitotic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
O95237	Metabolism;Signal Transduction;Disease;Metabolism of vitamins and cofactors;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Diseases of the neuronal system;Retinoid metabolism and transport
O95239	Hemostasis;Developmental Biology;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;L1CAM interactions;Axon guidance;Recycling pathway of L1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
O95243	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Displacement of DNA glycosylase by APEX1;Base Excision Repair;DNA Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites)
O95248	Metabolism;Synthesis of PIPs at the ER membrane;PI Metabolism;Phospholipid metabolism;Membrane Trafficking;Metabolism of lipids;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
O95249	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
O95251	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
O95255	Disease;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCC6 causes pseudoxanthoma elasticum (PXE)
O95256	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-18 signaling
O95258	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial Uncoupling;The fatty acid cycling model;The proton buffering model
O95259	Neuronal System;Potassium Channels;Voltage gated Potassium channels
O95263	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events
O95264	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
O95267	Hemostasis;Effects of PIP2 hydrolysis;Downstream signaling events of B Cell Receptor (BCR);Activation of RAS in B cells;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Integrin signaling;Signaling by GPCR;GPCR downstream signalling;Rap1 signalling;G alpha (q) signalling events;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);FLT3 Signaling;Signaling by the B Cell Receptor (BCR)
O95271	PIP3 activates AKT signaling;Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Metabolism of proteins;Degradation of AXIN;Signaling by WNT in cancer;XAV939 inhibits tankyrase, stabilizing AXIN;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers
O95274	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O95278	Metabolism;Disease;Glycogen storage diseases;Glycogen synthesis;Myoclonic epilepsy of Lafora;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates;Glycogen metabolism
O95279	Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
O95292	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O95294	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
O95295	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
O95298	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Innate Immune System;Immune System;Respiratory electron transport;Neutrophil degranulation;Complex I biogenesis
O95299	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O95302	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins
O95336	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates
O95340	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Glycosaminoglycan metabolism;Disease;Transport and synthesis of PAPS;Biological oxidations;Selenoamino acid metabolism;Metabolism of ingested H2SeO4 and H2SeO3 into H2Se;Diseases associated with glycosaminoglycan metabolism;Defective PAPSS2 causes SEMD-PA;Diseases of glycosylation;Diseases of metabolism;Metabolism of amino acids and derivatives;Metabolism of carbohydrates
O95342	Metabolism;Recycling of bile acids and salts;Disease;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of lipids;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2;Metabolism of steroids
O95347	Cell Cycle;Condensation of Prophase Chromosomes;Condensation of Prometaphase Chromosomes;Mitotic Prophase;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic
O95352	Adaptive Immune System;Macroautophagy;Disease;Innate Immune System;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;Neutrophil degranulation;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Autophagy;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O95363	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
O95371	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95372	Developmental Biology;L1CAM interactions;Axon guidance;Nervous system development
O95376	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O95377	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
O95379	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids
O95391	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
O95393	Extracellular matrix organization;Elastic fibre formation;Signal Transduction;Signaling by BMP;Molecules associated with elastic fibres;Signaling by TGF-beta family members
O95394	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
O95395	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
O95396	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
O95398	Hemostasis;Adaptive Immune System;Metabolism;Signal Transduction;Integration of energy metabolism;Immune System;Integrin signaling;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Rap1 signalling;Regulation of insulin secretion;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
O95399	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
O95400	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O95402	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
O95405-1	Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Loss of Function of SMAD2/3 in Cancer;Signaling by TGF-beta Receptor Complex in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;TGFBR1 KD Mutants in Cancer;Loss of Function of TGFBR1 in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by TGF-beta family members
O95406	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
O95407	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
O95415	Innate Immune System;Immune System;Neutrophil degranulation
O95427	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O95429	Signaling by FGFR in disease;Signal Transduction;Disease;FGFR1 mutant receptor activation;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Death Receptor Signalling;TNF signaling;Signaling by plasma membrane FGFR1 fusions;Cellular responses to external stimuli
O95436	Disease;Transport of small molecules;Metabolism of proteins;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Type II Na+/Pi cotransporters;Sodium-coupled phosphate cotransporters;Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM);SLC transporter disorders;Disorders of transmembrane transporters;Diseases of metabolism;Surfactant metabolism;Diseases associated with surfactant metabolism
O95445	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
O95450	Extracellular matrix organization;Collagen formation;Disease;Collagen biosynthesis and modifying enzymes;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
O95452	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
O95453	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Metabolism of RNA
O95460	Extracellular matrix organization;ECM proteoglycans
O95461	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective LARGE causes MDDGA6 and MDDGB6;O-linked glycosylation;Diseases of metabolism;Post-translational protein modification
O95466	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins
O95470	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
O95471	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
O95476	Cell Cycle;Nuclear Envelope Breakdown;Depolymerisation of the Nuclear Lamina;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
O95477	Metabolism;Signal Transduction;Disease;Plasma lipoprotein assembly, remodeling, and clearance;PPARA activates gene expression;Transport of small molecules;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCA1 causes Tangier disease;HDL assembly;Plasma lipoprotein assembly;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
O95484	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
O95486	Adaptive Immune System;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;Metabolism of proteins;Asparagine N-linked glycosylation;Metabolism of lipids;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Metabolism of steroids;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
O95487	Adaptive Immune System;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;Metabolism of proteins;Asparagine N-linked glycosylation;Metabolism of lipids;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Metabolism of steroids;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
O95497	Metabolism;Post-translational modification: synthesis of GPI-anchored proteins;Innate Immune System;Immune System;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation
O95498	Metabolism;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism;Metabolism of proteins;Post-translational protein modification
O95500	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
O95503	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers
O95528	Disease;Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport;Defective SLC2A10 causes arterial tortuosity syndrome (ATS);SLC transporter disorders;Disorders of transmembrane transporters
O95544	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
O95551	DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
O95563	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
O95571	Metabolism;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
O95573	Metabolism;Integration of energy metabolism;Free fatty acids regulate insulin secretion;Regulation of insulin secretion;Intracellular metabolism of fatty acids regulates insulin secretion;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
O95602	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
O95613	Macroautophagy;Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
O95619	Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors
O95622	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;Adrenaline,noradrenaline inhibits insulin secretion;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
O95628	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
O95630	Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;Post-translational protein modification
O95631	Developmental Biology;Netrin-1 signaling;DSCAM interactions;Signaling by ROBO receptors;DCC mediated attractive signaling;Netrin mediated repulsion signals;Role of second messengers in netrin-1 signaling;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Nervous system development
O95633	Signaling by Activin;Signal Transduction;Antagonism of Activin by Follistatin;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation;Signaling by TGF-beta family members
O95639	Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Influenza Infection;NS1 Mediated Effects on Host Pathways;Inhibition of Host mRNA Processing and RNA Silencing;Infectious disease;tRNA processing in the nucleus;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
O95644	Downstream signaling events of B Cell Receptor (BCR);Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by WNT;Calcineurin activates NFAT;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Beta-catenin independent WNT signaling;Ca2+ pathway;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Signaling by the B Cell Receptor (BCR)
O95665	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
O95670	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
O95674	Metabolism;Synthesis of PG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
O95677	DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair
O95678	Developmental Biology;Keratinization;Formation of the cornified envelope
O95684	Signaling by FGFR in disease;Cell Cycle;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
O95696	Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription)
O95707	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
O95711	Toll Like Receptor 4 (TLR4) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades
O95714	Adaptive Immune System;Cell Cycle;Immune System;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
O95716	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation
O95718	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O95721	Innate Immune System;Immune System;Membrane Trafficking;Vesicle-mediated transport;Neutrophil degranulation;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
O95727	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O95741	Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
O95749	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
O95750	PI3K Cascade;IRS-mediated signalling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;betaKlotho-mediated ligand binding;Signal Transduction;Disease;Immune System;Signaling by FGFR;FGFR4 ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR4;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR4 signaling;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
O95755	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation
O95757	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
O95760	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Negative regulation of the PI3K/AKT network;Metabolism of proteins;Interleukin-1 family signaling;Signaling by Interleukins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Interleukin-33 signaling
O95772	Metabolism;Metabolism of steroid hormones;Pregnenolone biosynthesis;Metabolism of lipids;Metabolism of steroids
O95777	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O95780	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
O95782	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Signaling by NTRKs;Nef Mediated CD4 Down-regulation;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;Signaling by NTRK1 (TRKA);Signaling by WNT;Membrane Trafficking;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;Transport of small molecules;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;PCP/CE pathway;Trafficking of GluR2-containing AMPA receptors;Axon guidance;Recycling pathway of L1;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDLR internalisation and degradation;LDL clearance;Plasma lipoprotein clearance;Signaling by Receptor Tyrosine Kinases;Nervous system development
O95786	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification;OAS antiviral response;Interferon Signaling;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;Negative regulators of DDX58/IFIH1 signaling
O95803	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
O95813	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL;Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
O95816	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
O95817	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
O95819	Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to external stimuli
O95822-2	Metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
O95832	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
O95835	Signal Transduction;Signaling by Hippo
O95837	Hemostasis;Metabolism;Signal Transduction;Integration of energy metabolism;Signaling by GPCR;GPCR downstream signalling;Signal amplification;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;G alpha (q) signalling events;ADP signalling through P2Y purinoceptor 1;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Thrombin signalling through proteinase activated receptors (PARs);Platelet activation, signaling and aggregation
O95838	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
O95843	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
O95847	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial Uncoupling;The fatty acid cycling model;The proton buffering model
O95848	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Synthesis of dolichyl-phosphate-glucose;Post-translational protein modification
O95858	Metabolism of proteins;Amyloid fiber formation
O95861	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
O95863	PIP3 activates AKT signaling;Signal Transduction;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers
O95864	Metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Metabolism of lipids;Fatty acid metabolism
O95865	Metabolism;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation
O95866	Hemostasis;GPVI-mediated activation cascade;Platelet activation, signaling and aggregation
O95867	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O95868	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O95886	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
O95907	Hemostasis;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Cell surface interactions at the vascular wall;Basigin interactions;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Proton-coupled monocarboxylate transport;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
O95918	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
O95922	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
O95925	Innate Immune System;Immune System;Antimicrobial peptides
O95926	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
O95944	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions
O95954	Metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
O95965	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates genes involved in cell migration
O95967	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
O95970	Developmental Biology;LGI-ADAM interactions
O95971	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
O95972	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
O95977	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding
O95980	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
O95983	PIP3 activates AKT signaling;Signal Transduction;Epigenetic regulation of gene expression;Generic Transcription Pathway;HDACs deacetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
O95989	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol
O95992	Metabolism;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
O95995	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO
O95997	Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
O95998	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling;Interleukin-18 signaling
O95999	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Metabolism of proteins;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Signaling by the B Cell Receptor (BCR)
O96000	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
O96006	SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of chromatin organization proteins;Post-translational protein modification
O96007	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
O96008	Mitochondrial protein import;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Protein localization;Autophagy;Selective autophagy
O96009	Metabolism of proteins;Surfactant metabolism
O96011	Class I peroxisomal membrane protein import;Protein localization
O96013	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Activation of RAC1;Nervous system development
O96014	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;Ca2+ pathway;PCP/CE pathway;GPCR ligand binding
O96015	Signal Transduction;Signaling by NTRKs;Retrograde neurotrophin signalling;Signaling by NTRK1 (TRKA);Signaling by Receptor Tyrosine Kinases
O96017	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;G2/M DNA damage checkpoint;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
O96018	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
O96019	Generic Transcription Pathway;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
O96020	G0 and Early G1;Cell Cycle;SCF(Skp2)-mediated degradation of p27/p21;Generic Transcription Pathway;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Mitotic G1 phase and G1/S transition;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli
O96024	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
O96028	Cell Cycle;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
O96033	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
P00156	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
P00167-1	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P00167	Metabolism;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P00325	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Ethanol oxidation
P00326	Metabolism;Signal Transduction;Biological oxidations;Phase I - Functionalization of compounds;Signaling by Retinoic Acid;RA biosynthesis pathway;Ethanol oxidation;Signaling by Nuclear Receptors
P00338	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
P00352	Metabolism;Signal Transduction;Biological oxidations;Phase I - Functionalization of compounds;Signaling by Retinoic Acid;RA biosynthesis pathway;Fructose metabolism;Fructose catabolism;Ethanol oxidation;Metabolism of carbohydrates;Signaling by Nuclear Receptors
P00367	Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
P00374	Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Cell Cycle;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Mitotic G1 phase and G1/S transition;G1/S-Specific Transcription;G1/S Transition;Cell Cycle, Mitotic;Metabolism of cofactors
P00387	Metabolism;Innate Immune System;Immune System;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Biological oxidations;Phase I - Functionalization of compounds;Neutrophil degranulation
P00390-1	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
P00390-2	Metabolism;Metabolism of nucleotides;Generic Transcription Pathway;Cellular responses to stress;Selenoamino acid metabolism;Metabolism of ingested H2SeO4 and H2SeO3 into H2Se;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;Interconversion of nucleotide di- and triphosphates;TP53 Regulates Metabolic Genes;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli
P00395	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P00403	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P00414	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P00439	Metabolism;Disease;Phenylketonuria;Diseases of metabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine metabolism;Phenylalanine metabolism
P00441	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Immune System;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Interleukin-12 family signaling;Signaling by Interleukins;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Cellular responses to external stimuli;Interleukin-12 signaling
P00450	Disease;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages);Defective CP causes aceruloplasminemia (ACERULOP);SLC transporter disorders;Disorders of transmembrane transporters;Post-translational protein modification;Post-translational protein phosphorylation;Iron uptake and transport
P00451	Hemostasis;Platelet degranulation ;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Transport to the Golgi and subsequent modification
P00480	Mitochondrial protein import;Metabolism;Urea cycle;Metabolism of amino acids and derivatives;Protein localization
P00488	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P00491	Metabolism;Metabolism of nucleotides;Innate Immune System;Immune System;Neutrophil degranulation;Purine salvage;Purine catabolism;Nucleobase catabolism;Nucleotide salvage
P00492	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
P00505	Metabolism;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Glyoxylate metabolism and glycine degradation;Gluconeogenesis;Glucose metabolism;Metabolism of amino acids and derivatives;Metabolism of carbohydrates;Aspartate and asparagine metabolism;Glutamate and glutamine metabolism
P00519	Hemostasis;Developmental Biology;Signal Transduction;Cell Cycle;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Generic Transcription Pathway;Signaling by ROBO receptors;Axon guidance;Role of ABL in ROBO-SLIT signaling;Mitotic G1 phase and G1/S transition;Myogenesis;Infectious disease;RHO GTPases Activate WASPs and WAVEs;HDR through Single Strand Annealing (SSA);DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Double Strand Break Response;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development;Factors involved in megakaryocyte development and platelet production
P00533	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PLCG1 events in ERBB2 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;Membrane Trafficking;Generic Transcription Pathway;EGFR interacts with phospholipase C-gamma;EGFR Transactivation by Gastrin;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by GPCR;L1CAM interactions;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Signal transduction by L1;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Gastrin-CREB signalling pathway via PKC and MAPK;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;PTK6 promotes HIF1A stabilization;Downregulation of ERBB2 signaling;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;FLT3 Signaling;HCMV Infection;HCMV Early Events;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Nervous system development
P00558	Metabolism;Disease;Infectious disease;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;Infection with Mycobacterium tuberculosis;Manipulation of host energy metabolism;Response of Mtb to phagocytosis
P00568	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P00588	Disease;Uptake and function of diphtheria toxin;Uptake and actions of bacterial toxins;Infectious disease
P00709	Metabolism;Lactose synthesis;Metabolism of carbohydrates
P00734	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Signal Transduction;Gamma carboxylation, hypusine formation and arylsulfatase activation;Complement cascade;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);GPCR downstream signalling;Metabolism of proteins;G alpha (q) signalling events;Thrombin signalling through proteinase activated receptors (PARs);GPCR ligand binding;Post-translational protein modification;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Regulation of Complement cascade
P00736	Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Regulation of Complement cascade
P00738	Innate Immune System;Immune System;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport;Neutrophil degranulation
P00739	Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport
P00740	Hemostasis;Extrinsic Pathway of Fibrin Clot Formation;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Post-translational protein modification
P00742	Hemostasis;Extrinsic Pathway of Fibrin Clot Formation;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Post-translational protein modification
P00746	Hemostasis;Platelet degranulation ;Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Alternative complement activation;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P00747	Hemostasis;Platelet degranulation ;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Signal Transduction;Signaling by PDGF;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Dissolution of Fibrin Clot;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by Receptor Tyrosine Kinases
P00748	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade)
P00749	Hemostasis;Innate Immune System;Immune System;Neutrophil degranulation;Dissolution of Fibrin Clot
P00750	Hemostasis;Signal Transduction;Signaling by PDGF;Dissolution of Fibrin Clot;Signaling by Receptor Tyrosine Kinases
P00751	Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Alternative complement activation;Activation of C3 and C5;Regulation of Complement cascade
P00797	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins
P00813	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
P00846	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P00915	Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;Cytokine Signaling in Immune system;Metabolism;Reversible hydration of carbon dioxide;O2/CO2 exchange in erythrocytes;Immune System;Transport of small molecules;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P00918	Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;Metabolism;Reversible hydration of carbon dioxide;O2/CO2 exchange in erythrocytes;Transport of small molecules
P00966	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
P00973	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;OAS antiviral response;Interferon alpha/beta signaling;Interferon Signaling
P01008	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P01009	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation;Transport to the Golgi and subsequent modification
P01011	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P01019	Metabolism;Signal Transduction;PPARA activates gene expression;Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding;Metabolism of lipids
P01023	Hemostasis;Platelet degranulation ;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Signaling by Rho GTPases;Rho GTPase cycle;Transport of small molecules;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;HDL assembly;Plasma lipoprotein assembly
P01024	Adaptive Immune System;Signal Transduction;Disease;Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Alternative complement activation;Activation of C3 and C5;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;GPCR ligand binding;Infectious disease;Post-translational protein modification;Neutrophil degranulation;Post-translational protein phosphorylation;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response);Regulation of Complement cascade
P01031	Signal Transduction;Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Activation of C3 and C5;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Regulation of Complement cascade
P01033	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Signaling by Interleukins;Post-translational protein modification;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
P01034	Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Post-translational protein phosphorylation;Amyloid fiber formation
P01040	Developmental Biology;Keratinization;Formation of the cornified envelope
P01042	Hemostasis;Platelet degranulation ;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);GPCR downstream signalling;Metabolism of proteins;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
P01100	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;FCERI mediated MAPK activation;Transcriptional Regulation by TP53;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Activation of the AP-1 family of transcription factors;Interleukin-4 and Interleukin-13 signaling;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Estrogen-dependent gene expression;NGF-stimulated transcription;TRIF(TICAM1)-mediated TLR4 signaling ;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P01106	Developmental Biology;Cytokine Signaling in Immune system;Transcription of E2F targets under negative control by DREAM complex;G0 and Early G1;Signaling by NOTCH;Signal Transduction;Cell Cycle;Disease;Immune System;Signaling by TGF-beta Receptor Complex;Signaling by WNT;Signaling by NOTCH1;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Metabolism of proteins;Binding of TCF/LEF:CTNNB1 to target gene promoters;Signaling by Interleukins;Mitotic G1 phase and G1/S transition;Diseases of signal transduction by growth factor receptors and second messengers;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of cell cycle factors;Transcriptional regulation by RUNX3;ESR-mediated signaling;RUNX3 regulates WNT signaling;Signaling by Nuclear Receptors;Signaling by TGF-beta family members;Estrogen-dependent gene expression;Transcriptional regulation of granulopoiesis
P01111	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;IRS-mediated signalling;SOS-mediated signalling;Downstream signaling events of B Cell Receptor (BCR);Activation of RAS in B cells;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;p38MAPK events;Signaling by EGFR;GRB2 events in EGFR signaling;SHC1 events in EGFR signaling;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by VEGF;GRB2 events in ERBB2 signaling;Cell surface interactions at the vascular wall;Tie2 Signaling;DAP12 interactions;EGFR Transactivation by Gastrin;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;Signaling by GPCR;NCAM signaling for neurite out-growth;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;VEGFR2 mediated cell proliferation;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;RAS signaling downstream of NF1 loss-of-function variants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;Insulin receptor signalling cascade;Signaling by Insulin receptor;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAS signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Activated NTRK2 signals through RAS;Erythropoietin activates RAS;Activated NTRK2 signals through FRS2 and FRS3;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;Estrogen-stimulated signaling through PRKCZ;RAS GTPase cycle mutants;Signaling downstream of RAS mutants;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development;Signaling by the B Cell Receptor (BCR)
P01112	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;IRS-mediated signalling;SOS-mediated signalling;Downstream signaling events of B Cell Receptor (BCR);Activation of RAS in B cells;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;p38MAPK events;Signaling by EGFR;GRB2 events in EGFR signaling;SHC1 events in EGFR signaling;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by VEGF;GRB2 events in ERBB2 signaling;Cell surface interactions at the vascular wall;Tie2 Signaling;DAP12 interactions;EGFR Transactivation by Gastrin;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;FCERI mediated MAPK activation;Signaling by GPCR;NCAM signaling for neurite out-growth;GPCR downstream signalling;EPHB-mediated forward signaling;G alpha (q) signalling events;Axon guidance;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;VEGFR2 mediated cell proliferation;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;RAS signaling downstream of NF1 loss-of-function variants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;Insulin receptor signalling cascade;Signaling by Insulin receptor;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAS signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Activated NTRK2 signals through RAS;Erythropoietin activates RAS;Activated NTRK2 signals through FRS2 and FRS3;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;Estrogen-stimulated signaling through PRKCZ;RAS GTPase cycle mutants;Signaling downstream of RAS mutants;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development;Signaling by the B Cell Receptor (BCR)
P01116-1	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;IRS-mediated signalling;SOS-mediated signalling;Downstream signaling events of B Cell Receptor (BCR);Activation of RAS in B cells;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;p38MAPK events;Signaling by EGFR;GRB2 events in EGFR signaling;SHC1 events in EGFR signaling;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by VEGF;GRB2 events in ERBB2 signaling;Cell surface interactions at the vascular wall;Tie2 Signaling;DAP12 interactions;EGFR Transactivation by Gastrin;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;Signaling by GPCR;NCAM signaling for neurite out-growth;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;VEGFR2 mediated cell proliferation;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;RAS signaling downstream of NF1 loss-of-function variants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;Insulin receptor signalling cascade;Signaling by Insulin receptor;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAS signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Activated NTRK2 signals through RAS;Erythropoietin activates RAS;Activated NTRK2 signals through FRS2 and FRS3;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;Estrogen-stimulated signaling through PRKCZ;Signaling downstream of RAS mutants;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development;Signaling by the B Cell Receptor (BCR)
P01116-2	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;IRS-mediated signalling;SOS-mediated signalling;Downstream signaling events of B Cell Receptor (BCR);Activation of RAS in B cells;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;p38MAPK events;Signaling by EGFR;GRB2 events in EGFR signaling;SHC1 events in EGFR signaling;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by VEGF;Signaling by WNT;GRB2 events in ERBB2 signaling;Cell surface interactions at the vascular wall;Tie2 Signaling;DAP12 interactions;EGFR Transactivation by Gastrin;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;Signaling by GPCR;NCAM signaling for neurite out-growth;Beta-catenin independent WNT signaling;GPCR downstream signalling;Ca2+ pathway;G alpha (q) signalling events;Axon guidance;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;VEGFR2 mediated cell proliferation;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;RAS signaling downstream of NF1 loss-of-function variants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;Insulin receptor signalling cascade;Signaling by Insulin receptor;Gastrin-CREB signalling pathway via PKC and MAPK;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAS signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Activated NTRK2 signals through RAS;Erythropoietin activates RAS;Activated NTRK2 signals through FRS2 and FRS3;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;Estrogen-stimulated signaling through PRKCZ;Signaling downstream of RAS mutants;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development;Signaling by the B Cell Receptor (BCR)
P01116	Disease;Generic Transcription Pathway;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates p14-ARF;RAS GTPase cycle mutants;Signaling downstream of RAS mutants
P01127	Hemostasis;Platelet degranulation ;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Extracellular matrix organization;Signal Transduction;Disease;Immune System;Downstream signal transduction;Signaling by PDGF;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Non-integrin membrane-ECM interactions;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P01130	Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Membrane Trafficking;Visual phototransduction;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Vesicle-mediated transport;Metabolism of fat-soluble vitamins;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Chylomicron clearance;LDL clearance;Plasma lipoprotein clearance;Retinoid metabolism and transport
P01133	Hemostasis;Platelet degranulation ;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PLCG1 events in ERBB2 signaling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;Membrane Trafficking;EGFR interacts with phospholipase C-gamma;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Downregulation of ERBB2 signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants
P01135	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;Negative regulation of the PI3K/AKT network;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Generic Transcription Pathway;EGFR interacts with phospholipase C-gamma;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Metabolism of proteins;Asparagine N-linked glycosylation;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Cargo concentration in the ER;Post-translational protein modification;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Estrogen-dependent gene expression;Transport to the Golgi and subsequent modification;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P01137	Hemostasis;Platelet degranulation ;Developmental Biology;Cytokine Signaling in Immune system;Extracellular matrix organization;Elastic fibre formation;Signal Transduction;Disease;Influenza Infection;Immune System;Influenza Virus Induced Apoptosis;Signaling by TGF-beta Receptor Complex;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Molecules associated with elastic fibres;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Loss of Function of SMAD2/3 in Cancer;Signaling by TGF-beta Receptor Complex in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;Loss of Function of TGFBR2 in Cancer;TGFBR2 MSI Frameshift Mutants in Cancer;TGFBR2 Kinase Domain Mutants in Cancer;TGFBR1 KD Mutants in Cancer;Loss of Function of TGFBR1 in Cancer;TGFBR1 LBD Mutants in Cancer;Transcriptional regulation of white adipocyte differentiation;Metabolism of proteins;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Deubiquitination;UCH proteinases;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Transcriptional regulation by RUNX3;RUNX3 regulates CDKN1A transcription;Regulation of RUNX3 expression and activity;RUNX3 regulates p14-ARF;Signaling by TGF-beta family members
P01138	Signal Transduction;Signaling by NTRKs;PLC-gamma1 signalling;Signalling to RAS;NGF processing;Prolonged ERK activation events;Frs2-mediated activation;ARMS-mediated activation;Retrograde neurotrophin signalling;Activation of TRKA receptors;Signaling by NTRK1 (TRKA);TRKA activation by NGF;Signalling to ERKs;Signalling to p38 via RIT and RIN;p75NTR signals via NF-kB;NRAGE signals death through JNK;p75NTR negatively regulates cell cycle via SC1;Ceramide signalling;p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;PI3K/AKT activation;Signalling to STAT3;Cell death signalling via NRAGE, NRIF and NADE;NFG and proNGF binds to p75NTR;NADE modulates death signalling;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Axonal growth stimulation;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Expression and Processing of Neurotrophins
P01148	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P01160	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;Metabolism of proteins;Muscle contraction;Cardiac conduction;Physiological factors;RNA Polymerase II Transcription;Gene expression (Transcription);Amyloid fiber formation
P01178	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Vasopressin-like receptors;G alpha (q) signalling events;GPCR ligand binding
P01185	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Signal Transduction;Disease;Membrane Trafficking;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Transport of small molecules;GPCR downstream signalling;Vasopressin-like receptors;Circadian Clock;G alpha (q) signalling events;G alpha (s) signalling events;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;GPCR ligand binding;Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI);SLC transporter disorders;Disorders of transmembrane transporters;Vesicle-mediated transport;Infectious disease;Transport of organic anions;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI);Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01189	Opioid Signalling;Cytokine Signaling in Immune system;Metabolism;Signal Transduction;Disease;Immune System;Androgen biosynthesis;Glucocorticoid biosynthesis;Metabolism of steroid hormones;G-protein activation;Peptide hormone biosynthesis;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Generic Transcription Pathway;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Metabolism of lipids;Metabolic disorders of biological oxidation enzymes;Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD);Infectious disease;Diseases of metabolism;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01210	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;GPCR ligand binding;Post-translational protein modification;Post-translational protein phosphorylation
P01213	Opioid Signalling;Signal Transduction;G-protein activation;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P01215	Metabolism;Signal Transduction;Disease;Androgen biosynthesis;Mineralocorticoid biosynthesis;Metabolism of steroid hormones;Metabolism of amine-derived hormones;Glycoprotein hormones;Peptide hormone biosynthesis;Thyroxine biosynthesis;Generic Transcription Pathway;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;Asparagine N-linked glycosylation;GPCR ligand binding;Metabolism of lipids;Infectious disease;Post-translational protein modification;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Metabolism of steroids;Transport to the Golgi and subsequent modification;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
P01222	Metabolism;Signal Transduction;Disease;Metabolism of amine-derived hormones;Glycoprotein hormones;Peptide hormone biosynthesis;Thyroxine biosynthesis;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Metabolism of amino acids and derivatives;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01225	Signal Transduction;Disease;Glycoprotein hormones;Peptide hormone biosynthesis;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01229	Metabolism;Signal Transduction;Disease;Androgen biosynthesis;Mineralocorticoid biosynthesis;Metabolism of steroid hormones;Glycoprotein hormones;Peptide hormone biosynthesis;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;Asparagine N-linked glycosylation;GPCR ligand binding;Metabolism of lipids;Infectious disease;Post-translational protein modification;Metabolism of steroids;Transport to the Golgi and subsequent modification;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
P01236	Prolactin receptor signaling;Cytokine Signaling in Immune system;Immune System;Metabolism of proteins;Amyloid fiber formation;Growth hormone receptor signaling
P01241	Prolactin receptor signaling;Cytokine Signaling in Immune system;Immune System;Peptide hormone metabolism;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin;Growth hormone receptor signaling
P01242	Prolactin receptor signaling;Cytokine Signaling in Immune system;Immune System;Growth hormone receptor signaling
P01258	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;Amyloid fiber formation
P01270	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01275	Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Peptide hormone metabolism;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);GPCR downstream signalling;Metabolism of proteins;Incretin synthesis, secretion, and inactivation;G alpha (q) signalling events;G alpha (s) signalling events;Glucagon-type ligand receptors;Synthesis, secretion, and deacylation of Ghrelin;Regulation of insulin secretion;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01282	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01286	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P01298	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P01303	Signal Transduction;Generic Transcription Pathway;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P01308	PIP3 activates AKT signaling;Developmental Biology;Metabolism;Signal Transduction;Integration of energy metabolism;Regulation of beta-cell development;Negative regulation of the PI3K/AKT network;ER to Golgi Anterograde Transport;Membrane Trafficking;Regulation of gene expression in beta cells;Generic Transcription Pathway;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin;Regulation of insulin secretion;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);IRS activation;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Insulin receptor recycling;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Transport to the Golgi and subsequent modification;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Amyloid fiber formation
P01344	Hemostasis;Platelet degranulation ;Signal Transduction;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by Receptor Tyrosine Kinases
P01350	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Gastrin-CREB signalling pathway via PKC and MAPK
P01374	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
P01375	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Transcriptional regulation of white adipocyte differentiation;Signaling by Interleukins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNFR1-mediated ceramide production;TNFR2 non-canonical NF-kB pathway;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Death Receptor Signalling;TNF signaling
P01559	Disease;Uptake and actions of bacterial toxins;Infectious disease;Intestinal infectious diseases
P01562	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01563	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01566	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01567	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01568	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01569	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01570	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01571	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01574	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to external stimuli;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P01579	Cytokine Signaling in Immune system;Immune System;Generic Transcription Pathway;Interleukin-12 family signaling;Signaling by Interleukins;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon gamma signaling;Regulation of IFNG signaling;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Interferon Signaling
P01583	Cytokine Signaling in Immune system;Disease;Immune System;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Interleukin-1 family signaling;Interleukin-1 processing;Signaling by Interleukins;Infectious disease;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Cellular responses to external stimuli;Interleukin-1 signaling;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P01584	Cytokine Signaling in Immune system;Disease;Innate Immune System;Immune System;Interleukin-1 family signaling;Interleukin-1 processing;Signaling by Interleukins;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CLEC7A/inflammasome pathway;Infectious disease;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Interleukin-1 signaling;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P01588	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Signal Transduction;Cellular responses to stress;Cellular responses to external stimuli;Signaling by Erythropoietin;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Erythropoietin activates Phospholipase C gamma (PLCG);Erythropoietin activates STAT5;Erythropoietin activates RAS
P01589	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Generic Transcription Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1;Interleukin-2 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P01591	Hemostasis;Cell surface interactions at the vascular wall;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport
P01593	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01594	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01597	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01599	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01601	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01602	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01611	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01614	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01615	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01619	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01624	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01699	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01700	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01701	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01703	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01704	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01705	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01706	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01709	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01714	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01715	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01717	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01718	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01721	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01730	Cytokine Signaling in Immune system;Adaptive Immune System;Defensins;Alpha-defensins;HIV Life Cycle;Early Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Nef Mediated CD4 Down-regulation;Innate Immune System;Immune System;Binding and entry of HIV virion;Vpu mediated degradation of CD4;Membrane Trafficking;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling;Signaling by Interleukins;Other interleukin signaling;Vesicle-mediated transport;Infectious disease;Antimicrobial peptides;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P01732	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P01733	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
P01737	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
P01742	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01743	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01762	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01763	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01764	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01766	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01767	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01768	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01772	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01780	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01782	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01814	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01817	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01824	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01825	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01833	Innate Immune System;Immune System;Neutrophil degranulation
P01834	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01848	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
P01850	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
P01854	Cytokine Signaling in Immune system;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
P01857	Cytokine Signaling in Immune system;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Signaling by Interleukins;Infectious disease;Interleukin-4 and Interleukin-13 signaling;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
P01859	Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
P01860	Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
P01861	Cytokine Signaling in Immune system;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Signaling by Interleukins;Infectious disease;Interleukin-4 and Interleukin-13 signaling;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
P01871	Hemostasis;Adaptive Immune System;Immune System;Cell surface interactions at the vascular wall;CD22 mediated BCR regulation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01876	Hemostasis;Cell surface interactions at the vascular wall;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport
P01877	Hemostasis;Cell surface interactions at the vascular wall;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport
P01880	Adaptive Immune System;Immune System;CD22 mediated BCR regulation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P01889	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P01891	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P01892	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Metabolism of proteins;Infectious disease;Post-translational protein modification;Interferon gamma signaling;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P01893	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P01903	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P01906	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P01909	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P01911	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P01912	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P01920	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P02042	Hemostasis;Factors involved in megakaryocyte development and platelet production
P02100	Hemostasis;Factors involved in megakaryocyte development and platelet production
P02144	Transport of small molecules;Intracellular oxygen transport
P02452	Hemostasis;GPVI-mediated activation cascade;Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Assembly of collagen fibrils and other multimeric structures;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Integrin cell surface interactions;Binding and Uptake of Ligands by Scavenger Receptors;Anchoring fibril formation;Crosslinking of collagen fibrils;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Scavenging by Class A Receptors;GP1b-IX-V activation signalling;Vesicle-mediated transport;Signaling by MET;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);MET activates PTK2 signaling;MET promotes cell motility;Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases
P02458	Developmental Biology;Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Immune System;Signaling by PDGF;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P02461	Developmental Biology;Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Immune System;Signaling by PDGF;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Binding and Uptake of Ligands by Scavenger Receptors;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Scavenging by Class A Receptors;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Vesicle-mediated transport;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P02462	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Binding and Uptake of Ligands by Scavenger Receptors;Anchoring fibril formation;Crosslinking of collagen fibrils;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Scavenging by Class A Receptors;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Vesicle-mediated transport;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P02511	Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Cellular responses to external stimuli
P02533	Developmental Biology;Cell-Cell communication;Type I hemidesmosome assembly;Cell junction organization;Keratinization;Formation of the cornified envelope
P02538	Developmental Biology;Keratinization;Formation of the cornified envelope
P02545-1	Apoptosis;Apoptotic cleavage of cellular proteins;Cell Cycle;Disease;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Breakdown of the nuclear lamina;Depolymerisation of the Nuclear Lamina;Programmed Cell Death;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Apoptotic execution phase;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P02545-2	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Depolymerisation of the Nuclear Lamina;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
P02545	Disease;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
P02549	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;L1CAM interactions;NCAM signaling for neurite out-growth;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;FLT3 Signaling;Nervous system development
P02585	Striated Muscle Contraction;Muscle contraction
P02647	Hemostasis;Platelet degranulation ;ABC transporters in lipid homeostasis;Metabolism;Signal Transduction;Disease;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;PPARA activates gene expression;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Visual phototransduction;Scavenging by Class B Receptors;Scavenging by Class A Receptors;Signaling by GPCR;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;ABC-family proteins mediated transport;GPCR downstream signalling;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;G alpha (i) signalling events;Metabolism of lipids;ABC transporter disorders;Disorders of transmembrane transporters;Vesicle-mediated transport;Defective ABCA1 causes Tangier disease;Post-translational protein modification;Metabolism of fat-soluble vitamins;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation;Chylomicron assembly;HDL assembly;Plasma lipoprotein assembly;Plasma lipoprotein remodeling;Chylomicron remodeling;HDL clearance;Plasma lipoprotein clearance;HDL remodeling;Retinoid metabolism and transport;Amyloid fiber formation
P02649	Signaling by ERBB4;Nuclear signaling by ERBB4;Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Generic Transcription Pathway;Binding and Uptake of Ligands by Scavenger Receptors;Visual phototransduction;Scavenging by Class A Receptors;Signaling by GPCR;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Vesicle-mediated transport;Post-translational protein modification;Metabolism of fat-soluble vitamins;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Post-translational protein phosphorylation;Chylomicron assembly;Plasma lipoprotein assembly;Plasma lipoprotein remodeling;Chylomicron remodeling;Chylomicron clearance;Plasma lipoprotein clearance;HDL remodeling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;Retinoid metabolism and transport
P02652	Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;PPARA activates gene expression;Visual phototransduction;Signaling by GPCR;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;GPCR downstream signalling;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;G alpha (i) signalling events;Metabolism of lipids;Post-translational protein modification;Metabolism of fat-soluble vitamins;Post-translational protein phosphorylation;Chylomicron assembly;Plasma lipoprotein assembly;Plasma lipoprotein remodeling;Chylomicron remodeling;Retinoid metabolism and transport
P02654	Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;VLDL assembly;Plasma lipoprotein assembly;Plasma lipoprotein clearance;VLDL clearance;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P02655	Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Chylomicron assembly;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein assembly;Plasma lipoprotein remodeling;Chylomicron remodeling;HDL remodeling;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;Retinoid metabolism and transport
P02656	Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Chylomicron assembly;Plasma lipoprotein assembly;Plasma lipoprotein remodeling;Chylomicron remodeling;HDL remodeling;Retinoid metabolism and transport
P02671	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Extracellular matrix organization;Signal Transduction;Disease;Innate Immune System;Immune System;Toll-like Receptor Cascades;Integrin cell surface interactions;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TLR by endogenous ligand;Post-translational protein modification;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);Post-translational protein phosphorylation;FLT3 Signaling;Signaling downstream of RAS mutants;Amyloid fiber formation
P02675	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Extracellular matrix organization;Signal Transduction;Disease;Innate Immune System;Immune System;Toll-like Receptor Cascades;Integrin cell surface interactions;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TLR by endogenous ligand;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);FLT3 Signaling;Signaling downstream of RAS mutants
P02679	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Extracellular matrix organization;Signal Transduction;Disease;Innate Immune System;Immune System;Toll-like Receptor Cascades;Integrin cell surface interactions;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TLR by endogenous ligand;Post-translational protein modification;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);Post-translational protein phosphorylation;FLT3 Signaling;Signaling downstream of RAS mutants
P02686	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P02708	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
P02724	Hemostasis;Cell surface interactions at the vascular wall
P02730	Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;O2/CO2 exchange in erythrocytes;Disease;Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA);SLC transporter disorders;Disorders of transmembrane transporters
P02741	Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation
P02743	Metabolism of proteins;Amyloid fiber formation
P02745	Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Regulation of Complement cascade
P02746	Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Regulation of Complement cascade
P02747	Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Regulation of Complement cascade
P02748	Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Regulation of Complement cascade
P02749	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P02750	Innate Immune System;Immune System;Neutrophil degranulation
P02751	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Degradation of the extracellular matrix;Extracellular matrix organization;Elastic fibre formation;Fibronectin matrix formation;Signal Transduction;Disease;Immune System;Cell surface interactions at the vascular wall;Molecules associated with elastic fibres;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);MET activates PTK2 signaling;MET promotes cell motility;Post-translational protein phosphorylation;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants
P02753	Metabolism;Signal Transduction;Disease;Metabolism of vitamins and cofactors;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism disease events;Diseases of the neuronal system;Retinoid metabolism and transport
P02760	Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport
P02763	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P02765	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
P02766	Metabolism;Extracellular matrix organization;Signal Transduction;Disease;Innate Immune System;Immune System;Metabolism of vitamins and cofactors;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Non-integrin membrane-ECM interactions;Signaling by GPCR;GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Neutrophil degranulation;Metabolism of fat-soluble vitamins;Diseases of the neuronal system;Retinoid metabolism and transport;Amyloid fiber formation
P02768	Hemostasis;Platelet degranulation ;Metabolism;Recycling of bile acids and salts;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of porphyrins;Heme biosynthesis;Heme degradation;Bile acid and bile salt metabolism;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of lipids;Vesicle-mediated transport;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Transport of organic anions;Post-translational protein phosphorylation;Metabolism of steroids;Plasma lipoprotein remodeling;HDL remodeling
P02771	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P02774	Metabolism;Vitamin D (calciferol) metabolism;Metabolism of lipids;Metabolism of steroids
P02775	Hemostasis;Platelet degranulation ;Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P02776	Hemostasis;Platelet degranulation ;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Signal Transduction;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
P02778	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P02786	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Transport of small molecules;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Iron uptake and transport;Transferrin endocytosis and recycling
P02787	Hemostasis;Platelet degranulation ;Membrane Trafficking;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Post-translational protein phosphorylation;Iron uptake and transport;Transferrin endocytosis and recycling
P02788	Mtb iron assimilation by chelation;Latent infection - Other responses of Mtb to phagocytosis;Disease;Innate Immune System;Immune System;Metabolism of proteins;Infectious disease;Neutrophil degranulation;Metal sequestration by antimicrobial proteins;Antimicrobial peptides;Infection with Mycobacterium tuberculosis;Amyloid fiber formation
P02790	Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport
P02792	Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Transport of small molecules;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Neutrophil degranulation;Iron uptake and transport
P02794	Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Transport of small molecules;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Neutrophil degranulation;Iron uptake and transport
P02795	Cytokine Signaling in Immune system;Immune System;Response to metal ions;Metallothioneins bind metals;Interferon gamma signaling;Cellular responses to external stimuli;Interferon Signaling
P02818	Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Generic Transcription Pathway;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development
P03372-3	PIP3 activates AKT signaling;Signal Transduction;Disease;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
P03372-4	PIP3 activates AKT signaling;Signal Transduction;Disease;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
P03372	Signaling by ERBB4;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Signal Transduction;Disease;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates estrogen receptor mediated transcription;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in WNT signaling;Regulation of RUNX2 expression and activity;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Estrogen-dependent gene expression
P03375	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P03377	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P03378	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P03428	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Viral Messenger RNA Synthesis;Viral RNP Complexes in the Host Cell Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Uncoating of the Influenza Virion;vRNA Synthesis;Viral mRNA Translation;cRNA Synthesis;vRNP Assembly;Infectious disease
P03431	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Viral Messenger RNA Synthesis;Viral RNP Complexes in the Host Cell Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Uncoating of the Influenza Virion;vRNA Synthesis;Viral mRNA Translation;cRNA Synthesis;vRNP Assembly;Infectious disease
P03433	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Viral Messenger RNA Synthesis;Viral RNP Complexes in the Host Cell Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Uncoating of the Influenza Virion;vRNA Synthesis;Viral mRNA Translation;cRNA Synthesis;vRNP Assembly;Infectious disease
P03452	Adaptive Immune System;Disease;Influenza Infection;Immune System;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Influenza Viral RNA Transcription and Replication;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Assembly of Viral Components at the Budding Site;Uncoating of the Influenza Virion;Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus;Viral mRNA Translation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Infectious disease
P03466	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Assembly of Viral Components at the Budding Site;Viral Messenger RNA Synthesis;Viral RNP Complexes in the Host Cell Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Uncoating of the Influenza Virion;vRNA Synthesis;Viral mRNA Translation;cRNA Synthesis;vRNP Assembly;Infectious disease
P03468	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Influenza Viral RNA Transcription and Replication;Entry of Influenza Virion into Host Cell via Endocytosis;Influenza Virus Induced Apoptosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Assembly of Viral Components at the Budding Site;Uncoating of the Influenza Virion;Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus;Viral mRNA Translation;Infectious disease
P03485	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Assembly of Viral Components at the Budding Site;Viral RNP Complexes in the Host Cell Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Uncoating of the Influenza Virion;Viral mRNA Translation;Infectious disease
P03496	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Disease;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;NS1 Mediated Effects on Host Pathways;Inhibition of Interferon Synthesis;Inhibition of Host mRNA Processing and RNA Silencing;Inhibition of IFN-beta;Inhibition of PKR;Viral mRNA Translation;Infectious disease;Interferon Signaling
P03508	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Viral RNP Complexes in the Host Cell Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Uncoating of the Influenza Virion;Viral mRNA Translation;Infectious disease
P03886	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P03891	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P03897	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P03905	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P03915	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P03923	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P03928	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P03950	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P03951	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade)
P03952	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
P03956	Hemostasis;Cytokine Signaling in Immune system;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Immune System;Cell surface interactions at the vascular wall;Basigin interactions;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
P03971	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
P03973	Innate Immune System;Immune System;Neutrophil degranulation
P03989	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P03999	Signal Transduction;Disease;The retinoid cycle in cones (daylight vision);Visual phototransduction;Retinoid cycle disease events;Diseases associated with visual transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding;Diseases of the neuronal system
P04000	Signal Transduction;Disease;The retinoid cycle in cones (daylight vision);Visual phototransduction;Retinoid cycle disease events;Diseases associated with visual transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding;Diseases of the neuronal system
P04001	Signal Transduction;Disease;The retinoid cycle in cones (daylight vision);Visual phototransduction;Retinoid cycle disease events;Diseases associated with visual transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding;Diseases of the neuronal system
P04003	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P04004	Extracellular matrix organization;Elastic fibre formation;Complement cascade;Innate Immune System;Immune System;Molecules associated with elastic fibres;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Regulation of Complement cascade
P04035-1	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;PPARA activates gene expression;Activation of gene expression by SREBF (SREBP);Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids
P04035-2	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
P04035	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P04040	Innate Immune System;Immune System;Generic Transcription Pathway;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Neutrophil degranulation;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;Peroxisomal protein import;Protein localization;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P04049	Hemostasis;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Innate Immune System;Immune System;Stimuli-sensing channels;Transport of small molecules;Rap1 signalling;GP1b-IX-V activation signalling;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative feedback regulation of MAPK pathway;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;FLT3 Signaling;Signaling downstream of RAS mutants;Ion channel transport
P04054	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
P04062	Metabolism;Glycosphingolipid metabolism;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids
P04066	Innate Immune System;Immune System;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Neutrophil degranulation;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
P04070	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Cell surface interactions at the vascular wall;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P04075	Hemostasis;Platelet degranulation ;Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P04080	Innate Immune System;Immune System;Neutrophil degranulation
P04083	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Muscle contraction;G alpha (q) signalling events;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;Smooth Muscle Contraction;Signaling by Interleukins;GPCR ligand binding;Interleukin-4 and Interleukin-13 signaling
P04085-1	Hemostasis;Platelet degranulation ;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Downstream signal transduction;Signaling by PDGF;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P04085-2	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Downstream signal transduction;Signaling by PDGF;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P04085	Extracellular matrix organization;Non-integrin membrane-ECM interactions
P04090	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;Relaxin receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P04114	Hemostasis;Metabolism;Signal Transduction;Innate Immune System;Immune System;Toll-like Receptor Cascades;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Membrane Trafficking;Cell surface interactions at the vascular wall;Binding and Uptake of Ligands by Scavenger Receptors;Visual phototransduction;Scavenging by Class B Receptors;Scavenging by Class A Receptors;Scavenging by Class F Receptors;Scavenging by Class H Receptors;Signaling by GPCR;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;GPCR downstream signalling;Metabolism of proteins;Platelet homeostasis;G alpha (i) signalling events;Platelet sensitization by LDL;Vesicle-mediated transport;Regulation of TLR by endogenous ligand;Post-translational protein modification;Metabolism of fat-soluble vitamins;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDL assembly;Post-translational protein phosphorylation;Chylomicron assembly;Plasma lipoprotein assembly;Plasma lipoprotein remodeling;Chylomicron remodeling;Chylomicron clearance;LDL clearance;LDL remodeling;Plasma lipoprotein clearance;VLDL clearance;Retinoid metabolism and transport
P04118	Metabolism;Signal Transduction;Digestion of dietary lipid;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Digestion;Digestion and absorption;Retinoid metabolism and transport
P04141	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Generic Transcription Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-10 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;Interleukin receptor SHC signaling;FLT3 Signaling
P04150-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-3	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-4	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-5	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-6	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-7	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-8	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150-9	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P04150	Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Circadian Clock;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by PTK6;PTK6 Expression;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Cellular responses to external stimuli;Signaling by Non-Receptor Tyrosine Kinases;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P04155	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P04156	Developmental Biology;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Nervous system development
P04179	Cytokine Signaling in Immune system;Mitochondrial biogenesis;Disease;Immune System;Organelle biogenesis and maintenance;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Interleukin-12 family signaling;Signaling by Interleukins;RNA Polymerase II Transcription;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Cellular responses to external stimuli;Interleukin-12 signaling;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Diseases of programmed cell death
P04180	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein remodeling;HDL remodeling
P04181	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
P04183	Metabolism;Metabolism of nucleotides;Cell Cycle;Mitotic G1 phase and G1/S transition;G1/S-Specific Transcription;G1/S Transition;Cell Cycle, Mitotic;Pyrimidine salvage;Nucleotide salvage
P04196	Hemostasis;Platelet degranulation ;Dissolution of Fibrin Clot;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P04211	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P04216	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P04217	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P04222	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P04229	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P04233	Hemostasis;Adaptive Immune System;Immune System;Cell surface interactions at the vascular wall;MHC class II antigen presentation
P04234	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Membrane Trafficking;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P04259	Developmental Biology;Keratinization;Formation of the cornified envelope
P04264	Developmental Biology;Innate Immune System;Immune System;Neutrophil degranulation;Keratinization;Formation of the cornified envelope
P04271	Signaling by ERBB4;Nuclear signaling by ERBB4;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;Advanced glycosylation endproduct receptor signaling;Signaling by Receptor Tyrosine Kinases;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P04275	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Extracellular matrix organization;Signal Transduction;Disease;Immune System;Integrin cell surface interactions;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;GP1b-IX-V activation signalling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);FLT3 Signaling;Signaling downstream of RAS mutants
P04279	Innate Immune System;Immune System;Metabolism of proteins;Antimicrobial peptides;Amyloid fiber formation
P04350	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
P04406	Metabolism;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P04424	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
P04430	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P04432	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P04433	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P04435	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
P04437	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
P04439	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Metabolism of proteins;Post-translational protein modification;Interferon gamma signaling;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P04440	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P04578	Defensins;Alpha-defensins;HIV Life Cycle;Budding and maturation of HIV virion;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Innate Immune System;Immune System;Synthesis and processing of ENV and VPU;Binding and entry of HIV virion;Assembly Of The HIV Virion;Dectin-2 family;C-type lectin receptors (CLRs);Infectious disease;Antimicrobial peptides
P04579	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P04580	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P04581	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P04582	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P04583	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P04585	Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Minus-strand DNA synthesis;Plus-strand DNA synthesis;2-LTR circle formation;Binding and entry of HIV virion;Assembly Of The HIV Virion;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated nuclear import of PICs;Infectious disease
P04591	Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Minus-strand DNA synthesis;Plus-strand DNA synthesis;2-LTR circle formation;Binding and entry of HIV virion;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated nuclear import of PICs;Infectious disease
P04601	Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of CD28 cell surface expression;Nef mediated downregulation of MHC class I complex cell surface expression;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Nef Mediated CD4 Down-regulation;Binding and entry of HIV virion;Assembly Of The HIV Virion;Nef Mediated CD8 Down-regulation;Infectious disease
P04608	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;Interactions of Tat with host cellular proteins;Infectious disease
P04618	Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Minus-strand DNA synthesis;Plus-strand DNA synthesis;2-LTR circle formation;Rev-mediated nuclear export of HIV RNA;Binding and entry of HIV virion;Assembly Of The HIV Virion;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;Infectious disease
P04624	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P04626	Signaling by ERBB2;Signaling by ERBB2 in Cancer;SHC1 events in ERBB2 signaling;PLCG1 events in ERBB2 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;GRB7 events in ERBB2 signaling;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Semaphorin interactions;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;Drug-mediated inhibition of ERBB2 signaling;Signaling by ERBB2 KD Mutants;Drug resistance in ERBB2 KD mutants;Resistance of ERBB2 KD mutants to trastuzumab;Resistance of ERBB2 KD mutants to sapitinib;Resistance of ERBB2 KD mutants to tesevatinib;Resistance of ERBB2 KD mutants to neratinib;Resistance of ERBB2 KD mutants to osimertinib;Resistance of ERBB2 KD mutants to afatinib;Resistance of ERBB2 KD mutants to AEE788;Resistance of ERBB2 KD mutants to lapatinib;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Drug resistance in ERBB2 TMD/JMD mutants;Nervous system development
P04628	Developmental Biology;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Transcriptional regulation of white adipocyte differentiation;Beta-catenin independent WNT signaling;PCP/CE pathway;Disassembly of the destruction complex and recruitment of AXIN to the membrane;GPCR ligand binding
P04629-1	Signal Transduction;Signaling by NTRKs;Prolonged ERK activation events;Frs2-mediated activation;Activation of TRKA receptors;Signaling by NTRK1 (TRKA);TRKA activation by NGF;Signalling to ERKs;Signaling by Receptor Tyrosine Kinases
P04629	Signal Transduction;Signaling by NTRKs;PLC-gamma1 signalling;Signalling to RAS;Prolonged ERK activation events;ARMS-mediated activation;Retrograde neurotrophin signalling;Activation of TRKA receptors;NGF-independant TRKA activation;Signaling by NTRK1 (TRKA);TRKA activation by NGF;Signalling to ERKs;Signalling to p38 via RIT and RIN;PI3K/AKT activation;Signalling to STAT3;Signaling by Receptor Tyrosine Kinases
P04632	Developmental Biology;Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Keratinization;Formation of the cornified envelope;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P04637	Apoptosis;Hemostasis;Intrinsic Pathway for Apoptosis;Activation of NOXA and translocation to mitochondria;Activation of BH3-only proteins;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Activation of PUMA and translocation to mitochondria;Signaling by NOTCH;Signal Transduction;Cell Cycle;Immune System;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);Oncogene Induced Senescence;DNA Damage/Telomere Stress Induced Senescence;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Autodegradation of the E3 ubiquitin ligase COP1;Transcriptional Regulation by TP53;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Signaling by Interleukins;Mitotic G2-G2/M phases;Programmed Cell Death;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of DNA Repair Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;TP53 Regulates Transcription of Caspase Activators and Caspases;TP53 Regulates Transcription of Death Receptors and Ligands;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Regulation of TP53 Expression;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;PTEN Regulation;PI5P Regulates TP53 Acetylation;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Stabilization of p53;Transcriptional activation of p53 responsive genes  ;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Transcriptional  activation of  cell cycle inhibitor p21 ;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX3;RUNX3 regulates CDKN1A transcription;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Factors involved in megakaryocyte development and platelet production
P04731	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P04732	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P04733	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P04745	Digestion of dietary carbohydrate;Digestion;Digestion and absorption
P04746	Digestion of dietary carbohydrate;Digestion;Digestion and absorption
P04792	Signal Transduction;Signaling by VEGF;VEGFA-VEGFR2 Pathway;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;MAPK family signaling cascades;MAPK6/MAPK4 signaling;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling
P04798	Metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of protectins
P04818	Metabolism;Metabolism of nucleotides;Cell Cycle;Mitotic G1 phase and G1/S transition;Interconversion of nucleotide di- and triphosphates;G1/S-Specific Transcription;G1/S Transition;Cell Cycle, Mitotic
P04839	ROS and RNS production in phagocytes;Cross-presentation of particulate exogenous antigens (phagosomes);Antigen processing-Cross presentation;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Cellular responses to stress;Detoxification of Reactive Oxygen Species;VEGFA-VEGFR2 Pathway;RHO GTPases Activate NADPH Oxidases;Neutrophil degranulation;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Class I MHC mediated antigen processing & presentation
P04843	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Translation
P04844	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Translation
P04853	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P04899	Hemostasis;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Signal Transduction;Integration of energy metabolism;Disease;Adenylate cyclase inhibitory pathway;G-protein activation;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;Metabolism of proteins;Signal amplification;Adrenaline,noradrenaline inhibits insulin secretion;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
P04908	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P04920	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P04921	Hemostasis;Cell surface interactions at the vascular wall
P04949	Disease;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR5);IRAK4 deficiency (TLR5);MyD88 cascade initiated on plasma membrane
P04958	Disease;Neurotoxicity of clostridium toxins;Toxicity of tetanus toxin (TeNT);Uptake and actions of bacterial toxins;Infectious disease
P05013	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P05014	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P05015	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P05019	Hemostasis;Platelet degranulation ;Signal Transduction;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Peptide hormone metabolism;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by Receptor Tyrosine Kinases
P05023	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P05026	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P05060	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P05062	Metabolism;Disease;Fructose metabolism;Hereditary fructose intolerance;Diseases of carbohydrate metabolism;Diseases of metabolism;Glycolysis;Gluconeogenesis;Glucose metabolism;Fructose catabolism;Metabolism of carbohydrates
P05067	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Extracellular matrix organization;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;Membrane Trafficking;trans-Golgi Network Vesicle Budding;ECM proteoglycans;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);GPCR downstream signalling;Metabolism of proteins;G alpha (q) signalling events;G alpha (i) signalling events;Lysosome Vesicle Biogenesis;Formyl peptide receptors bind formyl peptides and many other ligands;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;GPCR ligand binding;Vesicle-mediated transport;Infectious disease;Post-translational protein modification;Inflammasomes;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;The NLRP3 inflammasome;Advanced glycosylation endproduct receptor signaling;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Post-translational protein phosphorylation;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Diseases of programmed cell death;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response);TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Amyloid fiber formation
P05089	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Urea cycle;Metabolism of amino acids and derivatives
P05090	Signal Transduction;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of fatty acids;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P05091	Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Metabolism of serotonin;Serotonin clearance from the synaptic cleft;Ethanol oxidation
P05093	Metabolism;Disease;Androgen biosynthesis;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
P05106	Hemostasis;Platelet degranulation ;Developmental Biology;Cytokine Signaling in Immune system;Extracellular matrix organization;Elastic fibre formation;Signal Transduction;Disease;Immune System;Signaling by VEGF;Cell surface interactions at the vascular wall;PECAM1 interactions;Molecules associated with elastic fibres;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;L1CAM interactions;Axon guidance;VEGFA-VEGFR2 Pathway;Signal transduction by L1;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants;Nervous system development
P05107	Hemostasis;Cytokine Signaling in Immune system;Adaptive Immune System;Extracellular matrix organization;Toll Like Receptor 4 (TLR4) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Integrin cell surface interactions;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation
P05108	Metabolism;Disease;Metabolism of steroid hormones;Pregnenolone biosynthesis;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
P05109	Signal Transduction;Innate Immune System;Immune System;Toll-like Receptor Cascades;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate NADPH Oxidases;Regulation of TLR by endogenous ligand;Neutrophil degranulation;Metal sequestration by antimicrobial proteins;Antimicrobial peptides
P05111	Glycoprotein hormones;Peptide hormone biosynthesis;Peptide hormone metabolism;Metabolism of proteins
P05112	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Interleukin-18 signaling
P05113	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P05114	Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Repair
P05120	Hemostasis;Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Dissolution of Fibrin Clot;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P05121	Hemostasis;Platelet degranulation ;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Extracellular matrix organization;Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;ECM proteoglycans;Circadian Clock;RNA Polymerase II Transcription;Gene expression (Transcription);Dissolution of Fibrin Clot;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by TGF-beta family members
P05129	Hemostasis;Opioid Signalling;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Disinhibition of SNARE formation;DAG and IP3 signaling;Signal Transduction;Signaling by WNT;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;PCP/CE pathway;Trafficking of GluR2-containing AMPA receptors;G alpha (i) signalling events;G alpha (z) signalling events;WNT5A-dependent internalization of FZD4;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Intracellular signaling by second messengers
P05141	HIV Infection;Host Interactions of HIV factors;Disease;Interactions of Vpr with host cellular proteins;Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Infectious disease;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
P05154	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade)
P05155	Hemostasis;Platelet degranulation ;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Complement cascade;Innate Immune System;Immune System;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Regulation of Complement cascade
P05156	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P05160	Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade)
P05161	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Disease;Innate Immune System;Influenza Infection;Immune System;NS1 Mediated Effects on Host Pathways;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Termination of translesion DNA synthesis;Infectious disease;DNA Damage Bypass;DNA Repair;Interferon alpha/beta signaling;Interferon Signaling;Negative regulators of DDX58/IFIH1 signaling
P05164	ROS and RNS production in phagocytes;Innate Immune System;Immune System;Neutrophil degranulation;Events associated with phagocytolytic activity of PMN cells
P05165	Metabolism;Disease;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Metabolism of lipids;Diseases of metabolism;Propionyl-CoA catabolism;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
P05166	Metabolism;Disease;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Metabolism of lipids;Diseases of metabolism;Propionyl-CoA catabolism;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
P05177	Metabolism;Phase II - Conjugation of compounds;Methylation;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2;Xenobiotics;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Aflatoxin activation and detoxification;Metabolism of lipids;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of protectins;Biosynthesis of maresins;Biosynthesis of maresin-like SPMs
P05181	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions;Metabolism of lipids;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of maresins;Biosynthesis of maresin-like SPMs
P05186	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P05187	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
P05198	L13a-mediated translational silencing of Ceruloplasmin expression;Cellular responses to stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P05230	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR1b ligand binding and activation;FGFR3b ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR2 IIIa TM;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P05231	Interleukin-6 signaling;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Signaling by Interleukins;Infectious disease;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;Interleukin-6 family signaling;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Post-translational protein phosphorylation;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P05305	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P05362	Cytokine Signaling in Immune system;Adaptive Immune System;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions;Signaling by Interleukins;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Interferon gamma signaling;Interferon Signaling
P05386	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P05387	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P05388	Developmental Biology;Cytokine Signaling in Immune system;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Interleukin-12 family signaling;Signaling by Interleukins;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Interleukin-12 signaling;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P05412	PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;FCERI mediated MAPK activation;Transcriptional Regulation by TP53;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Activation of the AP-1 family of transcription factors;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Infectious disease;MAPK family signaling cascades;MAPK6/MAPK4 signaling;TP53 Regulates Transcription of DNA Repair Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;ESR-mediated signaling;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;TRIF(TICAM1)-mediated TLR4 signaling ;Diseases of programmed cell death;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P05413	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
P05423	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
P05452	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P05455	RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation
P05496	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation;Protein localization
P05534	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P05538	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P05546	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P05549-1	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
P05549	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;TFAP2 (AP-2) family regulates transcription of other transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;TFAP2 (AP-2) family regulates transcription of cell cycle factors;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
P05556	Hemostasis;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Extracellular matrix organization;Cell-Cell communication;Elastic fibre formation;Fibronectin matrix formation;Signal Transduction;Disease;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Basigin interactions;Molecules associated with elastic fibres;Integrin cell surface interactions;Laminin interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Semaphorin interactions;L1CAM interactions;Other semaphorin interactions;Axon guidance;Signal transduction by L1;Localization of the PINCH-ILK-PARVIN complex to focal adhesions;Cell-extracellular matrix interactions;Cell junction organization;CHL1 interactions;Signaling by Interleukins;Infectious disease;RHO GTPases Activate Formins;Interleukin-4 and Interleukin-13 signaling;Signaling by MET;Platelet Adhesion to exposed collagen;MET activates PTK2 signaling;MET interacts with TNS proteins;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases;HCMV Infection;HCMV Early Events;Nervous system development
P05771	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Disinhibition of SNARE formation;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Adaptive Immune System;Signal Transduction;Cell Cycle;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;Generic Transcription Pathway;Nuclear Envelope Breakdown;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;PCP/CE pathway;Trafficking of GluR2-containing AMPA receptors;G alpha (z) signalling events;Depolymerisation of the Nuclear Lamina;VEGFA-VEGFR2 Pathway;WNT5A-dependent internalization of FZD4;VEGFR2 mediated cell proliferation;RHO GTPases Activate NADPH Oxidases;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;Signaling by Receptor Tyrosine Kinases;Signaling by the B Cell Receptor (BCR)
P05783	Developmental Biology;Keratinization;Formation of the cornified envelope
P05787	Developmental Biology;Keratinization;Formation of the cornified envelope
P05814	Signaling by ERBB4;Nuclear signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases
P05877	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P05878	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P05879	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P05880	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P05881	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P05882	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P05919	Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Minus-strand DNA synthesis;Plus-strand DNA synthesis;2-LTR circle formation;Synthesis and processing of ENV and VPU;Binding and entry of HIV virion;Assembly Of The HIV Virion;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;Vpu mediated degradation of CD4;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated nuclear import of PICs;Infectious disease
P05937	Metabolism of proteins;Amyloid fiber formation
P05976	Striated Muscle Contraction;Muscle contraction
P05981	Signal Transduction;Signaling by MET;MET Receptor Activation;Signaling by MST1;Signaling by Receptor Tyrosine Kinases
P05997	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P06028	Hemostasis;Cell surface interactions at the vascular wall
P06126	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P06132	Metabolism;Metabolism of porphyrins;Heme biosynthesis
P06133	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
P06179	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The IPAF inflammasome
P06213	PIP3 activates AKT signaling;Signal Transduction;Negative regulation of the PI3K/AKT network;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;IRS activation;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Insulin receptor recycling;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases
P06239	Hemostasis;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Nef Mediated CD4 Down-regulation;Innate Immune System;Immune System;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Cell surface interactions at the vascular wall;PECAM1 interactions;DAP12 interactions;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;DAP12 signaling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CD28 dependent Vav1 pathway;CTLA4 inhibitory signaling;PD-1 signaling;Signaling by Interleukins;Interleukin-2 family signaling;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Interleukin-2 signaling
P06241-1	Developmental Biology;Signal Transduction;Signaling by NTRKs;Netrin-1 signaling;DCC mediated attractive signaling;Axon guidance;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through FYN;NTRK2 activates RAC1;Nervous system development
P06241	Hemostasis;GPVI-mediated activation cascade;Signaling by ERBB2;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Regulation of KIT signaling;Cell-Cell communication;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Signaling by VEGF;Negative regulation of the PI3K/AKT network;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;PECAM1 interactions;DAP12 interactions;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;Role of LAT2/NTAL/LAB on calcium mobilization;Nephrin family interactions;Semaphorin interactions;NCAM signaling for neurite out-growth;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CD28 dependent Vav1 pathway;CTLA4 inhibitory signaling;EPHB-mediated forward signaling;EPHA-mediated growth cone collapse;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Axon guidance;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Dectin-2 family;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Reelin signalling pathway;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Regulation of signaling by CBL;FLT3 Signaling;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P06276	Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Peptide hormone metabolism;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin;Metabolism of lipids
P06280	Metabolism;Glycosphingolipid metabolism;Innate Immune System;Immune System;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation
P06307	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P06310	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P06312	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P06315	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P06331	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P06340	Adaptive Immune System;Immune System;MHC class II antigen presentation
P06396	Apoptosis;Apoptotic cleavage of cellular proteins;Innate Immune System;Immune System;Caspase-mediated cleavage of cytoskeletal proteins;Metabolism of proteins;Programmed Cell Death;Neutrophil degranulation;Apoptotic execution phase;Amyloid fiber formation
P06400	Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Cell Cycle;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);Oncogene Induced Senescence;DNA Damage/Telomere Stress Induced Senescence;Mitotic G1 phase and G1/S transition;Mitotic Prophase;M Phase;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Cellular responses to external stimuli
P06401-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P06401	Signaling by ERBB4;Nuclear signaling by ERBB4;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HSP90 chaperone cycle for steroid hormone receptors (SHR);Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P06493	MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Signal Transduction;Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes;APC/C:Cdc20 mediated degradation of Cyclin B;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Phosphorylation of Emi1;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Organelle biogenesis and maintenance;Generic Transcription Pathway;Condensation of Prophase Chromosomes;MASTL Facilitates Mitotic Progression;Resolution of Sister Chromatid Cohesion;Condensation of Prometaphase Chromosomes;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope Breakdown;Activation of NIMA Kinases NEK9, NEK6, NEK7;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Nuclear Pore Complex (NPC) Disassembly;Transcriptional Regulation by TP53;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Depolymerisation of the Nuclear Lamina;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Regulation of TP53 Activity;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G1/S-Specific Transcription;G1/S Transition;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M DNA replication checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;Transcriptional regulation by RUNX2
P06576	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Cristae formation;Protein localization
P06681	Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Activation of C3 and C5;Regulation of Complement cascade
P06702	Signal Transduction;Innate Immune System;Immune System;Toll-like Receptor Cascades;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate NADPH Oxidases;Regulation of TLR by endogenous ligand;Neutrophil degranulation;Metal sequestration by antimicrobial proteins;Antimicrobial peptides
P06725	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P06727	Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Chylomicron assembly;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein assembly;Plasma lipoprotein remodeling;Chylomicron remodeling;Retinoid metabolism and transport;Amyloid fiber formation
P06729	Hemostasis;Cell surface interactions at the vascular wall
P06730	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;L13a-mediated translational silencing of Ceruloplasmin expression;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Signal Transduction;mTOR signalling;mTORC1-mediated signalling;Immune System;Metabolism of proteins;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;Metabolism of RNA;Interferon Signaling
P06731	Hemostasis;Post-translational modification: synthesis of GPI-anchored proteins;Cell surface interactions at the vascular wall;Metabolism of proteins;Post-translational protein modification
P06732	Metabolism;Creatine metabolism;Metabolism of amino acids and derivatives
P06733	Metabolism;Disease;Infectious disease;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;Infection with Mycobacterium tuberculosis;Manipulation of host energy metabolism;Response of Mtb to phagocytosis
P06734	Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Immune System;Signaling by NOTCH2;NOTCH2 intracellular domain regulates transcription;Signaling by Interleukins;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling
P06737	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P06744	Metabolism;Innate Immune System;Immune System;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Neutrophil degranulation;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription)
P06746	POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Resolution of AP sites via the single-nucleotide replacement pathway;Metabolism of proteins;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;PCNA-Dependent Long Patch Base Excision Repair;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Base Excision Repair;DNA Repair;Abasic sugar-phosphate removal via the single-nucleotide replacement pathway;Resolution of Abasic Sites (AP sites)
P06748	HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;SUMOylation of transcription cofactors;Metabolism of proteins;Infectious disease;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Chromosome Maintenance;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
P06753	Striated Muscle Contraction;Muscle contraction;Smooth Muscle Contraction
P06756	Hemostasis;Cross-presentation of particulate exogenous antigens (phagosomes);Antigen processing-Cross presentation;Developmental Biology;Adaptive Immune System;Extracellular matrix organization;Elastic fibre formation;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Cell surface interactions at the vascular wall;PECAM1 interactions;Molecules associated with elastic fibres;Integrin cell surface interactions;Laminin interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;L1CAM interactions;Axon guidance;VEGFA-VEGFR2 Pathway;Signal transduction by L1;Neutrophil degranulation;Signaling by Receptor Tyrosine Kinases;Nervous system development;Class I MHC mediated antigen processing & presentation
P06821	Disease;Influenza Infection;Virus Assembly and Release;Fusion and Uncoating of the Influenza Virion;Influenza Viral RNA Transcription and Replication;Entry of Influenza Virion into Host Cell via Endocytosis;Fusion of the Influenza Virion to the Host Cell Endosome;Release;Budding;Packaging of Eight RNA Segments;Assembly of Viral Components at the Budding Site;Uncoating of the Influenza Virion;Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus;Viral mRNA Translation;Infectious disease
P06850	Signal Transduction;Disease;Generic Transcription Pathway;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates transcription of neuronal ligands;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P06858	Developmental Biology;Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;Transcriptional regulation of white adipocyte differentiation;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Chylomicron remodeling;Retinoid metabolism and transport
P06865	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Glycosphingolipid metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Keratan sulfate degradation;CS/DS degradation;Hyaluronan metabolism;Hyaluronan uptake and degradation;Diseases associated with glycosaminoglycan metabolism;Defective HEXA causes GM2G1;Diseases of glycosylation;Sphingolipid metabolism;Metabolism of lipids;Diseases of metabolism;Metabolism of carbohydrates
P06870	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins
P06881	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P06899	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P07093	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Dissolution of Fibrin Clot
P07098	Digestion of dietary lipid;Digestion;Digestion and absorption
P07099	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
P07101	Metabolism;Metabolism of amine-derived hormones;Catecholamine biosynthesis;Metabolism of amino acids and derivatives
P07108	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
P07148	Metabolism;Triglyceride catabolism;Metabolism of porphyrins;Heme degradation;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Triglyceride metabolism
P07195	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
P07196	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation
P07202	Metabolism;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Metabolism of amino acids and derivatives
P07203	Metabolism;Metabolism of nucleotides;Synthesis of 5-eicosatetraenoic acids;Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Synthesis of 15-eicosatetraenoic acid derivatives;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Metabolism of lipids;Purine catabolism;Cellular responses to external stimuli;Nucleobase catabolism;Fatty acid metabolism
P07204	Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Cell surface interactions at the vascular wall
P07205	Metabolism;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P07225	Hemostasis;Platelet degranulation ;Intrinsic Pathway of Fibrin Clot Formation;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Complement cascade;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Regulation of Complement cascade
P07237	Cytokine Signaling in Immune system;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Interleukin-12 family signaling;Signaling by Interleukins;Hedgehog ligand biogenesis;Signaling by Hedgehog;Post-translational protein modification;VLDL assembly;Cellular responses to external stimuli;Post-translational protein phosphorylation;Chylomicron assembly;Plasma lipoprotein assembly;Interleukin-12 signaling;Interleukin-23 signaling
P07288	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
P07305	Apoptosis;Apoptosis induced DNA fragmentation;Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Programmed Cell Death;Apoptotic execution phase;Cellular responses to external stimuli
P07306	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification
P07307	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification
P07327	Metabolism;Signal Transduction;Biological oxidations;Phase I - Functionalization of compounds;Abacavir transport and metabolism;Abacavir metabolism;Signaling by Retinoic Acid;RA biosynthesis pathway;Ethanol oxidation;Signaling by Nuclear Receptors
P07332	Developmental Biology;Signaling by SCF-KIT;Signal Transduction;Semaphorin interactions;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Axon guidance;Signaling by Receptor Tyrosine Kinases;Nervous system development
P07333	Cytokine Signaling in Immune system;Immune System;Generic Transcription Pathway;Signaling by Interleukins;Other interleukin signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX
P07339	Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Innate Immune System;Immune System;Metabolism of Angiotensinogen to Angiotensins;MHC class II antigen presentation;Peptide hormone metabolism;Metabolism of proteins;Neutrophil degranulation;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P07355	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;Muscle contraction;Smooth Muscle Contraction;Interleukin-12 family signaling;Signaling by Interleukins;Neutrophil degranulation;Dissolution of Fibrin Clot;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P07357	Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Regulation of Complement cascade
P07358	Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Regulation of Complement cascade
P07359	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Generic Transcription Pathway;GP1b-IX-V activation signalling;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
P07360	Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Regulation of Complement cascade
P07384	Developmental Biology;Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Innate Immune System;Immune System;Neutrophil degranulation;Keratinization;Formation of the cornified envelope;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P07385	Signal Transduction;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Programmed Cell Death;Regulation of TNFR1 signaling;Regulation of necroptotic cell death;Death Receptor Signalling;TNF signaling
P07437	Cell Cycle;Innate Immune System;Immune System;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Neutrophil degranulation;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
P07438	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P07451	Metabolism;Reversible hydration of carbon dioxide
P07476	Developmental Biology;Keratinization;Formation of the cornified envelope
P07477	Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P07478	Collagen degradation;Defensins;Alpha-defensins;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Innate Immune System;Immune System;Neutrophil degranulation;Antimicrobial peptides
P07492	Signal Transduction;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);GPCR downstream signalling;Metabolism of proteins;Incretin synthesis, secretion, and inactivation;G alpha (q) signalling events;GPCR ligand binding
P07498	Transport of small molecules;Miscellaneous transport and binding events
P07510	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly sodium permeable postsynaptic acetylcholine nicotinic receptors
P07550	Signal Transduction;Disease;Membrane Trafficking;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;Metabolism of proteins;G alpha (s) signalling events;GPCR ligand binding;Vesicle-mediated transport;Infectious disease;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P07585	Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;CS/DS degradation;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective CHST3 causes SEDCJD;Defective CHST14 causes EDS, musculocontractural type;Defective CHSY1 causes TPBS;Diseases of glycosylation;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of carbohydrates
P07602	Hemostasis;Platelet degranulation ;Metabolism;Signal Transduction;Glycosphingolipid metabolism;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Sphingolipid metabolism;GPCR ligand binding;Metabolism of lipids;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P07686	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Glycosphingolipid metabolism;Innate Immune System;Immune System;Chondroitin sulfate/dermatan sulfate metabolism;Keratan sulfate degradation;CS/DS degradation;Hyaluronan metabolism;Hyaluronan uptake and degradation;Diseases associated with glycosaminoglycan metabolism;Defective HEXB causes GM2G2;Diseases of glycosylation;Sphingolipid metabolism;Metabolism of lipids;Diseases of metabolism;Neutrophil degranulation;Metabolism of carbohydrates
P07711	Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Assembly of collagen fibrils and other multimeric structures;Generic Transcription Pathway;MHC class II antigen presentation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes;Class I MHC mediated antigen processing & presentation
P07737	Hemostasis;Platelet degranulation ;Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;Signaling by ROBO receptors;Beta-catenin independent WNT signaling;PCP/CE pathway;Axon guidance;RHO GTPases Activate Formins;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Nervous system development
P07738	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P07741	Metabolism;Metabolism of nucleotides;Innate Immune System;Immune System;Neutrophil degranulation;Purine salvage;Nucleotide salvage
P07766	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Costimulation by the CD28 family;PD-1 signaling
P07814	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;tRNA modification in the nucleus and cytosol;Metabolism of amino acids and derivatives;tRNA processing;Translation;Metabolism of RNA
P07858	Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Assembly of collagen fibrils and other multimeric structures;MHC class II antigen presentation;Neutrophil degranulation
P07864	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
P07900	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Developmental Biology;Cytokine Signaling in Immune system;Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Signaling by EGFR in Cancer;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;Organelle biogenesis and maintenance;vRNP Assembly;Signaling by VEGF;Metabolism of vitamins and cofactors;Metabolism of nitric oxide: eNOS activation and regulation;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;eNOS activation;Gene Silencing by RNA;Binding and Uptake of Ligands by Scavenger Receptors;Cellular responses to stress;Regulation of PLK1 Activity at G2/M Transition;Scavenging by Class F Receptors;HSP90 chaperone cycle for steroid hormone receptors (SHR);HSF1 activation;Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Semaphorin interactions;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Sema3A PAK dependent Axon repulsion;Axon guidance;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Mitotic G2-G2/M phases;VEGFR2 mediated vascular permeability;Uptake and function of diphtheria toxin;Uptake and actions of bacterial toxins;PIWI-interacting RNA (piRNA) biogenesis;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Gene expression (Transcription);The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;Downregulation of ERBB2 signaling;ESR-mediated signaling;Cellular responses to external stimuli;Metabolism of cofactors;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Estrogen-dependent gene expression;Autophagy;Chaperone Mediated Autophagy;Constitutive Signaling by Overexpressed ERBB2;Aggrephagy;Drug-mediated inhibition of ERBB2 signaling;Selective autophagy;Signaling by ERBB2 KD Mutants;Drug resistance in ERBB2 KD mutants;Resistance of ERBB2 KD mutants to trastuzumab;Resistance of ERBB2 KD mutants to sapitinib;Resistance of ERBB2 KD mutants to tesevatinib;Resistance of ERBB2 KD mutants to neratinib;Resistance of ERBB2 KD mutants to osimertinib;Resistance of ERBB2 KD mutants to afatinib;Resistance of ERBB2 KD mutants to AEE788;Resistance of ERBB2 KD mutants to lapatinib;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Drug resistance in ERBB2 TMD/JMD mutants;Nervous system development
P07902	Metabolism;Disease;Diseases of glycosylation;Diseases associated with glycosylation precursor biosynthesis;Defective GALT can cause Galactosemia;Diseases of metabolism;Galactose catabolism;Metabolism of carbohydrates
P07910	SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of RNA binding proteins;Post-translational protein modification;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P07911	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification
P07919	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
P07942	Developmental Biology;Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;L1CAM interactions;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Axon guidance;Post-translational protein modification;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Post-translational protein phosphorylation;Signaling by Receptor Tyrosine Kinases;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P07947	Hemostasis;Signaling by ERBB2;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Disease;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;PECAM1 interactions;Generic Transcription Pathway;EPH-Ephrin signaling;Costimulation by the CD28 family;CD28 co-stimulation;CTLA4 inhibitory signaling;EPHB-mediated forward signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Signaling by Receptor Tyrosine Kinases;Regulation of signaling by CBL;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Nervous system development
P07948	Hemostasis;GPVI-mediated activation cascade;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Cell Cycle;Disease;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;PECAM1 interactions;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Costimulation by the CD28 family;CD28 co-stimulation;CTLA4 inhibitory signaling;EPHB-mediated forward signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Signaling by Interleukins;Mitotic G1 phase and G1/S transition;Interleukin-3, Interleukin-5 and GM-CSF signaling;Dectin-2 family;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Infectious disease;CD22 mediated BCR regulation;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Erythropoietin activates Phospholipase C gamma (PLCG);Erythropoietin activates STAT5;Erythropoietin activates RAS;Regulation of signaling by CBL;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Nervous system development;Growth hormone receptor signaling;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P07949	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
P07951	Striated Muscle Contraction;Muscle contraction;Smooth Muscle Contraction
P07954	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P07988	Disease;Metabolism of proteins;Diseases of metabolism;Surfactant metabolism;Diseases associated with surfactant metabolism;Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS);Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
P07992	HDR through Single Strand Annealing (SSA);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Fanconi Anemia Pathway;DNA Repair
P07996	Hemostasis;Platelet degranulation ;Extracellular matrix organization;Signal Transduction;Disease;Signaling by PDGF;Generic Transcription Pathway;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Signaling by Receptor Tyrosine Kinases
P07998	Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy
P08034	Gap junction trafficking and regulation;Oligomerization of connexins into connexons;Transport of connexins along the secretory pathway;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
P08047	Metabolism;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Signaling by TGF-beta Receptor Complex;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Activation of gene expression by SREBF (SREBP);Cellular Senescence;Oncogene Induced Senescence;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Cellular responses to external stimuli;Metabolism of steroids;Signaling by Nuclear Receptors;Signaling by TGF-beta family members;Estrogen-dependent gene expression
P08069	Signal Transduction;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling
P08100	Signal Transduction;Organelle biogenesis and maintenance;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
P08123	Hemostasis;GPVI-mediated activation cascade;Cytokine Signaling in Immune system;Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Assembly of collagen fibrils and other multimeric structures;Cell surface interactions at the vascular wall;Integrin cell surface interactions;Binding and Uptake of Ligands by Scavenger Receptors;Anchoring fibril formation;Crosslinking of collagen fibrils;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Scavenging by Class A Receptors;GP1b-IX-V activation signalling;Signaling by Interleukins;Vesicle-mediated transport;Interleukin-4 and Interleukin-13 signaling;Signaling by MET;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases
P08133	Muscle contraction;Smooth Muscle Contraction
P08134	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;Sema4D in semaphorin signaling;G alpha (12/13) signalling events;Sema4D induced cell migration and growth-cone collapse;Axon guidance;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases Activate Formins;RHO GTPases Activate Rhotekin and Rhophilins;Nervous system development
P08138	Signal Transduction;Axonal growth inhibition (RHOA activation);p75NTR signals via NF-kB;NRAGE signals death through JNK;p75NTR negatively regulates cell cycle via SC1;Ceramide signalling;Regulated proteolysis of p75NTR;p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;NFG and proNGF binds to p75NTR;NADE modulates death signalling;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Axonal growth stimulation;Death Receptor Signalling
P08151	Signal Transduction;Signaling by Hedgehog;Degradation of GLI1 by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;GLI proteins bind promoters of Hh responsive genes to promote transcription
P08172	Signal Transduction;Membrane Trafficking;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Muscarinic acetylcholine receptors;G alpha (i) signalling events;GPCR ligand binding;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P08173	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Muscarinic acetylcholine receptors;G alpha (i) signalling events;GPCR ligand binding
P08174	Signal Transduction;Complement cascade;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Metabolism of proteins;Asparagine N-linked glycosylation;GPCR ligand binding;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Regulation of Complement cascade
P08183	Metabolism;Abacavir transmembrane transport;Abacavir transport and metabolism;Transport of small molecules;ABC-family proteins mediated transport
P08185	Metabolism;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P08195	Hemostasis;Metabolism;Disease;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;SLC transporter disorders;Disorders of transmembrane transporters;Defective SLC7A7 causes lysinuric protein intolerance (LPI);Tryptophan catabolism;Metabolism of amino acids and derivatives
P08217	Developmental Biology;Keratinization;Formation of the cornified envelope
P08235-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P08235-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P08235-3	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P08235-4	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P08235	Cellular responses to stress;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;Cellular responses to external stimuli
P08236	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Innate Immune System;Immune System;HS-GAG degradation;Hyaluronan metabolism;Hyaluronan uptake and degradation;Mucopolysaccharidoses;MPS VII - Sly syndrome;Diseases of carbohydrate metabolism;Diseases of metabolism;Neutrophil degranulation;Metabolism of carbohydrates
P08237	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P08238	Developmental Biology;Metabolism;Signal Transduction;Cell Cycle;Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Biological oxidations;Phase I - Functionalization of compounds;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);HSF1 activation;Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Semaphorin interactions;Sema3A PAK dependent Axon repulsion;Axon guidance;Mitotic G2-G2/M phases;Uptake and function of diphtheria toxin;Uptake and actions of bacterial toxins;Infectious disease;Inflammasomes;Neutrophil degranulation;G2/M Transition;Cell Cycle, Mitotic;The NLRP3 inflammasome;The role of GTSE1 in G2/M progression after G2 checkpoint;Aryl hydrocarbon receptor signalling;ESR-mediated signaling;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Autophagy;Chaperone Mediated Autophagy;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response);Nervous system development
P08240	SRP-dependent cotranslational protein targeting to membrane;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Translation
P08243	Metabolism;Cellular responses to stress;ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Metabolism of amino acids and derivatives;Cellular responses to external stimuli;Aspartate and asparagine metabolism;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P08246	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Complement cascade;Innate Immune System;Immune System;Neutrophil degranulation;Antimicrobial peptides;Regulation of Complement cascade
P08253	Developmental Biology;Cytokine Signaling in Immune system;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Signal Transduction;Immune System;EPH-Ephrin signaling;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;EPH-ephrin mediated repulsion of cells;Axon guidance;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Nervous system development
P08254	Cytokine Signaling in Immune system;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Activation of Matrix Metalloproteinases;Signal Transduction;Immune System;Assembly of collagen fibrils and other multimeric structures;EGFR Transactivation by Gastrin;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Gastrin-CREB signalling pathway via PKC and MAPK;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
P08263	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Metabolism of porphyrins;Heme degradation;Biological oxidations
P08294	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
P08311	Cytokine Signaling in Immune system;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Disease;Innate Immune System;Immune System;Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Interleukin-1 family signaling;Interleukin-1 processing;Signaling by Interleukins;Infectious disease;Neutrophil degranulation;Antimicrobial peptides;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P08319	Metabolism;Signal Transduction;Biological oxidations;Phase I - Functionalization of compounds;Signaling by Retinoic Acid;RA biosynthesis pathway;Ethanol oxidation;Signaling by Nuclear Receptors
P08397	Metabolism;Metabolism of porphyrins;Heme biosynthesis
P08473	Innate Immune System;Immune System;Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins;Neutrophil degranulation
P08476	Signaling by Activin;Signal Transduction;Glycoprotein hormones;Peptide hormone biosynthesis;Antagonism of Activin by Follistatin;Peptide hormone metabolism;Metabolism of proteins;Signaling by TGF-beta family members
P08514	Hemostasis;Platelet degranulation ;Developmental Biology;Cytokine Signaling in Immune system;Extracellular matrix organization;Signal Transduction;Disease;Immune System;Generic Transcription Pathway;Integrin cell surface interactions;ECM proteoglycans;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;L1CAM interactions;Axon guidance;Signal transduction by L1;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;FLT3 Signaling;Signaling downstream of RAS mutants;Nervous system development
P08519	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein remodeling;LDL remodeling
P08559	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Glyoxylate metabolism and glycine degradation;Signaling by Retinoic Acid;Pyruvate metabolism;Metabolism of amino acids and derivatives;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
P08567	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P08571	Apoptosis;ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Caspase activation via Death Receptors in the presence of ligand;Disease;Toll Like Receptor 4 (TLR4) Cascade;Transfer of LPS from LBP carrier to CD14;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF-mediated programmed cell death;Diseases of Immune System;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Regulation of TLR by endogenous ligand;Neutrophil degranulation;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Class I MHC mediated antigen processing & presentation
P08572	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Binding and Uptake of Ligands by Scavenger Receptors;Anchoring fibril formation;Crosslinking of collagen fibrils;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Scavenging by Class A Receptors;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Vesicle-mediated transport;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P08574	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Protein localization
P08575	Developmental Biology;Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Neutrophil degranulation;Nervous system development
P08579	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P08581	PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Semaphorin interactions;Sema4D in semaphorin signaling;Sema4D mediated inhibition of cell attachment and migration;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by MET;MET Receptor Activation;Negative regulation of MET activity;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);MET activates RAS signaling;MET activates PI3K/AKT signaling;MET activates PTPN11;MET activates PTK2 signaling;InlB-mediated entry of Listeria monocytogenes into host cell;MET interacts with TNS proteins;MET activates RAP1 and RAC1;MET receptor recycling;MET activates STAT3;MET promotes cell motility;Listeria monocytogenes entry into host cells;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;MECP2 regulates neuronal receptors and channels;FLT3 Signaling;Nervous system development
P08582	Post-translational modification: synthesis of GPI-anchored proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P08588	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P08590	Striated Muscle Contraction;Muscle contraction
P08603	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P08620	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P08621	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P08631	Cytokine Signaling in Immune system;HIV Infection;Host Interactions of HIV factors;Disease;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Infectious disease;Regulation of signaling by CBL;FLT3 Signaling;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival
P08637	Adaptive Immune System;Disease;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival
P08648	Hemostasis;Developmental Biology;Extracellular matrix organization;Elastic fibre formation;Fibronectin matrix formation;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Integrin cell surface interactions;L1CAM interactions;Axon guidance;Signal transduction by L1;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates genes involved in cell migration;Nervous system development
P08651	RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation
P08670	Apoptosis;Apoptotic cleavage of cellular proteins;Cytokine Signaling in Immune system;Macroautophagy;Immune System;Caspase-mediated cleavage of cytoskeletal proteins;Striated Muscle Contraction;Muscle contraction;Signaling by Interleukins;Programmed Cell Death;Interleukin-4 and Interleukin-13 signaling;Apoptotic execution phase;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
P08684	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;Aflatoxin activation and detoxification;Metabolism of lipids;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of maresins;Biosynthesis of maresin-like SPMs
P08686	Metabolism;Disease;Mineralocorticoid biosynthesis;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
P08697	Hemostasis;Platelet degranulation ;Dissolution of Fibrin Clot;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P08700	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Generic Transcription Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in interleukin signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P08708	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P08709	Hemostasis;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Extrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Circadian Clock;Post-translational protein modification
P08727	Developmental Biology;Keratinization;Formation of the cornified envelope
P08729	Developmental Biology;Keratinization;Formation of the cornified envelope
P08754	Hemostasis;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signal Transduction;Disease;Adenylate cyclase inhibitory pathway;G-protein activation;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;Metabolism of proteins;Signal amplification;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
P08758	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P08779	Developmental Biology;Keratinization;Formation of the cornified envelope
P08833	Generic Transcription Pathway;ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein phosphorylation;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P08842	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
P08865	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P08887-2	Interleukin-6 signaling;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-6 family signaling
P08887	Interleukin-6 signaling;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-6 family signaling;Interleukin-4 and Interleukin-13 signaling;Transcriptional regulation of granulopoiesis
P08908	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (i) signalling events;GPCR ligand binding
P08912	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Muscarinic acetylcholine receptors;G alpha (q) signalling events;GPCR ligand binding
P08913	Hemostasis;Metabolism;Signal Transduction;Integration of energy metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;Adrenaline signalling through Alpha-2 adrenergic receptor;Metabolism of proteins;Adrenaline,noradrenaline inhibits insulin secretion;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;GPCR ligand binding;Surfactant metabolism;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P08949	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P08962	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P09001	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P09012	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P09016	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P09017	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P09038	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Extracellular matrix organization;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR1b ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Syndecan interactions;Non-integrin membrane-ECM interactions;Signaling by Interleukins;Transcriptional regulation of pluripotent stem cells;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-4 and Interleukin-13 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR2 IIIa TM;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P09086	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
P09104	Metabolism;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P09110	Metabolism;Innate Immune System;Immune System;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;alpha-linolenic acid (ALA) metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Neutrophil degranulation;Fatty acid metabolism;Peroxisomal protein import;TYSND1 cleaves peroxisomal proteins;Protein localization
P09132	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
P09172	Metabolism;Metabolism of amine-derived hormones;Catecholamine biosynthesis;Metabolism of amino acids and derivatives
P09210	Cytokine Signaling in Immune system;Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Immune System;Biological oxidations;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P09211	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Innate Immune System;Immune System;Biological oxidations;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Neutrophil degranulation;Cellular responses to external stimuli
P09234	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P09237	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Activation of Matrix Metalloproteinases;Signal Transduction;Assembly of collagen fibrils and other multimeric structures;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
P09238	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
P09326	Hemostasis;Cell surface interactions at the vascular wall
P09341	Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling;Neutrophil degranulation
P09382	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P09417	Metabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine metabolism;Phenylalanine metabolism
P09429	Apoptosis;Cytokine Signaling in Immune system;Apoptosis induced DNA fragmentation;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;Programmed Cell Death;Regulation of TLR by endogenous ligand;Neutrophil degranulation;Apoptotic execution phase;Advanced glycosylation endproduct receptor signaling;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P09455	Metabolism;Signal Transduction;Disease;Metabolism of vitamins and cofactors;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Diseases of the neuronal system;Retinoid metabolism and transport
P09467	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P09471	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Signal Transduction;Signaling by WNT;G-protein activation;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Ca2+ pathway;G alpha (i) signalling events;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P09486	Hemostasis;Platelet degranulation ;Signaling by ERBB4;Nuclear signaling by ERBB4;Extracellular matrix organization;Signal Transduction;Binding and Uptake of Ligands by Scavenger Receptors;ECM proteoglycans;Scavenging by Class H Receptors;Vesicle-mediated transport;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by Receptor Tyrosine Kinases
P09488	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P09493	Striated Muscle Contraction;Muscle contraction;Smooth Muscle Contraction
P09496-1	Adaptive Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
P09496	Developmental Biology;Adaptive Immune System;Gap junction trafficking and regulation;Signal Transduction;Disease;Signaling by NTRKs;Influenza Infection;Immune System;Entry of Influenza Virion into Host Cell via Endocytosis;Plasma lipoprotein assembly, remodeling, and clearance;Retrograde neurotrophin signalling;Signaling by NTRK1 (TRKA);Gap junction trafficking;Gap junction degradation;Signaling by WNT;Formation of annular gap junctions;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;Transport of small molecules;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;PCP/CE pathway;Axon guidance;Lysosome Vesicle Biogenesis;Recycling pathway of L1;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDLR internalisation and degradation;LDL clearance;Plasma lipoprotein clearance;Signaling by Receptor Tyrosine Kinases;Nervous system development
P09497	Developmental Biology;Gap junction trafficking and regulation;Signal Transduction;Gap junction trafficking;Gap junction degradation;Signaling by WNT;Formation of annular gap junctions;Membrane Trafficking;trans-Golgi Network Vesicle Budding;EPH-Ephrin signaling;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;PCP/CE pathway;Axon guidance;Lysosome Vesicle Biogenesis;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Nervous system development
P09529	Signaling by Activin;Signal Transduction;Glycoprotein hormones;Peptide hormone biosynthesis;Antagonism of Activin by Follistatin;Peptide hormone metabolism;Metabolism of proteins;Signaling by TGF-beta family members
P09544	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
P09601	Cytokine Signaling in Immune system;Metabolism;Immune System;Metabolism of porphyrins;Heme degradation;Transport of small molecules;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Iron uptake and transport;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P09603	Cytokine Signaling in Immune system;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Signaling by Interleukins;Other interleukin signaling;Post-translational protein modification;Interleukin-10 signaling;Post-translational protein phosphorylation
P09616	Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Infectious disease;Inflammasomes;The NLRP3 inflammasome;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P09619	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Downstream signal transduction;Signaling by PDGF;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P09622	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Glyoxylate metabolism and glycine degradation;Signaling by Retinoic Acid;Glycine degradation;Pyruvate metabolism;Branched-chain amino acid catabolism;Lysine catabolism;Metabolism of amino acids and derivatives;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
P09651	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases
P09661	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Metabolism of RNA;Interleukin-12 signaling
P09668	Adaptive Immune System;Innate Immune System;Immune System;MHC class II antigen presentation;Metabolism of proteins;Surfactant metabolism;Neutrophil degranulation
P09669	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P09681	Signal Transduction;Disease;Peptide hormone metabolism;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P09683	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P09693	Adaptive Immune System;Disease;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Membrane Trafficking;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Costimulation by the CD28 family;PD-1 signaling;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival
P09727	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
P09769	Hemostasis;Disease;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Platelet homeostasis;Platelet sensitization by LDL;Infectious disease;Neutrophil degranulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival
P09848	Disease;Digestion of dietary carbohydrate;Intestinal saccharidase deficiencies;Diseases of carbohydrate metabolism;Diseases of metabolism;Digestion;Digestion and absorption
P09871	Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Regulation of Complement cascade
P09874	POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;HDR through MMEJ (alt-NHEJ);DNA Double-Strand Break Repair;Homology Directed Repair;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;RNA Polymerase II Transcription;Base Excision Repair;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription);Signaling by TGF-beta family members
P09884	Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;Extension of Telomeres;Mitotic G1 phase and G1/S transition;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance
P09888	Hemostasis;Cell surface interactions at the vascular wall
P09912	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
P09913	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
P09914	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
P09917	Cytokine Signaling in Immune system;Metabolism;Innate Immune System;Immune System;Synthesis of 5-eicosatetraenoic acids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Synthesis of Lipoxins (LX);Arachidonic acid metabolism;Interleukin-1 family signaling;Signaling by Interleukins;Metabolism of lipids;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation;Fatty acid metabolism;Interleukin-18 signaling;Biosynthesis of D-series resolvins;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of EPA-derived SPMs;Biosynthesis of maresins;Biosynthesis of DPA-derived SPMs;Biosynthesis of E-series 18(S)-resolvins;Biosynthesis of aspirin-triggered D-series resolvins;Biosynthesis of E-series 18(R)-resolvins;Biosynthesis of DPAn-3 SPMs;Biosynthesis of DPAn-3-derived protectins and resolvins;Biosynthesis of DPAn-3-derived maresins;Biosynthesis of DPAn-3-derived 13-series resolvins;Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives
P09919	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling;Interleukin-10 signaling
P09923	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Metabolism of lipids;Post-translational protein modification;Digestion;Digestion and absorption
P09936	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification
P09958	Signaling by NODAL;Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Elastic fibre formation;Signaling by NOTCH;Activation of Matrix Metalloproteinases;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Gamma carboxylation, hypusine formation and arylsulfatase activation;Disease;Signaling by NTRKs;NGF processing;Signaling by TGF-beta Receptor Complex;Synthesis and processing of ENV and VPU;Plasma lipoprotein assembly, remodeling, and clearance;Assembly Of The HIV Virion;Signaling by PDGF;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;TGF-beta receptor signaling activates SMADs;Transport of small molecules;Metabolism of proteins;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease;Post-translational protein modification;Keratinization;Formation of the cornified envelope;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;Expression and Processing of Neurotrophins;Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;Amyloid fiber formation
P09960	Metabolism;Innate Immune System;Immune System;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Metabolism of lipids;Neutrophil degranulation;Fatty acid metabolism;Biosynthesis of D-series resolvins;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of EPA-derived SPMs;Biosynthesis of protectins;Biosynthesis of E-series 18(S)-resolvins;Biosynthesis of aspirin-triggered D-series resolvins;Biosynthesis of E-series 18(R)-resolvins
P09972	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P0C024	Metabolism;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
P0C0L4	Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Activation of C3 and C5;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation;Regulation of Complement cascade
P0C0L5	Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Activation of C3 and C5;Regulation of Complement cascade
P0C0P6	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P0C0S5	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P0C0S8	Disease;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;HCMV Infection;HCMV Early Events;HCMV Late Events
P0C0U1	Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;Influenza Virus Induced Apoptosis;Viral mRNA Translation;Infectious disease
P0C1Z6	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
P0C5Y4	Developmental Biology;Keratinization
P0C5Y9	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P0C604	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C617	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C623	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C626	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C628	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C629	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C645	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C646	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C7H8	Developmental Biology;Keratinization
P0C7I0	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
P0C7M3	Disease;Metabolism of proteins;Diseases of metabolism;Surfactant metabolism;Diseases associated with surfactant metabolism;Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
P0C7M7	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Biological oxidations
P0C7N1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C7N5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C7N8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C7T2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C7T3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P0C7X2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P0C869	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PG;Hydrolysis of LPC;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Metabolism of lipids
P0CB33	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P0CF74	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P0CG04	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P0CG13	Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Chromosome Maintenance
P0CG29	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P0CG30	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P0CG37	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL
P0CG47	Apoptosis;Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Signaling by ERBB2;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;ER-Phagosome pathway;Antigen processing-Cross presentation;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Downregulation of ERBB2:ERBB3 signaling;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Macroautophagy;Cell Cycle;Disease;Signaling by EGFR in Cancer;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Regulation of Apoptosis;Signaling by TGF-beta Receptor Complex;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Signaling by EGFR;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Toll Like Receptor 2 (TLR2) Cascade;EGFR downregulation;Cytosolic sensors of pathogen-associated DNA ;SCF(Skp2)-mediated degradation of p27/p21;Signaling by FGFR;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;Signaling by NOTCH2;Membrane Trafficking;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Regulation of activated PAK-2p34 by proteasome mediated degradation;NOTCH1 Intracellular Domain Regulates Transcription;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Regulation of PLK1 Activity at G2/M Transition;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Stimuli-sensing channels;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;FCERI mediated NF-kB activation;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Regulation of innate immune responses to cytosolic DNA;Glycogen storage diseases;Glycogen synthesis;Autodegradation of the E3 ubiquitin ligase COP1;Transcriptional Regulation by TP53;Signaling by ROBO receptors;Deactivation of the beta-catenin transactivating complex;Myoclonic epilepsy of Lafora;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;Circadian Clock;PCP/CE pathway;Axon guidance;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Asparagine N-linked glycosylation;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Regulation of FZD by ubiquitination;Interleukin-3, Interleukin-5 and GM-CSF signaling;Mitophagy;Pink/Parkin Mediated Mitophagy;RIPK1-mediated regulated necrosis;Regulated Necrosis;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of TP53 Activity;Signaling by Ligand-Responsive EGFR Variants in Cancer;Vesicle-mediated transport;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;Regulation of RAS by GAPs;Diseases of carbohydrate metabolism;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;Diseases of metabolism;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;Regulation of necroptotic cell death;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAP3K8 (TPL2)-dependent MAPK1/3 activation;MAPK1/MAPK3 signaling;HDR through Homologous Recombination (HRR);MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Josephin domain DUBs;Ub-specific processing proteases;Ovarian tumor domain proteases;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Double Strand Break Response;Processing of DNA double-strand break ends;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Fanconi Anemia Pathway;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;Signaling by MET;Negative regulation of MET activity;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of carbohydrates;RNA Polymerase II Transcription;Death Receptor Signalling;DNA Damage Bypass;DNA Repair;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;TNF signaling;Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;Protein ubiquitination;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Downregulation of ERBB2 signaling;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN localization;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Glycogen metabolism;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;TICAM1-dependent activation of IRF3/IRF7;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;Peroxisomal protein import;Regulation of signaling by CBL;Interferon Signaling;Endosomal Sorting Complex Required For Transport (ESCRT);Iron uptake and transport;Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Protein localization;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Modulation by Mtb of host immune system;Suppression of phagosomal maturation;Response of Mtb to phagocytosis;Alpha-protein kinase 1 signaling pathway;Aggrephagy;Selective autophagy;Pexophagy;Nervous system development;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane;Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR);Ion channel transport
P0CG48	Apoptosis;Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Signaling by ERBB2;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;ER-Phagosome pathway;Antigen processing-Cross presentation;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Downregulation of ERBB2:ERBB3 signaling;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Macroautophagy;Cell Cycle;Disease;Signaling by EGFR in Cancer;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Regulation of Apoptosis;Signaling by TGF-beta Receptor Complex;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Signaling by EGFR;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Toll Like Receptor 2 (TLR2) Cascade;EGFR downregulation;Cytosolic sensors of pathogen-associated DNA ;SCF(Skp2)-mediated degradation of p27/p21;Signaling by FGFR;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;Signaling by NOTCH2;Membrane Trafficking;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Regulation of activated PAK-2p34 by proteasome mediated degradation;NOTCH1 Intracellular Domain Regulates Transcription;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Regulation of PLK1 Activity at G2/M Transition;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Stimuli-sensing channels;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;FCERI mediated NF-kB activation;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Regulation of innate immune responses to cytosolic DNA;Glycogen storage diseases;Glycogen synthesis;Autodegradation of the E3 ubiquitin ligase COP1;Transcriptional Regulation by TP53;Signaling by ROBO receptors;Deactivation of the beta-catenin transactivating complex;Myoclonic epilepsy of Lafora;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;Circadian Clock;PCP/CE pathway;Axon guidance;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Asparagine N-linked glycosylation;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Regulation of FZD by ubiquitination;Interleukin-3, Interleukin-5 and GM-CSF signaling;Mitophagy;Pink/Parkin Mediated Mitophagy;RIPK1-mediated regulated necrosis;Regulated Necrosis;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of TP53 Activity;Signaling by Ligand-Responsive EGFR Variants in Cancer;Vesicle-mediated transport;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;Regulation of RAS by GAPs;Diseases of carbohydrate metabolism;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;Diseases of metabolism;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;Regulation of necroptotic cell death;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAP3K8 (TPL2)-dependent MAPK1/3 activation;MAPK1/MAPK3 signaling;HDR through Homologous Recombination (HRR);MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Josephin domain DUBs;Ub-specific processing proteases;Ovarian tumor domain proteases;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Double Strand Break Response;Processing of DNA double-strand break ends;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Fanconi Anemia Pathway;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;Signaling by MET;Negative regulation of MET activity;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of carbohydrates;RNA Polymerase II Transcription;Death Receptor Signalling;DNA Damage Bypass;DNA Repair;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;TNF signaling;Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;Protein ubiquitination;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Downregulation of ERBB2 signaling;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN localization;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Glycogen metabolism;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;TICAM1-dependent activation of IRF3/IRF7;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;Peroxisomal protein import;Regulation of signaling by CBL;Interferon Signaling;Endosomal Sorting Complex Required For Transport (ESCRT);Iron uptake and transport;Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Protein localization;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Modulation by Mtb of host immune system;Suppression of phagosomal maturation;Response of Mtb to phagocytosis;Alpha-protein kinase 1 signaling pathway;Aggrephagy;Selective autophagy;Pexophagy;Nervous system development;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane;Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR);Ion channel transport
P0CH99	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P0DI81	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
P0DJD7	Metabolism of proteins;Surfactant metabolism
P0DJD8	Metabolism of proteins;Surfactant metabolism
P0DJD9	Metabolism of proteins;Surfactant metabolism
P0DJI8	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class B Receptors;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;G alpha (q) signalling events;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;GPCR ligand binding;Vesicle-mediated transport;Interleukin-4 and Interleukin-13 signaling;Advanced glycosylation endproduct receptor signaling;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Amyloid fiber formation
P0DJM0	Disease;Infectious disease;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells
P0DML2	Prolactin receptor signaling;Cytokine Signaling in Immune system;Immune System;Growth hormone receptor signaling
P0DMM9	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
P0DMN0	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
P0DMS8	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Adenosine P1 receptors;Nucleotide-like (purinergic) receptors;G alpha (i) signalling events;GPCR ligand binding
P0DMV8	Disease;Innate Immune System;Influenza Infection;Immune System;Export of Viral Ribonucleoproteins from Nucleus;Viral RNP Complexes in the Host Cell Nucleus;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Infectious disease;Neutrophil degranulation;Metabolism of RNA;Cellular responses to external stimuli
P0DMV9	Innate Immune System;Immune System;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Neutrophil degranulation;Cellular responses to external stimuli
P0DN79	Metabolism;Cysteine formation from homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
P0DN86	Glycoprotein hormones;Peptide hormone biosynthesis;Generic Transcription Pathway;Peptide hormone metabolism;Metabolism of proteins;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
P0DOY2	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P0DOY3	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P0DP23	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Cam-PDE 1 activation;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Platelet degranulation ;Downstream signaling events of B Cell Receptor (BCR);Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Inositol phosphate metabolism;DAG and IP3 signaling;Mitochondrial biogenesis;Signal Transduction;PKA activation;Disease;Innate Immune System;Immune System;DARPP-32 events;Organelle biogenesis and maintenance;Synthesis of IP3 and IP4 in the cytosol;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;Metabolism of vitamins and cofactors;Membrane Trafficking;Metabolism of nitric oxide: eNOS activation and regulation;Calcineurin activates NFAT;eNOS activation;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Visual phototransduction;Fc epsilon receptor (FCERI) signaling;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Stimuli-sensing channels;FCERI mediated Ca+2 mobilization;Signaling by GPCR;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Metabolism of proteins;Muscle contraction;Ca2+ pathway;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;G alpha (i) signalling events;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through the activation of Adenylate Cyclase;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;Smooth Muscle Contraction;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding;Uptake and function of anthrax toxins;VEGFR2 mediated vascular permeability;VEGFR2 mediated cell proliferation;Uptake and actions of bacterial toxins;Cardiac conduction;Phase 0 - rapid depolarisation;Ion homeostasis;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);RHO GTPases activate IQGAPs;RHO GTPases activate PAKs;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Protein methylation;ESR-mediated signaling;Metabolism of cofactors;Glycogen metabolism;Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Loss of phosphorylation of MECP2 at T308;Regulation of MECP2 expression and activity;Ion transport by P-type ATPases;FLT3 Signaling;Negative regulation of NMDA receptor-mediated neuronal transmission;Activation of RAC1 downstream of NMDARs;Activation of AMPK downstream of NMDARs;Long-term potentiation;Signaling downstream of RAS mutants;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Disorders of developmental biology;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Ion channel transport
P0DP73	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
P0DP74	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
P0DPB5	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase III Chain Elongation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
P0DPD6	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
P0DPH7	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
P0DPH8	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
P0DPI0	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type A (BoNT/A);Uptake and actions of bacterial toxins;Infectious disease
P0DQD2	Disease;Infectious disease;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
P0DQD3	Disease;Infectious disease;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
P10070	Signal Transduction;Generic Transcription Pathway;Signaling by Hedgehog;Degradation of GLI2 by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;GLI proteins bind promoters of Hh responsive genes to promote transcription;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates chondrocyte maturation;RUNX2 regulates bone development
P10071	Signal Transduction;Generic Transcription Pathway;Signaling by Hedgehog;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;GLI proteins bind promoters of Hh responsive genes to promote transcription;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development
P10072	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P10082	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P10092	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P10109	Mitochondrial iron-sulfur cluster biogenesis;Metabolism;Disease;Metabolism of steroid hormones;Pregnenolone biosynthesis;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Electron transport from NADPH to Ferredoxin;Metabolism of lipids;Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
P10124	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P10144	Apoptosis;Intrinsic Pathway for Apoptosis;Signaling by NOTCH;Signal Transduction;Signaling by NOTCH2;NOTCH2 intracellular domain regulates transcription;Programmed Cell Death;Activation, myristolyation of BID and translocation to mitochondria
P10145	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Cellular responses to external stimuli
P10147	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P10153	Innate Immune System;Immune System;Neutrophil degranulation
P10176	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P10242	Hemostasis;Developmental Biology;Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Transcriptional regulation of granulopoiesis;Factors involved in megakaryocyte development and platelet production
P10243	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
P10244	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Polo-like kinase mediated events;Cell Cycle;Generic Transcription Pathway;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;G2/M Transition;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
P10253	Metabolism;Disease;Innate Immune System;Immune System;Glycogen storage diseases;Glycogen storage disease type II (GAA);Diseases of carbohydrate metabolism;Diseases of metabolism;Neutrophil degranulation;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P10275	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Generic Transcription Pathway;Cellular responses to stress;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HSP90 chaperone cycle for steroid hormone receptors (SHR);Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Cellular responses to external stimuli
P10276	Developmental Biology;Signal Transduction;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Signaling by Retinoic Acid;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Nuclear Receptors;Transcriptional regulation of granulopoiesis
P10301	Developmental Biology;Semaphorin interactions;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Sema4D in semaphorin signaling;Sema4D mediated inhibition of cell attachment and migration;Axon guidance;Nervous system development
P10314	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P10316	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P10319	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P10321	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P10323	Fertilization;Acrosome Reaction and Sperm:Oocyte Membrane Binding;Reproduction
P10398	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
P10412	Apoptosis;Apoptosis induced DNA fragmentation;Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Programmed Cell Death;Apoptotic execution phase;Cellular responses to external stimuli
P10415	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation of BH3-only proteins;Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Signaling by Interleukins;Programmed Cell Death;Inflammasomes;Interleukin-4 and Interleukin-13 signaling;The NLRP1 inflammasome;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Estrogen-dependent gene expression;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P10451	Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Signaling by PDGF;Generic Transcription Pathway;Integrin cell surface interactions;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 Regulates Immune Response and Cell Migration;Post-translational protein phosphorylation;Signaling by Receptor Tyrosine Kinases
P10515	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Glyoxylate metabolism and glycine degradation;Signaling by Retinoic Acid;Pyruvate metabolism;Metabolism of amino acids and derivatives;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
P10523	Signal Transduction;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P10586	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
P10588	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P10589	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P10599	Metabolism;Metabolism of nucleotides;Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;Metabolism of proteins;Interconversion of nucleotide di- and triphosphates;TP53 Regulates Metabolic Genes;Infectious disease;Protein repair;Inflammasomes;RNA Polymerase II Transcription;Gene expression (Transcription);The NLRP3 inflammasome;Cellular responses to external stimuli;FOXO-mediated transcription;Regulation of FOXO transcriptional activity by acetylation;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P10600	Hemostasis;Platelet degranulation ;Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;ECM proteoglycans;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P10606	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P10619	Adaptive Immune System;Metabolism;Disease;Glycosphingolipid metabolism;Innate Immune System;Immune System;MHC class II antigen presentation;Diseases of glycosylation;Metabolism of proteins;Sialic acid metabolism;Sphingolipid metabolism;Defective NEU1 causes sialidosis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Metabolism of lipids;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification;Neutrophil degranulation
P10620	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Innate Immune System;Immune System;Biological oxidations;Aflatoxin activation and detoxification;Neutrophil degranulation
P10632	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Metabolism of lipids;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of maresins;Biosynthesis of maresin-like SPMs
P10635	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Xenobiotics;CYP2E1 reactions;Metabolism of lipids;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of maresins;Biosynthesis of maresin-like SPMs
P10636-8	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Activation of AMPK downstream of NMDARs
P10636	Apoptosis;Apoptotic cleavage of cellular proteins;Caspase-mediated cleavage of cytoskeletal proteins;Programmed Cell Death;Apoptotic execution phase
P10643	Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Regulation of Complement cascade
P10644	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;DARPP-32 events;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Factors involved in megakaryocyte development and platelet production
P10645	Innate Immune System;Immune System;Antimicrobial peptides
P10646	Hemostasis;Extrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade)
P10696	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P10720	Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Cell surface interactions at the vascular wall
P10721	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P10745	Signal Transduction;The retinoid cycle in cones (daylight vision);Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P10746	Metabolism;Metabolism of porphyrins;Heme biosynthesis
P10747	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of CD28 cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CD28 dependent Vav1 pathway;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
P10767	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P10768	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P10809	Mitochondrial protein import;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation;Protein localization
P10826	Developmental Biology;Signal Transduction;Generic Transcription Pathway;Nuclear Receptor transcription pathway;Signaling by Retinoic Acid;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Nuclear Receptors
P10827-2	SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification
P10827	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P10828	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
P10844	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type B (BoNT/B);Uptake and actions of bacterial toxins;Infectious disease
P10909	Hemostasis;Platelet degranulation ;Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Antimicrobial peptides;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Regulation of Complement cascade
P10911	Signal Transduction;Axonal growth inhibition (RHOA activation);NRAGE signals death through JNK;p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
P10912	Prolactin receptor signaling;Cytokine Signaling in Immune system;Immune System;Growth hormone receptor signaling
P10914	Hemostasis;Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Factors involved in megakaryocyte development and platelet production
P10915	Extracellular matrix organization;ECM proteoglycans
P10916	Striated Muscle Contraction;Muscle contraction
P10966	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Nef Mediated CD8 Down-regulation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Infectious disease
P10997	Developmental Biology;Signal Transduction;Disease;Regulation of beta-cell development;Regulation of gene expression in beta cells;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;Amyloid fiber formation
P11021	Hemostasis;Platelet degranulation ;Adaptive Immune System;Immune System;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;ATF6 (ATF6-alpha) activates chaperones;PERK regulates gene expression;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Cellular responses to external stimuli;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P11047	Developmental Biology;Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;L1CAM interactions;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Axon guidance;Post-translational protein modification;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Post-translational protein phosphorylation;Signaling by Receptor Tyrosine Kinases;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P11055	Striated Muscle Contraction;Muscle contraction
P11086	Metabolism;Metabolism of amine-derived hormones;Catecholamine biosynthesis;Metabolism of amino acids and derivatives
P11142	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Macroautophagy;Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;L1CAM interactions;Metabolism of proteins;Axon guidance;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;CHL1 interactions;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Vesicle-mediated transport;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Clathrin-mediated endocytosis;Protein methylation;GABA synthesis, release, reuptake and degradation;Metabolism of RNA;Cellular responses to external stimuli;Autophagy;Lipophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Selective autophagy;Nervous system development
P11150	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Chylomicron clearance;Plasma lipoprotein clearance
P11161	Developmental Biology;Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Transcriptional regulation of white adipocyte differentiation;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P11166	Metabolism;Integration of energy metabolism;Disease;Cellular hexose transport;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Transport of small molecules;Regulation of insulin secretion;SLC-mediated transmembrane transport;Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1);SLC transporter disorders;Disorders of transmembrane transporters;Lactose synthesis;Metabolism of carbohydrates
P11168	Developmental Biology;Metabolism;Integration of energy metabolism;Disease;Regulation of beta-cell development;Cellular hexose transport;Regulation of gene expression in beta cells;Transport of small molecules;Regulation of insulin secretion;SLC-mediated transmembrane transport;Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS);SLC transporter disorders;Disorders of transmembrane transporters;Intestinal absorption;Digestion and absorption;Intestinal hexose absorption
P11169	Metabolism;Innate Immune System;Immune System;Cellular hexose transport;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Generic Transcription Pathway;Transport of small molecules;SLC-mediated transmembrane transport;Neutrophil degranulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates neuronal receptors and channels
P11171	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
P11172	Metabolism;Metabolism of nucleotides;Pyrimidine biosynthesis;Nucleobase biosynthesis
P11177	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Glyoxylate metabolism and glycine degradation;Signaling by Retinoic Acid;Pyruvate metabolism;Metabolism of amino acids and derivatives;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
P11182	Metabolism;Glyoxylate metabolism and glycine degradation;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
P11215	Hemostasis;Cytokine Signaling in Immune system;Extracellular matrix organization;Toll Like Receptor 4 (TLR4) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Cell surface interactions at the vascular wall;Integrin cell surface interactions;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation
P11216	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P11217	Metabolism;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P11226	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System
P11229	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Muscarinic acetylcholine receptors;G alpha (q) signalling events;GPCR ligand binding
P11233	Cytokine Signaling in Immune system;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Signaling by NTRKs;Signalling to RAS;Immune System;p38MAPK events;Signaling by NTRK1 (TRKA);Signalling to ERKs;Membrane Trafficking;Interleukin-12 family signaling;Signaling by Interleukins;Vesicle-mediated transport;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Signaling by Receptor Tyrosine Kinases;Interleukin-12 signaling
P11234	Signal Transduction;Signaling by NTRKs;Signalling to RAS;p38MAPK events;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by Receptor Tyrosine Kinases
P11245	Metabolism;Phase II - Conjugation of compounds;Acetylation;Biological oxidations
P11274	Signaling by FGFR in disease;Signal Transduction;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
P11277	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;L1CAM interactions;NCAM signaling for neurite out-growth;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;FLT3 Signaling;Nervous system development
P11279	Innate Immune System;Immune System;Neutrophil degranulation
P11296	Hemostasis;Cell surface interactions at the vascular wall
P11297	Hemostasis;Cell surface interactions at the vascular wall
P11309	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
P11310	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of saturated fatty acids;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Beta oxidation of octanoyl-CoA to hexanoyl-CoA;Fatty acid metabolism
P11362-1	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by FGFR1 amplification mutants;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;Signaling by FGFR;FGFR1 ligand binding and activation;FGFR1c ligand binding and activation;FGFR1c and Klotho ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;L1CAM interactions;NCAM signaling for neurite out-growth;Axon guidance;Signal transduction by L1;Phospholipase C-mediated cascade: FGFR1;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;Negative regulation of FGFR1 signaling;Signaling by FGFR1;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Nervous system development
P11362-19	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by FGFR1 amplification mutants;FGFR1 mutant receptor activation;Signaling by FGFR;FGFR1 ligand binding and activation;FGFR1b ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;Negative regulation of FGFR1 signaling;Signaling by FGFR1;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P11362	Signaling by FGFR in disease;Disease;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by plasma membrane FGFR1 fusions
P11387	SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of DNA replication proteins;Post-translational protein modification
P11388	Transcription of E2F targets under negative control by DREAM complex;G0 and Early G1;Cell Cycle;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Mitotic G1 phase and G1/S transition;SUMOylation of DNA replication proteins;Post-translational protein modification;Cell Cycle, Mitotic
P11413	Metabolism;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Pentose phosphate pathway;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription)
P11441	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P11464	Hemostasis;Cell surface interactions at the vascular wall
P11465	Hemostasis;Cell surface interactions at the vascular wall
P11473	Metabolism;Vitamin D (calciferol) metabolism;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Metabolism of lipids;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids
P11474	Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Nuclear Receptor transcription pathway;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
P11487	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR1b ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR2 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P11488	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Signal Transduction;G-protein activation;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;G alpha (i) signalling events;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P11498	Metabolism;Disease;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Diseases of metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P11509	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions
P11511	Metabolism;Disease;Estrogen biosynthesis;Metabolism of steroid hormones;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Metabolic disorders of biological oxidation enzymes;Defective CYP19A1 causes Aromatase excess syndrome (AEXS);Diseases of metabolism;Metabolism of steroids
P11532	Extracellular matrix organization;Non-integrin membrane-ECM interactions;Striated Muscle Contraction;Muscle contraction
P11586	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P11597	Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein remodeling;LDL remodeling;HDL remodeling;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P11678	Innate Immune System;Immune System;Neutrophil degranulation
P11686	Disease;Metabolism of proteins;Diseases of metabolism;Surfactant metabolism;Diseases associated with surfactant metabolism;Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS);Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
P11712	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Metabolism of lipids;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of maresins;Biosynthesis of maresin-like SPMs
P11717	Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Neutrophil degranulation;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P11766	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Ethanol oxidation
P11802	Developmental Biology;Reproduction;Meiosis;Signal Transduction;Cell Cycle;Disease;SCF(Skp2)-mediated degradation of p27/p21;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;RMTs methylate histone arginines;Chromatin modifying enzymes;Transcriptional regulation of white adipocyte differentiation;Mitotic G1 phase and G1/S transition;Chromatin organization;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;Signaling by PTK6;PTK6 Regulates Cell Cycle;Transcriptional regulation by RUNX2;Cellular responses to external stimuli;Signaling by Non-Receptor Tyrosine Kinases;Meiotic recombination;Transcriptional regulation of granulopoiesis;Diseases of Cellular Senescence;Evasion of Oncogene Induced Senescence Due to p16INK4A Defects;Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4;Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6;Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects;Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4;Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6;Diseases of cellular response to stress
P11831	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Signaling by Rho GTPases;RHO GTPase Effectors;Nuclear Events (kinase and transcription factor activation);RHO GTPases Activate Formins;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;NGF-stimulated transcription;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P11908	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates;5-Phosphoribose 1-diphosphate biosynthesis
P11912	Adaptive Immune System;Immune System;CD22 mediated BCR regulation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P11926	Metabolism;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Metabolism of amino acids and derivatives
P11940	Developmental Biology;L13a-mediated translational silencing of Ceruloplasmin expression;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Cap-dependent Translation Initiation;Translation;Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P12004	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Transcription of E2F targets under negative control by DREAM complex;G0 and Early G1;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Mitotic G1 phase and G1/S transition;SUMOylation of DNA replication proteins;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription);Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
P12018	Hemostasis;Cell surface interactions at the vascular wall
P12034-1	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P12035	Developmental Biology;Keratinization;Formation of the cornified envelope
P12074	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P12081	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
P12104	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
P12107	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Non-integrin membrane-ECM interactions;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases
P12109	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P12110	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P12111	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P12235	Mitochondrial protein import;HIV Infection;Host Interactions of HIV factors;Disease;Interactions of Vpr with host cellular proteins;Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Infectious disease;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Protein localization
P12236	Mitochondrial protein import;HIV Infection;Host Interactions of HIV factors;Disease;Influenza Infection;Influenza Virus Induced Apoptosis;Interactions of Vpr with host cellular proteins;Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Infectious disease;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane;Protein localization
P12259	Hemostasis;Platelet degranulation ;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation;Transport to the Golgi and subsequent modification
P12268	Metabolism;Metabolism of nucleotides;Innate Immune System;Immune System;Neutrophil degranulation;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P12270	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
P12271	Signal Transduction;Disease;The retinoid cycle in cones (daylight vision);Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Diseases of the neuronal system
P12272	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P12273	Transport of small molecules;Miscellaneous transport and binding events
P12277	Metabolism;Creatine metabolism;Metabolism of amino acids and derivatives
P12314	Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);Cytokine Signaling in Immune system;Adaptive Immune System;Disease;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Infectious disease;Interferon gamma signaling;Interferon Signaling;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Class I MHC mediated antigen processing & presentation
P12318	Disease;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Infectious disease;Neutrophil degranulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival
P12319	Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation
P12487	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P12488	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P12489	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P12490	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P12491	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P12493	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
P12532	Metabolism;Creatine metabolism;Metabolism of amino acids and derivatives
P12643	Extracellular matrix organization;Elastic fibre formation;Signal Transduction;Signaling by BMP;Generic Transcription Pathway;Molecules associated with elastic fibres;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Signaling by TGF-beta family members
P12644	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P12694	Metabolism;Glyoxylate metabolism and glycine degradation;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
P12724	Innate Immune System;Immune System;Neutrophil degranulation;Antimicrobial peptides
P12755	Signal Transduction;Signaling by TGF-beta Receptor Complex;Signaling by BMP;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
P12757	Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
P12814	Hemostasis;Platelet degranulation ;Extracellular matrix organization;Cell-Cell communication;Syndecan interactions;Non-integrin membrane-ECM interactions;Nephrin family interactions;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P12821	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins
P12829	Striated Muscle Contraction;Muscle contraction
P12830	Apoptosis;Apoptotic cleavage of cellular proteins;Adaptive Immune System;Degradation of the extracellular matrix;Extracellular matrix organization;Cell-Cell communication;Signal Transduction;Disease;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions;Apoptotic cleavage of cell adhesion  proteins;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization;Programmed Cell Death;RHO GTPases activate IQGAPs;Infectious disease;Apoptotic execution phase;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells
P12838	Defensins;Alpha-defensins;Innate Immune System;Immune System;Neutrophil degranulation;Antimicrobial peptides
P12872	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P12931-1	Hemostasis;PIP3 activates AKT signaling;Developmental Biology;Adaptive Immune System;Spry regulation of FGF signaling;Signaling by SCF-KIT;Regulation of KIT signaling;Cell-Cell communication;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;p38MAPK events;Signaling by EGFR;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Negative regulation of the PI3K/AKT network;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;PECAM1 interactions;EPH-Ephrin signaling;Integrin signaling;L1CAM interactions;NCAM signaling for neurite out-growth;Costimulation by the CD28 family;CD28 co-stimulation;CTLA4 inhibitory signaling;Signal regulatory protein family interactions;Signal amplification;EPHB-mediated forward signaling;EPHA-mediated growth cone collapse;Ephrin signaling;EPH-ephrin mediated repulsion of cells;ADP signalling through P2Y purinoceptor 1;Axon guidance;GP1b-IX-V activation signalling;Recycling pathway of L1;VEGFA-VEGFR2 Pathway;Mitotic G1 phase and G1/S transition;Thrombin signalling through proteinase activated receptors (PARs);Mitophagy;VEGFR2 mediated cell proliferation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Infectious disease;RHO GTPases Activate Formins;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);RET signaling;Receptor Mediated Mitophagy;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Autophagy;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;Selective autophagy;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Nervous system development
P12931-2	Gap junction trafficking and regulation;Regulation of gap junction activity;Membrane Trafficking;Vesicle-mediated transport
P12931	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB2;Signaling by ERBB4;Nuclear signaling by ERBB4;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Signaling by EGFR;GAB1 signalosome;Downstream signal transduction;Signaling by PDGF;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Signaling by GPCR;Netrin-1 signaling;Signaling by ROBO receptors;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;DCC mediated attractive signaling;Netrin mediated repulsion signals;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);MET activates PTK2 signaling;MET promotes cell motility;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;ESR-mediated signaling;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Regulation of RUNX3 expression and activity;Signaling by NTRK2 (TRKB);Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Activated NTRK2 signals through FYN;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through PI3K;FLT3 Signaling;Long-term potentiation;Signaling downstream of RAS mutants;Nervous system development
P12956	HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Disease;2-LTR circle formation;Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;IRF3-mediated induction of type I IFN;Infectious disease;DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);Neutrophil degranulation;DNA Repair
P12980	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P13010	HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Disease;2-LTR circle formation;Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;IRF3-mediated induction of type I IFN;Infectious disease;DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);Neutrophil degranulation;DNA Repair
P13051-1	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Displacement of DNA glycosylase by APEX1;Base Excision Repair;DNA Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites)
P13056	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
P13073	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P13164	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon alpha/beta signaling;Interferon Signaling
P13196	Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Metabolism of porphyrins;Heme biosynthesis;PPARA activates gene expression;Transcriptional activation of mitochondrial biogenesis;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
P13224	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);GP1b-IX-V activation signalling;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P13232	Interleukin-7 signaling;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins
P13236	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P13284	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;MHC class II antigen presentation;Interferon gamma signaling;Interferon Signaling
P13349	Developmental Biology;Myogenesis
P13385	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Transcriptional regulation of pluripotent stem cells
P13423	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
P13473	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Autophagy;Chaperone Mediated Autophagy
P13497-3	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;HDL assembly;Plasma lipoprotein assembly
P13497	Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Anchoring fibril formation;Crosslinking of collagen fibrils
P13498	ROS and RNS production in phagocytes;Cross-presentation of particulate exogenous antigens (phagosomes);Antigen processing-Cross presentation;Adaptive Immune System;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Cellular responses to stress;Detoxification of Reactive Oxygen Species;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate NADPH Oxidases;Neutrophil degranulation;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;Class I MHC mediated antigen processing & presentation
P13500	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling
P13501	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P13521	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P13533	Striated Muscle Contraction;Muscle contraction
P13535	Striated Muscle Contraction;Muscle contraction
P13569	Signal Transduction;Macroautophagy;Disease;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;ABC transporter disorders;Disorders of transmembrane transporters;RHO GTPases regulate CFTR trafficking;Vesicle-mediated transport;Defective CFTR causes cystic fibrosis;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
P13584	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
P13591	Developmental Biology;Cytokine Signaling in Immune system;Extracellular matrix organization;Signal Transduction;Immune System;ECM proteoglycans;L1CAM interactions;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Signal transduction by L1;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interferon gamma signaling;Interferon Signaling;FLT3 Signaling;Nervous system development
P13598	Adaptive Immune System;Extracellular matrix organization;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling
P13611	Metabolism;Extracellular matrix organization;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;CS/DS degradation;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective CHST3 causes SEDCJD;Defective CHST14 causes EDS, musculocontractural type;Defective CHSY1 causes TPBS;Diseases of glycosylation;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Post-translational protein modification;Metabolism of carbohydrates;Post-translational protein phosphorylation
P13612	Hemostasis;Adaptive Immune System;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Integrin cell surface interactions;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 Regulates Immune Response and Cell Migration
P13631	Developmental Biology;Signal Transduction;Generic Transcription Pathway;Nuclear Receptor transcription pathway;Signaling by Retinoic Acid;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Nuclear Receptors
P13637	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P13639	Eukaryotic Translation Elongation;Peptide chain elongation;Gamma carboxylation, hypusine formation and arylsulfatase activation;Disease;Innate Immune System;Immune System;Metabolism of proteins;Uptake and function of diphtheria toxin;Uptake and actions of bacterial toxins;Synthesis of diphthamide-EEF2;Infectious disease;Post-translational protein modification;Neutrophil degranulation;Translation;Protein methylation
P13640	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P13645	Developmental Biology;Keratinization;Formation of the cornified envelope
P13646	Developmental Biology;Keratinization;Formation of the cornified envelope
P13647	Developmental Biology;Cell-Cell communication;Type I hemidesmosome assembly;Cell junction organization;Keratinization;Formation of the cornified envelope
P13671	Complement cascade;Terminal pathway of complement;Innate Immune System;Immune System;Regulation of Complement cascade
P13674	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
P13686	Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P13688	Hemostasis;Extracellular matrix organization;Fibronectin matrix formation;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Neutrophil degranulation
P13716	Metabolism;Innate Immune System;Immune System;Metabolism of porphyrins;Heme biosynthesis;Neutrophil degranulation
P13725	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;Interleukin-4 and Interleukin-13 signaling;IL-6-type cytokine receptor ligand interactions
P13726	Hemostasis;Extrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P13727	Innate Immune System;Immune System;Neutrophil degranulation
P13746	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P13747	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;DAP12 signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P13760	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P13761	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P13762	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P13765	Adaptive Immune System;Immune System;MHC class II antigen presentation
P13796	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P13798	Innate Immune System;Immune System;Metabolism of proteins;Neutrophil degranulation;Eukaryotic Translation Termination;Translation
P13804	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
P13805	Striated Muscle Contraction;Muscle contraction
P13807	Metabolism;Disease;Glycogen storage diseases;Glycogen synthesis;Myoclonic epilepsy of Lafora;Glycogen storage disease type XV (GYG1);Glycogen storage disease type 0 (muscle GYS1);Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates;Glycogen metabolism
P13861	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;DARPP-32 events;Signaling by GPCR;Signaling by ROBO receptors;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Regulation of insulin secretion;Axon guidance;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;ROBO receptors bind AKAP5;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Nervous system development;Factors involved in megakaryocyte development and platelet production
P13866	Disease;Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport;SLC transporter disorders;Disorders of transmembrane transporters;Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM);Intestinal absorption;Digestion and absorption;Intestinal hexose absorption
P13929	Metabolism;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P13942	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Non-integrin membrane-ECM interactions;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases
P13945	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P13984	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;Generic Transcription Pathway;Transcriptional Regulation by TP53;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P13987	Complement cascade;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Regulation of Complement cascade
P13995	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P14060	Metabolism;Androgen biosynthesis;Mineralocorticoid biosynthesis;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P14061	Metabolism;Signal Transduction;Estrogen biosynthesis;Metabolism of steroid hormones;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of lipids;Metabolism of steroids
P14091	Adaptive Immune System;Immune System;MHC class II antigen presentation
P14136	Signaling by ERBB4;Nuclear signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;Autophagy;Chaperone Mediated Autophagy
P14138	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P14151	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Neutrophil degranulation
P14174	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Interleukin-12 family signaling;Signaling by Interleukins;Neutrophil degranulation;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P14207	Metabolism;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Metabolism of proteins;Post-translational protein modification
P14209	Hemostasis;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall
P14210	Hemostasis;Platelet degranulation ;PIP3 activates AKT signaling;Interleukin-7 signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-4 and Interleukin-13 signaling;Signaling by MET;MET Receptor Activation;Negative regulation of MET activity;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;MET activates RAS signaling;MET activates PI3K/AKT signaling;MET activates PTPN11;MET activates PTK2 signaling;MET interacts with TNS proteins;MET activates RAP1 and RAC1;MET receptor recycling;MET activates STAT3;MET promotes cell motility;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P14314	Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;Advanced glycosylation endproduct receptor signaling;Post-translational protein phosphorylation;Calnexin/calreticulin cycle
P14316	Hemostasis;Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Factors involved in megakaryocyte development and platelet production
P14324	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
P14373	PIP3 activates AKT signaling;Signal Transduction;Disease;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Metabolism of proteins;Infectious disease;Post-translational protein modification;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis
P14384	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P14410	Disease;Digestion of dietary carbohydrate;Intestinal saccharidase deficiencies;Diseases of carbohydrate metabolism;Diseases of metabolism;Digestion;Digestion and absorption
P14415	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P14416	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;Dopamine receptors;GPCR ligand binding
P14543	Degradation of the extracellular matrix;Extracellular matrix organization;Laminin interactions
P14550	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations;Formation of xylulose-5-phosphate;Metabolism of carbohydrates
P14555	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Metabolism of lipids;Antimicrobial peptides
P14598	ROS and RNS production in phagocytes;Cross-presentation of particulate exogenous antigens (phagosomes);Antigen processing-Cross presentation;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Cellular responses to stress;Detoxification of Reactive Oxygen Species;VEGFA-VEGFR2 Pathway;RHO GTPases Activate NADPH Oxidases;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Class I MHC mediated antigen processing & presentation
P14618-1	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P14618-2	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P14618	Innate Immune System;Immune System;Neutrophil degranulation
P14625	Cytokine Signaling in Immune system;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;ATF6 (ATF6-alpha) activates chaperones;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Signaling by Interleukins;Vesicle-mediated transport;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Post-translational protein phosphorylation
P14635	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Polo-like kinase mediated events;Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;APC/C:Cdc20 mediated degradation of Cyclin B;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Phosphorylation of Emi1;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Generic Transcription Pathway;Condensation of Prophase Chromosomes;MASTL Facilitates Mitotic Progression;Resolution of Sister Chromatid Cohesion;Condensation of Prometaphase Chromosomes;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope Breakdown;Activation of NIMA Kinases NEK9, NEK6, NEK7;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Nuclear Pore Complex (NPC) Disassembly;Transcriptional Regulation by TP53;Depolymerisation of the Nuclear Lamina;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G1/S Transition;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M DNA replication checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by RUNX2
P14649	Muscle contraction;Smooth Muscle Contraction
P14651	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P14652	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P14653	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P14672	Developmental Biology;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Cellular hexose transport;Membrane Trafficking;Transcriptional regulation of white adipocyte differentiation;Transport of small molecules;SLC-mediated transmembrane transport;Vesicle-mediated transport
P14678	SLBP independent Processing of Histone Pre-mRNAs;snRNP Assembly;Metabolism of non-coding RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
P14679	Metabolism;Melanin biosynthesis;Metabolism of amino acids and derivatives
P14735	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Peroxisomal protein import;Protein localization
P14770	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);GP1b-IX-V activation signalling;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P14778	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-10 signaling;Interleukin-1 signaling
P14780	Developmental Biology;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Activation of Matrix Metalloproteinases;Signal Transduction;Innate Immune System;Immune System;Assembly of collagen fibrils and other multimeric structures;EPH-Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Nervous system development
P14784	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-15 signaling;Interleukin-2 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P14854	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P14859	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P14866	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P14867	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;GABA receptor activation
P14868	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
P14902	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
P14920	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives;Peroxisomal protein import;Protein localization
P14921	Cellular responses to stress;Cellular Senescence;Oncogene Induced Senescence;Cellular responses to external stimuli
P14923	Developmental Biology;Cell-Cell communication;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Adherens junctions interactions;Cell-cell junction organization;VEGFA-VEGFR2 Pathway;Cell junction organization;VEGFR2 mediated vascular permeability;Neutrophil degranulation;Keratinization;Formation of the cornified envelope;Signaling by Receptor Tyrosine Kinases
P14927	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
P15018	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;IL-6-type cytokine receptor ligand interactions
P15036	Cellular responses to stress;Cellular Senescence;Oncogene Induced Senescence;Cellular responses to external stimuli
P15056	Cytokine Signaling in Immune system;Spry regulation of FGF signaling;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Prolonged ERK activation events;Frs2-mediated activation;ARMS-mediated activation;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signalling to p38 via RIT and RIN;Signaling by FGFR;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative feedback regulation of MAPK pathway;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants
P15059	Signal Transduction;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Programmed Cell Death;Regulation of TNFR1 signaling;Regulation of necroptotic cell death;Death Receptor Signalling;TNF signaling
P15086	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins
P15088	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins
P15090	Developmental Biology;Metabolism;Triglyceride catabolism;Transcriptional regulation of white adipocyte differentiation;Metabolism of lipids;Triglyceride metabolism
P15104	Neurotransmitter uptake and metabolism In glial cells;Transmission across Chemical Synapses;Neuronal System;Metabolism;Astrocytic Glutamate-Glutamine Uptake And Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
P15121	Metabolism;Metabolism of steroid hormones;Pregnenolone biosynthesis;Metabolism of lipids;Fructose metabolism;Fructose biosynthesis;Metabolism of carbohydrates;Metabolism of steroids
P15144	Innate Immune System;Immune System;Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins;Neutrophil degranulation
P15151	Adaptive Immune System;Cell-Cell communication;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adherens junctions interactions;Nectin/Necl  trans heterodimerization;Cell-cell junction organization;Cell junction organization
P15153	Hemostasis;GPVI-mediated activation cascade;ROS and RNS production in phagocytes;PIP3 activates AKT signaling;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Signaling by WNT;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Beta-catenin independent WNT signaling;PCP/CE pathway;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate NADPH Oxidases;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;Intracellular signaling by second messengers
P15169	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P15170	Developmental Biology;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Eukaryotic Translation Termination;Translation;Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P15172	Developmental Biology;Myogenesis
P15173	Developmental Biology;Myogenesis
P15248	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-9 signaling
P15259	Metabolism;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P15260	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Regulation of IFNG signaling;Interferon Signaling
P15289	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Innate Immune System;Immune System;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification;Neutrophil degranulation
P15291	Fertilization;Metabolism;Reproduction;Signaling by NOTCH;Signal Transduction;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Innate Immune System;Immune System;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Keratan sulfate biosynthesis;Interaction With Cumulus Cells And The Zona Pellucida;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Asparagine N-linked glycosylation;Lactose synthesis;Diseases of metabolism;Post-translational protein modification;Neutrophil degranulation;Metabolism of carbohydrates;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
P15309	Innate Immune System;Immune System;Neutrophil degranulation
P15311	Developmental Biology;Netrin-1 signaling;L1CAM interactions;Axon guidance;Recycling pathway of L1;Nervous system development
P15313	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
P15328	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification
P15336	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Mitochondrial biogenesis;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Cellular responses to stress;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Circadian Clock;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Activation of the AP-1 family of transcription factors;Chromatin organization;TP53 Regulates Transcription of DNA Repair Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression;NGF-stimulated transcription;TRIF(TICAM1)-mediated TLR4 signaling ;Response of EIF2AK4 (GCN2) to amino acid deficiency;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P15374	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Neddylation
P15382	Muscle contraction;Phase 3 - rapid repolarisation;Cardiac conduction;Phase 2 - plateau phase
P15391	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Disease;Complement cascade;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P15407	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P15428	Metabolism;Synthesis of Lipoxins (LX);Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism;Biosynthesis of D-series resolvins;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of EPA-derived SPMs;Biosynthesis of E-series 18(S)-resolvins
P15498	Hemostasis;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Signal Transduction;Disease;Innate Immune System;Immune System;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by VEGF;Signaling by Rho GTPases;Rho GTPase cycle;Negative regulation of the PI3K/AKT network;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Cell death signalling via NRAGE, NRIF and NADE;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent Vav1 pathway;G alpha (12/13) signalling events;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;VEGFR2 mediated vascular permeability;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Death Receptor Signalling;Platelet activation, signaling and aggregation;Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Erythropoietin activates RAS;Regulation of signaling by CBL;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P15502	Degradation of the extracellular matrix;Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P15509	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Metabolism of proteins;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Diseases of metabolism;RAF/MAP kinase cascade;MAPK family signaling cascades;Surfactant metabolism;MAPK1/MAPK3 signaling;Diseases associated with surfactant metabolism;Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4);Interleukin receptor SHC signaling;FLT3 Signaling
P15514	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;Negative regulation of the PI3K/AKT network;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;EGFR interacts with phospholipase C-gamma;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Metabolism of proteins;Asparagine N-linked glycosylation;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Cargo concentration in the ER;Post-translational protein modification;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Transport to the Golgi and subsequent modification;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P15515	Innate Immune System;Immune System;Antimicrobial peptides
P15516	Innate Immune System;Immune System;Antimicrobial peptides
P15529	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P15531	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P15538	Metabolism;Disease;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
P15559	Metabolism;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Metabolism of amino acids and derivatives
P15586	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Keratan sulfate degradation;Mucopolysaccharidoses;MPS IIID - Sanfilippo syndrome D;Lysosome Vesicle Biogenesis;Vesicle-mediated transport;Diseases of carbohydrate metabolism;Diseases of metabolism;Neutrophil degranulation;Metabolism of carbohydrates
P15622	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P15692-4	Signal Transduction;Signaling by VEGF;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Signaling by Receptor Tyrosine Kinases
P15692	Hemostasis;Platelet degranulation ;Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by VEGF;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Generic Transcription Pathway;Cellular responses to stress;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases
P15735	Metabolism;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P15813	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P15814	Hemostasis;Cell surface interactions at the vascular wall
P15848	Metabolism;Glycosaminoglycan metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Disease;Glycosphingolipid metabolism;The activation of arylsulfatases;Innate Immune System;Immune System;Chondroitin sulfate/dermatan sulfate metabolism;CS/DS degradation;Mucopolysaccharidoses;MPS VI - Maroteaux-Lamy syndrome;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Diseases of carbohydrate metabolism;Diseases of metabolism;Post-translational protein modification;Neutrophil degranulation;Metabolism of carbohydrates
P15880	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;RMTs methylate histone arginines;Chromatin modifying enzymes;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Chromatin organization;Infectious disease;Post-translational protein modification;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Protein methylation;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P15882	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
P15884	Developmental Biology;Myogenesis
P15907	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation;Termination of O-glycan biosynthesis
P15917	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
P15918	Interleukin-7 signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;MAPK family signaling cascades;MAPK6/MAPK4 signaling
P15923	Developmental Biology;Generic Transcription Pathway;Myogenesis;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs
P15924	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Innate Immune System;Immune System;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;Neutrophil degranulation;Keratinization;Formation of the cornified envelope;Apoptotic execution phase
P15927	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Activation of ATR in response to replication stress;Extension of Telomeres;Generic Transcription Pathway;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSF1 activation;Cellular response to heat stress;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Regulation of TP53 Activity;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Formation of Incision Complex in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Fanconi Anemia Pathway;Regulation of TP53 Activity through Phosphorylation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription);Cellular responses to external stimuli;Meiotic recombination
P15941	Cytokine Signaling in Immune system;Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Signaling by Interleukins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
P15954	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P15976	Hemostasis;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Factors involved in megakaryocyte development and platelet production
P16035	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Innate Immune System;Immune System;Neutrophil degranulation
P16050	Cytokine Signaling in Immune system;Metabolism;Immune System;Synthesis of Leukotrienes (LT) and Eoxins (EX);Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Synthesis of 15-eicosatetraenoic acid derivatives;Signaling by Interleukins;Metabolism of lipids;Interleukin-4 and Interleukin-13 signaling;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of EPA-derived SPMs;Biosynthesis of protectins;Biosynthesis of DPA-derived SPMs;Biosynthesis of E-series 18(S)-resolvins;Biosynthesis of E-series 18(R)-resolvins;Biosynthesis of DPAn-3 SPMs;Biosynthesis of DPAn-6 SPMs;Biosynthesis of DPAn-3-derived protectins and resolvins
P16066	Muscle contraction;Cardiac conduction;Physiological factors
P16070	Hemostasis;Cytokine Signaling in Immune system;Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Glycosaminoglycan metabolism;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Hyaluronan metabolism;Integrin cell surface interactions;Hyaluronan uptake and degradation;Neutrophil degranulation;Metabolism of carbohydrates;Interferon gamma signaling;Interferon Signaling
P16083	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
P16104	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P16109	Hemostasis;Platelet degranulation ;Cell surface interactions at the vascular wall;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P16112	Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Keratan sulfate degradation;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Defective ST3GAL3 causes MCT12 and EIEE15;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
P16118	Metabolism;PKA-mediated phosphorylation of key metabolic factors;Integration of energy metabolism;PP2A-mediated dephosphorylation of key metabolic factors;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
P16144	Extracellular matrix organization;Collagen formation;Cell-Cell communication;Assembly of collagen fibrils and other multimeric structures;Laminin interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;Type I hemidesmosome assembly;Cell junction organization
P16150	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions
P16152	Metabolism;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism
P16157	Developmental Biology;ER to Golgi Anterograde Transport;Membrane Trafficking;L1CAM interactions;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;NrCAM interactions;CHL1 interactions;Neurofascin interactions;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Nervous system development
P16188	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P16189	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P16190	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P16219	Metabolism;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of hexanoyl-CoA to butanoyl-CoA;Beta oxidation of butanoyl-CoA to acetyl-CoA;Fatty acid metabolism
P16220	Opioid Signalling;PKA-mediated phosphorylation of CREB;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;DAG and IP3 signaling;Signaling by NOTCH;Mitochondrial biogenesis;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Signaling by NOTCH2;AKT phosphorylates targets in the nucleus;Nuclear Events (kinase and transcription factor activation);CREB phosphorylation;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;NOTCH2 intracellular domain regulates transcription;PI3K/AKT Signaling in Cancer;Signaling by GPCR;NCAM signaling for neurite out-growth;GPCR downstream signalling;Circadian Clock;G alpha (q) signalling events;G alpha (i) signalling events;Axon guidance;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Constitutive Signaling by AKT1 E17K in Cancer;RNA Polymerase II Transcription;Gene expression (Transcription);Gastrin-CREB signalling pathway via PKC and MAPK;ESR-mediated signaling;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Regulation of MECP2 expression and activity;MECP2 regulates neuronal receptors and channels;MECP2 regulates transcription of neuronal ligands;MECP2 regulates transcription factors;NGF-stimulated transcription;TRIF(TICAM1)-mediated TLR4 signaling ;HCMV Infection;HCMV Early Events;Transcriptional regulation of granulopoiesis;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P16233	Metabolism;Signal Transduction;Digestion of dietary lipid;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Digestion;Digestion and absorption;Retinoid metabolism and transport
P16234	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Downstream signal transduction;Signaling by PDGF;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Imatinib-resistant PDGFR mutants;Sunitinib-resistant PDGFR mutants;Regorafenib-resistant PDGFR mutants;Sorafenib-resistant PDGFR mutants;Drug resistance of PDGFR mutants;PDGFR mutants bind TKIs
P16260	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
P16278	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Glycosphingolipid metabolism;Innate Immune System;Immune System;Keratan sulfate degradation;HS-GAG degradation;Mucopolysaccharidoses;MPS IV - Morquio syndrome B;Diseases of glycosylation;Metabolism of proteins;Sialic acid metabolism;Sphingolipid metabolism;Defective NEU1 causes sialidosis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Metabolism of lipids;Diseases associated with glycosylation precursor biosynthesis;Diseases of carbohydrate metabolism;Diseases of metabolism;Post-translational protein modification;Neutrophil degranulation;Metabolism of carbohydrates
P16284	Hemostasis;Platelet degranulation ;Extracellular matrix organization;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;PECAM1 interactions;Integrin cell surface interactions;Platelet homeostasis;Platelet sensitization by LDL;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P16298	Opioid Signalling;Downstream signaling events of B Cell Receptor (BCR);Developmental Biology;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;DARPP-32 events;Signaling by WNT;Calcineurin activates NFAT;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;Signaling by ROBO receptors;Beta-catenin independent WNT signaling;GPCR downstream signalling;Ca2+ pathway;G alpha (i) signalling events;Axon guidance;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);ROBO receptors bind AKAP5;Nervous system development;Signaling by the B Cell Receptor (BCR)
P16333	Developmental Biology;Adaptive Immune System;Cell-Cell communication;Signal Transduction;Disease;Innate Immune System;Immune System;Downstream signal transduction;Signaling by PDGF;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;TCR signaling;Generation of second messenger molecules;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Netrin-1 signaling;Nephrin family interactions;Signaling by ROBO receptors;DCC mediated attractive signaling;Axon guidance;Activation of RAC1;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P16383	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P16389	Neuronal System;Potassium Channels;Voltage gated Potassium channels
P16401	Apoptosis;Apoptosis induced DNA fragmentation;Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Programmed Cell Death;Apoptotic execution phase;Cellular responses to external stimuli
P16402	Apoptosis;Apoptosis induced DNA fragmentation;Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Programmed Cell Death;Apoptotic execution phase;Cellular responses to external stimuli
P16403	Apoptosis;Apoptosis induced DNA fragmentation;Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Programmed Cell Death;Apoptotic execution phase;Cellular responses to external stimuli
P16410	Adaptive Immune System;Immune System;Generic Transcription Pathway;Costimulation by the CD28 family;CTLA4 inhibitory signaling;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1
P16422	Hemostasis;Cell surface interactions at the vascular wall
P16435	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds
P16442	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;ABO blood group biosynthesis
P16444	Metabolism;Disease;Biological oxidations;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Aflatoxin activation and detoxification;Metabolism of lipids;Infectious disease;Fatty acid metabolism;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;LTC4-CYSLTR mediated IL4 production
P16455	MGMT-mediated DNA damage reversal;DNA Repair;DNA Damage Reversal
P16471	Prolactin receptor signaling;Cytokine Signaling in Immune system;Immune System;Growth hormone receptor signaling
P16473	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P16499	Signal Transduction;Signaling by WNT;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Ca2+ pathway;G alpha (i) signalling events
P16519	Insulin processing;Peptide hormone metabolism;Metabolism of proteins
P16520	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Peptide hormone metabolism;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Incretin synthesis, secretion, and inactivation;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P16581	Hemostasis;Cell surface interactions at the vascular wall
P16591	Signaling by SCF-KIT;Signal Transduction;Signaling by Receptor Tyrosine Kinases
P16615	Hemostasis;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P16619	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P16662	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
P16671	Hemostasis;Platelet degranulation ;Cross-presentation of particulate exogenous antigens (phagosomes);ER-Phagosome pathway;Antigen processing-Cross presentation;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Integration of energy metabolism;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;PPARA activates gene expression;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class B Receptors;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Free fatty acids regulate insulin secretion;Regulation of insulin secretion;Intracellular metabolism of fatty acids regulates insulin secretion;Signaling by Interleukins;Diseases of Immune System;Metabolism of lipids;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Vesicle-mediated transport;Regulation of TLR by endogenous ligand;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Class I MHC mediated antigen processing & presentation
P16767	Signal Transduction;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;Death Receptor Signalling;TNF signaling
P16870	Insulin processing;Peptide hormone metabolism;Metabolism of proteins
P16871	Interleukin-7 signaling;Cytokine Signaling in Immune system;Immune System;Membrane Trafficking;Signaling by Interleukins;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P16885	Hemostasis;GPVI-mediated activation cascade;Adaptive Immune System;Metabolism;Inositol phosphate metabolism;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Synthesis of IP3 and IP4 in the cytosol;TCR signaling;Generation of second messenger molecules;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;CLEC7A (Dectin-1) signaling;Dectin-2 family;C-type lectin receptors (CLRs);Infectious disease;Platelet activation, signaling and aggregation;Signaling by Erythropoietin;Erythropoietin activates Phospholipase C gamma (PLCG);Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P16930	Metabolism;Metabolism of amino acids and derivatives;Tyrosine catabolism;Phenylalanine and tyrosine metabolism
P16949	Signaling by ERBB4;Nuclear signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases
P17014	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17017	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17019	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17021	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17022	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17023	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17024	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17027	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17029	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17030	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17031	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17032	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17035	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17036	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17038	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17039	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P17066	Innate Immune System;Immune System;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Neutrophil degranulation;Cellular responses to external stimuli
P17081	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Membrane Trafficking;RHO GTPases regulate CFTR trafficking;Vesicle-mediated transport
P17096	HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;2-LTR circle formation;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated nuclear import of PICs;Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Infectious disease;Cellular responses to external stimuli
P17152	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation
P17174	Methionine salvage pathway;Metabolism;Sulfur amino acid metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of amino acids and derivatives;Metabolism of carbohydrates;Aspartate and asparagine metabolism
P17181	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling
P17213	Toll Like Receptor 4 (TLR4) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Neutrophil degranulation;Antimicrobial peptides
P17252	Hemostasis;Opioid Signalling;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Disinhibition of SNARE formation;Signaling by ERBB2;SHC1 events in ERBB2 signaling;Developmental Biology;Metabolism;Signaling by SCF-KIT;Regulation of KIT signaling;Extracellular matrix organization;DAG and IP3 signaling;Signal Transduction;Integration of energy metabolism;Cell Cycle;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;EGFR Transactivation by Gastrin;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Nuclear Envelope Breakdown;Syndecan interactions;Non-integrin membrane-ECM interactions;Signaling by GPCR;Signaling by ROBO receptors;Beta-catenin independent WNT signaling;GPCR downstream signalling;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Acetylcholine regulates insulin secretion;Ca2+ pathway;PCP/CE pathway;G alpha (q) signalling events;Trafficking of GluR2-containing AMPA receptors;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;Axon guidance;Depolymerisation of the Nuclear Lamina;VEGFA-VEGFR2 Pathway;HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;WNT5A-dependent internalization of FZD4;VEGFR2 mediated cell proliferation;RHO GTPases Activate NADPH Oxidases;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Gastrin-CREB signalling pathway via PKC and MAPK;RET signaling;Metabolism of RNA;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;ROBO receptors bind AKAP5;Nervous system development
P17275	Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Immune System;Signaling by TGF-beta Receptor Complex;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;NGF-stimulated transcription
P17301	Hemostasis;Developmental Biology;Extracellular matrix organization;Signal Transduction;Integrin cell surface interactions;Laminin interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;L1CAM interactions;Axon guidance;CHL1 interactions;Signaling by MET;Platelet Adhesion to exposed collagen;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases;Nervous system development
P17302	Gap junction trafficking and regulation;Oligomerization of connexins into connexons;Transport of connexins along the secretory pathway;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Gap junction degradation;Regulation of gap junction activity;Formation of annular gap junctions;Membrane Trafficking;Vesicle-mediated transport
P17405	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
P17480	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Promoter Opening;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
P17483	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P17516	Metabolism;Signal Transduction;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of lipids;Metabolism of fat-soluble vitamins;Metabolism of steroids;Retinoid metabolism and transport
P17535	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression;NGF-stimulated transcription
P17538	Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P17540	Metabolism;Creatine metabolism;Metabolism of amino acids and derivatives
P17542	Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Transcriptional regulation of granulopoiesis
P17568	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P17600	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle
P17612	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;DAG and IP3 signaling;Signal Transduction;PKA-mediated phosphorylation of key metabolic factors;Glucagon signaling in metabolic regulation;Triglyceride catabolism;PKA activation;Integration of energy metabolism;Cell Cycle;Disease;PKA activation in glucagon signalling;Innate Immune System;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;DARPP-32 events;Organelle biogenesis and maintenance;Signaling by VEGF;Generic Transcription Pathway;Regulation of PLK1 Activity at G2/M Transition;Signaling by GPCR;Signaling by ROBO receptors;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;Rap1 signalling;Muscle contraction;G alpha (i) signalling events;Regulation of insulin secretion;Axon guidance;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Interleukins;Mitotic G2-G2/M phases;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by Hedgehog;Metabolism of lipids;Cardiac conduction;Ion homeostasis;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Infectious disease;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);RET signaling;AURKA Activation by TPX2;HDL assembly;Plasma lipoprotein assembly;Triglyceride metabolism;Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;ROBO receptors bind AKAP5;Loss of phosphorylation of MECP2 at T308;Regulation of MECP2 expression and activity;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Nervous system development;Disorders of developmental biology;Factors involved in megakaryocyte development and platelet production
P17643	Metabolism;Melanin biosynthesis;Metabolism of amino acids and derivatives
P17655	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P17658	Neuronal System;Potassium Channels;Voltage gated Potassium channels
P17661	Striated Muscle Contraction;Muscle contraction
P17676	Developmental Biology;Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Transcriptional regulation of white adipocyte differentiation;Metabolism of proteins;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Transcriptional regulation of granulopoiesis;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P17677	Developmental Biology;L1CAM interactions;Axon guidance;Nervous system development
P17693	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P17706-2	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Regulation of IFNG signaling;Interferon Signaling
P17706	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Signaling by MET;Negative regulation of MET activity;Signaling by Receptor Tyrosine Kinases;Interleukin-37 signaling
P17707	Metabolism;Metabolism of polyamines;Metabolism of amino acids and derivatives
P17735	Metabolism;Metabolism of amino acids and derivatives;Tyrosine catabolism;Phenylalanine and tyrosine metabolism
P17752	Metabolism;Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Metabolism of amine-derived hormones;Serotonin and melatonin biosynthesis;Metabolism of amino acids and derivatives;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P17787	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly sodium permeable postsynaptic acetylcholine nicotinic receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
P17812	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P17844	Signal Transduction;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P17858	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P17861-2	ATF6 (ATF6-alpha) activates chaperones;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins
P17900	Metabolism;Glycosphingolipid metabolism;Innate Immune System;Immune System;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation
P17927	Complement cascade;Innate Immune System;Immune System;Generic Transcription Pathway;Neutrophil degranulation;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1;Regulation of Complement cascade
P17931	Innate Immune System;Immune System;Generic Transcription Pathway;Neutrophil degranulation;RNA Polymerase II Transcription;Gene expression (Transcription);Advanced glycosylation endproduct receptor signaling;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;RUNX2 regulates genes involved in differentiation of myeloid cells
P17936	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;TP53 Regulates Transcription of Cell Death Genes;Post-translational protein modification;TP53 Regulates Transcription of Death Receptors and Ligands;RNA Polymerase II Transcription;Gene expression (Transcription);Post-translational protein phosphorylation
P17947	Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Transcriptional regulation of granulopoiesis
P17948	Signal Transduction;Signaling by VEGF;Neurophilin interactions with VEGF and VEGFR;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Signaling by Receptor Tyrosine Kinases
P17980	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P17987	Cytokine Signaling in Immune system;Immune System;Organelle biogenesis and maintenance;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Interleukin-12 family signaling;Signaling by Interleukins;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P18031	Hemostasis;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Generic Transcription Pathway;Integrin signaling;Signaling by MET;Negative regulation of MET activity;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Interferon gamma signaling;Regulation of IFNG signaling;Signaling by PTK6;PTK6 Down-Regulation;Transcriptional Regulation by MECP2;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;MECP2 regulates neuronal receptors and channels;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;Growth hormone receptor signaling
P18054	Metabolism;Synthesis of Hepoxilins (HX) and Trioxilins (TrX);Synthesis of Lipoxins (LX);Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of DPA-derived SPMs;Biosynthesis of DPAn-3 SPMs;Biosynthesis of DPAn-6 SPMs;Biosynthesis of DPAn-3-derived maresins
P18065	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins
P18074	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Metabolism;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Cytosolic iron-sulfur cluster assembly;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
P18075	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P18077	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P18084	Cross-presentation of particulate exogenous antigens (phagosomes);Antigen processing-Cross presentation;Adaptive Immune System;Extracellular matrix organization;Elastic fibre formation;Immune System;Molecules associated with elastic fibres;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Muscle contraction;Smooth Muscle Contraction;Class I MHC mediated antigen processing & presentation
P18085	Organelle biogenesis and maintenance;ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P18089	Hemostasis;Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;Adrenaline signalling through Alpha-2 adrenergic receptor;G alpha (i) signalling events;G alpha (z) signalling events;GPCR ligand binding;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P18124	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P18146	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Immune System;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;Interferon alpha/beta signaling;Interferon Signaling
P18195	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class F Receptors;Vesicle-mediated transport
P18206	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Signal Transduction;Disease;Innate Immune System;Immune System;Muscle contraction;Smooth Muscle Contraction;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;FLT3 Signaling;Signaling downstream of RAS mutants
P18283	Metabolism;Generic Transcription Pathway;Synthesis of 5-eicosatetraenoic acids;Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Synthesis of 15-eicosatetraenoic acid derivatives;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;Metabolism of lipids;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;Fatty acid metabolism
P18405	Metabolism;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P18428	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;Transfer of LPS from LBP carrier to CD14;Innate Immune System;Immune System;Toll-like Receptor Cascades;Signaling by Interleukins;Regulation of TLR by endogenous ligand;Interleukin-4 and Interleukin-13 signaling
P18433	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Nervous system development
P18440	Metabolism;Phase II - Conjugation of compounds;Acetylation;Biological oxidations
P18462	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P18463	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P18464	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P18465	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P18505	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;GABA receptor activation
P18507	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;GABA receptor activation
P18509	Signal Transduction;Disease;Signaling by NTRKs;Activation of TRKA receptors;NGF-independant TRKA activation;Signaling by NTRK1 (TRKA);Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Signaling by Receptor Tyrosine Kinases;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P18510	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-10 signaling;Interleukin-1 signaling
P18545	Signal Transduction;Signaling by WNT;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Ca2+ pathway;G alpha (i) signalling events
P18564	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;Integrin cell surface interactions;ECM proteoglycans
P18577	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Rhesus blood group biosynthesis
P18615	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
P18621	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P18627	Adaptive Immune System;Immune System;MHC class II antigen presentation
P18640	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type C (BoNT/C);Uptake and actions of bacterial toxins;Infectious disease
P18669	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P18754	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Postmitotic nuclear pore complex (NPC) reformation
P18799	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P18825	Hemostasis;Metabolism;Signal Transduction;Integration of energy metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;Adrenaline signalling through Alpha-2 adrenergic receptor;Metabolism of proteins;Adrenaline,noradrenaline inhibits insulin secretion;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;GPCR ligand binding;Surfactant metabolism;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P18827	Hemostasis;Cytokine Signaling in Immune system;Metabolism;Extracellular matrix organization;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Immune System;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Cell surface interactions at the vascular wall;Visual phototransduction;Syndecan interactions;Non-integrin membrane-ECM interactions;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Signaling by Interleukins;Other interleukin signaling;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport
P18846	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);CREB phosphorylation;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P18847	Cellular responses to stress;ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P18848	Cellular responses to stress;ATF4 activates genes in response to endoplasmic reticulum  stress;ATF6 (ATF6-alpha) activates chaperones;PERK regulates gene expression;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P18850	ATF4 activates genes in response to endoplasmic reticulum  stress;ATF6 (ATF6-alpha) activates chaperones;PERK regulates gene expression;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins
P18858	POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;HIV Life Cycle;Early Phase of HIV Life Cycle;HIV Infection;Cell Cycle;Disease;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);PCNA-Dependent Long Patch Base Excision Repair;Infectious disease;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Transcription-Coupled Nucleotide Excision Repair (TC-NER);Gap-filling DNA repair synthesis and ligation in TC-NER;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;Chromosome Maintenance;DNA Repair;Resolution of Abasic Sites (AP sites)
P18859	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P18887	Resolution of AP sites via the single-nucleotide replacement pathway;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;HDR through MMEJ (alt-NHEJ);DNA Double-Strand Break Repair;Homology Directed Repair;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Transcription-Coupled Nucleotide Excision Repair (TC-NER);Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;DNA Repair;Resolution of Abasic Sites (AP sites)
P19012	Developmental Biology;Keratinization;Formation of the cornified envelope
P19013	Developmental Biology;Keratinization;Formation of the cornified envelope
P19022	Developmental Biology;Cell-Cell communication;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization;Myogenesis;Post-translational protein modification;Post-translational protein phosphorylation
P19086	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Signal Transduction;Disease;G-protein activation;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P19087	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Signal Transduction;Signaling by WNT;G-protein activation;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Ca2+ pathway;G alpha (i) signalling events;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P19099	Metabolism;Disease;Mineralocorticoid biosynthesis;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
P19105	Developmental Biology;EPH-Ephrin signaling;Ephrin signaling;Muscle contraction;Axon guidance;Smooth Muscle Contraction;Nervous system development
P19113	Metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
P19174	Hemostasis;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;PLCG1 events in ERBB2 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Inositol phosphate metabolism;DAG and IP3 signaling;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;PLC-gamma1 signalling;Innate Immune System;Immune System;Signaling by EGFR;Synthesis of IP3 and IP4 in the cytosol;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signaling by FGFR;Signaling by VEGF;TCR signaling;Generation of second messenger molecules;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;PECAM1 interactions;EGFR interacts with phospholipase C-gamma;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Netrin-1 signaling;Role of second messengers in netrin-1 signaling;Axon guidance;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;Downstream signaling of activated FGFR2;Downstream signaling of activated FGFR3;Downstream signaling of activated FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Signaling by FGFR3 point mutants in cancer;RET signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through PLCG1;Erythropoietin activates Phospholipase C gamma (PLCG);Signaling by NTRK3 (TRKC);Activated NTRK3 signals through PLCG1;Interferon Signaling;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Nervous system development
P19214	Hemostasis;Cell surface interactions at the vascular wall
P19224	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
P19235	Signal Transduction;Signaling by Erythropoietin;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Erythropoietin activates Phospholipase C gamma (PLCG);Erythropoietin activates STAT5;Erythropoietin activates RAS
P19237	Striated Muscle Contraction;Muscle contraction
P19256	Hemostasis;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Neutrophil degranulation
P19320	Cytokine Signaling in Immune system;Adaptive Immune System;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Interferon gamma signaling;Interferon Signaling
P19321	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type D (BoNT/D);Uptake and actions of bacterial toxins;Infectious disease
P19338	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P19367	Metabolism;Disease;Defective HK1 causes hexokinase deficiency (HK deficiency);SLC transporter disorders;Disorders of transmembrane transporters;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P19387	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P19388	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;Cytosolic sensors of pathogen-associated DNA ;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase III Chain Elongation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P19397	Innate Immune System;Immune System;Neutrophil degranulation
P19404	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P19419	Cytokine Signaling in Immune system;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Infectious disease;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;NGF-stimulated transcription;TRIF(TICAM1)-mediated TLR4 signaling ;HCMV Infection;HCMV Early Events;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P19429	Striated Muscle Contraction;Muscle contraction;Cardiac conduction;Ion homeostasis
P19438	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNFR1-mediated ceramide production;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;Interleukin-10 signaling;Death Receptor Signalling;TNF signaling
P19440	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Disease;Glutathione synthesis and recycling;Biological oxidations;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Aflatoxin activation and detoxification;Metabolism of lipids;Defective GGT1 causes Glutathionuria (GLUTH);Metabolic disorders of biological oxidation enzymes;Infectious disease;Diseases of metabolism;Fatty acid metabolism;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;LTC4-CYSLTR mediated IL4 production
P19447	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
P19474	Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;Interferon gamma signaling;Interferon Signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P19525	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Disease;Influenza Infection;Immune System;NS1 Mediated Effects on Host Pathways;Inhibition of PKR;Infectious disease;Interferon Signaling
P19526	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;ABO blood group biosynthesis
P19549	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P19550	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P19551	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P19623	Metabolism;Metabolism of polyamines;Metabolism of amino acids and derivatives
P19634	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan uptake and degradation;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers;Metabolism of carbohydrates
P19652	Hemostasis;Platelet degranulation ;Innate Immune System;Immune System;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P19784	PIP3 activates AKT signaling;Developmental Biology;Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;Macroautophagy;Cell Cycle;Signaling by WNT;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Generic Transcription Pathway;Condensation of Prometaphase Chromosomes;Transcriptional Regulation by TP53;L1CAM interactions;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Signal transduction by L1;Mitophagy;Metabolism of lipids;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;PTEN Regulation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Receptor Mediated Mitophagy;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Autophagy;Selective autophagy;Nervous system development
P19793	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Recycling of bile acids and salts;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;PPARA activates gene expression;Carnitine metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional regulation of white adipocyte differentiation;Nuclear Receptor transcription pathway;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;SUMOylation of intracellular receptors;Signaling by Retinoic Acid;Metabolism of lipids;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Post-translational protein modification;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;Fatty acid metabolism;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ;NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose;Transcriptional regulation of granulopoiesis;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis;NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 
P19801	Metabolism;Innate Immune System;Immune System;Biological oxidations;Phase I - Functionalization of compounds;Neutrophil degranulation
P19823	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P19835	Digestion of dietary lipid;Digestion;Digestion and absorption
P19838	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;p75NTR signals via NF-kB;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;TCR signaling;Downstream TCR signaling;NF-kB is activated and signals survival;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;FCERI mediated NF-kB activation;DEx/H-box helicases activate type I IFN and inflammatory cytokines production ;PKMTs methylate histone lysines;Chromatin modifying enzymes;Transcriptional regulation of white adipocyte differentiation;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Interleukin-1 processing;Signaling by Interleukins;MAP kinase activation;Chromatin organization;Diseases of Immune System;Diseases associated with the TLR signaling cascade;IkBA variant leads to EDA-ID;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;CLEC7A/inflammasome pathway;Infectious disease;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Inflammasomes;Neutrophil degranulation;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);The NLRP3 inflammasome;Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;HCMV Infection;HCMV Early Events;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response);TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Signaling by the B Cell Receptor (BCR)
P19875	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P19876	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P19878	ROS and RNS production in phagocytes;Cross-presentation of particulate exogenous antigens (phagosomes);Antigen processing-Cross presentation;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Cellular responses to stress;Detoxification of Reactive Oxygen Species;VEGFA-VEGFR2 Pathway;RHO GTPases Activate NADPH Oxidases;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Class I MHC mediated antigen processing & presentation
P19883	Signaling by Activin;Signal Transduction;Antagonism of Activin by Follistatin;Signaling by TGF-beta family members
P19957	Developmental Biology;Innate Immune System;Immune System;Antimicrobial peptides;Keratinization;Formation of the cornified envelope
P19961	Digestion of dietary carbohydrate;Digestion;Digestion and absorption
P19971	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Pyrimidine catabolism;Nucleobase catabolism;Nucleotide salvage
P20020	Hemostasis;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P20023	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P20036	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P20039	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P20042	L13a-mediated translational silencing of Ceruloplasmin expression;Cellular responses to stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P20061	Metabolism;Innate Immune System;Immune System;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Neutrophil degranulation
P20062	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective TCN2 causes hereditary megaloblastic anemia;Defective CD320 causes methylmalonic aciduria;Diseases of metabolism
P20132	Metabolism;Metabolism of amino acids and derivatives;Threonine catabolism
P20138	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
P20151	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
P20160	Innate Immune System;Immune System;Neutrophil degranulation
P20226	Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;SIRT1 negatively regulates rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA polymerase II transcribes snRNA genes;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P20248	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Cell Cycle;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;SCF(Skp2)-mediated degradation of p27/p21;Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Metabolism of proteins;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Regulation of TP53 Activity;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;Post-translational protein modification;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;G2 Phase;Orc1 removal from chromatin;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Cellular responses to external stimuli
P20265	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P20273	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;CD22 mediated BCR regulation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P20292	Metabolism;Synthesis of 5-eicosatetraenoic acids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Synthesis of Lipoxins (LX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism;Biosynthesis of specialized proresolving mediators (SPMs)
P20309	Metabolism;Signal Transduction;Integration of energy metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Muscarinic acetylcholine receptors;Acetylcholine regulates insulin secretion;G alpha (q) signalling events;Regulation of insulin secretion;GPCR ligand binding
P20333	Cytokine Signaling in Immune system;Innate Immune System;Immune System;Signaling by Interleukins;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation
P20336	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Innate Immune System;Immune System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Membrane Trafficking;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;GABA synthesis, release, reuptake and degradation;Rab regulation of trafficking
P20337	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
P20338	Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Membrane Trafficking;Metabolism of proteins;Metabolism of lipids;Vesicle-mediated transport;Post-translational protein modification;Signaling by MET;TBC/RABGAPs;RAB geranylgeranylation;MET receptor recycling;Signaling by Receptor Tyrosine Kinases;Rab regulation of trafficking
P20339	Hemostasis;Metabolism;PI Metabolism;Phospholipid metabolism;Disease;Synthesis of PIPs at the plasma membrane;Membrane Trafficking;Metabolism of proteins;Metabolism of lipids;Vesicle-mediated transport;Infectious disease;Post-translational protein modification;TBC/RABGAPs;Clathrin-mediated endocytosis;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis;Factors involved in megakaryocyte development and platelet production
P20340	Signaling by NOTCH;Signal Transduction;Innate Immune System;Immune System;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;COPI-independent Golgi-to-ER retrograde traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;TBC/RABGAPs;Golgi-to-ER retrograde transport;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P20366	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Tachykinin receptors bind tachykinins;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P20382	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
P20393	NR1D1 (REV-ERBA) represses gene expression;Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Nuclear Receptor transcription pathway;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
P20396	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P20472	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2
P20585	Disease;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MSH3;Defective Mismatch Repair Associated With MSH2;DNA Repair;Diseases of DNA repair
P20591	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
P20592	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
P20594	Muscle contraction;Cardiac conduction;Physiological factors
P20618	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P20645	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P20648	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
P20671	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P20674	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P20700	Apoptosis;Apoptotic cleavage of cellular proteins;Meiotic synapsis;Cytokine Signaling in Immune system;Reproduction;Meiosis;Cell Cycle;Disease;Immune System;Cellular responses to stress;Mitotic Metaphase and Anaphase;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Breakdown of the nuclear lamina;Depolymerisation of the Nuclear Lamina;Interleukin-12 family signaling;Signaling by Interleukins;Programmed Cell Death;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Apoptotic execution phase;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Cellular responses to external stimuli;Interleukin-12 signaling;Diseases of programmed cell death
P20701	Hemostasis;Adaptive Immune System;Extracellular matrix organization;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Integrin cell surface interactions;Neutrophil degranulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 Regulates Immune Response and Cell Migration
P20702	Hemostasis;Cytokine Signaling in Immune system;Extracellular matrix organization;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Integrin cell surface interactions;ECM proteoglycans;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation
P20711	Metabolism;Metabolism of amine-derived hormones;Catecholamine biosynthesis;Serotonin and melatonin biosynthesis;Metabolism of amino acids and derivatives
P20718	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins
P20774	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Keratan sulfate degradation;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Defective ST3GAL3 causes MCT12 and EIEE15;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
P20783	Signal Transduction;Signaling by NTRKs;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;NTF3 activates NTRK2 (TRKB) signaling;NTF3 activates NTRK3 signaling;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through PLCG1;Activated NTRK3 signals through RAS;Activated NTRK3 signals through PI3K
P20800	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P20807	Degradation of the extracellular matrix;Extracellular matrix organization
P20809	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
P20810	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P20813	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions
P20815	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;Aflatoxin activation and detoxification
P20823	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
P20827	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P20839	Metabolism;Metabolism of nucleotides;Innate Immune System;Immune System;Neutrophil degranulation;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P20849	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P20851	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P20853	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions
P20871	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P20888	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P20908	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P20916	Hemostasis;Developmental Biology;Signal Transduction;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Cell surface interactions at the vascular wall;Basigin interactions;Death Receptor Signalling;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P20929	Striated Muscle Contraction;Muscle contraction
P20930	Developmental Biology;Keratinization;Formation of the cornified envelope
P20933	Innate Immune System;Immune System;Neutrophil degranulation
P20936	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Downstream signal transduction;Signaling by PDGF;Signaling by VEGF;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Nervous system development
P20963-1	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Costimulation by the CD28 family;PD-1 signaling;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival
P21108	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates;5-Phosphoribose 1-diphosphate biosynthesis
P21127	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic
P21217	Metabolism;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
P21266	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P21281	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
P21283	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
P21291	MTF1 activates gene expression;Response to metal ions;Cellular responses to external stimuli
P21333	Hemostasis;Platelet degranulation ;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Cell-Cell communication;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;GP1b-IX-V activation signalling;Cell-extracellular matrix interactions;Cell junction organization;RHO GTPases activate PAKs;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;OAS antiviral response;Interferon Signaling
P21359	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RAS signaling downstream of NF1 loss-of-function variants;Oncogenic MAPK signaling;FLT3 Signaling
P21397	Neurotransmitter release cycle;Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Amine Oxidase reactions;Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB;Metabolism;Disease;Immune System;Norepinephrine Neurotransmitter Release Cycle;Biological oxidations;Phase I - Functionalization of compounds;Enzymatic degradation of dopamine by COMT;Enzymatic degradation of Dopamine by monoamine oxidase;Dopamine clearance from the synaptic cleft;Metabolism of serotonin;Serotonin clearance from the synaptic cleft;Signaling by Interleukins;Defective MAOA causes Brunner syndrome (BRUNS);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Interleukin-4 and Interleukin-13 signaling
P21399	Transport of small molecules;Iron uptake and transport
P21439	Metabolism;Disease;PPARA activates gene expression;Transport of small molecules;ABC-family proteins mediated transport;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1
P21452	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Tachykinin receptors bind tachykinins;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P21453	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;Signaling by Interleukins;GPCR ligand binding;Interleukin-4 and Interleukin-13 signaling
P21462	Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling;Neutrophil degranulation
P21506	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P21549	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives;Peroxisomal protein import;Protein localization
P21554	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P21579	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Disease;Neurotoxicity of clostridium toxins;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Membrane Trafficking;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Toxicity of botulinum toxin type B (BoNT/B);Toxicity of botulinum toxin type G (BoNT/G);Uptake and actions of bacterial toxins;Vesicle-mediated transport;Infectious disease;Neurexins and neuroligins;Protein-protein interactions at synapses;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;GABA synthesis, release, reuptake and degradation
P21580	Signal Transduction;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling;Negative regulators of DDX58/IFIH1 signaling
P21583-1	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P21589	Metabolism;Metabolism of nucleotides;Disease;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Infectious disease;Pyrimidine catabolism;Purine catabolism;Nucleobase catabolism;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P21673	Metabolism;Interconversion of polyamines;Metabolism of polyamines;Metabolism of amino acids and derivatives
P21675	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
P21695	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
P21709	Developmental Biology;EPH-Ephrin signaling;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Transcriptional regulation of pluripotent stem cells;Nervous system development
P21728	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Dopamine receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P21730	Signal Transduction;Complement cascade;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Neutrophil degranulation;Regulation of Complement cascade
P21731-2	Hemostasis;Signal amplification;Thromboxane signalling through TP receptor;Platelet activation, signaling and aggregation
P21731-3	Hemostasis;Signal amplification;Thromboxane signalling through TP receptor;Platelet activation, signaling and aggregation
P21731	Hemostasis;Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;Signal amplification;G alpha (q) signalling events;G alpha (12/13) signalling events;Thromboxane signalling through TP receptor;GPCR ligand binding;Platelet activation, signaling and aggregation
P21741	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH2;NOTCH2 Activation and Transmission of Signal to the Nucleus
P21754	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
P21757	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Vesicle-mediated transport
P21781	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR2;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P21796	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Macroautophagy;Transport of small molecules;Metabolism of proteins;Mitophagy;Pink/Parkin Mediated Mitophagy;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Mitochondrial calcium ion transport;Protein localization;Autophagy;Selective autophagy
P21802-1	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR2;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR2 IIIa TM;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P21802-17	Signaling by FGFR in disease;Disease;FGFR2 mutant receptor activation;Signaling by FGFR2 amplification mutants;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers
P21802-18	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR2;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR2 IIIa TM;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P21802-3	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR2;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR2 IIIa TM;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P21802-5	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR2;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR2 IIIa TM;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P21802	Signaling by FGFR in disease;Disease;FGFR2 mutant receptor activation;Signaling by FGFR2 amplification mutants;Activated point mutants of FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by FGFR2 IIIa TM;Signaling by FGFR2 fusions
P21810	Metabolism;Extracellular matrix organization;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;CS/DS degradation;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective CHST3 causes SEDCJD;Defective CHST14 causes EDS, musculocontractural type;Defective CHSY1 causes TPBS;Diseases of glycosylation;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of carbohydrates
P21815	Extracellular matrix organization;Integrin cell surface interactions;ECM proteoglycans
P21817	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
P21854	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
P21860-1	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;GRB7 events in ERBB2 signaling;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Disease;Immune System;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
P21912	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P21917	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Dopamine receptors;G alpha (i) signalling events;GPCR ligand binding
P21918	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Dopamine receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P21926	Hemostasis;Platelet degranulation ;Fertilization;Acrosome Reaction and Sperm:Oocyte Membrane Binding;Reproduction;Disease;Uptake and function of diphtheria toxin;Uptake and actions of bacterial toxins;Infectious disease;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P21941	Extracellular matrix organization;ECM proteoglycans
P21953	Metabolism;Glyoxylate metabolism and glycine degradation;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
P21964	Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Metabolism;Phase II - Conjugation of compounds;Methylation;Biological oxidations;Enzymatic degradation of dopamine by COMT;Enzymatic degradation of Dopamine by monoamine oxidase;Dopamine clearance from the synaptic cleft
P22001	Neuronal System;Potassium Channels;Voltage gated Potassium channels
P22033	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective MMAA causes methylmalonic aciduria type cblA;Defective MUT causes methylmalonic aciduria mut type;Metabolism of lipids;Diseases of metabolism;Propionyl-CoA catabolism;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
P22059	Metabolism;Sphingolipid de novo biosynthesis;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Sphingolipid metabolism;Metabolism of lipids;Metabolism of steroids
P22061	Metabolism of proteins;Protein repair
P22079	ROS and RNS production in phagocytes;Innate Immune System;Immune System;Events associated with phagocytolytic activity of PMN cells
P22083	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
P22087	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P22090	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P22102	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P22105	Extracellular matrix organization;ECM proteoglycans
P22223	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P22234	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P22301	Cytokine Signaling in Immune system;Disease;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Infectious disease;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival
P22303	Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Peptide hormone metabolism;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin;Metabolism of lipids
P22304	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;HS-GAG degradation;CS/DS degradation;Mucopolysaccharidoses;MPS II - Hunter syndrome;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates
P22307-1	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;Beta-oxidation of pristanoyl-CoA;Peroxisomal lipid metabolism;Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism
P22307	Metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;alpha-linolenic acid (ALA) metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;TYSND1 cleaves peroxisomal proteins;Protein localization
P22309	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Disease;Biological oxidations;Defective UGT1A1 causes hyperbilirubinemia;Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
P22310	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Disease;Metabolism of porphyrins;Heme degradation;Biological oxidations;Defective UGT1A4 causes hyperbilirubinemia;Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
P22314	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P22352	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
P22362	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P22392	Metabolism;Metabolism of nucleotides;Innate Immune System;Immune System;Interconversion of nucleotide di- and triphosphates;Neutrophil degranulation
P22413	Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
P22415	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P22455	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;betaKlotho-mediated ligand binding;Signal Transduction;Disease;Immune System;FGFR4 mutant receptor activation;Signaling by FGFR;FGFR4 ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR4;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR4 signaling;Signaling by FGFR4;Signaling by FGFR4 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P22459	Neuronal System;Potassium Channels;Voltage gated Potassium channels
P22460	Neuronal System;Potassium Channels;Voltage gated Potassium channels
P22466	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P22528	Developmental Biology;Keratinization;Formation of the cornified envelope
P22531	Developmental Biology;Keratinization;Formation of the cornified envelope
P22532	Developmental Biology;Keratinization;Formation of the cornified envelope
P22557	Metabolism;Metabolism of porphyrins;Heme biosynthesis
P22570	Mitochondrial iron-sulfur cluster biogenesis;Metabolism;Disease;Metabolism of steroid hormones;Pregnenolone biosynthesis;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Electron transport from NADPH to Ferredoxin;Metabolism of lipids;Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
P22607-1	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR3c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR3;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;Negative regulation of FGFR3 signaling;Signaling by FGFR3;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P22607-2	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR3b ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR3;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;Negative regulation of FGFR3 signaling;Signaling by FGFR3;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P22607	Signaling by FGFR in disease;Disease;Signaling by activated point mutants of FGFR3;FGFR3 mutant receptor activation;t(4;14) translocations of FGFR3;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer
P22612	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Metabolism;DAG and IP3 signaling;Signal Transduction;PKA-mediated phosphorylation of key metabolic factors;Glucagon signaling in metabolic regulation;Triglyceride catabolism;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Innate Immune System;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;DARPP-32 events;Signaling by VEGF;Signaling by GPCR;Signaling by ROBO receptors;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;Rap1 signalling;G alpha (i) signalling events;Regulation of insulin secretion;Axon guidance;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Hedgehog;Metabolism of lipids;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Infectious disease;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RET signaling;HDL assembly;Plasma lipoprotein assembly;Triglyceride metabolism;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;ROBO receptors bind AKAP5;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Nervous system development;Factors involved in megakaryocyte development and platelet production
P22626	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Metabolism of RNA;Interleukin-12 signaling
P22680	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids
P22681	Interleukin-6 signaling;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Cytokine Signaling in Immune system;Spry regulation of FGF signaling;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by TGF-beta Receptor Complex;Signaling by EGFR;EGFR downregulation;Signaling by FGFR;Membrane Trafficking;TGF-beta receptor signaling activates SMADs;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Vesicle-mediated transport;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Interleukin-6 family signaling;Signaling by MET;Negative regulation of MET activity;Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;Regulation of signaling by CBL
P22692	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P22694	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Metabolism;DAG and IP3 signaling;Signal Transduction;PKA-mediated phosphorylation of key metabolic factors;Glucagon signaling in metabolic regulation;Triglyceride catabolism;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Innate Immune System;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;DARPP-32 events;Signaling by VEGF;Signaling by GPCR;Signaling by ROBO receptors;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;Rap1 signalling;G alpha (i) signalling events;Regulation of insulin secretion;Axon guidance;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Hedgehog;Metabolism of lipids;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Infectious disease;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RET signaling;HDL assembly;Plasma lipoprotein assembly;Triglyceride metabolism;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;ROBO receptors bind AKAP5;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Nervous system development;Factors involved in megakaryocyte development and platelet production
P22695	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
P22732	Innate Immune System;Immune System;Neutrophil degranulation;Intestinal absorption;Digestion and absorption;Intestinal hexose absorption
P22735	Developmental Biology;Keratinization;Formation of the cornified envelope
P22736	PIP3 activates AKT signaling;Signal Transduction;Disease;AKT phosphorylates targets in the nucleus;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Nuclear Receptor transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers
P22748	Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;Metabolism;Reversible hydration of carbon dioxide;O2/CO2 exchange in erythrocytes;Transport of small molecules
P22749	Innate Immune System;Immune System;Antimicrobial peptides
P22760	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
P22792	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P22830	Metabolism;Metabolism of porphyrins;Heme biosynthesis
P22888	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P22891	Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Post-translational protein modification
P22894	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Innate Immune System;Immune System;Neutrophil degranulation
P22897	Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);Adaptive Immune System;Disease;Immune System;Infectious disease;Infection with Mycobacterium tuberculosis;Modulation by Mtb of host immune system;Class I MHC mediated antigen processing & presentation
P23025	Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;DNA Repair
P23083	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P23109	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
P23141	Metabolism;Metabolism of Angiotensinogen to Angiotensins;Biological oxidations;Phase I - Functionalization of compounds;Peptide hormone metabolism;Metabolism of proteins
P23142	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P23193	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
P23219	COX reactions;Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism
P23229	Hemostasis;Extracellular matrix organization;Collagen formation;Cell-Cell communication;Assembly of collagen fibrils and other multimeric structures;Cell surface interactions at the vascular wall;Basigin interactions;Integrin cell surface interactions;Laminin interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;Type I hemidesmosome assembly;Cell junction organization
P23246	Signal Transduction;Disease;Infectious disease;Signaling by PTK6;PTK6 Regulates Proteins Involved in RNA Processing;Signaling by Non-Receptor Tyrosine Kinases;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis
P23258	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
P23276	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
P23280	Metabolism;Reversible hydration of carbon dioxide
P23284	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
P23297	Innate Immune System;Immune System;Toll-like Receptor Cascades;Regulation of TLR by endogenous ligand
P23327	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P23352	Signal Transduction;Signaling by FGFR;FGFR1 ligand binding and activation;FGFR1c ligand binding and activation;Negative regulation of FGFR1 signaling;Signaling by FGFR1;Signaling by Receptor Tyrosine Kinases
P23368	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P23378	Metabolism;Glyoxylate metabolism and glycine degradation;Glycine degradation;Metabolism of amino acids and derivatives
P23381	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
P23396	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P23409	Developmental Biology;Myogenesis
P23415	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
P23416	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
P23434	Metabolism;Glyoxylate metabolism and glycine degradation;Glycine degradation;Metabolism of amino acids and derivatives
P23443	Signal Transduction;mTOR signalling;mTORC1-mediated signalling
P23458	Interleukin-6 signaling;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interleukin-7 signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Other interleukin signaling;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-6 family signaling;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;IL-6-type cytokine receptor ligand interactions;Interferon gamma signaling;Regulation of IFNG signaling;Interleukin-20 family signaling;Interleukin-15 signaling;Interleukin-35 Signalling;Interleukin-9 signaling;Interleukin-2 signaling;Interleukin-12 signaling;Interleukin-27 signaling;Interleukin-21 signaling;Interferon alpha/beta signaling;Interleukin receptor SHC signaling;Regulation of IFNA signaling;Interferon Signaling;FLT3 Signaling
P23467	Innate Immune System;Immune System;Neutrophil degranulation
P23468	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
P23471	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling
P23490	Developmental Biology;Keratinization;Formation of the cornified envelope
P23497	Cytokine Signaling in Immune system;Immune System;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification;Interferon gamma signaling;Interferon Signaling
P23510	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
P23511	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);PPARA activates gene expression;Generic Transcription Pathway;Activation of gene expression by SREBF (SREBP);ATF4 activates genes in response to endoplasmic reticulum  stress;ATF6 (ATF6-alpha) activates chaperones;PERK regulates gene expression;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes
P23515	Signal Transduction;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Death Receptor Signalling
P23526	Metabolism;Phase II - Conjugation of compounds;Methylation;Sulfur amino acid metabolism;Disease;Biological oxidations;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of amino acids and derivatives
P23527	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P23528	Hemostasis;Platelet degranulation ;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;Semaphorin interactions;EPHB-mediated forward signaling;Sema3A PAK dependent Axon repulsion;Axon guidance;Interleukin-12 family signaling;Signaling by Interleukins;RHO GTPases Activate ROCKs;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Nervous system development
P23560	Signal Transduction;Signaling by NTRKs;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;MECP2 regulates transcription of neuronal ligands;BDNF activates NTRK2 (TRKB) signaling;Activated NTRK2 signals through RAS;Activated NTRK2 signals through PLCG1;Activated NTRK2 signals through PI3K;Activated NTRK2 signals through FRS2 and FRS3;Activated NTRK2 signals through FYN;NTRK2 activates RAC1;Activated NTRK2 signals through CDK5
P23582	Muscle contraction;Cardiac conduction;Physiological factors
P23588	L13a-mediated translational silencing of Ceruloplasmin expression;Signal Transduction;mTOR signalling;mTORC1-mediated signalling;Metabolism of proteins;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;Metabolism of RNA
P23634	Hemostasis;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P23677	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
P23743	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
P23760	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
P23763	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type F (BoNT/F);Toxicity of botulinum toxin type G (BoNT/G);Uptake and actions of bacterial toxins;Infectious disease
P23769	Hemostasis;Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Transcriptional regulation of granulopoiesis;Factors involved in megakaryocyte development and platelet production
P23771	Hemostasis;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Generic Transcription Pathway;Metabolism of proteins;Signaling by Interleukins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Factors involved in megakaryocyte development and platelet production
P23786	Metabolism;PPARA activates gene expression;Carnitine metabolism;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Fatty acid metabolism
P23919	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P23921	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P23945	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P23946	Signaling by SCF-KIT;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Signal Transduction;Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins;Signaling by Receptor Tyrosine Kinases
P23975	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;SLC transporter disorders;Defective SLC6A2 causes orthostatic intolerance (OI);Disorders of transmembrane transporters
P24001	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling
P24043	Developmental Biology;Extracellular matrix organization;Signal Transduction;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P24046	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
P24071	Innate Immune System;Immune System;Neutrophil degranulation
P24158	Hemostasis;Cytokine Signaling in Immune system;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Innate Immune System;Immune System;Signaling by Interleukins;Other interleukin signaling;Neutrophil degranulation;Antimicrobial peptides
P24298	Metabolism;Metabolism of amino acids and derivatives;Alanine metabolism
P24311	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P24347	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
P24385	Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Cell Cycle;Immune System;SCF(Skp2)-mediated degradation of p27/p21;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Signaling by Interleukins;Mitotic G1 phase and G1/S transition;Chromatin organization;Interleukin-4 and Interleukin-13 signaling;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;Signaling by PTK6;PTK6 Regulates Cell Cycle;Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;ESR-mediated signaling;RUNX3 regulates WNT signaling;RUNX3 regulates p14-ARF;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Estrogen-dependent gene expression;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P24386	Membrane Trafficking;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;TP53 Regulates Transcription of Cell Death Genes;Vesicle-mediated transport;Post-translational protein modification;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P24387	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
P24390	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P24394	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
P24462	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics
P24468	Developmental Biology;Transcriptional regulation of white adipocyte differentiation
P24522	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
P24530	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P24534	Eukaryotic Translation Elongation;Metabolism of proteins;Translation
P24539	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P24557	Metabolism;Disease;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Eicosanoids;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Metabolic disorders of biological oxidation enzymes;Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD);Diseases of metabolism;Fatty acid metabolism
P24588	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Metabolism;Integration of energy metabolism;Signaling by ROBO receptors;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Regulation of insulin secretion;Axon guidance;ROBO receptors bind AKAP5;Nervous system development
P24592	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins
P24593	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P24723	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (z) signalling events;Platelet activation, signaling and aggregation
P24752	Metabolism;Metabolism of lipids;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;Ketone body metabolism;Utilization of Ketone Bodies;Synthesis of Ketone Bodies
P24821	Extracellular matrix organization;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P24844	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Generic Transcription Pathway;EPH-Ephrin signaling;Semaphorin interactions;EPHA-mediated growth cone collapse;Muscle contraction;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Smooth Muscle Contraction;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Nervous system development
P24863	Developmental Biology;Metabolism;Signaling by NOTCH;Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Signaling by NOTCH1;PPARA activates gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
P24864	G0 and Early G1;Signal Transduction;Cell Cycle;SCF(Skp2)-mediated degradation of p27/p21;Generic Transcription Pathway;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Mitotic G1 phase and G1/S transition;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by PTK6;PTK6 Regulates Cell Cycle;Cellular responses to external stimuli;Signaling by Non-Receptor Tyrosine Kinases
P24903	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions
P24928	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P24941	Hemostasis;Developmental Biology;Reproduction;Meiosis;G0 and Early G1;Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Activation of ATR in response to replication stress;Regulation of APC/C activators between G1/S and early anaphase;SCF(Skp2)-mediated degradation of p27/p21;Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Regulation of TP53 Activity;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;G2 Phase;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Signaling by PTK6;PTK6 Regulates Cell Cycle;Cellular responses to external stimuli;Signaling by Non-Receptor Tyrosine Kinases;Meiotic recombination;Transcriptional regulation of granulopoiesis;Factors involved in megakaryocyte development and platelet production
P25021	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Histamine receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P25024	Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Neutrophil degranulation
P25025	Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Neutrophil degranulation
P25054	Apoptosis;Apoptotic cleavage of cellular proteins;Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex;Metabolism of proteins;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;Programmed Cell Death;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants are not K63 polyubiquitinated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Apoptotic execution phase
P25063	Developmental Biology;L1CAM interactions;Axon guidance;Nervous system development
P25067	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Collagen chain trimerization
P25089	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;GPCR ligand binding
P25090	Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;GPCR ligand binding;Neutrophil degranulation
P25092	Disease;Uptake and actions of bacterial toxins;Infectious disease;Digestion;Intestinal infectious diseases;Digestion and absorption
P25098	Opioid Signalling;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;DAG and IP3 signaling;Signal Transduction;Membrane Trafficking;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (s) signalling events;G alpha (i) signalling events;Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Intracellular signaling by second messengers
P25100	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;G alpha (q) signalling events;G alpha (12/13) signalling events;GPCR ligand binding
P25101	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P25103	Signal Transduction;Membrane Trafficking;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Tachykinin receptors bind tachykinins;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P25105	Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling;Neutrophil degranulation;Interferon gamma signaling;Interferon Signaling
P25106	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P25116	Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;Thrombin signalling through proteinase activated receptors (PARs);GPCR ligand binding;Platelet activation, signaling and aggregation
P25189	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P25205	Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
P25208	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);PPARA activates gene expression;Generic Transcription Pathway;Activation of gene expression by SREBF (SREBP);ATF4 activates genes in response to endoplasmic reticulum  stress;ATF6 (ATF6-alpha) activates chaperones;PERK regulates gene expression;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes
P25311	Transport of small molecules;Miscellaneous transport and binding events
P25325	Metabolism;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
P25391	Developmental Biology;Extracellular matrix organization;Signal Transduction;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;L1CAM interactions;Axon guidance;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases;Nervous system development
P25398	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P25440	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates p14-ARF
P25445	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Generic Transcription Pathway;Regulation by c-FLIP;Transcriptional Regulation by TP53;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;Regulation of necroptotic cell death;TP53 Regulates Transcription of Death Receptors and Ligands;Dimerization of procaspase-8;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);FasL/ CD95L signaling
P25490	Developmental Biology;Signal Transduction;Generic Transcription Pathway;Metabolism of proteins;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P25685	Signal Transduction;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Cellular responses to external stimuli
P25705	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation;Protein localization
P25713	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P25774	Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Adaptive Immune System;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Assembly of collagen fibrils and other multimeric structures;MHC class II antigen presentation;Neutrophil degranulation;Class I MHC mediated antigen processing & presentation
P25786	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P25787	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P25788	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P25789	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P25791	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs
P25800	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs
P25815	Innate Immune System;Immune System;Neutrophil degranulation
P25874	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial Uncoupling;The fatty acid cycling model;The proton buffering model
P25929	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P25940	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Syndecan interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P25942-1	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
P25963	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;TCR signaling;Downstream TCR signaling;NF-kB is activated and signals survival;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;SUMOylation of immune response proteins;Diseases of Immune System;Diseases associated with the TLR signaling cascade;IkBA variant leads to EDA-ID;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Signaling by the B Cell Receptor (BCR)
P26006	Hemostasis;Extracellular matrix organization;Signal Transduction;Cell surface interactions at the vascular wall;Basigin interactions;Integrin cell surface interactions;Laminin interactions;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
P26010	Adaptive Immune System;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions
P26012	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;Integrin cell surface interactions
P26022	Innate Immune System;Immune System;Neutrophil degranulation
P26038	Developmental Biology;Cytokine Signaling in Immune system;Immune System;L1CAM interactions;Axon guidance;Recycling pathway of L1;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Nervous system development
P26045	Signal Transduction;Signaling by EGFR;EGFR downregulation;Signaling by Receptor Tyrosine Kinases
P26196	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Metabolism of RNA
P26232	Developmental Biology;Myogenesis
P26358	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;NoRC negatively regulates rRNA expression;SUMOylation of DNA methylation proteins;Negative epigenetic regulation of rRNA expression;DNA methylation;Post-translational protein modification;Gene expression (Transcription)
P26367	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P26368	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
P26371	Developmental Biology;Keratinization
P26373	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P26374	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P26439	Metabolism;Androgen biosynthesis;Mineralocorticoid biosynthesis;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P26440	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
P26441	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
P26572	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan trimming and elongation in the cis-Golgi
P26583	Apoptosis;Apoptosis induced DNA fragmentation;Programmed Cell Death;Apoptotic execution phase
P26599	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases
P26623	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Class I MHC mediated antigen processing & presentation
P26639	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
P26640	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
P26641	Eukaryotic Translation Elongation;Metabolism of proteins;Translation
P26651	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of RNA
P26678	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P26715	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P26717	Innate Immune System;Immune System;DAP12 interactions;DAP12 signaling
P26718	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;DAP12 signaling
P26842	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
P26927	Signal Transduction;Signaling by MST1;Signaling by Receptor Tyrosine Kinases
P26951	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P26992	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
P27037	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL;Signaling by Activin;Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
P27105	Innate Immune System;Immune System;Stimuli-sensing channels;Transport of small molecules;Neutrophil degranulation;Ion channel transport
P27144	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P27169	Metabolism;Synthesis of 5-eicosatetraenoic acids;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
P27338	Amine Oxidase reactions;Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB;Metabolism;Biological oxidations;Phase I - Functionalization of compounds
P27348	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;RHO GTPases activate PKNs;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors
P27352	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective GIF causes intrinsic factor deficiency;Defective AMN causes hereditary megaloblastic anemia 1;Defective CUBN causes hereditary megaloblastic anemia 1;Diseases of metabolism
P27361-3	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
P27361	Apoptosis;Hemostasis;Intrinsic Pathway for Apoptosis;MAPK3 (ERK1) activation;Formation of apoptosome;Cytochrome c-mediated apoptotic response;Apoptotic factor-mediated response;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;RAF-independent MAPK1/3 activation;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Spry regulation of FGF signaling;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Prolonged ERK activation events;Frs2-mediated activation;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by Rho GTPases;RHO GTPase Effectors;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Negative regulation of the PI3K/AKT network;ERKs are inactivated;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;FCERI mediated MAPK activation;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Signaling by GPCR;L1CAM interactions;NCAM signaling for neurite out-growth;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;RSK activation;Signal transduction by L1;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Activation of the AP-1 family of transcription factors;Thrombin signalling through proteinase activated receptors (PARs);Programmed Cell Death;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RHO GTPases Activate NADPH Oxidases;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative feedback regulation of MAPK pathway;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;PTEN Regulation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;Advanced glycosylation endproduct receptor signaling;Gastrin-CREB signalling pathway via PKC and MAPK;Transcriptional regulation by RUNX2;ESR-mediated signaling;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Interferon Signaling;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Regulation of the apoptosome activity;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis;Signaling downstream of RAS mutants;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Growth hormone receptor signaling
P27448	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
P27449	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Neutrophil degranulation;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
P27469	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
P27487	Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
P27539	Signaling by NODAL;Developmental Biology
P27540	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Xenobiotics;Cellular responses to stress;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Aryl hydrocarbon receptor signalling;Cellular responses to external stimuli
P27544	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
P27635	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P27658	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Collagen chain trimerization
P27694	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Activation of ATR in response to replication stress;Extension of Telomeres;Generic Transcription Pathway;Cellular responses to stress;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Regulation of HSF1-mediated heat shock response;HSF1 activation;Cellular response to heat stress;Transcriptional Regulation by TP53;Metabolism of proteins;Mitotic G1 phase and G1/S transition;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Regulation of TP53 Activity;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Formation of Incision Complex in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Fanconi Anemia Pathway;Regulation of TP53 Activity through Phosphorylation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription);Cellular responses to external stimuli;Meiotic recombination
P27695	Displacement of DNA glycosylase by APEX1;POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Resolution of AP sites via the single-nucleotide replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Base Excision Repair;DNA Repair;Abasic sugar-phosphate removal via the single-nucleotide replacement pathway;Resolution of Abasic Sites (AP sites)
P27707	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Purine salvage;Nucleotide salvage
P27708	Metabolism;Metabolism of nucleotides;Pyrimidine biosynthesis;Nucleobase biosynthesis
P27797	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Disease;Influenza Infection;Immune System;Virus Assembly and Release;Assembly of Viral Components at the Budding Site;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Scavenging by Class F Receptors;ATF6 (ATF6-alpha) activates chaperones;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Vesicle-mediated transport;Infectious disease;Post-translational protein modification;Calnexin/calreticulin cycle;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P27815	Opioid Signalling;Signal Transduction;DARPP-32 events;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events
P27824	Cytokine Signaling in Immune system;Adaptive Immune System;Disease;Influenza Infection;Immune System;Virus Assembly and Release;Assembly of Viral Components at the Budding Site;MHC class II antigen presentation;Metabolism of proteins;Asparagine N-linked glycosylation;Interleukin-12 family signaling;Signaling by Interleukins;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Infectious disease;Post-translational protein modification;Interleukin-35 Signalling;Calnexin/calreticulin cycle;Interleukin-27 signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P27918	Disease;Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Alternative complement activation;Activation of C3 and C5;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification;Neutrophil degranulation;Regulation of Complement cascade
P27930	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-10 signaling;Interleukin-1 signaling
P27958	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
P27986	Hemostasis;PI3K Cascade;IRS-mediated signalling;GPVI-mediated activation cascade;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;PI3K events in ERBB4 signaling;PIP3 activates AKT signaling;Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by SCF-KIT;PI Metabolism;Phospholipid metabolism;Cell-Cell communication;Signal Transduction;Disease;Signaling by EGFR in Cancer;Synthesis of PIPs at the plasma membrane;Signaling by NTRKs;Innate Immune System;Immune System;Signaling by EGFR;GAB1 signalosome;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signaling by FGFR;Signaling by VEGF;PI3K events in ERBB2 signaling;PI3K/AKT activation;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Tie2 Signaling;DAP12 interactions;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;Signaling by GPCR;Nephrin family interactions;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;G alpha (q) signalling events;Axon guidance;GP1b-IX-V activation signalling;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;PI-3K cascade:FGFR1;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;Downstream signaling of activated FGFR4;PI-3K cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-4 and Interleukin-13 signaling;Signaling by MET;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;MET activates PI3K/AKT signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;RET signaling;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Activated NTRK2 signals through PI3K;Signaling by NTRK3 (TRKC);Interleukin receptor SHC signaling;Regulation of signaling by CBL;Activated NTRK3 signals through PI3K;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P27987	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
P28062	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Interferon alpha/beta signaling;Interferon Signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P28065	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P28066	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P28067	Adaptive Immune System;Immune System;MHC class II antigen presentation
P28068	Adaptive Immune System;Immune System;MHC class II antigen presentation
P28070	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P28072	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P28074	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P28161	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P28221	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (i) signalling events;GPCR ligand binding
P28222	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (i) signalling events;GPCR ligand binding
P28223	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (q) signalling events;GPCR ligand binding
P28288	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport;Class I peroxisomal membrane protein import;Protein localization
P28289	Striated Muscle Contraction;Muscle contraction
P28300	Extracellular matrix organization;Collagen formation;Elastic fibre formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
P28328	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Peroxisomal protein import;Class I peroxisomal membrane protein import;Protein localization
P28329	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Acetylcholine Neurotransmitter Release Cycle;Metabolism of lipids
P28330	Metabolism;Metabolism of lipids;Beta oxidation of myristoyl-CoA to lauroyl-CoA;mitochondrial fatty acid beta-oxidation of saturated fatty acids;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA;Fatty acid metabolism
P28331	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P28332	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Ethanol oxidation
P28335	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (q) signalling events;GPCR ligand binding
P28336	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P28340	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Metabolism;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;Cytosolic iron-sulfur cluster assembly;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
P28347	Developmental Biology;YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates YAP1-mediated transcription;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P28472	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;GABA receptor activation
P28476	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
P28482	Apoptosis;Hemostasis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Cytochrome c-mediated apoptotic response;Apoptotic factor-mediated response;Opioid Signalling;phospho-PLA2 pathway;Ca-dependent events;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Spry regulation of FGF signaling;Signal Transduction;Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Prolonged ERK activation events;Frs2-mediated activation;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by Rho GTPases;RHO GTPase Effectors;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Negative regulation of the PI3K/AKT network;ERKs are inactivated;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;FCERI mediated MAPK activation;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Signaling by GPCR;L1CAM interactions;NCAM signaling for neurite out-growth;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;RSK activation;Signal transduction by L1;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Activation of the AP-1 family of transcription factors;Thrombin signalling through proteinase activated receptors (PARs);Programmed Cell Death;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RHO GTPases Activate NADPH Oxidases;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative feedback regulation of MAPK pathway;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;PTEN Regulation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;Advanced glycosylation endproduct receptor signaling;Gastrin-CREB signalling pathway via PKC and MAPK;Transcriptional regulation by RUNX2;ESR-mediated signaling;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Regulation of the apoptosome activity;Estrogen-stimulated signaling through PRKCZ;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis;Signaling downstream of RAS mutants;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Growth hormone receptor signaling
P28562	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
P28566	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (i) signalling events;GPCR ligand binding
P28676	Innate Immune System;Immune System;Neutrophil degranulation
P28702	Metabolism;Signal Transduction;PPARA activates gene expression;Generic Transcription Pathway;Nuclear Receptor transcription pathway;Regulation of lipid metabolism by PPARalpha;Signaling by Retinoic Acid;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ;NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis;NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 
P28715	Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;DNA Repair
P28749	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Signal Transduction;Cell Cycle;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;G1/S-Specific Transcription;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
P28799	Innate Immune System;Immune System;Neutrophil degranulation
P28845	Metabolism;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P28906-1	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P28907	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P28908	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
P29016	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P29017	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P29033	Gap junction trafficking and regulation;Oligomerization of connexins into connexons;Transport of connexins along the secretory pathway;Gap junction trafficking;Gap junction assembly;Transport of connexons to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport
P29074	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Generic Transcription Pathway;Interleukin-1 family signaling;Signaling by Interleukins;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Interleukin-37 signaling;MECP2 regulates neuronal receptors and channels
P29083	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Infectious disease;RNA Polymerase II Pre-transcription Events;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
P29084	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Infectious disease;RNA Polymerase II Pre-transcription Events;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
P29120	Peptide hormone biosynthesis;Insulin processing;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin
P29122	Signaling by NODAL;Developmental Biology;Signal Transduction;Signaling by NTRKs;NGF processing;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Keratinization;Formation of the cornified envelope;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Signaling by Receptor Tyrosine Kinases;Expression and Processing of Neurotrophins
P29144	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P29218	Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
P29274	Signal Transduction;Disease;Signaling by NTRKs;Activation of TRKA receptors;NGF-independant TRKA activation;Signaling by NTRK1 (TRKA);Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Metabolism of proteins;Adenosine P1 receptors;Nucleotide-like (purinergic) receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Surfactant metabolism;Signaling by Receptor Tyrosine Kinases;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P29275	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Metabolism of proteins;Adenosine P1 receptors;Nucleotide-like (purinergic) receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Surfactant metabolism;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P29279	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates YAP1-mediated transcription
P29317	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P29320	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P29322	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P29323	Developmental Biology;EPH-Ephrin signaling;L1CAM interactions;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P29350	Hemostasis;GPVI-mediated activation cascade;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Regulation of KIT signaling;Cell-Cell communication;Signal Transduction;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;PECAM1 interactions;Costimulation by the CD28 family;PD-1 signaling;Signal regulatory protein family interactions;Platelet homeostasis;Platelet sensitization by LDL;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;CD22 mediated BCR regulation;Neutrophil degranulation;Platelet activation, signaling and aggregation;Interferon gamma signaling;Regulation of IFNG signaling;Signaling by Receptor Tyrosine Kinases;Interleukin-37 signaling;Interferon alpha/beta signaling;Interleukin receptor SHC signaling;Regulation of IFNA signaling;Interferon Signaling;Growth hormone receptor signaling;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P29353-1	Signaling by ERBB2;SHC1 events in ERBB2 signaling;Signal Transduction;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;SHC-related events triggered by IGF1R;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling
P29353-2	Signaling by ERBB2;SHC1 events in ERBB2 signaling;Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Innate Immune System;Immune System;Signaling by FGFR;DAP12 interactions;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;SHC-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;SHC-mediated cascade:FGFR3;Downstream signaling of activated FGFR3;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by MET;MET activates RAS signaling;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Activated NTRK2 signals through RAS;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;FLT3 Signaling
P29353-3	Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Immune System;Signaling by FGFR;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;SHC-related events triggered by IGF1R;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;SHC-mediated cascade:FGFR3;Downstream signaling of activated FGFR3;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Activated NTRK2 signals through RAS;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;FLT3 Signaling
P29353	Hemostasis;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Signalling to RAS;Immune System;Signaling by EGFR;SHC1 events in EGFR signaling;Signaling by NTRK1 (TRKA);Signalling to ERKs;Cell surface interactions at the vascular wall;Tie2 Signaling;Integrin signaling;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Axon guidance;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);RET signaling;Interleukin-15 signaling;Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Interleukin-2 signaling;Erythropoietin activates RAS;Interleukin receptor SHC signaling;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Nervous system development
P29371	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Tachykinin receptors bind tachykinins;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P29372	Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Displacement of DNA glycosylase by APEX1;Base Excision Repair;DNA Repair;Depurination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites)
P29373	Signal Transduction;Signaling by Retinoic Acid;Signaling by Nuclear Receptors
P29374	HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization
P29375	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
P29400	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Anchoring fibril formation;Crosslinking of collagen fibrils;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;Signaling by ROBO receptors;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Regulation of expression of SLITs and ROBOs;Nervous system development
P29401	Metabolism;Integration of energy metabolism;Insulin effects increased synthesis of Xylulose-5-Phosphate;Pentose phosphate pathway;Metabolism of carbohydrates
P29459	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Interleukin-35 Signalling;Interleukin-12 signaling
P29460	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Interleukin-12 signaling;Interleukin-23 signaling
P29466	Cytokine Signaling in Immune system;Disease;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Generic Transcription Pathway;Transcriptional Regulation by TP53;Interleukin-1 family signaling;Interleukin-1 processing;Signaling by Interleukins;TP53 Regulates Transcription of Cell Death Genes;Infectious disease;Inflammasomes;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Gene expression (Transcription);The NLRP3 inflammasome;The AIM2 inflammasome;The IPAF inflammasome;Interleukin-37 signaling;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P29474	Hemostasis;ROS and RNS production in phagocytes;Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Metabolism of vitamins and cofactors;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation;NOSTRIN mediated eNOS trafficking;NOSIP mediated eNOS trafficking;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;ESR-mediated signaling;Metabolism of cofactors;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling
P29475	Hemostasis;ROS and RNS production in phagocytes;Innate Immune System;Immune System;Nitric oxide stimulates guanylate cyclase;Muscle contraction;Platelet homeostasis;Cardiac conduction;Ion homeostasis
P29508	Innate Immune System;Immune System;Neutrophil degranulation
P29536	Muscle contraction;Smooth Muscle Contraction
P29590-4	Developmental Biology;Transcriptional regulation of granulopoiesis
P29590	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Generic Transcription Pathway;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;Infectious disease;Post-translational protein modification;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon gamma signaling;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;Regulation of PTEN localization;Intracellular signaling by second messengers;Interferon Signaling;HCMV Infection;HCMV Early Events
P29597	Interleukin-6 signaling;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Other interleukin signaling;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-6 family signaling;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;IL-6-type cytokine receptor ligand interactions;Interleukin-20 family signaling;Interleukin-35 Signalling;Interleukin-12 signaling;Interleukin-23 signaling;Interleukin-27 signaling;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling
P29622	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P29692	Eukaryotic Translation Elongation;Metabolism of proteins;Translation
P29728	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;OAS antiviral response;Interferon alpha/beta signaling;Interferon Signaling
P29762	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
P29803	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Glyoxylate metabolism and glycine degradation;Signaling by Retinoic Acid;Pyruvate metabolism;Metabolism of amino acids and derivatives;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
P29965	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
P29966	Metabolism;Integration of energy metabolism;Acetylcholine regulates insulin secretion;Regulation of insulin secretion
P29972	Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;O2/CO2 exchange in erythrocytes;Transport of small molecules;Vasopressin regulates renal water homeostasis via Aquaporins;Passive transport by Aquaporins;Aquaporin-mediated transport
P29973	Signal Transduction;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P29992	Hemostasis;Metabolism;Signal Transduction;Integration of energy metabolism;Signaling by GPCR;GPCR downstream signalling;Signal amplification;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;G alpha (q) signalling events;ADP signalling through P2Y purinoceptor 1;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Thrombin signalling through proteinase activated receptors (PARs);Platelet activation, signaling and aggregation
P30038	Metabolism;Glyoxylate metabolism and glycine degradation;Proline catabolism;Metabolism of amino acids and derivatives
P30041	Innate Immune System;Immune System;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Neutrophil degranulation;Cellular responses to external stimuli
P30043	Metabolism;Metabolism of porphyrins;Heme degradation
P30044-1	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
P30044-2	Generic Transcription Pathway;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli
P30047	Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Metabolism of vitamins and cofactors;Metabolism of cofactors
P30048	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
P30049	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P30050	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P30084	Metabolism;Metabolism of lipids;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Beta oxidation of octanoyl-CoA to hexanoyl-CoA;Beta oxidation of hexanoyl-CoA to butanoyl-CoA;Beta oxidation of butanoyl-CoA to acetyl-CoA;Fatty acid metabolism
P30085	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P30086	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
P30101	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;Calnexin/calreticulin cycle;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30153	Hemostasis;Opioid Signalling;Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Signal Transduction;Integration of energy metabolism;PP2A-mediated dephosphorylation of key metabolic factors;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DARPP-32 events;Toll Like Receptor 2 (TLR2) Cascade;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Signaling by FGFR;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;ERKs are inactivated;Generic Transcription Pathway;MASTL Facilitates Mitotic Progression;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Transcriptional Regulation by TP53;Signaling by GPCR;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;GPCR downstream signalling;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;G alpha (i) signalling events;Platelet sensitization by LDL;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Regulation of TP53 Activity;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);AURKA Activation by TPX2;Metabolism of RNA;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Nonsense-Mediated Decay (NMD);TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;EML4 and NUDC in mitotic spindle formation;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P30154	Hemostasis;Opioid Signalling;Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Signal Transduction;Integration of energy metabolism;PP2A-mediated dephosphorylation of key metabolic factors;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DARPP-32 events;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;ERKs are inactivated;Generic Transcription Pathway;MASTL Facilitates Mitotic Progression;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Transcriptional Regulation by TP53;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;G alpha (i) signalling events;Platelet sensitization by LDL;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;EML4 and NUDC in mitotic spindle formation;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P30260	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P30273	Hemostasis;GPVI-mediated activation cascade;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Dectin-2 family;C-type lectin receptors (CLRs);Neutrophil degranulation;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation
P30279	Cell Cycle;Generic Transcription Pathway;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity
P30281	Developmental Biology;Signal Transduction;Cell Cycle;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Mitotic G1 phase and G1/S transition;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity
P30291	Hemostasis;Polo-like kinase mediated events;Cell Cycle;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M DNA replication checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;Factors involved in megakaryocyte development and platelet production
P30301	Transport of small molecules;Passive transport by Aquaporins;Aquaporin-mediated transport
P30304	Transcription of E2F targets under negative control by DREAM complex;G0 and Early G1;Polo-like kinase mediated events;Cell Cycle;Disease;Activation of ATR in response to replication stress;Metabolism of proteins;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P30305	Cell Cycle;Disease;Mitotic G2-G2/M phases;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P30307	Polo-like kinase mediated events;Signal Transduction;Cell Cycle;Disease;Activation of ATR in response to replication stress;Signaling by Rho GTPases;RHO GTPase Effectors;Generic Transcription Pathway;Transcriptional Regulation by TP53;Mitotic G2-G2/M phases;RHO GTPases activate PKNs;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
P30411	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
P30419	Apoptosis;Intrinsic Pathway for Apoptosis;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Programmed Cell Death;Infectious disease;Activation, myristolyation of BID and translocation to mitochondria
P30443	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30447	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30450	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30453	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30455	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30456	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30457	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30459	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30460	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30461	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30462	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30464	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30466	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30475	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30479	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30480	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30481	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30483	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30484	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30485	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30486	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30487	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30488	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30490	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30491	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30492	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30493	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30495	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30498	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30499	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30501	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30504	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30505	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30508	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30510	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30511	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30512	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30518	Signal Transduction;Disease;Membrane Trafficking;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Transport of small molecules;GPCR downstream signalling;Vasopressin-like receptors;G alpha (s) signalling events;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;GPCR ligand binding;SLC transporter disorders;Disorders of transmembrane transporters;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI);Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P30519	Metabolism;Innate Immune System;Immune System;Metabolism of porphyrins;Heme degradation;Transport of small molecules;Neutrophil degranulation;Iron uptake and transport
P30520	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P30530	Signal Transduction;Signaling by VEGF;VEGFA-VEGFR2 Pathway;Signaling by Receptor Tyrosine Kinases
P30531	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;GABA synthesis, release, reuptake and degradation;Reuptake of GABA
P30532	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
P30536	Metabolism;Metabolism of steroid hormones;Pregnenolone biosynthesis;Metabolism of lipids;Metabolism of steroids
P30542	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Adenosine P1 receptors;Nucleotide-like (purinergic) receptors;G alpha (i) signalling events;GPCR ligand binding
P30550	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P30556	Signal Transduction;Membrane Trafficking;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P30559	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Vasopressin-like receptors;G alpha (q) signalling events;GPCR ligand binding
P30566	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P30613-1	Metabolism;Integration of energy metabolism;ChREBP activates metabolic gene expression;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P30613-2	Developmental Biology;Metabolism;Regulation of beta-cell development;Regulation of gene expression in beta cells;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P30622	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases activate IQGAPs;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
P30626	Hemostasis;Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P30679	Hemostasis;Metabolism;Signal Transduction;Integration of energy metabolism;Signaling by GPCR;GPCR downstream signalling;Signal amplification;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;G alpha (q) signalling events;ADP signalling through P2Y purinoceptor 1;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Thrombin signalling through proteinase activated receptors (PARs);Platelet activation, signaling and aggregation
P30685	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P30690	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Class I MHC mediated antigen processing & presentation
P30711	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P30740	Innate Immune System;Immune System;Neutrophil degranulation
P30793	Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Metabolism of vitamins and cofactors;Metabolism of cofactors
P30825	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P30837	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Ethanol oxidation
P30838	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
P30872	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P30874	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P30876	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P30926	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Innate Immune System;Immune System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly sodium permeable postsynaptic acetylcholine nicotinic receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors;Neutrophil degranulation
P30939	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (i) signalling events;GPCR ligand binding
P30953	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P30954	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P30968	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P30988	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P30989	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P30990	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P30996	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type F (BoNT/F);Uptake and actions of bacterial toxins;Infectious disease
P31025	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of fatty acids
P31040	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P31146	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P31150	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P31151	Innate Immune System;Immune System;Neutrophil degranulation;Metal sequestration by antimicrobial proteins;Antimicrobial peptides
P31152	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
P31153	Metabolism;Phase II - Conjugation of compounds;Methylation;Biological oxidations
P31213	Metabolism;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P31249	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P31321	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;DARPP-32 events;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Factors involved in megakaryocyte development and platelet production
P31323	Hemostasis;Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Cell Cycle;Disease;PKA activation in glucagon signalling;DARPP-32 events;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Signaling by GPCR;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;G alpha (i) signalling events;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Infectious disease;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Factors involved in megakaryocyte development and platelet production
P31327	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
P31350	Metabolism;Metabolism of nucleotides;Cell Cycle;Generic Transcription Pathway;Mitotic G1 phase and G1/S transition;Interconversion of nucleotide di- and triphosphates;G1/S-Specific Transcription;G1/S Transition;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
P31358	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P31371	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3b ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P31391	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P31415	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
P31431	Hemostasis;Metabolism;Extracellular matrix organization;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Cell surface interactions at the vascular wall;Visual phototransduction;Syndecan interactions;Non-integrin membrane-ECM interactions;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport
P31483	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases
P31513	Metabolism;Disease;Biological oxidations;Phase I - Functionalization of compounds;FMO oxidises nucleophiles;Defective FMO3 causes Trimethylaminuria (TMAU);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
P31639	Disease;Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport;SLC transporter disorders;Disorders of transmembrane transporters;Defective SLC5A2 causes renal glucosuria (GLYS1)
P31641	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters
P31644	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
P31645	Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Serotonin clearance from the synaptic cleft
P31689	Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular responses to external stimuli
P31749	Apoptosis;Hemostasis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Signaling by ERBB2;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Downregulation of ERBB2:ERBB3 signaling;Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Signaling by NOTCH;Signal Transduction;Cell Cycle;Disease;mTOR signalling;Immune System;Regulation of beta-cell development;Signaling by VEGF;Signaling by WNT;Metabolism of vitamins and cofactors;AKT phosphorylates targets in the cytosol;AKT phosphorylates targets in the nucleus;Negative regulation of the PI3K/AKT network;Membrane Trafficking;TCF dependent signaling in response to WNT;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation;Regulation of gene expression in beta cells;AKT-mediated inactivation of FOXO1A;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Integrin signaling;Transcriptional Regulation by TP53;Signaling by GPCR;Deactivation of the beta-catenin transactivating complex;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CTLA4 inhibitory signaling;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Mitotic G1 phase and G1/S transition;VEGFR2 mediated vascular permeability;Programmed Cell Death;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Interleukin-4 and Interleukin-13 signaling;Regulation of TP53 Degradation;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Expression and Degradation;PTEN Regulation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;Downregulation of ERBB2 signaling;RAB GEFs exchange GTP for GDP on RABs;Transcriptional regulation by RUNX2;ESR-mediated signaling;RUNX2 regulates genes involved in cell migration;Regulation of PTEN stability and activity;Metabolism of RNA;Metabolism of cofactors;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Rab regulation of trafficking;Extra-nuclear estrogen signaling;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P31751	Apoptosis;Intrinsic Pathway for Apoptosis;PKB-mediated events;PI3K Cascade;Activation of BAD and translocation to mitochondria ;IRS-mediated signalling;Activation of BH3-only proteins;Signaling by ERBB2;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Downregulation of ERBB2:ERBB3 signaling;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Cell Cycle;Disease;Activation of AKT2;mTOR signalling;PDE3B signalling;Inhibition of TSC complex formation by PKB;Immune System;Regulation of beta-cell development;Signaling by VEGF;Signaling by WNT;AKT phosphorylates targets in the cytosol;AKT phosphorylates targets in the nucleus;Negative regulation of the PI3K/AKT network;Membrane Trafficking;TCF dependent signaling in response to WNT;Regulation of gene expression in beta cells;AKT-mediated inactivation of FOXO1A;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Transcriptional Regulation by TP53;Signaling by GPCR;Deactivation of the beta-catenin transactivating complex;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CTLA4 inhibitory signaling;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;VEGFA-VEGFR2 Pathway;Mitotic G1 phase and G1/S transition;VEGFR2 mediated vascular permeability;Programmed Cell Death;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Expression and Degradation;PTEN Regulation;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Insulin receptor signalling cascade;Signaling by Insulin receptor;Downregulation of ERBB2 signaling;RAB GEFs exchange GTP for GDP on RABs;Transcriptional regulation by RUNX2;ESR-mediated signaling;RUNX2 regulates genes involved in cell migration;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Rab regulation of trafficking;Extra-nuclear estrogen signaling;FLT3 Signaling;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P31785	Interleukin-7 signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-4 and Interleukin-13 signaling;Interleukin-15 signaling;Interleukin-9 signaling;Interleukin-2 signaling;Interleukin-21 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P31819	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P31872	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P31930	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
P31937	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
P31939	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P31941	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
P31943	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases
P31944	Developmental Biology;Keratinization;Formation of the cornified envelope
P31946	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Cytokine Signaling in Immune system;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Cell Cycle;Disease;mTOR signalling;mTORC1-mediated signalling;Signaling by NTRKs;Immune System;Prolonged ERK activation events;Frs2-mediated activation;ARMS-mediated activation;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Signaling by Hippo;Generic Transcription Pathway;Transcriptional Regulation by TP53;Rap1 signalling;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Programmed Cell Death;RHO GTPases activate PKNs;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;Signaling downstream of RAS mutants
P31947	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;RHO GTPases activate PKNs;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors
P31948	Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular responses to external stimuli
P31949	Innate Immune System;Immune System;Neutrophil degranulation
P31994	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P31997	Hemostasis;Extracellular matrix organization;Fibronectin matrix formation;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Neutrophil degranulation
P32004	Hemostasis;Developmental Biology;Cell surface interactions at the vascular wall;Basigin interactions;L1CAM interactions;Axon guidance;Recycling pathway of L1;Interaction between L1 and Ankyrins;Signal transduction by L1;Nervous system development
P32019	Metabolism;Inositol phosphate metabolism;Signal Transduction;Synthesis of IP2, IP, and Ins in the cytosol;Synthesis of IP3 and IP4 in the cytosol;Signaling by Rho GTPases;Rho GTPase cycle
P32119	Disease;Generic Transcription Pathway;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Cellular responses to external stimuli;Diseases of programmed cell death
P32121	Hemostasis;Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Disease;Immune System;Signaling by WNT;Signaling by NOTCH1;Membrane Trafficking;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Metabolism of proteins;PCP/CE pathway;G alpha (s) signalling events;Thrombin signalling through proteinase activated receptors (PARs);WNT5A-dependent internalization of FZD4;Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;FLT3 Signaling;Signaling downstream of RAS mutants
P32189	Metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
P32238	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P32239	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding;Gastrin-CREB signalling pathway via PKC and MAPK
P32241	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P32245	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P32246	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P32247	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P32248	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P32249	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P32297	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly sodium permeable postsynaptic acetylcholine nicotinic receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
P32298-1	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P32302	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P32320	Metabolism;Metabolism of nucleotides;Innate Immune System;Immune System;Neutrophil degranulation;Pyrimidine salvage;Nucleotide salvage
P32321	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P32322	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
P32418	Hemostasis;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Cardiac conduction;Ion homeostasis
P32455	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
P32456	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
P32519	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in BCR signaling;RUNX1 regulates transcription of genes involved in interleukin signaling
P32745	Signal Transduction;Organelle biogenesis and maintenance;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
P32754	Metabolism;Metabolism of amino acids and derivatives;Tyrosine catabolism;Phenylalanine and tyrosine metabolism
P32780	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
P32881	Hemostasis;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;TRAF6 mediated IRF7 activation;Factors involved in megakaryocyte development and platelet production
P32926	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;Keratinization;Formation of the cornified envelope;Apoptotic execution phase
P32927	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Metabolism of proteins;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Diseases of metabolism;RAF/MAP kinase cascade;MAPK family signaling cascades;Surfactant metabolism;MAPK1/MAPK3 signaling;Diseases associated with surfactant metabolism;Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4);Interleukin receptor SHC signaling;FLT3 Signaling
P32929	Metabolism;Degradation of cysteine and homocysteine;Cysteine formation from homocysteine;Sulfur amino acid metabolism;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Metabolism of amino acids and derivatives
P32942	Adaptive Immune System;Extracellular matrix organization;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling
P32969	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P32970	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
P32971	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
P33032	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P33076	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
P33121	Metabolism;PPARA activates gene expression;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
P33151	Cell-Cell communication;Signal Transduction;Signaling by VEGF;Adherens junctions interactions;Cell-cell junction organization;VEGFA-VEGFR2 Pathway;Cell junction organization;VEGFR2 mediated vascular permeability;Signaling by Receptor Tyrosine Kinases
P33176	Hemostasis;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;RHO GTPases activate KTN1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
P33240	tRNA processing in the nucleus;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
P33260	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics
P33261	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Metabolism of lipids;Fatty acid metabolism
P33316-2	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P33402	Hemostasis;Nitric oxide stimulates guanylate cyclase;Muscle contraction;Platelet homeostasis;Smooth Muscle Contraction
P33527	Metabolism;Metabolism of porphyrins;Heme degradation;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of lipids;Fatty acid metabolism
P33681	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CD28 dependent Vav1 pathway;CTLA4 inhibitory signaling;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-10 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
P33778	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P33897	ABC transporters in lipid homeostasis;Metabolism;Disease;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Transport of small molecules;ABC-family proteins mediated transport;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCD1 causes adrenoleukodystrophy (ALD);Fatty acid metabolism;Class I peroxisomal membrane protein import;Protein localization
P33908	Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification;N-glycan trimming and elongation in the cis-Golgi;Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2
P33947	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P33991	Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
P33992	Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
P33993	Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
P34059	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Innate Immune System;Immune System;Keratan sulfate degradation;Mucopolysaccharidoses;MPS IV - Morquio syndrome A;Diseases of carbohydrate metabolism;Diseases of metabolism;Neutrophil degranulation;Metabolism of carbohydrates
P34130	Signal Transduction;Signaling by NTRKs;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;NTF4 activates NTRK2 (TRKB) signaling;Activated NTRK2 signals through RAS;Activated NTRK2 signals through PLCG1;Activated NTRK2 signals through PI3K;Activated NTRK2 signals through FRS2 and FRS3
P34741	Hemostasis;Developmental Biology;Metabolism;Extracellular matrix organization;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Cell surface interactions at the vascular wall;Visual phototransduction;EPH-Ephrin signaling;Syndecan interactions;Non-integrin membrane-ECM interactions;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);GPCR downstream signalling;Metabolism of proteins;EPHB-mediated forward signaling;G alpha (i) signalling events;Axon guidance;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Post-translational protein modification;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Post-translational protein phosphorylation;Nervous system development;Retinoid metabolism and transport
P34810	Innate Immune System;Immune System;Neutrophil degranulation
P34896	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Carnitine synthesis;Metabolism of amino acids and derivatives
P34897	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P34903	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
P34913	Metabolism;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of maresins;Peroxisomal protein import;Protein localization
P34925	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Beta-catenin independent WNT signaling;PCP/CE pathway
P34931	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Cellular responses to external stimuli
P34932	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
P34947	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (s) signalling events
P34949	Disease;Diseases of glycosylation;Metabolism of proteins;Defective MPI causes MPI-CDG (CDG-1b);Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of GDP-mannose;Synthesis of substrates in N-glycan biosythesis;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
P34969	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P34972	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P34981	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P34982	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P34995	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;G alpha (q) signalling events;GPCR ligand binding
P34998	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P35030	Metabolism;Defensins;Alpha-defensins;Innate Immune System;Immune System;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Neutrophil degranulation;Antimicrobial peptides
P35052	Hemostasis;Developmental Biology;Metabolism;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Cell surface interactions at the vascular wall;Visual phototransduction;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Signaling by ROBO receptors;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Axon guidance;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Nervous system development;Retinoid metabolism and transport
P35070	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;Membrane Trafficking;EGFR interacts with phospholipase C-gamma;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Downregulation of ERBB2 signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
P35080	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by ROBO receptors;Axon guidance;RHO GTPases Activate Formins;Nervous system development
P35212	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
P35218	Metabolism;Reversible hydration of carbon dioxide
P35221	Developmental Biology;Cell-Cell communication;Signal Transduction;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Adherens junctions interactions;Cell-cell junction organization;VEGFA-VEGFR2 Pathway;Cell junction organization;VEGFR2 mediated vascular permeability;Myogenesis;RHO GTPases activate IQGAPs;Signaling by Receptor Tyrosine Kinases
P35222	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Cell-Cell communication;Signal Transduction;Disease;Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;Signaling by VEGF;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Peptide hormone metabolism;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production;Apoptotic cleavage of cell adhesion  proteins;Deactivation of the beta-catenin transactivating complex;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Beta-catenin independent WNT signaling;Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Ca2+ pathway;Adherens junctions interactions;Cell-cell junction organization;Binding of TCF/LEF:CTNNB1 to target gene promoters;VEGFA-VEGFR2 Pathway;Cell junction organization;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;VEGFR2 mediated vascular permeability;Myogenesis;Misspliced GSK3beta mutants stabilize beta-catenin;Programmed Cell Death;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;RHO GTPases activate IQGAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptotic execution phase;Transcriptional Regulation by VENTX;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells;Transcriptional regulation by RUNX3;RUNX3 regulates WNT signaling;Signaling by Receptor Tyrosine Kinases
P35225	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Interleukin-18 signaling
P35226	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers
P35227	Developmental Biology;Generic Transcription Pathway;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
P35228	Hemostasis;ROS and RNS production in phagocytes;Cytokine Signaling in Immune system;Disease;Innate Immune System;Immune System;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;Signaling by Interleukins;Infectious disease;Interleukin-4 and Interleukin-13 signaling;Peroxisomal protein import;Protein localization;Infection with Mycobacterium tuberculosis;Inhibition of nitric oxide production;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P35232	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Transport of small molecules;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Mitochondrial calcium ion transport;Processing of SMDT1;FLT3 Signaling;Signaling downstream of RAS mutants
P35236	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling
P35237	Hemostasis;Innate Immune System;Immune System;Neutrophil degranulation;Dissolution of Fibrin Clot
P35240	Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;RHO GTPases activate PAKs
P35241	Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Nervous system development
P35243	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P35244	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Activation of ATR in response to replication stress;Extension of Telomeres;Generic Transcription Pathway;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSF1 activation;Cellular response to heat stress;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Regulation of TP53 Activity;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Formation of Incision Complex in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Fanconi Anemia Pathway;Regulation of TP53 Activity through Phosphorylation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription);Cellular responses to external stimuli;Meiotic recombination
P35247	Adaptive Immune System;Cell-Cell communication;Disease;Toll Like Receptor 4 (TLR4) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Signal regulatory protein family interactions;Metabolism of proteins;Diseases of metabolism;Surfactant metabolism;Regulation of TLR by endogenous ligand;Diseases associated with surfactant metabolism;Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
P35249	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Activation of ATR in response to replication stress;Extension of Telomeres;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Regulation of TP53 Activity through Phosphorylation;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription)
P35250	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Activation of ATR in response to replication stress;Extension of Telomeres;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Regulation of TP53 Activity through Phosphorylation;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription)
P35251	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
P35268	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P35269	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;Generic Transcription Pathway;Transcriptional Regulation by TP53;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P35270	Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Metabolism of vitamins and cofactors;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation;Metabolism of cofactors
P35318	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P35321	Developmental Biology;Keratinization;Formation of the cornified envelope
P35325	Developmental Biology;Keratinization;Formation of the cornified envelope
P35326	Developmental Biology;Keratinization;Formation of the cornified envelope
P35346	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P35348	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;G alpha (q) signalling events;G alpha (12/13) signalling events;GPCR ligand binding
P35354	Cytokine Signaling in Immune system;Metabolism;Immune System;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging;Arachidonic acid metabolism;Synthesis of 15-eicosatetraenoic acid derivatives;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Signaling by Interleukins;Metabolism of lipids;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of EPA-derived SPMs;Biosynthesis of DPA-derived SPMs;Biosynthesis of DPAn-3 SPMs;Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives
P35367	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Histamine receptors;G alpha (q) signalling events;GPCR ligand binding
P35368	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Adrenoceptors;G alpha (q) signalling events;G alpha (12/13) signalling events;GPCR ligand binding
P35372	Opioid Signalling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;G-protein activation;Generic Transcription Pathway;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates neuronal receptors and channels
P35398	Cytokine Signaling in Immune system;RORA activates gene expression;Metabolism;Immune System;PPARA activates gene expression;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;SUMOylation of intracellular receptors;Signaling by Interleukins;Metabolism of lipids;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription)
P35408	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P35414	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P35442	Signal Transduction;Disease;Signaling by PDGF;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification;Signaling by Receptor Tyrosine Kinases
P35443	Signal Transduction;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases
P35462	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Dopamine receptors;G alpha (i) signalling events;GPCR ligand binding
P35475	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;HS-GAG degradation;CS/DS degradation;Mucopolysaccharidoses;MPS I - Hurler syndrome;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates
P35498	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
P35499	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
P35503	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Signal Transduction;Biological oxidations;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
P35504	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
P35520	Metabolism;Cysteine formation from homocysteine;Sulfur amino acid metabolism;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Metabolism of amino acids and derivatives
P35523	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P35527	Developmental Biology;Keratinization;Formation of the cornified envelope
P35548	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
P35555	Degradation of the extracellular matrix;Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;Integrin cell surface interactions;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
P35556	Degradation of the extracellular matrix;Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P35557	Developmental Biology;Metabolism;Disease;Regulation of Glucokinase by Glucokinase Regulatory Protein;Regulation of beta-cell development;Regulation of gene expression in beta cells;Generic Transcription Pathway;Defective GCK causes maturity-onset diabetes of the young 2 (MODY2);SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P35558	Developmental Biology;Metabolism;Signal Transduction;Generic Transcription Pathway;Abacavir transport and metabolism;Abacavir metabolism;Transcriptional regulation of white adipocyte differentiation;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 
P35568	PI3K Cascade;IRS-mediated signalling;SOS-mediated signalling;PIP3 activates AKT signaling;Interleukin-7 signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Signaling by NTRK1 (TRKA);PI3K/AKT activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Signaling by Leptin;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;IRS activation;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through PI3K;FLT3 Signaling;Growth hormone receptor signaling
P35573	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P35575	Metabolism;Disease;Generic Transcription Pathway;Glycogen storage diseases;Glycogen storage disease type Ia (G6PC);Diseases of carbohydrate metabolism;Diseases of metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P35579	Developmental Biology;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;Semaphorin interactions;EPHA-mediated growth cone collapse;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Vesicle-mediated transport;Infectious disease;Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Nervous system development
P35580	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Semaphorin interactions;EPHA-mediated growth cone collapse;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Nervous system development
P35606	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P35609	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Platelet degranulation ;Cytokine Signaling in Immune system;Cell-Cell communication;Signal Transduction;Immune System;Nephrin family interactions;Striated Muscle Contraction;Muscle contraction;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation
P35610	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;LDL clearance;Plasma lipoprotein clearance
P35611	Apoptosis;Apoptotic cleavage of cellular proteins;Caspase-mediated cleavage of cytoskeletal proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Transport of small molecules;Metabolism of proteins;Miscellaneous transport and binding events;Programmed Cell Death;Apoptotic execution phase
P35612	Transport of small molecules;Miscellaneous transport and binding events
P35613	Hemostasis;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Cell surface interactions at the vascular wall;Basigin interactions;Integrin cell surface interactions;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Proton-coupled monocarboxylate transport;Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT);SLC transporter disorders;Disorders of transmembrane transporters;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
P35625	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P35626	Signal Transduction;Membrane Trafficking;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P35637	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P35638	Generic Transcription Pathway;Cellular responses to stress;ATF4 activates genes in response to endoplasmic reticulum  stress;ATF6 (ATF6-alpha) activates chaperones;PERK regulates gene expression;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P35658	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
P35659	Developmental Biology;Epigenetic regulation of gene expression;Generic Transcription Pathway;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Transcriptional regulation of granulopoiesis
P35670	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
P35680	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;Regulation of gene expression in early pancreatic precursor cells
P35712	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
P35749	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Semaphorin interactions;EPHA-mediated growth cone collapse;Muscle contraction;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Smooth Muscle Contraction;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Nervous system development
P35754	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P35790	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
P35813	Signal Transduction;mTOR signalling;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Energy dependent regulation of mTOR by LKB1-AMPK;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
P35858	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins
P35869	Metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Xenobiotics;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Aryl hydrocarbon receptor signalling
P35900	Developmental Biology;Keratinization;Formation of the cornified envelope
P35908	Developmental Biology;Keratinization;Formation of the cornified envelope
P35913	Signal Transduction;Signaling by WNT;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Ca2+ pathway;G alpha (i) signalling events
P35914	Metabolism;Metabolism of lipids;Ketone body metabolism;Synthesis of Ketone Bodies;Peroxisomal protein import;Protein localization
P35916	Signaling by NOTCH;Signal Transduction;Signaling by VEGF;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
P35961	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
P35968	Extracellular matrix organization;Signal Transduction;Disease;Signaling by VEGF;Neurophilin interactions with VEGF and VEGFR;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Integrin cell surface interactions;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by Receptor Tyrosine Kinases;Signaling by PDGFR in disease;Signaling by membrane-tethered fusions of PDGFRA or PDGFRB
P35998	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P36021	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of organic anions
P36222	Innate Immune System;Immune System;Neutrophil degranulation
P36269	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Disease;Glutathione synthesis and recycling;Biological oxidations;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Aflatoxin activation and detoxification;Metabolism of lipids;Infectious disease;Fatty acid metabolism;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;LTC4-CYSLTR mediated IL4 production
P36382	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
P36383	Electric Transmission Across Gap Junctions;Transmission across Electrical Synapses ;Neuronal System;Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
P36402	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Deactivation of the beta-catenin transactivating complex;Beta-catenin independent WNT signaling;Ca2+ pathway;Binding of TCF/LEF:CTNNB1 to target gene promoters;Repression of WNT target genes;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates WNT signaling
P36404	Transport of small molecules;Post-chaperonin tubulin folding pathway;Protein folding;Metabolism of proteins;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
P36405	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;Trafficking of myristoylated proteins to the cilium
P36507	RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Prolonged ERK activation events;Frs2-mediated activation;Signaling by NTRK1 (TRKA);Signalling to ERKs;L1CAM interactions;Axon guidance;Signal transduction by L1;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative feedback regulation of MAPK pathway;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants;Nervous system development
P36537	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
P36542	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P36543	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
P36544	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
P36551	Metabolism;Metabolism of porphyrins;Heme biosynthesis
P36578	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P36639-1	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
P36639-2	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
P36639-3	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
P36639-4	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
P36871	Metabolism;Disease;Innate Immune System;Immune System;Glycogen synthesis;Diseases of glycosylation;Defective PGM1 causes PGM1-CDG (CDG1t);Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Neutrophil degranulation;Metabolism of carbohydrates;Glycogen metabolism
P36873	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Signal Transduction;Triglyceride catabolism;Cell Cycle;Signaling by TGF-beta Receptor Complex;Signaling by Rho GTPases;RHO GTPase Effectors;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Circadian Clock;Metabolism of lipids;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Triglyceride metabolism;Signaling by TGF-beta family members;EML4 and NUDC in mitotic spindle formation
P36888	PI3K Cascade;IRS-mediated signalling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;STAT5 Activation
P36894	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
P36896	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL;Signaling by Activin;Signal Transduction;Signaling by TGF-beta family members
P36897	Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Loss of Function of SMAD2/3 in Cancer;Signaling by TGF-beta Receptor Complex in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;Loss of Function of TGFBR2 in Cancer;TGFBR2 Kinase Domain Mutants in Cancer;TGFBR1 KD Mutants in Cancer;Loss of Function of TGFBR1 in Cancer;TGFBR1 LBD Mutants in Cancer;Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Signaling by TGF-beta family members
P36941	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
P36954	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P36956-1	Developmental Biology;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);PPARA activates gene expression;Activation of gene expression by SREBF (SREBP);Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids
P36956-3	Metabolism;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);PPARA activates gene expression;Activation of gene expression by SREBF (SREBP);Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
P36956	RORA activates gene expression;Generic Transcription Pathway;Circadian Clock;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P36957	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Glyoxylate metabolism and glycine degradation;Lysine catabolism;Metabolism of amino acids and derivatives;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P36959	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
P36969-2	Metabolism;Metabolism of lipids;Biosynthesis of D-series resolvins;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of EPA-derived SPMs;Biosynthesis of E-series 18(S)-resolvins;Biosynthesis of aspirin-triggered D-series resolvins;Biosynthesis of E-series 18(R)-resolvins
P36969	Metabolism;Synthesis of 5-eicosatetraenoic acids;Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Synthesis of 15-eicosatetraenoic acid derivatives;Metabolism of lipids;Fatty acid metabolism
P36980	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
P37023	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
P37058	Metabolism;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Metabolism of steroids;Fatty acid metabolism
P37059	Metabolism;Estrogen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P37088	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P37108	Innate Immune System;Immune System;SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Neutrophil degranulation;Translation
P37173	Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Loss of Function of SMAD2/3 in Cancer;Signaling by TGF-beta Receptor Complex in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;Loss of Function of TGFBR2 in Cancer;TGFBR2 MSI Frameshift Mutants in Cancer;TGFBR2 Kinase Domain Mutants in Cancer;TGFBR1 KD Mutants in Cancer;Loss of Function of TGFBR1 in Cancer;TGFBR1 LBD Mutants in Cancer;Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;UCH proteinases;Post-translational protein modification;Signaling by TGF-beta family members
P37198	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
P37231	PIP3 activates AKT signaling;Developmental Biology;Metabolism;Signal Transduction;PPARA activates gene expression;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional regulation of white adipocyte differentiation;Nuclear Receptor transcription pathway;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;SUMOylation of intracellular receptors;Metabolism of lipids;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;MECP2 regulates transcription factors
P37268	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;PPARA activates gene expression;Activation of gene expression by SREBF (SREBP);Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids
P37275	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
P37287	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P37288	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Vasopressin-like receptors;G alpha (q) signalling events;GPCR ligand binding;Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI);SLC transporter disorders;Disorders of transmembrane transporters
P37802	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P37837	Cytokine Signaling in Immune system;Metabolism;Integration of energy metabolism;Insulin effects increased synthesis of Xylulose-5-Phosphate;Disease;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Diseases of carbohydrate metabolism;Diseases of metabolism;TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P;TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P;Pentose phosphate pathway disease;Pentose phosphate pathway;Metabolism of carbohydrates;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P37840	Metabolism of proteins;Amyloid fiber formation
P38117	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Metabolism of proteins;Post-translational protein modification;Respiratory electron transport;Protein methylation
P38159	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P38398	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Generic Transcription Pathway;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);Deubiquitination;Metalloprotease DUBs;DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Nonhomologous End-Joining (NHEJ);Homologous DNA Pairing and Strand Exchange;DNA Double Strand Break Response;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Post-translational protein modification;TP53 Regulates Transcription of DNA Repair Genes;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional Regulation by E2F6;Meiotic recombination
P38405	Opioid Signalling;G-protein mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signal Transduction;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
P38435	Gamma-carboxylation of protein precursors;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Post-translational protein modification
P38484	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Regulation of IFNG signaling;Interferon Signaling
P38567	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
P38570	Extracellular matrix organization;Integrin cell surface interactions
P38571	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;LDL clearance;Plasma lipoprotein clearance
P38606	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
P38646	Mitochondrial protein import;Cytokine Signaling in Immune system;Mitochondrial biogenesis;Immune System;Organelle biogenesis and maintenance;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Interleukin-12 family signaling;Signaling by Interleukins;Cristae formation;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Cellular responses to external stimuli;Interleukin-12 signaling;Protein localization
P38919	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Developmental Biology;Cytokine Signaling in Immune system;Transport of Mature mRNA derived from an Intron-Containing Transcript;Immune System;Signaling by ROBO receptors;Axon guidance;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Interferon Signaling;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P38936	PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Cell Cycle;Disease;Immune System;SCF(Skp2)-mediated degradation of p27/p21;AKT phosphorylates targets in the cytosol;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Signaling by Interleukins;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Interleukin-4 and Interleukin-13 signaling;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;G2/M Transition;Cell Cycle, Mitotic;Transcriptional activation of p53 responsive genes  ;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional  activation of  cell cycle inhibitor p21 ;RNA Polymerase II Transcription;Gene expression (Transcription);The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of cell cycle factors;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;RUNX3 regulates CDKN1A transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;FOXO-mediated transcription;Transcriptional regulation of granulopoiesis;FOXO-mediated transcription of cell cycle genes
P39019	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P39023	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P39059	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Collagen chain trimerization
P39060	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Activation of Matrix Metalloproteinases;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Laminin interactions;Collagen chain trimerization
P39086	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Ionotropic activity of kainate receptors;Activation of Na-permeable kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding
P39210	Peroxisomal protein import;Protein localization
P39656	Innate Immune System;Immune System;SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Neutrophil degranulation;Translation;Advanced glycosylation endproduct receptor signaling
P39687	HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of RNA
P39748	POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;HIV Life Cycle;Early Phase of HIV Life Cycle;HIV Infection;Cell Cycle;Disease;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;PCNA-Dependent Long Patch Base Excision Repair;Infectious disease;HDR through MMEJ (alt-NHEJ);DNA Double-Strand Break Repair;Homology Directed Repair;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;Chromosome Maintenance;DNA Repair;Resolution of Abasic Sites (AP sites)
P39877	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
P39880	Signaling by FGFR in disease;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
P39900	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization
P39905	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
P40123	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Role of ABL in ROBO-SLIT signaling;Nervous system development
P40126	Metabolism;Melanin biosynthesis;Metabolism of amino acids and derivatives
P40136	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
P40145	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
P40189-1	Interleukin-6 signaling;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-6 family signaling
P40189-2	Interleukin-6 signaling;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling
P40189	Interleukin-6 signaling;Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions;Interleukin-35 Signalling;Interleukin-27 signaling
P40197	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);GP1b-IX-V activation signalling;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P40198	Hemostasis;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Neutrophil degranulation
P40199	Hemostasis;Extracellular matrix organization;Fibronectin matrix formation;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Neutrophil degranulation
P40200	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P40222	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling
P40225	Hemostasis;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P40227	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P40238	Hemostasis;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
P40259	Adaptive Immune System;Immune System;CD22 mediated BCR regulation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P40261	Metabolism;Phase II - Conjugation of compounds;Methylation;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging;Biological oxidations;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Metabolism of amino acids and derivatives
P40305	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
P40306	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P40337	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Adaptive Immune System;Immune System;Cellular responses to stress;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Metabolism of proteins;Post-translational protein modification;Neddylation;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P40394	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Ethanol oxidation
P40424	Developmental Biology;Signaling by NOTCH;Signal Transduction;Transcriptional regulation of pluripotent stem cells;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
P40429	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P40616	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
P40692	Reproduction;Meiosis;Cell Cycle;Disease;Generic Transcription Pathway;Transcriptional Regulation by TP53;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MLH1;Defective Mismatch Repair Associated With PMS2;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Meiotic recombination;Diseases of DNA repair
P40763	Interleukin-6 signaling;Apoptosis;Intrinsic Pathway for Apoptosis;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Signaling by FGFR in disease;Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to STAT3;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Signaling by Leptin;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Interleukin-1 family signaling;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-2 family signaling;Transcriptional regulation of pluripotent stem cells;Programmed Cell Death;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-6 family signaling;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Signaling by MET;Signaling by PTK6;PTK6 Activates STAT3;Interleukin-20 family signaling;MET activates STAT3;Cellular responses to external stimuli;Interleukin-15 signaling;Interleukin-35 Signalling;Interleukin-9 signaling;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Interleukin-37 signaling;Interleukin-23 signaling;Interleukin-27 signaling;Interleukin-21 signaling;Transcriptional regulation of granulopoiesis;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Growth hormone receptor signaling
P40818	Signaling by ERBB2;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Metabolism of proteins;Regulation of FZD by ubiquitination;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Signaling by MET;Negative regulation of MET activity;Downregulation of ERBB2 signaling;Signaling by Receptor Tyrosine Kinases
P40855	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport;Class I peroxisomal membrane protein import;Protein localization
P40879	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers;Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1);SLC transporter disorders;Disorders of transmembrane transporters
P40925	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P40926	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P40933	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-15 signaling
P40937	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Activation of ATR in response to replication stress;Extension of Telomeres;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Regulation of TP53 Activity through Phosphorylation;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription)
P40938	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Activation of ATR in response to replication stress;Extension of Telomeres;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;PCNA-Dependent Long Patch Base Excision Repair;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Regulation of TP53 Activity through Phosphorylation;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites);Gene expression (Transcription)
P40939	Metabolism;Acyl chain remodeling of CL;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids;Beta oxidation of myristoyl-CoA to lauroyl-CoA;mitochondrial fatty acid beta-oxidation of saturated fatty acids;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of palmitoyl-CoA to myristoyl-CoA;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Beta oxidation of octanoyl-CoA to hexanoyl-CoA;Beta oxidation of hexanoyl-CoA to butanoyl-CoA;Fatty acid metabolism
P41002	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P41091	L13a-mediated translational silencing of Ceruloplasmin expression;Cellular responses to stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P41134	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Cellular responses to stress;Cellular Senescence;Oncogene Induced Senescence;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P41143	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-4 and Interleukin-13 signaling
P41145	Signal Transduction;Generic Transcription Pathway;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates neuronal receptors and channels
P41146	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P41159	Developmental Biology;Signal Transduction;Signaling by Leptin;Peptide hormone metabolism;Transcriptional regulation of white adipocyte differentiation;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and deacylation of Ghrelin
P41180	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P41181	Transport of small molecules;Vasopressin regulates renal water homeostasis via Aquaporins;Passive transport by Aquaporins;Aquaporin-mediated transport
P41182	Cytokine Signaling in Immune system;Immune System;Generic Transcription Pathway;Transcriptional Regulation by TP53;Signaling by Interleukins;TP53 Regulates Transcription of Cell Death Genes;Interleukin-4 and Interleukin-13 signaling;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell death genes
P41208	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Repair;AURKA Activation by TPX2
P41212	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by PDGFR in disease;Signaling by membrane-tethered fusions of PDGFRA or PDGFRB
P41217	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P41218	Innate Immune System;Immune System;Neutrophil degranulation
P41220	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events
P41221	Signal Transduction;Disease;Signaling by WNT;Membrane Trafficking;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Beta-catenin independent WNT signaling;Ca2+ pathway;PCP/CE pathway;Asymmetric localization of PCP proteins;GPCR ligand binding;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
P41222	Metabolism;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism
P41223	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P41225	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
P41226	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Termination of translesion DNA synthesis;DNA Damage Bypass;DNA Repair;Interferon Signaling;Negative regulators of DDX58/IFIH1 signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P41229	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
P41231	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Metabolism of proteins;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;GPCR ligand binding;Surfactant metabolism
P41235-5	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
P41235-6	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
P41235-7	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
P41235	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P41238	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
P41240	Hemostasis;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Immune System;Signaling by EGFR;GAB1 signalosome;TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Integrin signaling;Costimulation by the CD28 family;PD-1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants
P41247	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
P41250	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
P41252	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
P41273	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
P41279	Cytokine Signaling in Immune system;Adaptive Immune System;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P41439	Innate Immune System;Immune System;Neutrophil degranulation
P41440	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P41586	Signal Transduction;Disease;Signaling by NTRKs;Activation of TRKA receptors;NGF-independant TRKA activation;Signaling by NTRK1 (TRKA);Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Signaling by Receptor Tyrosine Kinases;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P41587	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P41594	Neuronal System;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;Neurexins and neuroligins;Protein-protein interactions at synapses
P41595	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (q) signalling events;GPCR ligand binding
P41597	Cytokine Signaling in Immune system;Beta defensins;Defensins;Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling;Antimicrobial peptides
P41732	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cell surface interactions at the vascular wall;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
P41743	Cell-Cell communication;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;p75NTR recruits signalling complexes;Tight junction interactions;Cell-cell junction organization;Cell junction organization;Death Receptor Signalling
P41785	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The IPAF inflammasome
P41797	Innate Immune System;Immune System;Antimicrobial peptides
P41968	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P42025	Adaptive Immune System;Innate Immune System;Immune System;MHC class II antigen presentation;Neutrophil degranulation
P42081	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CD28 dependent Vav1 pathway;CTLA4 inhibitory signaling;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-10 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
P42126	Metabolism;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
P42167-1	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Depolymerisation of the Nuclear Lamina;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
P42224-1	Interleukin-6 signaling;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;Interferon gamma signaling;Regulation of IFNG signaling;Signaling by Receptor Tyrosine Kinases;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling
P42224-2	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling
P42224	Interleukin-6 signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Signaling by FGFR in disease;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signaling by NOTCH;Signal Transduction;Disease;Immune System;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Downstream signal transduction;Signaling by PDGF;Generic Transcription Pathway;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-2 family signaling;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-6 family signaling;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Interleukin-20 family signaling;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Interleukin-35 Signalling;Interleukin-9 signaling;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Interleukin-27 signaling;Interleukin-21 signaling;Interferon Signaling;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Growth hormone receptor signaling
P42226	Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Downstream signal transduction;Signaling by PDGF;STAT6-mediated induction of chemokines;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Signaling by Receptor Tyrosine Kinases
P42229	Prolactin receptor signaling;Signaling by FGFR in disease;Signaling by ERBB4;Nuclear signaling by ERBB4;Interleukin-7 signaling;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signal Transduction;Disease;Immune System;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Downstream signal transduction;Signaling by PDGF;Signaling by Leptin;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-20 family signaling;Interleukin-15 signaling;Interleukin-9 signaling;Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Interleukin-2 signaling;Interleukin-21 signaling;Erythropoietin activates STAT5;FLT3 Signaling;STAT5 Activation;Growth hormone receptor signaling
P42261	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Activation of AMPA receptors;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;Transport to the Golgi and subsequent modification;Long-term potentiation
P42262	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Generic Transcription Pathway;Activation of AMPA receptors;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;Activation of NMDA receptors and postsynaptic events;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates neuronal receptors and channels;Long-term potentiation
P42263	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of AMPA receptors;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors;Unblocking of NMDA receptors, glutamate binding and activation;Activation of NMDA receptors and postsynaptic events;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
P42285	Major pathway of rRNA processing in the nucleolus and cytosol;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P42330	Metabolism;Signal Transduction;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of vitamins and cofactors;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Retinoic Acid;RA biosynthesis pathway;Metabolism of lipids;Metabolism of fat-soluble vitamins;Metabolism of steroids;Fatty acid metabolism;Signaling by Nuclear Receptors;Retinoid metabolism and transport
P42331	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
P42336	Hemostasis;PI3K Cascade;IRS-mediated signalling;GPVI-mediated activation cascade;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;PI3K events in ERBB4 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by SCF-KIT;PI Metabolism;Phospholipid metabolism;Cell-Cell communication;Signal Transduction;Disease;Signaling by EGFR in Cancer;Synthesis of PIPs at the plasma membrane;Signaling by NTRKs;Innate Immune System;Immune System;Signaling by EGFR;GAB1 signalosome;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signaling by FGFR;Signaling by VEGF;PI3K events in ERBB2 signaling;PI3K/AKT activation;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Tie2 Signaling;DAP12 interactions;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;Signaling by GPCR;Nephrin family interactions;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;G alpha (q) signalling events;Axon guidance;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;PI-3K cascade:FGFR1;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;Downstream signaling of activated FGFR4;PI-3K cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by MET;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;MET activates PI3K/AKT signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;RET signaling;ESR-mediated signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Activated NTRK2 signals through PI3K;Signaling by NTRK3 (TRKC);Interleukin receptor SHC signaling;Regulation of signaling by CBL;Activated NTRK3 signals through PI3K;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development
P42338	Hemostasis;PI3K Cascade;IRS-mediated signalling;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;PI Metabolism;Phospholipid metabolism;Cell-Cell communication;Signal Transduction;Disease;Synthesis of PIPs at the plasma membrane;Signaling by NTRKs;Innate Immune System;Immune System;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signaling by VEGF;PI3K/AKT activation;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Tie2 Signaling;DAP12 interactions;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;Nephrin family interactions;Axon guidance;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;RET signaling;Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Interleukin receptor SHC signaling;Regulation of signaling by CBL;FLT3 Signaling;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development
P42345	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Macroautophagy;Disease;mTOR signalling;mTORC1-mediated signalling;Immune System;Signaling by VEGF;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Autophagy;Amino acids regulate mTORC1
P42356	Metabolism;Synthesis of PIPs at the ER membrane;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Metabolism of lipids
P42357	Metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
P42566	Signal Transduction;Disease;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases
P42568	Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
P42574	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of caspases through apoptosome-mediated cleavage;Cytochrome c-mediated apoptotic response;SMAC (DIABLO) binds to IAPs ;SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ;Apoptotic cleavage of cellular proteins;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;Cytokine Signaling in Immune system;Apoptosis induced DNA fragmentation;Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Immune System;p75 NTR receptor-mediated signalling;Signaling by Hippo;Cell death signalling via NRAGE, NRIF and NADE;NADE modulates death signalling;Stimulation of the cell death response by PAK-2p34;Caspase-mediated cleavage of cytoskeletal proteins;Apoptotic cleavage of cell adhesion  proteins;Caspase activation via Dependence Receptors in the absence of ligand;Signaling by Interleukins;Other interleukin signaling;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Death Receptor Signalling;Apoptotic execution phase
P42575	Signal Transduction;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;NADE modulates death signalling;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription)
P42677	Developmental Biology;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Signal Transduction;Cell Cycle;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Signaling by Rho GTPases;RHO GTPase Effectors;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;RHO GTPases Activate Formins;Major pathway of rRNA processing in the nucleolus and cytosol;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;EML4 and NUDC in mitotic spindle formation;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P42679	Signaling by ERBB2;Signal Transduction;Downregulation of ERBB2 signaling;Signaling by Receptor Tyrosine Kinases
P42680	Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signal Transduction;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by Receptor Tyrosine Kinases
P42681	Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization
P42684	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Role of ABL in ROBO-SLIT signaling;Nervous system development
P42685	PIP3 activates AKT signaling;Signal Transduction;Innate Immune System;Immune System;Neutrophil degranulation;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers
P42695	Cell Cycle;Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
P42701	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-12 signaling;Interleukin-23 signaling
P42702	Cytokine Signaling in Immune system;Immune System;Generic Transcription Pathway;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in interleukin signaling
P42704	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
P42765	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
P42766	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P42768	Adaptive Immune System;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;TCR signaling;Generation of second messenger molecules;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
P42771	Cell Cycle;Disease;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Diseases of Cellular Senescence;Evasion of Oncogene Induced Senescence Due to p16INK4A Defects;Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4;Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6;Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects;Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4;Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6;Diseases of cellular response to stress
P42772	Signal Transduction;Cell Cycle;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;Signaling by TGF-beta family members
P42773	Cell Cycle;Cellular responses to stress;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli
P42785	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Innate Immune System;Immune System;Neutrophil degranulation
P42830	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P42858	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Regulation of MECP2 expression and activity
P42892	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
P42898	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P43003	Neurotransmitter release cycle;Neurotransmitter uptake and metabolism In glial cells;Transmission across Chemical Synapses;Neuronal System;Disease;Astrocytic Glutamate-Glutamine Uptake And Metabolism;Glutamate Neurotransmitter Release Cycle;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Defective SLC1A3 causes episodic ataxia 6 (EA6);SLC transporter disorders;Disorders of transmembrane transporters
P43004	Neurotransmitter release cycle;Neurotransmitter uptake and metabolism In glial cells;Transmission across Chemical Synapses;Neuronal System;Astrocytic Glutamate-Glutamine Uptake And Metabolism;Glutamate Neurotransmitter Release Cycle;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P43005	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Disease;Glutamate Neurotransmitter Release Cycle;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA);SLC transporter disorders;Disorders of transmembrane transporters
P43007	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P43026	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P43034	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Vesicle-mediated transport;RHO GTPases Activate Formins;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;EML4 and NUDC in mitotic spindle formation
P43080	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P43088	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;G alpha (q) signalling events;GPCR ligand binding
P43115	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;G alpha (i) signalling events;GPCR ligand binding
P43116	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P43119	Hemostasis;Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;Prostacyclin signalling through prostacyclin receptor;Platelet homeostasis;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P43146	Apoptosis;Developmental Biology;Netrin-1 signaling;DSCAM interactions;Signaling by ROBO receptors;DCC mediated attractive signaling;Netrin mediated repulsion signals;Caspase activation via Dependence Receptors in the absence of ligand;Role of second messengers in netrin-1 signaling;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Nervous system development
P43155	Metabolism;Beta-oxidation of pristanoyl-CoA;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
P43166	Metabolism;Reversible hydration of carbon dioxide
P43220	Metabolism;Signal Transduction;Integration of energy metabolism;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P43234	Adaptive Immune System;Immune System;MHC class II antigen presentation
P43235	Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Generic Transcription Pathway;MHC class II antigen presentation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
P43246	Disease;Generic Transcription Pathway;Transcriptional Regulation by TP53;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MSH3;Defective Mismatch Repair Associated With MSH2;Defective Mismatch Repair Associated With MSH6;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Diseases of DNA repair
P43250	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events
P43251	Metabolism;Disease;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective BTD causes biotidinase deficiency;Diseases of metabolism
P43268	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
P43304	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
P43307	SRP-dependent cotranslational protein targeting to membrane;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Translation
P43308	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
P43351	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;HDR through Single Strand Annealing (SSA);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Post-translational protein modification;DNA Repair
P43353	Metabolism;Sphingolipid de novo biosynthesis;Innate Immune System;Immune System;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation
P43354	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
P43378	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling
P43403	Adaptive Immune System;Immune System;TCR signaling;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules
P43405	Hemostasis;GPVI-mediated activation cascade;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Integrin signaling;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;CLEC7A (Dectin-1) signaling;Dectin-2 family;C-type lectin receptors (CLRs);Infectious disease;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Interleukin-2 signaling;Regulation of signaling by CBL;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P43487	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Rev-mediated nuclear export of HIV RNA;Interactions of Rev with host cellular proteins;Infectious disease
P43489	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
P43490	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging;Circadian Clock
P43626	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P43627	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P43628	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P43629	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P43630	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P43631	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions
P43632	Innate Immune System;Immune System;DAP12 interactions
P43657	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;GPCR ligand binding
P43681	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly sodium permeable postsynaptic acetylcholine nicotinic receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
P43686	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P43694	Hemostasis;YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;Peptide hormone metabolism;Metabolism of proteins;Muscle contraction;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Cardiac conduction;Physiological factors;RNA Polymerase II Transcription;Gene expression (Transcription);Factors involved in megakaryocyte development and platelet production
P43897	Metabolism of proteins;Mitochondrial translation;Mitochondrial translation elongation;Translation
P45378	Striated Muscle Contraction;Muscle contraction
P45379	Striated Muscle Contraction;Muscle contraction
P45381	Metabolism;Metabolism of amino acids and derivatives;Aspartate and asparagine metabolism
P45452	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Activation of Matrix Metalloproteinases;Assembly of collagen fibrils and other multimeric structures;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates genes involved in cell migration
P45844	ABC transporters in lipid homeostasis;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;ABC-family proteins mediated transport;Plasma lipoprotein remodeling;HDL remodeling;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P45880	Transport of small molecules;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Mitochondrial calcium ion transport
P45954	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
P45973	Hemostasis;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of chromatin organization proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6;Factors involved in megakaryocyte development and platelet production
P45974	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
P45983	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BIM and translocation to mitochondria ;Activation of BH3-only proteins;Developmental Biology;Cytokine Signaling in Immune system;Activation of BMF and translocation to mitochondria;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Cellular Senescence;FCERI mediated MAPK activation;Netrin-1 signaling;DSCAM interactions;Axon guidance;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Activation of the AP-1 family of transcription factors;Programmed Cell Death;Infectious disease;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Death Receptor Signalling;DNA Repair;Cellular responses to external stimuli;Interleukin-38 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P45984	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Cellular Senescence;FCERI mediated MAPK activation;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Activation of the AP-1 family of transcription factors;Cellular responses to external stimuli;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P45985	Cytokine Signaling in Immune system;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Cellular Senescence;FCERI mediated MAPK activation;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Cellular responses to external stimuli;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P46019	Metabolism;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P46020	Metabolism;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P46059	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Proton/oligopeptide cotransporters
P46060	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Interactions of Rev with host cellular proteins;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of DNA replication proteins;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
P46087	Generic Transcription Pathway;rRNA modification in the nucleus and cytosol;rRNA processing;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;rRNA processing in the nucleus and cytosol;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation;Metabolism of RNA
P46092	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P46093	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P46094	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P46098	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
P46108	Hemostasis;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by NTRKs;Innate Immune System;Immune System;Prolonged ERK activation events;ARMS-mediated activation;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Integrin signaling;p130Cas linkage to MAPK signaling for integrins;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Infectious disease;Signaling by MET;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAP1 and RAC1;MET receptor recycling;MET promotes cell motility;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Regulation of signaling by CBL;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
P46109	Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Immune System;Prolonged ERK activation events;Frs2-mediated activation;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by MET;MET activates RAP1 and RAC1;MET receptor recycling;MET promotes cell motility;Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Erythropoietin activates RAS;Regulation of signaling by CBL
P46199	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Translation
P46379	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P46439	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
P46459	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P46527	PIP3 activates AKT signaling;Signal Transduction;Cell Cycle;Disease;SCF(Skp2)-mediated degradation of p27/p21;Signaling by Rho GTPases;RHO GTPase Effectors;AKT phosphorylates targets in the cytosol;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;RHO GTPases activate CIT;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by PTK6;PTK6 Regulates Cell Cycle;ESR-mediated signaling;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
P46531	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Processing in the Endoplasmic Reticulum;Pre-NOTCH Transcription and Translation;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;FBXW7 Mutants and NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Defective LFNG causes SCDO3;Diseases of signal transduction by growth factor receptors and second messengers;Diseases of metabolism;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
P46587	Innate Immune System;Immune System;Antimicrobial peptides
P46597	Metabolism;Metabolism of amine-derived hormones;Serotonin and melatonin biosynthesis;Metabolism of amino acids and derivatives
P46663	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
P46695	PIP3 activates AKT signaling;Signal Transduction;Negative regulation of the PI3K/AKT network;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
P46721	Metabolism;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of lipids;Transport of organic anions;Metabolism of steroids
P46734-3	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
P46734	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;Cellular responses to external stimuli;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P46736	Cell Cycle;Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
P46776	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P46777	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P46778	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P46779	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P46781	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P46782	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P46783	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P46926	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P46934	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Signaling by ERBB4;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Immune System;PTEN Regulation;Regulation of PTEN localization;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Interferon Signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P46937	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Signal Transduction;Signaling by Hippo;YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;RUNX3 regulates YAP1-mediated transcription;Signaling by Receptor Tyrosine Kinases;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P46939	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P46940	Cytokine Signaling in Immune system;Metabolism;Cell-Cell communication;Signal Transduction;Integration of energy metabolism;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Nephrin family interactions;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Regulation of insulin secretion;RHO GTPases activate IQGAPs;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
P46952	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
P46976	Metabolism;Disease;Innate Immune System;Immune System;Glycogen storage diseases;Glycogen synthesis;Myoclonic epilepsy of Lafora;Glycogen storage disease type XV (GYG1);Glycogen storage disease type 0 (muscle GYS1);Glycogen storage disease type II (GAA);Diseases of carbohydrate metabolism;Diseases of metabolism;Neutrophil degranulation;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
P46977	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification
P47211	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P47710	Transport of small molecules;Miscellaneous transport and binding events
P47712	Hemostasis;Opioid Signalling;phospho-PLA2 pathway;Ca-dependent events;G-protein mediated events;PLC beta mediated events;Metabolism;Acyl chain remodelling of PC;Acyl chain remodeling of CL;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Hydrolysis of LPC;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;Membrane Trafficking;Arachidonic acid metabolism;Signaling by GPCR;GPCR downstream signalling;Signal amplification;Platelet homeostasis;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;Platelet sensitization by LDL;Metabolism of lipids;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Platelet activation, signaling and aggregation;Golgi-to-ER retrograde transport;Fatty acid metabolism
P47736	Developmental Biology;Adaptive Immune System;Immune System;Rap1 signalling;Axon guidance;RET signaling;Nervous system development
P47755	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Advanced glycosylation endproduct receptor signaling;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;Factors involved in megakaryocyte development and platelet production
P47756	Hemostasis;Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;Factors involved in megakaryocyte development and platelet production
P47804	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding
P47813	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
P47869	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
P47870	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;GABA receptor activation
P47872	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P47881	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P47883	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P47884	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P47887	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P47888	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P47890	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P47893	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P47895	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
P47897	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
P47898	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (i) signalling events;GPCR ligand binding
P47900	Hemostasis;Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Signal amplification;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;ADP signalling through P2Y purinoceptor 1;GPCR ligand binding;Platelet activation, signaling and aggregation
P47901	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Vasopressin-like receptors;G alpha (q) signalling events;GPCR ligand binding;Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI);SLC transporter disorders;Disorders of transmembrane transporters
P47914	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P47928	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P47944	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P47985	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
P47989	Adaptive Immune System;Metabolism;Metabolism of nucleotides;Immune System;Purine catabolism;Butyrophilin (BTN) family interactions;Nucleobase catabolism
P47992	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P48023	Apoptosis;Cytokine Signaling in Immune system;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Disease;Immune System;Generic Transcription Pathway;Regulation by c-FLIP;Signaling by Interleukins;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Regulation of necroptotic cell death;Interleukin-4 and Interleukin-13 signaling;Dimerization of procaspase-8;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);FasL/ CD95L signaling;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes;Diseases of programmed cell death
P48029	Metabolism;Creatine metabolism;Metabolism of amino acids and derivatives
P48039	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P48047	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P48048	Neuronal System;Inwardly rectifying K+ channels;Potassium transport channels;Potassium Channels
P48050	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;Classical Kir channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P48051	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P48058	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of AMPA receptors;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors;Unblocking of NMDA receptors, glutamate binding and activation;Activation of NMDA receptors and postsynaptic events;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
P48059	Cell-Cell communication;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization
P48060	Metabolism;Innate Immune System;Immune System;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Neutrophil degranulation
P48061	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Signaling by ROBO receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Axon guidance;GPCR ligand binding;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression;Nervous system development
P48065	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Metabolism;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Creatine metabolism;Metabolism of amino acids and derivatives;GABA synthesis, release, reuptake and degradation;Reuptake of GABA
P48066	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Creatine metabolism;Metabolism of amino acids and derivatives;GABA synthesis, release, reuptake and degradation;Reuptake of GABA
P48067	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters
P48145	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P48146	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P48163	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
P48165	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
P48167	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
P48169	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
P48200	Transport of small molecules;Iron uptake and transport
P48201	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P48357-1	Signal Transduction;Signaling by Leptin
P48426	PIP3 activates AKT signaling;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of lipids;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of PIPs in the nucleus;Intracellular signaling by second messengers
P48431	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by WNT;TCF dependent signaling in response to WNT;Generic Transcription Pathway;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Deactivation of the beta-catenin transactivating complex;Signaling by Interleukins;Transcriptional regulation of pluripotent stem cells;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2
P48436	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Generic Transcription Pathway;Deactivation of the beta-catenin transactivating complex;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2
P48443	Signal Transduction;Generic Transcription Pathway;Nuclear Receptor transcription pathway;Signaling by Retinoic Acid;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by Nuclear Receptors
P48444	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P48448	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
P48449	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
P48454	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Opioid Signalling;Activation of BH3-only proteins;Signal Transduction;DARPP-32 events;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Programmed Cell Death
P48506	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Disease;Glutathione synthesis and recycling;Biological oxidations;Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
P48507	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Disease;Glutathione synthesis and recycling;Biological oxidations;Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
P48509	Extracellular matrix organization;Collagen formation;Cell-Cell communication;Assembly of collagen fibrils and other multimeric structures;Type I hemidesmosome assembly;Cell junction organization
P48544	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P48546	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P48547	Neuronal System;Potassium Channels;Voltage gated Potassium channels
P48549	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P48551-2	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling
P48552	Signal Transduction;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Circadian Clock;Post-translational protein modification;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis;NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 
P48553	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
P48556	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P48595	Innate Immune System;Immune System;Neutrophil degranulation
P48637	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Disease;Glutathione synthesis and recycling;Biological oxidations;Defective GSS causes Glutathione synthetase deficiency (GSS deficiency);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
P48643	Organelle biogenesis and maintenance;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P48645	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
P48651	Metabolism;Synthesis of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
P48664	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Glutamate Neurotransmitter Release Cycle;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P48668	Developmental Biology;Keratinization;Formation of the cornified envelope
P48723	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
P48728	Metabolism;Glyoxylate metabolism and glycine degradation;Glycine degradation;Metabolism of amino acids and derivatives
P48729	Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;Signaling by Hedgehog;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;Activation of SMO;Diseases of signal transduction by growth factor receptors and second messengers
P48730	Cell Cycle;Organelle biogenesis and maintenance;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Circadian Clock;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Vesicle-mediated transport;Post-translational protein modification;Major pathway of rRNA processing in the nucleolus and cytosol;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;rRNA processing;AURKA Activation by TPX2;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Transport to the Golgi and subsequent modification
P48735	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P48736	Hemostasis;GPVI-mediated activation cascade;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Signaling by GPCR;GPCR downstream signalling;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;Metabolism of lipids;Platelet activation, signaling and aggregation;Signaling by Erythropoietin;Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
P48739	Metabolism;PI and PC transport between ER and Golgi membranes;Glycerophospholipid biosynthesis;PI Metabolism;Phospholipid metabolism;Metabolism of lipids
P48740	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Binding and Uptake of Ligands by Scavenger Receptors;Ficolins bind to repetitive carbohydrate structures on the target cell surface;Scavenging by Class A Receptors;Vesicle-mediated transport
P48741	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
P48751	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P48764	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers
P48775	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
P48788	Striated Muscle Contraction;Muscle contraction
P48960	Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding;Neutrophil degranulation
P48995	Developmental Biology;Adaptive Immune System;Immune System;Stimuli-sensing channels;TRP channels;Netrin-1 signaling;Transport of small molecules;Muscle contraction;Role of second messengers in netrin-1 signaling;Axon guidance;Cardiac conduction;Ion homeostasis;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR);Ion channel transport
P49005	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
P49019	Signal Transduction;Hydroxycarboxylic acid-binding receptors;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P49023	Cell-Cell communication;Signal Transduction;Signaling by EGFR;GAB1 signalosome;Signaling by VEGF;Muscle contraction;VEGFA-VEGFR2 Pathway;Smooth Muscle Contraction;Localization of the PINCH-ILK-PARVIN complex to focal adhesions;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases
P49069	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P49116	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P49137	Cytokine Signaling in Immune system;Metabolism;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Signalling to RAS;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;p38MAPK events;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;Nuclear Events (kinase and transcription factor activation);CREB phosphorylation;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;VEGFA-VEGFR2 Pathway;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of lipids;Metabolism of RNA;Cellular responses to external stimuli;Fatty acid metabolism;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P49146	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P49184	Innate Immune System;Immune System;Neutrophil degranulation
P49189	Metabolism;Carnitine synthesis;Metabolism of amino acids and derivatives
P49190	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P49207	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P49238	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P49247	Metabolism;Disease;RPIA deficiency: failed conversion of R5P to RU5P;Diseases of carbohydrate metabolism;Diseases of metabolism;RPIA deficiency: failed conversion of RU5P to R5P;Pentose phosphate pathway disease;Pentose phosphate pathway;Metabolism of carbohydrates
P49257	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
P49279	ROS and RNS production in phagocytes;Innate Immune System;Immune System;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Neutrophil degranulation;Antimicrobial peptides;Ion influx/efflux at host-pathogen interface
P49281	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1);SLC transporter disorders;Disorders of transmembrane transporters;Iron uptake and transport
P49286	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P49327	Metabolism;Signal Transduction;Integration of energy metabolism;ChREBP activates metabolic gene expression;Regulation of cholesterol biosynthesis by SREBP (SREBF);Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism of steroids;Fatty acid metabolism;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
P49336	Developmental Biology;Metabolism;Signaling by NOTCH;Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Signaling by NOTCH1;PPARA activates gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
P49354	Apoptosis;Apoptotic cleavage of cellular proteins;Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Programmed Cell Death;Apoptotic execution phase
P49356	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P49366	Gamma carboxylation, hypusine formation and arylsulfatase activation;Hypusine synthesis from eIF5A-lysine;Metabolism of proteins;Post-translational protein modification
P49368	Organelle biogenesis and maintenance;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P49406	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P49407	Hemostasis;Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Disease;Immune System;Signaling by NOTCH1;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by GPCR;GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Thrombin signalling through proteinase activated receptors (PARs);Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;FLT3 Signaling;Signaling downstream of RAS mutants
P49411	Metabolism of proteins;Mitochondrial translation;Mitochondrial translation elongation;Translation
P49418	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
P49419	Metabolism;Choline catabolism;Lysine catabolism;Metabolism of amino acids and derivatives
P49427	Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Metabolism of proteins;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P49441	Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
P49448	Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
P49450	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
P49454	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Polo-like kinase mediated events;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Mitotic G2-G2/M phases;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
P49458	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
P49459	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P49585	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
P49588	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
P49589	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
P49590	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
P49591	Metabolism;Selenoamino acid metabolism;Selenocysteine synthesis;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
P49593	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of NMDA receptors and postsynaptic events;Negative regulation of NMDA receptor-mediated neuronal transmission
P49619	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
P49638	Metabolism;Metabolism of vitamins and cofactors;Metabolism of fat-soluble vitamins;Vitamin E
P49639	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P49641	Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
P49642	Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;Extension of Telomeres;Mitotic G1 phase and G1/S transition;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance
P49643	Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;Extension of Telomeres;Mitotic G1 phase and G1/S transition;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance
P49662	Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
P49674	Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by WNT;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Circadian Clock;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Major pathway of rRNA processing in the nucleolus and cytosol;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;rRNA processing;AURKA Activation by TPX2;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P49675	Metabolism;Metabolism of steroid hormones;Pregnenolone biosynthesis;Metabolism of lipids;Metabolism of steroids
P49682	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P49683	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
P49685	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P49711	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P49715	Developmental Biology;Transcriptional regulation of white adipocyte differentiation;Transcriptional regulation of granulopoiesis
P49716	Developmental Biology;Cytokine Signaling in Immune system;Disease;Immune System;Transcriptional regulation of white adipocyte differentiation;Signaling by Interleukins;Infectious disease;Interleukin-4 and Interleukin-13 signaling;HCMV Infection;HCMV Late Events
P49720	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P49721	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P49736	Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
P49746	Signal Transduction;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases
P49747	Extracellular matrix organization;Integrin cell surface interactions;ECM proteoglycans
P49748	Metabolism;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of palmitoyl-CoA to myristoyl-CoA;Fatty acid metabolism
P49753	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism;Peroxisomal protein import;Protein localization
P49755	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P49757	Developmental Biology;Signaling by NOTCH;Signal Transduction;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signaling by Hedgehog;Degradation of GLI1 by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;Nervous system development
P49758	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;G alpha (i) signalling events;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P49763	Signal Transduction;Signaling by VEGF;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Signaling by Receptor Tyrosine Kinases
P49765	Hemostasis;Platelet degranulation ;Signal Transduction;Signaling by VEGF;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by Receptor Tyrosine Kinases
P49767	Hemostasis;Platelet degranulation ;Signal Transduction;Signaling by VEGF;VEGF ligand-receptor interactions;VEGF binds to VEGFR leading to receptor dimerization;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Signaling by Receptor Tyrosine Kinases
P49768	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Degradation of the extracellular matrix;Extracellular matrix organization;Signaling by NOTCH;Signal Transduction;Disease;Innate Immune System;Immune System;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Signaling by NOTCH2;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;EPH-Ephrin signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;EPH-ephrin mediated repulsion of cells;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Neutrophil degranulation;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Noncanonical activation of NOTCH3;Nervous system development
P49770	Metabolism of proteins;Eukaryotic Translation Initiation;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation
P49771	PI3K Cascade;IRS-mediated signalling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;STAT5 Activation
P49790	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
P49792	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;EML4 and NUDC in mitotic spindle formation
P49795	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events
P49796	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events
P49798	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events
P49802	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;G alpha (i) signalling events;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P49810	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Signaling by NOTCH2;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;EPH-Ephrin signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;EPH-ephrin mediated repulsion of cells;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Noncanonical activation of NOTCH3;Nervous system development
P49815	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;Disease;mTOR signalling;Inhibition of TSC complex formation by PKB;AKT phosphorylates targets in the cytosol;Membrane Trafficking;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;RNA Polymerase II Transcription;Gene expression (Transcription);TBC/RABGAPs;Intracellular signaling by second messengers;Rab regulation of trafficking;Autophagy
P49821	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P49840	PIP3 activates AKT signaling;Signal Transduction;Disease;AKT phosphorylates targets in the cytosol;PI3K/AKT Signaling in Cancer;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Constitutive Signaling by AKT1 E17K in Cancer;Intracellular signaling by second messengers;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis
P49841	PIP3 activates AKT signaling;Developmental Biology;Signal Transduction;Cell Cycle;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Beta-catenin phosphorylation cascade;AKT phosphorylates targets in the cytosol;TCF dependent signaling in response to WNT;Epigenetic regulation of gene expression;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Semaphorin interactions;CRMPs in Sema3A signaling;Axon guidance;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Misspliced GSK3beta mutants stabilize beta-catenin;Signaling by Hedgehog;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;S Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Cellular responses to external stimuli;Intracellular signaling by second messengers;Nervous system development
P49848	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
P49862	Degradation of the extracellular matrix;Extracellular matrix organization
P49888	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
P49895	Metabolism;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Regulation of thyroid hormone activity;Metabolism of amino acids and derivatives
P49902	Metabolism;Metabolism of nucleotides;Abacavir transport and metabolism;Abacavir metabolism;Purine catabolism;Nucleobase catabolism
P49908	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P49913	Innate Immune System;Immune System;Neutrophil degranulation;Antimicrobial peptides
P49914	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
P49915	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
P49916	Resolution of AP sites via the single-nucleotide replacement pathway;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;HDR through MMEJ (alt-NHEJ);DNA Double-Strand Break Repair;Homology Directed Repair;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Transcription-Coupled Nucleotide Excision Repair (TC-NER);Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;DNA Repair;Resolution of Abasic Sites (AP sites)
P49917	HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Disease;2-LTR circle formation;Infectious disease;DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
P49918	Cell Cycle;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic
P49959	Reproduction;Meiosis;Cell Cycle;Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Generic Transcription Pathway;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;IRF3-mediated induction of type I IFN;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through MMEJ (alt-NHEJ);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Sensing of DNA Double Strand Breaks;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Nonhomologous End-Joining (NHEJ);Homologous DNA Pairing and Strand Exchange;DNA Double Strand Break Response;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Cellular responses to external stimuli;Meiotic recombination
P49961	Metabolism;Metabolism of nucleotides;Disease;Infectious disease;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
P50052	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P50053	Metabolism;Disease;Fructose metabolism;Essential fructosuria;Diseases of carbohydrate metabolism;Diseases of metabolism;Fructose catabolism;Metabolism of carbohydrates
P50120	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
P50135	Metabolism;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
P50148	Hemostasis;Metabolism;Signal Transduction;Integration of energy metabolism;Signaling by GPCR;GPCR downstream signalling;Signal amplification;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;G alpha (q) signalling events;ADP signalling through P2Y purinoceptor 1;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Thrombin signalling through proteinase activated receptors (PARs);Platelet activation, signaling and aggregation
P50150	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P50151	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P50213	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P50225	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
P50226	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
P50281	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
P50336	Metabolism;Metabolism of porphyrins;Heme biosynthesis
P50391	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P50395	Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;Membrane Trafficking;Vesicle-mediated transport;Neutrophil degranulation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P50402	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Depolymerisation of the Nuclear Lamina;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P50406	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P50416	RORA activates gene expression;Metabolism;Signal Transduction;PPARA activates gene expression;Carnitine metabolism;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Signaling by Retinoic Acid;Metabolism of lipids;Fatty acid metabolism;Signaling by Nuclear Receptors
P50440	Metabolism;Creatine metabolism;Metabolism of amino acids and derivatives
P50443	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Glycosaminoglycan metabolism;Disease;Transport and synthesis of PAPS;Biological oxidations;Diseases associated with glycosaminoglycan metabolism;Defective SLC26A2 causes chondrodysplasias;Diseases of glycosylation;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers;SLC transporter disorders;Disorders of transmembrane transporters;Diseases of metabolism;Metabolism of carbohydrates
P50452	Hemostasis;Dissolution of Fibrin Clot
P50454	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
P50458	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of expression of SLITs and ROBOs;Nervous system development
P50502	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
P50542-1	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Peroxisomal protein import;Protein localization
P50542-2	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Peroxisomal protein import;Protein localization
P50542	Macroautophagy;Autophagy;Selective autophagy;Pexophagy
P50548	Cellular responses to stress;Cellular Senescence;Oncogene Induced Senescence;Cellular responses to external stimuli
P50552	Developmental Biology;Adaptive Immune System;Cell-Cell communication;Immune System;TCR signaling;Generation of second messenger molecules;Signaling by ROBO receptors;Axon guidance;Cell-extracellular matrix interactions;Cell junction organization;Nervous system development
P50553	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P50570	Developmental Biology;Adaptive Immune System;Metabolism;Gap junction trafficking and regulation;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;Signaling by NTRKs;Innate Immune System;Immune System;Toll-like Receptor Cascades;Retrograde neurotrophin signalling;Signaling by NTRK1 (TRKA);Gap junction trafficking;Gap junction degradation;Formation of annular gap junctions;Nuclear Events (kinase and transcription factor activation);Membrane Trafficking;trans-Golgi Network Vesicle Budding;Metabolism of nitric oxide: eNOS activation and regulation;NOSTRIN mediated eNOS trafficking;MHC class II antigen presentation;L1CAM interactions;Axon guidance;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Recycling pathway of L1;Vesicle-mediated transport;Clathrin-mediated endocytosis;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;Nervous system development
P50579	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P50583	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
P50591	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Regulation by c-FLIP;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Regulation of necroptotic cell death;Dimerization of procaspase-8;Death Receptor Signalling;TRAIL  signaling
P50613	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Cell Cycle;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Metabolism of RNA
P50747	Metabolism;Disease;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Diseases of metabolism
P50748	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
P50750	Formation of RNA Pol II elongation complex ;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Signaling by TGF-beta Receptor Complex;Interactions of Tat with host cellular proteins;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by TGF-beta family members;Estrogen-dependent gene expression
P50876	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
P50897	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
P50914	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P50990	Innate Immune System;Immune System;Organelle biogenesis and maintenance;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Neutrophil degranulation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P50991	Organelle biogenesis and maintenance;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P50993	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P51003	mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
P51114	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
P51124	Complement cascade;Initial triggering of complement;Innate Immune System;Immune System;Alternative complement activation
P51148	Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Metabolism of proteins;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;TBC/RABGAPs;Clathrin-mediated endocytosis;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P51149	Adaptive Immune System;Disease;Innate Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;Metabolism of proteins;Vesicle-mediated transport;Infectious disease;Post-translational protein modification;Neutrophil degranulation;TBC/RABGAPs;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of autophagy;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P51151	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P51153	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P51159	Innate Immune System;Immune System;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P51161	Metabolism;Recycling of bile acids and salts;Signal Transduction;Triglyceride catabolism;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids;Triglyceride metabolism;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
P51164	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
P51168	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51170	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51172	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51178	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
P51398	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P51449-2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 Regulates Immune Response and Cell Migration
P51449	Cytokine Signaling in Immune system;Immune System;Generic Transcription Pathway;Nuclear Receptor transcription pathway;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription)
P51451	Adaptive Immune System;Immune System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in BCR signaling;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P51452	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;ERKs are inactivated;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P51460	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;Relaxin receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P51511	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
P51512	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
P51530	Telomere Maintenance;Cell Cycle;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Chromosome Maintenance;DNA Repair;Gene expression (Transcription)
P51531	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
P51532	Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Signaling by Interleukins;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P51553	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;Protein localization
P51570	Metabolism;Disease;Diseases of glycosylation;Diseases associated with glycosylation precursor biosynthesis;Defective GALK1 can cause Galactosemia II (GALCT2);Diseases of metabolism;Galactose catabolism;Metabolism of carbohydrates
P51571	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
P51572	Apoptosis;Apoptotic cleavage of cellular proteins;Adaptive Immune System;Immune System;Programmed Cell Death;Apoptotic execution phase;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P51575	Hemostasis;Elevation of cytosolic Ca2+ levels;Innate Immune System;Immune System;Platelet homeostasis;Platelet calcium homeostasis;Neutrophil degranulation
P51580	Metabolism;Phase II - Conjugation of compounds;Methylation;Disease;Biological oxidations;Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
P51582	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;P2Y receptors;Nucleotide-like (purinergic) receptors;G alpha (i) signalling events;GPCR ligand binding
P51587	Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;DNA Repair;Meiotic recombination
P51589	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Xenobiotics;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
P51606	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
P51608-1	Disease;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Loss of MECP2 binding ability to 5hmC-DNA;Loss of phosphorylation of MECP2 at T308;Loss of MECP2 binding ability to the NCoR/SMRT complex;Loss of MECP2 binding ability to 5mC-DNA;Regulation of MECP2 expression and activity;MECP2 regulates neuronal receptors and channels;MECP2 regulates transcription of neuronal ligands;MECP2 regulates transcription factors;MECP2 regulates transcription of genes involved in GABA signaling;Disorders of developmental biology
P51608-2	Disease;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Loss of MECP2 binding ability to 5hmC-DNA;Loss of phosphorylation of MECP2 at T308;Loss of MECP2 binding ability to the NCoR/SMRT complex;Loss of MECP2 binding ability to 5mC-DNA;Regulation of MECP2 expression and activity;MECP2 regulates neuronal receptors and channels;MECP2 regulates transcription of neuronal ligands;MECP2 regulates transcription factors;MECP2 regulates transcription of genes involved in GABA signaling;Disorders of developmental biology
P51610	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;UCH proteinases;Post-translational protein modification
P51617-1	Signal Transduction;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;p75NTR recruits signalling complexes;Death Receptor Signalling
P51617	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;Negative regulation of the PI3K/AKT network;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Generic Transcription Pathway;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Interleukin-1 signaling;IRAK1 recruits IKK complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P51636	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
P51648-1	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P51648-2	Metabolism;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Class I peroxisomal membrane protein import;Protein localization
P51649	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;GABA synthesis, release, reuptake and degradation;Degradation of GABA
P51654	Metabolism;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Visual phototransduction;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Post-translational protein modification;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Post-translational protein phosphorylation;Retinoid metabolism and transport
P51659	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;alpha-linolenic acid (ALA) metabolism;Beta-oxidation of pristanoyl-CoA;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism;Peroxisomal protein import;TYSND1 cleaves peroxisomal proteins;Protein localization
P51665	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P51668	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Signal Transduction;Cell Cycle;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Signaling by TGF-beta Receptor Complex;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Signaling by BMP;TCR signaling;Downstream TCR signaling;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;FCERI mediated NF-kB activation;Metabolism of proteins;Regulation of mitotic cell cycle;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Protein ubiquitination;Transcriptional Regulation by VENTX;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;Neddylation;Cellular responses to external stimuli;Signaling by TGF-beta family members;Peroxisomal protein import;Negative regulators of DDX58/IFIH1 signaling;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Protein localization;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P51671	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;Signaling by Interleukins;GPCR ligand binding;Interleukin-4 and Interleukin-13 signaling
P51677	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P51679	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P51681	Cytokine Signaling in Immune system;Signal Transduction;HIV Life Cycle;Early Phase of HIV Life Cycle;HIV Infection;Disease;Immune System;Binding and entry of HIV virion;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Infectious disease;Interleukin-10 signaling
P51684	Beta defensins;Defensins;Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Antimicrobial peptides
P51685	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P51686	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P51687	Metabolism;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
P51688	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;HS-GAG degradation;Mucopolysaccharidoses;MPS IIIA - Sanfilippo syndrome A;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates
P51689	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
P51690	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
P51692	Prolactin receptor signaling;Signaling by FGFR in disease;Interleukin-7 signaling;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signal Transduction;Disease;Immune System;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Downstream signal transduction;Signaling by PDGF;Signaling by Leptin;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Interleukin-20 family signaling;Interleukin-15 signaling;Interleukin-9 signaling;Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Interleukin-2 signaling;Interleukin-21 signaling;Erythropoietin activates STAT5;FLT3 Signaling;STAT5 Activation;Growth hormone receptor signaling
P51784	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
P51786	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P51787	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Muscle contraction;Phase 3 - rapid repolarisation;Cardiac conduction;Phase 2 - plateau phase
P51788	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51790	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51793	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51795	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51797	Disease;Stimuli-sensing channels;Transport of small molecules;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Ion channel transport
P51798	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51800	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51801	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P51805	Developmental Biology;Semaphorin interactions;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Axon guidance;Nervous system development
P51809	Cytokine Signaling in Immune system;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Interleukin-12 family signaling;Signaling by Interleukins;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Interleukin-12 signaling
P51810	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P51811	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
P51812	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;CREB phosphorylation;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Signaling by GPCR;L1CAM interactions;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;RSK activation;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Gastrin-CREB signalling pathway via PKC and MAPK;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P51813	Apoptosis;Apoptotic cleavage of cellular proteins;Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Programmed Cell Death;Metabolism of lipids;Apoptotic execution phase
P51814	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P51815	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P51817	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;DAG and IP3 signaling;Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival
P51828	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
P51841	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P51843-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P51843-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P51857	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
P51858	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
P51864	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL
P51884	Metabolism;Extracellular matrix organization;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Keratan sulfate degradation;Integrin cell surface interactions;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Defective ST3GAL3 causes MCT12 and EIEE15;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
P51888	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Keratan sulfate degradation;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Defective ST3GAL3 causes MCT12 and EIEE15;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
P51946	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Cell Cycle;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Metabolism of RNA
P51948	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Cell Cycle;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Metabolism of RNA
P51955	Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
P51959	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription)
P51965	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Metabolism of proteins;Regulation of mitotic cell cycle;Post-translational protein modification;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Protein ubiquitination;Transcriptional Regulation by VENTX;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;Cellular responses to external stimuli;Interferon Signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P51970	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P51991	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P51993	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
P52209	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates
P52272	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases
P52292	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;DAG and IP3 signaling;Signal Transduction;Disease;Influenza Infection;Immune System;NS1 Mediated Effects on Host Pathways;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;Activation of NMDA receptors and postsynaptic events;Infectious disease;DNA Double-Strand Break Repair;Sensing of DNA Double Strand Breaks;DNA Double Strand Break Response;DNA Repair;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Interferon Signaling
P52294	Apoptosis;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Apoptosis induced DNA fragmentation;HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;NS1 Mediated Effects on Host Pathways;Interactions of Vpr with host cellular proteins;Vpr-mediated nuclear import of PICs;Programmed Cell Death;Infectious disease;Apoptotic execution phase;Interferon Signaling;Infection with Mycobacterium tuberculosis;Inhibition of nitric oxide production;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P52298	SLBP independent Processing of Histone Pre-mRNAs;Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated elongation of the HIV-1 transcript;FGFR2 mutant receptor activation;Signaling by FGFR;snRNP Assembly;Metabolism of non-coding RNA;Signaling by ROBO receptors;Axon guidance;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Pre-transcription Events;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;RNA Polymerase II Transcription Elongation;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Processing of Intronless Pre-mRNAs;Signaling by FGFR2 IIIa TM;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P52333	Interleukin-7 signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-4 and Interleukin-13 signaling;Interleukin-20 family signaling;Interleukin-15 signaling;Interleukin-9 signaling;Interleukin-2 signaling;Interleukin-21 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P52429	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
P52434	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;Cytosolic sensors of pathogen-associated DNA ;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase III Chain Elongation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P52435	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P52564-1	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
P52564	Developmental Biology;Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Transcriptional Regulation by TP53;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;Myogenesis;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P52565	Signal Transduction;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Axonal growth stimulation;Death Receptor Signalling
P52566	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
P52569-1	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P52569-2	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
P52594	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P52597	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by FGFR;Interleukin-12 family signaling;Signaling by Interleukins;Signaling by FGFR2;FGFR2 alternative splicing;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases;Interleukin-12 signaling
P52616	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The IPAF inflammasome
P52630	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling
P52655	Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Infectious disease;RNA Polymerase II Pre-transcription Events;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P52657	Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Infectious disease;RNA Polymerase II Pre-transcription Events;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P52701	Disease;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MSH2;Defective Mismatch Repair Associated With MSH6;DNA Repair;Diseases of DNA repair
P52732	Hemostasis;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
P52735	Hemostasis;GPVI-mediated activation cascade;Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by VEGF;Signaling by Rho GTPases;Rho GTPase cycle;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Cell death signalling via NRAGE, NRIF and NADE;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Signaling by GPCR;L1CAM interactions;GPCR downstream signalling;EPH-ephrin mediated repulsion of cells;G alpha (12/13) signalling events;Axon guidance;VEGFA-VEGFR2 Pathway;Signal transduction by L1;VEGFR2 mediated vascular permeability;Infectious disease;Death Receptor Signalling;Platelet activation, signaling and aggregation;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
P52736	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P52737	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P52738	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P52739	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification
P52742	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P52744	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P52747	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter
P52756	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P52757	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
P52758	Metabolism;Metabolism of amino acids and derivatives;Threonine catabolism
P52788	Metabolism;Metabolism of polyamines;Metabolism of amino acids and derivatives
P52789	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P52790	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
P52797	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P52798	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P52799	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P52803	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P52815	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P52824	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
P52848	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
P52849	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
P52888	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P52895	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
P52907	Hemostasis;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Interleukin-12 family signaling;Signaling by Interleukins;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Advanced glycosylation endproduct receptor signaling;Golgi-to-ER retrograde transport;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Cellular responses to external stimuli;Interleukin-12 signaling;Transport to the Golgi and subsequent modification;Factors involved in megakaryocyte development and platelet production
P52926	Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular responses to external stimuli
P52945	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells;Regulation of gene expression in early pancreatic precursor cells
P52948-3	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
P52948-4	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
P52948-5	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
P52952	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;Muscle contraction;Cardiac conduction;Physiological factors;RNA Polymerase II Transcription;Gene expression (Transcription)
P52961	Defensins;Alpha-defensins;Innate Immune System;Immune System;Antimicrobial peptides
P53004	Metabolism;Metabolism of porphyrins;Heme degradation
P53007	Metabolism;Metabolism of lipids;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
P53041	Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair;ESR-mediated signaling;Signaling by Nuclear Receptors;FLT3 Signaling
P53350	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Polo-like kinase mediated events;Signal Transduction;Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Regulation of APC/C activators between G1/S and early anaphase;Phosphorylation of the APC/C;Phosphorylation of Emi1;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Condensation of Prophase Chromosomes;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope Breakdown;Activation of NIMA Kinases NEK9, NEK6, NEK7;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases Activate Formins;Mitotic Prophase;Mitotic Prometaphase;Mitotic Metaphase/Anaphase Transition;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;EML4 and NUDC in mitotic spindle formation
P53355	Apoptosis;Caspase activation via Dependence Receptors in the absence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death
P53365	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
P53384	Metabolism;Cytosolic iron-sulfur cluster assembly
P53396	Metabolism;Integration of energy metabolism;ChREBP activates metabolic gene expression;Innate Immune System;Immune System;Metabolism of lipids;Neutrophil degranulation;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
P53420	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Anchoring fibril formation;Crosslinking of collagen fibrils;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
P53539	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression;NGF-stimulated transcription
P53567	Cellular responses to stress;ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
P53582	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P53597	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
P53602	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Synthesis of Dolichyl-phosphate;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Metabolism of lipids;Post-translational protein modification;Metabolism of steroids
P53611	Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;TP53 Regulates Transcription of Cell Death Genes;Post-translational protein modification;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);RAB geranylgeranylation
P53618	Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P53621	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P53634	Adaptive Immune System;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Neutrophil degranulation;Transport to the Golgi and subsequent modification
P53667	Developmental Biology;Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;Semaphorin interactions;EPHB-mediated forward signaling;Sema3A PAK dependent Axon repulsion;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Nervous system development
P53671	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Semaphorin interactions;EPHB-mediated forward signaling;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;RHO GTPases Activate ROCKs;Nervous system development
P53675	Developmental Biology;Gap junction trafficking and regulation;Gap junction trafficking;Gap junction degradation;Formation of annular gap junctions;Membrane Trafficking;EPH-Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Nervous system development
P53680-1	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
P53680	Developmental Biology;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Signaling by NTRKs;Nef Mediated CD4 Down-regulation;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;Signaling by NTRK1 (TRKA);Signaling by WNT;Membrane Trafficking;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;Transport of small molecules;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;PCP/CE pathway;Axon guidance;Recycling pathway of L1;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDLR internalisation and degradation;LDL clearance;Plasma lipoprotein clearance;Signaling by Receptor Tyrosine Kinases;Nervous system development
P53708	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;Integrin cell surface interactions;ECM proteoglycans
P53778	Developmental Biology;Mitochondrial biogenesis;Signal Transduction;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;p38MAPK events;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Netrin-1 signaling;DSCAM interactions;Axon guidance;VEGFA-VEGFR2 Pathway;Myogenesis;Signaling by Receptor Tyrosine Kinases;Nervous system development
P53779	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Oxidative Stress Induced Senescence;Cellular Senescence;FCERI mediated MAPK activation;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Activation of the AP-1 family of transcription factors;Cellular responses to external stimuli;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P53794	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Inositol transporters
P53803	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;Cytosolic sensors of pathogen-associated DNA ;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase III Chain Elongation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P53816	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
P53985	Hemostasis;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Disease;Cell surface interactions at the vascular wall;Basigin interactions;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Proton-coupled monocarboxylate transport;Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT);SLC transporter disorders;Disorders of transmembrane transporters;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
P53990	Cell Cycle;Innate Immune System;Immune System;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Neutrophil degranulation;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Sealing of the nuclear envelope (NE) by ESCRT-III
P53992	Adaptive Immune System;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;Metabolism of proteins;Asparagine N-linked glycosylation;Metabolism of lipids;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Metabolism of steroids;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P54105	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
P54108	Innate Immune System;Immune System;Neutrophil degranulation
P54132	Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Generic Transcription Pathway;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Post-translational protein modification;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Chromosome Maintenance;DNA Repair;Gene expression (Transcription);Meiotic recombination
P54136	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
P54198	Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular responses to external stimuli
P54219	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters
P54252	Generic Transcription Pathway;Metabolism of proteins;Deubiquitination;Josephin domain DUBs;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
P54259	PIP3 activates AKT signaling;Signal Transduction;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers
P54274	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Packaging Of Telomere Ends;Telomere Extension By Telomerase;Extension of Telomeres;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Cellular responses to external stimuli
P54278	Disease;Generic Transcription Pathway;Transcriptional Regulation by TP53;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MLH1;Defective Mismatch Repair Associated With PMS2;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Diseases of DNA repair
P54284	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Metabolism;Integration of energy metabolism;NCAM signaling for neurite out-growth;Muscle contraction;Adrenaline,noradrenaline inhibits insulin secretion;NCAM1 interactions;Regulation of insulin secretion;Axon guidance;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Nervous system development
P54289	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
P54315	Digestion of dietary lipid;Digestion;Digestion and absorption
P54317	Digestion of dietary lipid;Digestion;Digestion and absorption
P54368	Metabolism;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Metabolism of amino acids and derivatives
P54577	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
P54578	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
P54619	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Mitochondrial biogenesis;Signal Transduction;Macroautophagy;mTOR signalling;Organelle biogenesis and maintenance;Membrane Trafficking;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Autophagy;Lipophagy;Activation of AMPK downstream of NMDARs;Selective autophagy
P54646	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Mitochondrial biogenesis;Signal Transduction;Macroautophagy;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism;mTOR signalling;Organelle biogenesis and maintenance;Membrane Trafficking;Carnitine metabolism;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Metabolism of lipids;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Fatty acid metabolism;Autophagy;Lipophagy;Activation of AMPK downstream of NMDARs;Selective autophagy
P54652	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Cellular responses to external stimuli
P54687	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
P54707	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
P54709	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P54710	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P54725	Metabolism of proteins;Deubiquitination;Josephin domain DUBs;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
P54727	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Deubiquitination;Josephin domain DUBs;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
P54750	Hemostasis;Opioid Signalling;Calmodulin induced events;Cam-PDE 1 activation;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;DAG and IP3 signaling;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects;G alpha (s) signalling events;G alpha (i) signalling events;Intracellular signaling by second messengers
P54753	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P54756	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P54760	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P54762	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P54764	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P54793	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
P54802	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;HS-GAG degradation;Mucopolysaccharidoses;MPS IIIB - Sanfilippo syndrome B;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates
P54803	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
P54819	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
P54826	Signal Transduction;Signaling by Hedgehog;Ligand-receptor interactions;Hedgehog 'on' state;Activation of SMO
P54829	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling
P54840	Metabolism;Disease;Glycogen storage diseases;Glycogen synthesis;Glycogen storage disease type 0 (liver GYS2);Glycogen storage disease type IV (GBE1);Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates;Glycogen metabolism
P54855	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
P54868	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Ketone body metabolism;Synthesis of Ketone Bodies
P54886-1	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
P54886-2	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
P54920	ER to Golgi Anterograde Transport;Membrane Trafficking;trans-Golgi Network Vesicle Budding;COPII-mediated vesicle transport;Metabolism of proteins;Golgi Associated Vesicle Biogenesis;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P55001	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P55010	Metabolism of proteins;Eukaryotic Translation Initiation;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
P55011	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Cation-coupled Chloride cotransporters
P55017	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Cation-coupled Chloride cotransporters;Defective SLC12A3 causes Gitelman syndrome (GS);SLC transporter disorders;Disorders of transmembrane transporters
P55036	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P55042	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
P55055	Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;PPARA activates gene expression;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transport of small molecules;Nuclear Receptor transcription pathway;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;SUMOylation of intracellular receptors;Metabolism of lipids;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);VLDLR internalisation and degradation;Plasma lipoprotein clearance;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ;NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
P55056	Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;VLDL assembly;Plasma lipoprotein assembly;Plasma lipoprotein clearance;VLDL clearance;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P55058-1	Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein remodeling;HDL remodeling;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P55058-2	Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein remodeling;HDL remodeling;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P55064	Transport of small molecules;Passive transport by Aquaporins;Aquaporin-mediated transport
P55072	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion Synthesis by POLH;Signal Transduction;Macroautophagy;Disease;Innate Immune System;Immune System;Cellular responses to stress;HSF1 activation;Cellular response to heat stress;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of signal transduction by growth factor receptors and second messengers;Defective CFTR causes cystic fibrosis;Deubiquitination;Josephin domain DUBs;Ovarian tumor domain proteases;Post-translational protein modification;Neutrophil degranulation;DNA Damage Bypass;DNA Repair;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Protein methylation;Cellular responses to external stimuli;Autophagy;Aggrephagy;Selective autophagy
P55073	Metabolism;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Regulation of thyroid hormone activity;Metabolism of amino acids and derivatives
P55075-1	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3b ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P55081	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P55082	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P55083	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P55084	Metabolism;Acyl chain remodeling of CL;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids;Beta oxidation of myristoyl-CoA to lauroyl-CoA;mitochondrial fatty acid beta-oxidation of saturated fatty acids;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of palmitoyl-CoA to myristoyl-CoA;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Beta oxidation of octanoyl-CoA to hexanoyl-CoA;Beta oxidation of hexanoyl-CoA to butanoyl-CoA;Fatty acid metabolism
P55085	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P55087	Transport of small molecules;Vasopressin regulates renal water homeostasis via Aquaporins;Passive transport by Aquaporins;Aquaporin-mediated transport
P55089	Signal Transduction;Peptide hormone metabolism;Signaling by GPCR;Class B/2 (Secretin family receptors);Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin;GPCR ligand binding
P55103	Glycoprotein hormones;Peptide hormone biosynthesis;Peptide hormone metabolism;Metabolism of proteins
P55145	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P55157	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;VLDL assembly;Chylomicron assembly;Plasma lipoprotein assembly
P55160	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Neutrophil degranulation;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
P55196-2	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P55199	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Transcription-Coupled Nucleotide Excision Repair (TC-NER);TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
P55201	Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription)
P55210	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of caspases through apoptosome-mediated cleavage;Cytochrome c-mediated apoptotic response;SMAC (DIABLO) binds to IAPs ;SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ;Apoptotic cleavage of cellular proteins;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;Caspase-mediated cleavage of cytoskeletal proteins;Programmed Cell Death;Apoptotic execution phase
P55211	Apoptosis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Activation of caspases through apoptosome-mediated cleavage;Cytochrome c-mediated apoptotic response;SMAC (DIABLO) binds to IAPs ;SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;PIP3 activates AKT signaling;Signal Transduction;Disease;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;AKT phosphorylates targets in the cytosol;PI3K/AKT Signaling in Cancer;Caspase activation via Dependence Receptors in the absence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Intracellular signaling by second messengers;Regulation of the apoptosome activity
P55212	Apoptosis;Apoptotic cleavage of cellular proteins;Generic Transcription Pathway;Caspase-mediated cleavage of cytoskeletal proteins;Breakdown of the nuclear lamina;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptotic execution phase
P55259	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P55263	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
P55265	Cytokine Signaling in Immune system;Immune System;mRNA Editing: A to I Conversion;mRNA Editing;C6 deamination of adenosine;Formation of editosomes by ADAR proteins;Metabolism of RNA;Interferon alpha/beta signaling;Interferon Signaling
P55268	Extracellular matrix organization;Signal Transduction;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Post-translational protein phosphorylation;Signaling by Receptor Tyrosine Kinases
P55273	Cell Cycle;Cellular responses to stress;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli
P55283	Developmental Biology;Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization;Myogenesis
P55285	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P55286	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P55287	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P55289	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P55290	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
P55291	Developmental Biology;Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization;Myogenesis
P55316	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Regulation of MECP2 expression and activity;FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
P55317	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
P55318	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
P55327	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
P55347	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
P55735	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Gene Silencing by RNA;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;Asparagine N-linked glycosylation;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;Amino acids regulate mTORC1;EML4 and NUDC in mitotic spindle formation;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P55769	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P55773-2	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;GPCR ligand binding
P55786	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P55789	Mitochondrial protein import;Protein localization
P55795	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P55809	Metabolism;Metabolism of lipids;Ketone body metabolism;Utilization of Ketone Bodies
P55851	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial Uncoupling;The fatty acid cycling model;The proton buffering model
P55854	SUMOylation;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);SUMO is proteolytically processed;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Processing and activation of SUMO;SUMOylation of transcription factors;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of intracellular receptors;SUMOylation of chromatin organization proteins;SUMOylation of DNA replication proteins;SUMOylation of immune response proteins;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
P55884	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
P55895	Interleukin-7 signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;MAPK family signaling cascades;MAPK6/MAPK4 signaling
P55916	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial Uncoupling;The fatty acid cycling model;The proton buffering model
P55957	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation and oligomerization of BAK protein;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation, translocation and oligomerization of BAX;Activation of BH3-only proteins;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription);Activation, myristolyation of BID and translocation to mitochondria
P56134	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P56159	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
P56178	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
P56179	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
P56180	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Metabolism of lipids
P56181	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P56182	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P56192	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
P56199	Hemostasis;Developmental Biology;Extracellular matrix organization;Integrin cell surface interactions;Laminin interactions;Semaphorin interactions;L1CAM interactions;Muscle contraction;Other semaphorin interactions;Axon guidance;Smooth Muscle Contraction;CHL1 interactions;Platelet Adhesion to exposed collagen;Nervous system development
P56202	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P56211	Cell Cycle;MASTL Facilitates Mitotic Progression;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
P56277	Mitochondrial protein import;Protein localization
P56282	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Cell Cycle;Mitotic G1 phase and G1/S transition;PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
P56373	Hemostasis;Elevation of cytosolic Ca2+ levels;Platelet homeostasis;Platelet calcium homeostasis
P56377	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease
P56381	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P56385	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
P56524	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Notch-HLH transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;SUMOylation of chromatin organization proteins;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;RUNX2 regulates chondrocyte maturation;RUNX2 regulates bone development;RUNX3 regulates p14-ARF
P56539	Muscle contraction;Smooth Muscle Contraction
P56545	Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Repression of WNT target genes;Signaling by WNT in cancer;TCF7L2 mutants don't bind CTBP;Diseases of signal transduction by growth factor receptors and second messengers
P56556	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
P56559	Signal Transduction;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
P56589	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport;Class I peroxisomal membrane protein import;Protein localization
P56693	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
P56696	Neuronal System;Potassium Channels;Voltage gated Potassium channels
P56703	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
P56704	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;GPCR ligand binding;RNF mutants show enhanced WNT signaling and proliferation;Diseases of signal transduction by growth factor receptors and second messengers
P56705	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Beta-catenin independent WNT signaling;PCP/CE pathway;GPCR ligand binding
P56706	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
P56746	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P56747	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P56748	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P56749	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P56750	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P56817	Metabolism of proteins;Amyloid fiber formation
P56856	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P56880	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P56937	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
P56945	Hemostasis;Signal Transduction;Downstream signal transduction;Signaling by PDGF;Signaling by VEGF;Integrin signaling;p130Cas linkage to MAPK signaling for integrins;VEGFA-VEGFR2 Pathway;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases
P56962	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
P56975	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
P57053	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P57054	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P57057	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P57059	Circadian Clock
P57081	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
P57087	Hemostasis;Extracellular matrix organization;Cell surface interactions at the vascular wall;Integrin cell surface interactions
P57103	Hemostasis;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Cardiac conduction;Ion homeostasis;Mitochondrial calcium ion transport
P57678	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
P57679	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO
P57723	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Transcriptional activation of p53 responsive genes  ;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Transcriptional  activation of  cell cycle inhibitor p21 ;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
P57729	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P57735	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
P57739	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P57740	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
P57764	Innate Immune System;Immune System;Neutrophil degranulation
P57771	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P57772	Metabolism;Selenoamino acid metabolism;Selenocysteine synthesis;Metabolism of amino acids and derivatives
P57773	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
P57775	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P57789	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK related potassium channel (TREK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
P58004	Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;Amino acids regulate mTORC1
P58005	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription)
P58012	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;Post-translational protein modification
P58166	Glycoprotein hormones;Peptide hormone biosynthesis;Peptide hormone metabolism;Metabolism of proteins
P58170	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P58173	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P58180	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P58181	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P58182	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P58215	Extracellular matrix organization;Collagen formation;Elastic fibre formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
P58294	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
P58335-1	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
P58335-4	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
P58397	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
P58400	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
P58401	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
P58549	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P58753	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Class I MHC mediated antigen processing & presentation
P58876	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P59025	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P59095	Metabolism;Metabolism of steroid hormones;Pregnenolone biosynthesis;Metabolism of lipids;Metabolism of steroids
P59190	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
P59510	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
P59533	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59534	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59535	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59536	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59537	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59538	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59539	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59540	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59541	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59542	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59543	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59544	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59551	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
P59646	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
P59665	Defensins;Alpha-defensins;Innate Immune System;Immune System;Neutrophil degranulation;Antimicrobial peptides
P59666	Defensins;Alpha-defensins;Innate Immune System;Immune System;Antimicrobial peptides
P59768	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P59796	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
P59827	Innate Immune System;Immune System;Antimicrobial peptides
P59861	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
P59901	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
P59922	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
P59923	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P59990	Developmental Biology;Keratinization
P59991	Developmental Biology;Keratinization
P59998	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
P60006	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli
P60014	Developmental Biology;Keratinization
P60022	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
P60033	Adaptive Immune System;Complement cascade;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Regulation of Complement cascade
P60059	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Class I MHC mediated antigen processing & presentation
P60174	Metabolism;Glycolysis;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
P60228	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
P60328	Developmental Biology;Keratinization
P60329	Developmental Biology;Keratinization
P60331	Developmental Biology;Keratinization
P60368	Developmental Biology;Keratinization
P60369	Developmental Biology;Keratinization
P60370	Developmental Biology;Keratinization
P60371	Developmental Biology;Keratinization
P60372	Developmental Biology;Keratinization
P60409	Developmental Biology;Keratinization
P60410	Developmental Biology;Keratinization
P60411	Developmental Biology;Keratinization
P60412	Developmental Biology;Keratinization
P60413	Developmental Biology;Keratinization
P60468	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane;Class I MHC mediated antigen processing & presentation
P60484	PIP3 activates AKT signaling;Adaptive Immune System;Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Disease;Synthesis of PIPs at the plasma membrane;Immune System;Synthesis of IP3 and IP4 in the cytosol;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Transcriptional Regulation by TP53;Metabolism of proteins;Metabolism of lipids;TP53 Regulates Metabolic Genes;Diseases of signal transduction by growth factor receptors and second messengers;PTEN Loss of Function in Cancer;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN mRNA translation;Regulation of PTEN localization;Regulation of PTEN stability and activity;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers
P60510	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;DNA Repair
P60520	Macroautophagy;Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking;Autophagy
P60568	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Generic Transcription Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1;Interleukin-2 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
P60604	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P60660	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Semaphorin interactions;EPHA-mediated growth cone collapse;Muscle contraction;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Smooth Muscle Contraction;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Nervous system development
P60709	Hemostasis;Developmental Biology;Cytokine Signaling in Immune system;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Cell-Cell communication;Gap junction trafficking and regulation;Signal Transduction;Disease;Innate Immune System;Immune System;Gap junction trafficking;Gap junction degradation;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Formation of annular gap junctions;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Epigenetic regulation of gene expression;EPH-Ephrin signaling;HATs acetylate histones;Chromatin modifying enzymes;L1CAM interactions;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;EPHB-mediated forward signaling;EPH-ephrin mediated repulsion of cells;Adherens junctions interactions;Cell-cell junction organization;Axon guidance;Recycling pathway of L1;VEGFA-VEGFR2 Pathway;Interaction between L1 and Ankyrins;Cell-extracellular matrix interactions;Cell junction organization;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RHO GTPases Activate Formins;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;DNA Repair;Gene expression (Transcription);Clathrin-mediated endocytosis;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development;Factors involved in megakaryocyte development and platelet production
P60763	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway
P60842	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;L13a-mediated translational silencing of Ceruloplasmin expression;Immune System;Metabolism of proteins;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;Metabolism of RNA;Interferon Signaling
P60852	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
P60866	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P60880	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Metabolism;Integration of energy metabolism;Disease;Innate Immune System;Immune System;Neurotoxicity of clostridium toxins;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Regulation of insulin secretion;Signaling by Interleukins;Other interleukin signaling;Toxicity of botulinum toxin type A (BoNT/A);Toxicity of botulinum toxin type C (BoNT/C);Toxicity of botulinum toxin type E (BoNT/E);Uptake and actions of bacterial toxins;Infectious disease;Neutrophil degranulation;GABA synthesis, release, reuptake and degradation
P60891	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates;5-Phosphoribose 1-diphosphate biosynthesis
P60896	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P60900	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P60903	Hemostasis;Dissolution of Fibrin Clot
P60953	Hemostasis;GPVI-mediated activation cascade;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by EGFR;EGFR downregulation;Signaling by VEGF;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;Signaling by GPCR;Netrin-1 signaling;Signaling by ROBO receptors;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent Vav1 pathway;EPHB-mediated forward signaling;G-protein beta:gamma signalling;DCC mediated attractive signaling;Axon guidance;Inactivation of CDC42 and RAC1;VEGFA-VEGFR2 Pathway;Interleukin-12 family signaling;Signaling by Interleukins;Myogenesis;RHO GTPases activate KTN1;RHO GTPases activate IQGAPs;RHO GTPases activate PAKs;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RHO GTPases Activate Formins;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Platelet activation, signaling and aggregation;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;G beta:gamma signalling through CDC42;Signaling by Receptor Tyrosine Kinases;Interleukin-12 signaling;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development;Factors involved in megakaryocyte development and platelet production
P61006	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Cell Cycle;Organelle biogenesis and maintenance;Membrane Trafficking;Regulation of PLK1 Activity at G2/M Transition;Metabolism of proteins;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport;Post-translational protein modification;G2/M Transition;Cell Cycle, Mitotic;TBC/RABGAPs;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P61009	SRP-dependent cotranslational protein targeting to membrane;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin;Translation
P61011	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
P61018	Signal Transduction;Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Signaling by MET;RAB geranylgeranylation;MET receptor recycling;Signaling by Receptor Tyrosine Kinases
P61019	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Metabolism of proteins;Post-translational protein modification;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RAB geranylgeranylation
P61020	Innate Immune System;Immune System;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;TBC/RABGAPs;Clathrin-mediated endocytosis;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P61024	Cell Cycle;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry
P61026	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Innate Immune System;Immune System;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P61073	Developmental Biology;Signal Transduction;HIV Life Cycle;Early Phase of HIV Life Cycle;HIV Infection;Disease;Binding and entry of HIV virion;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Signaling by ROBO receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Axon guidance;GPCR ligand binding;Infectious disease;Nervous system development
P61077	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Adaptive Immune System;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Signaling by TGF-beta Receptor Complex;Signaling by BMP;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Cellular responses to stress;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Neddylation;Cellular responses to external stimuli;Signaling by TGF-beta family members;Peroxisomal protein import;Negative regulators of DDX58/IFIH1 signaling;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Protein localization;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P61081	Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by TGF-beta Receptor Complex;TGF-beta receptor signaling activates SMADs;Metabolism of proteins;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;Post-translational protein modification;Neddylation;Signaling by TGF-beta family members;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P61086	Adaptive Immune System;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Negative regulators of DDX58/IFIH1 signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P61088	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Adaptive Immune System;Macroautophagy;Cell Cycle;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;Toll Like Receptor 2 (TLR2) Cascade;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Interleukin-1 signaling;Interferon Signaling;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Autophagy;Aggrephagy;Selective autophagy;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P61106	Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Innate Immune System;Immune System;Membrane Trafficking;Metabolism of proteins;Metabolism of lipids;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P61158	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
P61160	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Neutrophil degranulation;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
P61163	Adaptive Immune System;Cell Cycle;Immune System;Organelle biogenesis and maintenance;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Regulation of PLK1 Activity at G2/M Transition;HSP90 chaperone cycle for steroid hormone receptors (SHR);Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
P61201	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
P61204	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Metabolism of lipids;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P61218	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;Cytosolic sensors of pathogen-associated DNA ;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase III Chain Elongation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P61221	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;OAS antiviral response;Interferon alpha/beta signaling;Interferon Signaling
P61224	Hemostasis;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Disease;Innate Immune System;Immune System;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Rap1 signalling;Interleukin-12 family signaling;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);MET activates RAP1 and RAC1;MET promotes cell motility;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Signaling by Receptor Tyrosine Kinases;Interleukin-12 signaling;FLT3 Signaling;Signaling downstream of RAS mutants
P61225	Innate Immune System;Immune System;Neutrophil degranulation
P61244	Transcription of E2F targets under negative control by DREAM complex;G0 and Early G1;Cell Cycle;Generic Transcription Pathway;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
P61247	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P61254	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P61266	Developmental Biology;Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type C (BoNT/C);Uptake and actions of bacterial toxins;Infectious disease;LGI-ADAM interactions
P61278	Signal Transduction;Generic Transcription Pathway;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates transcription of neuronal ligands
P61289	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P61296	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2
P61313	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P61326	Developmental Biology;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signaling by ROBO receptors;Axon guidance;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P61328	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation
P61353	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P61371	Developmental Biology;Peptide hormone metabolism;Signaling by ROBO receptors;Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Axon guidance;Regulation of expression of SLITs and ROBOs;Nervous system development
P61421	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Transport of small molecules;Metabolism of proteins;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
P61457	Metabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine metabolism;Phenylalanine metabolism
P61513	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P61586	Hemostasis;GPVI-mediated activation cascade;Signaling by ERBB2;Developmental Biology;Signal Transduction;Signaling by NTRKs;Innate Immune System;Immune System;Signaling by TGF-beta Receptor Complex;Signaling by NTRK1 (TRKA);Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Signaling by VEGF;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Signaling by WNT;PI3K/AKT activation;Axonal growth stimulation;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);EPH-Ephrin signaling;Signaling by GPCR;Semaphorin interactions;Signaling by ROBO receptors;Beta-catenin independent WNT signaling;GPCR downstream signalling;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;EPHB-mediated forward signaling;EPHA-mediated growth cone collapse;G-protein beta:gamma signalling;Sema4D in semaphorin signaling;PCP/CE pathway;G alpha (12/13) signalling events;Sema4D mediated inhibition of cell attachment and migration;Sema4D induced cell migration and growth-cone collapse;Axon guidance;VEGFA-VEGFR2 Pathway;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases activate KTN1;RHO GTPases Activate ROCKs;RHO GTPases Activate Formins;RHO GTPases Activate Rhotekin and Rhophilins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;ERBB2 Regulates Cell Motility;Neutrophil degranulation;Death Receptor Signalling;Platelet activation, signaling and aggregation;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;SLIT2:ROBO1 increases RHOA activity;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;Nervous system development
P61601	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding
P61619	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation;Class I MHC mediated antigen processing & presentation
P61626	Innate Immune System;Immune System;Metabolism of proteins;Neutrophil degranulation;Antimicrobial peptides;Amyloid fiber formation
P61647	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
P61758	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins
P61764-1	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;GABA synthesis, release, reuptake and degradation
P61764	Neuronal System;Metabolism;Integration of energy metabolism;Regulation of insulin secretion;Neurexins and neuroligins;Protein-protein interactions at synapses
P61769	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;DAP12 signaling;Metabolism of proteins;Infectious disease;Neutrophil degranulation;Interferon gamma signaling;Interferon Signaling;Infection with Mycobacterium tuberculosis;Modulation by Mtb of host immune system;Amyloid fiber formation;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
P61803	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification
P61812	Hemostasis;Platelet degranulation ;Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;ECM proteoglycans;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P61916	Innate Immune System;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Neutrophil degranulation;LDL clearance;Plasma lipoprotein clearance
P61923	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P61927	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P61952	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P61956	Metabolism;Vitamin D (calciferol) metabolism;SUMOylation;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);SUMO is proteolytically processed;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Processing and activation of SUMO;SUMOylation of transcription factors;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of intracellular receptors;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Metabolism of lipids;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair;Metabolism of steroids
P61962	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation
P61964	Developmental Biology;Generic Transcription Pathway;PKMTs methylate histone lysines;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Neddylation
P61966	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease
P61978	Disease;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of RNA binding proteins;Infectious disease;Post-translational protein modification;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA;HCMV Infection;HCMV Late Events
P61981	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Generic Transcription Pathway;Regulation of PLK1 Activity at G2/M Transition;Transcriptional Regulation by TP53;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Programmed Cell Death;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases activate PKNs;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;AURKA Activation by TPX2;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors
P62072	Mitochondrial protein import;Protein localization
P62079	Metabolism of proteins;Amyloid fiber formation
P62081	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62136	Opioid Signalling;Metabolism;Signal Transduction;Triglyceride catabolism;Signaling by TGF-beta Receptor Complex;DARPP-32 events;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Signaling by GPCR;GPCR downstream signalling;Circadian Clock;G alpha (i) signalling events;Metabolism of lipids;Triglyceride metabolism;Signaling by TGF-beta family members
P62140	Metabolism;Signal Transduction;Triglyceride catabolism;Cell Cycle;Signaling by TGF-beta Receptor Complex;Signaling by Rho GTPases;RHO GTPase Effectors;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Regulation of PLK1 Activity at G2/M Transition;Circadian Clock;Mitotic G2-G2/M phases;Metabolism of lipids;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;G2/M Transition;Cell Cycle, Mitotic;Triglyceride metabolism;Signaling by TGF-beta family members
P62191	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Asparagine N-linked glycosylation;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P62195	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P62241	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62244	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62249	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62253	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P62256	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P62258	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Cell Cycle;Disease;Organelle biogenesis and maintenance;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Signaling by Hippo;Cell death signalling via NRAGE, NRIF and NADE;NADE modulates death signalling;Generic Transcription Pathway;Cellular responses to stress;Regulation of PLK1 Activity at G2/M Transition;Regulation of HSF1-mediated heat shock response;HSF1 activation;Cellular response to heat stress;Transcriptional Regulation by TP53;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Programmed Cell Death;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases activate PKNs;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;AURKA Activation by TPX2;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;RAB GEFs exchange GTP for GDP on RABs;Cellular responses to external stimuli;Rab regulation of trafficking;Diseases of programmed cell death
P62263	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62266	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62269	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62273	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62277	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62280	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62304	SLBP independent Processing of Histone Pre-mRNAs;snRNP Assembly;Metabolism of non-coding RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
P62306	SLBP independent Processing of Histone Pre-mRNAs;snRNP Assembly;Metabolism of non-coding RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
P62308	SLBP independent Processing of Histone Pre-mRNAs;snRNP Assembly;Metabolism of non-coding RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
P62310	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P62312	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P62314	snRNP Assembly;Metabolism of non-coding RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P62316	snRNP Assembly;Metabolism of non-coding RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P62318	SLBP independent Processing of Histone Pre-mRNAs;snRNP Assembly;Metabolism of non-coding RNA;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
P62324	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
P62328	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
P62330	Signal Transduction;Membrane Trafficking;Vesicle-mediated transport;Signaling by MET;TBC/RABGAPs;Clathrin-mediated endocytosis;MET receptor recycling;Signaling by Receptor Tyrosine Kinases;Rab regulation of trafficking
P62333	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P62424	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62487	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P62491	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Transport of small molecules;Metabolism of proteins;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Cilium Assembly;Anchoring of the basal body to the plasma membrane;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport;Post-translational protein modification;TBC/RABGAPs;RAB geranylgeranylation;Rab regulation of trafficking
P62495	Developmental Biology;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Eukaryotic Translation Termination;Translation;Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62508	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P62699	Innate Immune System;Immune System;Neutrophil degranulation
P62701	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62714	Hemostasis;Opioid Signalling;Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Signal Transduction;Integration of energy metabolism;PP2A-mediated dephosphorylation of key metabolic factors;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DARPP-32 events;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signaling by FGFR;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;ERKs are inactivated;Generic Transcription Pathway;MASTL Facilitates Mitotic Progression;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Transcriptional Regulation by TP53;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;G alpha (i) signalling events;Platelet sensitization by LDL;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Regulation of TP53 Activity;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;EML4 and NUDC in mitotic spindle formation;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P62736	Signaling by NOTCH;Signal Transduction;Muscle contraction;Smooth Muscle Contraction;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
P62745	Hemostasis;GPVI-mediated activation cascade;Developmental Biology;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;Sema4D in semaphorin signaling;G alpha (12/13) signalling events;Sema4D induced cell migration and growth-cone collapse;Axon guidance;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases Activate Formins;RHO GTPases Activate Rhotekin and Rhophilins;Platelet activation, signaling and aggregation;Nervous system development
P62750	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62753	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Signal Transduction;Disease;mTOR signalling;mTORC1-mediated signalling;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62805	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HDACs deacetylate histones;PKMTs methylate histone lysines;HDMs demethylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;SUMOylation of chromatin organization proteins;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P62807	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
P62820	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Golgi-to-ER retrograde transport;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
P62826	Metabolism;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Regulation of cholesterol biosynthesis by SREBP (SREBF);Influenza Infection;Export of Viral Ribonucleoproteins from Nucleus;NEP/NS2 Interacts with the Cellular Export Machinery;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Metabolism of lipids;Transcriptional regulation by small RNAs;Infectious disease;tRNA processing in the nucleus;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Metabolism of steroids;Postmitotic nuclear pore complex (NPC) reformation
P62829	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62834	Hemostasis;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signal Transduction;Integration of energy metabolism;Disease;Signaling by NTRKs;Innate Immune System;Immune System;Prolonged ERK activation events;Frs2-mediated activation;ARMS-mediated activation;Signaling by NTRK1 (TRKA);Signalling to ERKs;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Rap1 signalling;Regulation of insulin secretion;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by MET;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);MET activates RAP1 and RAC1;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants
P62837	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Adaptive Immune System;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;TCR signaling;Downstream TCR signaling;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Metabolism of proteins;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;Neddylation;Cellular responses to external stimuli;Peroxisomal protein import;Negative regulators of DDX58/IFIH1 signaling;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Protein localization;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P62841	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62847	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62851	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62854	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62857	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62861	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62873	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Olfactory Signaling Pathway;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P62875	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;Viral Messenger RNA Synthesis;Cytosolic sensors of pathogen-associated DNA ;FGFR2 mutant receptor activation;Signaling by FGFR;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Transcriptional regulation by small RNAs;PIWI-interacting RNA (piRNA) biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Nucleotide Excision Repair;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase III Chain Elongation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Pol II CTD phosphorylation and interaction with CE;Signaling by FGFR2 IIIa TM;ESR-mediated signaling;Metabolism of RNA;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression
P62877	Recognition of DNA damage by PCNA-containing replication complex;Prolactin receptor signaling;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Immune System;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;TCF dependent signaling in response to WNT;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Cellular responses to stress;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;FBXW7 Mutants and NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;Mitotic G2-G2/M phases;Degradation of DVL;Signaling by Hedgehog;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Orc1 removal from chromatin;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;RNA Polymerase II Transcription;DNA Damage Bypass;DNA Repair;Gene expression (Transcription);FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Neddylation;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P62879	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P62888	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62891	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62899	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62906	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62910	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62913	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62917	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62937	Hemostasis;Platelet degranulation ;Downstream signaling events of B Cell Receptor (BCR);Cytokine Signaling in Immune system;Adaptive Immune System;Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Minus-strand DNA synthesis;Plus-strand DNA synthesis;Innate Immune System;Immune System;Binding and entry of HIV virion;Assembly Of The HIV Virion;APOBEC3G mediated resistance to HIV-1 infection;Calcineurin activates NFAT;Cell surface interactions at the vascular wall;Basigin interactions;Interleukin-12 family signaling;Signaling by Interleukins;Infectious disease;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Signaling by the B Cell Receptor (BCR)
P62942	Downstream signaling events of B Cell Receptor (BCR);Adaptive Immune System;Signal Transduction;Disease;Immune System;Signaling by TGF-beta Receptor Complex;Calcineurin activates NFAT;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Signaling by TGF-beta Receptor Complex in Cancer;Loss of Function of TGFBR1 in Cancer;TGFBR1 LBD Mutants in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by TGF-beta family members;Signaling by the B Cell Receptor (BCR)
P62945	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P62955	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
P62979	Apoptosis;Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Signaling by ERBB2;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;ER-Phagosome pathway;Antigen processing-Cross presentation;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Downregulation of ERBB2:ERBB3 signaling;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Signaling by NOTCH;Signal Transduction;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Macroautophagy;Cell Cycle;Disease;Signaling by EGFR in Cancer;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Regulation of Apoptosis;Signaling by TGF-beta Receptor Complex;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Signaling by EGFR;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;SRP-dependent cotranslational protein targeting to membrane;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Toll Like Receptor 2 (TLR2) Cascade;EGFR downregulation;Cytosolic sensors of pathogen-associated DNA ;SCF(Skp2)-mediated degradation of p27/p21;Signaling by FGFR;Viral mRNA Translation;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;Signaling by NOTCH2;Membrane Trafficking;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Regulation of activated PAK-2p34 by proteasome mediated degradation;NOTCH1 Intracellular Domain Regulates Transcription;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Regulation of PLK1 Activity at G2/M Transition;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Stimuli-sensing channels;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;FCERI mediated NF-kB activation;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Regulation of innate immune responses to cytosolic DNA;Glycogen storage diseases;Glycogen synthesis;Autodegradation of the E3 ubiquitin ligase COP1;Transcriptional Regulation by TP53;Signaling by ROBO receptors;Deactivation of the beta-catenin transactivating complex;Myoclonic epilepsy of Lafora;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;Circadian Clock;PCP/CE pathway;Axon guidance;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Asparagine N-linked glycosylation;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Regulation of FZD by ubiquitination;Interleukin-3, Interleukin-5 and GM-CSF signaling;Mitophagy;Pink/Parkin Mediated Mitophagy;RIPK1-mediated regulated necrosis;Regulated Necrosis;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of TP53 Activity;Signaling by Ligand-Responsive EGFR Variants in Cancer;Vesicle-mediated transport;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;Regulation of RAS by GAPs;Diseases of carbohydrate metabolism;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;Diseases of metabolism;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;Regulation of necroptotic cell death;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAP3K8 (TPL2)-dependent MAPK1/3 activation;MAPK1/MAPK3 signaling;HDR through Homologous Recombination (HRR);MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Josephin domain DUBs;Ub-specific processing proteases;Ovarian tumor domain proteases;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Double Strand Break Response;Processing of DNA double-strand break ends;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Fanconi Anemia Pathway;Major pathway of rRNA processing in the nucleolus and cytosol;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;Signaling by MET;Negative regulation of MET activity;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;Metabolism of carbohydrates;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;RNA Polymerase II Transcription;Death Receptor Signalling;DNA Damage Bypass;DNA Repair;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;TNF signaling;Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;Protein ubiquitination;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Downregulation of ERBB2 signaling;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;rRNA processing in the nucleus and cytosol;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN localization;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Glycogen metabolism;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;TICAM1-dependent activation of IRF3/IRF7;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;Peroxisomal protein import;Regulation of signaling by CBL;Interferon Signaling;Endosomal Sorting Complex Required For Transport (ESCRT);Iron uptake and transport;Nonsense-Mediated Decay (NMD);Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Protein localization;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Response of EIF2AK4 (GCN2) to amino acid deficiency;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Modulation by Mtb of host immune system;Suppression of phagosomal maturation;Response of Mtb to phagocytosis;Alpha-protein kinase 1 signaling pathway;Aggrephagy;Selective autophagy;Pexophagy;Nervous system development;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR);Ion channel transport
P62987	Apoptosis;Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Translesion Synthesis by POLH;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Signaling by ERBB2;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;ER-Phagosome pathway;Antigen processing-Cross presentation;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Downregulation of ERBB2:ERBB3 signaling;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Signaling by NOTCH;Signal Transduction;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Macroautophagy;Cell Cycle;Disease;Signaling by EGFR in Cancer;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Regulation of Apoptosis;Signaling by TGF-beta Receptor Complex;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Signaling by EGFR;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;SRP-dependent cotranslational protein targeting to membrane;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Toll Like Receptor 2 (TLR2) Cascade;EGFR downregulation;Cytosolic sensors of pathogen-associated DNA ;SCF(Skp2)-mediated degradation of p27/p21;Signaling by FGFR;Viral mRNA Translation;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;Signaling by NOTCH2;Membrane Trafficking;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Regulation of activated PAK-2p34 by proteasome mediated degradation;NOTCH1 Intracellular Domain Regulates Transcription;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Regulation of PLK1 Activity at G2/M Transition;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Stimuli-sensing channels;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;FCERI mediated NF-kB activation;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Regulation of innate immune responses to cytosolic DNA;Glycogen storage diseases;Glycogen synthesis;Autodegradation of the E3 ubiquitin ligase COP1;Transcriptional Regulation by TP53;Signaling by ROBO receptors;Deactivation of the beta-catenin transactivating complex;Myoclonic epilepsy of Lafora;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;Circadian Clock;PCP/CE pathway;Axon guidance;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Asparagine N-linked glycosylation;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Regulation of FZD by ubiquitination;Interleukin-3, Interleukin-5 and GM-CSF signaling;Mitophagy;Pink/Parkin Mediated Mitophagy;RIPK1-mediated regulated necrosis;Regulated Necrosis;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of TP53 Activity;Signaling by Ligand-Responsive EGFR Variants in Cancer;Vesicle-mediated transport;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;Regulation of RAS by GAPs;Diseases of carbohydrate metabolism;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;Diseases of metabolism;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;Regulation of necroptotic cell death;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAP3K8 (TPL2)-dependent MAPK1/3 activation;MAPK1/MAPK3 signaling;HDR through Homologous Recombination (HRR);MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Josephin domain DUBs;Ub-specific processing proteases;Ovarian tumor domain proteases;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Double Strand Break Response;Processing of DNA double-strand break ends;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Fanconi Anemia Pathway;Major pathway of rRNA processing in the nucleolus and cytosol;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;Signaling by MET;Negative regulation of MET activity;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;Metabolism of carbohydrates;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;RNA Polymerase II Transcription;Death Receptor Signalling;DNA Damage Bypass;DNA Repair;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;TNF signaling;Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;Protein ubiquitination;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Downregulation of ERBB2 signaling;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;rRNA processing in the nucleus and cytosol;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN localization;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Glycogen metabolism;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;TICAM1-dependent activation of IRF3/IRF7;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;Peroxisomal protein import;Regulation of signaling by CBL;Interferon Signaling;Endosomal Sorting Complex Required For Transport (ESCRT);Iron uptake and transport;Nonsense-Mediated Decay (NMD);Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Protein localization;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Response of EIF2AK4 (GCN2) to amino acid deficiency;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Modulation by Mtb of host immune system;Suppression of phagosomal maturation;Response of Mtb to phagocytosis;Alpha-protein kinase 1 signaling pathway;Aggrephagy;Selective autophagy;Pexophagy;Nervous system development;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR);Ion channel transport
P62993-1	Hemostasis;PI3K Cascade;IRS-mediated signalling;SOS-mediated signalling;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Signaling by SCF-KIT;Regulation of KIT signaling;Cell-Cell communication;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Signaling by Rho GTPases;RHO GTPase Effectors;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;Membrane Trafficking;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Tie2 Signaling;DAP12 interactions;EGFR Transactivation by Gastrin;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;Signaling by GPCR;NCAM signaling for neurite out-growth;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent Vav1 pathway;Signal regulatory protein family interactions;G alpha (q) signalling events;Axon guidance;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Vesicle-mediated transport;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by MET;Negative regulation of MET activity;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Gastrin-CREB signalling pathway via PKC and MAPK;MET activates RAS signaling;MET activates PI3K/AKT signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;RET signaling;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;MET activates PTPN11;InlB-mediated entry of Listeria monocytogenes into host cell;MET activates RAP1 and RAC1;MET receptor recycling;MET promotes cell motility;Listeria monocytogenes entry into host cells;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through RAS;Erythropoietin activates RAS;Activated NTRK2 signals through PI3K;Activated NTRK2 signals through FRS2 and FRS3;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;Interleukin receptor SHC signaling;Regulation of signaling by CBL;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;STAT5 Activation;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P62993	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-15 signaling
P62995	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P63000	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Developmental Biology;Adaptive Immune System;Signaling by SCF-KIT;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Signaling by NTRKs;Innate Immune System;Immune System;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by VEGF;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Signaling by WNT;Negative regulation of the PI3K/AKT network;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Cell death signalling via NRAGE, NRIF and NADE;DAP12 interactions;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;FCERI mediated MAPK activation;Netrin-1 signaling;Semaphorin interactions;L1CAM interactions;DSCAM interactions;Signaling by ROBO receptors;Beta-catenin independent WNT signaling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent Vav1 pathway;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Sema4D in semaphorin signaling;PCP/CE pathway;Sema4D mediated inhibition of cell attachment and migration;DCC mediated attractive signaling;Axon guidance;Activation of RAC1;Inactivation of CDC42 and RAC1;Post NMDA receptor activation events;VEGFA-VEGFR2 Pathway;Activation of NMDA receptors and postsynaptic events;Signal transduction by L1;VEGFR2 mediated vascular permeability;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases activate KTN1;RHO GTPases activate IQGAPs;RHO GTPases activate PAKs;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RHO GTPases Activate Formins;RHO GTPases Activate NADPH Oxidases;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Neutrophil degranulation;Signaling by MET;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Death Receptor Signalling;Platelet activation, signaling and aggregation;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;MET activates RAP1 and RAC1;MET promotes cell motility;Signaling by NTRK2 (TRKB);Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through FYN;NTRK2 activates RAC1;Activated NTRK2 signals through CDK5;Activation of RAC1 downstream of NMDARs;Leishmania infection;Parasite infection;Leishmania phagocytosis;Killing mechanisms;FCGR3A-mediated phagocytosis;WNT5:FZD7-mediated leishmania damping;Nervous system development;Factors involved in megakaryocyte development and platelet production
P63010-1	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
P63010	Developmental Biology;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Signaling by NTRKs;Nef Mediated CD4 Down-regulation;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;Signaling by NTRK1 (TRKA);Signaling by WNT;Membrane Trafficking;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;Transport of small molecules;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;PCP/CE pathway;Axon guidance;Recycling pathway of L1;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDLR internalisation and degradation;LDL clearance;Plasma lipoprotein clearance;Signaling by Receptor Tyrosine Kinases;Nervous system development
P63027	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Integration of energy metabolism;Disease;Immune System;Neurotoxicity of clostridium toxins;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Regulation of insulin secretion;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Signaling by Interleukins;Other interleukin signaling;Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type B (BoNT/B);Toxicity of botulinum toxin type F (BoNT/F);Toxicity of tetanus toxin (TeNT);Toxicity of botulinum toxin type G (BoNT/G);Uptake and actions of bacterial toxins;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;GABA synthesis, release, reuptake and degradation;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
P63092	Hemostasis;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;Prostacyclin signalling through prostacyclin receptor;Platelet homeostasis;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;GPCR ligand binding;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
P63096	Hemostasis;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Signal Transduction;Integration of energy metabolism;Disease;Adenylate cyclase inhibitory pathway;G-protein activation;Signaling by GPCR;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;Metabolism of proteins;Signal amplification;Adrenaline,noradrenaline inhibits insulin secretion;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Regulation of insulin secretion;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
P63098	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Opioid Signalling;Activation of BH3-only proteins;Downstream signaling events of B Cell Receptor (BCR);Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;DARPP-32 events;Signaling by WNT;Calcineurin activates NFAT;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Ca2+ pathway;G alpha (i) signalling events;Programmed Cell Death;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Signaling by the B Cell Receptor (BCR)
P63104	Apoptosis;Hemostasis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Cytokine Signaling in Immune system;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signaling by NOTCH;Signal Transduction;Cell Cycle;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;Membrane Trafficking;TCF dependent signaling in response to WNT;Generic Transcription Pathway;Transcriptional Regulation by TP53;Deactivation of the beta-catenin transactivating complex;Rap1 signalling;GP1b-IX-V activation signalling;Signaling by Interleukins;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Interleukin-3, Interleukin-5 and GM-CSF signaling;Programmed Cell Death;RHO GTPases activate PKNs;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;Platelet activation, signaling and aggregation;Metabolism of RNA;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Negative regulation of NOTCH4 signaling;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors
P63146	Recognition of DNA damage by PCNA-containing replication complex;Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;DNA Damage Bypass;DNA Repair;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P63151	Cell Cycle;Mitotic Metaphase and Anaphase;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Mitotic Anaphase;M Phase;Cyclin D associated events in G1;G1 Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P63162	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P63165	Cytokine Signaling in Immune system;Cell Cycle;Immune System;Generic Transcription Pathway;Mitotic Metaphase and Anaphase;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);SUMO is proteolytically processed;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Processing and activation of SUMO;SUMOylation of transcription factors;SUMOylation of ubiquitinylation proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of intracellular receptors;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;SUMOylation of DNA methylation proteins;SUMOylation of immune response proteins;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Interferon gamma signaling;Regulation of IFNG signaling;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;Interferon Signaling;Postmitotic nuclear pore complex (NPC) reformation
P63167	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BIM and translocation to mitochondria ;Activation of BH3-only proteins;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Innate Immune System;Immune System;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;HSP90 chaperone cycle for steroid hormone receptors (SHR);Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Programmed Cell Death;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Intraflagellar transport;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Autophagy;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy
P63172	Innate Immune System;Immune System;Neutrophil degranulation
P63173	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P63208	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Prolactin receptor signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;Vpu mediated degradation of CD4;Toll Like Receptor 2 (TLR2) Cascade;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;TCR signaling;Downstream TCR signaling;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Fc epsilon receptor (FCERI) signaling;Regulation of PLK1 Activity at G2/M Transition;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;FBXW7 Mutants and NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling;FCERI mediated NF-kB activation;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Transport of small molecules;Metabolism of proteins;Circadian Clock;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Signaling by Hedgehog;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;C-type lectin receptors (CLRs);Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Post-translational protein modification;Orc1 removal from chromatin;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Neddylation;Signaling by NOTCH4;Interleukin-1 signaling;Iron uptake and transport;TRIF(TICAM1)-mediated TLR4 signaling ;Negative regulation of NOTCH4 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
P63211	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Olfactory Signaling Pathway;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P63215	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P63218	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P63220	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P63241	Gamma carboxylation, hypusine formation and arylsulfatase activation;Hypusine synthesis from eIF5A-lysine;Metabolism of proteins;Post-translational protein modification
P63244	Signal Transduction;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNFR1-mediated ceramide production;Death Receptor Signalling;TNF signaling
P63252	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;Classical Kir channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P63261	Developmental Biology;Cytokine Signaling in Immune system;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Cell-Cell communication;Gap junction trafficking and regulation;Signal Transduction;Disease;Innate Immune System;Immune System;Gap junction trafficking;Gap junction degradation;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Formation of annular gap junctions;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;L1CAM interactions;EPHB-mediated forward signaling;EPH-ephrin mediated repulsion of cells;Adherens junctions interactions;Cell-cell junction organization;Axon guidance;Recycling pathway of L1;VEGFA-VEGFR2 Pathway;Interaction between L1 and Ankyrins;Cell-extracellular matrix interactions;Cell junction organization;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RHO GTPases Activate Formins;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Clathrin-mediated endocytosis;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling downstream of RAS mutants;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
P63267	Muscle contraction;Smooth Muscle Contraction
P63272	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
P63279	Meiotic synapsis;Metabolism;Reproduction;Meiosis;Cell Cycle;Vitamin D (calciferol) metabolism;Generic Transcription Pathway;Mitotic Metaphase and Anaphase;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMO is transferred from E1 to E2 (UBE2I, UBC9);SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Processing and activation of SUMO;SUMOylation of transcription factors;SUMOylation of ubiquitinylation proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of intracellular receptors;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;SUMOylation of DNA methylation proteins;SUMOylation of immune response proteins;Metabolism of lipids;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;Metabolism of steroids;Postmitotic nuclear pore complex (NPC) reformation
P63316	Striated Muscle Contraction;Muscle contraction
P67775	Hemostasis;Opioid Signalling;Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Signal Transduction;Integration of energy metabolism;PP2A-mediated dephosphorylation of key metabolic factors;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DARPP-32 events;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signaling by FGFR;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;ERKs are inactivated;Generic Transcription Pathway;MASTL Facilitates Mitotic Progression;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Transcriptional Regulation by TP53;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;G alpha (i) signalling events;Platelet sensitization by LDL;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Regulation of TP53 Activity;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Nonsense-Mediated Decay (NMD);TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;EML4 and NUDC in mitotic spindle formation;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P67809	Signaling by NOTCH;Signal Transduction;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Noncanonical activation of NOTCH3
P67812	SRP-dependent cotranslational protein targeting to membrane;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin;Translation
P67870	PIP3 activates AKT signaling;Developmental Biology;Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;Macroautophagy;Cell Cycle;Innate Immune System;Immune System;Signaling by WNT;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Generic Transcription Pathway;Condensation of Prometaphase Chromosomes;Transcriptional Regulation by TP53;L1CAM interactions;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Signal transduction by L1;Mitophagy;Metabolism of lipids;Regulation of TP53 Activity;Neutrophil degranulation;Regulation of TP53 Activity through Phosphorylation;PTEN Regulation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Receptor Mediated Mitophagy;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Autophagy;Selective autophagy;Nervous system development
P67936	Striated Muscle Contraction;Muscle contraction;Smooth Muscle Contraction
P68032	Striated Muscle Contraction;Muscle contraction
P68036	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;E3 ubiquitin ligases ubiquitinate target proteins;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P68104	Eukaryotic Translation Elongation;Peptide chain elongation;Innate Immune System;Immune System;Cellular responses to stress;HSF1 activation;Cellular response to heat stress;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Translation;Protein methylation;Cellular responses to external stimuli;Autophagy;Chaperone Mediated Autophagy
P68106	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
P68133	Striated Muscle Contraction;Muscle contraction
P68363	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
P68366	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Platelet degranulation ;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
P68371	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Innate Immune System;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
P68400	PIP3 activates AKT signaling;Developmental Biology;Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;Macroautophagy;Cell Cycle;Signaling by WNT;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Generic Transcription Pathway;Condensation of Prometaphase Chromosomes;Transcriptional Regulation by TP53;L1CAM interactions;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Signal transduction by L1;Mitophagy;Metabolism of lipids;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;PTEN Regulation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Receptor Mediated Mitophagy;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Autophagy;Selective autophagy;Nervous system development
P68402	Innate Immune System;Immune System;Membrane Trafficking;Vesicle-mediated transport;Neutrophil degranulation;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
P68431	Hemostasis;Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Reproduction;Meiosis;Signaling by NOTCH;Signal Transduction;Cell Cycle;Disease;Immune System;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;HDACs deacetylate histones;PKMTs methylate histone lysines;HDMs demethylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Signaling by Interleukins;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation;Factors involved in megakaryocyte development and platelet production
P68871	Hemostasis;Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;O2/CO2 exchange in erythrocytes;Innate Immune System;Immune System;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Transport of small molecules;Vesicle-mediated transport;Neutrophil degranulation;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Factors involved in megakaryocyte development and platelet production
P69723	Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Minus-strand DNA synthesis;Plus-strand DNA synthesis;2-LTR circle formation;Binding and entry of HIV virion;Assembly Of The HIV Virion;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;Vif-mediated degradation of APOBEC3G;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated nuclear import of PICs;Infectious disease
P69726	Uncoating of the HIV Virion;HIV Life Cycle;Budding and maturation of HIV virion;Reverse Transcription of HIV RNA;Integration of provirus;Early Phase of HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Minus-strand DNA synthesis;Plus-strand DNA synthesis;2-LTR circle formation;Binding and entry of HIV virion;Assembly Of The HIV Virion;Integration of viral DNA into host genomic DNA;Interactions of Vpr with host cellular proteins;Autointegration results in viral DNA circles;APOBEC3G mediated resistance to HIV-1 infection;Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization;Vpr-mediated nuclear import of PICs;Infectious disease
P69891	Hemostasis;Factors involved in megakaryocyte development and platelet production
P69892	Hemostasis;Factors involved in megakaryocyte development and platelet production
P69905	Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;O2/CO2 exchange in erythrocytes;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Transport of small molecules;Vesicle-mediated transport
P71828	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P71971	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P78310	Hemostasis;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall
P78316	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P78317	Adaptive Immune System;Immune System;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;DNA Repair;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
P78324	Hemostasis;Cell-Cell communication;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Signal regulatory protein family interactions;Neutrophil degranulation
P78325	Degradation of the extracellular matrix;Extracellular matrix organization;Innate Immune System;Immune System;Neutrophil degranulation
P78329	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Metabolism of lipids;Fatty acid metabolism
P78330	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
P78333	Metabolism;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Visual phototransduction;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Hedgehog ligand biogenesis;Signaling by Hedgehog;Release of Hh-Np from the secreting cell;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport
P78344	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
P78345	tRNA processing in the nucleus;Major pathway of rRNA processing in the nucleolus and cytosol;tRNA processing;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P78346	tRNA processing in the nucleus;Major pathway of rRNA processing in the nucleolus and cytosol;tRNA processing;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
P78348	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
P78352	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;L1CAM interactions;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Axon guidance;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;NrCAM interactions;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding;RHO GTPases activate CIT;RAF/MAP kinase cascade;LGI-ADAM interactions;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Nervous system development
P78356	PIP3 activates AKT signaling;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of lipids;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of PIPs in the nucleus;Intracellular signaling by second messengers
P78357	Developmental Biology;L1CAM interactions;Axon guidance;Neurofascin interactions;Nervous system development
P78363	Signal Transduction;Disease;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;Transport of small molecules;ABC-family proteins mediated transport;GPCR downstream signalling;G alpha (i) signalling events;Diseases of the neuronal system
P78364	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers
P78367	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
P78368	Metabolism;Signal Transduction;Sphingolipid de novo biosynthesis;Signaling by WNT;TCF dependent signaling in response to WNT;Sphingolipid metabolism;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Metabolism of lipids
P78369	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
P78371	Innate Immune System;Immune System;Organelle biogenesis and maintenance;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Neutrophil degranulation;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
P78380	Hemostasis;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Neutrophil degranulation
P78381	Disease;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M);SLC transporter disorders;Disorders of transmembrane transporters;Transport of nucleotide sugars
P78382	Disease;Transport of small molecules;Metabolism of proteins;Sialic acid metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F);SLC transporter disorders;Disorders of transmembrane transporters;Post-translational protein modification;Transport of nucleotide sugars
P78385	Developmental Biology;Keratinization;Formation of the cornified envelope
P78386	Developmental Biology;Keratinization;Formation of the cornified envelope
P78396	G0 and Early G1;Cell Cycle;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;SCF(Skp2)-mediated degradation of p27/p21;Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Metabolism of proteins;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Regulation of TP53 Activity;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;Post-translational protein modification;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;G2 Phase;Orc1 removal from chromatin;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Cellular responses to external stimuli
P78406	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
P78410	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
P78417	Cytokine Signaling in Immune system;Metabolism;Phase II - Conjugation of compounds;Methylation;Glutathione conjugation;Immune System;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Biological oxidations;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
P78423	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P78426	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells;Regulation of gene expression in early pancreatic precursor cells
P78504	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus
P78508	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium transport channels;Potassium Channels;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
P78509	Developmental Biology;Axon guidance;Reelin signalling pathway;Nervous system development
P78524	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P78527	Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;IRF3-mediated induction of type I IFN;Metabolism of proteins;DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);Post-translational protein modification;DNA Repair;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
P78536	Signaling by ERBB4;Nuclear signaling by ERBB4;Cytokine Signaling in Immune system;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Signaling by NOTCH;Signal Transduction;Disease;Immune System;Signaling by EGFR;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Hedgehog ligand biogenesis;Signaling by Hedgehog;Release of Hh-Np from the secreting cell;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Death Receptor Signalling;TNF signaling;Signaling by Receptor Tyrosine Kinases;Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;Growth hormone receptor signaling
P78537	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
P78540	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
P78543	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription)
P78545	Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing
P78549	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Displacement of DNA glycosylase by APEX1;Disease;Base Excision Repair;DNA Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Diseases of Base Excision Repair;Defective Base Excision Repair Associated with NTHL1;Defective NTHL1 substrate processing;Defective NTHL1 substrate binding;Diseases of DNA repair
P78552	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
P78556	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
P78560	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Gene expression (Transcription)
P78563	mRNA Editing: A to I Conversion;mRNA Editing;C6 deamination of adenosine;Formation of editosomes by ADAR proteins;Metabolism of RNA
P79483	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
P80098	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR ligand binding
P80108	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
P80162	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
P80188	Cytokine Signaling in Immune system;Innate Immune System;Immune System;Transport of small molecules;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Neutrophil degranulation;Metal sequestration by antimicrobial proteins;Antimicrobial peptides;Iron uptake and transport
P80217	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
P80294	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P80297	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
P80365	Metabolism;Glucocorticoid biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
P80370	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus
P80404	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;GABA synthesis, release, reuptake and degradation;Degradation of GABA
P80511	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;Neutrophil degranulation;Advanced glycosylation endproduct receptor signaling;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
P80748	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
P81274	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
P81277	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
P81534	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
P81605	Innate Immune System;Immune System;Antimicrobial peptides
P82094	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
P82251	Hemostasis;Disease;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;SLC transporter disorders;Defective SLC3A1 causes cystinuria (CSNU);Disorders of transmembrane transporters;Defective SLC7A9 causes cystinuria (CSNU)
P82650	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82663	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82664	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82673	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82675	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82909	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82912	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82914	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82921	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82930	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82932	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82933	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
P82979	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
P82987	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
P83369	SLBP independent Processing of Histone Pre-mRNAs;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
P83436	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
P83731	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P83859	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
P83876	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
P83881	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P83916	Disease;Infectious disease;HCMV Infection;HCMV Early Events
P84022	Signaling by NODAL;Developmental Biology;Cytokine Signaling in Immune system;Signaling by Activin;Signaling by NOTCH;Signal Transduction;Disease;Immune System;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Loss of Function of SMAD4 in Cancer;Loss of Function of SMAD2/3 in Cancer;Signaling by TGF-beta Receptor Complex in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;SMAD4 MH2 Domain Mutants in Cancer;SMAD2/3 MH2 Domain Mutants in Cancer;TGFBR1 KD Mutants in Cancer;Loss of Function of TGFBR1 in Cancer;Metabolism of proteins;Interleukin-1 family signaling;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates CDKN1A transcription;RUNX3 regulates BCL2L11 (BIM) transcription;Signaling by TGF-beta family members;Interleukin-37 signaling;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;FOXO-mediated transcription of cell cycle genes
P84077	Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;PI Metabolism;Phospholipid metabolism;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the Golgi membrane;Nef Mediated CD4 Down-regulation;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Metabolism of proteins;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Asparagine N-linked glycosylation;Interleukin-12 family signaling;Signaling by Interleukins;Metabolism of lipids;Vesicle-mediated transport;Infectious disease;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Transport to the Golgi and subsequent modification
P84085	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
P84095	Hemostasis;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;RHO GTPase Effectors;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;RHO GTPases activate KTN1;Diseases of signal transduction by growth factor receptors and second messengers;Neutrophil degranulation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;Intracellular signaling by second messengers
P84098	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
P84103	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
P84243	Hemostasis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Signal Transduction;Cell Cycle;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;Transcriptional regulation of granulopoiesis;Amyloid fiber formation;Factors involved in megakaryocyte development and platelet production
P85037	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification
P85298	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
P85299	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Disease;Immune System;Signaling by VEGF;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Transcriptional Regulation by TP53;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases
P86397	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
P86790	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P86791	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
P98066	Innate Immune System;Immune System;Neutrophil degranulation
P98077	Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Signalling to RAS;Immune System;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;VEGFA-VEGFR2 Pathway;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
P98082	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction degradation;Formation of annular gap junctions;Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
P98088	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
P98095	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
P98155	Developmental Biology;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Axon guidance;Reelin signalling pathway;VLDLR internalisation and degradation;Plasma lipoprotein clearance;VLDL clearance;Nervous system development
P98160	Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Integrin cell surface interactions;Visual phototransduction;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport;Amyloid fiber formation
P98161	Organelle biogenesis and maintenance;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
P98164	Metabolism;Signal Transduction;Vitamin D (calciferol) metabolism;Metabolism of vitamins and cofactors;Membrane Trafficking;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of lipids;Vesicle-mediated transport;Metabolism of fat-soluble vitamins;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Metabolism of steroids;Retinoid metabolism and transport
P98170	Apoptosis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Activation of caspases through apoptosome-mediated cleavage;Cytochrome c-mediated apoptotic response;SMAC (DIABLO) binds to IAPs ;SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;PIP3 activates AKT signaling;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex;RIPK1-mediated regulated necrosis;Regulated Necrosis;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Regulation of necroptotic cell death;PTEN Regulation;Death Receptor Signalling;TNF signaling;Regulation of PTEN localization;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Regulation of the apoptosome activity
P98171	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
P98172	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
P98174	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
P98177	PIP3 activates AKT signaling;Signal Transduction;Disease;AKT phosphorylates targets in the nucleus;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;FOXO-mediated transcription of cell death genes;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Regulation of FOXO transcriptional activity by acetylation;FOXO-mediated transcription of cell cycle genes
P98182	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
P98187	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
P98194	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
P98196	Innate Immune System;Immune System;Transport of small molecules;Neutrophil degranulation;Ion transport by P-type ATPases;Ion channel transport
P98198	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
P99999	Apoptosis;Intrinsic Pathway for Apoptosis;Release of apoptotic factors from the mitochondria;Formation of apoptosome;Activation of caspases through apoptosome-mediated cleavage;Cytochrome c-mediated apoptotic response;SMAC (DIABLO) binds to IAPs ;SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Organelle biogenesis and maintenance;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;Regulation of the apoptosome activity
P9WFK7	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Suppression of autophagy;Response of Mtb to phagocytosis
P9WFZ7	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WFZ9	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WG35	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WG67	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGE7	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGE9	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGN3	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGN5	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGN7	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGN9	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGP1	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGP3	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WGP5	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGU1	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Modulation by Mtb of host immune system
P9WGU5	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WGY5	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Antimicrobial action and antimicrobial resistance in Mtb
P9WGY7	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Antimicrobial action and antimicrobial resistance in Mtb
P9WGY9	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Antimicrobial action and antimicrobial resistance in Mtb
P9WGZ1	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Antimicrobial action and antimicrobial resistance in Mtb
P9WHH1	Latent infection - Other responses of Mtb to phagocytosis;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WHH9	Latent infection - Other responses of Mtb to phagocytosis;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WI47	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Inhibition of nitric oxide production;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WIA1	Disease;Infectious disease;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Blockage of phagosome acidification;Modulation by Mtb of host immune system;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WIE3	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WIE5	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WIS7	Latent infection - Other responses of Mtb to phagocytosis;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WJH7	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WJM5	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WJY3	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WK45	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WL31	Mtb iron assimilation by chelation;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WN25	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WNE1	Latent infection - Other responses of Mtb to phagocytosis;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WNE5	Mtb iron assimilation by chelation;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WNK3	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Inhibition of membrane repair;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
P9WNK7	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Manipulation of host energy metabolism;Modulation by Mtb of host immune system;Response of Mtb to phagocytosis
P9WPQ9	Mtb iron assimilation by chelation;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WQB5	Latent infection - Other responses of Mtb to phagocytosis;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WQB7	Tolerance of reactive oxygen produced by macrophages;Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WQJ5	Latent infection - Other responses of Mtb to phagocytosis;Tolerance by Mtb to nitric oxide produced by macrophages;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WQJ7	Mtb iron assimilation by chelation;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
P9WQJ9	Mtb iron assimilation by chelation;Latent infection - Other responses of Mtb to phagocytosis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
Q00056	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
Q00059	Mitochondrial biogenesis;Mitochondrial transcription initiation;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Gene expression (Transcription);Transcription from mitochondrial promoters
Q00169	Developmental Biology;Cytokine Signaling in Immune system;Immune System;Netrin-1 signaling;Role of second messengers in netrin-1 signaling;Axon guidance;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Nervous system development
Q00266	Metabolism;Phase II - Conjugation of compounds;Methylation;Sulfur amino acid metabolism;Disease;Biological oxidations;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of amino acids and derivatives
Q00341	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;HDL clearance;Plasma lipoprotein clearance
Q00403	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Infectious disease;RNA Polymerase II Pre-transcription Events;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q00496	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type E (BoNT/E);Uptake and actions of bacterial toxins;Infectious disease
Q00534	Cell Cycle;Disease;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Oncogene Induced Senescence;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;Cellular responses to external stimuli;Diseases of Cellular Senescence;Evasion of Oncogene Induced Senescence Due to p16INK4A Defects;Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6;Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects;Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6;Diseases of cellular response to stress
Q00535	Hemostasis;Opioid Signalling;Developmental Biology;Signal Transduction;Disease;Signaling by NTRKs;DARPP-32 events;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Generic Transcription Pathway;Transcriptional Regulation by TP53;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;CRMPs in Sema3A signaling;G alpha (i) signalling events;Axon guidance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;Activated NTRK2 signals through CDK5;Diseases of programmed cell death;Nervous system development;Factors involved in megakaryocyte development and platelet production
Q00597	Generic Transcription Pathway;Transcriptional Regulation by TP53;Fanconi Anemia Pathway;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q00610-1	Adaptive Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q00610	Developmental Biology;Adaptive Immune System;Gap junction trafficking and regulation;Signal Transduction;Disease;Signaling by NTRKs;Influenza Infection;Immune System;Entry of Influenza Virion into Host Cell via Endocytosis;Plasma lipoprotein assembly, remodeling, and clearance;Retrograde neurotrophin signalling;Signaling by NTRK1 (TRKA);Gap junction trafficking;Gap junction degradation;Signaling by WNT;Formation of annular gap junctions;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;Transport of small molecules;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;PCP/CE pathway;Axon guidance;Lysosome Vesicle Biogenesis;Recycling pathway of L1;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDLR internalisation and degradation;LDL clearance;Plasma lipoprotein clearance;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q00613	Macroautophagy;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;HSF1 activation;Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Cellular responses to external stimuli;Autophagy;Aggrephagy;Selective autophagy
Q00653	Cytokine Signaling in Immune system;ZBP1(DAI) mediated induction of type I IFNs;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;SUMOylation;SUMO E3 ligases SUMOylate target proteins;DEx/H-box helicases activate type I IFN and inflammatory cytokines production ;PKMTs methylate histone lysines;Chromatin modifying enzymes;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-1 processing;Signaling by Interleukins;SUMOylation of immune response proteins;Chromatin organization;Diseases of Immune System;Diseases associated with the TLR signaling cascade;IkBA variant leads to EDA-ID;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Infectious disease;TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;Post-translational protein modification;Inflammasomes;The NLRP3 inflammasome;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response);TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q00722	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Inositol phosphate metabolism;Signal Transduction;Integration of energy metabolism;Synthesis of IP3 and IP4 in the cytosol;Signaling by WNT;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;G-protein beta:gamma signalling;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G beta:gamma signalling through PLC beta;G alpha (i) signalling events;Regulation of insulin secretion;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Activation of kainate receptors upon glutamate binding;Presynaptic function of Kainate receptors
Q00765	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q00796	Metabolism;Fructose metabolism;Fructose biosynthesis;Formation of xylulose-5-phosphate;Metabolism of carbohydrates
Q00839	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q00872	Striated Muscle Contraction;Muscle contraction
Q00887	Hemostasis;Cell surface interactions at the vascular wall
Q00888	Hemostasis;Cell surface interactions at the vascular wall
Q00889	Hemostasis;Cell surface interactions at the vascular wall
Q00973	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q00975	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System
Q00978	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
Q00987	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;PIP3 activates AKT signaling;Signal Transduction;Cell Cycle;Disease;AKT phosphorylates targets in the cytosol;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;SUMOylation of ubiquitinylation proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q00994	Signal Transduction;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;NADE modulates death signalling;Death Receptor Signalling
Q01064	Hemostasis;Opioid Signalling;Calmodulin induced events;Cam-PDE 1 activation;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;DAG and IP3 signaling;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects;G alpha (s) signalling events;G alpha (i) signalling events;Intracellular signaling by second messengers
Q01081	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q01082	Developmental Biology;Cytokine Signaling in Immune system;Cell-Cell communication;Signal Transduction;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;Nephrin family interactions;L1CAM interactions;NCAM signaling for neurite out-growth;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;FLT3 Signaling;Nervous system development
Q01085	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases
Q01094	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of NOXA and translocation to mitochondria;Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Activation of BH3-only proteins;Developmental Biology;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;Activation of PUMA and translocation to mitochondria;G0 and Early G1;Signaling by NOTCH;Signal Transduction;Cell Cycle;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Programmed Cell Death;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;CDC6 association with the ORC:origin complex;Assembly of the pre-replicative complex;G2 Phase;DNA Replication Pre-Initiation;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;DNA Replication;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Transcriptional regulation of granulopoiesis
Q01101	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
Q01105	Cell Cycle;Condensation of Prophase Chromosomes;HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Metabolism of RNA
Q01113	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-9 signaling
Q01118	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q01130	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q01167	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification
Q01196	Developmental Biology;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates estrogen receptor mediated transcription;Regulation of RUNX1 Expression and Activity;RUNX1 regulates expression of components of tight junctions;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;RUNX1 regulates transcription of genes involved in BCR signaling;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;RUNX1 regulates transcription of genes involved in interleukin signaling;RUNX1 regulates transcription of genes involved in WNT signaling;RUNX2 regulates genes involved in differentiation of myeloid cells;RUNX3 regulates p14-ARF;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Transcriptional regulation of granulopoiesis
Q01201	Cytokine Signaling in Immune system;Innate Immune System;Immune System;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling
Q01344	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin receptor SHC signaling;FLT3 Signaling
Q01362	Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation
Q01432	Metabolism;Metabolism of nucleotides;Innate Immune System;Immune System;Neutrophil degranulation;Purine salvage;Nucleotide salvage
Q01433	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
Q01449	Muscle contraction;Smooth Muscle Contraction
Q01453	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q01469	Metabolism;Signal Transduction;Triglyceride catabolism;Innate Immune System;Immune System;Signaling by Retinoic Acid;Metabolism of lipids;Neutrophil degranulation;Triglyceride metabolism;Signaling by Nuclear Receptors
Q01484	Developmental Biology;ER to Golgi Anterograde Transport;Membrane Trafficking;L1CAM interactions;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Nervous system development
Q01518	Hemostasis;Platelet degranulation ;Developmental Biology;Innate Immune System;Immune System;Signaling by ROBO receptors;Axon guidance;Role of ABL in ROBO-SLIT signaling;Neutrophil degranulation;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Nervous system development
Q01523	Defensins;Alpha-defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q01524	Defensins;Alpha-defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q01543	Developmental Biology;Transcriptional regulation of granulopoiesis
Q01546	Developmental Biology;Keratinization;Formation of the cornified envelope
Q01581	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;PPARA activates gene expression;Activation of gene expression by SREBF (SREBP);Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids
Q01628	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
Q01629	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
Q01638-2	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-33 signaling
Q01638	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Negative regulation of the PI3K/AKT network;Interleukin-1 family signaling;Signaling by Interleukins;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Interleukin-33 signaling
Q01650	Hemostasis;Metabolism;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q01658	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q01668	Developmental Biology;Metabolism;Integration of energy metabolism;NCAM signaling for neurite out-growth;Muscle contraction;Adrenaline,noradrenaline inhibits insulin secretion;NCAM1 interactions;Regulation of insulin secretion;Axon guidance;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Nervous system development
Q01718	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Metabolic disorders of biological oxidation enzymes;Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD);Infectious disease;Diseases of metabolism;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q01726	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q01740	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;FMO oxidises nucleophiles
Q01780	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q01813	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
Q01814	Hemostasis;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
Q01826	Apoptosis;Apoptotic cleavage of cellular proteins;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of chromatin organization proteins;Programmed Cell Death;Post-translational protein modification;Apoptotic execution phase
Q01831	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q01851	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q01860	Developmental Biology;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Transcriptional regulation of pluripotent stem cells
Q01955	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Anchoring fibril formation;Crosslinking of collagen fibrils;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q01959	Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Disease;Dopamine clearance from the synaptic cleft;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS);SLC transporter disorders;Disorders of transmembrane transporters
Q01968	Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the Golgi membrane;Synthesis of IP2, IP, and Ins in the cytosol;Synthesis of IP3 and IP4 in the cytosol;Signaling by Rho GTPases;Rho GTPase cycle;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Metabolism of lipids;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q01970	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Inositol phosphate metabolism;Signal Transduction;Integration of energy metabolism;Synthesis of IP3 and IP4 in the cytosol;Signaling by WNT;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;G-protein beta:gamma signalling;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G beta:gamma signalling through PLC beta;G alpha (i) signalling events;Regulation of insulin secretion;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Activation of kainate receptors upon glutamate binding;Presynaptic function of Kainate receptors
Q01973	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;WNT5A-dependent internalization of FZD2, FZD5 and ROR2
Q01974	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;WNT5A-dependent internalization of FZD2, FZD5 and ROR2
Q02045	Muscle contraction;Smooth Muscle Contraction
Q02078	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Myogenesis;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q02080	Developmental Biology;Myogenesis
Q02083	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System
Q02094	Erythrocytes take up carbon dioxide and release oxygen;Erythrocytes take up oxygen and release carbon dioxide;O2/CO2 exchange in erythrocytes;Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Rhesus glycoproteins mediate ammonium transport.;Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN);SLC transporter disorders;Disorders of transmembrane transporters
Q02108	Hemostasis;Nitric oxide stimulates guanylate cyclase;Muscle contraction;Platelet homeostasis;Smooth Muscle Contraction
Q02127	Metabolism;Metabolism of nucleotides;Pyrimidine biosynthesis;Nucleobase biosynthesis
Q02153	Hemostasis;Nitric oxide stimulates guanylate cyclase;Muscle contraction;Platelet homeostasis;Smooth Muscle Contraction
Q02156	Hemostasis;Effects of PIP2 hydrolysis;Signaling by ERBB2;SHC1 events in ERBB2 signaling;DAG and IP3 signaling;Signal Transduction;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (z) signalling events;Platelet activation, signaling and aggregation;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases
Q02161	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Rhesus blood group biosynthesis
Q02218	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Glyoxylate metabolism and glycine degradation;Lysine catabolism;Metabolism of amino acids and derivatives;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
Q02223	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q02224	Hemostasis;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Vesicle-mediated transport;RHO GTPases Activate Formins;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;EML4 and NUDC in mitotic spindle formation;Kinesins;Factors involved in megakaryocyte development and platelet production
Q02241	Hemostasis;Adaptive Immune System;Cell Cycle;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Telophase/Cytokinesis;M Phase;Cell Cycle, Mitotic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q02246	Developmental Biology;L1CAM interactions;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;NrCAM interactions;Nervous system development
Q02252	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q02297-10	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;GRB7 events in ERBB2 signaling;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Disease;Immune System;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
Q02297	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;GRB7 events in ERBB2 signaling;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Long-term potentiation;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
Q02318	Metabolism;Disease;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
Q02338	Metabolism;Metabolism of lipids;Ketone body metabolism;Utilization of Ketone Bodies;Synthesis of Ketone Bodies
Q02363	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q02386	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q02388	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;ER to Golgi Anterograde Transport;Membrane Trafficking;Assembly of collagen fibrils and other multimeric structures;COPII-mediated vesicle transport;Integrin cell surface interactions;Anchoring fibril formation;Laminin interactions;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Collagen chain trimerization;Transport to the Golgi and subsequent modification
Q02410	Neurotransmitter release cycle;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Dopamine Neurotransmitter Release Cycle;Activation of NMDA receptors and postsynaptic events;Neurexins and neuroligins;Protein-protein interactions at synapses;Assembly and cell surface presentation of NMDA receptors
Q02413	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Innate Immune System;Immune System;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;Neutrophil degranulation;Keratinization;Formation of the cornified envelope;Apoptotic execution phase
Q02447	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;Post-translational protein modification
Q02487	Developmental Biology;Keratinization;Formation of the cornified envelope
Q02505	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q02535	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q02539	Apoptosis;Apoptosis induced DNA fragmentation;Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Programmed Cell Death;Apoptotic execution phase;Cellular responses to external stimuli
Q02543	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q02548	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in BCR signaling
Q02556	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
Q02641	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;NCAM signaling for neurite out-growth;Muscle contraction;NCAM1 interactions;Axon guidance;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Nervous system development
Q02643	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q02742	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q02747	Digestion;Digestion and absorption
Q02750	MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Prolonged ERK activation events;Frs2-mediated activation;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signalling to ERKs;L1CAM interactions;Axon guidance;Signal transduction by L1;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative feedback regulation of MAPK pathway;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAP3K8 (TPL2)-dependent MAPK1/3 activation;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Signaling by Receptor Tyrosine Kinases;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Signaling downstream of RAS mutants;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q02763	Hemostasis;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Cell surface interactions at the vascular wall;Tie2 Signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q02790	Signal Transduction;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;ESR-mediated signaling;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q02809	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q02817	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q02818	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q02846	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q02878	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q02880	SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of DNA replication proteins;Post-translational protein modification
Q02928	Metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Fatty acid metabolism
Q02978	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
Q02985	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
Q03001-3	Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures
Q03001	Cell-Cell communication;Type I hemidesmosome assembly;Cell junction organization
Q03013	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations;Metabolism of lipids;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of DHA-derived sulfido conjugates;Biosynthesis of maresin conjugates in tissue regeneration (MCTR)
Q03052	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q03060-6	Circadian Clock
Q03111	Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q03112	PIP3 activates AKT signaling;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q03113	Hemostasis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Thrombin signalling through proteinase activated receptors (PARs);Platelet activation, signaling and aggregation
Q03135	Hemostasis;Metabolism;Signal Transduction;Triglyceride catabolism;Signaling by VEGF;Signaling by WNT;TCF dependent signaling in response to WNT;Metabolism of nitric oxide: eNOS activation and regulation;Cell surface interactions at the vascular wall;eNOS activation;NOSTRIN mediated eNOS trafficking;Basigin interactions;Generic Transcription Pathway;VEGFA-VEGFR2 Pathway;Disassembly of the destruction complex and recruitment of AXIN to the membrane;VEGFR2 mediated vascular permeability;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Triglyceride metabolism;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
Q03154	Metabolism;Disease;Biological oxidations;Aflatoxin activation and detoxification;Defective ACY1 causes encephalopathy;Metabolic disorders of biological oxidation enzymes;Diseases of metabolism
Q03164	Developmental Biology;Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Transcriptional regulation of granulopoiesis
Q03181	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Carnitine metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Generic Transcription Pathway;Nuclear Receptor transcription pathway;Signaling by Retinoic Acid;Metabolism of lipids;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;RNA Polymerase II Transcription;Gene expression (Transcription);Fatty acid metabolism;Signaling by Nuclear Receptors
Q03188	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q03393	Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Metabolism of vitamins and cofactors;Metabolism of cofactors
Q03405	Hemostasis;Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Dissolution of Fibrin Clot
Q03426	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
Q03431	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q03468	Epigenetic regulation of gene expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription)
Q03518	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q03519	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q03591	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
Q03692	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Non-integrin membrane-ECM interactions;Collagen chain trimerization
Q03721	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q03936	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q04206	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;p75NTR signals via NF-kB;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;TCR signaling;Downstream TCR signaling;NF-kB is activated and signals survival;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;FCERI mediated NF-kB activation;SUMOylation;SUMO E3 ligases SUMOylate target proteins;DEx/H-box helicases activate type I IFN and inflammatory cytokines production ;PKMTs methylate histone lysines;Chromatin modifying enzymes;Transcriptional regulation of white adipocyte differentiation;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-1 processing;Signaling by Interleukins;SUMOylation of immune response proteins;Chromatin organization;Diseases of Immune System;Diseases associated with the TLR signaling cascade;IkBA variant leads to EDA-ID;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;CLEC7A/inflammasome pathway;Infectious disease;Post-translational protein modification;Inflammasomes;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);The NLRP3 inflammasome;Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response);TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Signaling by the B Cell Receptor (BCR)
Q04323	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification
Q04446	Metabolism;Disease;Glycogen storage diseases;Glycogen synthesis;Glycogen storage disease type IV (GBE1);Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates;Glycogen metabolism
Q04609	Metabolism;Metabolism of amino acids and derivatives;Aspartate and asparagine metabolism
Q04637	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Developmental Biology;Cytokine Signaling in Immune system;L13a-mediated translational silencing of Ceruloplasmin expression;Signal Transduction;mTOR signalling;mTORC1-mediated signalling;Immune System;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Interferon Signaling;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q04656	Innate Immune System;Immune System;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Transport of small molecules;Antimicrobial peptides;Ion influx/efflux at host-pathogen interface;Cellular responses to external stimuli;Ion transport by P-type ATPases;Ion channel transport
Q04671	Metabolism;Melanin biosynthesis;Metabolism of amino acids and derivatives
Q04695	Developmental Biology;Keratinization;Formation of the cornified envelope
Q04721	Signaling by NOTCH;Signal Transduction;Disease;Pre-NOTCH Processing in the Endoplasmic Reticulum;Pre-NOTCH Transcription and Translation;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Signaling by NOTCH2;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;NOTCH2 Activation and Transmission of Signal to the Nucleus;Notch-HLH transcription pathway;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Defective LFNG causes SCDO3;Diseases of metabolism;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q04724	Signaling by NOTCH;Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;NOTCH1 Intracellular Domain Regulates Transcription;Deactivation of the beta-catenin transactivating complex;Repression of WNT target genes
Q04725	Signaling by NOTCH;Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;NOTCH1 Intracellular Domain Regulates Transcription;Deactivation of the beta-catenin transactivating complex;Repression of WNT target genes
Q04726-3	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription
Q04726	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Deactivation of the beta-catenin transactivating complex;Repression of WNT target genes;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q04727	Signaling by NOTCH;Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;NOTCH1 Intracellular Domain Regulates Transcription;Deactivation of the beta-catenin transactivating complex;Repression of WNT target genes
Q04756	Signal Transduction;Signaling by MET;MET Receptor Activation;Signaling by Receptor Tyrosine Kinases
Q04759	Apoptosis;Hemostasis;Apoptotic cleavage of cellular proteins;Effects of PIP2 hydrolysis;Developmental Biology;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;TCR signaling;Downstream TCR signaling;Generic Transcription Pathway;Visual phototransduction;Fc epsilon receptor (FCERI) signaling;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;FCERI mediated NF-kB activation;Signaling by GPCR;Netrin-1 signaling;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Axon guidance;Programmed Cell Death;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptotic execution phase;Platelet activation, signaling and aggregation;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Nervous system development
Q04760	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q04826	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q04828	Metabolism;Signal Transduction;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of lipids;Metabolism of fat-soluble vitamins;Metabolism of steroids;Retinoid metabolism and transport
Q04837	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q04844	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly sodium permeable postsynaptic acetylcholine nicotinic receptors
Q04864	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Adaptive Immune System;Immune System;Signaling by the B Cell Receptor (BCR)
Q04874	Hemostasis;Cell surface interactions at the vascular wall
Q04875	Hemostasis;Cell surface interactions at the vascular wall
Q04876	Hemostasis;Cell surface interactions at the vascular wall
Q04877	Hemostasis;Cell surface interactions at the vascular wall
Q04878	Hemostasis;Cell surface interactions at the vascular wall
Q04879	Hemostasis;Cell surface interactions at the vascular wall
Q04880	Hemostasis;Cell surface interactions at the vascular wall
Q04881	Hemostasis;Cell surface interactions at the vascular wall
Q04882	Hemostasis;Cell surface interactions at the vascular wall
Q04883	Hemostasis;Cell surface interactions at the vascular wall
Q04884	Hemostasis;Cell surface interactions at the vascular wall
Q04885	Hemostasis;Cell surface interactions at the vascular wall
Q04912	Signal Transduction;Signaling by MST1;Signaling by Receptor Tyrosine Kinases
Q04917	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;RHO GTPases activate PKNs;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
Q05033	Hemostasis;Cell surface interactions at the vascular wall
Q05034	Hemostasis;Cell surface interactions at the vascular wall
Q05048	mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q05066	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q05086	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q05193	Developmental Biology;Adaptive Immune System;Gap junction trafficking and regulation;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;Signaling by NTRKs;Innate Immune System;Immune System;Toll-like Receptor Cascades;Retrograde neurotrophin signalling;Signaling by NTRK1 (TRKA);Gap junction trafficking;Gap junction degradation;Formation of annular gap junctions;Membrane Trafficking;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;EPH-ephrin mediated repulsion of cells;Axon guidance;Recycling pathway of L1;Vesicle-mediated transport;Clathrin-mediated endocytosis;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q05209	Signaling by ERBB2;Signaling by ERBB2 in Cancer;SHC1 events in ERBB2 signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by EGFR;EGFR downregulation;Signaling by PDGF;Interleukin-1 family signaling;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Downregulation of ERBB2 signaling;Signaling by Receptor Tyrosine Kinases;Interleukin-37 signaling;Constitutive Signaling by Overexpressed ERBB2
Q05215	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q05329	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);GABA synthesis;GABA synthesis, release, reuptake and degradation;Transcriptional Regulation by MECP2;MECP2 regulates transcription of genes involved in GABA signaling
Q05397	Apoptosis;Hemostasis;Apoptotic cleavage of cellular proteins;Developmental Biology;Cytokine Signaling in Immune system;Cell-Cell communication;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Netrin-1 signaling;NCAM signaling for neurite out-growth;Signal regulatory protein family interactions;EPHB-mediated forward signaling;DCC mediated attractive signaling;Axon guidance;VEGFA-VEGFR2 Pathway;Programmed Cell Death;Infectious disease;RHO GTPases Activate WASPs and WAVEs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by MET;Apoptotic execution phase;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);MET activates PTK2 signaling;MET promotes cell motility;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
Q05469	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
Q05513	Hemostasis;GPVI-mediated activation cascade;Signal Transduction;Signaling by TGF-beta Receptor Complex;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;RHO GTPases Activate NADPH Oxidases;Platelet activation, signaling and aggregation;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;Extra-nuclear estrogen signaling;Estrogen-stimulated signaling through PRKCZ
Q05516	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q05519	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q05586	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Nervous system development
Q05639	Eukaryotic Translation Elongation;Metabolism of proteins;Translation
Q05655	Apoptosis;Hemostasis;Apoptotic cleavage of cellular proteins;Opioid Signalling;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Effects of PIP2 hydrolysis;Signaling by ERBB2;SHC1 events in ERBB2 signaling;Cytokine Signaling in Immune system;DAG and IP3 signaling;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;VEGFA-VEGFR2 Pathway;HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;VEGFR2 mediated cell proliferation;Programmed Cell Death;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);RHO GTPases Activate NADPH Oxidases;Neutrophil degranulation;Apoptotic execution phase;Platelet activation, signaling and aggregation;Interferon gamma signaling;Metabolism of RNA;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Interferon Signaling
Q05682	Muscle contraction;Smooth Muscle Contraction
Q05707	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Collagen chain trimerization
Q05823	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;OAS antiviral response;Interferon alpha/beta signaling;Interferon Signaling
Q05901	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
Q05923	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q05932-1	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q05932-2	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q05940	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters
Q05996	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
Q06033	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q06055	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
Q06124	Interleukin-6 signaling;Hemostasis;PI3K Cascade;MAPK3 (ERK1) activation;IRS-mediated signalling;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;GPVI-mediated activation cascade;Prolactin receptor signaling;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Spry regulation of FGF signaling;Signaling by SCF-KIT;Cell-Cell communication;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Innate Immune System;Immune System;Toll-like Receptor Cascades;Signaling by EGFR;GAB1 signalosome;Downstream signal transduction;Signaling by PDGF;Signaling by FGFR;Negative regulation of the PI3K/AKT network;Cell surface interactions at the vascular wall;PECAM1 interactions;Tie2 Signaling;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Signaling by Leptin;Netrin-1 signaling;Costimulation by the CD28 family;CTLA4 inhibitory signaling;PD-1 signaling;Signal regulatory protein family interactions;Platelet homeostasis;Netrin mediated repulsion signals;Axon guidance;Platelet sensitization by LDL;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Downstream signaling of activated FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;FRS-mediated FGFR2 signaling;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Interleukin-6 family signaling;Signaling by MET;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;Interferon gamma signaling;Regulation of IFNG signaling;RET signaling;Interleukin-20 family signaling;MET activates PTPN11;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;Signaling by NTRK2 (TRKB);Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Interleukin-37 signaling;Activated NTRK2 signals through FRS2 and FRS3;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;STAT5 Activation;Nervous system development
Q06136	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q06141	Innate Immune System;Immune System;Antimicrobial peptides
Q06187	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;GPCR downstream signalling;G-protein beta:gamma signalling;G alpha (q) signalling events;G alpha (12/13) signalling events;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Infectious disease;RHO GTPases Activate WASPs and WAVEs;G beta:gamma signalling through BTK;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Class I MHC mediated antigen processing & presentation;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q06203	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
Q06210	Disease;Diseases of glycosylation;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Defective GFPT1 causes CMSTA1;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
Q06265	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q06278	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamins B6 activation to pyridoxal phosphate
Q06323	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q06330	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Signaling by NOTCH2;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q06413	Developmental Biology;Cytokine Signaling in Immune system;Mitochondrial biogenesis;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Circadian Clock;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Myogenesis;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Signaling by Receptor Tyrosine Kinases;MECP2 regulates transcription factors;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q06481	Hemostasis;Platelet degranulation ;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
Q06495	Disease;Transport of small molecules;Metabolism of proteins;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Type II Na+/Pi cotransporters;Sodium-coupled phosphate cotransporters;Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1);SLC transporter disorders;Disorders of transmembrane transporters;Surfactant metabolism
Q06520	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;PPARA activates gene expression;Biological oxidations;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q06546	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q06547-1	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q06547-2	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q06547-3	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q06547-4	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q06587	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q06609	Reproduction;Meiosis;Cell Cycle;Generic Transcription Pathway;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional Regulation by E2F6;Meiotic recombination
Q06643	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
Q06730	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q06732	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q06828	Metabolism;Extracellular matrix organization;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Keratan sulfate degradation;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Defective ST3GAL3 causes MCT12 and EIEE15;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q06830	Disease;Generic Transcription Pathway;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Cellular responses to external stimuli;Diseases of programmed cell death
Q06889	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q06945	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q07000	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q07001	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly sodium permeable postsynaptic acetylcholine nicotinic receptors
Q07011	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q07020	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q07021	Apoptosis;Hemostasis;Intrinsic Pathway for Apoptosis;Apoptotic factor-mediated response;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Disease;Programmed Cell Death;Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function;Diseases of programmed cell death
Q07065	Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Surfactant metabolism;Post-translational protein modification;Neutrophil degranulation;Post-translational protein phosphorylation
Q07075	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins
Q07092	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Collagen chain trimerization
Q07157	Apoptosis;Apoptotic cleavage of cellular proteins;Gap junction trafficking and regulation;Signal Transduction;Regulation of gap junction activity;Membrane Trafficking;Signaling by Hippo;Generic Transcription Pathway;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;Vesicle-mediated transport;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptotic execution phase;Transcriptional regulation by RUNX1;RUNX1 regulates expression of components of tight junctions
Q07283	Developmental Biology;Keratinization;Formation of the cornified envelope
Q07325	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q07326	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q07343	Opioid Signalling;Signal Transduction;DARPP-32 events;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q07352	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of RNA
Q07627	Developmental Biology;Keratinization
Q07654	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q07666	Signal Transduction;Signaling by PTK6;PTK6 Regulates Proteins Involved in RNA Processing;Signaling by Non-Receptor Tyrosine Kinases
Q07699	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q07812	Apoptosis;Intrinsic Pathway for Apoptosis;Release of apoptotic factors from the mitochondria;Apoptotic factor-mediated response;Activation, translocation and oligomerization of BAX;Signal Transduction;Signaling by NTRKs;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Signaling by Receptor Tyrosine Kinases;Signaling by NTRK3 (TRKC);NTRK3 as a dependence receptor
Q07817	Apoptosis;Intrinsic Pathway for Apoptosis;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Cytokine Signaling in Immune system;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Signaling by Interleukins;Programmed Cell Death;Inflammasomes;Interleukin-4 and Interleukin-13 signaling;The NLRP1 inflammasome
Q07820	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q07837	Disease;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;SLC transporter disorders;Defective SLC3A1 causes cystinuria (CSNU);Disorders of transmembrane transporters;Defective SLC7A9 causes cystinuria (CSNU)
Q07864	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Cell Cycle;Mitotic G1 phase and G1/S transition;PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
Q07866	Hemostasis;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;RHO GTPases activate KTN1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q07869	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional regulation of white adipocyte differentiation;Nuclear Receptor transcription pathway;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;SUMOylation of intracellular receptors;Metabolism of lipids;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids
Q07889	Hemostasis;IRS-mediated signalling;SOS-mediated signalling;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Signalling to RAS;Innate Immune System;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;SHC1 events in EGFR signaling;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;GRB2 events in ERBB2 signaling;Cell surface interactions at the vascular wall;Cell death signalling via NRAGE, NRIF and NADE;Tie2 Signaling;DAP12 interactions;EGFR Transactivation by Gastrin;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);DAP12 signaling;IGF1R signaling cascade;IRS-related events triggered by IGF1R;SHC-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;Signaling by GPCR;NCAM signaling for neurite out-growth;Signaling by ROBO receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (12/13) signalling events;Axon guidance;Activation of RAC1;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;FRS-mediated FGFR1 signaling;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by MET;Death Receptor Signalling;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);Gastrin-CREB signalling pathway via PKC and MAPK;MET activates RAS signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;RET signaling;Interleukin-15 signaling;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through RAS;Erythropoietin activates RAS;Activated NTRK2 signals through FRS2 and FRS3;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through RAS;Interleukin receptor SHC signaling;FLT3 Signaling;Constitutive Signaling by Overexpressed ERBB2;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Signaling by PDGFR in disease;Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants;Signaling by PDGFRA extracellular domain mutants;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q07890	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;Signaling by ROBO receptors;GPCR downstream signalling;G alpha (12/13) signalling events;Axon guidance;Activation of RAC1;Signaling by Interleukins;Interleukin-2 family signaling;Death Receptor Signalling;Interleukin-15 signaling;Nervous system development
Q07954	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Vesicle-mediated transport;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q07955	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q07960	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q07973	Metabolism;Disease;Vitamin D (calciferol) metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Vitamins;Phase I - Functionalization of compounds;Metabolism of lipids;Defective CYP24A1 causes Hypercalcemia, infantile (HCAI);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
Q08043	Cell-Cell communication;Nephrin family interactions;Striated Muscle Contraction;Muscle contraction
Q08050	Polo-like kinase mediated events;Cell Cycle;Mitotic G2-G2/M phases;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic
Q08116	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events
Q08117	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Repression of WNT target genes
Q08170	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q08209	Opioid Signalling;Downstream signaling events of B Cell Receptor (BCR);Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;DARPP-32 events;Signaling by WNT;Calcineurin activates NFAT;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;Ca2+ pathway;G alpha (i) signalling events;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Signaling by the B Cell Receptor (BCR)
Q08211	ZBP1(DAI) mediated induction of type I IFNs;Innate Immune System;Immune System;RIP-mediated NFkB activation via ZBP1;Cytosolic sensors of pathogen-associated DNA ;DEx/H-box helicases activate type I IFN and inflammatory cytokines production ;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q08289	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Metabolism;Integration of energy metabolism;NCAM signaling for neurite out-growth;Muscle contraction;Adrenaline,noradrenaline inhibits insulin secretion;NCAM1 interactions;Regulation of insulin secretion;Axon guidance;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Nervous system development
Q08334	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling;Interleukin-10 signaling;Interleukin-20 family signaling
Q08345	Extracellular matrix organization;Non-integrin membrane-ECM interactions
Q08357	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium-coupled phosphate cotransporters;SLC transporter disorders;Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1);Disorders of transmembrane transporters
Q08379	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Disease;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Transport to the Golgi and subsequent modification;Diseases of programmed cell death
Q08380	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q08397	Extracellular matrix organization;Collagen formation;Elastic fibre formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
Q08426	Metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q08431	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation;Amyloid fiber formation
Q08462	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
Q08477	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
Q08493	Opioid Signalling;Signal Transduction;DARPP-32 events;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events
Q08495	Transport of small molecules;Miscellaneous transport and binding events
Q08499	Opioid Signalling;Signal Transduction;DARPP-32 events;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events
Q08554	Developmental Biology;Innate Immune System;Immune System;Neutrophil degranulation;Keratinization;Formation of the cornified envelope
Q08623	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage
Q08708	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q08722	Hemostasis;Extracellular matrix organization;Cell-Cell communication;Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Integrin cell surface interactions;Signal regulatory protein family interactions;Neutrophil degranulation
Q08752	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors
Q08828	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Vasopressin regulates renal water homeostasis via Aquaporins;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of Adenylate Cyclase;Activation of NMDA receptors and postsynaptic events;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
Q08881	Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Generation of second messenger molecules;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization
Q08945	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q08999	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
Q08AG7	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q08AH1	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of benzoate with glycine;Conjugation of phenylacetate with glutamine;Biological oxidations
Q08AH3	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Biological oxidations
Q08AM6	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Metabolism of lipids
Q08AN1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q08ER8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q08ET2	Innate Immune System;Immune System;DAP12 interactions;Neutrophil degranulation
Q08J23	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q09013	Muscle contraction;Cardiac conduction;Ion homeostasis
Q09028	PIP3 activates AKT signaling;Developmental Biology;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Polo-like kinase mediated events;Signal Transduction;Cell Cycle;Disease;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;HDACs deacetylate histones;PKMTs methylate histone lysines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Chromatin organization;Positive epigenetic regulation of rRNA expression;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Regulation of TP53 Activity;Infectious disease;Deposition of new CENPA-containing nucleosomes at the centromere;Regulation of TP53 Activity through Acetylation;PTEN Regulation;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;S Phase;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Chromosome Maintenance;Gene expression (Transcription);Nucleosome assembly;Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers;HCMV Infection;HCMV Early Events
Q09160	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q09161	SLBP independent Processing of Histone Pre-mRNAs;Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signaling by FGFR in disease;Developmental Biology;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated elongation of the HIV-1 transcript;FGFR2 mutant receptor activation;Signaling by FGFR;snRNP Assembly;Metabolism of non-coding RNA;Signaling by ROBO receptors;Axon guidance;Signaling by FGFR2;Signaling by FGFR2 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Pre-transcription Events;FGFR2 alternative splicing;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;RNA Polymerase II Transcription Elongation;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Processing of Intronless Pre-mRNAs;Signaling by FGFR2 IIIa TM;Metabolism of RNA;Signaling by Receptor Tyrosine Kinases;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q09327	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;Reactions specific to the hybrid N-glycan synthesis pathway;N-glycan antennae elongation in the medial/trans-Golgi
Q09328	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
Q09428	Neuronal System;ATP sensitive Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Integration of energy metabolism;Disease;Regulation of insulin secretion;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCC8 can cause hypoglycemias and hyperglycemias
Q09470	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q09472	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Developmental Biology;RORA activates gene expression;Metabolism;Polo-like kinase mediated events;Signaling by NOTCH;Signal Transduction;Cell Cycle;Disease;Signaling by NTRKs;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Cytosolic sensors of pathogen-associated DNA ;Regulation of beta-cell development;Signaling by NTRK1 (TRKA);Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;Signaling by NOTCH1;Signaling by NOTCH2;Nuclear Events (kinase and transcription factor activation);PPARA activates gene expression;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;Epigenetic regulation of gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;Cellular responses to stress;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;SUMOylation;SUMO E3 ligases SUMOylate target proteins;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production;HATs acetylate histones;Chromatin modifying enzymes;Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Transcriptional Regulation by TP53;Transcriptional regulation of white adipocyte differentiation;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Mitotic G2-G2/M phases;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Metabolism of lipids;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Metalloprotease DUBs;Nucleotide Excision Repair;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity through Methylation;PI5P Regulates TP53 Acetylation;G2/M Transition;Cell Cycle, Mitotic;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;RUNX3 regulates NOTCH signaling;Regulation of RUNX3 expression and activity;RUNX3 regulates p14-ARF;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription;Estrogen-dependent gene expression;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;NGF-stimulated transcription;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes;Transcriptional regulation of granulopoiesis;Regulation of FOXO transcriptional activity by acetylation
Q09FC8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q0D2K0	Transport of small molecules;Miscellaneous transport and binding events
Q0IIM8	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q0JRZ9	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q0PNE2	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q0VD83	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein clearance;VLDL clearance
Q0VDF9	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q0VG06	Fanconi Anemia Pathway;DNA Repair
Q0VGL1	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q0WX57	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q0Z7S8	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
Q10469	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Asparagine N-linked glycosylation;Defective MGAT2 causes MGAT2-CDG (CDG-2a);Diseases of metabolism;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
Q10471	Membrane Trafficking;Metabolism of proteins;O-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;O-linked glycosylation of mucins
Q10472	Membrane Trafficking;Metabolism of proteins;O-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;O-linked glycosylation of mucins
Q10567	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease
Q10570	Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;tRNA processing in the nucleus;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q10586	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
Q10588	Metabolism;Post-translational modification: synthesis of GPI-anchored proteins;Innate Immune System;Immune System;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation
Q10589	Cytokine Signaling in Immune system;Innate Immune System;Immune System;Neutrophil degranulation;Interferon alpha/beta signaling;Interferon Signaling
Q10713	Mitochondrial protein import;Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1;Protein localization
Q10981	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;ABO blood group biosynthesis;Lewis blood group biosynthesis
Q11128	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q11130	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q11201	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q11203	Metabolism;Signaling by NOTCH;Signal Transduction;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Keratan sulfate biosynthesis;Diseases associated with glycosaminoglycan metabolism;Defective ST3GAL3 causes MCT12 and EIEE15;Diseases of glycosylation;Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Diseases of metabolism;Post-translational protein modification;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q11206	Metabolism;Signaling by NOTCH;Signal Transduction;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Keratan sulfate biosynthesis;Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis;O-linked glycosylation of mucins;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation;Termination of O-glycan biosynthesis
Q12756	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q12769	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
Q12770	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Metabolism of lipids;Metabolism of steroids
Q12772	Developmental Biology;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);PPARA activates gene expression;Activation of gene expression by SREBF (SREBP);Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q12774	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q12778	PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Regulation of beta-cell development;AKT phosphorylates targets in the nucleus;Regulation of gene expression in beta cells;AKT-mediated inactivation of FOXO1A;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;FOXO-mediated transcription of cell death genes;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Regulation of FOXO transcriptional activity by acetylation;FOXO-mediated transcription of cell cycle genes
Q12788	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q12789	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
Q12791	Hemostasis;Neuronal System;Ca2+ activated K+ channels;Potassium Channels;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
Q12794	Metabolism;Glycosaminoglycan metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;CS/DS degradation;Hyaluronan metabolism;Hyaluronan uptake and degradation;MPS IX - Natowicz syndrome;Mucopolysaccharidoses;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates
Q12797	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
Q12798	Macroautophagy;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
Q12802	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q12805	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q12809	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Muscle contraction;Phase 3 - rapid repolarisation;Cardiac conduction
Q12824	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q12829	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q12834	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Amplification of signal from the kinetochores;Inactivation of APC/C via direct inhibition of the APC/C complex;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of Emi1;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Metabolism of proteins;Regulation of mitotic cell cycle;RHO GTPases Activate Formins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q12836	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
Q12837	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q12840	Hemostasis;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;RHO GTPases activate KTN1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q12841	Signal Transduction;Signaling by BMP;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation;Signaling by TGF-beta family members
Q12846	Hemostasis;Disinhibition of SNARE formation;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Signaling by Interleukins;Other interleukin signaling;Vesicle-mediated transport;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Class I MHC mediated antigen processing & presentation
Q12849	Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;Viral mRNA Translation;Infectious disease
Q12857	RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation
Q12860	Developmental Biology;Signaling by NOTCH;Signal Transduction;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;NOTCH2 Activation and Transmission of Signal to the Nucleus;L1CAM interactions;Axon guidance;Neurofascin interactions;Nervous system development
Q12864	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
Q12866	Hemostasis;Cell surface interactions at the vascular wall
Q12873	PIP3 activates AKT signaling;Signal Transduction;Epigenetic regulation of gene expression;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HDACs deacetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Metabolism of proteins;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;SUMOylation of chromatin organization proteins;Chromatin organization;Positive epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Post-translational protein modification;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q12874	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q12879	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Generic Transcription Pathway;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;Activation of NMDA receptors and postsynaptic events;Neurexins and neuroligins;Protein-protein interactions at synapses;RNA Polymerase II Transcription;Gene expression (Transcription);Synaptic adhesion-like molecules;Transcriptional Regulation by MECP2;MECP2 regulates neuronal receptors and channels;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation
Q12882	Metabolism;Metabolism of nucleotides;Pyrimidine catabolism;Nucleobase catabolism
Q12887	Metabolism;Metabolism of porphyrins;Heme biosynthesis
Q12888	Cell Cycle;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
Q12889	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
Q12891	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan uptake and degradation;Metabolism of carbohydrates
Q12893	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification
Q12899	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q12901	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q12904	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
Q12905	Innate Immune System;Immune System;Neutrophil degranulation
Q12907	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q12908	Metabolism;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q12912	Innate Immune System;Immune System;Neutrophil degranulation
Q12913	Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Neutrophil degranulation;Signaling by MET;Negative regulation of MET activity;Signaling by Receptor Tyrosine Kinases
Q12918	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q12923	Cytokine Signaling in Immune system;Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Metabolism of lipids;Interleukin-37 signaling
Q12926	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q12931	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
Q12933	Apoptosis;Cytokine Signaling in Immune system;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Regulation by c-FLIP;Metabolism of proteins;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;TNFR1-induced proapoptotic signaling;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNFR2 non-canonical NF-kB pathway;Regulation of necroptotic cell death;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Dimerization of procaspase-8;Death Receptor Signalling;TNF signaling;TRAF6 mediated IRF7 activation;TRAF6 mediated NF-kB activation
Q12955	Developmental Biology;ER to Golgi Anterograde Transport;Membrane Trafficking;L1CAM interactions;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Nervous system development
Q12959	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;L1CAM interactions;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Axon guidance;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;NrCAM interactions;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Nervous system development
Q12962	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Metabolism of proteins;Chromatin organization;Regulation of TP53 Activity;Infectious disease;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q12967	Signal Transduction;Signaling by NTRKs;Signalling to RAS;p38MAPK events;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by Receptor Tyrosine Kinases
Q12968	Downstream signaling events of B Cell Receptor (BCR);Adaptive Immune System;Innate Immune System;Immune System;Calcineurin activates NFAT;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Signaling by the B Cell Receptor (BCR)
Q12974	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q12979	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q12980	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q12981	Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q12982	Developmental Biology;Myogenesis
Q12996	mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q13002	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Ionotropic activity of kainate receptors;Activation of Na-permeable kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding
Q13003	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding;Presynaptic function of Kainate receptors
Q13007	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q13009	Developmental Biology;Signal Transduction;Signaling by NTRKs;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;EPH-Ephrin signaling;Signaling by GPCR;GPCR downstream signalling;EPHB-mediated forward signaling;EPH-ephrin mediated repulsion of cells;G alpha (12/13) signalling events;Axon guidance;Death Receptor Signalling;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through CDK5;Nervous system development
Q13011	Peroxisomal protein import;Protein localization
Q13017	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q13018	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q13042	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13043	Signal Transduction;Signaling by Hippo
Q13046	Hemostasis;Cell surface interactions at the vascular wall
Q13049	Adaptive Immune System;Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13057	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q13061	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
Q13077	Signal Transduction;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Death Receptor Signalling;TNF signaling
Q13084	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q13085	Metabolism;Integration of energy metabolism;ChREBP activates metabolic gene expression;Disease;Regulation of cholesterol biosynthesis by SREBP (SREBF);Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Carnitine metabolism;Activation of gene expression by SREBF (SREBP);Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Metabolism of lipids;Diseases of metabolism;Fatty acyl-CoA biosynthesis;Metabolism of steroids;Fatty acid metabolism
Q13093	Peptide hormone metabolism;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin
Q13094	Hemostasis;GPVI-mediated activation cascade;Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Generation of second messenger molecules;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Platelet activation, signaling and aggregation
Q13098	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q13099	Signal Transduction;Macroautophagy;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
Q13103	Hemostasis;Platelet degranulation ;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
Q13105	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q13106	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q13107	Signal Transduction;Metabolism of proteins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling
Q13114	Cytokine Signaling in Immune system;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Diseases of Immune System;Diseases associated with the TLR signaling cascade;TRAF3 deficiency - HSE;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;TICAM1-dependent activation of IRF3/IRF7;TRAF3-dependent IRF activation pathway;Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling 
Q13115	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;ERKs are inactivated;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q13126	Methionine salvage pathway;Cytokine Signaling in Immune system;Metabolism;Sulfur amino acid metabolism;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Metabolism of amino acids and derivatives;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
Q13127	PIP3 activates AKT signaling;Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q13131	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signal Transduction;Macroautophagy;mTOR signalling;Generic Transcription Pathway;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Autophagy;Activation of AMPK downstream of NMDARs
Q13133-1	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
Q13133-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q13133	Metabolism;Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;PPARA activates gene expression;Transport of small molecules;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;VLDLR internalisation and degradation;Plasma lipoprotein clearance;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ;NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis;NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 
Q13136	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q13144	Metabolism of proteins;Eukaryotic Translation Initiation;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation
Q13145	Signal Transduction;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Signaling by TGF-beta family members
Q13151	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q13153	Developmental Biology;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;TCR signaling;Generation of second messenger molecules;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;FCERI mediated MAPK activation;Signaling by GPCR;Netrin-1 signaling;Semaphorin interactions;L1CAM interactions;DSCAM interactions;Signaling by ROBO receptors;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent Vav1 pathway;EPHB-mediated forward signaling;Ephrin signaling;Muscle contraction;G-protein beta:gamma signalling;Sema3A PAK dependent Axon repulsion;Axon guidance;Activation of RAC1;VEGFA-VEGFR2 Pathway;Signal transduction by L1;Smooth Muscle Contraction;VEGFR2 mediated vascular permeability;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;RHO GTPases activate PKNs;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;MAPK family signaling cascades;MAPK6/MAPK4 signaling;G beta:gamma signalling through CDC42;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q13155	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
Q13156	Cell Cycle;Mitotic G1 phase and G1/S transition;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Cell Cycle, Mitotic;DNA Replication
Q13158	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;TRIF-mediated programmed cell death;Regulation by c-FLIP;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;TNFR1-induced proapoptotic signaling;Programmed Cell Death;Regulation of necroptotic cell death;Dimerization of procaspase-8;Death Receptor Signalling;FasL/ CD95L signaling;TRAIL  signaling;TNF signaling;TLR3-mediated TICAM1-dependent programmed cell death;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;TRIF(TICAM1)-mediated TLR4 signaling 
Q13162	Innate Immune System;Immune System;Neutrophil degranulation
Q13163	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Signalling to ERK5;Signaling by Receptor Tyrosine Kinases
Q13164	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Signalling to ERK5;ERKs are inactivated;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Gastrin-CREB signalling pathway via PKC and MAPK;RET signaling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q13177	Apoptosis;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Regulation of Apoptosis;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;TCR signaling;Generation of second messenger molecules;Regulation of PAK-2p34 activity by PS-GAP/RHG10;Regulation of activated PAK-2p34 by proteasome mediated degradation;Stimulation of the cell death response by PAK-2p34;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;FCERI mediated MAPK activation;Semaphorin interactions;Signaling by ROBO receptors;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent Vav1 pathway;Ephrin signaling;Muscle contraction;Sema3A PAK dependent Axon repulsion;Axon guidance;Activation of RAC1;VEGFA-VEGFR2 Pathway;Smooth Muscle Contraction;Interleukin-12 family signaling;Signaling by Interleukins;VEGFR2 mediated vascular permeability;Programmed Cell Death;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;RHO GTPases activate PAKs;Infectious disease;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Apoptotic execution phase;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Signaling by Receptor Tyrosine Kinases;Interleukin-12 signaling;Nervous system development
Q13183	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Sodium-coupled sulphate, di- and tri-carboxylate transporters
Q13185	Epigenetic regulation of gene expression;Generic Transcription Pathway;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Positive epigenetic regulation of rRNA expression;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
Q13188	Signal Transduction;Signaling by Hippo
Q13190	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Q13191	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13200	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q13201	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q13202	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q13216	Metabolism of proteins;Nucleotide Excision Repair;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Repair;Neddylation
Q13217	Disease;Innate Immune System;Influenza Infection;Immune System;Influenza Viral RNA Transcription and Replication;Viral mRNA Translation;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Infectious disease;Post-translational protein modification;Neutrophil degranulation;Post-translational protein phosphorylation
Q13219	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins
Q13224	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Immune System;Generic Transcription Pathway;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses;RNA Polymerase II Transcription;Gene expression (Transcription);Synaptic adhesion-like molecules;Transcriptional Regulation by MECP2;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;MECP2 regulates neuronal receptors and channels;Activated NTRK2 signals through FYN;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Nervous system development
Q13227	Metabolism;Signal Transduction;Disease;PPARA activates gene expression;Generic Transcription Pathway;HDACs deacetylate histones;Chromatin modifying enzymes;Regulation of lipid metabolism by PPARalpha;Chromatin organization;Metabolism of lipids;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Signaling by Nuclear Receptors;Loss of MECP2 binding ability to the NCoR/SMRT complex;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;HCMV Infection;HCMV Early Events;Disorders of developmental biology
Q13231	Innate Immune System;Immune System;Digestion of dietary carbohydrate;Neutrophil degranulation;Digestion;Digestion and absorption
Q13232	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q13233	Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;Fc epsilon receptor (FCERI) signaling;FCERI mediated MAPK activation;TRAF6 mediated NF-kB activation;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q13237	Hemostasis;Metabolism;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Signal Transduction;Signaling by WNT;Metabolism of vitamins and cofactors;Beta-catenin independent WNT signaling;Nitric oxide stimulates guanylate cyclase;Ca2+ pathway;Platelet homeostasis;cGMP effects;Metabolism of cofactors
Q13241	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;DAP12 signaling
Q13242	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q13243	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q13247	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q13253	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q13255	Neuronal System;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;Neurexins and neuroligins;Protein-protein interactions at synapses
Q13257	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Amplification of signal from the kinetochores;Inactivation of APC/C via direct inhibition of the APC/C complex;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q13258	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q13261	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-15 signaling
Q13263	Disease;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Infectious disease;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);HCMV Infection;HCMV Early Events
Q13277	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling
Q13285	Developmental Biology;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Transcriptional regulation of pluripotent stem cells;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
Q13303	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Innate Immune System;Immune System;Neutrophil degranulation
Q13304	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Leukotriene receptors;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;G alpha (i) signalling events;GPCR ligand binding
Q13309	Adaptive Immune System;Cell Cycle;Immune System;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;SCF(Skp2)-mediated degradation of p27/p21;Generic Transcription Pathway;Metabolism of proteins;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Orc1 removal from chromatin;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13315	Reproduction;Meiosis;Macroautophagy;Cell Cycle;Generic Transcription Pathway;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Autodegradation of the E3 ubiquitin ligase COP1;Transcriptional Regulation by TP53;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Sensing of DNA Double Strand Breaks;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Nonhomologous End-Joining (NHEJ);Homologous DNA Pairing and Strand Exchange;DNA Double Strand Break Response;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;TP53 Regulates Transcription of DNA Repair Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 Regulates Transcription of Caspase Activators and Caspases;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Degradation;Regulation of TP53 Activity through Methylation;Regulation of TP53 Expression and Degradation;G2/M DNA damage checkpoint;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Cellular responses to external stimuli;Meiotic recombination;Autophagy;Selective autophagy;Pexophagy
Q13316	Extracellular matrix organization;ECM proteoglycans;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q13319	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q13322	Developmental Biology;Signaling by SCF-KIT;Signal Transduction;Cellular responses to stress;Axon guidance;IRS activation;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;RET signaling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Response of EIF2AK1 (HRI) to heme deficiency;Nervous system development
Q13324-1	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q13324-2	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q13324	Signal Transduction;Disease;Peptide hormone metabolism;Signaling by GPCR;GPCR downstream signalling;Metabolism of proteins;G alpha (s) signalling events;Synthesis, secretion, and deacylation of Ghrelin;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q13330	PIP3 activates AKT signaling;Signal Transduction;Epigenetic regulation of gene expression;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HDACs deacetylate histones;SUMOylation of transcription factors;Chromatin modifying enzymes;Metabolism of proteins;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Post-translational protein modification;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q13332	Neuronal System;Extracellular matrix organization;Signal Transduction;Signaling by NTRKs;ECM proteoglycans;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;Signaling by Receptor Tyrosine Kinases;Signaling by NTRK3 (TRKC)
Q13336	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport
Q13347	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
Q13349	Extracellular matrix organization;Integrin cell surface interactions
Q13352	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;RHO GTPase Effectors;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Death Receptor Signalling;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q13356	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions
Q13361	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q13362	Hemostasis;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Disease;Immune System;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;Generic Transcription Pathway;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Transcriptional Regulation by TP53;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;Platelet sensitization by LDL;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;FLT3 Signaling;EML4 and NUDC in mitotic spindle formation
Q13363	Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Deactivation of the beta-catenin transactivating complex;SUMOylation of transcription cofactors;Metabolism of proteins;Repression of WNT target genes;Signaling by WNT in cancer;TCF7L2 mutants don't bind CTBP;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification
Q13370	PKB-mediated events;PI3K Cascade;IRS-mediated signalling;Cytokine Signaling in Immune system;Signal Transduction;PDE3B signalling;Immune System;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q13371	Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
Q13393	Metabolism;Synthesis of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism of lipids;Neutrophil degranulation
Q13398	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q13402	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q13404	Cytokine Signaling in Immune system;Adaptive Immune System;Macroautophagy;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;Toll Like Receptor 2 (TLR2) Cascade;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Interleukin-1 signaling;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Autophagy;Aggrephagy;Selective autophagy;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13405	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q13409	Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;HSP90 chaperone cycle for steroid hormone receptors (SHR);Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Autophagy;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy
Q13410	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
Q13415	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Assembly of the ORC complex at the origin of replication;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q13416	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Assembly of the ORC complex at the origin of replication;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q13418	Cell-Cell communication;Localization of the PINCH-ILK-PARVIN complex to focal adhesions;Cell-extracellular matrix interactions;Cell junction organization
Q13421	Post-translational modification: synthesis of GPI-anchored proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q13422-1	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
Q13423	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
Q13426	HIV Life Cycle;Integration of provirus;Early Phase of HIV Life Cycle;HIV Infection;Disease;2-LTR circle formation;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Infectious disease;DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);Post-translational protein modification;DNA Repair
Q13433	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q13435	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q13438	Signal Transduction;Disease;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of signal transduction by growth factor receptors and second messengers;Defective CFTR causes cystic fibrosis;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q13439	Disease;Membrane Trafficking;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Signaling by PDGFR in disease;Signaling by membrane-tethered fusions of PDGFRA or PDGFRB
Q13442	Innate Immune System;Immune System;Neutrophil degranulation
Q13443	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization
Q13444	Degradation of the extracellular matrix;Extracellular matrix organization;Invadopodia formation
Q13449	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q13451	Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Signaling by Nuclear Receptors;MECP2 regulates neuronal receptors and channels
Q13454	Transport of small molecules;Metabolism of proteins;Asparagine N-linked glycosylation;Miscellaneous transport and binding events;Post-translational protein modification
Q13459	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Signaling by ROBO receptors;Axon guidance;Infectious disease;SLIT2:ROBO1 increases RHOA activity;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
Q13464	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;EPHB-mediated forward signaling;EPHA-mediated growth cone collapse;Sema4D in semaphorin signaling;G alpha (12/13) signalling events;Sema4D induced cell migration and growth-cone collapse;Axon guidance;VEGFA-VEGFR2 Pathway;Programmed Cell Death;RHO GTPases Activate ROCKs;Neutrophil degranulation;Apoptotic execution phase;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q13467	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;Ca2+ pathway;PCP/CE pathway;Asymmetric localization of PCP proteins;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;GPCR ligand binding;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;RNF mutants show enhanced WNT signaling and proliferation;Diseases of signal transduction by growth factor receptors and second messengers
Q13469	Downstream signaling events of B Cell Receptor (BCR);Adaptive Immune System;Innate Immune System;Immune System;Calcineurin activates NFAT;Generic Transcription Pathway;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1;Signaling by the B Cell Receptor (BCR)
Q13472	Reproduction;Meiosis;Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Meiotic recombination
Q13474	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q13477-1	Adaptive Immune System;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions
Q13478	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling;Interleukin-18 signaling
Q13480	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Signaling by NTRKs;Immune System;Signaling by EGFR;GAB1 signalosome;Signaling by FGFR;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Axon guidance;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Downstream signaling of activated FGFR1;PI-3K cascade:FGFR1;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;Downstream signaling of activated FGFR4;PI-3K cascade:FGFR4;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by MET;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;MET activates PI3K/AKT signaling;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;RET signaling;MET activates PTPN11;MET activates RAP1 and RAC1;MET receptor recycling;MET promotes cell motility;Signaling by NTRK2 (TRKB);Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Activated NTRK2 signals through PI3K;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 ECD mutants;Nervous system development
Q13485	Signaling by NODAL;Developmental Biology;Signaling by Activin;Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Signaling by BMP;Generic Transcription Pathway;TGF-beta receptor signaling activates SMADs;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Loss of Function of SMAD4 in Cancer;Loss of Function of SMAD2/3 in Cancer;Signaling by TGF-beta Receptor Complex in Cancer;SMAD4 MH2 Domain Mutants in Cancer;SMAD2/3 MH2 Domain Mutants in Cancer;Metabolism of proteins;Transcriptional regulation of pluripotent stem cells;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;RUNX2 regulates bone development;RUNX3 regulates CDKN1A transcription;RUNX3 regulates BCL2L11 (BIM) transcription;Signaling by TGF-beta family members;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;FOXO-mediated transcription of cell cycle genes
Q13487	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q13488	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Neutrophil degranulation;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q13489	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;Metabolism of proteins;RIPK1-mediated regulated necrosis;Regulated Necrosis;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNFR2 non-canonical NF-kB pathway;Regulation of necroptotic cell death;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling 
Q13490	Apoptosis;Apoptotic cleavage of cellular proteins;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;Metabolism of proteins;RIPK1-mediated regulated necrosis;Regulated Necrosis;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNFR2 non-canonical NF-kB pathway;Regulation of necroptotic cell death;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;Apoptotic execution phase;TNF signaling;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling 
Q13492	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q13495	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Signaling by NOTCH2;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q13496	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Metabolism of lipids
Q13501	Cytokine Signaling in Immune system;Signal Transduction;Macroautophagy;Immune System;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Interleukin-1 family signaling;Signaling by Interleukins;Mitophagy;Pink/Parkin Mediated Mitophagy;Death Receptor Signalling;Interleukin-1 signaling;Autophagy;Selective autophagy;Pexophagy
Q13503	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q13505	Mitochondrial protein import;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation;Protein localization
Q13506	Developmental Biology;Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q13507	Hemostasis;Effects of PIP2 hydrolysis;Developmental Biology;Elevation of cytosolic Ca2+ levels;Signal Transduction;Generic Transcription Pathway;Stimuli-sensing channels;TRP channels;Signaling by GPCR;Netrin-1 signaling;Transport of small molecules;GPCR downstream signalling;G alpha (q) signalling events;Platelet homeostasis;Platelet calcium homeostasis;Role of second messengers in netrin-1 signaling;Axon guidance;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Transcriptional Regulation by MECP2;MECP2 regulates neuronal receptors and channels;Nervous system development;Ion channel transport
Q13508	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q13509	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q13510	Metabolism;Glycosphingolipid metabolism;Innate Immune System;Immune System;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation
Q13519	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q13520	Transport of small molecules;Passive transport by Aquaporins;Aquaporin-mediated transport
Q13526	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Signaling by Rho GTPases;RHO GTPase Effectors;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;RHO GTPases Activate NADPH Oxidases;Regulation of TP53 Activity through Phosphorylation;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon Signaling;Negative regulators of DDX58/IFIH1 signaling
Q13530	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
Q13535	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Fanconi Anemia Pathway;TP53 Regulates Transcription of DNA Repair Genes;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Cellular responses to external stimuli
Q13541	Signal Transduction;mTOR signalling;mTORC1-mediated signalling;Metabolism of proteins;Eukaryotic Translation Initiation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Cap-dependent Translation Initiation;Translation
Q13546	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Cytosolic sensors of pathogen-associated DNA ;TRIF-mediated programmed cell death;Stimuli-sensing channels;TRP channels;Regulation by c-FLIP;Transport of small molecules;Metabolism of proteins;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;TNFR1-induced proapoptotic signaling;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Regulation of necroptotic cell death;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification;Dimerization of procaspase-8;Death Receptor Signalling;TNF signaling;TLR3-mediated TICAM1-dependent programmed cell death;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Ion channel transport
Q13547	Hemostasis;PIP3 activates AKT signaling;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Signaling by NOTCH;Signal Transduction;Cell Cycle;Disease;Signaling by TGF-beta Receptor Complex;p75NTR negatively regulates cell cycle via SC1;p75 NTR receptor-mediated signalling;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Epigenetic regulation of gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Transcriptional Regulation by TP53;Deactivation of the beta-catenin transactivating complex;Metabolism of proteins;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Mitotic G1 phase and G1/S transition;SUMOylation of chromatin organization proteins;Repression of WNT target genes;Chromatin organization;Positive epigenetic regulation of rRNA expression;Negative epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Regulation of TP53 Activity through Acetylation;PTEN Regulation;G1/S-Specific Transcription;G1/S Transition;Cell Cycle, Mitotic;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Death Receptor Signalling;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN gene transcription;Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by TGF-beta family members;Estrogen-dependent gene expression;Loss of MECP2 binding ability to 5mC-DNA;Regulation of MECP2 expression and activity;MECP2 regulates neuronal receptors and channels;MECP2 regulates transcription of neuronal ligands;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Disorders of developmental biology;Factors involved in megakaryocyte development and platelet production
Q13554	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;DAG and IP3 signaling;Signal Transduction;Disease;Immune System;Generic Transcription Pathway;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;G alpha (i) signalling events;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;Cardiac conduction;Phase 0 - rapid depolarisation;Ion homeostasis;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon gamma signaling;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Regulation of MECP2 expression and activity;Interferon Signaling;Ion transport by P-type ATPases;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Signaling downstream of RAS mutants;Ion channel transport
Q13555	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;DAG and IP3 signaling;Signal Transduction;Disease;Immune System;Generic Transcription Pathway;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;G alpha (i) signalling events;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;Cardiac conduction;Phase 0 - rapid depolarisation;Ion homeostasis;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon gamma signaling;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Regulation of MECP2 expression and activity;Interferon Signaling;Ion transport by P-type ATPases;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Signaling downstream of RAS mutants;Ion channel transport
Q13557	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;DAG and IP3 signaling;Signal Transduction;Disease;Immune System;Generic Transcription Pathway;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;G alpha (i) signalling events;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;Cardiac conduction;Phase 0 - rapid depolarisation;Ion homeostasis;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon gamma signaling;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Regulation of MECP2 expression and activity;Interferon Signaling;Ion transport by P-type ATPases;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Signaling downstream of RAS mutants;Ion channel transport
Q13561	Adaptive Immune System;Cell Cycle;Immune System;Organelle biogenesis and maintenance;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Regulation of PLK1 Activity at G2/M Transition;HSP90 chaperone cycle for steroid hormone receptors (SHR);Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
Q13562	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
Q13563	Organelle biogenesis and maintenance;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
Q13564	Metabolism of proteins;Post-translational protein modification;Neddylation
Q13568	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
Q13569	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Displacement of DNA glycosylase by APEX1;Epigenetic regulation of gene expression;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;TET1,2,3 and TDG demethylate DNA;Post-translational protein modification;Base Excision Repair;DNA Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Gene expression (Transcription)
Q13572	Hemostasis;Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol;Synthesis of IP3 and IP4 in the cytosol;Factors involved in megakaryocyte development and platelet production
Q13573	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Metabolism of RNA;Signaling by TGF-beta family members;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q13574	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
Q13576	Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate IQGAPs;Neutrophil degranulation
Q13586	Hemostasis;Adaptive Immune System;Elevation of cytosolic Ca2+ levels;Immune System;Muscle contraction;Platelet homeostasis;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q13588	Signaling by SCF-KIT;Signal Transduction;Signaling by Receptor Tyrosine Kinases
Q13591	Developmental Biology;Disease;Semaphorin interactions;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Other semaphorin interactions;Axon guidance;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification;Nervous system development
Q13601	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q13606	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q13607	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q13608	Peroxisomal protein import;Protein localization
Q13613	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q13614	Metabolism;Synthesis of PIPs at the ER membrane;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Metabolism of lipids
Q13615	Metabolism;PI Metabolism;Phospholipid metabolism;Macroautophagy;Synthesis of PIPs at the plasma membrane;Metabolism of lipids;Autophagy
Q13616	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Prolactin receptor signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signaling by NOTCH;Signal Transduction;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;Toll Like Receptor 2 (TLR2) Cascade;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signaling by NOTCH1;TCR signaling;Downstream TCR signaling;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Fc epsilon receptor (FCERI) signaling;Regulation of PLK1 Activity at G2/M Transition;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;FBXW7 Mutants and NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling;FCERI mediated NF-kB activation;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Transport of small molecules;Metabolism of proteins;Circadian Clock;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Signaling by Hedgehog;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;C-type lectin receptors (CLRs);Diseases of signal transduction by growth factor receptors and second messengers;TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Post-translational protein modification;Orc1 removal from chromatin;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Neddylation;Signaling by NOTCH4;Interleukin-1 signaling;Iron uptake and transport;TRIF(TICAM1)-mediated TLR4 signaling ;Negative regulation of NOTCH4 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q13617	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Developmental Biology;Adaptive Immune System;Immune System;Cellular responses to stress;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Post-translational protein modification;Neddylation;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13618	Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Immune System;Signaling by WNT;TCF dependent signaling in response to WNT;Metabolism of proteins;Degradation of DVL;Signaling by Hedgehog;Hedgehog 'on' state;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;Neddylation;FLT3 Signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13619	Recognition of DNA damage by PCNA-containing replication complex;Metabolism of proteins;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Damage Bypass;DNA Repair;Neddylation
Q13620	Recognition of DNA damage by PCNA-containing replication complex;Metabolism of proteins;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Damage Bypass;DNA Repair;Neddylation
Q13621	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Cation-coupled Chloride cotransporters;SLC transporter disorders;Defective SLC12A1 causes Bartter syndrome 1 (BS1);Disorders of transmembrane transporters
Q13625	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;TP53 Regulates Transcription of Death Receptors and Ligands;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q13627	G0 and Early G1;Cell Cycle;Mitotic G1 phase and G1/S transition;Cell Cycle, Mitotic
Q13630	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;GDP-fucose biosynthesis
Q13634	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
Q13635	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding;Signaling by Hedgehog;Hedgehog 'off' state;Ligand-receptor interactions;Hedgehog 'on' state;Activation of SMO
Q13636	Innate Immune System;Immune System;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q13637	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q13639	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Serotonin receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q13651	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-10 signaling
Q13671	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q13683	Extracellular matrix organization;Integrin cell surface interactions;Laminin interactions;ECM proteoglycans
Q13685	Hemostasis;Signal Transduction;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Signaling by EGFR;Signaling by VEGF;Signal amplification;Thromboxane signalling through TP receptor;Platelet activation, signaling and aggregation;Signaling by Receptor Tyrosine Kinases
Q13698	Developmental Biology;NCAM signaling for neurite out-growth;Muscle contraction;NCAM1 interactions;Axon guidance;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Nervous system development
Q13705	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL;Signaling by Activin;Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q13724	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Asparagine N-linked glycosylation;Defective MOGS causes MOGS-CDG (CDG-2b);N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Diseases of metabolism;Post-translational protein modification
Q13733	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
Q13740	Developmental Biology;L1CAM interactions;Axon guidance;Nervous system development
Q13751	Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Cell-Cell communication;Signal Transduction;Assembly of collagen fibrils and other multimeric structures;Anchoring fibril formation;Laminin interactions;Non-integrin membrane-ECM interactions;Type I hemidesmosome assembly;Cell junction organization;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
Q13753	Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Cell-Cell communication;Signal Transduction;Assembly of collagen fibrils and other multimeric structures;Anchoring fibril formation;Laminin interactions;Non-integrin membrane-ECM interactions;Type I hemidesmosome assembly;Cell junction organization;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
Q13761	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Binding of TCF/LEF:CTNNB1 to target gene promoters;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates CDKN1A transcription;RUNX3 regulates NOTCH signaling;Regulation of RUNX3 expression and activity;RUNX3 Regulates Immune Response and Cell Migration;RUNX3 regulates WNT signaling;RUNX3 regulates YAP1-mediated transcription;RUNX3 regulates RUNX1-mediated transcription;RUNX3 regulates p14-ARF;RUNX3 regulates BCL2L11 (BIM) transcription
Q13769	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q13790	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein remodeling;LDL remodeling
Q13794	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of NOXA and translocation to mitochondria;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation of BH3-only proteins;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
Q13795	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q13797	Developmental Biology;Extracellular matrix organization;Integrin cell surface interactions;ECM proteoglycans;L1CAM interactions;Axon guidance;Signal transduction by L1;Nervous system development
Q13813	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Cytokine Signaling in Immune system;Cell-Cell communication;Signal Transduction;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;Caspase-mediated cleavage of cytoskeletal proteins;Nephrin family interactions;L1CAM interactions;NCAM signaling for neurite out-growth;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Programmed Cell Death;Vesicle-mediated transport;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;Apoptotic execution phase;Transport to the Golgi and subsequent modification;FLT3 Signaling;Nervous system development
Q13822	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q13825	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q13835	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Innate Immune System;Immune System;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;Neutrophil degranulation;Keratinization;Formation of the cornified envelope;Apoptotic execution phase
Q13838	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q13867	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q13868	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q13873	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q13875	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2
Q13882	Signaling by ERBB2;Signal Transduction;Cell Cycle;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;PTK6 Regulates Proteins Involved in RNA Processing;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;PTK6 Regulates Cell Cycle;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;PTK6 Down-Regulation;PTK6 Expression;PTK6 Activates STAT3;PTK6 promotes HIF1A stabilization;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases
Q13885	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q13887	Developmental Biology;Transcriptional regulation of white adipocyte differentiation;Transcriptional regulation of granulopoiesis
Q13888	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
Q13889	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
Q13895	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q13901	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q13905	Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Immune System;Prolonged ERK activation events;Frs2-mediated activation;Downstream signal transduction;Signaling by PDGF;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by MET;MET activates RAP1 and RAC1;MET promotes cell motility;Signaling by Erythropoietin;Signaling by Receptor Tyrosine Kinases;Erythropoietin activates RAS;Regulation of signaling by CBL
Q13907	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
Q13936	Developmental Biology;Metabolism;Integration of energy metabolism;NCAM signaling for neurite out-growth;Muscle contraction;Adrenaline,noradrenaline inhibits insulin secretion;NCAM1 interactions;Regulation of insulin secretion;Axon guidance;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Nervous system development
Q13946	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events
Q13948	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
Q13950-1	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;Regulation of RUNX2 expression and activity;RUNX2 regulates osteoblast differentiation;RUNX2 regulates chondrocyte maturation;RUNX2 regulates bone development;RUNX2 regulates genes involved in cell migration;RUNX2 regulates genes involved in differentiation of myeloid cells
Q13950-2	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;Regulation of RUNX2 expression and activity;RUNX2 regulates osteoblast differentiation;RUNX2 regulates chondrocyte maturation;RUNX2 regulates bone development;RUNX2 regulates genes involved in cell migration;RUNX2 regulates genes involved in differentiation of myeloid cells
Q13951	Developmental Biology;Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates estrogen receptor mediated transcription;Regulation of RUNX1 Expression and Activity;RUNX1 regulates expression of components of tight junctions;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;RUNX1 regulates transcription of genes involved in BCR signaling;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;RUNX1 regulates transcription of genes involved in interleukin signaling;RUNX1 regulates transcription of genes involved in WNT signaling;Regulation of RUNX2 expression and activity;RUNX2 regulates osteoblast differentiation;RUNX2 regulates chondrocyte maturation;RUNX2 regulates bone development;RUNX2 regulates genes involved in cell migration;RUNX2 regulates genes involved in differentiation of myeloid cells;Regulation of RUNX3 expression and activity;RUNX3 Regulates Immune Response and Cell Migration;RUNX3 regulates RUNX1-mediated transcription;RUNX3 regulates p14-ARF;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Transcriptional regulation of granulopoiesis
Q13952	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);PPARA activates gene expression;Generic Transcription Pathway;Activation of gene expression by SREBF (SREBP);ATF4 activates genes in response to endoplasmic reticulum  stress;ATF6 (ATF6-alpha) activates chaperones;PERK regulates gene expression;Unfolded Protein Response (UPR);ATF6 (ATF6-alpha) activates chaperone genes;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes
Q13972	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q13976-1	Hemostasis;Adaptive Immune System;Immune System;Nitric oxide stimulates guanylate cyclase;Rap1 signalling;Platelet homeostasis;cGMP effects
Q13976	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;Ca2+ pathway
Q14002	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q14003	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q14004	Innate Immune System;Immune System;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of DNA Repair Genes;Neutrophil degranulation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14005	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling
Q14008	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;AURKA Activation by TPX2;EML4 and NUDC in mitotic spindle formation
Q14012	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Negative regulation of NMDA receptor-mediated neuronal transmission;Activation of RAC1 downstream of NMDARs
Q14019	Innate Immune System;Immune System;Neutrophil degranulation
Q14028	Signal Transduction;Organelle biogenesis and maintenance;Visual phototransduction;Activation of the phototransduction cascade;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
Q14031	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;Anchoring fibril formation;Crosslinking of collagen fibrils;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Collagen chain trimerization
Q14032	Metabolism;Recycling of bile acids and salts;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids;Peroxisomal protein import;Protein localization
Q14050	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q14055	Developmental Biology;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Signaling by PDGF;Assembly of collagen fibrils and other multimeric structures;Integrin cell surface interactions;ECM proteoglycans;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q14061	Mitochondrial protein import;Protein localization
Q14088	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;TBC/RABGAPs;RAB geranylgeranylation;Rab regulation of trafficking
Q14103-3	AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of RNA
Q14103-4	AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of RNA
Q14103	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q14108	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q14112	Extracellular matrix organization;Laminin interactions
Q14114	Hemostasis;Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;Platelet homeostasis;G alpha (i) signalling events;Platelet sensitization by LDL;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q14116-2	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-18 signaling
Q14116	Cytokine Signaling in Immune system;Disease;Immune System;Interleukin-1 family signaling;Interleukin-1 processing;Signaling by Interleukins;Infectious disease;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Interleukin-18 signaling;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
Q14117	Metabolism;Metabolism of nucleotides;Pyrimidine catabolism;Nucleobase catabolism
Q14118	Developmental Biology;Extracellular matrix organization;Disease;Non-integrin membrane-ECM interactions;ECM proteoglycans;Signaling by ROBO receptors;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Axon guidance;Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3;Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2;Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1;O-linked glycosylation;Diseases of metabolism;Post-translational protein modification;Regulation of expression of SLITs and ROBOs;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q14123	Opioid Signalling;Calmodulin induced events;Cam-PDE 1 activation;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;DAG and IP3 signaling;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Intracellular signaling by second messengers
Q14126	Apoptosis;Apoptotic cleavage of cellular proteins;Developmental Biology;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;Keratinization;Formation of the cornified envelope;Apoptotic execution phase
Q14134	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q14137	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q14139	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q14142	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q14145	Adaptive Immune System;Immune System;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q14152	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
Q14155-1	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Activation of RAC1 downstream of NMDARs
Q14155	Developmental Biology;Signal Transduction;Signaling by EGFR;EGFR downregulation;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;EPH-Ephrin signaling;Signaling by GPCR;GPCR downstream signalling;Ephrin signaling;G alpha (12/13) signalling events;Axon guidance;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q14159	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair
Q14160	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins
Q14162	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class F Receptors;Vesicle-mediated transport
Q14164	Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of immune response proteins;Post-translational protein modification;TICAM1-dependent activation of IRF3/IRF7;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling 
Q14165	Innate Immune System;Immune System;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;Neutrophil degranulation
Q14166	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q14181	Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;Extension of Telomeres;Mitotic G1 phase and G1/S transition;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance
Q14185	Hemostasis;Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Netrin-1 signaling;DCC mediated attractive signaling;Axon guidance;VEGFA-VEGFR2 Pathway;Infectious disease;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development;Factors involved in megakaryocyte development and platelet production
Q14186	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of NOXA and translocation to mitochondria;Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Activation of BH3-only proteins;Developmental Biology;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;Activation of PUMA and translocation to mitochondria;G0 and Early G1;Signaling by NOTCH;Signal Transduction;Cell Cycle;Signaling by TGF-beta Receptor Complex;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;Programmed Cell Death;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Signaling by TGF-beta family members;Transcriptional regulation of granulopoiesis
Q14188	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of NOXA and translocation to mitochondria;Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Activation of BH3-only proteins;Developmental Biology;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;Activation of PUMA and translocation to mitochondria;G0 and Early G1;Signaling by NOTCH;Signal Transduction;Cell Cycle;Signaling by TGF-beta Receptor Complex;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;Programmed Cell Death;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Signaling by TGF-beta family members;Transcriptional regulation of granulopoiesis
Q14191	Telomere Maintenance;Cell Cycle;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;Generic Transcription Pathway;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Post-translational protein modification;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Chromosome Maintenance;DNA Repair;Gene expression (Transcription)
Q14192	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q14194	Developmental Biology;Semaphorin interactions;CRMPs in Sema3A signaling;Axon guidance;Nervous system development
Q14195	Developmental Biology;Semaphorin interactions;CRMPs in Sema3A signaling;Axon guidance;Nervous system development
Q14197	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q14203-2	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q14203	Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
Q14204	Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Innate Immune System;Immune System;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;HSP90 chaperone cycle for steroid hormone receptors (SHR);Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Autophagy;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy
Q14209	Cell Cycle;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Mitotic G1 phase and G1/S transition;CDC6 association with the ORC:origin complex;Assembly of the pre-replicative complex;DNA Replication Pre-Initiation;Cyclin D associated events in G1;G1 Phase;Cell Cycle, Mitotic;DNA Replication;Cellular responses to external stimuli
Q14210	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q14213	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-35 Signalling;Interleukin-27 signaling
Q14232	Metabolism of proteins;Eukaryotic Translation Initiation;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation
Q14240	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;L13a-mediated translational silencing of Ceruloplasmin expression;Immune System;Metabolism of proteins;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;Metabolism of RNA;Interferon Signaling
Q14241	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q14242	Hemostasis;Cell surface interactions at the vascular wall
Q14246	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q14247	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;RHO GTPases activate PAKs;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q14254	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
Q14258	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Termination of translesion DNA synthesis;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;DNA Damage Bypass;DNA Repair;Interferon gamma signaling;Interferon Signaling;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;Negative regulators of DDX58/IFIH1 signaling
Q14289	Cytokine Signaling in Immune system;Cell-Cell communication;Signal Transduction;Immune System;Signaling by VEGF;Signal regulatory protein family interactions;VEGFA-VEGFR2 Pathway;Signaling by Interleukins;Interleukin-2 family signaling;Signaling by Receptor Tyrosine Kinases;Interleukin-2 signaling
Q14314	Innate Immune System;Immune System;Neutrophil degranulation
Q14315	Cell-Cell communication;Cell-extracellular matrix interactions;Cell junction organization
Q14318	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q14324	Striated Muscle Contraction;Muscle contraction
Q14330	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q14332	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;Ca2+ pathway;PCP/CE pathway;Asymmetric localization of PCP proteins;Disassembly of the destruction complex and recruitment of AXIN to the membrane;GPCR ligand binding;WNT5A-dependent internalization of FZD2, FZD5 and ROR2
Q14344	Hemostasis;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;Signal amplification;G alpha (12/13) signalling events;Thromboxane signalling through TP receptor;Thrombin signalling through proteinase activated receptors (PARs);Death Receptor Signalling;Platelet activation, signaling and aggregation
Q14353	Metabolism;Generic Transcription Pathway;Creatine metabolism;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2
Q14376	Metabolism;Disease;Diseases of glycosylation;Diseases associated with glycosylation precursor biosynthesis;Defective GALE can cause Epimerase-deficiency galactosemia (EDG);Diseases of metabolism;Galactose catabolism;Metabolism of carbohydrates
Q14393	Hemostasis;Platelet degranulation ;Gamma-carboxylation of protein precursors;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus;Removal of aminoterminal propeptides from gamma-carboxylated proteins;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins;Gamma carboxylation, hypusine formation and arylsulfatase activation;Cell surface interactions at the vascular wall;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
Q14397	Metabolism;Disease;Regulation of Glucokinase by Glucokinase Regulatory Protein;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
Q14409	Metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q14410	Metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q14416	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q14432	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events
Q14435	Signal Transduction;Disease;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR3c ligand binding and activation;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);O-linked glycosylation;Signaling by FGFR3;Diseases of metabolism;Post-translational protein modification;Signaling by Receptor Tyrosine Kinases;O-linked glycosylation of mucins
Q14439	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q14442	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q14449	Hemostasis;Cell surface interactions at the vascular wall;Tie2 Signaling
Q14451	Hemostasis;Signaling by ERBB2;Developmental Biology;GRB7 events in ERBB2 signaling;Signaling by SCF-KIT;Signal Transduction;Downstream signal transduction;Signaling by PDGF;Cell surface interactions at the vascular wall;Tie2 Signaling;Axon guidance;RET signaling;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q14457	Macroautophagy;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Autophagy
Q14469	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Signaling by NOTCH1;Signaling by NOTCH2;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q14493	Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
Q14500	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;Classical Kir channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q14512	Signal Transduction;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2b ligand binding and activation;Signaling by FGFR2;Signaling by Receptor Tyrosine Kinases
Q14515	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q14524	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q14525	Developmental Biology;Keratinization;Formation of the cornified envelope
Q14526	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;Post-translational protein modification
Q14527	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q14532	Developmental Biology;Keratinization;Formation of the cornified envelope
Q14533	Developmental Biology;Keratinization;Formation of the cornified envelope
Q14534	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
Q14541	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells;Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14542	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
Q14554	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q14563	Developmental Biology;Semaphorin interactions;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Axon guidance;Nervous system development
Q14565	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
Q14566	Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q14571	Hemostasis;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Effects of PIP2 hydrolysis;Adaptive Immune System;Elevation of cytosolic Ca2+ levels;Metabolism;DAG and IP3 signaling;Signal Transduction;Integration of energy metabolism;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by WNT;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Beta-catenin independent WNT signaling;GPCR downstream signalling;Muscle contraction;Ca2+ pathway;G alpha (q) signalling events;Platelet homeostasis;Platelet calcium homeostasis;G alpha (i) signalling events;Regulation of insulin secretion;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Cardiac conduction;Ion homeostasis;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Infectious disease;Platelet activation, signaling and aggregation;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q14573	Hemostasis;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Effects of PIP2 hydrolysis;Adaptive Immune System;Elevation of cytosolic Ca2+ levels;Metabolism;DAG and IP3 signaling;Signal Transduction;Integration of energy metabolism;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by WNT;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Beta-catenin independent WNT signaling;GPCR downstream signalling;Muscle contraction;Ca2+ pathway;G alpha (q) signalling events;Platelet homeostasis;Platelet calcium homeostasis;G alpha (i) signalling events;Regulation of insulin secretion;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Cardiac conduction;Ion homeostasis;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Infectious disease;Platelet activation, signaling and aggregation;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q14574	Developmental Biology;Keratinization;Formation of the cornified envelope
Q14582	Signaling by ERBB4;Nuclear signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases
Q14584	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14586	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14587	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14588	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14590	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14592	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14593	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14596	Macroautophagy;Autophagy;Selective autophagy;Pexophagy
Q14623	Signal Transduction;Disease;Generic Transcription Pathway;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding;Hedgehog ligand biogenesis;Signaling by Hedgehog;Release of Hh-Np from the secreting cell;Hh mutants abrogate ligand secretion;Ligand-receptor interactions;Hedgehog 'on' state;Activation of SMO;HHAT G278V abrogates palmitoylation of Hh-Np;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates chondrocyte maturation;RUNX2 regulates bone development
Q14624	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q14626	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
Q14627	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q14642	Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
Q14643	Hemostasis;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Effects of PIP2 hydrolysis;Adaptive Immune System;Elevation of cytosolic Ca2+ levels;Metabolism;DAG and IP3 signaling;Signal Transduction;Integration of energy metabolism;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by WNT;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Fc epsilon receptor (FCERI) signaling;FCERI mediated Ca+2 mobilization;Signaling by GPCR;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Beta-catenin independent WNT signaling;GPCR downstream signalling;Nitric oxide stimulates guanylate cyclase;Muscle contraction;Ca2+ pathway;G alpha (q) signalling events;Platelet homeostasis;Platelet calcium homeostasis;cGMP effects;G alpha (i) signalling events;Regulation of insulin secretion;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Cardiac conduction;Ion homeostasis;CLEC7A (Dectin-1) induces NFAT activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Infectious disease;Platelet activation, signaling and aggregation;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q14644	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q14653	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;ZBP1(DAI) mediated induction of type I IFNs;IRF3 mediated activation of type 1 IFN;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production;Regulation of innate immune responses to cytosolic DNA;IRF3-mediated induction of type I IFN;Interferon gamma signaling;TICAM1-dependent activation of IRF3/IRF7;Interferon alpha/beta signaling;Interferon Signaling;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling 
Q14654	Neuronal System;ATP sensitive Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Integration of energy metabolism;Disease;Transport of small molecules;ABC-family proteins mediated transport;Muscle contraction;Regulation of insulin secretion;Cardiac conduction;Ion homeostasis;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia;Defective ABCC8 can cause hypoglycemias and hyperglycemias
Q14657	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q14669	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q14671	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q14674	Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
Q14676	Cell Cycle;Generic Transcription Pathway;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;TP53 Regulates Transcription of DNA Repair Genes;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q14677	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q14678	Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Signaling by PDGFR in disease;Signaling by membrane-tethered fusions of PDGFRA or PDGFRB
Q14679	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q14683	Meiotic synapsis;Reproduction;Meiosis;Signal Transduction;Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q14686	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;PPARA activates gene expression;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Metabolism of steroids
Q14690	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q14691	Cell Cycle;Unwinding of DNA;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication
Q14692	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q14693	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Cell Cycle;Nuclear Envelope Breakdown;Depolymerisation of the Nuclear Lamina;Metabolism of lipids;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Triglyceride biosynthesis;Triglyceride metabolism
Q14694	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Metabolism of proteins;Termination of translesion DNA synthesis;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;DNA Damage Bypass;DNA Repair
Q14697	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;Calnexin/calreticulin cycle
Q14703	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Plasma lipoprotein assembly, remodeling, and clearance;ATF6 (ATF6-alpha) activates chaperones;Unfolded Protein Response (UPR);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Metabolism of lipids;Post-translational protein modification;CREB3 factors activate genes;Post-translational protein phosphorylation;Metabolism of steroids;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q14721	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Metabolism;Integration of energy metabolism;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Regulation of insulin secretion
Q14722	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q14738	Hemostasis;Opioid Signalling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Signal Transduction;Integration of energy metabolism;PP2A-mediated dephosphorylation of key metabolic factors;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DARPP-32 events;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;ERKs are inactivated;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;G alpha (i) signalling events;Platelet sensitization by LDL;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism;EML4 and NUDC in mitotic spindle formation;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q14739	Metabolism;Cell Cycle;Cholesterol biosynthesis;Generic Transcription Pathway;Mitotic Metaphase and Anaphase;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Metabolism of lipids;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;Transcriptional Regulation by MECP2;Regulation of MECP2 expression and activity
Q14746	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q14749	Metabolism;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives
Q14764	Innate Immune System;Immune System;Neutrophil degranulation
Q14765	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-20 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-35 Signalling;Interleukin-12 signaling;Interleukin-23 signaling;Interleukin-21 signaling
Q14766	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q14767	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q14773	Adaptive Immune System;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions
Q14781	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q14789	ER to Golgi Anterograde Transport;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Metabolism of proteins;Golgi Associated Vesicle Biogenesis;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification
Q14790	Apoptosis;Intrinsic Pathway for Apoptosis;Apoptotic cleavage of cellular proteins;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;TRIF-mediated programmed cell death;Caspase-mediated cleavage of cytoskeletal proteins;Regulation by c-FLIP;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;TNFR1-induced proapoptotic signaling;Programmed Cell Death;Regulation of TNFR1 signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CLEC7A/inflammasome pathway;Regulation of necroptotic cell death;Dimerization of procaspase-8;Death Receptor Signalling;Activation, myristolyation of BID and translocation to mitochondria;Apoptotic execution phase;FasL/ CD95L signaling;TRAIL  signaling;TNF signaling;TLR3-mediated TICAM1-dependent programmed cell death;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;TRIF(TICAM1)-mediated TLR4 signaling 
Q147X3	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q14802	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
Q14807	Hemostasis;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q14814	Developmental Biology;Mitochondrial biogenesis;Signal Transduction;Signaling by NTRKs;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Transcriptional activation of mitochondrial biogenesis;Circadian Clock;Myogenesis;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q14831	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q14832	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q14833	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q14839	PIP3 activates AKT signaling;Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Epigenetic regulation of gene expression;Generic Transcription Pathway;HDACs deacetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q14849	Metabolism;Metabolism of steroid hormones;Pregnenolone biosynthesis;Metabolism of lipids;Metabolism of steroids
Q14865	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q14872	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);PPARA activates gene expression;Activation of gene expression by SREBF (SREBP);Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;MTF1 activates gene expression;Response to metal ions;Cellular responses to external stimuli;Metabolism of steroids
Q14894	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives
Q14896	Striated Muscle Contraction;Muscle contraction
Q14914	Metabolism;Synthesis of Leukotrienes (LT) and Eoxins (EX);Synthesis of Lipoxins (LX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism;Biosynthesis of specialized proresolving mediators (SPMs)
Q14916	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters
Q14919	Signaling by NODAL;Developmental Biology;Signaling by Activin;Signal Transduction;Signaling by TGF-beta family members
Q14929	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14938	RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation
Q14940	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers
Q14943	Innate Immune System;Immune System;DAP12 interactions
Q14953	Innate Immune System;Immune System;DAP12 interactions
Q14954	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions
Q14956	Signal Transduction;Signaling by PTK6;PTK6 promotes HIF1A stabilization;Signaling by Non-Receptor Tyrosine Kinases
Q14957	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;Activation of NMDA receptors and postsynaptic events;Neurexins and neuroligins;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation
Q14964	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q14966	Developmental Biology;Transcriptional regulation of white adipocyte differentiation
Q14973	Metabolism;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q14974	Apoptosis;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Apoptosis induced DNA fragmentation;Metabolism;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Regulation of cholesterol biosynthesis by SREBP (SREBF);Innate Immune System;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;NS1 Mediated Effects on Host Pathways;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Mitotic Metaphase and Anaphase;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Programmed Cell Death;Metabolism of lipids;Infectious disease;Neutrophil degranulation;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Apoptotic execution phase;Metabolism of steroids;Interferon Signaling;Postmitotic nuclear pore complex (NPC) reformation;Infection with Mycobacterium tuberculosis;Inhibition of nitric oxide production;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
Q14980	Cell Cycle;Recruitment of NuMA to mitotic centrosomes;Mitotic Prophase;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic
Q14982	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q14993	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Collagen chain trimerization
Q14994-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14994-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14995	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q14997	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q14999	Adaptive Immune System;Immune System;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q149N8	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q14C86	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q14CB8	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q14CN2	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q14CN4	Developmental Biology;Keratinization;Formation of the cornified envelope
Q14CW9	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q14D33	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q15003	Cell Cycle;Condensation of Prometaphase Chromosomes;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic
Q15004	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;DNA Repair
Q15005	SRP-dependent cotranslational protein targeting to membrane;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin;Translation
Q15007	Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15008	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q15011	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins
Q15014	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q15018	Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;Post-translational protein modification
Q15019	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q15021	Cell Cycle;Condensation of Prometaphase Chromosomes;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic
Q15022	PIP3 activates AKT signaling;Developmental Biology;Signal Transduction;Disease;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMO E3 ligases SUMOylate target proteins;PKMTs methylate histone lysines;Chromatin modifying enzymes;Metabolism of proteins;SUMOylation of chromatin organization proteins;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Infectious disease;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers;HCMV Infection;HCMV Early Events
Q15024	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q15025	Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification
Q15029	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15031	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q15034	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q15040	Metabolism of proteins;Deubiquitination;Josephin domain DUBs;Post-translational protein modification
Q15042	Membrane Trafficking;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q15043	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q15046	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
Q15047	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q15051	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q15052	Cell-Cell communication;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G-protein beta:gamma signalling;G alpha (12/13) signalling events;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization;Death Receptor Signalling;G beta:gamma signalling through CDC42
Q15054	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
Q15056	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
Q15058	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate CIT
Q15061	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q15067-1	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q15067-2	Metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;alpha-linolenic acid (ALA) metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism
Q15067	Peroxisomal protein import;TYSND1 cleaves peroxisomal proteins;Protein localization
Q15070	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q15075	Toll Like Receptor 9 (TLR9) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades
Q15077	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;GPCR ligand binding
Q15078	Developmental Biology;Signal Transduction;Disease;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Generic Transcription Pathway;Transcriptional Regulation by TP53;Semaphorin interactions;CRMPs in Sema3A signaling;Axon guidance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;Activated NTRK2 signals through CDK5;Diseases of programmed cell death;Nervous system development
Q15080	ROS and RNS production in phagocytes;Cross-presentation of particulate exogenous antigens (phagosomes);Antigen processing-Cross presentation;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Cellular responses to stress;Detoxification of Reactive Oxygen Species;VEGFA-VEGFR2 Pathway;RHO GTPases Activate NADPH Oxidases;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Class I MHC mediated antigen processing & presentation
Q15084	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q15102	Membrane Trafficking;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q15109	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;Advanced glycosylation endproduct receptor signaling;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q15113	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
Q15116	Adaptive Immune System;Immune System;Costimulation by the CD28 family;PD-1 signaling
Q15118	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
Q15119	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
Q15120	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
Q15121	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q15125	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Cholesterol biosynthesis via desmosterol;Cholesterol biosynthesis via lathosterol;Metabolism of steroids
Q15126	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids
Q15139	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q15147	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Metabolism;Inositol phosphate metabolism;Signal Transduction;Synthesis of IP3 and IP4 in the cytosol;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events
Q15149	Apoptosis;Apoptotic cleavage of cellular proteins;Extracellular matrix organization;Collagen formation;Cell-Cell communication;Assembly of collagen fibrils and other multimeric structures;Caspase-mediated cleavage of cytoskeletal proteins;Type I hemidesmosome assembly;Cell junction organization;Programmed Cell Death;Apoptotic execution phase
Q15154	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q15165	Metabolism;Synthesis of 5-eicosatetraenoic acids;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
Q15166	Metabolism;Synthesis of 5-eicosatetraenoic acids;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
Q15172	Hemostasis;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Disease;Immune System;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;Platelet sensitization by LDL;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Intracellular signaling by second messengers;FLT3 Signaling;EML4 and NUDC in mitotic spindle formation
Q15173	Hemostasis;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Disease;Immune System;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Costimulation by the CD28 family;CTLA4 inhibitory signaling;Metabolism of proteins;Platelet homeostasis;Platelet sensitization by LDL;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Intracellular signaling by second messengers;FLT3 Signaling;EML4 and NUDC in mitotic spindle formation
Q15181	Metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Pyrophosphate hydrolysis;Translation
Q15185	Metabolism;Signal Transduction;Biological oxidations;Phase I - Functionalization of compounds;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);HSF1 activation;Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Metabolism of lipids;Aryl hydrocarbon receptor signalling;ESR-mediated signaling;Cellular responses to external stimuli;Fatty acid metabolism;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q15223	Cell-Cell communication;Adherens junctions interactions;Nectin/Necl  trans heterodimerization;Cell-cell junction organization;Cell junction organization
Q15238	Hemostasis;Cell surface interactions at the vascular wall
Q15262	Signal Transduction;Signaling by EGFR;EGFR downregulation;Signaling by Receptor Tyrosine Kinases
Q15269	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q15274	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q15276	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q15283	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q15286	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;TBC/RABGAPs;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q15287	Developmental Biology;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signaling by ROBO receptors;Axon guidance;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q15291	Developmental Biology;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Deactivation of the beta-catenin transactivating complex;Metabolism of proteins;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Neddylation
Q15293	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q15303-1	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression;FLT3 Signaling;Long-term potentiation;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
Q15303-2	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;Downregulation of ERBB4 signaling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Long-term potentiation;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
Q15303-3	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;Downregulation of ERBB4 signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;ESR-mediated signaling;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Estrogen-dependent gene expression;FLT3 Signaling;Long-term potentiation;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
Q15306	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
Q15311	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q15323	Developmental Biology;Keratinization;Formation of the cornified envelope
Q15327	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q15329	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Signal Transduction;Cell Cycle;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
Q15345	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q15349	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;CREB phosphorylation;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Signaling by GPCR;L1CAM interactions;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;RSK activation;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Gastrin-CREB signalling pathway via PKC and MAPK;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q15361	Epigenetic regulation of gene expression;Metabolism of proteins;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;Negative epigenetic regulation of rRNA expression;Surfactant metabolism;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q15363	Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q15365	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15366	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA;Negative regulators of DDX58/IFIH1 signaling
Q15369	Formation of RNA Pol II elongation complex ;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Developmental Biology;Adaptive Immune System;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Immune System;Vif-mediated degradation of APOBEC3G;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Neddylation;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q15370	Formation of RNA Pol II elongation complex ;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Developmental Biology;Adaptive Immune System;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Immune System;Vif-mediated degradation of APOBEC3G;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Neddylation;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q15375	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
Q15382	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q15386	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q15388	Mitochondrial protein import;Macroautophagy;Metabolism of proteins;Mitophagy;Pink/Parkin Mediated Mitophagy;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Protein localization;Autophagy;Selective autophagy
Q15389	Hemostasis;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Cell surface interactions at the vascular wall;Tie2 Signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q15391	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;P2Y receptors;Nucleotide-like (purinergic) receptors;G alpha (i) signalling events;GPCR ligand binding
Q15392	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Cholesterol biosynthesis via desmosterol;Cholesterol biosynthesis via lathosterol;Metabolism of steroids
Q15393	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15398	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
Q15399	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Beta defensins;Defensins;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Regulation of TLR by endogenous ligand;Antimicrobial peptides;Class I MHC mediated antigen processing & presentation
Q15404	Cell-Cell communication;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization
Q15406-1	Developmental Biology;Generic Transcription Pathway;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Nuclear Receptor transcription pathway;Transcriptional regulation of pluripotent stem cells;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15406-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15406-3	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15406-4	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15406-5	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15413	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
Q15418	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;CREB phosphorylation;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Signaling by GPCR;L1CAM interactions;GPCR downstream signalling;G alpha (q) signalling events;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;RSK activation;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Gastrin-CREB signalling pathway via PKC and MAPK;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q15424	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification
Q15427	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15428	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15431	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q15436	Adaptive Immune System;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;Metabolism of proteins;Asparagine N-linked glycosylation;Metabolism of lipids;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Metabolism of steroids;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q15438	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
Q15459	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15464	Signal Transduction;Signaling by VEGF;VEGFA-VEGFR2 Pathway;Signaling by Receptor Tyrosine Kinases
Q15465	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Release of Hh-Np from the secreting cell;Hh mutants abrogate ligand secretion;Ligand-receptor interactions;Hedgehog 'on' state;Activation of SMO;HHAT G278V abrogates palmitoylation of Hh-Np;Diseases of signal transduction by growth factor receptors and second messengers
Q15466	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15477	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Metabolism of RNA
Q15485	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Ficolins bind to repetitive carbohydrate structures on the target cell surface
Q15517	Developmental Biology;Keratinization;Formation of the cornified envelope
Q15526	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15528	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q15542	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q15543	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q15544	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q15545	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q15554	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Packaging Of Telomere Ends;Telomere Extension By Telomerase;Extension of Telomeres;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Cellular responses to external stimuli
Q15561	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates YAP1-mediated transcription
Q15562	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates YAP1-mediated transcription
Q15569	Cell-Cell communication;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization
Q15572	Epigenetic regulation of gene expression;SIRT1 negatively regulates rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q15573	Epigenetic regulation of gene expression;SIRT1 negatively regulates rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q15582	Metabolism of proteins;Amyloid fiber formation
Q15583	Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
Q15596	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Recycling of bile acids and salts;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Signaling by Rho GTPases;RHO GTPase Effectors;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);SUMOylation;SUMO E3 ligases SUMOylate target proteins;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional regulation of white adipocyte differentiation;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Post-translational protein modification;ESR-mediated signaling;Metabolism of steroids;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q15612	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q15615	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q15617	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q15619	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q15620	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q15622	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q15628	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Signal Transduction;Regulation by c-FLIP;RIPK1-mediated regulated necrosis;Regulated Necrosis;CASP8 activity is inhibited;Caspase activation via extrinsic apoptotic signalling pathway;TNFR1-induced proapoptotic signaling;Programmed Cell Death;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Regulation of necroptotic cell death;Dimerization of procaspase-8;Death Receptor Signalling;TNF signaling
Q15629	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
Q15631	Gene Silencing by RNA;Small interfering RNA (siRNA) biogenesis;Gene expression (Transcription)
Q15633	MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Small interfering RNA (siRNA) biogenesis;Gene expression (Transcription)
Q15637	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15642	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q15643	Organelle biogenesis and maintenance;Membrane Trafficking;Cilium Assembly;Intraflagellar transport;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
Q15646	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;OAS antiviral response;Interferon alpha/beta signaling;Interferon Signaling
Q15648	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);Transcriptional regulation of white adipocyte differentiation;Nuclear Receptor transcription pathway;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Metabolism of steroids;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q15652	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q15653	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Signaling by the B Cell Receptor (BCR)
Q15661	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
Q15669	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q15672	Cytokine Signaling in Immune system;Immune System;Generic Transcription Pathway;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
Q15678	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling
Q15691	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;EML4 and NUDC in mitotic spindle formation
Q15696	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15700	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation
Q15717	HuR (ELAVL1) binds and stabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q15722	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Leukotriene receptors;G alpha (q) signalling events;GPCR ligand binding
Q15723	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in BCR signaling
Q15726	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q15735	Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of IP2, IP, and Ins in the cytosol;Synthesis of IP3 and IP4 in the cytosol;Metabolism of lipids
Q15738	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
Q15742	Developmental Biology;Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q15743	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q15744	Developmental Biology;Transcriptional regulation of granulopoiesis
Q15746	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Muscle contraction;Smooth Muscle Contraction;RHO GTPases activate PAKs
Q15750	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;TNFR1-induced NFkappaB signaling pathway;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Alpha-protein kinase 1 signaling pathway;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane
Q15751	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q15758	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q15759	Developmental Biology;Cytokine Signaling in Immune system;Mitochondrial biogenesis;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Signalling to RAS;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;p38MAPK events;Toll Like Receptor 2 (TLR2) Cascade;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Transcriptional Regulation by TP53;Netrin-1 signaling;DSCAM interactions;Axon guidance;VEGFA-VEGFR2 Pathway;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;Activation of the AP-1 family of transcription factors;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Myogenesis;Regulation of TP53 Activity;RHO GTPases Activate NADPH Oxidases;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q15761	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q15762	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q15768	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Ephrin signaling;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
Q15771	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation
Q15776	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15788	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Recycling of bile acids and salts;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);SUMOylation;SUMO E3 ligases SUMOylate target proteins;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional regulation of white adipocyte differentiation;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;Post-translational protein modification;ESR-mediated signaling;Metabolism of steroids;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis
Q15796	Signaling by NODAL;Developmental Biology;Signaling by Activin;Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Loss of Function of SMAD4 in Cancer;Loss of Function of SMAD2/3 in Cancer;Signaling by TGF-beta Receptor Complex in Cancer;SMAD2/3 Phosphorylation Motif Mutants in Cancer;SMAD4 MH2 Domain Mutants in Cancer;SMAD2/3 MH2 Domain Mutants in Cancer;TGFBR1 KD Mutants in Cancer;Loss of Function of TGFBR1 in Cancer;Metabolism of proteins;Transcriptional regulation of pluripotent stem cells;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;FOXO-mediated transcription of cell cycle genes
Q15797	Signal Transduction;Signaling by BMP;Generic Transcription Pathway;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates bone development;Signaling by TGF-beta family members
Q15800	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
Q15811	Developmental Biology;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Membrane Trafficking;Cell death signalling via NRAGE, NRIF and NADE;EPH-Ephrin signaling;Signaling by GPCR;GPCR downstream signalling;EPHB-mediated forward signaling;G alpha (12/13) signalling events;Axon guidance;Vesicle-mediated transport;Death Receptor Signalling;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Nervous system development
Q15813	Post-chaperonin tubulin folding pathway;Protein folding;Metabolism of proteins
Q15814	Post-chaperonin tubulin folding pathway;Protein folding;Metabolism of proteins
Q15819	Adaptive Immune System;Cell Cycle;Immune System;Metabolism of proteins;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q15822	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
Q15825	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
Q15831	Metabolism;Signal Transduction;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism;mTOR signalling;Generic Transcription Pathway;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell death genes
Q15833	Hemostasis;Platelet degranulation ;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q15835	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q15836	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Class I MHC mediated antigen processing & presentation
Q15842	Neuronal System;ATP sensitive Potassium channels;Inwardly rectifying K+ channels;Potassium Channels
Q15843	Signal Transduction;Signaling by TGF-beta Receptor Complex;Membrane Trafficking;TGF-beta receptor signaling activates SMADs;Transport of small molecules;Metabolism of proteins;Vesicle-mediated transport;Deubiquitination;UCH proteinases;Post-translational protein modification;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation;Signaling by TGF-beta family members;Iron uptake and transport
Q15847	Developmental Biology;Transcriptional regulation of white adipocyte differentiation
Q15848	Developmental Biology;Metabolism;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism;Transcriptional regulation of white adipocyte differentiation
Q15849	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport
Q15853	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q15858	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q15878	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Metabolism;Integration of energy metabolism;Regulation of insulin secretion
Q15904	Signal Transduction;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Ion channel transport
Q15906	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q15907	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;TBC/RABGAPs;RAB geranylgeranylation;Rab regulation of trafficking
Q15910	PIP3 activates AKT signaling;Developmental Biology;Signal Transduction;Disease;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Infectious disease;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers;HCMV Infection;HCMV Early Events
Q15911	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates CDKN1A transcription
Q15928	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15935	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15937	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15940	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q15973	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q16099	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding
Q16134	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
Q16143	MTF1 activates gene expression;Response to metal ions;Cellular responses to external stimuli
Q16181	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
Q16186	Metabolism of proteins;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification
Q16222	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q16254	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Signal Transduction;Cell Cycle;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Transcriptional Regulation by TP53;Mitotic G1 phase and G1/S transition;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;Cyclin D associated events in G1;G1 Phase;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
Q16270	Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Cellular responses to external stimuli;Post-translational protein phosphorylation
Q16280	Organelle biogenesis and maintenance;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
Q16288	Neuronal System;Signal Transduction;Signaling by NTRKs;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses;Signaling by Receptor Tyrosine Kinases;NTF3 activates NTRK3 signaling;Signaling by NTRK3 (TRKC);Activated NTRK3 signals through PLCG1;Activated NTRK3 signals through RAS;Activated NTRK3 signals through PI3K;NTRK3 as a dependence receptor
Q16322	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q16348	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Proton/oligopeptide cotransporters
Q16363	Extracellular matrix organization;Signal Transduction;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
Q16394	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;HS-GAG biosynthesis;Diseases associated with glycosaminoglycan metabolism;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q16401	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q16445	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
Q16478	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding
Q16512	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
Q16513	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate PKNs
Q16514	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q16515	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q16518	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q16520	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q16526	Circadian Clock
Q16531	Recognition of DNA damage by PCNA-containing replication complex;Metabolism of proteins;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Damage Bypass;DNA Repair;Neddylation
Q16533	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q16537	Hemostasis;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Disease;Immune System;Signaling by Rho GTPases;Degradation of beta-catenin by the destruction complex;RHO GTPase Effectors;Signaling by WNT;Beta-catenin phosphorylation cascade;Negative regulation of the PI3K/AKT network;TCF dependent signaling in response to WNT;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Costimulation by the CD28 family;CTLA4 inhibitory signaling;Platelet homeostasis;Platelet sensitization by LDL;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Diseases of signal transduction by growth factor receptors and second messengers;RHO GTPases Activate Formins;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Intracellular signaling by second messengers;FLT3 Signaling;EML4 and NUDC in mitotic spindle formation
Q16539	Hemostasis;Developmental Biology;Cytokine Signaling in Immune system;Mitochondrial biogenesis;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Signalling to RAS;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;p38MAPK events;Toll Like Receptor 2 (TLR2) Cascade;Organelle biogenesis and maintenance;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Transcriptional Regulation by TP53;Netrin-1 signaling;DSCAM interactions;Signal amplification;Platelet homeostasis;ADP signalling through P2Y purinoceptor 1;Axon guidance;Platelet sensitization by LDL;VEGFA-VEGFR2 Pathway;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;Activation of the AP-1 family of transcription factors;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Myogenesis;Regulation of TP53 Activity;Infectious disease;RHO GTPases Activate NADPH Oxidases;Neutrophil degranulation;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Metabolism of RNA;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;Nervous system development;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q16540	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q16543	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants;Signal Transduction;Disease;Signaling by EGFR in Cancer;Constitutive Signaling by EGFRvIII;Signaling by EGFRvIII in Cancer;Signaling by Ligand-Responsive EGFR Variants in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;Downregulation of ERBB2 signaling;Signaling by Receptor Tyrosine Kinases;Constitutive Signaling by Overexpressed ERBB2;Drug-mediated inhibition of ERBB2 signaling;Signaling by ERBB2 KD Mutants;Drug resistance in ERBB2 KD mutants;Resistance of ERBB2 KD mutants to trastuzumab;Resistance of ERBB2 KD mutants to sapitinib;Resistance of ERBB2 KD mutants to tesevatinib;Resistance of ERBB2 KD mutants to neratinib;Resistance of ERBB2 KD mutants to osimertinib;Resistance of ERBB2 KD mutants to afatinib;Resistance of ERBB2 KD mutants to AEE788;Resistance of ERBB2 KD mutants to lapatinib;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Drug resistance in ERBB2 TMD/JMD mutants
Q16552	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q16553	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q16555	Developmental Biology;Semaphorin interactions;L1CAM interactions;CRMPs in Sema3A signaling;Axon guidance;Recycling pathway of L1;Nervous system development
Q16557	Hemostasis;Cell surface interactions at the vascular wall
Q16558	Hemostasis;Neuronal System;Ca2+ activated K+ channels;Potassium Channels;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
Q16560	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q16566	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;DAG and IP3 signaling;Mitochondrial biogenesis;Signal Transduction;Disease;Organelle biogenesis and maintenance;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;Activation of NMDA receptors and postsynaptic events;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Intracellular signaling by second messengers;Loss of phosphorylation of MECP2 at T308;Regulation of MECP2 expression and activity;Negative regulation of NMDA receptor-mediated neuronal transmission;Disorders of developmental biology
Q16570	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
Q16572	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Membrane Trafficking;Acetylcholine Neurotransmitter Release Cycle;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q16576	PIP3 activates AKT signaling;Developmental Biology;Signal Transduction;Cell Cycle;Disease;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;HDACs deacetylate histones;PKMTs methylate histone lysines;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Metabolism of proteins;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Regulation of TP53 Activity;Infectious disease;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Chromosome Maintenance;Gene expression (Transcription);Nucleosome assembly;Regulation of PTEN gene transcription;Neddylation;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers;HCMV Infection;HCMV Early Events
Q16581	Signal Transduction;Disease;Complement cascade;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding;Infectious disease;Neutrophil degranulation;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response);Regulation of Complement cascade
Q16584	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
Q16587	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q16589	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
Q16594	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q16595	Mitochondrial protein import;Mitochondrial iron-sulfur cluster biogenesis;Metabolism;Protein localization
Q16602	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q16610	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q16611	Apoptosis;Intrinsic Pathway for Apoptosis;Activation and oligomerization of BAK protein;Release of apoptotic factors from the mitochondria;Apoptotic factor-mediated response;Programmed Cell Death
Q16613	Metabolism;Metabolism of amine-derived hormones;Serotonin and melatonin biosynthesis;Metabolism of amino acids and derivatives
Q16619	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
Q16620	Signal Transduction;Signaling by NTRKs;Activation of TRKA receptors;NGF-independant TRKA activation;Signaling by NTRK1 (TRKA);Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;BDNF activates NTRK2 (TRKB) signaling;NTF3 activates NTRK2 (TRKB) signaling;NTF4 activates NTRK2 (TRKB) signaling;Activated NTRK2 signals through RAS;Activated NTRK2 signals through PLCG1;Activated NTRK2 signals through PI3K;Activated NTRK2 signals through FRS2 and FRS3;Activated NTRK2 signals through FYN;NTRK2 activates RAC1;Activated NTRK2 signals through CDK5
Q16621	Hemostasis;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Factors involved in megakaryocyte development and platelet production
Q16623	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Metabolism;Integration of energy metabolism;Disease;Immune System;Neurotoxicity of clostridium toxins;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Regulation of insulin secretion;Signaling by Interleukins;Other interleukin signaling;Toxicity of botulinum toxin type C (BoNT/C);Uptake and actions of bacterial toxins;Infectious disease;LGI-ADAM interactions;Neurexins and neuroligins;Protein-protein interactions at synapses;GABA synthesis, release, reuptake and degradation;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Q16625	Apoptosis;Apoptotic cleavage of cellular proteins;Generic Transcription Pathway;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptotic execution phase;Transcriptional regulation by RUNX1;RUNX1 regulates expression of components of tight junctions
Q16629	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q16630	Signaling by FGFR in disease;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
Q16635	Mitochondrial protein import;Metabolism;Acyl chain remodeling of CL;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids;Protein localization
Q16637	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
Q16644	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Signalling to RAS;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;p38MAPK events;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by VEGF;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;VEGFA-VEGFR2 Pathway;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q16647	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Eicosanoids;Sterols are 12-hydroxylated by CYP8B1;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism
Q16649	Circadian Clock
Q16651	Developmental Biology;Keratinization;Formation of the cornified envelope
Q16654	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Signal Transduction;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Signaling by Nuclear Receptors
Q16656	Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;PPARA activates gene expression;Transcriptional activation of mitochondrial biogenesis;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q16658	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q16659	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
Q16661	Digestion;Digestion and absorption
Q16665	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cytokine Signaling in Immune system;Signaling by NOTCH;Signal Transduction;Immune System;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Cellular responses to stress;Metabolism of proteins;Circadian Clock;Signaling by Interleukins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Interleukin-4 and Interleukin-13 signaling;Signaling by PTK6;PTK6 Expression;PTK6 promotes HIF1A stabilization;Neddylation;Cellular responses to external stimuli;Signaling by Non-Receptor Tyrosine Kinases
Q16666	Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;IRF3-mediated induction of type I IFN
Q16671	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q16678	Metabolism;Disease;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET);Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Metabolism of lipids;Defective CYP1B1 causes Glaucoma;Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Fatty acid metabolism
Q16690	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q16695	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Reproduction;Meiosis;Telomere Maintenance;Signal Transduction;Cell Cycle;Packaging Of Telomere Ends;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Cellular responses to stress;Condensation of Prophase Chromosomes;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Cellular responses to external stimuli;Meiotic recombination
Q16696	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Xenobiotics;CYP2E1 reactions;Aflatoxin activation and detoxification
Q16698	Metabolism;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q16706	Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
Q16718	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q16719	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q16720	Hemostasis;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
Q16739	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q16760	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
Q16762	Metabolism;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q16763	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q16769	Innate Immune System;Immune System;Neutrophil degranulation
Q16772	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
Q16773	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine metabolism;Phenylalanine metabolism;Glutamate and glutamine metabolism
Q16774	Metabolism;Metabolism of nucleotides;Abacavir transport and metabolism;Abacavir metabolism;Interconversion of nucleotide di- and triphosphates
Q16775-2	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q16777	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q16778	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q16787	Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Cell-Cell communication;Signal Transduction;Assembly of collagen fibrils and other multimeric structures;Anchoring fibril formation;Laminin interactions;Non-integrin membrane-ECM interactions;ECM proteoglycans;Type I hemidesmosome assembly;Cell junction organization;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
Q16790	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Metabolism;Reversible hydration of carbon dioxide;Cellular responses to stress;Cellular responses to external stimuli
Q16795	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q16798	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
Q16816	Metabolism;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
Q16822	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
Q16827	Signal Transduction;Signaling by NTRKs;Signaling by Receptor Tyrosine Kinases;Signaling by NTRK3 (TRKC)
Q16828	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;ERKs are inactivated;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q16829	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;ERKs are inactivated;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;FLT3 Signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q16831	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Pyrimidine catabolism;Nucleobase catabolism;Nucleotide salvage
Q16832	Extracellular matrix organization;Non-integrin membrane-ECM interactions
Q16836	Metabolism;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Beta oxidation of octanoyl-CoA to hexanoyl-CoA;Beta oxidation of hexanoyl-CoA to butanoyl-CoA;Beta oxidation of butanoyl-CoA to acetyl-CoA;Fatty acid metabolism
Q16842	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q16850	Developmental Biology;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Metabolism of steroids;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q16851	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Formation of the active cofactor, UDP-glucuronate;Biological oxidations;Glycogen synthesis;Metabolism of carbohydrates;Glycogen metabolism
Q16853	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
Q16854	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
Q16864	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q16873	Metabolism;Synthesis of 5-eicosatetraenoic acids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Synthesis of Lipoxins (LX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism;Biosynthesis of DHA-derived SPMs;Biosynthesis of specialized proresolving mediators (SPMs);Biosynthesis of DHA-derived sulfido conjugates;Biosynthesis of maresin conjugates in tissue regeneration (MCTR);Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)
Q16875	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
Q16877	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Regulation of glycolysis by fructose 2,6-bisphosphate metabolism
Q16878	Metabolism;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q16880	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q16881	Metabolism;Metabolism of nucleotides;Disease;PPARA activates gene expression;Generic Transcription Pathway;Cellular responses to stress;Selenoamino acid metabolism;Metabolism of ingested H2SeO4 and H2SeO3 into H2Se;Detoxification of Reactive Oxygen Species;Transcriptional Regulation by TP53;Regulation of lipid metabolism by PPARalpha;Interconversion of nucleotide di- and triphosphates;Metabolism of ingested MeSeO2H into MeSeH;Uptake and function of diphtheria toxin;Uptake and actions of bacterial toxins;Metabolism of lipids;TP53 Regulates Metabolic Genes;Infectious disease;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli
Q16890	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q16891	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation
Q17R88	Signal Transduction;p75 NTR receptor-mediated signalling;NFG and proNGF binds to p75NTR;Death Receptor Signalling
Q17R89	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q17RB8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q17RR3	Digestion of dietary lipid;Digestion;Digestion and absorption
Q17RS7	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair
Q17RW2	Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases
Q17RY6	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q1EHB4	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers
Q1RMZ1	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q1ZYL8	Fertilization;Acrosome Reaction and Sperm:Oocyte Membrane Binding;Reproduction
Q24JP5	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q29718	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q29836	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q29865	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q29940	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q29960	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q29963	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q29974	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q29980	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q29983	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q29RF7	Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic
Q2I0M5	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination
Q2KJY2	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q2M1P5	Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state;Hedgehog 'on' state
Q2M1Z3	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q2M2I5	Developmental Biology;Keratinization;Formation of the cornified envelope
Q2M2I8	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q2M3G0	Transport of small molecules;ABC-family proteins mediated transport
Q2M3M2	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q2M5E4	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events
Q2MJR0	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RAS signaling downstream of NF1 loss-of-function variants;Oncogenic MAPK signaling;FLT3 Signaling
Q2MKA7	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination
Q2MV58	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q2NKJ3	Telomere Maintenance;Cell Cycle;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;Extension of Telomeres;Chromosome Maintenance
Q2NKX8	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q2NL67	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q2NL82	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q2PPJ7	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport
Q2Q1W2	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q2QD12	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates
Q2T9J0	Peroxisomal protein import;TYSND1 cleaves peroxisomal proteins;Protein localization
Q2TAA5	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG11 causes ALG11-CDG (CDG-1p);Diseases of metabolism;Post-translational protein modification
Q2TAC6	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q2UY09	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Collagen chain trimerization
Q2VIQ3	Hemostasis;Developmental Biology;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;L1CAM interactions;Axon guidance;Recycling pathway of L1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q2VPK5	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q2Y0W8	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q2YD98	Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Repair
Q30134	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q30154	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q30167	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q30201	Transport of small molecules;Iron uptake and transport;Transferrin endocytosis and recycling
Q30KP8	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KP9	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ1	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ3	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ4	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ5	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ6	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ7	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ8	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KQ9	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q30KR1	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q31610	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q31612	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q32M45	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q32M78	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q32MQ0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q32MZ4	Signaling by FGFR in disease;Disease;Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
Q32NB8	Metabolism;Synthesis of PG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q32P28	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q32P41	tRNA modification in the nucleus and cytosol;Synthesis of wybutosine at G37 of tRNA(Phe);tRNA processing;Metabolism of RNA
Q32ZL2	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Lysosphingolipid and LPA receptors;GPCR ligand binding
Q330K2	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q3B726	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q3E731	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q3I5F7	Metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism
Q3KNW5	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport
Q3KP31	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q3KQV3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q3KRB8	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q3L8U1	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;PPARA activates gene expression;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids;Metabolism of steroids
Q3LFD5	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
Q3LHN0	Developmental Biology;Keratinization
Q3LHN1	Developmental Biology;Keratinization
Q3LHN2	Developmental Biology;Keratinization
Q3LI54	Developmental Biology;Keratinization
Q3LI58	Developmental Biology;Keratinization
Q3LI59	Developmental Biology;Keratinization
Q3LI61	Developmental Biology;Keratinization
Q3LI63	Developmental Biology;Keratinization
Q3LI64	Developmental Biology;Keratinization
Q3LI66	Developmental Biology;Keratinization
Q3LI67	Developmental Biology;Keratinization
Q3LI70	Developmental Biology;Keratinization
Q3LI72	Developmental Biology;Keratinization
Q3LI73	Developmental Biology;Keratinization
Q3LI76	Developmental Biology;Keratinization
Q3LI77	Developmental Biology;Keratinization
Q3LI81	Developmental Biology;Keratinization
Q3LI83	Developmental Biology;Keratinization
Q3LIE5	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
Q3LXA3	Metabolism;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Fructose metabolism;Fructose catabolism;Metabolism of carbohydrates
Q3MII6	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q3MIS6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q3MIV0	Developmental Biology;Keratinization
Q3MJ16	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Hydrolysis of LPC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q3MUY2	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q3SXY8	Macroautophagy;Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;ARL13B-mediated ciliary trafficking of INPP5E;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
Q3SXZ3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q3SXZ7	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q3SY46	Developmental Biology;Keratinization
Q3SY52	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q3SY69	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q3SY77	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q3SY84	Developmental Biology;Keratinization;Formation of the cornified envelope
Q3SY89	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q3SYC2	Metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q3SYF9	Developmental Biology;Keratinization
Q3SYG4	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q3ZCM7	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q3ZCQ8	Mitochondrial protein import;Protein localization
Q3ZCX4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q45877	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type B (BoNT/B);Toxicity of botulinum toxin type A (BoNT/A);Uptake and actions of bacterial toxins;Infectious disease
Q45878	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type B (BoNT/B);Toxicity of botulinum toxin type A (BoNT/A);Uptake and actions of bacterial toxins;Infectious disease
Q460N5	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q495M3	Disease;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Proton-coupled neutral amino acid transporters;Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG);SLC transporter disorders;Disorders of transmembrane transporters
Q495W5	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q496F6	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions
Q496H8	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q496J9	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type A (BoNT/A);Toxicity of botulinum toxin type F (BoNT/F);Uptake and actions of bacterial toxins;Infectious disease
Q49A17	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q49AA0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q49AN0	Circadian Clock
Q49B96	Mitochondrial protein import;Protein localization
Q4AC94	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q4ADV7	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q4FZB7	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q4G0N4	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q4G0N8	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q4G176	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q4JDL3	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling
Q4KMG0	Developmental Biology;Signal Transduction;Myogenesis;Signaling by Hedgehog;Ligand-receptor interactions;Hedgehog 'on' state;Activation of SMO
Q4KMP7	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q4KMQ2	Innate Immune System;Immune System;Stimuli-sensing channels;Transport of small molecules;Neutrophil degranulation;Ion channel transport
Q4KWH8	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
Q4LE39	Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
Q4QD44	Disease;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival
Q4QY38	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q4U2R6	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q4U2R8	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation/anion/zwitterion transport;Organic anion transport
Q4V348	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q4VCS5-1	Signal Transduction;Signaling by Hippo
Q4VNC0	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q4VNC1	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q4ZG55	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q4ZJI4	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q504Q3	Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Metabolism of RNA
Q52LA3	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Polo-like kinase mediated events;Cell Cycle;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;S Phase;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry
Q52LG2	Developmental Biology;Keratinization
Q52LJ0	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q52LW3	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q52M93	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q53EL6	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
Q53ET0	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Circadian Clock
Q53EU6	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q53FA7	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription)
Q53FT3	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q53FV1	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q53FZ2	Metabolism;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of butanoyl-CoA to acetyl-CoA;Fatty acid metabolism
Q53G59	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Degradation of DVL
Q53GD3	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metabolism of lipids
Q53GI3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q53GL7	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q53GQ0	Metabolism;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Metabolism of steroids;Fatty acid metabolism
Q53GS7	Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q53GS9	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q53GT1	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q53H12	Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Disease;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q53H54	tRNA modification in the nucleus and cytosol;Synthesis of wybutosine at G37 of tRNA(Phe);tRNA processing;Metabolism of RNA
Q53H76	Metabolism;Acyl chain remodelling of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q53H96	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
Q53HL2	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of DNA replication proteins;RHO GTPases Activate Formins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q53HV7	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Displacement of DNA glycosylase by APEX1;Base Excision Repair;DNA Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites)
Q53QZ3	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q53T94	Epigenetic regulation of gene expression;SIRT1 negatively regulates rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q53TN4	Transport of small molecules;Iron uptake and transport
Q53TQ3	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q53ZZ1	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q562F6	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q56NI9	Cell Cycle;Establishment of Sister Chromatid Cohesion;S Phase;Cell Cycle, Mitotic
Q57230	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type B (BoNT/B);Toxicity of botulinum toxin type A (BoNT/A);Uptake and actions of bacterial toxins;Infectious disease
Q587J7	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q58A45	Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Metabolism of RNA
Q58EX2	Cell-Cell communication;SDK interactions;Cell-cell junction organization;Cell junction organization
Q58HT5	Metabolism;Arachidonic acid metabolism;Metabolism of lipids;Wax and plasmalogen biosynthesis;Fatty acid metabolism;Wax biosynthesis
Q58WW2	Metabolism of proteins;Post-translational protein modification;Neddylation
Q5BIV9	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q5BJF6	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q5BKT4	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Post-translational protein modification
Q5D862	Innate Immune System;Immune System;Neutrophil degranulation
Q5DT21	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5EBL8	Metabolism;Innate Immune System;Immune System;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Antimicrobial peptides;Ion influx/efflux at host-pathogen interface;Ion transport by P-type ATPases;Ion channel transport
Q5EE01	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
Q5FBB7	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q5FVE4	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q5FWF5	Cell Cycle;Establishment of Sister Chromatid Cohesion;S Phase;Cell Cycle, Mitotic
Q5FYA8	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
Q5FYB0	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
Q5FYB1	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
Q5GJ75	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids
Q5GLZ8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5H8A3	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
Q5H8A4	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q5H9L4	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q5H9R7	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q5H9S7	Metabolism of proteins;Post-translational protein modification;Neddylation
Q5HYA8	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q5HYJ1	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q5HYK3	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
Q5HYK7	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q5HYK9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5I7T1	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Post-translational protein modification
Q5J5C9	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q5JNZ3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5JPH6	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q5JPI9	Metabolism of proteins;Post-translational protein modification;Protein methylation
Q5JQS5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q5JRA6	ER to Golgi Anterograde Transport;Membrane Trafficking;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Post-translational protein phosphorylation;Transport to the Golgi and subsequent modification
Q5JRS4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q5JRX3	Mitochondrial protein import;Protein localization
Q5JS37	Innate Immune System;Immune System;Neutrophil degranulation
Q5JSL3	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q5JSP0	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q5JT25	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation
Q5JTC6	Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex;Diseases of signal transduction by growth factor receptors and second messengers
Q5JTJ3	Mitochondrial protein import;Protein localization
Q5JTW2	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q5JTZ9	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q5JUW0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5JV73	Innate Immune System;Immune System;Neutrophil degranulation
Q5JVG2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5JVG8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5JVS0	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q5JWF2	Hemostasis;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;GPCR downstream signalling;Prostacyclin signalling through prostacyclin receptor;Platelet homeostasis;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;GPCR ligand binding;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q5JZY3	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
Q5K4L6	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q5KSL6	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
Q5KU26	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Vesicle-mediated transport
Q5MCW4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5MNZ6	Macroautophagy;Autophagy
Q5MNZ9	Macroautophagy;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Autophagy
Q5MY95	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism
Q5NUL3	Signal Transduction;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);GPCR downstream signalling;Metabolism of proteins;Incretin synthesis, secretion, and inactivation;G alpha (q) signalling events;Free fatty acid receptors;GPCR ligand binding
Q5NV61	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV62	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV64	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV65	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV66	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV67	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV68	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV69	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV75	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV79	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV80	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV81	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV82	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV83	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV84	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV85	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV86	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV87	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV89	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV90	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV91	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5NV92	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade
Q5QGT7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q5QGZ9	Innate Immune System;Immune System;Neutrophil degranulation
Q5QJU3	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q5QNW6	Disease;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Infectious disease;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;HCMV Infection;HCMV Early Events;HCMV Late Events
Q5QP82	Metabolism of proteins;Post-translational protein modification;Neddylation
Q5RI15	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5RKV6	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q5S007	Signal Transduction;Signaling by PTK6;PTK6 promotes HIF1A stabilization;Signaling by Non-Receptor Tyrosine Kinases
Q5SGD2	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q5SQ64	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q5SQI0	Organelle biogenesis and maintenance;Cilium Assembly
Q5SRE5	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q5SRI9	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan trimming and elongation in the cis-Golgi
Q5SSG8	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q5ST30	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q5SV97	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q5SW96	Plasma lipoprotein assembly, remodeling, and clearance;Membrane Trafficking;Transport of small molecules;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Chylomicron clearance;LDL clearance;Plasma lipoprotein clearance
Q5SXM1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5SXM2	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q5SY16	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q5SYC1	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Vesicle-mediated transport
Q5SZD4	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Conjugation of benzoate with glycine;Biological oxidations
Q5T011	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q5T084	Digestion of dietary carbohydrate;Digestion;Digestion and absorption
Q5T0F9	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Sealing of the nuclear envelope (NE) by ESCRT-III
Q5T0N5	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q5T160	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q5T1C6	PI3K Cascade;IRS-mediated signalling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signal Transduction;Activation of AKT2;Immune System;Signaling by VEGF;Negative regulation of the PI3K/AKT network;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;Metabolism of lipids;Insulin receptor signalling cascade;Signaling by Insulin receptor;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q5T1R4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
Q5T2D2	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q5T2D3	PIP3 activates AKT signaling;Signal Transduction;Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers
Q5T2R2	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
Q5T3U5	Transport of small molecules;ABC-family proteins mediated transport
Q5T442	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q5T447	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5T4S7	Adaptive Immune System;Innate Immune System;Immune System;Neutrophil degranulation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5T4W7	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
Q5T5A8	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T5B0	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T5D7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5T5U3	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q5T653	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q5T6S3	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Gene expression (Transcription)
Q5T6X5	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q5T751	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T752	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T753	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T754	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T7B8	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q5T7P2	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T7P3	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T871	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5T8D3	Metabolism;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Class I peroxisomal membrane protein import;Protein localization
Q5T8I9	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q5T9A4	Innate Immune System;Immune System;Neutrophil degranulation
Q5T9L3	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking
Q5TA45	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5TA50	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q5TA76	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5TA77	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5TA78	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5TA79	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5TA81	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5TA82	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5TA89	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;NOTCH1 Intracellular Domain Regulates Transcription;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q5TAH2	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q5TAP6	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q5TAQ9	Metabolism of proteins;Post-translational protein modification;Neddylation
Q5TAT6	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Collagen chain trimerization
Q5TAX3	Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Metabolism of RNA
Q5TB80	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q5TCH4	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
Q5TCM9	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5TCS8	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q5TCZ1	Extracellular matrix organization;Invadopodia formation
Q5TEC3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5TEU4	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q5TF39	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q5TG30	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q5TGZ0	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation
Q5TKA1	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Polo-like kinase mediated events;Cell Cycle;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;S Phase;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry
Q5TYW1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5TZ20	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q5U5Q3	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5U5R9	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5U5Z8	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q5UE93	Hemostasis;GPVI-mediated activation cascade;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Signaling by GPCR;GPCR downstream signalling;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;Metabolism of lipids;Platelet activation, signaling and aggregation
Q5UIP0	DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
Q5VIR6	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q5VIY5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5VST9	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q5VT52	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5VT66	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
Q5VT97	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q5VTB9	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5VTE0	Eukaryotic Translation Elongation;Metabolism of proteins;Translation
Q5VTR2	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q5VTY9	Signal Transduction;Disease;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants abrogate ligand secretion;HHAT G278V abrogates palmitoylation of Hh-Np;Diseases of signal transduction by growth factor receptors and second messengers
Q5VU57	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q5VV41	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q5VV42	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q5VV43	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q5VV52	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q5VV67	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q5VVJ2	Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;Post-translational protein modification
Q5VVQ6	Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification
Q5VVX9	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5VWC8	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q5VWG9	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q5VWK5	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Interleukin-23 signaling
Q5VWQ8	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q5VWX1	Signal Transduction;Signaling by PTK6;PTK6 Regulates Proteins Involved in RNA Processing;Signaling by Non-Receptor Tyrosine Kinases
Q5VXI9	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5VXJ0	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5VY80	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q5VYS8	Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Metabolism of RNA
Q5VYX0	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q5VYY2	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5VZ72	Fertilization;Acrosome Reaction and Sperm:Oocyte Membrane Binding;Reproduction
Q5VZ89	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q5VZE5	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q5VZK9	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q5VZM2	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q5VZY2	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis
Q5W064	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5XG87	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q5XKE5	Developmental Biology;Keratinization;Formation of the cornified envelope
Q5XKP0	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation
Q5XPI4	Adaptive Immune System;Immune System;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5XUX0	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5XUX1	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5XX13	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q5XXA6	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q5Y7A7	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q60393	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type G (BoNT/G);Uptake and actions of bacterial toxins;Infectious disease
Q60I27	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q63HM1	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q63HN8	Adaptive Immune System;Disease;Immune System;Infectious disease;Suppression of apoptosis;Infection with Mycobacterium tuberculosis;Response of Mtb to phagocytosis;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q643R3	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q658P3	Generic Transcription Pathway;Transcriptional Regulation by TP53;Transport of small molecules;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription);Iron uptake and transport;Transferrin endocytosis and recycling
Q659A1	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q66GS9	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q66K46	Hemostasis;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q66LE6	Cell Cycle;MASTL Facilitates Mitotic Progression;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q674R7	Macroautophagy;Autophagy
Q674X7	Developmental Biology;Keratinization;Formation of the cornified envelope
Q676U5	Macroautophagy;Autophagy
Q67FW5	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q684P5	Adaptive Immune System;Immune System;Rap1 signalling
Q685J3	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q68CJ9	Plasma lipoprotein assembly, remodeling, and clearance;Unfolded Protein Response (UPR);Transport of small molecules;Metabolism of proteins;CREB3 factors activate genes;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q68CK6	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Conjugation of benzoate with glycine;Conjugation of phenylacetate with glutamine;Biological oxidations
Q68CL5	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q68CP4	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Innate Immune System;Immune System;HS-GAG degradation;Mucopolysaccharidoses;MPS IIIC - Sanfilippo syndrome C;Diseases of carbohydrate metabolism;Diseases of metabolism;Neutrophil degranulation;Metabolism of carbohydrates
Q68CP9	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q68CQ4	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q68CZ1	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q68CZ2	Signal Transduction;Signaling by MET;MET interacts with TNS proteins;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
Q68CZ6	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q68D51	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q68D85	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q68DD2	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Hydrolysis of LPC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q68DI1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q68DK7	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q68DV7	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;RNF mutants show enhanced WNT signaling and proliferation;Diseases of signal transduction by growth factor receptors and second messengers
Q68DY1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q68DY9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q68E01	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q68EM7	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q695T7	Disease;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Defective SLC6A19 causes Hartnup disorder (HND);SLC transporter disorders;Disorders of transmembrane transporters
Q6A162	Developmental Biology;Keratinization;Formation of the cornified envelope
Q6A163	Developmental Biology;Keratinization;Formation of the cornified envelope
Q6AI14	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers
Q6AW86	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6AZW8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6AZZ1	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q6B0I6	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q6BCY4	Erythrocytes take up carbon dioxide and release oxygen;O2/CO2 exchange in erythrocytes;Transport of small molecules
Q6DHV7	Metabolism;Metabolism of nucleotides;Abacavir transport and metabolism;Abacavir metabolism;Purine salvage;Nucleotide salvage
Q6E213	Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;The retinoid cycle in cones (daylight vision);Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of lipids;Wax and plasmalogen biosynthesis;Wax biosynthesis
Q6EBC2	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
Q6ECI4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6EIG7	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
Q6EMB2	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q6FI13	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q6FI81	Metabolism;Cytosolic iron-sulfur cluster assembly
Q6FIF0	Peroxisomal protein import;Protein localization
Q6GMR7	Metabolism;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
Q6GPH4	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
Q6GPI1	Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q6GQQ9	Signal Transduction;Metabolism of proteins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling
Q6GTS8	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial Uncoupling;Oleoyl-phe metabolism
Q6GTX8	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
Q6H3X3	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q6H8Q1	Developmental Biology;Netrin-1 signaling;DCC mediated attractive signaling;Axon guidance;Nervous system development
Q6I9Y2	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q6IA17	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling
Q6IA69	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q6IA86	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q6IAA8	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Innate Immune System;Immune System;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;Neutrophil degranulation;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q6IAN0	Metabolism;Metabolism of lipids;Plasmalogen biosynthesis;Wax and plasmalogen biosynthesis
Q6IB77	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Conjugation of benzoate with glycine;Biological oxidations
Q6IBW4	Cell Cycle;Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q6IE81	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q6IED9	Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6IEG0	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q6IEU7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IEV9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IEY1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IEZ7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IF00	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IF36	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IF42	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IF63	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IF82	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IF99	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IFG1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IFH4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IFN5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6IMI4	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
Q6IN84	rRNA modification in the mitochondrion;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q6IPM2	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO
Q6IPR3	tRNA modification in the nucleus and cytosol;Synthesis of wybutosine at G37 of tRNA(Phe);tRNA processing;Metabolism of RNA
Q6IPT4	Erythrocytes take up carbon dioxide and release oxygen;O2/CO2 exchange in erythrocytes;Transport of small molecules
Q6IPU0	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q6IQ16	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state
Q6IQ20	Signal Transduction;Disease;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Biosynthesis of A2E, implicated in retinal degradation;Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Diseases of the neuronal system
Q6IQ21	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6IQ22	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q6IQ26	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q6IQ55	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q6IS24	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q6ISS4	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q6ISU1	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
Q6IV72	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6IWH7	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q6J4K2	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Mitochondrial calcium ion transport
Q6JQN1	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q6JVE5	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of fatty acids
Q6KB66	Developmental Biology;Keratinization;Formation of the cornified envelope
Q6KC79	Cell Cycle;Cohesin Loading onto Chromatin;Mitotic Telophase/Cytokinesis;M Phase;Cell Cycle, Mitotic
Q6L8G4	Developmental Biology;Keratinization
Q6L8G5	Developmental Biology;Keratinization
Q6L8G8	Developmental Biology;Keratinization
Q6L8G9	Developmental Biology;Keratinization
Q6L8H1	Developmental Biology;Keratinization
Q6L8H2	Developmental Biology;Keratinization
Q6L8H4	Developmental Biology;Keratinization
Q6L8Q7	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;OAS antiviral response;Interferon Signaling
Q6MZP7	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Polo-like kinase mediated events;Cell Cycle;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;S Phase;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry
Q6MZZ7	Degradation of the extracellular matrix;Extracellular matrix organization
Q6N021	Epigenetic regulation of gene expression;TET1,2,3 and TDG demethylate DNA;Gene expression (Transcription)
Q6NS38	ALKBH2 mediated reversal of alkylation damage;DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
Q6NSJ5	Transport of small molecules;Miscellaneous transport and binding events
Q6NSZ9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6NT55	Metabolism;Disease;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Metabolism of lipids;Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Fatty acid metabolism
Q6NTF7	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
Q6NUI2	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q6NUK4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q6NUM9	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q6NUN0	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Biological oxidations
Q6NUN9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6NUQ1	Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q6NUS6	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q6NUS8	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q6NVV3	Transport of small molecules;Miscellaneous transport and binding events
Q6NVY1	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q6NW40	Developmental Biology;Netrin-1 signaling;Axon guidance;Nervous system development
Q6NX45	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6NX49	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6NXG1	Signal Transduction;Disease;Signaling by FGFR;Signaling by FGFR2;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases
Q6NXT4	Insulin processing;Peptide hormone metabolism;Transport of small molecules;Metabolism of proteins;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc efflux and compartmentalization by the SLC30 family
Q6NYC1	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q6NZ36	Fanconi Anemia Pathway;DNA Repair
Q6NZ67	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q6NZI2	RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q6NZY7	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
Q6P050	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6P0N0	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
Q6P161	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q6P179	Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q6P1A2	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6P1J6	Metabolism;Acyl chain remodelling of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of lipids;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q6P1J9	Formation of RNA Pol II elongation complex ;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Metabolism of proteins;Signaling by Hedgehog;Hedgehog 'on' state;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q6P1K2	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q6P1L6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P1L8	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q6P1M0	Disease;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;SLC transporter disorders;Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS);Disorders of transmembrane transporters;Transport of fatty acids
Q6P1X5	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q6P280	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P2C8	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P2D0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P2E9	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Metabolism of RNA
Q6P2Q9	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q6P3S1	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q6P3V2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P3W2	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Synthesis of diphthamide-EEF2;Post-translational protein modification
Q6P461	Metabolism;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of butanoyl-CoA to acetyl-CoA;Fatty acid metabolism
Q6P499	Transport of small molecules;Miscellaneous transport and binding events
Q6P4A8	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Hydrolysis of LPC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6P4F1	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q6P4F2	Mitochondrial iron-sulfur cluster biogenesis;Metabolism;Disease;Metabolism of steroid hormones;Pregnenolone biosynthesis;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Electron transport from NADPH to Ferredoxin;Metabolism of lipids;Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
Q6P4F7	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q6P4R8	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q6P531	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations;Aflatoxin activation and detoxification
Q6P582	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q6P587	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
Q6P589	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids
Q6P597	Hemostasis;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;RHO GTPases activate KTN1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q6P5R6	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q6P5W5	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family;Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ);SLC transporter disorders;Disorders of transmembrane transporters
Q6P5Z2	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate PKNs
Q6P6C2	DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
Q6P988	Signal Transduction;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Hedgehog ligand biogenesis;Signaling by Hedgehog;Release of Hh-Np from the secreting cell;Post-translational protein modification;Post-translational protein phosphorylation
Q6P9A1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P9A2	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q6P9A3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P9B9	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6P9F7	Transport of small molecules;Miscellaneous transport and binding events
Q6PCB0	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q6PCB7	Metabolism;PPARA activates gene expression;Transport of small molecules;Regulation of lipid metabolism by PPARalpha;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of lipids;Transport of fatty acids
Q6PCB8	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Proton-coupled monocarboxylate transport
Q6PCE3	Metabolism;Glycogen synthesis;Glycolysis;Glycogen breakdown (glycogenolysis);Glucose metabolism;Galactose catabolism;Metabolism of carbohydrates;Glycogen metabolism
Q6PCT2	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6PD62	Formation of RNA Pol II elongation complex ;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q6PEX3	Developmental Biology;Keratinization
Q6PEY0	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q6PEY2	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q6PF04	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6PFW1	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol
Q6PG37	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6PGP7	Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Metabolism of RNA
Q6PGQ7	Cell Cycle;Regulation of PLK1 Activity at G2/M Transition;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic
Q6PH85	Metabolism of proteins;Post-translational protein modification;Neddylation
Q6PHR2	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state
Q6PHW0	Metabolism;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Metabolism of amino acids and derivatives
Q6PI25	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q6PI48	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q6PI73	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q6PI98	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q6PIF2	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q6PIL0	Hemostasis;Adaptive Immune System;Disease;Complement cascade;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Classical antibody-mediated complement activation;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;Fcgamma receptor (FCGR) dependent phagocytosis;FCGR activation;Regulation of actin dynamics for phagocytic cup formation;Role of phospholipids in phagocytosis;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;FCERI mediated NF-kB activation;Vesicle-mediated transport;Infectious disease;CD22 mediated BCR regulation;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Leishmania parasite growth and survival;Regulation of Complement cascade;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q6PIL6	Muscle contraction;Cardiac conduction;Phase 1 - inactivation of fast Na+ channels
Q6PIU1	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q6PIU2	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;LDL clearance;Plasma lipoprotein clearance
Q6PIZ9	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
Q6PJ21	Metabolism of proteins;Post-translational protein modification;Neddylation
Q6PJF5	Disease;Infectious disease;Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q6PJG9	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
Q6PJI9	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q6PJP8	Fanconi Anemia Pathway;DNA Repair
Q6PK81	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6PKD1	Hemostasis;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q6PKX4	Developmental Biology;Axon guidance;RET signaling;Nervous system development
Q6PL18	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
Q6PXP3	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q6Q0C0	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6Q788	Metabolism;Plasma lipoprotein assembly, remodeling, and clearance;PPARA activates gene expression;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Post-translational protein modification;Post-translational protein phosphorylation;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Chylomicron remodeling
Q6QHC5	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q6QHF9	Amine Oxidase reactions;PAOs oxidise polyamines to amines;Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Interconversion of polyamines;Metabolism of polyamines;Metabolism of amino acids and derivatives;Peroxisomal protein import;Protein localization
Q6QNY0	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q6R327	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Disease;Immune System;Signaling by VEGF;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Transcriptional Regulation by TP53;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases
Q6R6M4	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q6RW13	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q6STE5	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);RMTs methylate histone arginines;Chromatin modifying enzymes;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Metabolism of steroids
Q6SVX2	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SVX3	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SVZ0	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SVZ5	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SW04	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW10	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SW29	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW31	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SW37	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW43	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW46	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW48	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW50	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW55	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SW59	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW62	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SW63	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW65	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW66	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW67	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW70	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SW73	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW77	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW79	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SW81	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW84	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW85	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW87	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW89	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SW94	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SW99	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SWA0	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SWA3	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SWA4	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SWB7	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SWB8	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SWB9	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SWC3	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SWC5	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SWC6	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SWC7	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q6SWD1	Disease;Infectious disease;HCMV Infection;HCMV Early Events;HCMV Late Events
Q6SWD5	Disease;Infectious disease;HCMV Infection;HCMV Early Events
Q6SZW1-1	Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex
Q6T4P5	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Lysosphingolipid and LPA receptors;GPCR ligand binding
Q6TCH7	Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q6TGC4	Chromatin modifying enzymes;Chromatin organization
Q6U736	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding
Q6U841	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q6UB35	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q6UN15	Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Disease;Diseases of signal transduction by growth factor receptors and second messengers;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA;Signaling by PDGFR in disease;Signaling by cytosolic PDGFRA and PDGFRB fusion proteins
Q6UQ28	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q6UUV7	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Circadian Clock
Q6UUV9	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Circadian Clock
Q6UVK1	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;CS/DS degradation;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective CHST3 causes SEDCJD;Defective CHST14 causes EDS, musculocontractural type;Defective CHSY1 causes TPBS;Diseases of glycosylation;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of carbohydrates
Q6UW15	Innate Immune System;Immune System;Antimicrobial peptides
Q6UW88	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;Negative regulation of the PI3K/AKT network;Membrane Trafficking;EGFR interacts with phospholipase C-gamma;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
Q6UWB1	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-35 Signalling;Interleukin-27 signaling
Q6UWE0	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6UWL6	Cell-Cell communication;Nephrin family interactions
Q6UWM9	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q6UWN0	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q6UWN5	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q6UWN8	Developmental Biology;Keratinization;Formation of the cornified envelope
Q6UWP7	Metabolism;Acyl chain remodeling of CL;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6UWR7	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids;Glycerophospholipid catabolism
Q6UWU2	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Glycosphingolipid metabolism;Keratan sulfate degradation;HS-GAG degradation;Sphingolipid metabolism;Metabolism of lipids;Metabolism of carbohydrates
Q6UWV6	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q6UWW0	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of fatty acids
Q6UWW8	Metabolism;Plasma lipoprotein assembly, remodeling, and clearance;Biological oxidations;Phase I - Functionalization of compounds;Transport of small molecules;LDL clearance;Plasma lipoprotein clearance
Q6UWY0	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
Q6UWZ7	Cell Cycle;Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
Q6UX04	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q6UX06	Innate Immune System;Immune System;Neutrophil degranulation
Q6UX39	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q6UX41	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
Q6UX72	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q6UX82	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q6UXB3	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q6UXB4	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q6UXG3	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q6UXG8	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
Q6UXH0	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q6UXL0	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q6UXN2	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q6UXV1	Fertilization;Acrosome Reaction and Sperm:Oocyte Membrane Binding;Reproduction
Q6UXV4	Hemostasis;Platelet degranulation ;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Cristae formation
Q6UXX9	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination
Q6UXZ3	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q6UXZ4	Developmental Biology;Netrin-1 signaling;Netrin mediated repulsion signals;Axon guidance;Nervous system development
Q6UY14	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q6V0L0	Metabolism;Signal Transduction;Disease;Biological oxidations;Cytochrome P450 - arranged by substrate type;Vitamins;Phase I - Functionalization of compounds;Signaling by Retinoic Acid;RA biosynthesis pathway;Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Signaling by Nuclear Receptors
Q6V9R5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6VAB6	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
Q6VMQ6	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q6VN20	Signal Transduction;Signaling by MET;MET activates RAS signaling;Signaling by Receptor Tyrosine Kinases
Q6VUC0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors
Q6VVB1	Metabolism;Disease;Glycogen storage diseases;Glycogen synthesis;Myoclonic epilepsy of Lafora;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates;Glycogen metabolism
Q6VVX0	Metabolism;Disease;Vitamin D (calciferol) metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Vitamins;Phase I - Functionalization of compounds;Metabolism of lipids;Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Metabolism of steroids
Q6VY07	HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Infectious disease
Q6W4X9	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q6W5P4	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q6WBX8	Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q6WCQ1	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q6X9E4	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6XPR3	Developmental Biology;Keratinization;Formation of the cornified envelope
Q6XPS3	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Metabolism of lipids
Q6XQN6	Metabolism;Innate Immune System;Immune System;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging;Neutrophil degranulation
Q6XR72	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters
Q6XYQ8	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q6XZB0	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6Y1H2	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q6Y288	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q6YBV0	Metabolism;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q6YHK3	Hemostasis;Platelet degranulation ;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q6YHU6	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q6YP21	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q6ZMB0	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q6ZMC9	Innate Immune System;Immune System;DAP12 interactions
Q6ZMG9	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q6ZMH5	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q6ZMJ2	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Vesicle-mediated transport
Q6ZMJ4	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling
Q6ZMM2	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q6ZMP0	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q6ZMR3	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q6ZMT4	Disease;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q6ZMU5	Muscle contraction;Smooth Muscle Contraction
Q6ZMV8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZMV9	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q6ZMW2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZMY9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZMZ0	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6ZN11	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZN18	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;Gene expression (Transcription)
Q6ZN44	Apoptosis;Developmental Biology;Netrin-1 signaling;Netrin mediated repulsion signals;Caspase activation via Dependence Receptors in the absence of ligand;Axon guidance;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Nervous system development
Q6ZN57	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZN66	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q6ZN79	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZNA4	Adaptive Immune System;Signal Transduction;Immune System;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Signaling by TGF-beta family members;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6ZNB7	Metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q6ZNC4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZNC8	Metabolism;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6ZNE5	Macroautophagy;Autophagy
Q6ZNG0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZNG1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZNI0	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q6ZNJ1	Innate Immune System;Immune System;Neutrophil degranulation
Q6ZP29	Transport of small molecules;Miscellaneous transport and binding events
Q6ZPD8	Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6ZQN7	Innate Immune System;Immune System;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Neutrophil degranulation;Transport of organic anions
Q6ZQW0	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q6ZQY3	Metabolism;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives;Aspartate and asparagine metabolism
Q6ZR52	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZRH7	Fertilization;Sperm Motility And Taxes;Reproduction
Q6ZRI8	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q6ZS11	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q6ZS27	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZS82	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q6ZSI9	Degradation of the extracellular matrix;Extracellular matrix organization
Q6ZSS3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q6ZSZ5	Signal Transduction;Signaling by TGF-beta Receptor Complex;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling;Signaling by TGF-beta family members
Q6ZT98	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q6ZTW0	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q6ZUJ8	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q6ZUM4	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q6ZUT9	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q6ZUV0	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q6ZUX7	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q6ZV29	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids;Glycerophospholipid catabolism
Q6ZVD8	PIP3 activates AKT signaling;Signal Transduction;Negative regulation of the PI3K/AKT network;Intracellular signaling by second messengers
Q6ZVK8-1	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
Q6ZVN8	Developmental Biology;Netrin-1 signaling;Axon guidance;Nervous system development
Q6ZVT0	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q6ZVZ8	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q6ZW31	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q6ZW49	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
Q6ZW61	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q6ZWL3	Metabolism;Signal Transduction;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q6ZWT7	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q6ZYL4	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
Q701N2	Developmental Biology;Keratinization
Q701N4	Developmental Biology;Keratinization
Q70626	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
Q709F0	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q70CQ1	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q70CQ2	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q70CQ3	Macroautophagy;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Autophagy;Selective autophagy;Pexophagy
Q70EL2	Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);DNA Repair
Q70EL4	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;DNA Repair
Q70HW3	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q70J99	Innate Immune System;Immune System;Neutrophil degranulation
Q70JA7	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q70SY1	Unfolded Protein Response (UPR);Metabolism of proteins;CREB3 factors activate genes
Q70Z35	PIP3 activates AKT signaling;Signal Transduction;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers
Q70Z44	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
Q712K3	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q717R9	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;Trafficking of myristoylated proteins to the cilium
Q719H9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
Q71DI3	Hemostasis;Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Reproduction;Meiosis;Signaling by NOTCH;Signal Transduction;Cell Cycle;Disease;Immune System;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;HDACs deacetylate histones;PKMTs methylate histone lysines;HDMs demethylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Signaling by Interleukins;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation;Factors involved in megakaryocyte development and platelet production
Q71F23	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q71F56	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q71RS6	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6);SLC transporter disorders;Disorders of transmembrane transporters
Q71SY5	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q71U36	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;AURKA Activation by TPX2;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q71UI9	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;RMTs methylate histone arginines;Chromatin modifying enzymes;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;Transcriptional regulation of granulopoiesis
Q71UM5	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q75MW2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q75N03	Disease;Infectious disease;Listeria monocytogenes entry into host cells;InlA-mediated entry of Listeria monocytogenes into host cells
Q75N90	Degradation of the extracellular matrix;Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q75QN2	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q75T13	Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q75V66	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q765I0	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q76EJ3	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Keratan sulfate biosynthesis;HS-GAG biosynthesis;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of carbohydrates;Transport of nucleotide sugars
Q76L83	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification
Q76LX8	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q76N89	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Degradation of DVL
Q76NM5	Hemostasis;Cell surface interactions at the vascular wall
Q76RF1	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death
Q7D8E1	Latent infection - Other responses of Mtb to phagocytosis;Cell redox homeostasis;Disease;Infectious disease;Infection with Mycobacterium tuberculosis
Q7KYR7	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
Q7KZ85	Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q7KZF4	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q7KZN9	Metabolism;Metabolism of porphyrins;Heme biosynthesis
Q7L014	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q7L0J3	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type A (BoNT/A);Toxicity of botulinum toxin type F (BoNT/F);Toxicity of botulinum toxin type E (BoNT/E);Uptake and actions of bacterial toxins;Infectious disease
Q7L0Q8	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q7L0Y3	tRNA processing in the mitochondrion;tRNA modification in the mitochondrion;tRNA processing;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q7L190	Developmental Biology;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Transcriptional regulation of pluripotent stem cells
Q7L1I2	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type A (BoNT/A);Toxicity of botulinum toxin type F (BoNT/F);Toxicity of botulinum toxin type E (BoNT/E);Uptake and actions of bacterial toxins;Infectious disease
Q7L1S5-2	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q7L1T6	Erythrocytes take up carbon dioxide and release oxygen;O2/CO2 exchange in erythrocytes;Transport of small molecules
Q7L1V2	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q7L1W4	Transport of small molecules;Miscellaneous transport and binding events
Q7L266	Metabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine metabolism;Phenylalanine metabolism
Q7L2H7	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
Q7L2Z9	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q7L3B6	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q7L3S4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7L3T8	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q7L4E1	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q7L523	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Metabolism of proteins;TP53 Regulates Metabolic Genes;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q7L576	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Neutrophil degranulation;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q7L590	Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q7L591	Innate Immune System;Immune System;Neutrophil degranulation
Q7L592	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q7L5A8	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q7L5D6	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Q7L5L3	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids;Glycerophospholipid catabolism
Q7L5N1	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q7L5N7	Metabolism;Acyl chain remodelling of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q7L5Y6	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7L7L0	Disease;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;HCMV Infection;HCMV Early Events;HCMV Late Events
Q7L7X3	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q7L804	Transport of small molecules;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport
Q7L8W6	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Synthesis of diphthamide-EEF2;Post-translational protein modification
Q7L945	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7L9B9	Signal Transduction;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q7L9L4	Signal Transduction;Signaling by Hippo
Q7LBC6	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q7LBE3	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers
Q7LC44	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q7LDG7	Hemostasis;Effects of PIP2 hydrolysis;Adaptive Immune System;Signal Transduction;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Integrin signaling;Signaling by GPCR;GPCR downstream signalling;Rap1 signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
Q7LFL8	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q7LFX5	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q7LG56	Metabolism;Metabolism of nucleotides;Generic Transcription Pathway;Transcriptional Regulation by TP53;Interconversion of nucleotide di- and triphosphates;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7LGA3	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q7LGC8	Metabolism;Glycosaminoglycan metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Diseases associated with glycosaminoglycan metabolism;Defective CHST3 causes SEDCJD;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q7RTN6	Signal Transduction;mTOR signalling;Energy dependent regulation of mTOR by LKB1-AMPK
Q7RTP0	Transport of small molecules;Miscellaneous transport and binding events
Q7RTR2	Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;IRF3-mediated induction of type I IFN
Q7RTR8	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q7RTS3	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in early pancreatic precursor cells
Q7RTS7	Developmental Biology;Keratinization;Formation of the cornified envelope
Q7RTT9	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
Q7RTV0	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q7RTV2	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations
Q7RTW8	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q7RTX0	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q7RTX1	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q7RTX7	Fertilization;Sperm Motility And Taxes;Reproduction
Q7RTY9	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q7RTZ2	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q7Z2D5	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Lysosphingolipid and LPA receptors;GPCR ligand binding
Q7Z2F6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7Z2H8	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Proton-coupled neutral amino acid transporters
Q7Z2K8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates neuronal receptors and channels
Q7Z2W4	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q7Z2W7	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q7Z2W9	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q7Z340	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7Z392	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q7Z398	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7Z3B1	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q7Z3B3	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q7Z3B4	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q7Z3C6	Macroautophagy;Autophagy
Q7Z3J2	Innate Immune System;Immune System;Neutrophil degranulation
Q7Z3S7	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
Q7Z3T1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q7Z3T8	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q7Z3V4	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7Z3V5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7Z3Y7	Developmental Biology;Keratinization;Formation of the cornified envelope
Q7Z3Y8	Developmental Biology;Keratinization;Formation of the cornified envelope
Q7Z3Y9	Developmental Biology;Keratinization;Formation of the cornified envelope
Q7Z3Z0	Developmental Biology;Keratinization;Formation of the cornified envelope
Q7Z3Z4	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q7Z401	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q7Z403	Innate Immune System;Immune System;Neutrophil degranulation
Q7Z406	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;EPH-Ephrin signaling;Semaphorin interactions;EPHA-mediated growth cone collapse;Sema4D in semaphorin signaling;Sema4D induced cell migration and growth-cone collapse;Axon guidance;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;Nervous system development
Q7Z412	Peroxisomal protein import;Class I peroxisomal membrane protein import;Protein localization
Q7Z418	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK-related spinal cord K+ channel (TRESK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q7Z419	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7Z434	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;Negative regulators of DDX58/IFIH1 signaling
Q7Z449	Metabolism;Disease;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Miscellaneous substrates;Arachidonic acid metabolism;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE);Metabolism of lipids;Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Fatty acid metabolism
Q7Z460	Developmental Biology;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Signaling by ROBO receptors;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Axon guidance;Role of ABL in ROBO-SLIT signaling;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;AURKA Activation by TPX2;EML4 and NUDC in mitotic spindle formation;Nervous system development
Q7Z494	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;Trafficking of myristoylated proteins to the cilium
Q7Z4F1	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q7Z4G1	Metabolism of proteins;Post-translational protein modification;Neddylation
Q7Z4G4	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q7Z4H4	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;Calcitonin-like ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q7Z4H7	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q7Z4I7	Cell-Cell communication;Cell-extracellular matrix interactions;Cell junction organization
Q7Z4K8	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q7Z4L5	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q7Z4N2	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q7Z4N8	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q7Z4R8	Innate Immune System;Immune System;Neutrophil degranulation
Q7Z4S6	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q7Z4T8	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q7Z4W1	Metabolism;Disease;Formation of xylulose-5-phosphate;Essential pentosuria;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates
Q7Z4W3	Developmental Biology;Keratinization
Q7Z553	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q7Z569	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
Q7Z5G4	Innate Immune System;Immune System;Neutrophil degranulation
Q7Z5H3	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q7Z5J4	Circadian Clock
Q7Z5K2	Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic
Q7Z5N4	Cell-Cell communication;SDK interactions;Cell-cell junction organization;Cell junction organization
Q7Z5P4	Metabolism;Metabolism of lipids;Lipid particle organization
Q7Z5P9	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q7Z5Q5	Fanconi Anemia Pathway;DNA Repair
Q7Z5R6	Hemostasis;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation);FLT3 Signaling;Signaling downstream of RAS mutants
Q7Z5W3	MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Gene expression (Transcription)
Q7Z624	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Post-translational protein modification;Protein methylation
Q7Z628	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q7Z698	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by FGFR;Signaling by FGFR1;Regulation of RAS by GAPs;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RAS signaling downstream of NF1 loss-of-function variants;Oncogenic MAPK signaling;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q7Z699	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by FGFR;Signaling by FGFR1;Regulation of RAS by GAPs;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RAS signaling downstream of NF1 loss-of-function variants;Oncogenic MAPK signaling;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q7Z6A9	Adaptive Immune System;Immune System;Costimulation by the CD28 family
Q7Z6B7	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by ROBO receptors;Axon guidance;Inactivation of CDC42 and RAC1;Nervous system development
Q7Z6E9	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7Z6I6	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q7Z6J0	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7Z6J4	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q7Z6J8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7Z6J9	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q7Z6M1	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q7Z6M4	rRNA modification in the mitochondrion;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q7Z6P3	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation
Q7Z6R9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors
Q7Z6V5	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q7Z6Z6	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
Q7Z6Z7	Adaptive Immune System;Innate Immune System;Immune System;Neutrophil degranulation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7Z794	Developmental Biology;Keratinization;Formation of the cornified envelope
Q7Z7A1-3	Signaling by FGFR in disease;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
Q7Z7A1	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q7Z7A3	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q7Z7B1	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q7Z7B7	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q7Z7B8	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q7Z7C8	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q7Z7E8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q7Z7F7	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q7Z7H8	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q7Z7K2	Developmental Biology;Transcriptional regulation of white adipocyte differentiation
Q7Z7M8	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q7Z7M9	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q7Z7N9	Innate Immune System;Immune System;Neutrophil degranulation
Q86SE9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q86SF2	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q86SG5	Innate Immune System;Immune System;Metal sequestration by antimicrobial proteins;Antimicrobial peptides
Q86SJ6	Developmental Biology;Keratinization;Formation of the cornified envelope
Q86SK9	Developmental Biology;Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q86SQ4	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q86SQ7	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q86SQ9	Disease;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Synthesis of Dolichyl-phosphate;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective DHDDS causes retinitis pigmentosa 59;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
Q86SR1	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q86SS6	Neuronal System;Membrane Trafficking;Vesicle-mediated transport;Neurexins and neuroligins;Protein-protein interactions at synapses;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q86SX6	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q86SZ2	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q86T03	Metabolism;PI Metabolism;Phospholipid metabolism;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of lipids;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of PIPs in the nucleus
Q86T29	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86T82	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q86TB9	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Metabolism of RNA
Q86TH1	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q86TI0	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport
Q86TJ2	HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q86TJ5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86TL0	Macroautophagy;Autophagy
Q86TM6	Signal Transduction;Disease;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q86TS9	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q86TU7	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q86TX2	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q86U10	Metabolism;Metabolism of amino acids and derivatives;Aspartate and asparagine metabolism
Q86U28	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q86U42	Disease;Influenza Infection;NS1 Mediated Effects on Host Pathways;Inhibition of Host mRNA Processing and RNA Silencing;Infectious disease;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q86U44	Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q86U70	Developmental Biology;Generic Transcription Pathway;Signaling by ROBO receptors;Axon guidance;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of expression of SLITs and ROBOs;Nervous system development
Q86U86	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q86UD5	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q86UE3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86UE6	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q86UF1	Metabolism of proteins;Amyloid fiber formation
Q86UK0	ABC transporters in lipid homeostasis;Disease;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B
Q86UK5	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state;Activation of SMO
Q86UL3	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q86UL8	Cell-Cell communication;Nephrin family interactions
Q86UN2	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q86UN3	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q86UP0	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
Q86UP2	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;RHO GTPases activate KTN1;Post-translational protein modification;Post-translational protein phosphorylation
Q86UQ0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86UQ4	Innate Immune System;Immune System;Neutrophil degranulation
Q86UR1	Signal Transduction;Disease;Signaling by Rho GTPases;RHO GTPase Effectors;Infectious disease;RHO GTPases Activate NADPH Oxidases;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
Q86UR5	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Norepinephrine Neurotransmitter Release Cycle;Glutamate Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle;Acetylcholine Neurotransmitter Release Cycle;GABA synthesis, release, reuptake and degradation
Q86US8	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q86UT5	Disease;Uptake and actions of bacterial toxins;Infectious disease;Intestinal infectious diseases
Q86UT6	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling
Q86UU0	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Deactivation of the beta-catenin transactivating complex
Q86UV5	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q86UW9	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus
Q86UX7	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q86V21	Metabolism;Metabolism of lipids;Ketone body metabolism;Synthesis of Ketone Bodies
Q86V24	Metabolism;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism
Q86V71	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86V81	Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q86V97	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q86VB7	Disease;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors;Vesicle-mediated transport;Infectious disease;Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q86VD9	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q86VE9	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
Q86VF5	Metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q86VH2	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q86VH4	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q86VH5	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q86VI3	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate IQGAPs
Q86VL8	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport
Q86VN1	Disease;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events
Q86VP1	Signal Transduction;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Regulation of TNFR1 signaling;Death Receptor Signalling;TNF signaling;Negative regulators of DDX58/IFIH1 signaling
Q86VP6	Innate Immune System;Immune System;Transport of small molecules;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Neddylation;Iron uptake and transport
Q86VW1	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport
Q86VW2	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events
Q86VX2	Metabolism of proteins;Post-translational protein modification;Neddylation
Q86VX9	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q86VZ5	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q86W42	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q86W47	Hemostasis;Neuronal System;Ca2+ activated K+ channels;Potassium Channels;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
Q86W56	POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Base Excision Repair;DNA Repair;Resolution of Abasic Sites (AP sites)
Q86W92	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q86WA6	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
Q86WA8	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Peroxisomal protein import;Protein localization
Q86WA9	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers
Q86WC4	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q86WG5	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Membrane Trafficking;Metabolism of lipids;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q86WI3	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling
Q86WJ1	Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;DNA Repair
Q86WQ0	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86WT1	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q86WT6	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q86WU2	Mitochondrial protein import;Protein localization
Q86WV5	Telomere Maintenance;Cell Cycle;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;Extension of Telomeres;Chromosome Maintenance
Q86WV6	Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;STAT6-mediated induction of chemokines;IRF3-mediated induction of type I IFN;Neutrophil degranulation
Q86WX3	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q86WZ6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86X10	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport
Q86X29	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;LDL clearance;Plasma lipoprotein clearance;VLDL clearance
Q86X52	Metabolism;Glycosaminoglycan metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Diseases associated with glycosaminoglycan metabolism;Defective CHSY1 causes TPBS;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q86X55	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);RMTs methylate histone arginines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Metabolism of steroids;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q86X67	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q86X83	Metabolism of proteins;Post-translational protein modification;Neddylation
Q86XD5	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q86XE3	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q86XE5	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives
Q86XF0	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q86XI2	Cell Cycle;Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q86XK2	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q86XL3	Cell Cycle;Mitotic Metaphase and Anaphase;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
Q86XM0	Fertilization;Sperm Motility And Taxes;Reproduction
Q86XN6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86XP0	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Hydrolysis of LPC;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q86XP1	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
Q86XP3	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q86XQ3	Fertilization;Sperm Motility And Taxes;Reproduction
Q86XR7	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TRIF-mediated programmed cell death;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Neutrophil degranulation;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
Q86XR8	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q86XS8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q86XT2	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q86XT4	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q86XT9	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Death Receptors and Ligands;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86XU0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86Y01	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus
Q86Y07-2	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
Q86Y13	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q86Y22	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Integrin cell surface interactions;Collagen chain trimerization
Q86Y25	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86Y34	Innate Immune System;Immune System;Neutrophil degranulation
Q86Y38	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Metabolism of carbohydrates
Q86Y39	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q86Y46	Developmental Biology;Keratinization;Formation of the cornified envelope
Q86Y91	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q86Y97	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q86YB8	Insulin processing;Peptide hormone metabolism;Metabolism of proteins
Q86YC2	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;DNA Repair
Q86YE8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86YF9	Signal Transduction;Signaling by Hedgehog;Hedgehog 'on' state
Q86YH6	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
Q86YL7	Hemostasis;GPVI-mediated activation cascade;Platelet activation, signaling and aggregation
Q86YM7	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q86YN1	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Synthesis of Dolichyl-phosphate;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q86YN6	Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity
Q86YP4	PIP3 activates AKT signaling;Signal Transduction;Epigenetic regulation of gene expression;Generic Transcription Pathway;HDACs deacetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q86YR5	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q86YS6	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation
Q86YS7	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport
Q86YT5	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Sodium-coupled sulphate, di- and tri-carboxylate transporters
Q86YT6	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus
Q86YT9	Hemostasis;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall
Q86YV0	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q86YW0	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
Q86YW5	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q86YW7	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q86YZ3	Innate Immune System;Immune System;Neutrophil degranulation
Q86Z02	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;Muscle contraction;Cardiac conduction;Physiological factors;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q86Z14	PI3K Cascade;IRS-mediated signalling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;betaKlotho-mediated ligand binding;Signal Transduction;Disease;Immune System;Signaling by FGFR;FGFR4 ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade; FGFR4;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR4 signaling;Signaling by FGFR4;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q8HWS3	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
Q8IU54	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling;Interleukin-20 family signaling
Q8IU57	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling;Interleukin-20 family signaling
Q8IU60	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Metabolism of RNA
Q8IU80	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization
Q8IU89	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q8IUA7	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
Q8IUB9	Developmental Biology;Keratinization
Q8IUC0	Developmental Biology;Keratinization
Q8IUC1	Developmental Biology;Keratinization
Q8IUC2	Developmental Biology;Keratinization
Q8IUC4	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Rhotekin and Rhophilins
Q8IUC6	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;ZBP1(DAI) mediated induction of type I IFNs;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;RIP-mediated NFkB activation via ZBP1;Cytosolic sensors of pathogen-associated DNA ;TRIF-mediated programmed cell death;Diseases of Immune System;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Diseases associated with the TLR signaling cascade;TICAM1 deficiency - HSE;TRAF3 deficiency - HSE;TLR3-mediated TICAM1-dependent programmed cell death;TICAM1-dependent activation of IRF3/IRF7;TICAM1,TRAF6-dependent induction of TAK1 complex;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
Q8IUC8	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q8IUD6	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;Negative regulators of DDX58/IFIH1 signaling
Q8IUE6	Disease;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;HCMV Infection;HCMV Early Events;HCMV Late Events
Q8IUF8	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q8IUG1	Developmental Biology;Keratinization
Q8IUN9	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
Q8IUQ0	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Vesicle-mediated transport
Q8IUQ4	Developmental Biology;Adaptive Immune System;Immune System;Netrin-1 signaling;Metabolism of proteins;Axon guidance;Nervous system development;Amyloid fiber formation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8IUR0	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q8IUR6	Unfolded Protein Response (UPR);Metabolism of proteins;CREB3 factors activate genes
Q8IUR7	Innate Immune System;Immune System;Neutrophil degranulation
Q8IUX1	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q8IUZ0	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q8IUZ5	Metabolism;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Lysine catabolism;Metabolism of amino acids and derivatives
Q8IV01	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q8IV04	Innate Immune System;Immune System;Membrane Trafficking;Vesicle-mediated transport;Neutrophil degranulation;TBC/RABGAPs;Rab regulation of trafficking
Q8IV08	Metabolism;Synthesis of PG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism of lipids
Q8IV16	Metabolism;Signal Transduction;Post-translational modification: synthesis of GPI-anchored proteins;Plasma lipoprotein assembly, remodeling, and clearance;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;Metabolism of proteins;G alpha (i) signalling events;Post-translational protein modification;Metabolism of fat-soluble vitamins;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Chylomicron remodeling;Retinoid metabolism and transport
Q8IV42	Metabolism;Selenoamino acid metabolism;Selenocysteine synthesis;Metabolism of amino acids and derivatives
Q8IV48	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q8IV53	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8IV61	Downstream signaling events of B Cell Receptor (BCR);Activation of RAS in B cells;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Immune System;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Signaling by the B Cell Receptor (BCR)
Q8IV63	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Signaling by NTRKs;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);ERK/MAPK targets;ERKs are inactivated;Interleukin-17 signaling;Signaling by Interleukins;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;Signaling by Receptor Tyrosine Kinases;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q8IV77	Organelle biogenesis and maintenance;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
Q8IVA1	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q8IVB4	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers;Defective SLC9A9 causes autism 16 (AUTS16);SLC transporter disorders;Disorders of transmembrane transporters
Q8IVC4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IVF5	Metabolism;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;PPARA activates gene expression;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;Regulation of lipid metabolism by PPARalpha;G alpha (12/13) signalling events;Metabolism of lipids;Death Receptor Signalling
Q8IVF7	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins
Q8IVG9	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;GPCR ligand binding
Q8IVH4	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective MMAA causes methylmalonic aciduria type cblA;Defective MUT causes methylmalonic aciduria mut type;Metabolism of lipids;Diseases of metabolism;Propionyl-CoA catabolism;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q8IVI9	Metabolism;Metabolism of nitric oxide: eNOS activation and regulation;NOSTRIN mediated eNOS trafficking
Q8IVJ1	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters
Q8IVK1	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8IVL5	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q8IVL6	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q8IVN8	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8IVP5	Macroautophagy;Mitophagy;Receptor Mediated Mitophagy;Autophagy;Selective autophagy
Q8IVP9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IVQ6	Metabolism;Signal Transduction;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
Q8IVS2	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q8IVS8	Metabolism;Fructose metabolism;Fructose catabolism;Metabolism of carbohydrates
Q8IVT5	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAP2K and MAPK activation;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
Q8IVU3	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8IW35	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q8IW41	Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Transcriptional Regulation by TP53;Regulation of TP53 Activity;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli
Q8IW45	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q8IW52	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q8IW93	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q8IWA0	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q8IWA4	Hemostasis;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Autophagy;Selective autophagy;Factors involved in megakaryocyte development and platelet production
Q8IWA5	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metabolism of lipids;Neutrophil degranulation
Q8IWE4	Metabolism of proteins;Post-translational protein modification;Neddylation
Q8IWF6	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8IWI9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
Q8IWJ2	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q8IWL1	Cell-Cell communication;Disease;Toll Like Receptor 4 (TLR4) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signal regulatory protein family interactions;Metabolism of proteins;Diseases of metabolism;Surfactant metabolism;Regulation of TLR by endogenous ligand;Diseases associated with surfactant metabolism;Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF);Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
Q8IWL2	Cell-Cell communication;Disease;Toll Like Receptor 4 (TLR4) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Signal regulatory protein family interactions;Metabolism of proteins;Diseases of metabolism;Surfactant metabolism;Regulation of TLR by endogenous ligand;Diseases associated with surfactant metabolism;Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5);Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
Q8IWL3	Mitochondrial protein import;Mitochondrial iron-sulfur cluster biogenesis;Metabolism;Protein localization
Q8IWT0	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q8IWT1	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q8IWT3	Metabolism of proteins;Post-translational protein modification;Neddylation
Q8IWT6	Transport of small molecules;Miscellaneous transport and binding events
Q8IWU4	Insulin processing;Peptide hormone metabolism;Transport of small molecules;Metabolism of proteins;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc efflux and compartmentalization by the SLC30 family
Q8IWU9	Metabolism;Metabolism of amine-derived hormones;Serotonin and melatonin biosynthesis;Metabolism of amino acids and derivatives
Q8IWV2	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q8IWV7	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8IWV8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8IWW6	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8IWW8	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Interconversion of 2-oxoglutarate and 2-hydroxyglutarate
Q8IWX5	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q8IWX8	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8IWY4	Degradation of the extracellular matrix;Extracellular matrix organization
Q8IWZ4	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q8IWZ6	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q8IWZ8	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8IX03	Signaling by NOTCH;Signal Transduction;Signaling by Hippo;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
Q8IX07	Hemostasis;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Factors involved in megakaryocyte development and platelet production
Q8IX12	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8IX19	Innate Immune System;Immune System;Neutrophil degranulation
Q8IX30	Degradation of the extracellular matrix;Extracellular matrix organization
Q8IXE1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8IXF9	Transport of small molecules;Passive transport by Aquaporins;Aquaporin-mediated transport
Q8IXH7	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q8IXI1	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8IXI2	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q8IXJ6	Cell Cycle;Mitotic Metaphase and Anaphase;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
Q8IXJ9	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification
Q8IXK0	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q8IXK2	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins
Q8IXL6	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q8IXL7	Metabolism of proteins;Protein repair
Q8IXM3	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q8IXN7	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
Q8IXQ6	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q8IXQ9	Metabolism of proteins;Post-translational protein modification;Protein methylation
Q8IXW5	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IXY8	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8IY17	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids;Glycerophospholipid catabolism
Q8IY18	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification
Q8IY26	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
Q8IY31	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8IY34	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Proton/oligopeptide cotransporters
Q8IY37	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q8IY57	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Transcriptional Regulation by E2F6
Q8IY63	Signal Transduction;Signaling by Hippo
Q8IY81	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q8IY92	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Fanconi Anemia Pathway;DNA Repair
Q8IYB3	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q8IYB9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IYD1	Developmental Biology;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Eukaryotic Translation Termination;Translation;Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q8IYD8	Fanconi Anemia Pathway;DNA Repair
Q8IYF1	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q8IYH5	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q8IYI6	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
Q8IYI8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IYJ0	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8IYJ3	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q8IYK4	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q8IYL2	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q8IYL9	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q8IYM9	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q8IYN0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IYS5	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
Q8IYU2	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8IYU8	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q8IYV9	Fertilization;Acrosome Reaction and Sperm:Oocyte Membrane Binding;Reproduction
Q8IYW5	Cell Cycle;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
Q8IYX0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IZ26	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IZ52	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q8IZC6	Extracellular matrix organization;Collagen formation;Signal Transduction;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Collagen chain trimerization;Signaling by Receptor Tyrosine Kinases
Q8IZC7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8IZD2	Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q8IZD4	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Metabolism of RNA
Q8IZD6	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport
Q8IZD9	Hemostasis;Signal Transduction;Signaling by NTRKs;Signaling by NTRK2 (TRKB);Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through FYN;NTRK2 activates RAC1;Factors involved in megakaryocyte development and platelet production
Q8IZF0	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8IZF2	Metabolism of proteins;Surfactant metabolism
Q8IZH2	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of RNA
Q8IZI9	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q8IZJ0	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q8IZJ1	Apoptosis;Developmental Biology;Netrin-1 signaling;Netrin mediated repulsion signals;Caspase activation via Dependence Receptors in the absence of ligand;Axon guidance;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Nervous system development
Q8IZJ6	Metabolism;Metabolism of amino acids and derivatives;Threonine catabolism
Q8IZK6	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q8IZL2	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Signaling by NOTCH2;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q8IZL8	Signal Transduction;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;Signaling by PTK6;PTK6 Expression;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Signaling by Non-Receptor Tyrosine Kinases
Q8IZM6	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8IZN7	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8IZP0	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q8IZP1	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q8IZP7	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q8IZS6	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8IZS8	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
Q8IZT8	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q8IZU3	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q8IZU8	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Dermatan sulfate biosynthesis;Metabolism of carbohydrates
Q8IZU9	Cell-Cell communication;Nephrin family interactions
Q8IZV5	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
Q8IZW8	Signal Transduction;Signaling by MET;MET interacts with TNS proteins;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
Q8IZX4	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q8IZY2	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
Q8N0S2	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q8N0S6	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q8N0U8	Metabolism;Metabolism of vitamins and cofactors;Metabolism of vitamin K;Metabolism of fat-soluble vitamins
Q8N0V4	Developmental Biology;LGI-ADAM interactions
Q8N0W3	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;GDP-fucose biosynthesis
Q8N0W4	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q8N0Y3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N0Y5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N0Z6	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N103	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8N104	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8N114	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q8N122	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q8N126	Cell-Cell communication;Adherens junctions interactions;Nectin/Necl  trans heterodimerization;Cell-cell junction organization;Cell junction organization
Q8N127	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N130	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Type II Na+/Pi cotransporters;Sodium-coupled phosphate cotransporters;Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH);SLC transporter disorders;Disorders of transmembrane transporters
Q8N135	Developmental Biology;LGI-ADAM interactions
Q8N138	Metabolism;Sphingolipid de novo biosynthesis;Innate Immune System;Immune System;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation
Q8N139	ABC transporters in lipid homeostasis;Generic Transcription Pathway;Transport of small molecules;ABC-family proteins mediated transport;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
Q8N140	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification
Q8N142	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
Q8N144	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q8N145	Developmental Biology;LGI-ADAM interactions
Q8N146	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N148	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N149	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8N157	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q8N158	Metabolism;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Visual phototransduction;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport
Q8N159	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
Q8N162	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N163	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q8N183	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q8N184	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N1B4	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q8N1E6	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8N1F7	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q8N1F8	Innate Immune System;Immune System;Neutrophil degranulation
Q8N1I0	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q8N1M1	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8N1N4	Developmental Biology;Keratinization;Formation of the cornified envelope
Q8N1Q1	Metabolism;Reversible hydration of carbon dioxide
Q8N1Q8	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q8N1W1	Developmental Biology;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Nervous system development
Q8N1W2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N201	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N257	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q8N264	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8N2A8	Metabolism;Synthesis of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Gene Silencing by RNA;Metabolism of lipids;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q8N2C7	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8N2G4	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q8N2G8	Innate Immune System;Immune System;Neutrophil degranulation
Q8N2H4	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q8N2H9	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;IRAK1 recruits IKK complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q8N2I2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N2K0	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Arachidonate production from DAG;Platelet activation, signaling and aggregation
Q8N2K1-1	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Q8N2K1	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8N2Q7	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q8N2S1	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q8N2W9	Metabolism;Cell Cycle;Vitamin D (calciferol) metabolism;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;SUMOylation of ubiquitinylation proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of intracellular receptors;SUMOylation of DNA replication proteins;SUMOylation of immune response proteins;Metabolism of lipids;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;Metabolism of steroids
Q8N2Z9	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Fanconi Anemia Pathway;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;DNA Repair;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q8N302	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q8N307	Signal Transduction;Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;Signaling by MET;MET activates RAS signaling;Signaling by Receptor Tyrosine Kinases;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q8N335	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8N339	Response to metal ions;Metallothioneins bind metals;Cellular responses to external stimuli
Q8N349	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N370	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q8N387	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q8N392	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8N393	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N3A8	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q8N3C0	ALKBH3 mediated reversal of alkylation damage;DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
Q8N3E9	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
Q8N3I7	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q8N3J5	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q8N3J6	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
Q8N3J9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N3R9	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q8N3T1	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q8N3U4	Meiotic synapsis;Reproduction;Meiosis;Signal Transduction;Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q8N3Y1	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8N3Y3	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification
Q8N3Y7	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
Q8N423	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
Q8N428	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q8N441	Signal Transduction;Signaling by FGFR;Signaling by FGFR1;FGFRL1 modulation of FGFR1 signaling;Signaling by Receptor Tyrosine Kinases
Q8N461	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8N465	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Interconversion of 2-oxoglutarate and 2-hydroxyglutarate
Q8N474	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
Q8N488	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Transcriptional Regulation by E2F6
Q8N4A0	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q8N4C8	Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to external stimuli
Q8N4E7	Transport of small molecules;Iron uptake and transport
Q8N4F0	Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Antimicrobial peptides;Post-translational protein phosphorylation
Q8N4H5	Mitochondrial protein import;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Protein localization;Autophagy;Selective autophagy
Q8N4J0	Metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
Q8N4M1	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metabolism of lipids
Q8N4N8	Hemostasis;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Vesicle-mediated transport;RHO GTPases Activate Formins;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;EML4 and NUDC in mitotic spindle formation;Kinesins;Factors involved in megakaryocyte development and platelet production
Q8N4P2	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8N4Q1	Mitochondrial protein import;Protein localization
Q8N4T4	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q8N4T8	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
Q8N4V1	Transport of small molecules;Miscellaneous transport and binding events
Q8N4Z0	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q8N587	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N5B7	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q8N5C8	Cytokine Signaling in Immune system;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;TNFR1-induced NFkappaB signaling pathway;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Death Receptor Signalling;TNF signaling;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Alpha-protein kinase 1 signaling pathway;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane
Q8N5D0	Metabolism of proteins;Post-translational protein modification;Neddylation
Q8N5N7	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q8N5P1	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N5S9	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;DAG and IP3 signaling;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;Activation of NMDA receptors and postsynaptic events;Intracellular signaling by second messengers;Activation of RAC1 downstream of NMDARs
Q8N5V2	Developmental Biology;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;EPH-Ephrin signaling;Signaling by GPCR;GPCR downstream signalling;EPHA-mediated growth cone collapse;G alpha (12/13) signalling events;Axon guidance;Death Receptor Signalling;Nervous system development
Q8N5X7	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
Q8N5Y2	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q8N5Y8	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q8N5Z0	Metabolism;Lysine catabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q8N628	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8N661	Metabolism;Acyl chain remodelling of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8N668	Metabolism of proteins;Post-translational protein modification;Neddylation
Q8N684	mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q8N687	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8N688	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8N690	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8N695	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters
Q8N697	Innate Immune System;Immune System;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Proton/oligopeptide cotransporters;Neutrophil degranulation
Q8N6C8	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
Q8N6D2	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8N6F1	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q8N6G5	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q8N6G6	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8N6H7	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q8N6M3	Metabolism;Metabolism of lipids;Lipid particle organization
Q8N6M6	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins
Q8N6N7	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q8N6P7	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q8N6Q3	Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Innate Immune System;Immune System;Cell surface interactions at the vascular wall;Neutrophil degranulation
Q8N6T3	ER to Golgi Anterograde Transport;Membrane Trafficking;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Clathrin-mediated endocytosis;Transport to the Golgi and subsequent modification
Q8N6T7	Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;DNA Repair
Q8N6U8	Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state;Hedgehog 'on' state
Q8N720	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N726	Apoptosis;Intrinsic Pathway for Apoptosis;Apoptotic factor-mediated response;Cell Cycle;Disease;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Transcriptional Regulation by TP53;Metabolism of proteins;Programmed Cell Death;Regulation of TP53 Activity;Post-translational protein modification;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Cellular responses to external stimuli;Diseases of Cellular Senescence;Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function;Diseases of programmed cell death;Evasion of Oncogene Induced Senescence Due to p14ARF Defects;Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects;Diseases of cellular response to stress
Q8N729	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q8N7E2	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8N7H5	Formation of RNA Pol II elongation complex ;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q8N7K0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N7M0	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8N7P3	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q8N7Q3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N823	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N841	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q8N859	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N883	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N884	Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA 
Q8N8D1	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8N8J6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N8N0	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q8N8N7	Metabolism;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism
Q8N8Q8	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N8Q9	Transport of small molecules;Miscellaneous transport and binding events
Q8N8R3	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q8N8S7	Developmental Biology;Adaptive Immune System;Immune System;TCR signaling;Generation of second messenger molecules;Signaling by ROBO receptors;Axon guidance;Nervous system development
Q8N8V2	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q8N8Y2	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q8N8Z8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N907	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL
Q8N972	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N983	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q8N988	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N9A8	Cell Cycle;Nuclear Envelope Breakdown;Depolymerisation of the Nuclear Lamina;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q8N9B5	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N9B8	Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q8N9F0	Metabolism;Metabolism of amino acids and derivatives;Aspartate and asparagine metabolism
Q8N9F7	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids;Glycerophospholipid catabolism
Q8N9F8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N9I0	Neuronal System;Disease;Neurotoxicity of clostridium toxins;Membrane Trafficking;Toxicity of botulinum toxin type B (BoNT/B);Uptake and actions of bacterial toxins;Vesicle-mediated transport;Infectious disease;Neurexins and neuroligins;Protein-protein interactions at synapses;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q8N9K5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N9L9	Metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q8N9N2	ALKBH3 mediated reversal of alkylation damage;DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
Q8N9N5	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8N9R8	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins
Q8N9Z0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NA29	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8NA42	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NAC3	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins
Q8NAN2	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8NAT1	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification
Q8NAV1	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8NB16	Stimuli-sensing channels;TRP channels;Transport of small molecules;RIPK1-mediated regulated necrosis;Regulated Necrosis;Programmed Cell Death;Ion channel transport
Q8NB49	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q8NB78	Signal Transduction;HDMs demethylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;UCH proteinases;Post-translational protein modification;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q8NB91	Fanconi Anemia Pathway;DNA Repair
Q8NBF2	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q8NBJ4	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q8NBJ5	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q8NBJ7	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
Q8NBK3	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
Q8NBL1	Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in the Endoplasmic Reticulum;Pre-NOTCH Expression and Processing
Q8NBM8	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q8NBN7	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
Q8NBP7	Plasma lipoprotein assembly, remodeling, and clearance;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Post-translational protein modification;VLDLR internalisation and degradation;Post-translational protein phosphorylation;LDL clearance;Plasma lipoprotein clearance
Q8NBQ5	Metabolism;Estrogen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
Q8NBQ7	Transport of small molecules;Passive transport by Aquaporins;Aquaporin-mediated transport
Q8NBS9	Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Neutrophil degranulation
Q8NBT2	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q8NBU5	Class I peroxisomal membrane protein import;Protein localization
Q8NBV8	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q8NBW4	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q8NBX0	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q8NBZ0	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q8NC06	Metabolism;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism
Q8NC26	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NC56	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Depolymerisation of the Nuclear Lamina;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Sealing of the nuclear envelope (NE) by ESCRT-III
Q8NC69	Adaptive Immune System;Signal Transduction;Immune System;Generic Transcription Pathway;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates estrogen receptor mediated transcription;ESR-mediated signaling;Neddylation;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NC96	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q8NCC3	Metabolism;Hydrolysis of LPC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8NCD3	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
Q8NCE0	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q8NCE2	Metabolism;PI Metabolism;Phospholipid metabolism;Macroautophagy;Synthesis of PIPs at the plasma membrane;Metabolism of lipids;Autophagy
Q8NCG5	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q8NCG7	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Arachidonate production from DAG;Platelet activation, signaling and aggregation
Q8NCH0	Metabolism;Glycosaminoglycan metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Dermatan sulfate biosynthesis;Diseases associated with glycosaminoglycan metabolism;Defective CHST14 causes EDS, musculocontractural type;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q8NCK3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NCL4	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q8NCM2	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q8NCM8	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q8NCN5	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q8NCQ5	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NCR0	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification
Q8NCS7	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metabolism of lipids
Q8NCW0	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Signaling by WNT in cancer;Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling;Diseases of signal transduction by growth factor receptors and second messengers
Q8NCW5	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q8NCW6	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q8ND04	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q8ND25	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8ND30	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q8NDG6	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q8NDL9	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q8NDP4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NDQ6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NDV1	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q8NDV3	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q8NDV7	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;Gene Silencing by RNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;Post-transcriptional silencing by small RNAs;Transcriptional regulation by small RNAs;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q8NDW4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NDX2	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters;Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25);SLC transporter disorders;Disorders of transmembrane transporters
Q8NDX5	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q8NDX6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NE09	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q8NE22	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NE62	Metabolism;Choline catabolism;Metabolism of amino acids and derivatives
Q8NE65	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NE71	Transport of small molecules;ABC-family proteins mediated transport
Q8NE86	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q8NEB5	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis
Q8NEB9	PI3K Cascade;IRS-mediated signalling;Cytokine Signaling in Immune system;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Macroautophagy;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Toll Like Receptor 9 (TLR9) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Metabolism of lipids;RHO GTPases Activate NADPH Oxidases;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Autophagy
Q8NEC5	Fertilization;Sperm Motility And Taxes;Reproduction
Q8NEE6	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NEG7	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8NEK5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NEL9	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8NEM0	Cell Cycle;Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q8NEM1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NEM7	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q8NEM8	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q8NEP9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NER1	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q8NER5	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL;Signaling by Activin;Signal Transduction;Signaling by TGF-beta family members
Q8NES3	Signaling by NOTCH;Signal Transduction;Disease;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Defective LFNG causes SCDO3;Diseases of metabolism
Q8NES8	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8NET1	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8NET5	Innate Immune System;Immune System;Neutrophil degranulation
Q8NET6	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q8NET8	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q8NEV9	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-27 signaling
Q8NEW0	Insulin processing;Peptide hormone metabolism;Transport of small molecules;Metabolism of proteins;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc efflux and compartmentalization by the SLC30 family
Q8NEX9	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q8NEY4	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q8NEZ2	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q8NEZ3	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q8NEZ4	Developmental Biology;Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q8NEZ5	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NF37	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PG;Synthesis of PA;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Metabolism of lipids;Neutrophil degranulation
Q8NF50	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q8NF91	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q8NFA2	Signal Transduction;Disease;Signaling by Rho GTPases;RHO GTPase Effectors;Infectious disease;RHO GTPases Activate NADPH Oxidases;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
Q8NFD5	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q8NFF2	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI);SLC transporter disorders;Disorders of transmembrane transporters
Q8NFF5	Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q8NFG4	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q8NFH3	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
Q8NFH4	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
Q8NFH5	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q8NFH8	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q8NFI3	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification
Q8NFJ6	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q8NFJ9	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q8NFL0	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins
Q8NFM4	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;DAG and IP3 signaling;Signal Transduction;Glucagon signaling in metabolic regulation;PKA activation;Integration of energy metabolism;Disease;PKA activation in glucagon signalling;Adenylate cyclase activating pathway;Adenylate cyclase inhibitory pathway;Signaling by GPCR;Transport of small molecules;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;G alpha (z) signalling events;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Signaling by Hedgehog;Hedgehog 'off' state;Infectious disease;Intracellular signaling by second messengers;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;FCGR3A-mediated IL10 synthesis;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors
Q8NFM7	Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q8NFP4	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q8NFP7	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol
Q8NFP9	Opioid Signalling;PKA-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;DAG and IP3 signaling;Signaling by NOTCH;Signal Transduction;PKA activation;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Activation of NMDA receptors and postsynaptic events;Intracellular signaling by second messengers;Assembly and cell surface presentation of NMDA receptors
Q8NFQ5	Innate Immune System;Immune System;Antimicrobial peptides
Q8NFR3	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q8NFR9	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins
Q8NFT2	Transport of small molecules;Iron uptake and transport;Transferrin endocytosis and recycling
Q8NFT8	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus
Q8NFU0	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8NFU1	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8NFU3	Metabolism;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q8NFU5	Metabolism;Inositol phosphate metabolism;Synthesis of IPs in the nucleus
Q8NFU7	Epigenetic regulation of gene expression;TET1,2,3 and TDG demethylate DNA;Gene expression (Transcription)
Q8NFW1	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Collagen chain trimerization
Q8NFW8	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q8NFW9	Insulin processing;Peptide hormone metabolism;Metabolism of proteins
Q8NFY4	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
Q8NFY9	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NFZ3	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q8NFZ4	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q8NFZ5	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Metabolism of proteins;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q8NG11	Innate Immune System;Immune System;Metabolism of proteins;Neutrophil degranulation;Amyloid fiber formation
Q8NG27	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NG31	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q8NG35	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8NG41	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q8NG57	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q8NG68	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q8NG75	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG76	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG77	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG78	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG80	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG81	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG83	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG84	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG85	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG92	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG94	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG95	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG97	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG98	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NG99	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGA0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGA1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGA2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGA5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGA6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGA8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGB2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGB4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGB6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGB8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGB9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGC9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGD0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGD1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGD2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGD3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGD4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGD5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGE9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGF9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGG8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGH3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGH5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGH6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGH7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGH8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGH9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGI9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGJ9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGK0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGK1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGK3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGK4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGK5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGK6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGK9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGL9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGM1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGM8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGM9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGN8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGP0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGP2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGP3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGP4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGP6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGP8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGP9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGQ1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGQ2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGQ3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGQ4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGQ5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGQ6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGR9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGS9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGT0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGT1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGT2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGT5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGT7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGT9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGU1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGU2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGU4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGU9	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q8NGV0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGV5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGV6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGV7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGW1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGW6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGX9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGY9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGZ0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGZ2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGZ3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGZ4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGZ5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGZ6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NGZ9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH00	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH01	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH02	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH03	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH04	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH05	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH06	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH07	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH08	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH09	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH10	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH16	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH18	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH19	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH21	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH37	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH40	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH41	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH42	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH43	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH48	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH49	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH50	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH51	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH53	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH54	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH55	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH56	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH57	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH59	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH60	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH61	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH63	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH64	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH67	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH69	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH70	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH72	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH73	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH74	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH76	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH79	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH80	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH81	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH83	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH85	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH87	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH89	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH90	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH92	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH93	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NH94	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHA4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHA6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHA8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHB1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHB7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHB8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHC4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHC5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHC6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHC7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHC8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8NHE4	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q8NHG7	Innate Immune System;Immune System;Neutrophil degranulation
Q8NHG8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NHH1	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q8NHJ6	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8NHL6	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8NHM5	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q8NHP1	Metabolism;Biological oxidations;Aflatoxin activation and detoxification
Q8NHP6	Innate Immune System;Immune System;Neutrophil degranulation
Q8NHQ1	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q8NHU3	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q8NHV4	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q8NHW3	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
Q8NHW4	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q8NHX9	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8NHY0	Metabolism;Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q8NHY2	Cell Cycle;Autodegradation of the E3 ubiquitin ligase COP1;Metabolism of proteins;Post-translational protein modification;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Neddylation
Q8NHY6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8NHZ8	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NI17	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
Q8NI22	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q8NI27	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q8NI29	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8NI32	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q8NI35	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q8NI36	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q8NI77	Hemostasis;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Vesicle-mediated transport;RHO GTPases Activate Formins;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;EML4 and NUDC in mitotic spindle formation;Kinesins;Factors involved in megakaryocyte development and platelet production
Q8TA94	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TAA3	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q8TAA5	Mitochondrial protein import;Protein localization
Q8TAC2	Metabolism of proteins;Deubiquitination;Josephin domain DUBs;Post-translational protein modification
Q8TAD4	Insulin processing;Peptide hormone metabolism;Transport of small molecules;Metabolism of proteins;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc efflux and compartmentalization by the SLC30 family
Q8TAE7	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q8TAE8	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q8TAF3	Recognition of DNA damage by PCNA-containing replication complex;Disease;Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Fanconi Anemia Pathway;DNA Damage Bypass;DNA Repair;Signaling by PDGFR in disease;Signaling by cytosolic PDGFRA and PDGFRB fusion proteins
Q8TAF7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TAG9	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
Q8TAM1	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q8TAM2	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q8TAP6	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q8TAQ2	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q8TAQ5	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TAS1	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
Q8TAT2	Signal Transduction;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2b ligand binding and activation;Signaling by FGFR2;Signaling by Receptor Tyrosine Kinases
Q8TAT5	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Disease;Base Excision Repair;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Diseases of Base Excision Repair;Defective Base Excision Repair Associated with NEIL3;NEIL3-mediated resolution of ICLs;Diseases of DNA repair
Q8TAT6	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion Synthesis by POLH;DNA Damage Bypass;DNA Repair
Q8TAU3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TAV3	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Miscellaneous substrates;Xenobiotics
Q8TAV4	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8TAW3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TAX7	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q8TB24	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8TB36	Class I peroxisomal membrane protein import;Protein localization
Q8TB37	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q8TB40	Metabolism;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8TB52	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8TB61	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Glycosaminoglycan metabolism;Transport and synthesis of PAPS;Biological oxidations;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of carbohydrates;Transport of nucleotide sugars
Q8TB69	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TB72	Metabolism of proteins;Post-translational protein modification;Neddylation
Q8TB92	Metabolism;Metabolism of lipids;Ketone body metabolism;Synthesis of Ketone Bodies
Q8TBA6	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
Q8TBB1	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8TBC4	Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Metabolism of proteins;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8TBE1	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q8TBE9	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q8TBF2	Metabolism;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Fatty acid metabolism
Q8TBF4	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8TBF5	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q8TBG4	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q8TBJ4	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Lysosphingolipid and LPA receptors;GPCR ligand binding
Q8TBK2	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q8TBN0	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8TBP0	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q8TBX8	PIP3 activates AKT signaling;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of lipids;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Synthesis of PIPs in the nucleus;Intracellular signaling by second messengers
Q8TBZ3	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q8TBZ6	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q8TBZ8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TC07	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q8TC12	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Retinoic Acid;RA biosynthesis pathway;Metabolism of fat-soluble vitamins;Signaling by Nuclear Receptors;Retinoid metabolism and transport
Q8TC21	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TC41	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8TC59	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q8TCB6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8TCC3	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q8TCC7	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation/anion/zwitterion transport;Organic anion transport
Q8TCD5	Metabolism;Metabolism of nucleotides;Pyrimidine catabolism;Purine catabolism;Nucleobase catabolism
Q8TCG2	Metabolism;Synthesis of PIPs at the ER membrane;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Metabolism of lipids
Q8TCT0	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q8TCT1	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q8TCT7	Signal Transduction;Regulation of TNFR1 signaling;Death Receptor Signalling;TNF signaling
Q8TCT8	Signal Transduction;Regulation of TNFR1 signaling;Death Receptor Signalling;TNF signaling
Q8TCU4	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q8TCU5	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of NMDA receptors and postsynaptic events;Assembly and cell surface presentation of NMDA receptors
Q8TCU6	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q8TCW9	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q8TCX1	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8TCX5	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Rhotekin and Rhophilins
Q8TCZ2	Hemostasis;Cell surface interactions at the vascular wall
Q8TD07	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8TD16	Membrane Trafficking;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q8TD17	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TD19	Cell Cycle;Nuclear Envelope Breakdown;Activation of NIMA Kinases NEK9, NEK6, NEK7;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic;EML4 and NUDC in mitotic spindle formation
Q8TD20	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q8TD23	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TD30-1	Metabolism;Metabolism of amino acids and derivatives;Alanine metabolism
Q8TD43	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q8TD46	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8TD47	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q8TD55	Innate Immune System;Immune System;Neutrophil degranulation
Q8TD84	Developmental Biology;Netrin-1 signaling;DSCAM interactions;Axon guidance;Nervous system development
Q8TDB6	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8TDB8	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q8TDD2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development
Q8TDD5	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q8TDE3	Innate Immune System;Immune System;Antimicrobial peptides
Q8TDF6	Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q8TDL5	Innate Immune System;Immune System;Antimicrobial peptides
Q8TDM5	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q8TDN1	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q8TDN2	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q8TDN4	Hemostasis;Cell Cycle;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;Factors involved in megakaryocyte development and platelet production
Q8TDN7	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q8TDQ0	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling
Q8TDQ1	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q8TDQ7	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
Q8TDR0	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8TDS4	Signal Transduction;Hydroxycarboxylic acid-binding receptors;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q8TDS5	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;G alpha (i) signalling events;GPCR ligand binding
Q8TDU6	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q8TDU9	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Relaxin receptors;GPCR ligand binding
Q8TDV5	Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
Q8TDW0	Transport of small molecules;Miscellaneous transport and binding events
Q8TDX5	Metabolism;Tryptophan catabolism;Metabolism of amino acids and derivatives
Q8TDX6	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q8TDX7	Cell Cycle;Nuclear Envelope Breakdown;Activation of NIMA Kinases NEK9, NEK6, NEK7;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic;EML4 and NUDC in mitotic spindle formation
Q8TDY2	Macroautophagy;Autophagy
Q8TDZ2	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q8TE02	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q8TE04	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q8TE23	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q8TE49	Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification
Q8TE54	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers
Q8TE56	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8TE57	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8TE58	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8TE59	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8TE60	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8TEA1	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q8TEB1	Metabolism of proteins;Post-translational protein modification;Neddylation
Q8TEB7	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification
Q8TED0	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q8TED1	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
Q8TED4-2	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
Q8TEH3	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8TEK3	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q8TEL6	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q8TEM1	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
Q8TEP8	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q8TEQ6	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
Q8TEQ8	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q8TER5	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q8TES7	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q8TEW0	Cell-Cell communication;Signal Transduction;Signaling by TGF-beta Receptor Complex;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Tight junction interactions;Cell-cell junction organization;Cell junction organization;Signaling by TGF-beta family members
Q8TEW6	Developmental Biology;Axon guidance;RET signaling;Nervous system development
Q8TEY5	Unfolded Protein Response (UPR);Metabolism of proteins;CREB3 factors activate genes
Q8TEY7	Developmental Biology;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Regulation of expression of SLITs and ROBOs;Nervous system development
Q8TF09	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8TF20	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TF32	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TF39	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TF40	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q8TF45	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TF47	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8TF61	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8TF62	Innate Immune System;Immune System;Transport of small molecules;Neutrophil degranulation;Ion transport by P-type ATPases;Ion channel transport
Q8TF71	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q8TF74	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q8VNV4	Metabolism;Metabolism of porphyrins;Heme degradation
Q8WTQ1	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q8WTQ7	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q8WTR4	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids;Glycerophospholipid catabolism
Q8WTR7	SLBP independent Processing of Histone Pre-mRNAs;Generic Transcription Pathway;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
Q8WTS1	Metabolism;Triglyceride catabolism;Metabolism of lipids;Triglyceride metabolism
Q8WTS6	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q8WTT0	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs);Neutrophil degranulation
Q8WTV0-2	Plasma lipoprotein assembly, remodeling, and clearance;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class B Receptors;Transport of small molecules;Vesicle-mediated transport;HDL clearance;Plasma lipoprotein clearance
Q8WTW3	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q8WTW4	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q8WTX7	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q8WU03	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Conjugation of benzoate with glycine;Biological oxidations
Q8WU17	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q8WU20	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Prolonged ERK activation events;Frs2-mediated activation;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by FGFR;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Axon guidance;Downstream signaling of activated FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;FRS-mediated FGFR2 signaling;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR4 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 fusions in cancer;Signaling by FGFR3 point mutants in cancer;RET signaling;Signaling by NTRK2 (TRKB);Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Activated NTRK2 signals through FRS2 and FRS3;FLT3 Signaling;Nervous system development
Q8WU67	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8WU68	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q8WUA2	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8WUA4	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
Q8WUD1	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q8WUD6	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8WUF5	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8WUG5	Transport of small molecules;Iron uptake and transport
Q8WUI4	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Notch-HLH transcription pathway;Metabolism of proteins;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q8WUJ3	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan biosynthesis and export;Metabolism of carbohydrates
Q8WUK0	Metabolism;Synthesis of PG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8WUM0	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
Q8WUM4	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
Q8WUM9	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium-coupled phosphate cotransporters
Q8WUP2	Cell-Cell communication;Cell-extracellular matrix interactions;Cell junction organization
Q8WUW1	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q8WUX1	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q8WUX2	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations
Q8WUX9	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
Q8WUY9	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8WV16	Metabolism of proteins;Post-translational protein modification;Neddylation
Q8WV22	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification
Q8WV24	Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;Interaction between PHLDA1 and AURKA
Q8WV28	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Signaling by Interleukins;Interleukin-3, Interleukin-5 and GM-CSF signaling;Regulation of signaling by CBL;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q8WV37	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8WV44	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WVB6	Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Chromosome Maintenance
Q8WVC0	Formation of RNA Pol II elongation complex ;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q8WVD3	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WVE0	Metabolism of proteins;Post-translational protein modification;Protein methylation
Q8WVF2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development
Q8WVJ9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2
Q8WVK2	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8WVK7	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q8WVM0	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;rRNA modification in the mitochondrion;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q8WVM7	Meiotic synapsis;Reproduction;Meiosis;Signal Transduction;Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q8WVM8	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q8WVN8	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WVP5	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids
Q8WVQ1	Innate Immune System;Immune System;Neutrophil degranulation
Q8WVS4	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8WVT3	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8WVV5	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
Q8WVX9	Metabolism;Metabolism of lipids;Wax and plasmalogen biosynthesis;Wax biosynthesis
Q8WVZ9	Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Immune System;Metabolism of proteins;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;Neddylation;FLT3 Signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WW01	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q8WW22	Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular responses to external stimuli
Q8WW27	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
Q8WW35	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8WW38	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q8WW43	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Signaling by NOTCH2;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;EPH-Ephrin signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Metabolism of proteins;EPH-ephrin mediated repulsion of cells;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Noncanonical activation of NOTCH3;Nervous system development;Amyloid fiber formation
Q8WWA0	Innate Immune System;Immune System;Antimicrobial peptides
Q8WWC4	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q8WWG1	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Downregulation of ERBB2 signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
Q8WWG9	Muscle contraction;Phase 3 - rapid repolarisation;Cardiac conduction;Phase 2 - plateau phase
Q8WWH4	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q8WWI1	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WWI5	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metabolism of lipids;Choline catabolism;Metabolism of amino acids and derivatives
Q8WWM9	Metabolism;Metabolism of nitric oxide: eNOS activation and regulation;eNOS activation;Transport of small molecules;Intracellular oxygen transport
Q8WWN8	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8WWQ2	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG degradation;Metabolism of carbohydrates
Q8WWQ8	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan uptake and degradation;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class H Receptors;Vesicle-mediated transport;Metabolism of carbohydrates
Q8WWR8-2	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q8WWR8	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q8WWT9	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Sodium-coupled sulphate, di- and tri-carboxylate transporters
Q8WWV6	Hemostasis;Cell surface interactions at the vascular wall
Q8WWX0	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WWX8	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Inositol transporters
Q8WWY3	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8WWY8	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q8WWZ1	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-38 signaling;Interleukin-36 pathway
Q8WWZ3	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q8WWZ4	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
Q8WWZ7	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
Q8WX39	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of fatty acids
Q8WX92	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Signaling by NTRKs;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Signaling by Receptor Tyrosine Kinases;Signaling by NTRK3 (TRKC);NTRK3 as a dependence receptor
Q8WXA8	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System
Q8WXB1	Metabolism of proteins;Post-translational protein modification;Protein methylation
Q8WXB4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8WXD0	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;Relaxin receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q8WXD2	Hemostasis;Platelet degranulation ;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Post-translational protein phosphorylation
Q8WXD5	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
Q8WXE1	Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Fanconi Anemia Pathway;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q8WXE9	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q8WXF3	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;G alpha (i) signalling events;Relaxin receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q8WXG1	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
Q8WXG6-3	Signal Transduction;Membrane Trafficking;Regulation of TNFR1 signaling;Vesicle-mediated transport;Death Receptor Signalling;TNF signaling;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8WXG6-5	Signal Transduction;Regulation of TNFR1 signaling;Death Receptor Signalling;TNF signaling
Q8WXG9	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q8WXH0	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q8WXH4	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WXH5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
Q8WXH6	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q8WXI2	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
Q8WXI3	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WXI4	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q8WXI7	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q8WXI8	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs);Neutrophil degranulation
Q8WXI9	PIP3 activates AKT signaling;Signal Transduction;Epigenetic regulation of gene expression;Generic Transcription Pathway;HDACs deacetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q8WXJ9	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WXK1	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WXK3	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WXK4	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WXS5	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;LGI-ADAM interactions
Q8WXS8	Extracellular matrix organization;Collagen formation;Disease;Collagen biosynthesis and modifying enzymes;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q8WXX7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q8WY07	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q8WY54	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of NMDA receptors and postsynaptic events;Negative regulation of NMDA receptor-mediated neuronal transmission
Q8WY64	Adaptive Immune System;Signal Transduction;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;VLDLR internalisation and degradation;Plasma lipoprotein clearance;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q8WYA0	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q8WYA1	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
Q8WYA6	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q8WYB5	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q8WYH8	Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8WYK0	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q8WYN0	Macroautophagy;Autophagy
Q8WYP3	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q8WYP5	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
Q8WYQ3	Mitochondrial protein import;Protein localization
Q8WYQ5	MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2
Q8WYR1	Hemostasis;GPVI-mediated activation cascade;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Signaling by GPCR;GPCR downstream signalling;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;Metabolism of lipids;Platelet activation, signaling and aggregation;Signaling by Erythropoietin;Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
Q8WZ04	Neurotransmitter clearance;Transmission across Chemical Synapses;Neuronal System;Enzymatic degradation of dopamine by COMT;Dopamine clearance from the synaptic cleft
Q8WZ42	Hemostasis;Platelet degranulation ;Striated Muscle Contraction;Muscle contraction;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q8WZ55	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q8WZ64	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q8WZ73	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q8WZ84	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8WZ92	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8WZ94	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q8WZA1	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3;O-linked glycosylation;Diseases of metabolism;Post-translational protein modification
Q8WZA2	Hemostasis;Adaptive Immune System;Metabolism;Signal Transduction;Integration of energy metabolism;Immune System;Integrin signaling;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Rap1 signalling;Regulation of insulin secretion;Platelet activation, signaling and aggregation;Platelet Aggregation (Plug Formation)
Q8WZA6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q92185	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q92186	Developmental Biology;NCAM signaling for neurite out-growth;Metabolism of proteins;Sialic acid metabolism;NCAM1 interactions;Axon guidance;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;Transport to the Golgi and subsequent modification;Nervous system development;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
Q92187	Developmental Biology;NCAM signaling for neurite out-growth;Metabolism of proteins;Sialic acid metabolism;NCAM1 interactions;Axon guidance;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;Nervous system development
Q92466	Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Post-translational protein modification;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Neddylation
Q92478	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q92481	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
Q92482	Transport of small molecules;Vasopressin regulates renal water homeostasis via Aquaporins;Passive transport by Aquaporins;Aquaporin-mediated transport
Q92496	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
Q92499	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q92502	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q92504	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q92506	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
Q92520	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q92521	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q92523	Metabolism;Signal Transduction;Carnitine metabolism;Signaling by Retinoic Acid;Metabolism of lipids;Fatty acid metabolism;Signaling by Nuclear Receptors
Q92526	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
Q92529	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Signaling by NTRKs;Signalling to RAS;Immune System;Signaling by NTRK1 (TRKA);Signalling to ERKs;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Nervous system development
Q92530	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q92535	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q92536	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q92538	Organelle biogenesis and maintenance;ER to Golgi Anterograde Transport;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Metabolism of proteins;Asparagine N-linked glycosylation;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q92539	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Cell Cycle;Nuclear Envelope Breakdown;Depolymerisation of the Nuclear Lamina;Metabolism of lipids;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Triglyceride biosynthesis;Triglyceride metabolism
Q92540	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q92541	Formation of RNA Pol II elongation complex ;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q92542	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Degradation of the extracellular matrix;Extracellular matrix organization;Signaling by NOTCH;Signal Transduction;Disease;Innate Immune System;Immune System;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Signaling by NOTCH2;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;EPH-Ephrin signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Metabolism of proteins;EPH-ephrin mediated repulsion of cells;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Neutrophil degranulation;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Noncanonical activation of NOTCH3;Nervous system development;Amyloid fiber formation
Q92546	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q92547	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q92551	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol;Synthesis of IPs in the nucleus
Q92552	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q92556	Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Signaling by VEGF;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q92558	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q92560	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Post-translational protein modification;DNA Repair
Q92562	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Metabolism of lipids
Q92564	Metabolism of proteins;Post-translational protein modification;Neddylation
Q92569	Hemostasis;GPVI-mediated activation cascade;PIP3 activates AKT signaling;Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by SCF-KIT;PI Metabolism;Phospholipid metabolism;Signal Transduction;Disease;Synthesis of PIPs at the plasma membrane;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;G alpha (q) signalling events;Axon guidance;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Platelet activation, signaling and aggregation;RET signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;Interleukin receptor SHC signaling;Regulation of signaling by CBL;Nervous system development
Q92570-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q92570-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q92570	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q92572	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q92574	Signal Transduction;Macroautophagy;mTOR signalling;Inhibition of TSC complex formation by PKB;Membrane Trafficking;Generic Transcription Pathway;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;Vesicle-mediated transport;RNA Polymerase II Transcription;Gene expression (Transcription);TBC/RABGAPs;Rab regulation of trafficking;Autophagy
Q92581	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers;Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH);SLC transporter disorders;Disorders of transmembrane transporters
Q92583	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR ligand binding
Q92585	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Signaling by NOTCH2;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q92597	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription)
Q92598	Binding and Uptake of Ligands by Scavenger Receptors;Cellular responses to stress;Scavenging by Class F Receptors;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Vesicle-mediated transport;Cellular responses to external stimuli
Q92600	Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q92604	Metabolism;Acyl chain remodelling of PG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q92608	Hemostasis;HIV Infection;Host Interactions of HIV factors;Disease;Nef and signal transduction;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Infectious disease;Neutrophil degranulation;Factors involved in megakaryocyte development and platelet production
Q92611	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q92613	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q92614	Signaling by FGFR in disease;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
Q92616	Cellular responses to stress;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency
Q92619	Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;Neutrophil degranulation
Q92620	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q92621	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q92626	Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
Q92630	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q92633	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding
Q92636	Signal Transduction;TNFR1-mediated ceramide production;Death Receptor Signalling;TNF signaling
Q92637	Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Interferon gamma signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation
Q92643	Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q92664	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter
Q92665	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q92667	Hemostasis;Transport of small molecules;Mitochondrial calcium ion transport;Factors involved in megakaryocyte development and platelet production
Q92670	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q92673	Metabolism of proteins;Amyloid fiber formation
Q92674	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q92681	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport;Intestinal absorption;Digestion and absorption;Intestinal hexose absorption
Q92685	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG3 causes ALG3-CDG (CDG-1d);Diseases of metabolism;Post-translational protein modification
Q92686	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Long-term potentiation
Q92692	Adaptive Immune System;Cell-Cell communication;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adherens junctions interactions;Nectin/Necl  trans heterodimerization;Cell-cell junction organization;Cell junction organization
Q92696	Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;TP53 Regulates Transcription of Cell Death Genes;Post-translational protein modification;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);RAB geranylgeranylation
Q92729	Signaling by SCF-KIT;Signal Transduction;Signaling by Receptor Tyrosine Kinases
Q92730	Developmental Biology;Semaphorin interactions;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Sema4D in semaphorin signaling;Sema4D mediated inhibition of cell attachment and migration;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Nervous system development
Q92731	PIP3 activates AKT signaling;Signal Transduction;Disease;Negative regulation of the PI3K/AKT network;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Nuclear Receptor transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;RNA Polymerase II Transcription;Gene expression (Transcription);ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
Q92733	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q92734	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q92736	Stimuli-sensing channels;Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion channel transport
Q92738	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q92743	Degradation of the extracellular matrix;Extracellular matrix organization
Q92747	Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;EPH-Ephrin signaling;EPHB-mediated forward signaling;Axon guidance;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Clathrin-mediated endocytosis;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
Q92748	Metabolism;Carnitine metabolism;Metabolism of lipids;Fatty acid metabolism
Q92750	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q92752	Extracellular matrix organization;ECM proteoglycans
Q92753	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q92754	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;TFAP2 (AP-2) family regulates transcription of other transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;TFAP2 (AP-2) family regulates transcription of cell cycle factors
Q92759	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;Epigenetic regulation of gene expression;Generic Transcription Pathway;Transcriptional Regulation by TP53;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Infectious disease;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;RNA Polymerase II Pre-transcription Events;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;TP53 Regulates Transcription of DNA Repair Genes;mRNA Capping;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;DNA Repair;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Elongation;RNA Polymerase II Transcription Initiation And Promoter Clearance;RNA Pol II CTD phosphorylation and interaction with CE;Metabolism of RNA
Q92764	Developmental Biology;Keratinization;Formation of the cornified envelope
Q92769	Hemostasis;PIP3 activates AKT signaling;Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;p75NTR negatively regulates cell cycle via SC1;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Epigenetic regulation of gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Transcriptional Regulation by TP53;Metabolism of proteins;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;SUMOylation of chromatin organization proteins;Chromatin organization;Positive epigenetic regulation of rRNA expression;Negative epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;Regulation of TP53 Activity through Acetylation;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Death Receptor Signalling;Gene expression (Transcription);Regulation of PTEN gene transcription;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Regulation of MECP2 expression and activity;MECP2 regulates neuronal receptors and channels;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development;Factors involved in megakaryocyte development and platelet production
Q92777	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Serotonin Neurotransmitter Release Cycle;Dopamine Neurotransmitter Release Cycle
Q92781	Signal Transduction;Disease;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors;Diseases of the neuronal system
Q92783	Signal Transduction;Disease;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Infectious disease;Deubiquitination;Metalloprotease DUBs;Post-translational protein modification;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases;Endosomal Sorting Complex Required For Transport (ESCRT)
Q92793	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Signaling by NOTCH;Mitochondrial biogenesis;Signal Transduction;Disease;Regulation of cholesterol biosynthesis by SREBP (SREBF);Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Cytosolic sensors of pathogen-associated DNA ;Organelle biogenesis and maintenance;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;Signaling by NOTCH1;PPARA activates gene expression;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Cellular responses to stress;Activation of gene expression by SREBF (SREBP);Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;SUMOylation;SUMO E3 ligases SUMOylate target proteins;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production;HATs acetylate histones;Chromatin modifying enzymes;Cellular response to heat stress;Attenuation phase;HSF1-dependent transactivation;Notch-HLH transcription pathway;Transcriptional Regulation by TP53;Transcriptional regulation of white adipocyte differentiation;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;TP53 Regulates Transcription of Cell Death Genes;Diseases of signal transduction by growth factor receptors and second messengers;Post-translational protein modification;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX1;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells;RUNX3 regulates NOTCH signaling;Cellular responses to external stimuli;Metabolism of steroids;Signaling by Nuclear Receptors;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription;Estrogen-dependent gene expression;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes;Regulation of FOXO transcriptional activity by acetylation
Q92794	Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q92796	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;L1CAM interactions;Axon guidance;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;NrCAM interactions;Ionotropic activity of kainate receptors;Activation of Ca-permeable Kainate Receptor;Activation of kainate receptors upon glutamate binding;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neurexins and neuroligins;Protein-protein interactions at synapses;Synaptic adhesion-like molecules;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Nervous system development
Q92797	Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q92804	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q92805	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q92806	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q92813	Metabolism;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Regulation of thyroid hormone activity;Metabolism of amino acids and derivatives
Q92817	Developmental Biology;Keratinization;Formation of the cornified envelope
Q92819	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan biosynthesis and export;Metabolism of carbohydrates
Q92820	Innate Immune System;Immune System;Neutrophil degranulation
Q92823	Developmental Biology;L1CAM interactions;Axon guidance;Interaction between L1 and Ankyrins;NrCAM interactions;Neurofascin interactions;Nervous system development
Q92824	Signal Transduction;Signaling by NTRKs;NGF processing;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Signaling by Receptor Tyrosine Kinases;Expression and Processing of Neurotrophins
Q92830	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;Epigenetic regulation of gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HATs acetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Metabolism of proteins;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q92831	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;YAP1- and WWTR1 (TAZ)-stimulated gene expression;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;Epigenetic regulation of gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HATs acetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Metabolism of proteins;Muscle contraction;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Cardiac conduction;Physiological factors;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Metalloprotease DUBs;Post-translational protein modification;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX3 regulates NOTCH signaling;Signaling by Nuclear Receptors;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription;Estrogen-dependent gene expression;FOXO-mediated transcription;Regulation of FOXO transcriptional activity by acetylation
Q92833	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Gene expression (Transcription)
Q92835	Hemostasis;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Immune System;Synthesis of IP3 and IP4 in the cytosol;TCR signaling;Downstream TCR signaling;Cell surface interactions at the vascular wall;PECAM1 interactions;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Metabolism of lipids;Interleukin receptor SHC signaling
Q92837	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Beta-catenin phosphorylation cascade;TCF dependent signaling in response to WNT;Disassembly of the destruction complex and recruitment of AXIN to the membrane
Q92838-3	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q92838	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q92839	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan biosynthesis and export;Metabolism of carbohydrates
Q92841	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification
Q92844	Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;TICAM1-dependent activation of IRF3/IRF7;TRAF6 mediated IRF7 activation;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling 
Q92845	Hemostasis;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Immune System;Organelle biogenesis and maintenance;Membrane Trafficking;MHC class II antigen presentation;Cilium Assembly;Intraflagellar transport;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q92847	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q92851	Signal Transduction;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);FasL/ CD95L signaling;TRAIL  signaling;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
Q92854	Developmental Biology;Semaphorin interactions;Sema4D in semaphorin signaling;Sema4D mediated inhibition of cell attachment and migration;Sema4D induced cell migration and growth-cone collapse;Other semaphorin interactions;Axon guidance;Nervous system development
Q92859	Developmental Biology;Netrin-1 signaling;Axon guidance;Myogenesis;Nervous system development
Q92871	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of GDP-mannose;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q92878	Reproduction;Meiosis;Cell Cycle;Generic Transcription Pathway;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through MMEJ (alt-NHEJ);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Sensing of DNA Double Strand Breaks;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Nonhomologous End-Joining (NHEJ);Homologous DNA Pairing and Strand Exchange;DNA Double Strand Break Response;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Cellular responses to external stimuli;Meiotic recombination
Q92882	Innate Immune System;Immune System;Neutrophil degranulation
Q92887	Metabolism;Disease;Metabolism of porphyrins;Heme degradation;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCC2 causes Dubin-Johnson syndrome
Q92888	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q92889	HDR through Single Strand Annealing (SSA);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Fanconi Anemia Pathway;DNA Repair
Q92890	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion Synthesis by POLH;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;DNA Damage Bypass;DNA Repair
Q92896	Hemostasis;Cell surface interactions at the vascular wall
Q92900	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q92901	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q92902	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q92903	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PI;Phospholipid metabolism;Metabolism of lipids
Q92905	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q92908	Hemostasis;Metabolism of proteins;Surfactant metabolism;Factors involved in megakaryocyte development and platelet production
Q92911	Metabolism;Disease;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters;Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1);SLC transporter disorders;Disorders of transmembrane transporters;Metabolism of amino acids and derivatives
Q92913	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation
Q92914	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation
Q92915	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation
Q92917	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q92922	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q92925	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q92930	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;TBC/RABGAPs;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q92932	Innate Immune System;Immune System;Neutrophil degranulation
Q92934	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation of BH3-only proteins;PIP3 activates AKT signaling;Signal Transduction;Disease;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;AKT phosphorylates targets in the cytosol;Cell death signalling via NRAGE, NRIF and NADE;PI3K/AKT Signaling in Cancer;Programmed Cell Death;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Death Receptor Signalling;Intracellular signaling by second messengers
Q92935	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q92945	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Metabolism of RNA
Q92947	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives
Q92952	Neuronal System;Ca2+ activated K+ channels;Potassium Channels
Q92953	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q92956	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Costimulation by the CD28 family;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q92959	Disease;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2);SLC transporter disorders;Disorders of transmembrane transporters;Transport of organic anions
Q92963	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signalling to p38 via RIT and RIN;Signaling by Receptor Tyrosine Kinases
Q92966	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q92968	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Peroxisomal protein import;Class I peroxisomal membrane protein import;Protein localization
Q92973	Cell Cycle;Organelle biogenesis and maintenance;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Cilium Assembly;Intraflagellar transport;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Metabolism of RNA;Postmitotic nuclear pore complex (NPC) reformation
Q92974	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q92979	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q92985	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Cytosolic sensors of pathogen-associated DNA ;DEx/H-box helicases activate type I IFN and inflammatory cytokines production ;Interferon gamma signaling;TICAM1-dependent activation of IRF3/IRF7;Interferon alpha/beta signaling;Interferon Signaling;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;MyD88 dependent cascade initiated on endosome
Q92989	tRNA processing in the nucleus;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q92990	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q92993	Signal Transduction;Cell Cycle;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Sensing of DNA Double Strand Breaks;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Nonhomologous End-Joining (NHEJ);Homologous DNA Pairing and Strand Exchange;DNA Double Strand Break Response;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);ESR-mediated signaling;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q92994	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
Q92995	PIP3 activates AKT signaling;Signal Transduction;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers
Q92997	Signal Transduction;Disease;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;WNT mediated activation of DVL;Beta-catenin independent WNT signaling;PCP/CE pathway;Degradation of DVL;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Negative regulation of TCF-dependent signaling by DVL-interacting proteins;Infectious disease;RHO GTPases Activate Formins;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
Q93008	Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Signaling by TGF-beta family members;Peroxisomal protein import;Protein localization;Amyloid fiber formation
Q93009	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;Deubiquitination;Ub-specific processing proteases;Nucleotide Excision Repair;Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PTEN Regulation;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Regulation of PTEN localization;Intracellular signaling by second messengers
Q93033	Adaptive Immune System;Immune System;TCR signaling;Generation of second messenger molecules
Q93034	Signaling by ERBB2;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Immune System;Vif-mediated degradation of APOBEC3G;Metabolism of proteins;Infectious disease;Post-translational protein modification;Downregulation of ERBB2 signaling;Neddylation;Signaling by Receptor Tyrosine Kinases;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q93038	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q93050	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Transport of small molecules;Neutrophil degranulation;Signaling by Insulin receptor;Insulin receptor recycling;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Ion channel transport
Q93063	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;HS-GAG biosynthesis;Diseases associated with glycosaminoglycan metabolism;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q93070	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q93074	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q93075	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q93077	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q93079	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q93084	Hemostasis;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
Q93086	Hemostasis;Elevation of cytosolic Ca2+ levels;Platelet homeostasis;Platelet calcium homeostasis
Q93088	Metabolism;Sulfur amino acid metabolism;Choline catabolism;Metabolism of amino acids and derivatives
Q93091	Innate Immune System;Immune System;Antimicrobial peptides
Q93097	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q93098	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Disassembly of the destruction complex and recruitment of AXIN to the membrane;GPCR ligand binding
Q93099	Metabolism;Metabolism of amino acids and derivatives;Tyrosine catabolism;Phenylalanine and tyrosine metabolism
Q93100	Metabolism;Glycogen breakdown (glycogenolysis);Metabolism of carbohydrates;Glycogen metabolism
Q95365	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q95604	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q95IE3	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q969D9	Interleukin-7 signaling;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins
Q969E1	Innate Immune System;Immune System;Antimicrobial peptides
Q969E3	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q969F1	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
Q969F8	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q969G2	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of expression of SLITs and ROBOs;Nervous system development
Q969G3	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q969G6	Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q969H0-1	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;FBXW7 Mutants and NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
Q969H0-4	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;FBXW7 Mutants and NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
Q969H0	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q969H4	Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;FLT3 Signaling;Signaling downstream of RAS mutants
Q969H6	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q969H8	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q969I3	Metabolism;Phase II - Conjugation of compounds;Amino Acid conjugation;Conjugation of carboxylic acids;Conjugation of salicylate with glycine;Conjugation of benzoate with glycine;Biological oxidations
Q969I6	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q969J2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q969J5	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q969K3	Adaptive Immune System;Immune System;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q969L4	SLBP independent Processing of Histone Pre-mRNAs;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs;Metabolism of RNA
Q969M2	Electric Transmission Across Gap Junctions;Transmission across Electrical Synapses ;Neuronal System;Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q969M7	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q969N2	Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q969N4	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q969P5	Adaptive Immune System;Immune System;Generic Transcription Pathway;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Neddylation;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q969Q0	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q969Q1	Adaptive Immune System;Immune System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q969Q5	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation
Q969R5	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of chromatin organization proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
Q969R8	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q969S0	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleotide sugars
Q969S2	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;Base Excision Repair;DNA Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites)
Q969S8	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Chromatin organization;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription)
Q969S9	Metabolism of proteins;Mitochondrial translation;Mitochondrial translation termination;Translation
Q969T4	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q969T7	Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Metabolism of RNA
Q969U6	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q969V1	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
Q969V5	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q969V6	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;RHO GTPases Activate Formins;Post-translational protein modification
Q969W0	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q969W8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q969W9	Signal Transduction;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Signaling by TGF-beta family members
Q969X1	Innate Immune System;Immune System;Neutrophil degranulation
Q969X2	Metabolism;Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q969X6	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q969Y2	tRNA modification in the mitochondrion;tRNA processing;Metabolism of RNA
Q969Z3	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
Q96A00	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate PKNs
Q96A05	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q96A08	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q96A29	Disease;Transport of small molecules;Metabolism of proteins;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C);SLC transporter disorders;Disorders of transmembrane transporters;Post-translational protein modification;GDP-fucose biosynthesis;Transport of nucleotide sugars
Q96A32	Muscle contraction;Smooth Muscle Contraction
Q96A35	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q96A44	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96A46	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q96A54	Metabolism;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism
Q96A56	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96A65	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
Q96A70	Metabolism;Agmatine biosynthesis;Metabolism of polyamines;Metabolism of amino acids and derivatives
Q96A72	Developmental Biology;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signaling by ROBO receptors;Axon guidance;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q96A83	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Collagen chain trimerization
Q96A98	Signal Transduction;Disease;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q96AA3	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective RFT1 causes RFT1-CDG (CDG-1n);Diseases of metabolism;Post-translational protein modification
Q96AC1	Cell-Cell communication;Cell-extracellular matrix interactions;Cell junction organization
Q96AC6	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q96AD5	Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Metabolism of lipids;Post-translational protein modification;Post-translational protein phosphorylation
Q96AH0	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96AH8	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;TBC/RABGAPs;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q96AJ1	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q96AJ9	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q96AP0	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Packaging Of Telomere Ends;Telomere Extension By Telomerase;Extension of Telomeres;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Cellular responses to external stimuli
Q96AP7	Hemostasis;Cell surface interactions at the vascular wall
Q96AQ7-1	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q96AQ7	Metabolism;Metabolism of lipids;Lipid particle organization
Q96AT9	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates
Q96AV8	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96AX2	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;RAB geranylgeranylation
Q96AX9	Adaptive Immune System;Signaling by NOTCH;Signal Transduction;Disease;Immune System;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96AY2	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Fanconi Anemia Pathway;DNA Repair
Q96AZ6	Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling
Q96B01	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;DNA Repair
Q96B02	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96B26	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q96B33	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q96B36	PIP3 activates AKT signaling;Signal Transduction;Disease;mTOR signalling;mTORC1-mediated signalling;AKT phosphorylates targets in the cytosol;PI3K/AKT Signaling in Cancer;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q96B49	Mitochondrial protein import;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Protein localization;Autophagy;Selective autophagy
Q96B86	Developmental Biology;Netrin-1 signaling;Axon guidance;Nervous system development
Q96B97	Developmental Biology;Adaptive Immune System;Signal Transduction;Disease;Immune System;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;Axon guidance;Vesicle-mediated transport;Infectious disease;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Reelin signalling pathway;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases;Nervous system development;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q96BA8	Unfolded Protein Response (UPR);Metabolism of proteins;CREB3 factors activate genes
Q96BD0	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of organic anions
Q96BD5	Hemostasis;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;Factors involved in megakaryocyte development and platelet production
Q96BD6	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96BD8	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q96BH1	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96BI1	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport;Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1);SLC transporter disorders;Disorders of transmembrane transporters
Q96BI3	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Signaling by NOTCH2;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;EPH-Ephrin signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Metabolism of proteins;EPH-ephrin mediated repulsion of cells;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Noncanonical activation of NOTCH3;Nervous system development;Amyloid fiber formation
Q96BM1	Metabolism of proteins;Post-translational protein modification;Neddylation
Q96BM9	Innate Immune System;Immune System;Neutrophil degranulation
Q96BN2	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q96BN8	Signal Transduction;Metabolism of proteins;Regulation of TNFR1 signaling;Post-translational protein modification;Death Receptor Signalling;TNF signaling;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
Q96BP2	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q96BP3	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q96BR1	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q96BR6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96BT3	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q96BT7	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q96BV0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96BY6	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q96BZ4	Metabolism;Synthesis of PG;Glycerophospholipid biosynthesis;Inositol phosphate metabolism;Phospholipid metabolism;Innate Immune System;Immune System;Synthesis of IP3 and IP4 in the cytosol;Fcgamma receptor (FCGR) dependent phagocytosis;Role of phospholipids in phagocytosis;Metabolism of lipids
Q96BZ9	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;TBC/RABGAPs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q96C10	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta
Q96C24	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q96C28	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96C36	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
Q96C86	Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Metabolism of RNA
Q96CB8	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96CB9	rRNA modification in the mitochondrion;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q96CD0	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96CD2	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q96CF2	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
Q96CG3	Innate Immune System;Immune System;Alpha-protein kinase 1 signaling pathway
Q96CJ1	Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q96CM8	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q96CN9	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q96CS2	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q96CS3	Innate Immune System;Immune System;Neutrophil degranulation
Q96CS4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96CV9	Cell Cycle;Membrane Trafficking;Regulation of PLK1 Activity at G2/M Transition;Mitotic G2-G2/M phases;Vesicle-mediated transport;G2/M Transition;Cell Cycle, Mitotic;TBC/RABGAPs;Rab regulation of trafficking
Q96CW1-2	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
Q96CW1	Developmental Biology;Adaptive Immune System;Gap junction trafficking and regulation;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of CD28 cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Signaling by NTRKs;Nef Mediated CD4 Down-regulation;Immune System;Plasma lipoprotein assembly, remodeling, and clearance;Retrograde neurotrophin signalling;Nef Mediated CD8 Down-regulation;Signaling by NTRK1 (TRKA);Gap junction trafficking;Gap junction degradation;Signaling by WNT;Formation of annular gap junctions;Membrane Trafficking;MHC class II antigen presentation;EPH-Ephrin signaling;L1CAM interactions;Transport of small molecules;Beta-catenin independent WNT signaling;EPH-ephrin mediated repulsion of cells;PCP/CE pathway;Axon guidance;Recycling pathway of L1;WNT5A-dependent internalization of FZD4;WNT5A-dependent internalization of FZD2, FZD5 and ROR2;Vesicle-mediated transport;Infectious disease;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;VLDLR internalisation and degradation;LDL clearance;Plasma lipoprotein clearance;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q96CW5	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q96CW9	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q96D31	Hemostasis;Adaptive Immune System;Elevation of cytosolic Ca2+ levels;Immune System;Muscle contraction;Platelet homeostasis;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q96D71	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q96D96	Fertilization;ROS and RNS production in phagocytes;Sperm Motility And Taxes;Reproduction;Innate Immune System;Immune System;Neutrophil degranulation
Q96DA2	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q96DA6	Mitochondrial protein import;Protein localization
Q96DB2	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96DC9	Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification
Q96DE0	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
Q96DE5	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli
Q96DG6	Metabolism;Biological oxidations;Phase I - Functionalization of compounds
Q96DI7	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q96DN6	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification
Q96DP5	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Translation
Q96DR4	Metabolism;Metabolism of steroid hormones;Pregnenolone biosynthesis;Metabolism of lipids;Metabolism of steroids
Q96DR5	Innate Immune System;Immune System;Antimicrobial peptides
Q96DR7	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q96DR8	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q96DT6	Macroautophagy;Autophagy
Q96DU3	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q96DU7	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
Q96DV4	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q96DX5	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96DX8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96DZ1	Signal Transduction;Disease;Transport of small molecules;ABC-family proteins mediated transport;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of signal transduction by growth factor receptors and second messengers;Defective CFTR causes cystic fibrosis
Q96DZ5	Signal Transduction;Regulation of TNFR1 signaling;Death Receptor Signalling;TNF signaling
Q96E11	Metabolism of proteins;Mitochondrial translation;Mitochondrial translation termination;Translation
Q96E14	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q96E17	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q96E22	Disease;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Synthesis of Dolichyl-phosphate;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective DHDDS causes retinitis pigmentosa 59;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
Q96E29	Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Autophagy;Selective autophagy
Q96E52	Apoptosis;Regulation of Apoptosis;Programmed Cell Death
Q96E93	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q96EA4	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q96EB1	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q96EB6	Epigenetic regulation of gene expression;Generic Transcription Pathway;Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Circadian Clock;SIRT1 negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase II Transcription;Gene expression (Transcription);Cellular responses to external stimuli;FOXO-mediated transcription;Regulation of FOXO transcriptional activity by acetylation
Q96EC8	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q96EE3-1	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
Q96EE3-2	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
Q96EE3	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q96EF0	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q96EF6	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96EG1	Metabolism;Gamma carboxylation, hypusine formation and arylsulfatase activation;Glycosphingolipid metabolism;The activation of arylsulfatases;Metabolism of proteins;Sphingolipid metabolism;Metabolism of lipids;Post-translational protein modification
Q96EH5	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q96EK6	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q96EK7	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q96EL2	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q96EL3	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q96EN8	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
Q96EP0	Signal Transduction;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Death Receptor Signalling;TNF signaling
Q96EQ8	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling
Q96ES7	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q96EU6	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q96EU7	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);O-linked glycosylation;Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins
Q96EV8	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q96EX3	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q96EY5	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q96EY7	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q96EY8	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective MMAB causes methylmalonic aciduria type cblB;Diseases of metabolism
Q96EY9	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q96EZ8	HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q96F07	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q96F24-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96F24-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96F25	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS);Diseases of metabolism;Post-translational protein modification
Q96F44	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96F46	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins
Q96F86	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Metabolism of RNA
Q96FA3	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;IRAK1 recruits IKK complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q96FC9	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q96FE5	Signal Transduction;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Death Receptor Signalling
Q96FF9	Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;S Phase;Cell Cycle, Mitotic
Q96FI4	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Disease;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;Base Excision Repair;DNA Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Diseases of Base Excision Repair;Defective Base Excision Repair Associated with NEIL1;Diseases of DNA repair
Q96FJ0	Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;Post-translational protein modification
Q96FJ2	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Adaptive Immune System;Activation of BMF and translocation to mitochondria;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Programmed Cell Death;Cilium Assembly;Intraflagellar transport;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Autophagy;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy
Q96FL8	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport
Q96FL9	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q96FN5	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q96FS4	Adaptive Immune System;Immune System;Rap1 signalling
Q96FT7	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q96FT9	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q96FV9	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q96FW1	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification
Q96FX2	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Synthesis of diphthamide-EEF2;Post-translational protein modification
Q96FX7	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q96FX8	Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;Keratinization;Formation of the cornified envelope;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96FZ7	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
Q96G01	Membrane Trafficking;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q96G03	Metabolism;Innate Immune System;Immune System;Glycogen synthesis;Neutrophil degranulation;Glycogen breakdown (glycogenolysis);Galactose catabolism;Pentose phosphate pathway;Metabolism of carbohydrates;Glycogen metabolism
Q96G04	Metabolism of proteins;Post-translational protein modification;Protein methylation
Q96G21	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q96G23	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q96G25	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96G61	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol
Q96G74	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Negative regulators of DDX58/IFIH1 signaling
Q96G91	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q96GA3	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q96GA7	Metabolism;Metabolism of amino acids and derivatives;Threonine catabolism
Q96GC5	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q96GC6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96GD3-2	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q96GD4	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Signaling by Rho GTPases;RHO GTPase Effectors;Generic Transcription Pathway;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of mitotic cell cycle;SUMOylation of DNA replication proteins;Regulation of TP53 Activity;RHO GTPases Activate Formins;Post-translational protein modification;Regulation of TP53 Activity through Phosphorylation;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Regulation of MECP2 expression and activity;EML4 and NUDC in mitotic spindle formation
Q96GE5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96GF1	Disease;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;ABC transporter disorders;Disorders of transmembrane transporters;Defective CFTR causes cystic fibrosis;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q96GG9	Metabolism of proteins;Post-translational protein modification;Neddylation
Q96GM1	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Lysosphingolipid and LPA receptors;GPCR ligand binding
Q96GM5	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
Q96GR2	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q96GW7	Metabolism;Degradation of the extracellular matrix;Extracellular matrix organization;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;CS/DS degradation;ECM proteoglycans;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective CHST3 causes SEDCJD;Defective CHST14 causes EDS, musculocontractural type;Defective CHSY1 causes TPBS;Diseases of glycosylation;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of carbohydrates
Q96GW9	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q96GX1	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q96GX5	Cell Cycle;MASTL Facilitates Mitotic Progression;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q96GX9	Apoptosis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Cytochrome c-mediated apoptotic response;Apoptotic factor-mediated response;Methionine salvage pathway;Metabolism;Sulfur amino acid metabolism;Programmed Cell Death;Metabolism of amino acids and derivatives;Regulation of the apoptosome activity
Q96GY3	Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;G0 and Early G1;Polo-like kinase mediated events;Cell Cycle;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S-Specific Transcription;G1/S Transition;S Phase;G2/M Transition;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry
Q96H20	Disease;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events
Q96H22	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q96H40	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96H78	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q96H86	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96H96	Mitochondrial protein import;Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors;Protein localization
Q96HA1	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q96HC4	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q96HD9	Metabolism;Biological oxidations;Aflatoxin activation and detoxification
Q96HE7	Cellular responses to stress;Insulin processing;Peptide hormone metabolism;Detoxification of Reactive Oxygen Species;Metabolism of proteins;Cellular responses to external stimuli
Q96HF1	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
Q96HI0	SUMOylation;SUMO is proteolytically processed;Processing and activation of SUMO;Metabolism of proteins;Post-translational protein modification
Q96HJ5	Innate Immune System;Immune System;Neutrophil degranulation
Q96HN2	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q96HP0	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q96HQ0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96HR3	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96HR9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96HS1-2	Macroautophagy;Mitophagy;Receptor Mediated Mitophagy;Autophagy;Selective autophagy
Q96HW7	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96HY7	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives
Q96I15	Metabolism;Metabolism of ingested SeMet, Sec, MeSec into H2Se;Selenoamino acid metabolism;Metabolism of amino acids and derivatives
Q96I25	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q96I27	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96I36	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96I59	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q96I99	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
Q96IF1	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Developmental Biology;Cell Cycle;Cellular responses to stress;Regulation of PLK1 Activity at G2/M Transition;Mitotic G2-G2/M phases;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;G2/M Transition;Cell Cycle, Mitotic;Cellular responses to external stimuli
Q96IG2	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96IJ6	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of GDP-mannose;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q96IT1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96IU4	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
Q96IV0	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification
Q96IW7	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q96IY1	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q96IY4	Complement cascade;Innate Immune System;Immune System;Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins;Regulation of Complement cascade
Q96J01	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q96J02	Signaling by ERBB4;Downregulation of ERBB4 signaling;Adaptive Immune System;Signaling by NOTCH;Signal Transduction;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus;Generic Transcription Pathway;Signaling by Hedgehog;Degradation of GLI1 by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Signaling by Receptor Tyrosine Kinases;Negative regulators of DDX58/IFIH1 signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96J66	Transport of small molecules;ABC-family proteins mediated transport
Q96J84	Cell-Cell communication;Nephrin family interactions
Q96J92	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q96J94	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q96JA1	Signal Transduction;Signaling by EGFR;Signaling by MET;Negative regulation of MET activity;Signaling by Receptor Tyrosine Kinases
Q96JA3	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q96JB2	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q96JB6	Extracellular matrix organization;Collagen formation;Elastic fibre formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
Q96JC4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96JC9	Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q96JE7	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q96JF0	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q96JH7	Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification
Q96JJ3	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q96JJ7	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q96JK2	Metabolism of proteins;Post-translational protein modification;Neddylation
Q96JK9	Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulation of beta-cell development;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by NOTCH1;Signaling by NOTCH2;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates NOTCH signaling;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q96JL9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96JP0	Metabolism of proteins;Post-translational protein modification;Neddylation
Q96JT2	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q96JW4	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters
Q96JY0	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q96K12	Metabolism;Metabolism of lipids;Wax and plasmalogen biosynthesis;Wax biosynthesis
Q96K58	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96K75	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96K76	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q96K83	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development
Q96KE9	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96KK3	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q96KK4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96KK5	Disease;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;HCMV Infection;HCMV Early Events;HCMV Late Events
Q96KN8	Metabolism;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q96KN9	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q96KP1	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
Q96KP4	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations
Q96KP6	Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification
Q96KQ4	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;TP53 Regulates Transcription of Death Receptors and Ligands;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96KQ7	Epigenetic regulation of gene expression;Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;PKMTs methylate histone lysines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional Regulation by E2F6;Cellular responses to external stimuli
Q96KS0	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cellular responses to stress;Cellular responses to external stimuli
Q96KX2	Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
Q96L21	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q96L33	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q96L34	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q96L42	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q96L46	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Diseases of programmed cell death
Q96L50	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96L58	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Diseases associated with glycosaminoglycan metabolism;Diseases of glycosylation;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of carbohydrates
Q96L73	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q96L91	Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization;Cellular responses to external stimuli
Q96L93	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q96LA8	Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q96LB3	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q96LB4	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q96LB8	Innate Immune System;Immune System;Antimicrobial peptides
Q96LB9	Innate Immune System;Immune System;Antimicrobial peptides
Q96LC7	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q96LC9	Apoptosis;Intrinsic Pathway for Apoptosis;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation of BH3-only proteins;Activation of BMF and translocation to mitochondria;Programmed Cell Death
Q96LD8	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification;Neddylation
Q96LI5	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q96LR5	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96LT4	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q96LT9	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q96LW1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96LX8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96M32	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q96M96	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q96MA6	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q96MD2	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q96ME1	Adaptive Immune System;Cell Cycle;Immune System;Metabolism of proteins;Mitotic G2-G2/M phases;Post-translational protein modification;G2/M Transition;Cell Cycle, Mitotic;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96MF6	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
Q96MF7	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification
Q96MG7	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification
Q96MI9	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q96MK3	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q96MM6	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q96MM7	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q96MN2	ZBP1(DAI) mediated induction of type I IFNs;IRF3 mediated activation of type 1 IFN;Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;IRF3-mediated induction of type I IFN
Q96MP8	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96MR9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96MS0-1	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Regulation of expression of SLITs and ROBOs;ROBO receptors bind AKAP5;Nervous system development
Q96MT3	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins
Q96MT8	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q96MU6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96MU8	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Signaling by WNT in cancer;Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling;Diseases of signal transduction by growth factor receptors and second messengers
Q96MW5	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q96N20	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96N22	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96N28	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96N38	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96N66	Metabolism;Acyl chain remodelling of PI;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q96N67	Hemostasis;Signal Transduction;Signaling by MET;MET activates RAP1 and RAC1;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases;Factors involved in megakaryocyte development and platelet production
Q96N76	Metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
Q96N77	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96N87	Disease;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria;SLC transporter disorders;Disorders of transmembrane transporters
Q96NA2	Adaptive Immune System;Immune System;MHC class II antigen presentation
Q96NB3	Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Repair
Q96ND8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96NG5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96NG8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96NI8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96NJ3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96NL3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96NL6	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q96NR8	Signal Transduction;Disease;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Diseases of the neuronal system
Q96NS5	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96NT5	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Transport of small molecules;Iron uptake and transport
Q96NU7	Metabolism;Histidine catabolism;Metabolism of amino acids and derivatives
Q96NW4	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q96NW7	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;Signal Transduction;Innate Immune System;Immune System;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation
Q96NY8	Cell-Cell communication;Adherens junctions interactions;Nectin/Necl  trans heterodimerization;Cell-cell junction organization;Cell junction organization
Q96NY9	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Fanconi Anemia Pathway;DNA Repair
Q96P16	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96P20	Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Metabolism of proteins;Infectious disease;Deubiquitination;Metalloprotease DUBs;Post-translational protein modification;Inflammasomes;The NLRP3 inflammasome;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
Q96P26	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism
Q96P44	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Collagen chain trimerization
Q96P48	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;Signaling by Non-Receptor Tyrosine Kinases
Q96P56	Fertilization;Sperm Motility And Taxes;Reproduction
Q96P63	Innate Immune System;Immune System;Neutrophil degranulation
Q96P65	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
Q96P68	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q96P88	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q96PC2	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol
Q96PC3	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease
Q96PC5	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q96PD4	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q96PD5	Innate Immune System;Immune System;Antimicrobial peptides
Q96PD6	Metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q96PD7	Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids;Triglyceride biosynthesis;Triglyceride metabolism
Q96PE2	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q96PE3	Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of IP2, IP, and Ins in the cytosol;Metabolism of lipids
Q96PE6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96PE7	Metabolism;Metabolism of lipids;Propionyl-CoA catabolism;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q96PH1	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
Q96PH6	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q96PK6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates bone development
Q96PL1	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Vesicle-mediated transport
Q96PL2	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q96PM5	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion Synthesis by POLH;Adaptive Immune System;Immune System;DNA Damage Bypass;DNA Repair;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96PM9	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;Regulation of TP53 Activity through Association with Co-factors;Transcriptional activation of p53 responsive genes  ;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Transcriptional  activation of  cell cycle inhibitor p21 ;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96PN6	Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
Q96PP8	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q96PP9	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q96PQ1	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q96PQ6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96PQ7	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96PR1	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Metabolism;Integration of energy metabolism;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Regulation of insulin secretion
Q96PS8	Transport of small molecules;Passive transport by Aquaporins;Aquaporin-mediated transport
Q96PU4	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification
Q96PU5	Adaptive Immune System;Signal Transduction;HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Immune System;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Stimuli-sensing channels;Transport of small molecules;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Ion channel transport
Q96PU8	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q96PV0	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q96PX8	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q96PY5	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins
Q96PZ0	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q96Q05	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q96Q11	tRNA processing in the nucleus;tRNA processing in the mitochondrion;tRNA processing;Metabolism of RNA
Q96Q15	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q96Q27	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q96Q42	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q96Q80	Disease;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective CFTR causes cystic fibrosis
Q96Q83	ALKBH3 mediated reversal of alkylation damage;DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
Q96Q89	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q96Q91	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q96QB1	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q96QD5	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q96QD8	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Glutamate Neurotransmitter Release Cycle;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q96QD9	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q96QE2	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Inositol transporters
Q96QF0	Organelle biogenesis and maintenance;Membrane Trafficking;Cilium Assembly;Anchoring of the basal body to the plasma membrane;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q96QG7	Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the late endosome membrane;Synthesis of IP2, IP, and Ins in the cytosol;Metabolism of lipids
Q96QI5	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q96QK1	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking
Q96QP1	Innate Immune System;Immune System;Alpha-protein kinase 1 signaling pathway
Q96QT4	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q96QV1	Signal Transduction;Signaling by Hedgehog;Ligand-receptor interactions;Hedgehog 'on' state
Q96QV6	Disease;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;HCMV Infection;HCMV Early Events;HCMV Late Events
Q96R08	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R09	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R27	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R28	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R30	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R45	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R47	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R48	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R54	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R67	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R69	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R72	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96R84	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RA2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RB7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RC9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RD0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RD1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RD2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RD3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q96RD6	Electric Transmission Across Gap Junctions;Transmission across Electrical Synapses ;Neuronal System
Q96RD7	Electric Transmission Across Gap Junctions;Transmission across Electrical Synapses ;Neuronal System;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The NLRP3 inflammasome
Q96RE9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96RF0	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q96RI0	Hemostasis;Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;Thrombin signalling through proteinase activated receptors (PARs);GPCR ligand binding;Platelet activation, signaling and aggregation
Q96RI1-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96RI1-2	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Nuclear Receptor transcription pathway;Metabolism of proteins;SUMOylation of intracellular receptors;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96RI1-3	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96RI1-4	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96RI1	Metabolism;Recycling of bile acids and salts;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Metabolism of steroids
Q96RI8	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q96RI9	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q96RJ0	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q96RJ3	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
Q96RK1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors
Q96RK4	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q96RL1	Cell Cycle;Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
Q96RL6	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q96RM1	Developmental Biology;Keratinization;Formation of the cornified envelope
Q96RN5	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96RP3	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q96RP8	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q96RP9	Metabolism of proteins;Mitochondrial translation;Mitochondrial translation elongation;Translation
Q96RQ3	Metabolism;Disease;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Diseases of metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q96RQ9	Metabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine metabolism;Phenylalanine metabolism
Q96RR1	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q96RR4	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;DAG and IP3 signaling;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Post NMDA receptor activation events;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde;Activation of NMDA receptors and postsynaptic events;Intracellular signaling by second messengers;Activation of RAC1 downstream of NMDARs;Activation of AMPK downstream of NMDARs
Q96RS0	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;snRNP Assembly;Metabolism of non-coding RNA;PPARA activates gene expression;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids;Metabolism of RNA;Metabolism of steroids
Q96RT1	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signal Transduction;Disease;Diseases of signal transduction by growth factor receptors and second messengers;Downregulation of ERBB2 signaling;Signaling by Receptor Tyrosine Kinases;Constitutive Signaling by Overexpressed ERBB2;Drug-mediated inhibition of ERBB2 signaling;Signaling by ERBB2 KD Mutants;Drug resistance in ERBB2 KD mutants;Resistance of ERBB2 KD mutants to trastuzumab;Resistance of ERBB2 KD mutants to sapitinib;Resistance of ERBB2 KD mutants to tesevatinib;Resistance of ERBB2 KD mutants to neratinib;Resistance of ERBB2 KD mutants to osimertinib;Resistance of ERBB2 KD mutants to afatinib;Resistance of ERBB2 KD mutants to AEE788;Resistance of ERBB2 KD mutants to lapatinib;Signaling by ERBB2 ECD mutants;Signaling by ERBB2 TMD/JMD mutants;Drug resistance in ERBB2 TMD/JMD mutants
Q96RT7	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q96RT8	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q96RU2	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q96RU3	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q96RU7	PI3K Cascade;IRS-mediated signalling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signal Transduction;Activation of AKT2;Immune System;Signaling by VEGF;PPARA activates gene expression;Negative regulation of the PI3K/AKT network;Cellular responses to stress;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;Regulation of lipid metabolism by PPARalpha;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;Metabolism of lipids;Insulin receptor signalling cascade;Signaling by Insulin receptor;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Response of EIF2AK4 (GCN2) to amino acid deficiency;Response of EIF2AK1 (HRI) to heme deficiency
Q96RU8	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q96RY7	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q96S06	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q96S15	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q96S21	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q96S37	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation/anion/zwitterion transport;Organic anion transport;Defective SLC22A12 causes renal hypouricemia 1 (RHUC1);SLC transporter disorders;Disorders of transmembrane transporters
Q96S42	Signaling by NODAL;Developmental Biology;Regulation of signaling by NODAL
Q96S44	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;tRNA modification in the nucleus and cytosol;Regulation of TP53 Activity through Phosphorylation;tRNA processing;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q96S52	Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q96S59	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;L1CAM interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by MET;MET activates RAS signaling;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Nervous system development
Q96SA4	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
Q96SB8	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification
Q96SD1	DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
Q96SE7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96SI1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
Q96SK3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96SL4	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
Q96SN7	Hemostasis;Adaptive Immune System;Elevation of cytosolic Ca2+ levels;Immune System;Muscle contraction;Platelet homeostasis;Platelet calcium homeostasis;Cardiac conduction;Ion homeostasis;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q96SN8	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q96SQ5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96SQ9	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Miscellaneous substrates;Xenobiotics;CYP2E1 reactions
Q96SR6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96ST2	Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q96ST3	Hemostasis;Metabolism;Disease;Epigenetic regulation of gene expression;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Metabolism of lipids;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Loss of MECP2 binding ability to 5mC-DNA;Regulation of MECP2 expression and activity;MECP2 regulates neuronal receptors and channels;MECP2 regulates transcription of neuronal ligands;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Disorders of developmental biology;Factors involved in megakaryocyte development and platelet production
Q96ST8	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q96SU4	Metabolism;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q96SY0	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q96SZ4	Developmental Biology;Transcriptional regulation of pluripotent stem cells
Q96SZ5	Metabolism;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q96T21	Metabolism;Selenoamino acid metabolism;Selenocysteine synthesis;Metabolism of amino acids and derivatives
Q96T23	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
Q96T51	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q96T53	Peptide hormone metabolism;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin
Q96T54	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK-related alkaline pH activated K+ channel (TALK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q96T55	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK-related alkaline pH activated K+ channel (TALK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q96T60	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway;Base Excision Repair;DNA Repair;Resolution of Abasic Sites (AP sites)
Q96T66	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q96T68	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q96T76	Metabolism;Cytosolic iron-sulfur cluster assembly
Q96T83	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers
Q96T88	Epigenetic regulation of gene expression;DNA methylation;Gene expression (Transcription)
Q96T91	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Hormone ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q96TA2	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q98325	Apoptosis;Caspase activation via Death Receptors in the presence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death
Q99062	Developmental Biology;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Other interleukin signaling;Transcriptional regulation of granulopoiesis
Q99075	Signaling by ERBB2;Signaling by ERBB2 in Cancer;Signaling by ERBB4;SHC1 events in ERBB2 signaling;PI3K events in ERBB4 signaling;SHC1 events in ERBB4 signaling;Nuclear signaling by ERBB4;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by EGFR in Cancer;Immune System;Signaling by EGFR;GRB2 events in EGFR signaling;GAB1 signalosome;SHC1 events in EGFR signaling;EGFR downregulation;GRB2 events in ERBB2 signaling;PI3K events in ERBB2 signaling;Negative regulation of the PI3K/AKT network;Membrane Trafficking;EGFR interacts with phospholipase C-gamma;EGFR Transactivation by Gastrin;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Uptake and function of diphtheria toxin;Uptake and actions of bacterial toxins;Signaling by Overexpressed Wild-Type EGFR in Cancer;Inhibition of Signaling by Overexpressed EGFR;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;ERBB2 Regulates Cell Motility;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Gastrin-CREB signalling pathway via PKC and MAPK;ERBB2 Activates PTK6 Signaling;Signaling by PTK6;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;PTK6 promotes HIF1A stabilization;Downregulation of ERBB2 signaling;ESR-mediated signaling;Intracellular signaling by second messengers;Signaling by Non-Receptor Tyrosine Kinases;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling;FLT3 Signaling;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;Signaling by ERBB2 KD Mutants;Signaling by ERBB2 TMD/JMD mutants
Q99081	Developmental Biology;Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Generic Transcription Pathway;Myogenesis;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q99102	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q99217	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q99250	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q99259	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);GABA synthesis;GABA synthesis, release, reuptake and degradation;Transcriptional Regulation by MECP2;MECP2 regulates transcription of genes involved in GABA signaling
Q99418	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
Q99424	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;Beta-oxidation of pristanoyl-CoA;Peroxisomal lipid metabolism;Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q99426	Post-chaperonin tubulin folding pathway;Protein folding;Metabolism of proteins
Q99435	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Nervous system development
Q99436	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q99437	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q99439	Cytokine Signaling in Immune system;Innate Immune System;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Neutrophil degranulation;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
Q99447	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q99456	Developmental Biology;Keratinization;Formation of the cornified envelope
Q99459	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q99460	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q99466	Signaling by NOTCH;Signal Transduction;Disease;Pre-NOTCH Processing in the Endoplasmic Reticulum;Pre-NOTCH Transcription and Translation;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Notch-HLH transcription pathway;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Defective LFNG causes SCDO3;Diseases of metabolism;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription;NOTCH4 Activation and Transmission of Signal to the Nucleus;Negative regulation of NOTCH4 signaling
Q99467	Toll Like Receptor 4 (TLR4) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades
Q99471	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins
Q99487	Hemostasis;Platelet homeostasis
Q99489	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives;Peroxisomal protein import;Protein localization
Q99490	Developmental Biology;Netrin-1 signaling;Axon guidance;Nervous system development
Q99496	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q99497	Macroautophagy;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
Q99500	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
Q99502	DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair
Q99504	DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair
Q99518	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;FMO oxidises nucleophiles
Q99519	Metabolism;Disease;Glycosphingolipid metabolism;Innate Immune System;Immune System;Diseases of glycosylation;Metabolism of proteins;Sialic acid metabolism;Sphingolipid metabolism;Defective NEU1 causes sialidosis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Metabolism of lipids;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification;Neutrophil degranulation
Q99523	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q99527	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q99536	Innate Immune System;Immune System;Neutrophil degranulation
Q99538	Adaptive Immune System;Metabolism;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Vitamin D (calciferol) metabolism;MHC class II antigen presentation;Metabolism of lipids;Metabolism of steroids
Q99541	Metabolism;Macroautophagy;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Autophagy;Lipophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Selective autophagy
Q99542	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization
Q99543	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q99547	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q99551	Mitochondrial biogenesis;Mitochondrial transcription termination;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Gene expression (Transcription);Transcription from mitochondrial promoters
Q99558	Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
Q99567	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
Q99569	Developmental Biology;Keratinization;Formation of the cornified envelope
Q99570	PI3K Cascade;IRS-mediated signalling;Cytokine Signaling in Immune system;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Macroautophagy;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Toll Like Receptor 9 (TLR9) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Metabolism of lipids;RHO GTPases Activate NADPH Oxidases;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;Autophagy
Q99571	Hemostasis;Elevation of cytosolic Ca2+ levels;Disease;Platelet homeostasis;Platelet calcium homeostasis;Infectious disease;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
Q99572	Hemostasis;Elevation of cytosolic Ca2+ levels;Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Platelet homeostasis;Platelet calcium homeostasis;Infectious disease;Inflammasomes;The NLRP3 inflammasome;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
Q99575	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q99576	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q99578	Signal Transduction;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signalling to p38 via RIT and RIN;Signaling by Receptor Tyrosine Kinases
Q99593	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;Muscle contraction;Cardiac conduction;Physiological factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q99594	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates YAP1-mediated transcription
Q99595	Mitochondrial protein import;Protein localization
Q99598	Gene Silencing by RNA;Small interfering RNA (siRNA) biogenesis;Gene expression (Transcription)
Q99608	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling
Q99611	Metabolism;Selenoamino acid metabolism;Selenocysteine synthesis;Metabolism of amino acids and derivatives
Q99613	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
Q99615	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q99616	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q99619	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q99623	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q99624	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q99626	Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation
Q99627	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q99638	Cell Cycle;Activation of ATR in response to replication stress;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q99640	Polo-like kinase mediated events;Cell Cycle;Mitotic G2-G2/M phases;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic;G2/M DNA replication checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints
Q99643	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
Q99650	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
Q99653	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan uptake and degradation;Metabolism of carbohydrates
Q99661	Hemostasis;Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Vesicle-mediated transport;RHO GTPases Activate Formins;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;EML4 and NUDC in mitotic spindle formation;Kinesins;Factors involved in megakaryocyte development and platelet production
Q99665	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-35 Signalling;Interleukin-12 signaling
Q99676	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q99677	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;P2Y receptors;Nucleotide-like (purinergic) receptors;GPCR ligand binding
Q99678	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q99683	Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to external stimuli
Q99684	Developmental Biology;Transcriptional regulation of granulopoiesis
Q99685	Hemostasis;Effects of PIP2 hydrolysis;Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;Triglyceride catabolism;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Arachidonate production from DAG;Metabolism of lipids;Platelet activation, signaling and aggregation;Triglyceride metabolism
Q99697	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of other transcription factors
Q99704	Developmental Biology;Signal Transduction;Axon guidance;Signaling by PTK6;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1;RET signaling;Signaling by Non-Receptor Tyrosine Kinases;Nervous system development
Q99705	Signal Transduction;Organelle biogenesis and maintenance;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q99706	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q99707	Metabolism;Phase II - Conjugation of compounds;Methylation;Sulfur amino acid metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Biological oxidations;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE;Defective MTR causes methylmalonic aciduria and homocystinuria type cblG;Diseases of metabolism;Metabolism of amino acids and derivatives
Q99708	Reproduction;Meiosis;Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through MMEJ (alt-NHEJ);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription);Transcriptional Regulation by E2F6;Meiotic recombination
Q99712	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q99714	Metabolism;tRNA processing in the mitochondrion;tRNA modification in the mitochondrion;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;tRNA processing;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q99715	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Collagen chain trimerization
Q99717	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q99726	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc efflux and compartmentalization by the SLC30 family
Q99728	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);Deubiquitination;UCH proteinases;Metalloprotease DUBs;DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Nonhomologous End-Joining (NHEJ);Homologous DNA Pairing and Strand Exchange;DNA Double Strand Break Response;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Post-translational protein modification;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q99731	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Interleukins;GPCR ligand binding;Interleukin-10 signaling
Q99735	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations;Aflatoxin activation and detoxification
Q99741	Transcription of E2F targets under negative control by DREAM complex;G0 and Early G1;Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q99743	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids
Q99747	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q99748	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
Q99755	PIP3 activates AKT signaling;Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the plasma membrane;Negative regulation of the PI3K/AKT network;Metabolism of lipids;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
Q99757	Metabolism;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Cellular responses to stress;Detoxification of Reactive Oxygen Species;Metabolism of amino acids and derivatives;Cellular responses to external stimuli
Q99758	ABC transporters in lipid homeostasis;Disease;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of metabolism;Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3);Surfactant metabolism;Diseases associated with surfactant metabolism;Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3)
Q99759	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling
Q99766	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Mitochondrial biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Formation of ATP by chemiosmotic coupling;Organelle biogenesis and maintenance;Cristae formation
Q99767	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q99788	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding
Q99798	Mitochondrial protein import;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;Protein localization
Q99807	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
Q99808	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
Q99814	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Developmental Biology;Signal Transduction;Macroautophagy;Cellular responses to stress;Metabolism of proteins;Transcriptional regulation of pluripotent stem cells;Post-translational protein modification;Signaling by PTK6;PTK6 Expression;Neddylation;Cellular responses to external stimuli;Signaling by Non-Receptor Tyrosine Kinases;Autophagy;Selective autophagy;Pexophagy
Q99816	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q99819	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q99829	Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Innate Immune System;Immune System;Metabolism of lipids;Neutrophil degranulation
Q99832	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Folding of actin by CCT/TriC;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
Q99835	Signal Transduction;Organelle biogenesis and maintenance;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium;Hedgehog 'on' state;Activation of SMO
Q99836	ER-Phagosome pathway;Antigen processing-Cross presentation;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;p75NTR signals via NF-kB;p75 NTR receptor-mediated signalling;Negative regulation of the PI3K/AKT network;p75NTR recruits signalling complexes;DEx/H-box helicases activate type I IFN and inflammatory cytokines production ;Interleukin-1 family signaling;Signaling by Interleukins;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);MyD88 deficiency (TLR5);IRAK4 deficiency (TLR5);IRAK4 deficiency (TLR2/4);PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Death Receptor Signalling;Intracellular signaling by second messengers;Interleukin-1 signaling;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Class I MHC mediated antigen processing & presentation
Q99848	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q99856	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription)
Q99871	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q99873	Signal Transduction;Generic Transcription Pathway;RMTs methylate histone arginines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Estrogen-dependent gene expression
Q99877	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q99878	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Metalloprotease DUBs;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q99879	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q99880	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Disease;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;HDACs deacetylate histones;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Infectious disease;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;HCMV Infection;HCMV Early Events;HCMV Late Events;Transcriptional regulation of granulopoiesis;Amyloid fiber formation
Q99884	Metabolism;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Creatine metabolism;Metabolism of amino acids and derivatives
Q99895	Metabolism;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q99928	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;GABA receptor activation
Q99933	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q99942	Disease;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;ABC transporter disorders;Disorders of transmembrane transporters;Defective CFTR causes cystic fibrosis;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q99943	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Integration of energy metabolism;ChREBP activates metabolic gene expression;Metabolism of lipids
Q99952	Signaling by ERBB2;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Downregulation of ERBB2 signaling;Signaling by Receptor Tyrosine Kinases;Interleukin-37 signaling
Q99956	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q99959	Developmental Biology;Keratinization;Formation of the cornified envelope
Q99961	Signal Transduction;Disease;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases
Q99962	Developmental Biology;Adaptive Immune System;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Retrograde neurotrophin signalling;Signaling by EGFR;EGFR downregulation;Signaling by NTRK1 (TRKA);Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;L1CAM interactions;Axon guidance;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Recycling pathway of L1;Vesicle-mediated transport;Infectious disease;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q99963	Signal Transduction;Disease;Signaling by NTRKs;Signaling by EGFR;EGFR downregulation;Signaling by NTRK1 (TRKA);Nuclear Events (kinase and transcription factor activation);Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Signaling by MET;Negative regulation of MET activity;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells;Signaling by Receptor Tyrosine Kinases;NGF-stimulated transcription
Q99965	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
Q99966	Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q99967	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Generic Transcription Pathway;Cellular responses to stress;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of other transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;Cellular responses to external stimuli;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes
Q99969	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q99983	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Keratan sulfate degradation;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Defective ST3GAL3 causes MCT12 and EIEE15;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d);Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q99986	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
Q99996	Cell Cycle;Disease;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Muscle contraction;Mitotic G2-G2/M phases;Phase 3 - rapid repolarisation;Cardiac conduction;Phase 2 - plateau phase;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q99IB8	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
Q9BPU6	Developmental Biology;Semaphorin interactions;CRMPs in Sema3A signaling;Axon guidance;Nervous system development
Q9BPU9	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9BPV8	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;P2Y receptors;Nucleotide-like (purinergic) receptors;G alpha (i) signalling events;GPCR ligand binding
Q9BPW9	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
Q9BPX1	Metabolism;Estrogen biosynthesis;Metabolism of steroid hormones;Metabolism of lipids;Metabolism of steroids
Q9BPX3	Cell Cycle;Condensation of Prometaphase Chromosomes;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic
Q9BPX6	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q9BPZ7	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Disease;Immune System;Signaling by VEGF;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Transcriptional Regulation by TP53;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription);Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases
Q9BQ15	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BQ16	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
Q9BQ31	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Metabolism;Integration of energy metabolism;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Regulation of insulin secretion
Q9BQ48	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BQ51	Adaptive Immune System;Immune System;Costimulation by the CD28 family;PD-1 signaling
Q9BQ52	tRNA processing in the nucleus;tRNA processing in the mitochondrion;tRNA processing;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q9BQ83	HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Fanconi Anemia Pathway;DNA Repair
Q9BQ90	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q9BQ95	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Respiratory electron transport;Complex I biogenesis;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q9BQA1	snRNP Assembly;Metabolism of non-coding RNA;RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization;Metabolism of RNA
Q9BQB4	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
Q9BQB6	Metabolism;Metabolism of vitamins and cofactors;Metabolism of vitamin K;Metabolism of fat-soluble vitamins
Q9BQC3	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Synthesis of diphthamide-EEF2;Post-translational protein modification
Q9BQC6	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BQE3	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9BQE4	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q9BQG0	Epigenetic regulation of gene expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Gene expression (Transcription)
Q9BQG2	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q9BQI3	Cellular responses to stress;Cellular responses to external stimuli;Response of EIF2AK1 (HRI) to heme deficiency
Q9BQI5	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9BQK8	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Cell Cycle;Nuclear Envelope Breakdown;Depolymerisation of the Nuclear Lamina;Metabolism of lipids;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Triglyceride biosynthesis;Triglyceride metabolism
Q9BQQ3	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Transport to the Golgi and subsequent modification
Q9BQQ7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9BQS7	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;SLC transporter disorders;Disorders of transmembrane transporters;Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum);Iron uptake and transport
Q9BQT8	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives
Q9BR01	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
Q9BR09	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9BR61	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q9BR84	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BRA0	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q9BRB3-2	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9BRC7	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
Q9BRF8	Innate Immune System;Immune System;Neutrophil degranulation
Q9BRG1	Disease;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events
Q9BRI3	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc efflux and compartmentalization by the SLC30 family
Q9BRJ2	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BRK0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9BRK3	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q9BRL7	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q9BRQ0	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Deactivation of the beta-catenin transactivating complex
Q9BRQ6	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation
Q9BRQ8	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BRR0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BRR6	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
Q9BRR9	Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;Neutrophil degranulation
Q9BRS2	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9BRT9	Cell Cycle;Unwinding of DNA;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication
Q9BRV3	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q9BRV8	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation
Q9BRX5	Cell Cycle;Unwinding of DNA;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication
Q9BRX9	Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q9BRY0	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q9BRZ2	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA
Q9BS16	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q9BS18	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9BS26	Innate Immune System;Immune System;Neutrophil degranulation
Q9BS31	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BS34	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BSA4	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9BSB4	Macroautophagy;Autophagy
Q9BSD3	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q9BSE5	Metabolism;Agmatine biosynthesis;Metabolism of polyamines;Metabolism of amino acids and derivatives
Q9BSG1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BSH3	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q9BSH4	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BSI4	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Packaging Of Telomere Ends;Telomere Extension By Telomerase;Extension of Telomeres;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Cellular responses to external stimuli
Q9BSJ2	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q9BSJ8	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q9BSK1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BSK4	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9BSL1	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9BST9	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Rhotekin and Rhophilins
Q9BSV6	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q9BSW2	Innate Immune System;Immune System;Neutrophil degranulation
Q9BSY4	Mitochondrial protein import;Protein localization
Q9BT04	Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
Q9BT09	Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades
Q9BT22	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG1 causes ALG1-CDG (CDG-1k);Diseases of metabolism;Post-translational protein modification
Q9BT25	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9BT40	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9BT43	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9BT78	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q9BT81	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q9BT88	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9BTA9	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q9BTC0-1	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q9BTC8	PIP3 activates AKT signaling;Signal Transduction;Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;PTEN Regulation;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q9BTE1	Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
Q9BTE7	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9BTK6	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
Q9BTM1	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Developmental Biology;Reproduction;Meiosis;Signaling by NOTCH;Telomere Maintenance;Signal Transduction;Cell Cycle;Packaging Of Telomere Ends;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Gene Silencing by RNA;Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Generic Transcription Pathway;Cellular responses to stress;Condensation of Prophase Chromosomes;Oxidative Stress Induced Senescence;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;RMTs methylate histone arginines;Chromatin modifying enzymes;SIRT1 negatively regulates rRNA expression;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;NoRC negatively regulates rRNA expression;Chromatin organization;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;DNA methylation;Transcriptional regulation by small RNAs;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase II Transcription;RNA Polymerase I Transcription;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Gene expression (Transcription);Nucleosome assembly;Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Meiotic recombination;Transcriptional regulation of granulopoiesis
Q9BTM9	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9BTN0	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
Q9BTP7	Fanconi Anemia Pathway;DNA Repair
Q9BTT4	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BTU6	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Metabolism of lipids
Q9BTV6	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Synthesis of diphthamide-EEF2;Post-translational protein modification
Q9BTV7	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9BTW9	Post-chaperonin tubulin folding pathway;Protein folding;Metabolism of proteins
Q9BTX1	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q9BTY2	Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Post-translational protein phosphorylation
Q9BTZ2	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors;Peroxisomal protein import;Protein localization
Q9BU02	Metabolism;Vitamin B1 (thiamin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9BU19	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BU23	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q9BU40	Signal Transduction;Signaling by BMP;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation;Signaling by TGF-beta family members
Q9BU61	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9BU64	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q9BU76	Innate Immune System;Immune System;Neutrophil degranulation
Q9BU89	Gamma carboxylation, hypusine formation and arylsulfatase activation;Hypusine synthesis from eIF5A-lysine;Metabolism of proteins;Post-translational protein modification
Q9BUA6	Muscle contraction;Smooth Muscle Contraction
Q9BUB4	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9BUB5	Spry regulation of FGF signaling;Signal Transduction;Signaling by FGFR;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by Receptor Tyrosine Kinases
Q9BUD6	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9BUE0	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9BUE6	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q9BUF5	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9BUF7	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q9BUH8	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9BUI4	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9BUJ2	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9BUK0	Mitochondrial protein import;Protein localization
Q9BUL9	tRNA processing in the nucleus;Major pathway of rRNA processing in the nucleolus and cytosol;tRNA processing;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9BUM1	Metabolism;Disease;Glycogen storage diseases;Severe congenital neutropenia type 4 (G6PC3);Diseases of carbohydrate metabolism;Diseases of metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
Q9BUN8	Disease;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;ABC transporter disorders;Disorders of transmembrane transporters;Defective CFTR causes cystic fibrosis;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q9BUQ8	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9BUR4	Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Chromosome Maintenance
Q9BUR5	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation
Q9BUT1	Metabolism;Metabolism of lipids;Ketone body metabolism;Synthesis of Ketone Bodies
Q9BUU2	Metabolism of proteins;Post-translational protein modification;Protein methylation
Q9BUX1	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations;Cellular responses to stress;Cellular responses to external stimuli;Response of EIF2AK1 (HRI) to heme deficiency
Q9BUY5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BV10	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG12 causes ALG12-CDG (CDG-1g);Diseases of metabolism;Post-translational protein modification
Q9BV20	Methionine salvage pathway;Metabolism;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q9BV23	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Arachidonate production from DAG;Platelet activation, signaling and aggregation
Q9BV38	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9BV40	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Neutrophil degranulation;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Class I MHC mediated antigen processing & presentation
Q9BV57	Methionine salvage pathway;Metabolism;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q9BV68	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9BV73	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9BV79	Metabolism;Metabolism of lipids;mitochondrial fatty acid beta-oxidation of saturated fatty acids;Mitochondrial Fatty Acid Beta-Oxidation;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA;Fatty acid metabolism
Q9BV90	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9BV94	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9BV97	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BVA1	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9BVC3	Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Extension of Telomeres;Chromosome Maintenance
Q9BVC4	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Macroautophagy;Disease;mTOR signalling;mTORC1-mediated signalling;Immune System;Signaling by VEGF;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Autophagy;Amino acids regulate mTORC1
Q9BVC5	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q9BVG3	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9BVG8-2	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins
Q9BVG9	Metabolism;Synthesis of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9BVH7	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9BVI0	Cell Cycle;Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Expression and Degradation;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BVI4	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9BVJ6	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9BVK2	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG8 causes ALG8-CDG (CDG-1h);Diseases of metabolism;Post-translational protein modification
Q9BVK6	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9BVL2-1	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q9BVL2-2	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation
Q9BVP2	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9BVS4	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9BVS5	tRNA modification in the mitochondrion;tRNA processing;Metabolism of RNA
Q9BVV7	Mitochondrial protein import;Protein localization
Q9BVW5	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;DNA Repair
Q9BW19	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9BW27	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signal Transduction;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Signaling by Rho GTPases;Metabolism of non-coding RNA;RHO GTPase Effectors;Gene Silencing by RNA;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;SUMOylation;Nuclear Envelope (NE) Reassembly;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events;Postmitotic nuclear pore complex (NPC) reformation;EML4 and NUDC in mitotic spindle formation
Q9BW60	Metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9BW61	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9BW83	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q9BW91-1	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
Q9BW92	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q9BWD1	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
Q9BWF2	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9BWF3	Circadian Clock
Q9BWJ5	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9BWM5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BWP8	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System;Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Vesicle-mediated transport
Q9BWS9	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9BWT6	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
Q9BWU1	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9BWV1-1	Developmental Biology;Myogenesis
Q9BWV1	Signal Transduction;Signaling by Hedgehog;Ligand-receptor interactions;Hedgehog 'on' state;Activation of SMO
Q9BWV7	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q9BWX5	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9BX10	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9BX26	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q9BX63	Metabolism;Cell Cycle;Generic Transcription Pathway;Cytosolic iron-sulfur cluster assembly;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q9BX66	Muscle contraction;Smooth Muscle Contraction
Q9BX67	Hemostasis;Extracellular matrix organization;Cell surface interactions at the vascular wall;Integrin cell surface interactions
Q9BX79	Signal Transduction;Disease;Visual phototransduction;Retinoid cycle disease events;The canonical retinoid cycle in rods (twilight vision);Diseases associated with visual transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Diseases of the neuronal system
Q9BX82	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BX84	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q9BX95	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9BXA5	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q9BXB1	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination
Q9BXB5	Metabolism;Acyl chain remodelling of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9BXC0	Signal Transduction;Hydroxycarboxylic acid-binding receptors;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q9BXC9	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q9BXD5	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9BXH1	Apoptosis;Intrinsic Pathway for Apoptosis;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell death genes
Q9BXI2	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
Q9BXI3	Metabolism;Metabolism of nucleotides;Pyrimidine catabolism;Purine catabolism;Nucleobase catabolism
Q9BXI6	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9BXJ7	Metabolism;Disease;Plasma lipoprotein assembly, remodeling, and clearance;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective AMN causes hereditary megaloblastic anemia 1;Defective CUBN causes hereditary megaloblastic anemia 1;Transport of small molecules;Diseases of metabolism;HDL clearance;Plasma lipoprotein clearance
Q9BXL7	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Signaling by the B Cell Receptor (BCR)
Q9BXM0-1	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q9BXM0	Developmental Biology;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q9BXM7	Macroautophagy;Generic Transcription Pathway;Mitophagy;Pink/Parkin Mediated Mitophagy;RNA Polymerase II Transcription;Gene expression (Transcription);Autophagy;FOXO-mediated transcription;FOXO-mediated transcription of cell death genes;Selective autophagy
Q9BXN1	Extracellular matrix organization;ECM proteoglycans
Q9BXN2	Innate Immune System;Immune System;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs)
Q9BXP5	RNA polymerase II transcribes snRNA genes;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9BXP8	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins
Q9BXR0	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9BXR5	Disease;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Diseases of Immune System;Diseases associated with the TLR signaling cascade;IRAK4 deficiency (TLR5);MyD88 cascade initiated on plasma membrane
Q9BXR6	Complement cascade;Innate Immune System;Immune System;Regulation of Complement cascade
Q9BXS0	Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Collagen chain trimerization
Q9BXS1	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
Q9BXS5	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Innate Immune System;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease;Neutrophil degranulation
Q9BXS9	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers
Q9BXT2	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
Q9BXT4	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q9BXT5	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
Q9BXT6	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q9BXU0	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q9BXU7	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9BXW4	Macroautophagy;Autophagy
Q9BXW6	Adaptive Immune System;Metabolism;Immune System;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;MHC class II antigen presentation;Metabolism of lipids;Metabolism of steroids
Q9BXW9	Generic Transcription Pathway;Transcriptional Regulation by TP53;Fanconi Anemia Pathway;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q9BXX0	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q9BXY4	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Generic Transcription Pathway;Regulation of FZD by ubiquitination;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in WNT signaling
Q9BY07	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q9BY11	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q9BY14	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9BY15	Signal Transduction;Innate Immune System;Immune System;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding;Neutrophil degranulation
Q9BY31	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BY32	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism
Q9BY41-1	Cell Cycle;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
Q9BY41	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Chromatin organization;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BY43	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
Q9BY49	Metabolism;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q9BY50	SRP-dependent cotranslational protein targeting to membrane;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin;Translation
Q9BY60	Macroautophagy;Autophagy
Q9BY64	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q9BY66	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q9BY67	Cell-Cell communication;Adherens junctions interactions;Nectin/Necl  trans heterodimerization;Cell-cell junction organization;Cell junction organization
Q9BY76	Developmental Biology;Metabolism;Plasma lipoprotein assembly, remodeling, and clearance;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Transport of small molecules;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q9BY77	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9BY84	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Infectious disease;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Infection with Mycobacterium tuberculosis;Suppression of autophagy;Response of Mtb to phagocytosis
Q9BYB0	Neuronal System;Developmental Biology;Axon guidance;Neurexins and neuroligins;Protein-protein interactions at synapses;RET signaling;Nervous system development
Q9BYC2	Metabolism;Metabolism of lipids;Ketone body metabolism;Utilization of Ketone Bodies
Q9BYC5	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
Q9BYC8	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BYC9	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BYD1	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BYD2	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BYD3	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BYD6	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BYE3	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9BYE4	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9BYE7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
Q9BYF1	Metabolism of Angiotensinogen to Angiotensins;Peptide hormone metabolism;Metabolism of proteins
Q9BYG0	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q9BYG4	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q9BYG5	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q9BYJ0	Signal Transduction;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR2b ligand binding and activation;Signaling by FGFR2;Signaling by Receptor Tyrosine Kinases
Q9BYJ1	Metabolism;Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
Q9BYJ4	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9BYK8	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Mitochondrial biogenesis;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;PPARA activates gene expression;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids;Metabolism of steroids
Q9BYM8	Adaptive Immune System;Signal Transduction;Immune System;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Death Receptor Signalling;TNF signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9BYN8	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BYP7	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9BYP8	Developmental Biology;Keratinization
Q9BYP9	Developmental Biology;Keratinization
Q9BYQ0	Developmental Biology;Keratinization
Q9BYQ2	Developmental Biology;Keratinization
Q9BYQ3	Developmental Biology;Keratinization
Q9BYQ4	Developmental Biology;Keratinization
Q9BYQ5	Developmental Biology;Keratinization
Q9BYQ6	Developmental Biology;Keratinization
Q9BYQ7	Developmental Biology;Keratinization
Q9BYQ8	Developmental Biology;Keratinization
Q9BYQ9	Developmental Biology;Keratinization
Q9BYR0	Developmental Biology;Keratinization
Q9BYR2	Developmental Biology;Keratinization
Q9BYR3	Developmental Biology;Keratinization
Q9BYR4	Developmental Biology;Keratinization
Q9BYR5	Developmental Biology;Keratinization
Q9BYR6	Developmental Biology;Keratinization
Q9BYR7	Developmental Biology;Keratinization
Q9BYR8	Developmental Biology;Keratinization
Q9BYR9	Developmental Biology;Keratinization
Q9BYS1	Developmental Biology;Keratinization
Q9BYT5	Developmental Biology;Keratinization
Q9BYT8	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding
Q9BYT9	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9BYU5	Developmental Biology;Keratinization
Q9BYV1	Metabolism;Metabolism of nucleotides;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives;Pyrimidine catabolism;Nucleobase catabolism
Q9BYV7	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q9BYV8	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9BYW1	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q9BYW2	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q9BYW3	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q9BYX2	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9BYX4	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;Negative regulators of DDX58/IFIH1 signaling
Q9BYX7	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9BYZ2	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q9BYZ6	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9BZ23	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q9BZ29	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9BZ71	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PI;Phospholipid metabolism;Metabolism of lipids
Q9BZ72	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PI;Phospholipid metabolism;Metabolism of lipids
Q9BZ95	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q9BZC7	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
Q9BZD2	Disease;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS);SLC transporter disorders;Disorders of transmembrane transporters;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
Q9BZD4	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9BZE1	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9BZE2	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9BZE9	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Membrane Trafficking;Vesicle-mediated transport
Q9BZF1	Metabolism;Acyl chain remodelling of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9BZF2	Metabolism;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q9BZF3	Metabolism;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q9BZF9	Apoptosis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Cytochrome c-mediated apoptotic response;Apoptotic factor-mediated response;Programmed Cell Death;Regulation of the apoptosome activity
Q9BZG1	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q9BZG8	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Synthesis of diphthamide-EEF2;Post-translational protein modification
Q9BZI7	Developmental Biology;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signaling by ROBO receptors;Axon guidance;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9BZJ0	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9BZK7	Developmental Biology;RORA activates gene expression;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Metabolism;Signaling by NOTCH;Mitochondrial biogenesis;Signal Transduction;Disease;Regulation of cholesterol biosynthesis by SREBP (SREBF);Organelle biogenesis and maintenance;Signaling by NOTCH1;PPARA activates gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of gene expression by SREBF (SREBP);Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Chromatin organization;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of steroids;Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Signaling by Nuclear Receptors;Loss of MECP2 binding ability to the NCoR/SMRT complex;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;HCMV Infection;HCMV Early Events;Disorders of developmental biology
Q9BZL6	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9BZM1	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9BZM2	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9BZM4	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9BZM5	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9BZM6	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9BZP6	Digestion of dietary carbohydrate;Digestion;Digestion and absorption
Q9BZQ4	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9BZQ6	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9BZR6	Signal Transduction;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Death Receptor Signalling
Q9BZR8	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9BZR9	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9BZS1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in WNT signaling
Q9BZV2	Metabolism;Vitamin B1 (thiamin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9BZW2	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Sodium-coupled sulphate, di- and tri-carboxylate transporters
Q9BZW8	Hemostasis;Cell surface interactions at the vascular wall
Q9BZX2	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage
Q9BZY9	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9BZZ2	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9C000	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The NLRP1 inflammasome
Q9C005	Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q9C026	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9C030	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9C035	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9C037	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9C040	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9C075	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9C086	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q9C0B1	DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
Q9C0C2	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9C0C7	Macroautophagy;Autophagy
Q9C0C9	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9C0D9	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q9C0E4	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
Q9C0F3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9C0H2	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9C0H5	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by ROBO receptors;Axon guidance;Inactivation of CDC42 and RAC1;Nervous system development
Q9C0I1	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the early endosome membrane;Metabolism of lipids
Q9C0I4	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9C0J1	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins
Q9C0J8	Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q9C0J9	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
Q9C0K1	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q9C0K7	Signal Transduction;mTOR signalling;Energy dependent regulation of mTOR by LKB1-AMPK
Q9GIY3	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q9GZK3	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9GZK4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9GZK6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9GZK7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9GZL7	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9GZM6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9GZM8	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9GZN2	Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
Q9GZP0	Signal Transduction;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases
Q9GZP9	Signal Transduction;Disease;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of signal transduction by growth factor receptors and second messengers;Defective CFTR causes cystic fibrosis;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9GZQ3	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9GZQ4	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
Q9GZQ6	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
Q9GZQ8	Macroautophagy;Membrane Trafficking;Mitophagy;Pink/Parkin Mediated Mitophagy;Vesicle-mediated transport;TBC/RABGAPs;Receptor Mediated Mitophagy;Rab regulation of trafficking;Autophagy;Selective autophagy;Pexophagy
Q9GZR5	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9GZS1	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q9GZS3	Formation of RNA Pol II elongation complex ;Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Metabolism of RNA
Q9GZS9	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of carbohydrates
Q9GZT4	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
Q9GZT5	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q9GZT9	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cellular responses to stress;Cellular responses to external stimuli
Q9GZU1	Stimuli-sensing channels;TRP channels;Transport of small molecules;Iron uptake and transport;Transferrin endocytosis and recycling;Ion channel transport
Q9GZV3	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Disease;Acetylcholine Neurotransmitter Release Cycle;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;SLC transporter disorders;Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A);Disorders of transmembrane transporters
Q9GZV4	Gamma carboxylation, hypusine formation and arylsulfatase activation;Hypusine synthesis from eIF5A-lysine;Metabolism of proteins;Post-translational protein modification
Q9GZV5	Developmental Biology;Signal Transduction;Signaling by TGF-beta Receptor Complex;Signaling by Hippo;YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Muscle contraction;Cardiac conduction;Physiological factors;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;RUNX3 regulates YAP1-mediated transcription;Signaling by TGF-beta family members;EGR2 and SOX10-mediated initiation of Schwann cell myelination;Nervous system development
Q9GZV8	Developmental Biology;Transcriptional regulation of pluripotent stem cells
Q9GZV9	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR1c and Klotho ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Post-translational protein phosphorylation;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q9GZX3	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Disease;Keratan sulfate biosynthesis;Diseases associated with glycosaminoglycan metabolism;Defective CHST6 causes MCDC1;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q9GZX5	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9GZX6	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q9GZY0	Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9GZY6	Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization
Q9GZZ0	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
Q9GZZ7	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;RET signaling;FLT3 Signaling;Nervous system development
Q9GZZ9	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H008	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
Q9H013	Extracellular matrix organization;Invadopodia formation
Q9H015	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation transport;Organic cation/anion/zwitterion transport
Q9H040	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion Synthesis by POLH;DNA Damage Bypass;DNA Repair
Q9H063	PIP3 activates AKT signaling;Signal Transduction;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q9H074	Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Metabolism of RNA
Q9H081	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9H082	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;TBC/RABGAPs;RAB geranylgeranylation;Rab regulation of trafficking
Q9H0A0	rRNA modification in the nucleus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H0A8	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9H0B6	Hemostasis;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;RHO GTPases activate KTN1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9H0B8	Innate Immune System;Immune System;Neutrophil degranulation
Q9H0C5	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H0D6	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H0E2	Cytokine Signaling in Immune system;Innate Immune System;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Neutrophil degranulation;Interleukin-1 signaling
Q9H0E3	Epigenetic regulation of gene expression;HATs acetylate histones;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
Q9H0E7	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9H0E9	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9H0F6	Neuronal System;Signal Transduction;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Neurexins and neuroligins;Protein-protein interactions at synapses;Death Receptor Signalling;TNF signaling
Q9H0F7	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q9H0H0	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H0H3	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H0H5	Hemostasis;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9H0L4	mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q9H0M0	Signaling by ERBB4;Downregulation of ERBB4 signaling;Adaptive Immune System;Signal Transduction;Immune System;Generic Transcription Pathway;Stimuli-sensing channels;Transport of small molecules;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Signaling by Receptor Tyrosine Kinases;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Ion channel transport
Q9H0M5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H0P0-4	Metabolism;Metabolism of nucleotides;Pyrimidine catabolism;Nucleobase catabolism
Q9H0Q3	Transport of small molecules;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Ion channel transport
Q9H0R5	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9H0R8	Macroautophagy;Autophagy
Q9H0S4	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H0T7	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q9H0U3	Innate Immune System;Immune System;Transport of small molecules;Metabolism of proteins;Asparagine N-linked glycosylation;Miscellaneous transport and binding events;Post-translational protein modification;Neutrophil degranulation
Q9H0U4	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Golgi-to-ER retrograde transport;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q9H0U6	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9H0V9	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q9H0W5	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9H0W8	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9H0X9	Metabolism;Acyl chain remodelling of PS;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9H0Y0	Macroautophagy;Autophagy
Q9H115	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9H156	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q9H160	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of TP53 Activity;Post-translational protein modification;Regulation of TP53 Activity through Acetylation;PI5P Regulates TP53 Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H171	ZBP1(DAI) mediated induction of type I IFNs;IRF3 mediated activation of type 1 IFN;Innate Immune System;Immune System;RIP-mediated NFkB activation via ZBP1;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA
Q9H172	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport
Q9H195	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q9H1A4	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H1B5	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Metabolism of carbohydrates
Q9H1C0	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding
Q9H1C4	Disease;Trafficking and processing of endosomal TLR;Innate Immune System;Immune System;Toll-like Receptor Cascades;Diseases of Immune System;Diseases associated with the TLR signaling cascade;UNC93B1 deficiency - HSE
Q9H1C7	Innate Immune System;Immune System;Neutrophil degranulation
Q9H1D0	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q9H1D9	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9H1E1	Innate Immune System;Immune System;Antimicrobial peptides
Q9H1H9	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins
Q9H1I8	ALKBH3 mediated reversal of alkylation damage;DNA Repair;DNA Damage Reversal;Reversal of alkylation damage by DNA dioxygenases
Q9H1J1-2	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9H1J1	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9H1J5	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);Disassembly of the destruction complex and recruitment of AXIN to the membrane;GPCR ligand binding
Q9H1J7	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Beta-catenin independent WNT signaling;PCP/CE pathway
Q9H1K0	Hemostasis;Toll Like Receptor 9 (TLR9) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Factors involved in megakaryocyte development and platelet production
Q9H1K1-1	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q9H1K4	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters
Q9H1M3	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q9H1M4	Beta defensins;Defensins;Innate Immune System;Immune System;Antimicrobial peptides
Q9H1N7	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Glycosaminoglycan metabolism;Transport and synthesis of PAPS;Biological oxidations;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of carbohydrates;Transport of nucleotide sugars
Q9H1P3	Metabolism;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q9H1Y0	Macroautophagy;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Mitophagy;Pink/Parkin Mediated Mitophagy;Receptor Mediated Mitophagy;Negative regulators of DDX58/IFIH1 signaling;Autophagy;Selective autophagy
Q9H1Y3	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Opsins;GPCR ligand binding
Q9H204	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9H205	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H207	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H208	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H209	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H210	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H211	Cell Cycle;Mitotic G1 phase and G1/S transition;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;G1/S-Specific Transcription;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication
Q9H221	ABC transporters in lipid homeostasis;Signal Transduction;Disease;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCG8 causes gallbladder disease 4 and sitosterolemia;Defective ABCG5 causes sitosterolemia;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9H222	ABC transporters in lipid homeostasis;Signal Transduction;Disease;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCG8 causes gallbladder disease 4 and sitosterolemia;Defective ABCG5 causes sitosterolemia;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9H227	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q9H228	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding
Q9H237	Signal Transduction;Disease;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by WNT in cancer;WNT ligand secretion is abrogated by the PORCN inhibitor LGK974;Diseases of signal transduction by growth factor receptors and second messengers
Q9H244	Hemostasis;Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;ADP signalling through P2Y purinoceptor 12;Signal amplification;P2Y receptors;Nucleotide-like (purinergic) receptors;G alpha (i) signalling events;GPCR ligand binding;Platelet activation, signaling and aggregation
Q9H252	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9H254	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;L1CAM interactions;NCAM signaling for neurite out-growth;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;FLT3 Signaling;Nervous system development
Q9H255	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H257	Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs)
Q9H267	Disease;Infectious disease;Infection with Mycobacterium tuberculosis;Prevention of phagosomal-lysosomal fusion;Suppression of phagosomal maturation;Response of Mtb to phagocytosis
Q9H293	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins
Q9H295	Unfolded Protein Response (UPR);Metabolism of proteins;CREB3 factors activate genes
Q9H2A2	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
Q9H2A7	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q9H2A9	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;Reactions specific to the complex N-glycan synthesis pathway
Q9H2B4	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Glycosaminoglycan metabolism;Transport and synthesis of PAPS;Biological oxidations;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Multifunctional anion exchangers;Metabolism of carbohydrates
Q9H2C0	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H2C2	Metabolism;Cholesterol biosynthesis;Metabolism of lipids;Metabolism of steroids
Q9H2C5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H2C8	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H2D1	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9H2E6	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
Q9H2F3	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q9H2F5	Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
Q9H2G4	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q9H2G9	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q9H2H0	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by DVL-interacting proteins
Q9H2H8	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9H2H9	Neurotransmitter uptake and metabolism In glial cells;Transmission across Chemical Synapses;Neuronal System;Astrocytic Glutamate-Glutamine Uptake And Metabolism;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q9H2J7	Amino acid transport across the plasma membrane;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters
Q9H2K0	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Translation
Q9H2K2	PIP3 activates AKT signaling;Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Metabolism of proteins;Degradation of AXIN;Signaling by WNT in cancer;XAV939 inhibits tankyrase, stabilizing AXIN;Diseases of signal transduction by growth factor receptors and second messengers;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers
Q9H2M3	Metabolism;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q9H2M9	Membrane Trafficking;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9H2P9	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Synthesis of diphthamide-EEF2;Post-translational protein modification
Q9H2S1	Neuronal System;Ca2+ activated K+ channels;Potassium Channels
Q9H2U1	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
Q9H2U2	Metabolism;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Pyrophosphate hydrolysis;Translation
Q9H2W6	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9H2X6	YAP1- and WWTR1 (TAZ)-stimulated gene expression;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;SUMOylation of transcription cofactors;Metabolism of proteins;Muscle contraction;Cardiac conduction;Physiological factors;Regulation of TP53 Activity;Post-translational protein modification;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Transcriptional Regulation by MECP2;Regulation of MECP2 expression and activity
Q9H2X9	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Cation-coupled Chloride cotransporters
Q9H300	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q9H310	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Rhesus glycoproteins mediate ammonium transport.
Q9H313-3	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9H324	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9H334-8	Developmental Biology;Transcriptional regulation of pluripotent stem cells
Q9H339	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H340	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H341	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H342	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H343	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H344	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H346	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H3D4	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;Generic Transcription Pathway;Transcriptional Regulation by TP53;Programmed Cell Death;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain;TP53 Regulates Transcription of Caspase Activators and Caspases;TP53 Regulates Transcription of Death Receptors and Ligands;Regulation of TP53 Activity through Association with Co-factors;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H3H1	tRNA modification in the nucleus and cytosol;tRNA modification in the mitochondrion;tRNA processing;Metabolism of RNA
Q9H3H5	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2;Diseases of metabolism;Post-translational protein modification
Q9H3K6	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling
Q9H3L0	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD;Diseases of metabolism
Q9H3M0	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9H3M7	Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Generic Transcription Pathway;Infectious disease;Inflammasomes;RNA Polymerase II Transcription;Gene expression (Transcription);The NLRP3 inflammasome;FOXO-mediated transcription;Regulation of FOXO transcriptional activity by acetylation;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
Q9H3M9	Metabolism of proteins;Deubiquitination;Josephin domain DUBs;Post-translational protein modification
Q9H3N8	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Histamine receptors;G alpha (i) signalling events;GPCR ligand binding
Q9H3P2	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q9H3P7	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q9H3R0	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
Q9H3R1	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q9H3R2	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q9H3R5	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q9H3S1	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
Q9H3S4	Metabolism;Vitamin B1 (thiamin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9H3S5	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9H3S7	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling
Q9H3Y6	Signal Transduction;Signaling by PTK6;PTK6 Down-Regulation;Signaling by Non-Receptor Tyrosine Kinases
Q9H3Z4	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Innate Immune System;Immune System;Neutrophil degranulation;GABA synthesis, release, reuptake and degradation
Q9H410	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Neutrophil degranulation;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9H427	Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9H444	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
Q9H461	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;GPCR ligand binding;RNF mutants show enhanced WNT signaling and proliferation;Diseases of signal transduction by growth factor receptors and second messengers
Q9H469	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H477	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates
Q9H479	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Post-translational protein modification
Q9H488	Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in the Endoplasmic Reticulum;Pre-NOTCH Expression and Processing
Q9H490	Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9H492	Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Receptor Mediated Mitophagy;Autophagy;Selective autophagy
Q9H4A3	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9H4A9	Metabolism;Disease;Biological oxidations;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Aflatoxin activation and detoxification;Metabolism of lipids;Infectious disease;Fatty acid metabolism;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;LTC4-CYSLTR mediated IL4 production
Q9H4B4	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H4B6	Signal Transduction;Signaling by Hippo
Q9H4B7	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9H4B8	Metabolism;Disease;Biological oxidations;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Aflatoxin activation and detoxification;Metabolism of lipids;Infectious disease;Fatty acid metabolism;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;LTC4-CYSLTR mediated IL4 production
Q9H4E5	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9H4F1	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q9H4G0	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9H4I9	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q9H4L4	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H4L5	Metabolism;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q9H4M3	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H4M7	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9H4M9	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9H4P4	Signaling by ERBB2;Adaptive Immune System;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Immune System;Downregulation of ERBB2 signaling;Signaling by Receptor Tyrosine Kinases;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H4X1	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H4Y5	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Biological oxidations
Q9H4Z2	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
Q9H553	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG2 causes ALG2-CDG (CDG-1i);Diseases of metabolism;Post-translational protein modification
Q9H583	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H598	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;GABA synthesis, release, reuptake and degradation
Q9H5I1	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q9H5J4	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Metabolism of steroids;Fatty acid metabolism
Q9H5J8	Epigenetic regulation of gene expression;SIRT1 negatively regulates rRNA expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q9H5K3	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification
Q9H5Q4	Mitochondrial biogenesis;Mitochondrial transcription initiation;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis;Gene expression (Transcription);Transcription from mitochondrial promoters
Q9H5Y7	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q9H611	Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;Chromosome Maintenance
Q9H633	tRNA processing in the nucleus;Major pathway of rRNA processing in the nucleolus and cytosol;tRNA processing;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H668	Telomere Maintenance;Cell Cycle;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;Extension of Telomeres;Chromosome Maintenance
Q9H672	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H6A0	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9H6D7	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9H6H4	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H6I2	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q9H6Q4	Metabolism;Cytosolic iron-sulfur cluster assembly
Q9H6R3	Metabolism;Metabolism of lipids;Ketone body metabolism;Synthesis of Ketone Bodies
Q9H6R4	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H6T0	Signal Transduction;Signaling by FGFR;Signaling by FGFR2;FGFR2 alternative splicing;Signaling by Receptor Tyrosine Kinases
Q9H6U8	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG9 causes ALG9-CDG (CDG-1l);Diseases of metabolism;Post-translational protein modification
Q9H6X2-1	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
Q9H6X2-2	Disease;Uptake and function of anthrax toxins;Uptake and actions of bacterial toxins;Infectious disease
Q9H6Z9	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cellular responses to stress;Cellular responses to external stimuli
Q9H707	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H765	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H772	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q9H773	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q9H7B4	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q9H7D0	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9H7L9	Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;Metabolism of proteins;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Gene expression (Transcription)
Q9H7P6	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q9H7P9	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q9H7R0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H7R5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H7S9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H7T0	Fertilization;Sperm Motility And Taxes;Reproduction
Q9H7X3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H7X7	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q9H7Z6	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9H7Z7	Metabolism;Innate Immune System;Immune System;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Neutrophil degranulation;Fatty acid metabolism
Q9H814	snRNP Assembly;Metabolism of non-coding RNA;RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9H816	Fanconi Anemia Pathway;DNA Repair
Q9H832	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H840	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
Q9H841	Transport of small molecules;Miscellaneous transport and binding events
Q9H845	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9H853	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9H867	Metabolism of proteins;Post-translational protein modification;Protein methylation
Q9H8E8	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9H8G1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H8H0	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H8H3	Innate Immune System;Immune System;Neutrophil degranulation
Q9H8M1	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
Q9H8M9	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q9H8P0	Metabolism;Disease;Androgen biosynthesis;Metabolism of steroid hormones;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Synthesis of Dolichyl-phosphate;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ;Metabolism of lipids;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification;Metabolism of steroids
Q9H8S9	Signal Transduction;Signaling by Hippo
Q9H8V3	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q9H8W5	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9H8X2	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol;Synthesis of IPs in the nucleus
Q9H8Y8	Golgi Cisternae Pericentriolar Stack Reorganization;Cell Cycle;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q9H900	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9H902	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9H903	Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9H936	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters
Q9H944	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H963	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9H974	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9H981	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q9H999	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q9H9A5	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9H9A7	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q9H9B1	Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;PKMTs methylate histone lysines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional Regulation by E2F6;Cellular responses to external stimuli
Q9H9E3	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q9H9F9	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q9H9G7	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;Small interfering RNA (siRNA) biogenesis;Post-transcriptional silencing by small RNAs;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9H9H4	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q9H9J2	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9H9J4	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9H9L3	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9H9L4	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9H9P5	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9H9P8	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Interconversion of 2-oxoglutarate and 2-hydroxyglutarate
Q9H9Q2	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q9H9Q4	DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
Q9H9S0	Developmental Biology;Cytokine Signaling in Immune system;Immune System;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Signaling by Interleukins;Transcriptional regulation of pluripotent stem cells;Interleukin-4 and Interleukin-13 signaling
Q9H9S3	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Immune System;SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation;Class I MHC mediated antigen processing & presentation
Q9H9S4	Signal Transduction;mTOR signalling;Energy dependent regulation of mTOR by LKB1-AMPK
Q9H9T3	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9H9Y6	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q9H9Z2	Developmental Biology;Transcriptional regulation of pluripotent stem cells
Q9HA47	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage
Q9HA64	Gamma carboxylation, hypusine formation and arylsulfatase activation;Metabolism of proteins;Post-translational protein modification
Q9HA65	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9HA77	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q9HA82	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9HAB3	Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9HAB8	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q9HAF1	Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HAH1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HAJ7	Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
Q9HAN9	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9HAP6	Neurotransmitter release cycle;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Dopamine Neurotransmitter Release Cycle;Activation of NMDA receptors and postsynaptic events;RHO GTPases Activate Rhotekin and Rhophilins;Neurexins and neuroligins;Protein-protein interactions at synapses;Assembly and cell surface presentation of NMDA receptors
Q9HAQ2	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9HAS3	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
Q9HAT0	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Rhotekin and Rhophilins
Q9HAT1	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q9HAT8	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;IRAK1 recruits IKK complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q9HAU0	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9HAU4	Adaptive Immune System;Signal Transduction;Immune System;Signaling by TGF-beta Receptor Complex;Signaling by WNT;Signaling by BMP;TCF dependent signaling in response to WNT;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Asymmetric localization of PCP proteins;Degradation of AXIN;Signaling by Hedgehog;Hedgehog 'on' state;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by TGF-beta family members;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9HAU5	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9HAV0	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q9HAV4	MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Gene expression (Transcription)
Q9HAV5	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q9HAV7	Mitochondrial protein import;Protein localization
Q9HAW0	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9HAW4	Apoptosis;Apoptotic cleavage of cellular proteins;Cell Cycle;Activation of ATR in response to replication stress;Metabolism of proteins;Programmed Cell Death;Deubiquitination;Ub-specific processing proteases;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;Post-translational protein modification;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;Apoptotic execution phase
Q9HAW7	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q9HAW8	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q9HAW9	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q9HAY6	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q9HAZ2	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q9HB03	Metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9HB14	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;Tandem pore domain halothane-inhibited K+ channel (THIK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9HB15	Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9HB19	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9HB20	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9HB21	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9HB29	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-38 signaling;Interleukin-36 pathway
Q9HB55	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Miscellaneous substrates;Xenobiotics
Q9HB63	Developmental Biology;Extracellular matrix organization;Non-integrin membrane-ECM interactions;Netrin-1 signaling;Axon guidance;Nervous system development
Q9HB65	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HB75	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HB89	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;GPCR ligand binding
Q9HB90	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q9HB96	Fanconi Anemia Pathway;DNA Repair
Q9HBA0	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q9HBA9	Metabolism;Metabolism of amino acids and derivatives;Aspartate and asparagine metabolism
Q9HBE4	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-21 signaling
Q9HBE5	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-21 signaling
Q9HBG4	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Ion channel transport
Q9HBG6	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q9HBH0	Signal Transduction;Innate Immune System;Immune System;Signaling by Rho GTPases;Rho GTPase cycle;Neutrophil degranulation
Q9HBH5	Signal Transduction;Signaling by Retinoic Acid;RA biosynthesis pathway;Signaling by Nuclear Receptors
Q9HBI1	Cell-Cell communication;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization
Q9HBI6	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Miscellaneous substrates;Eicosanoids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Metabolism of lipids;Fatty acid metabolism
Q9HBJ8	Insulin processing;Peptide hormone metabolism;Metabolism of proteins
Q9HBK9	Metabolism;Phase II - Conjugation of compounds;Methylation;Biological oxidations
Q9HBL8	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
Q9HBM1	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9HBM6	HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Transcription of the HIV genome;Generic Transcription Pathway;Transcriptional Regulation by TP53;Metabolism of proteins;Regulation of TP53 Activity;Infectious disease;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
Q9HBT7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HBT8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HBU6	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q9HBW0	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding
Q9HBX8	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination
Q9HBX9	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;Relaxin receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9HBY0	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate NADPH Oxidases
Q9HBY8	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9HBZ2	Metabolism;PPARA activates gene expression;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Xenobiotics;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Aryl hydrocarbon receptor signalling
Q9HC10	Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Q9HC16-1	HIV Infection;Host Interactions of HIV factors;Disease;Vif-mediated degradation of APOBEC3G;APOBEC3G mediated resistance to HIV-1 infection;Infectious disease
Q9HC16-3	HIV Infection;Host Interactions of HIV factors;Disease;Vif-mediated degradation of APOBEC3G;APOBEC3G mediated resistance to HIV-1 infection;Infectious disease
Q9HC21	Metabolism;Vitamin B1 (thiamin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9HC23	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q9HC29	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q9HC35	Cell Cycle;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic;EML4 and NUDC in mitotic spindle formation
Q9HC36	rRNA modification in the mitochondrion;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q9HC52	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA methylation proteins;Post-translational protein modification;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers
Q9HC58	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers
Q9HC62	SUMOylation;SUMO is proteolytically processed;Processing and activation of SUMO;Metabolism of proteins;Post-translational protein modification
Q9HC73	Interleukin-7 signaling;Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins
Q9HC77	Cell Cycle;Organelle biogenesis and maintenance;Generic Transcription Pathway;Regulation of PLK1 Activity at G2/M Transition;Transcriptional Regulation by TP53;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);AURKA Activation by TPX2
Q9HC84	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q9HC96	Degradation of the extracellular matrix;Extracellular matrix organization
Q9HC97	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding
Q9HC98	Cell Cycle;Nuclear Envelope Breakdown;Activation of NIMA Kinases NEK9, NEK6, NEK7;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic;EML4 and NUDC in mitotic spindle formation
Q9HCB6	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9HCC0	Metabolism;Disease;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in vitamin and cofactor metabolism;Defects in biotin (Btn) metabolism;Defective HLCS causes multiple carboxylase deficiency;Diseases of metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q9HCE1	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9HCE5	Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9HCE6	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q9HCE7	Adaptive Immune System;Signal Transduction;Immune System;Signaling by TGF-beta Receptor Complex;Signaling by WNT;Signaling by BMP;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins;Signaling by Hedgehog;Hedgehog 'on' state;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Signaling by TGF-beta family members;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9HCE9	Stimuli-sensing channels;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Transport of small molecules;Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation;Ion channel transport
Q9HCF6	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q9HCG1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HCG7	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q9HCG8	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9HCI7	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9HCJ0	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;Gene Silencing by RNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;Post-transcriptional silencing by small RNAs;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9HCJ1	Transport of small molecules;Miscellaneous transport and binding events
Q9HCK4	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of commissural axon pathfinding by SLIT and ROBO;Regulation of cortical dendrite branching;Regulation of expression of SLITs and ROBOs;ROBO receptors bind AKAP5;Nervous system development
Q9HCK5	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;Small interfering RNA (siRNA) biogenesis;Post-transcriptional silencing by small RNAs;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9HCK8	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q9HCL2	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Signal Transduction;Regulation of cholesterol biosynthesis by SREBP (SREBF);Generic Transcription Pathway;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription);Triglyceride biosynthesis;Transcriptional regulation by RUNX1;RUNX1 regulates estrogen receptor mediated transcription;ESR-mediated signaling;Metabolism of steroids;Triglyceride metabolism;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q9HCL3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HCM2	Developmental Biology;Generic Transcription Pathway;Semaphorin interactions;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Other semaphorin interactions;Axon guidance;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Nervous system development
Q9HCM3	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q9HCM4	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9HCM9	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9HCN2	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HCN6	Hemostasis;GPVI-mediated activation cascade;Cell surface interactions at the vascular wall;Platelet Adhesion to exposed collagen;Platelet activation, signaling and aggregation
Q9HCQ5	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q9HCR9	Hemostasis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects;G alpha (s) signalling events
Q9HCS2	Metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Fatty acids;Phase I - Functionalization of compounds;Eicosanoids
Q9HCS4	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Deactivation of the beta-catenin transactivating complex;Beta-catenin independent WNT signaling;Ca2+ pathway;Binding of TCF/LEF:CTNNB1 to target gene promoters;Repression of WNT target genes;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX3;RUNX3 regulates WNT signaling
Q9HCS7	Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;DNA Repair;Metabolism of RNA
Q9HCT0	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;FGFR2 mutant receptor activation;Signaling by FGFR;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR1b ligand binding and activation;FGFR2b ligand binding and activation;Negative regulation of the PI3K/AKT network;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR2 in disease;FGFRL1 modulation of FGFR1 signaling;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q9HCU5	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q9HCU8	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Telomere Maintenance;Cell Cycle;Polymerase switching on the C-strand of the telomere;Processive synthesis on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate from the C-strand;Extension of Telomeres;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;Chromosome Maintenance;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
Q9HCU9	HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9HCX3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HCX4	Hemostasis;Effects of PIP2 hydrolysis;Developmental Biology;Elevation of cytosolic Ca2+ levels;Signal Transduction;Stimuli-sensing channels;TRP channels;Signaling by GPCR;Netrin-1 signaling;Transport of small molecules;GPCR downstream signalling;G alpha (q) signalling events;Platelet homeostasis;Platelet calcium homeostasis;Role of second messengers in netrin-1 signaling;Axon guidance;Platelet activation, signaling and aggregation;Nervous system development;Ion channel transport
Q9HCZ1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9HD20	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q9HD23	Transport of small molecules;Miscellaneous transport and binding events
Q9HD26	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases regulate CFTR trafficking
Q9HD33	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9HD34	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q9HD40	Metabolism;Selenoamino acid metabolism;Selenocysteine synthesis;Metabolism of amino acids and derivatives
Q9HD42	Disease;Infectious disease;HCMV Infection;HCMV Late Events
Q9HD47	Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation
Q9HD67	Developmental Biology;Disease;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Netrin-1 signaling;Axon guidance;Infectious disease;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
Q9HD89	Innate Immune System;Immune System;Generic Transcription Pathway;Neutrophil degranulation;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
Q9HDB5	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9HDD0	Metabolism;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9LBS8	Disease;Neurotoxicity of clostridium toxins;Toxicity of botulinum toxin type B (BoNT/B);Toxicity of botulinum toxin type A (BoNT/A);Toxicity of botulinum toxin type E (BoNT/E);Uptake and actions of bacterial toxins;Infectious disease
Q9MY60	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q9NNW7	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
Q9NNX6	Adaptive Immune System;Innate Immune System;Immune System;C-type lectin receptors (CLRs);CD209 (DC-SIGN) signaling;Butyrophilin (BTN) family interactions
Q9NP31	Signal Transduction;Signaling by VEGF;VEGFA-VEGFR2 Pathway;Signaling by Receptor Tyrosine Kinases
Q9NP55	Innate Immune System;Immune System;Antimicrobial peptides
Q9NP56	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events
Q9NP58	Mitochondrial ABC transporters;Disease;Transport of small molecules;ABC-family proteins mediated transport;ABC transporter disorders;Disorders of transmembrane transporters;Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7)
Q9NP59	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages);Defective CP causes aceruloplasminemia (ACERULOP);SLC transporter disorders;Disorders of transmembrane transporters;Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum);Iron uptake and transport
Q9NP60	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q9NP61	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9NP70	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q9NP71	Metabolism;PKA-mediated phosphorylation of key metabolic factors;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism;ChREBP activates metabolic gene expression;PP2A-mediated dephosphorylation of key metabolic factors
Q9NP72	Innate Immune System;Immune System;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9NP73	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS);Diseases of metabolism;Post-translational protein modification
Q9NP77	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NP78	Transport of small molecules;ABC-family proteins mediated transport
Q9NP79	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT)
Q9NP80	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NP81	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q9NP84	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
Q9NP85	Cell-Cell communication;Nephrin family interactions
Q9NP87	DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
Q9NP90	Innate Immune System;Immune System;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9NP91	Disease;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG);SLC transporter disorders;Disorders of transmembrane transporters
Q9NP92	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NP94	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q9NP95	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by activated point mutants of FGFR1;FGFR1 mutant receptor activation;FGFR2 mutant receptor activation;Signaling by activated point mutants of FGFR3;Signaling by FGFR;FGFR3 ligand binding and activation;FGFR2 ligand binding and activation;FGFR1 ligand binding and activation;FGFR4 ligand binding and activation;FGFR3b ligand binding and activation;FGFR3c ligand binding and activation;FGFR1c ligand binding and activation;FGFR2c ligand binding and activation;Negative regulation of the PI3K/AKT network;FGFR3 mutant receptor activation;Activated point mutants of FGFR2;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Phospholipase C-mediated cascade; FGFR2;Phospholipase C-mediated cascade; FGFR3;Phospholipase C-mediated cascade; FGFR4;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;SHC-mediated cascade:FGFR2;FRS-mediated FGFR2 signaling;SHC-mediated cascade:FGFR3;FRS-mediated FGFR3 signaling;Downstream signaling of activated FGFR3;PI-3K cascade:FGFR3;FRS-mediated FGFR4 signaling;Downstream signaling of activated FGFR4;SHC-mediated cascade:FGFR4;PI-3K cascade:FGFR4;Negative regulation of FGFR1 signaling;Negative regulation of FGFR2 signaling;Negative regulation of FGFR3 signaling;Negative regulation of FGFR4 signaling;Signaling by FGFR1;Signaling by FGFR2;Signaling by FGFR3;Signaling by FGFR4;Signaling by FGFR2 in disease;Signaling by FGFR1 in disease;Signaling by FGFR3 in disease;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by FGFR3 point mutants in cancer;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q9NP97	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q9NP99	Hemostasis;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Cell surface interactions at the vascular wall;DAP12 interactions
Q9NPA1	Hemostasis;Neuronal System;Ca2+ activated K+ channels;Potassium Channels;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
Q9NPA2	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Innate Immune System;Immune System;Neutrophil degranulation
Q9NPA3	Metabolism;Carnitine metabolism;Metabolism of lipids;Fatty acid metabolism
Q9NPA8	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9NPB1	Metabolism;Metabolism of nucleotides;Pyrimidine catabolism;Nucleobase catabolism
Q9NPB6	Cell-Cell communication;Signal Transduction;Signaling by TGF-beta Receptor Complex;Signaling by WNT;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Beta-catenin independent WNT signaling;PCP/CE pathway;Tight junction interactions;Cell-cell junction organization;Cell junction organization;Asymmetric localization of PCP proteins;Signaling by TGF-beta family members
Q9NPB8	Metabolism;Hydrolysis of LPC;Hydrolysis of LPE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NPB9	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR ligand binding
Q9NPC1	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Leukotriene receptors;G alpha (q) signalling events;GPCR ligand binding
Q9NPC2	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK-releated acid-sensitive K+ channel (TASK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9NPD3	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NPD5	Metabolism;Recycling of bile acids and salts;Disease;Metabolism of porphyrins;Heme degradation;Bile acid and bile salt metabolism;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of lipids;Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR);SLC transporter disorders;Disorders of transmembrane transporters;Transport of organic anions;Metabolism of steroids
Q9NPD7	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9NPD8	Metabolism of proteins;Post-translational protein modification;Fanconi Anemia Pathway;DNA Repair;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
Q9NPE3	Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;rRNA modification in the nucleus and cytosol;rRNA processing;Chromosome Maintenance;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NPF0	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective CD320 causes methylmalonic aciduria;Diseases of metabolism
Q9NPF2	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q9NPF4	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9NPF5	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9NPF7	Cytokine Signaling in Immune system;Immune System;Interleukin-12 family signaling;Signaling by Interleukins;Interleukin-4 and Interleukin-13 signaling;Interleukin-23 signaling
Q9NPG1	Signal Transduction;Signaling by WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;Ca2+ pathway;PCP/CE pathway;Asymmetric localization of PCP proteins;GPCR ligand binding
Q9NPG2	Transport of small molecules;Intracellular oxygen transport
Q9NPG3	Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular responses to external stimuli
Q9NPH0	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NPH2	Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
Q9NPH3-1	Neuronal System;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Negative regulation of the PI3K/AKT network;Receptor-type tyrosine-protein phosphatases;Interleukin-1 family signaling;Signaling by Interleukins;Protein-protein interactions at synapses;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Interleukin-36 pathway;Interleukin-33 signaling;Interleukin-1 signaling
Q9NPH5	Cellular responses to stress;Detoxification of Reactive Oxygen Species;Cellular responses to external stimuli
Q9NPH9	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q9NPI1	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NPI5	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9NPI6	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9NPI8	Fanconi Anemia Pathway;DNA Repair
Q9NPI9	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium transport channels;Potassium Channels;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q9NPJ1	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q9NPJ3	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q9NPJ4	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9NPJ6	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NPL8	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9NPP4	Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;Inflammasomes;TP53 Regulates Transcription of Caspase Activators and Caspases;RNA Polymerase II Transcription;Gene expression (Transcription);The IPAF inflammasome
Q9NPY3	Innate Immune System;Immune System;Neutrophil degranulation
Q9NPZ5	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Metabolism of carbohydrates
Q9NQ11	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q9NQ25	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9NQ36	Signal Transduction;Hedgehog ligand biogenesis;Signaling by Hedgehog;Release of Hh-Np from the secreting cell
Q9NQ38	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9NQ40	Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9NQ48	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
Q9NQ50	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NQ66	Opioid Signalling;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Inositol phosphate metabolism;Signal Transduction;Integration of energy metabolism;Synthesis of IP3 and IP4 in the cytosol;Signaling by WNT;Signaling by GPCR;Beta-catenin independent WNT signaling;GPCR downstream signalling;G-protein beta:gamma signalling;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G beta:gamma signalling through PLC beta;G alpha (i) signalling events;Regulation of insulin secretion;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Activation of kainate receptors upon glutamate binding;Presynaptic function of Kainate receptors
Q9NQ69	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of expression of SLITs and ROBOs;Nervous system development
Q9NQ76	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q9NQ86	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NQ87	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
Q9NQ88	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NQ90	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9NQ92	RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization
Q9NQ94	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
Q9NQA5	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q9NQB0	Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Peptide hormone metabolism;Deactivation of the beta-catenin transactivating complex;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Beta-catenin independent WNT signaling;Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Ca2+ pathway;Binding of TCF/LEF:CTNNB1 to target gene promoters;Repression of WNT target genes;Signaling by WNT in cancer;TCF7L2 mutants don't bind CTBP;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX3;RUNX3 regulates WNT signaling
Q9NQC1	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9NQC3	Signal Transduction;Axonal growth inhibition (RHOA activation);p75NTR regulates axonogenesis;p75 NTR receptor-mediated signalling;Death Receptor Signalling
Q9NQC7	Signal Transduction;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Metabolism of proteins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling;Negative regulators of DDX58/IFIH1 signaling
Q9NQC8	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q9NQG5	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NQG7	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9NQI0	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q9NQL2	PIP3 activates AKT signaling;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;Autophagy;Amino acids regulate mTORC1
Q9NQN1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9NQP4	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins
Q9NQR1	Cell Cycle;Generic Transcription Pathway;Condensation of Prophase Chromosomes;PKMTs methylate histone lysines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NQR4	Innate Immune System;Immune System;Neutrophil degranulation
Q9NQR9	Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of carbohydrates
Q9NQS1	Apoptosis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Cytochrome c-mediated apoptotic response;Apoptotic factor-mediated response;Programmed Cell Death;Regulation of the apoptosome activity
Q9NQS3	Cell-Cell communication;Adherens junctions interactions;Nectin/Necl  trans heterodimerization;Cell-cell junction organization;Cell junction organization
Q9NQS5	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Neutrophil degranulation;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9NQS7	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of DNA replication proteins;RHO GTPases Activate Formins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9NQT4	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NQT5	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NQT8	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9NQU5	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Activation of RAC1;Nervous system development
Q9NQV7	Reproduction;Meiosis;Cell Cycle;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;Meiotic recombination
Q9NQW5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NQX3	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
Q9NQX5	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9NQX6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NQZ2	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NQZ5	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NQZ7	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism
Q9NQZ8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NR11	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NR12	Developmental Biology;Axon guidance;RET signaling;Nervous system development
Q9NR19	Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Biological oxidations;Phase I - Functionalization of compounds;Transcriptional activation of mitochondrial biogenesis;Ethanol oxidation
Q9NR28	Apoptosis;Intrinsic Pathway for Apoptosis;Release of apoptotic factors from the mitochondria;Formation of apoptosome;Cytochrome c-mediated apoptotic response;SMAC (DIABLO) binds to IAPs ;SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ;SMAC, XIAP-regulated apoptotic response;Apoptotic factor-mediated response;Programmed Cell Death;Regulation of the apoptosome activity
Q9NR30	Epigenetic regulation of gene expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;Gene expression (Transcription);rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NR33	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Cell Cycle;Mitotic G1 phase and G1/S transition;PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
Q9NR34	Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification;N-glycan trimming and elongation in the cis-Golgi;Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2
Q9NR45	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9NR48	PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization
Q9NR50	Metabolism of proteins;Eukaryotic Translation Initiation;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation
Q9NR61	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus
Q9NR63	Metabolism;Signal Transduction;Disease;Biological oxidations;Cytochrome P450 - arranged by substrate type;Vitamins;Phase I - Functionalization of compounds;Signaling by Retinoic Acid;RA biosynthesis pathway;Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Signaling by Nuclear Receptors
Q9NR71	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q9NR77	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives;Class I peroxisomal membrane protein import;Protein localization
Q9NR80	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q9NR81	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q9NR82	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9NR96	PI3K Cascade;IRS-mediated signalling;Cytokine Signaling in Immune system;Signal Transduction;Trafficking and processing of endosomal TLR;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Insulin receptor signalling cascade;Signaling by Insulin receptor;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome
Q9NR97	Trafficking and processing of endosomal TLR;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome
Q9NRA0	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9NRA1-1	Signal Transduction;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases
Q9NRA2	Disease;Transport of small molecules;Metabolism of proteins;Sialic acid metabolism;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective SLC17A5 causes Salla disease (SD) and ISSD;SLC transporter disorders;Disorders of transmembrane transporters;Post-translational protein modification
Q9NRB3	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q9NRC6	Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;L1CAM interactions;NCAM signaling for neurite out-growth;Metabolism of proteins;Axon guidance;Interaction between L1 and Ankyrins;Asparagine N-linked glycosylation;Vesicle-mediated transport;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Post-translational protein modification;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;FLT3 Signaling;Nervous system development
Q9NRD1	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NRD5	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cell surface interactions at the vascular wall;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
Q9NRD8	Metabolism;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Metabolism of amino acids and derivatives
Q9NRD9	Metabolism;Metabolism of amine-derived hormones;Thyroxine biosynthesis;Metabolism of amino acids and derivatives
Q9NRF2-2	Prolactin receptor signaling;Cytokine Signaling in Immune system;Signal Transduction;Immune System;Signaling by Leptin;Growth hormone receptor signaling
Q9NRF2	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9NRF8	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q9NRF9	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Cell Cycle;Mitotic G1 phase and G1/S transition;PCNA-Dependent Long Patch Base Excision Repair;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA replication initiation;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Base Excision Repair;DNA Damage Bypass;DNA Repair;Resolution of Abasic Sites (AP sites)
Q9NRG4	Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NRG9	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
Q9NRH3	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q9NRJ3	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q9NRJ4	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9NRK6	Mitochondrial ABC transporters;Transport of small molecules;ABC-family proteins mediated transport
Q9NRM0	Disease;Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport;Defective SLC2A9 causes hypouricemia renal 2 (RHUC2);SLC transporter disorders;Disorders of transmembrane transporters
Q9NRM1	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q9NRM6	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins
Q9NRM7	Signal Transduction;Signaling by Hippo
Q9NRN7	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q9NRP2	Mitochondrial protein import;Protein localization
Q9NRR4	MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Gene expression (Transcription)
Q9NRR6	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Organelle biogenesis and maintenance;Metabolism of lipids;Cilium Assembly;Cargo trafficking to the periciliary membrane;ARL13B-mediated ciliary trafficking of INPP5E
Q9NRV9	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Formyl peptide receptors bind formyl peptides and many other ligands;GPCR ligand binding
Q9NRW1	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;COPI-independent Golgi-to-ER retrograde traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;TBC/RABGAPs;Golgi-to-ER retrograde transport;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9NRW3	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
Q9NRW7	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Factors involved in megakaryocyte development and platelet production
Q9NRX1	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NRX2	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NRX5	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
Q9NRY4	Developmental Biology;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Semaphorin interactions;Sema4D in semaphorin signaling;Sema4D mediated inhibition of cell attachment and migration;Axon guidance;Signaling by PTK6;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases;Signaling by Non-Receptor Tyrosine Kinases;Nervous system development
Q9NRY5	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q9NRZ5	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NRZ7	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Membrane Trafficking;Metabolism of lipids;Vesicle-mediated transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q9NS00	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);O-linked glycosylation;Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins
Q9NS15	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q9NS28	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events
Q9NS40	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9NS56	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of immune response proteins;Post-translational protein modification
Q9NS61	Muscle contraction;Cardiac conduction;Phase 1 - inactivation of fast Na+ channels
Q9NS62	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9NS67	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9NS69	Mitochondrial protein import;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Protein localization;Autophagy;Selective autophagy
Q9NS73	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9NS75	Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Class B/2 (Secretin family receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Leukotriene receptors;G alpha (q) signalling events;G alpha (s) signalling events;Glucagon-type ligand receptors;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;LTC4-CYSLTR mediated IL4 production
Q9NS82	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q9NS84	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q9NS87	Hemostasis;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9NS91	Recognition of DNA damage by PCNA-containing replication complex;Metabolism of proteins;Post-translational protein modification;DNA Damage Bypass;DNA Repair;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q9NSA0	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation/anion/zwitterion transport;Organic anion transport
Q9NSA1	Plasma lipoprotein assembly, remodeling, and clearance;Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling
Q9NSA2	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Muscle contraction;Cardiac conduction;Phase 1 - inactivation of fast Na+ channels
Q9NSA3	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q9NSB2	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9NSB4	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9NSB8	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9NSC2	Developmental Biology;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Transcriptional regulation of pluripotent stem cells
Q9NSC5	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9NSC7	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9NSD5	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;GABA synthesis, release, reuptake and degradation;Reuptake of GABA
Q9NSD7	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Relaxin receptors;GPCR ligand binding
Q9NSD9	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
Q9NSE2	Interleukin-7 signaling;Cytokine Signaling in Immune system;Immune System;Metabolism of proteins;Signaling by Interleukins;Post-translational protein modification;Neddylation;Growth hormone receptor signaling
Q9NSE4	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q9NSI6	Interleukin-7 signaling;Cytokine Signaling in Immune system;Immune System;Chromatin modifying enzymes;Signaling by Interleukins;Chromatin organization
Q9NSK0	Hemostasis;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Membrane Trafficking;MHC class II antigen presentation;RHO GTPases activate KTN1;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9NSP4	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Deposition of new CENPA-containing nucleosomes at the centromere;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Chromosome Maintenance;Nucleosome assembly;EML4 and NUDC in mitotic spindle formation
Q9NST1	Metabolism;Acyl chain remodeling of DAG and TAG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NSU2	Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;Regulation by TREX1;IRF3-mediated induction of type I IFN
Q9NSV4	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases Activate Formins
Q9NSY2	Metabolism;Recycling of bile acids and salts;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q9NT22	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q9NT62	Macroautophagy;Autophagy
Q9NT99	Neuronal System;Receptor-type tyrosine-protein phosphatases;Protein-protein interactions at synapses
Q9NTG7	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;Regulation of FOXO transcriptional activity by acetylation
Q9NTI2	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q9NTI5	Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic
Q9NTJ3	Cell Cycle;Condensation of Prophase Chromosomes;Condensation of Prometaphase Chromosomes;Mitotic Prophase;Mitotic Prometaphase;M Phase;Cell Cycle, Mitotic
Q9NTJ4	Metabolism;Metabolism of carbohydrates;Lysosomal oligosaccharide catabolism
Q9NTJ5	Metabolism;Synthesis of PIPs at the ER membrane;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Metabolism of lipids
Q9NTK5	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9NTM9	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q9NTN3	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Disease;Formation of the active cofactor, UDP-glucuronate;Biological oxidations;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD);Metabolic disorders of biological oxidation enzymes;Diseases of metabolism;Transport of nucleotide sugars
Q9NTQ9	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q9NTX7	PIP3 activates AKT signaling;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Metabolism of proteins;Degradation of AXIN;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers
Q9NUB1	Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Ethanol oxidation
Q9NUD9	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9NUI1	Metabolism;Beta-oxidation of very long chain fatty acids;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q9NUJ1	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q9NUN5	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF;Diseases of metabolism
Q9NUN7	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9NUP1	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q9NUP7	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9NUP9	Neurotransmitter release cycle;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Dopamine Neurotransmitter Release Cycle;Activation of NMDA receptors and postsynaptic events;Neurexins and neuroligins;Protein-protein interactions at synapses;Assembly and cell surface presentation of NMDA receptors
Q9NUQ2	Metabolism;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NUQ9	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9NUT2	Mitochondrial ABC transporters;Transport of small molecules;ABC-family proteins mediated transport
Q9NUV7	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9NUW8	DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
Q9NUX5	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Packaging Of Telomere Ends;Telomere Extension By Telomerase;Extension of Telomeres;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Cellular responses to external stimuli
Q9NUZ1	Metabolism;Beta-oxidation of pristanoyl-CoA;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism
Q9NV06	Metabolism of proteins;Post-translational protein modification;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Neddylation;Metabolism of RNA
Q9NV23	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
Q9NV31	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NV35	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
Q9NV56	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9NV58	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NV66	tRNA modification in the nucleus and cytosol;Synthesis of wybutosine at G37 of tRNA(Phe);tRNA processing;Metabolism of RNA
Q9NV70	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
Q9NV72	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NV88	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NV96	Innate Immune System;Immune System;Neutrophil degranulation
Q9NVC6	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NVD7	Cell-Cell communication;Localization of the PINCH-ILK-PARVIN complex to focal adhesions;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components;Cell junction organization
Q9NVE7	Metabolism;Coenzyme A biosynthesis;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism
Q9NVF9	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q9NVG8	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9NVH1	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation
Q9NVH2	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NVH6	Metabolism;Carnitine synthesis;Metabolism of amino acids and derivatives
Q9NVI1	Generic Transcription Pathway;Transcriptional Regulation by TP53;Fanconi Anemia Pathway;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q9NVK5	Signaling by FGFR in disease;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
Q9NVM4	RMTs methylate histone arginines;Chromatin modifying enzymes;Chromatin organization
Q9NVM9	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NVR0	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NVR2	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NVS2	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NVS9	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamins B6 activation to pyridoxal phosphate
Q9NVU0	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9NVW2	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NVX0	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9NVZ3	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9NW08	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9NW13	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NW15	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9NW38	Fanconi Anemia Pathway;DNA Repair
Q9NW64	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9NWA0	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9NWB1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;MECP2 regulates transcription factors
Q9NWB7	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q9NWF4	Metabolism;Vitamin B2 (riboflavin) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9NWF9	Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Negative regulators of DDX58/IFIH1 signaling
Q9NWM0-3	Amine Oxidase reactions;PAOs oxidise polyamines to amines;Metabolism;Biological oxidations;Phase I - Functionalization of compounds;Interconversion of polyamines;Metabolism of polyamines;Metabolism of amino acids and derivatives
Q9NWM8	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q9NWQ8	Adaptive Immune System;Signal Transduction;Immune System;Signaling by EGFR;GAB1 signalosome;TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Signaling by Receptor Tyrosine Kinases
Q9NWR8	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q9NWS9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NWT6	Cellular response to hypoxia;Cellular responses to stress;Cellular responses to external stimuli
Q9NWT8	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NWU5	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NWV8	Cell Cycle;Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
Q9NWW6	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9NWW9	Metabolism;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NWX5	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NWX6	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9NWZ3	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Negative regulation of the PI3K/AKT network;Interleukin-1 family signaling;Signaling by Interleukins;Diseases of Immune System;Diseases associated with the TLR signaling cascade;IRAK4 deficiency (TLR5);IRAK4 deficiency (TLR2/4);PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers;Interleukin-1 signaling;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q9NWZ5	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage
Q9NWZ8	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
Q9NX08	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9NX09	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NX14	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9NX20	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NX24	Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;rRNA modification in the nucleus and cytosol;rRNA processing;Chromosome Maintenance;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NX46	POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Base Excision Repair;DNA Repair;Resolution of Abasic Sites (AP sites)
Q9NX57	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q9NX62	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
Q9NX63	Mitochondrial protein import;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation;Protein localization
Q9NX65	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NX70	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9NX74	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9NX76	Innate Immune System;Immune System;Neutrophil degranulation
Q9NXA8	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q9NXB0	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q9NXB9	Metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9NXC5	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q9NXD2	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the early endosome membrane;Metabolism of lipids
Q9NXE4	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q9NXE8	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9NXF1	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NXF7	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9NXF8	Signal Transduction;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling
Q9NXG2	rRNA modification in the nucleus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NXH8	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9NXH9	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9NXK8	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NXL2	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling
Q9NXR1	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Organelle biogenesis and maintenance;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;AURKA Activation by TPX2;EML4 and NUDC in mitotic spindle formation
Q9NXR7	Cell Cycle;Metabolism of proteins;Deubiquitination;Metalloprotease DUBs;DNA Double-Strand Break Repair;Homology Directed Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Nonhomologous End-Joining (NHEJ);DNA Double Strand Break Response;Processing of DNA double-strand break ends;Post-translational protein modification;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair
Q9NXR8	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9NXT0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NXX6	SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification
Q9NY12	Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;rRNA modification in the nucleus and cytosol;rRNA processing;Chromosome Maintenance;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NY15	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class H Receptors;Vesicle-mediated transport
Q9NY25	Innate Immune System;Immune System;DAP12 interactions;Neutrophil degranulation
Q9NY26	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q9NY27	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;DNA Repair
Q9NY28	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q9NY37	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9NY46	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q9NY47	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Metabolism;Integration of energy metabolism;Muscle contraction;Adrenaline,noradrenaline inhibits insulin secretion;Regulation of insulin secretion;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
Q9NY59	Metabolism;Signal Transduction;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids;TNFR1-mediated ceramide production;Death Receptor Signalling;TNF signaling
Q9NY61	Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Death Receptor Signalling
Q9NY64	Cellular hexose transport;Membrane Trafficking;Transport of small molecules;SLC-mediated transmembrane transport;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9NY65	Hemostasis;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Immune System;Organelle biogenesis and maintenance;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;HSP90 chaperone cycle for steroid hormone receptors (SHR);L1CAM interactions;Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Asparagine N-linked glycosylation;Mitotic G2-G2/M phases;Cilium Assembly;RHO GTPases activate IQGAPs;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Assembly and cell surface presentation of NMDA receptors;Autophagy;Activation of AMPK downstream of NMDARs;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy;Sealing of the nuclear envelope (NE) by ESCRT-III;Nervous system development;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9NY72	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q9NY84	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9NY91	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q9NY97	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins
Q9NYA1	Metabolism;Signal Transduction;Sphingolipid de novo biosynthesis;Signaling by VEGF;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Sphingolipid metabolism;VEGFA-VEGFR2 Pathway;VEGFR2 mediated cell proliferation;Metabolism of lipids;ESR-mediated signaling;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Extra-nuclear estrogen signaling
Q9NYA4	Metabolism;PI Metabolism;Phospholipid metabolism;Signal Transduction;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Metabolism of lipids;Signaling by TGF-beta family members
Q9NYB0	Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Meiotic synapsis;Reproduction;Meiosis;Telomere Maintenance;Cell Cycle;Packaging Of Telomere Ends;Telomere Extension By Telomerase;Extension of Telomeres;Cellular responses to stress;Cellular Senescence;DNA Damage/Telomere Stress Induced Senescence;Base Excision Repair;Chromosome Maintenance;DNA Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;Cellular responses to external stimuli
Q9NYB5	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of organic anions
Q9NYB9	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9NYF0	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Degradation of DVL
Q9NYF5	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9NYG5	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9NYG8	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;TWIK related potassium channel (TREK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9NYH9	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9NYJ1	Mitochondrial protein import;Protein localization
Q9NYJ8	Signaling by ERBB4;Nuclear signaling by ERBB4;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;TNFR1-induced NFkappaB signaling pathway;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Death Receptor Signalling;TNF signaling;Signaling by Receptor Tyrosine Kinases;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Alpha-protein kinase 1 signaling pathway;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane
Q9NYK1	Trafficking and processing of endosomal TLR;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome
Q9NYK5	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NYL5	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Bile acid and bile salt metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Metabolism of steroids
Q9NYL9	Striated Muscle Contraction;Muscle contraction
Q9NYM4	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9NYM9	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q9NYP7	Metabolism;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism;Linoleic acid (LA) metabolism;alpha-linolenic acid (ALA) metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9NYP9	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
Q9NYQ3	Metabolism;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q9NYR8	Signal Transduction;Visual phototransduction;The canonical retinoid cycle in rods (twilight vision);Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q9NYR9	Cytokine Signaling in Immune system;ZBP1(DAI) mediated induction of type I IFNs;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q9NYS0	Cytokine Signaling in Immune system;ZBP1(DAI) mediated induction of type I IFNs;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q9NYS7	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9NYT6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NYU1	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9NYU2	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9NYV4	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NYV6	RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Gene expression (Transcription)
Q9NYV7	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYV8	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYV9	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW0	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW1	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW2	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW3	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW4	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW5	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW6	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYW7	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding
Q9NYY1	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q9NYY3	Disease;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Leishmania infection;CD163 mediating an anti-inflammatory response;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9NYZ2	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q9NYZ3	Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint
Q9NYZ4	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9NZ01	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9NZ08	Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q9NZ09	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q9NZ20	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Acyl chain remodelling of PG;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NZ32	Adaptive Immune System;Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
Q9NZ42	Signaling by ERBB4;Nuclear signaling by ERBB4;Developmental Biology;Signaling by NOTCH;Signal Transduction;Disease;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Signaling by NOTCH1;Signaling by NOTCH2;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;EPH-Ephrin signaling;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Metabolism of proteins;EPH-ephrin mediated repulsion of cells;Axon guidance;Diseases of signal transduction by growth factor receptors and second messengers;Death Receptor Signalling;Signaling by Receptor Tyrosine Kinases;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;NOTCH4 Activation and Transmission of Signal to the Nucleus;Noncanonical activation of NOTCH3;Nervous system development;Amyloid fiber formation
Q9NZ43	Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q9NZ52	Signal Transduction;Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Signaling by MET;TBC/RABGAPs;MET receptor recycling;Signaling by Receptor Tyrosine Kinases;Rab regulation of trafficking;Amyloid fiber formation
Q9NZ53	Metabolism;Phase II - Conjugation of compounds;Cytosolic sulfonation of small molecules;Biological oxidations
Q9NZ71	Metabolism;Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;Cytosolic iron-sulfur cluster assembly;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Chromosome Maintenance;DNA Repair
Q9NZ94	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9NZB8-1	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
Q9NZB8-5	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
Q9NZC2	Developmental Biology;Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;DAP12 interactions;DAP12 signaling;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
Q9NZC3	Metabolism;PI Metabolism;Phospholipid metabolism;Metabolism of lipids;Glycerophospholipid catabolism
Q9NZC7	Signaling by ERBB4;Nuclear signaling by ERBB4;Signal Transduction;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Negative regulation of activity of TFAP2 (AP-2) family transcription factors;Activation of the TFAP2 (AP-2) family of transcription factors;Signaling by Receptor Tyrosine Kinases
Q9NZD2	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids
Q9NZE8	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9NZF1	Innate Immune System;Immune System;Neutrophil degranulation
Q9NZH6	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling;Interleukin-18 signaling
Q9NZH7	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-36 pathway
Q9NZH8	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-36 pathway
Q9NZI2	Muscle contraction;Cardiac conduction;Phase 1 - inactivation of fast Na+ channels
Q9NZI5	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9NZI8	Signal Transduction;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Metabolism of RNA
Q9NZJ0	Recognition of DNA damage by PCNA-containing replication complex;Metabolism of proteins;Post-translational protein modification;DNA Damage Bypass;DNA Repair;Neddylation
Q9NZJ5	PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins
Q9NZJ6	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
Q9NZJ9	Metabolism;Inositol phosphate metabolism;Synthesis of pyrophosphates in the cytosol
Q9NZK5	Innate Immune System;Immune System;Metabolism of proteins;Surfactant metabolism;Neutrophil degranulation
Q9NZK7	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9NZL3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NZL6	Metabolism;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9NZL9	Metabolism;Phase II - Conjugation of compounds;Methylation;Biological oxidations;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9NZM3	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9NZN1	Neuronal System;Cytokine Signaling in Immune system;Immune System;Receptor-type tyrosine-protein phosphatases;Interleukin-1 family signaling;Signaling by Interleukins;Protein-protein interactions at synapses;Interleukin-38 signaling
Q9NZN3	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9NZN4	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9NZN5	Developmental Biology;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by Rho GTPases;Rho GTPase cycle;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;Semaphorin interactions;GPCR downstream signalling;Sema4D in semaphorin signaling;G alpha (12/13) signalling events;Sema4D induced cell migration and growth-cone collapse;Axon guidance;Death Receptor Signalling;Nervous system development
Q9NZN8	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9NZP0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9NZP2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9NZP5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9NZQ3	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9NZQ7	Adaptive Immune System;Immune System;Costimulation by the CD28 family;PD-1 signaling
Q9NZQ8	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q9NZQ9	Striated Muscle Contraction;Muscle contraction
Q9NZR1	Striated Muscle Contraction;Muscle contraction
Q9NZS2	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9NZT1	Innate Immune System;Immune System;Neutrophil degranulation
Q9NZU0	Developmental Biology;Signal Transduction;Signaling by FGFR;Signaling by ROBO receptors;Axon guidance;Downstream signaling of activated FGFR1;Signaling by FGFR1;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q9NZU1	Signal Transduction;Signaling by FGFR;Downstream signaling of activated FGFR1;Signaling by FGFR1;Signaling by Receptor Tyrosine Kinases
Q9NZU5	Metabolism of proteins;Surfactant metabolism
Q9NZV6	Metabolism of proteins;Protein repair
Q9NZV7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9NZV8	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Muscle contraction;Cardiac conduction;Phase 1 - inactivation of fast Na+ channels
Q9NZW4	Extracellular matrix organization;ECM proteoglycans
Q9NZZ3	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT)
Q9P000	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Neddylation
Q9P013	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9P015	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9P031	Metabolism of proteins;Surfactant metabolism
Q9P032	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9P035	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9P086	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9P0G3	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9P0J0	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9P0J1	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q9P0J6	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9P0J7	Innate Immune System;Immune System;Neutrophil degranulation
Q9P0K1	Developmental Biology;LGI-ADAM interactions
Q9P0L0	Metabolism;Sphingolipid de novo biosynthesis;Innate Immune System;Immune System;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Q9P0L1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9P0M4	Cytokine Signaling in Immune system;Immune System;Interleukin-17 signaling;Signaling by Interleukins
Q9P0M9	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9P0N5	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q9P0N9	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9P0P0	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
Q9P0S2	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9P0S3	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9P0U1	Mitochondrial protein import;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Protein localization;Autophagy;Selective autophagy
Q9P0U3	SUMOylation;SUMO is proteolytically processed;Processing and activation of SUMO;Metabolism of proteins;Post-translational protein modification
Q9P0U4	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q9P0V3	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q9P0W2	Hemostasis;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;Factors involved in megakaryocyte development and platelet production
Q9P0X4	Developmental Biology;NCAM signaling for neurite out-growth;NCAM1 interactions;Axon guidance;Nervous system development
Q9P0Z9	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives;Peroxisomal protein import;Protein localization
Q9P104	Developmental Biology;Axon guidance;RET signaling;Nervous system development
Q9P107	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9P109	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q9P121	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9P126	Hemostasis;GPVI-mediated activation cascade;Platelet activation, signaling and aggregation
Q9P127	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9P1A6	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9P1P4	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9P1P5	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;G alpha (s) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9P1Q0	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q9P1Q5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9P1U0	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription Termination;RNA Polymerase I Transcription;Gene expression (Transcription)
Q9P1W8	Hemostasis;Cell-Cell communication;Cell surface interactions at the vascular wall;Signal regulatory protein family interactions
Q9P1Z3	Neuronal System;HCN channels;Potassium Channels
Q9P209	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9P212	Metabolism;Inositol phosphate metabolism;Synthesis of IP3 and IP4 in the cytosol
Q9P218	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Collagen chain trimerization
Q9P219	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by DVL-interacting proteins
Q9P227	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9P232	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9P241	Transport of small molecules;Ion transport by P-type ATPases;Ion channel transport
Q9P244	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
Q9P255	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9P258	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9P267	Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification
Q9P272	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9P278	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q9P283	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9P286	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Activation of RAC1;Nervous system development
Q9P289	Apoptosis;Apoptotic cleavage of cellular proteins;Programmed Cell Death;Apoptotic execution phase
Q9P296	Signal Transduction;Complement cascade;Innate Immune System;Immune System;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR ligand binding;Regulation of Complement cascade
Q9P299	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9P2D8	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9P2E2	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Organelle biogenesis and maintenance;Activation of NMDA receptors and postsynaptic events;Cilium Assembly;Intraflagellar transport;Assembly and cell surface presentation of NMDA receptors
Q9P2E5	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Chondroitin sulfate biosynthesis;Metabolism of carbohydrates
Q9P2F6	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9P2H3	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q9P2I0	Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q9P2J3	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9P2J5	Metabolism;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Metabolism of amino acids and derivatives;Translation
Q9P2J8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9P2J9	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Regulation of pyruvate dehydrogenase (PDH) complex;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q9P2K1	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q9P2K6	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9P2K8	Cellular responses to stress;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency
Q9P2L0	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q9P2M4	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9P2M7	Signal Transduction;Signaling by TGF-beta Receptor Complex;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Signaling by TGF-beta family members
Q9P2N2	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9P2N4	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9P2N6	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9P2N7	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9P2P5	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9P2R7	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle
Q9P2S2	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9P2T1	Metabolism;Metabolism of nucleotides;Purine salvage;Nucleotide salvage
Q9P2U7	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Glutamate Neurotransmitter Release Cycle;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters
Q9P2U8	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters
Q9P2W1	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
Q9P2W3	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Peptide hormone metabolism;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Incretin synthesis, secretion, and inactivation;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q9P2W7	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Metabolism of carbohydrates
Q9P2W9	Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport
Q9P2X0	Synthesis of dolichyl-phosphate mannose;Post-translational modification: synthesis of GPI-anchored proteins;Disease;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective DPM1 causes DPM1-CDG (CDG-1e);Defective DPM3 causes DPM3-CDG (CDG-1o);Defective DPM2 causes DPM2-CDG (CDG-1u);Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
Q9P2X3	Cellular responses to stress;Cellular responses to external stimuli;Response of EIF2AK4 (GCN2) to amino acid deficiency
Q9P2Y5	Macroautophagy;Autophagy
Q9TNN7	ER-Phagosome pathway;Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q9TQE0	Cytokine Signaling in Immune system;Adaptive Immune System;Immune System;TCR signaling;Downstream TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse;Generation of second messenger molecules;MHC class II antigen presentation;Costimulation by the CD28 family;PD-1 signaling;Interferon gamma signaling;Interferon Signaling
Q9U4X0	Hemostasis;Cell surface interactions at the vascular wall
Q9UBB5	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;RNA Polymerase I Promoter Opening;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Gene expression (Transcription)
Q9UBB9	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9UBC0	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;Regulation of gene expression in early pancreatic precursor cells
Q9UBC2	Signal Transduction;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Signaling by Receptor Tyrosine Kinases
Q9UBC3	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;NoRC negatively regulates rRNA expression;SUMOylation of DNA methylation proteins;Negative epigenetic regulation of rRNA expression;DNA methylation;Post-translational protein modification;Gene expression (Transcription)
Q9UBC9	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9UBD3	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q9UBD5	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Assembly of the ORC complex at the origin of replication;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q9UBD6	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Rhesus glycoproteins mediate ammonium transport.
Q9UBD9	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
Q9UBE0	SUMOylation;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);Processing and activation of SUMO;Metabolism of proteins;Post-translational protein modification
Q9UBE8	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;Ca2+ pathway
Q9UBF2	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9UBF6	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UBF8	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Metabolism of lipids
Q9UBG0	Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation
Q9UBH0	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-36 pathway
Q9UBI1	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Neddylation
Q9UBI6	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q9UBJ2	ABC transporters in lipid homeostasis;Transport of small molecules;ABC-family proteins mediated transport;Class I peroxisomal membrane protein import;Protein localization
Q9UBK2	Developmental Biology;Metabolism;Mitochondrial biogenesis;Organelle biogenesis and maintenance;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional activation of mitochondrial biogenesis;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional regulation of white adipocyte differentiation;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Circadian Clock;Metabolism of lipids;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;FOXO-mediated transcription;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
Q9UBK5	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9UBK8	Metabolism;Phase II - Conjugation of compounds;Methylation;Sulfur amino acid metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Biological oxidations;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE;Defective MTR causes methylmalonic aciduria and homocystinuria type cblG;Diseases of metabolism;Metabolism of amino acids and derivatives
Q9UBK9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by E2F6
Q9UBL3	Developmental Biology;Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Deactivation of the beta-catenin transactivating complex;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q9UBL6	Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9UBL9	Hemostasis;Elevation of cytosolic Ca2+ levels;Platelet homeostasis;Platelet calcium homeostasis
Q9UBM1	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9UBM4	Degradation of the extracellular matrix;Extracellular matrix organization
Q9UBM7	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Cholesterol biosynthesis;Activation of gene expression by SREBF (SREBP);Metabolism of lipids;Cholesterol biosynthesis via desmosterol;Cholesterol biosynthesis via lathosterol;Metabolism of steroids
Q9UBM8	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
Q9UBN1	Presynaptic depolarization and calcium channel opening;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;LGI-ADAM interactions
Q9UBN4	Developmental Biology;Stimuli-sensing channels;TRP channels;Netrin-1 signaling;Transport of small molecules;Role of second messengers in netrin-1 signaling;Axon guidance;Nervous system development;Ion channel transport
Q9UBN6	Hemostasis;Signal Transduction;Cell surface interactions at the vascular wall;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Death Receptors and Ligands;RNA Polymerase II Transcription;Death Receptor Signalling;Gene expression (Transcription);TRAIL  signaling
Q9UBN7	Signaling by NOTCH;Signal Transduction;Macroautophagy;Disease;Organelle biogenesis and maintenance;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Cellular responses to stress;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;HSF1 activation;Cellular response to heat stress;Notch-HLH transcription pathway;Cilium Assembly;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Cellular responses to external stimuli;Autophagy;Chaperone Mediated Autophagy;Late endosomal microautophagy;Aggrephagy;Selective autophagy
Q9UBP0	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Sealing of the nuclear envelope (NE) by ESCRT-III
Q9UBP5	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q9UBP6	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9UBQ0	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking
Q9UBQ5	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
Q9UBQ6	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q9UBQ7	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives
Q9UBR1	Metabolism;Metabolism of nucleotides;Pyrimidine catabolism;Nucleobase catabolism
Q9UBR2	Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Metabolism of Angiotensinogen to Angiotensins;COPII-mediated vesicle transport;Peptide hormone metabolism;Metabolism of proteins;Lysosome Vesicle Biogenesis;Asparagine N-linked glycosylation;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Neutrophil degranulation;Transport to the Golgi and subsequent modification
Q9UBR4	Developmental Biology;Signaling by ROBO receptors;Axon guidance;Regulation of expression of SLITs and ROBOs;Nervous system development
Q9UBS0	PIP3 activates AKT signaling;Signal Transduction;Disease;AKT phosphorylates targets in the nucleus;PI3K/AKT Signaling in Cancer;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Intracellular signaling by second messengers
Q9UBS3	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q9UBS4	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins
Q9UBS5	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q9UBS8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UBT2	SUMOylation;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);Processing and activation of SUMO;Metabolism of proteins;Post-translational protein modification
Q9UBT3	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Signaling by WNT in cancer;Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling;Diseases of signal transduction by growth factor receptors and second messengers
Q9UBT6	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion synthesis by POLK;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Gap-filling DNA repair synthesis and ligation in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;DNA Damage Bypass;DNA Repair
Q9UBU2	Signal Transduction;Disease;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;Signaling by WNT in cancer;Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling;Diseases of signal transduction by growth factor receptors and second messengers
Q9UBU3-1	Signal Transduction;Peptide hormone metabolism;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Metabolism of proteins;G alpha (q) signalling events;Synthesis, secretion, and deacylation of Ghrelin;GPCR ligand binding
Q9UBU3-2	Peptide hormone metabolism;Metabolism of proteins;Synthesis, secretion, and deacylation of Ghrelin
Q9UBU7	Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;G1/S Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q9UBU8	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9UBU9	Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9UBV2	Signaling by NOTCH;Signal Transduction;Disease;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Transport of small molecules;ABC-family proteins mediated transport;Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;ABC transporter disorders;Disorders of transmembrane transporters;Diseases of signal transduction by growth factor receptors and second messengers;Defective CFTR causes cystic fibrosis;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9UBV4	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q9UBV7	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;A tetrasaccharide linker sequence is required for GAG synthesis;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Diseases of glycosylation;Diseases of metabolism;Metabolism of carbohydrates
Q9UBW5	Disease;Innate Immune System;Immune System;Diseases of signal transduction by growth factor receptors and second messengers;Neutrophil degranulation;Signaling by PDGFR in disease;Signaling by membrane-tethered fusions of PDGFRA or PDGFRB
Q9UBW7	Signaling by FGFR in disease;Disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers
Q9UBW8	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q9UBX1	Adaptive Immune System;Immune System;MHC class II antigen presentation
Q9UBX3	Metabolism;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Organic anion transporters;Gluconeogenesis;Glucose metabolism;Metabolism of amino acids and derivatives;Metabolism of carbohydrates
Q9UBX5	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q9UBX8	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;Asparagine N-linked glycosylation;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
Q9UBY0	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers
Q9UBY5	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;Lysosphingolipid and LPA receptors;GPCR ligand binding
Q9UBZ9	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion synthesis by POLK;Translesion synthesis by POLI;Termination of translesion DNA synthesis;DNA Damage Bypass;DNA Repair
Q9UC06	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UD71	Opioid Signalling;Signal Transduction;DARPP-32 events;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q9UDR5	Metabolism;Lysine catabolism;Metabolism of amino acids and derivatives
Q9UDV6	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UDV7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UDW1	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport
Q9UDW3	mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9UDY2	Apoptosis;Apoptotic cleavage of cellular proteins;Signal Transduction;Signaling by Hippo;Apoptotic cleavage of cell adhesion  proteins;Programmed Cell Death;Apoptotic execution phase
Q9UDY6	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9UDY8	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Adaptive Immune System;Innate Immune System;Immune System;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CLEC7A/inflammasome pathway;Signaling by the B Cell Receptor (BCR)
Q9UEF7-1	PI3K Cascade;IRS-mediated signalling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by FGFR;FGFR1 ligand binding and activation;FGFR1c and Klotho ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;Negative regulation of FGFR1 signaling;Signaling by FGFR1;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q9UEF7-2	PI3K Cascade;IRS-mediated signalling;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Signaling by FGFR;FGFR1 ligand binding and activation;FGFR1c and Klotho ligand binding and activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Phospholipase C-mediated cascade: FGFR1;Downstream signaling of activated FGFR1;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;FRS-mediated FGFR1 signaling;Negative regulation of FGFR1 signaling;Signaling by FGFR1;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;FLT3 Signaling
Q9UER7	Disease;Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Transcriptional Regulation by TP53;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of TP53 Activity;Infectious disease;Post-translational protein modification;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;RNA Polymerase II Transcription;Gene expression (Transcription);HCMV Infection;HCMV Early Events
Q9UET6	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9UEU0	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9UEW3	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class A Receptors;Vesicle-mediated transport
Q9UEY8	Transport of small molecules;Miscellaneous transport and binding events
Q9UF12	Metabolism;Glyoxylate metabolism and glycine degradation;Proline catabolism;Metabolism of amino acids and derivatives
Q9UF33	Developmental Biology;EPH-Ephrin signaling;EPHA-mediated growth cone collapse;EPH-ephrin mediated repulsion of cells;Axon guidance;Nervous system development
Q9UFF9	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9UG01	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q9UG56	Metabolism;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q9UGB7	Metabolism;Inositol phosphate metabolism;Synthesis of IP2, IP, and Ins in the cytosol
Q9UGC6	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;G alpha (i) signalling events;G alpha (z) signalling events
Q9UGC7	Metabolism of proteins;Mitochondrial translation;Mitochondrial translation termination;Translation
Q9UGF5	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9UGF6	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9UGF7	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9UGH3	Metabolism;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9UGI0	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Metabolism of proteins;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification
Q9UGI6	Neuronal System;Ca2+ activated K+ channels;Potassium Channels
Q9UGI9	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Mitochondrial biogenesis;Signal Transduction;Macroautophagy;mTOR signalling;Organelle biogenesis and maintenance;Membrane Trafficking;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Autophagy;Lipophagy;Activation of AMPK downstream of NMDARs;Selective autophagy
Q9UGJ0	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Metabolism;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Mitochondrial biogenesis;Signal Transduction;Macroautophagy;AMPK inhibits chREBP transcriptional activation activity;Integration of energy metabolism;mTOR signalling;Organelle biogenesis and maintenance;Membrane Trafficking;Carnitine metabolism;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Metabolism of lipids;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Fatty acid metabolism;Autophagy;Lipophagy;Activation of AMPK downstream of NMDARs;Selective autophagy
Q9UGJ1	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q9UGK3	Signal Transduction;Signaling by PTK6;PTK6 Activates STAT3;Signaling by Non-Receptor Tyrosine Kinases
Q9UGL1	Generic Transcription Pathway;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of cell cycle factors
Q9UGM1	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
Q9UGM3	Metabolism of proteins;Surfactant metabolism
Q9UGM6	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q9UGN4	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
Q9UGN5	POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;HDR through MMEJ (alt-NHEJ);DNA Double-Strand Break Repair;Homology Directed Repair;DNA Damage Recognition in GG-NER;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Dual Incision in GG-NER;Base Excision Repair;DNA Repair;Resolution of Abasic Sites (AP sites)
Q9UGP4	Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Cellular responses to stress;Cellular responses to external stimuli
Q9UGP5	DNA Double-Strand Break Repair;Nonhomologous End-Joining (NHEJ);DNA Repair
Q9UGQ3	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
Q9UGY1	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9UH17	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
Q9UH73	Developmental Biology;Transcriptional regulation of white adipocyte differentiation
Q9UH77	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UH90	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UH92	Metabolism;Integration of energy metabolism;ChREBP activates metabolic gene expression
Q9UH99	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q9UHA4	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Innate Immune System;Immune System;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;FLT3 Signaling;Autophagy;Amino acids regulate mTORC1
Q9UHA7	Cytokine Signaling in Immune system;Immune System;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-36 pathway
Q9UHB4	Metabolism;Cytosolic iron-sulfur cluster assembly
Q9UHB7	Formation of RNA Pol II elongation complex ;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q9UHB9	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
Q9UHC1	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
Q9UHC3	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9UHC7	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Immune System;AKT phosphorylates targets in the cytosol;PTEN Regulation;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UHC9-2	Intestinal absorption;Intestinal lipid absorption;Digestion and absorption
Q9UHD0	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q9UHD2	Cytokine Signaling in Immune system;ZBP1(DAI) mediated induction of type I IFNs;IRF3 mediated activation of type 1 IFN;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;DDX58/IFIH1-mediated induction of interferon-alpha/beta;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;STAT6-mediated induction of chemokines;IRF3-mediated induction of type I IFN;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-37 signaling;TICAM1-dependent activation of IRF3/IRF7;TRAF3-dependent IRF activation pathway;TRAF6 mediated IRF7 activation;Negative regulators of DDX58/IFIH1 signaling;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling 
Q9UHD9	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9UHE5	Metabolism of proteins;Amyloid fiber formation
Q9UHF0	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Tachykinin receptors bind tachykinins;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q9UHF3	Metabolism of proteins;Amyloid fiber formation
Q9UHF4	Cytokine Signaling in Immune system;Immune System;Signaling by Interleukins;Interleukin-20 family signaling
Q9UHH9	Cytokine Signaling in Immune system;Metabolism;Inositol phosphate metabolism;Immune System;Synthesis of IPs in the nucleus;Interferon alpha/beta signaling;Interferon Signaling
Q9UHI5	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q9UHI6	snRNP Assembly;Metabolism of non-coding RNA;Metabolism of RNA
Q9UHI7	Metabolism;Vitamin C (ascorbate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
Q9UHI8	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9UHJ6	Metabolism;Pentose phosphate pathway;Metabolism of carbohydrates
Q9UHK6	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Bile acid and bile salt metabolism;Beta-oxidation of pristanoyl-CoA;Peroxisomal lipid metabolism;Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q9UHL4	Innate Immune System;Immune System;Neutrophil degranulation
Q9UHM6	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;Opsins;GPCR ligand binding
Q9UHN1	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q9UHP3	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9UHP7	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9UHQ9	Hemostasis;Platelet degranulation ;Erythrocytes take up carbon dioxide and release oxygen;O2/CO2 exchange in erythrocytes;Transport of small molecules;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9UHR5	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
Q9UHV7	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UHV9	Prefoldin mediated transfer of substrate  to CCT/TriC;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Chaperonin-mediated protein folding;Protein folding;Metabolism of proteins
Q9UHW9	Disease;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Cation-coupled Chloride cotransporters;Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN);SLC transporter disorders;Disorders of transmembrane transporters
Q9UHX1	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9UHX3	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q9UHY1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UHY7	Methionine salvage pathway;Metabolism;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q9UI08	Developmental Biology;Adaptive Immune System;Signal Transduction;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;TCR signaling;Generation of second messenger molecules;Signaling by ROBO receptors;Axon guidance;RHO GTPases Activate Formins;Nervous system development
Q9UI09	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9UI10	Metabolism of proteins;Eukaryotic Translation Initiation;Recycling of eIF2:GDP;Cap-dependent Translation Initiation;Translation
Q9UI12	ROS and RNS production in phagocytes;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;The role of Nef in HIV-1 replication and disease pathogenesis;Nef Mediated CD4 Down-regulation;Innate Immune System;Immune System;Nef Mediated CD8 Down-regulation;Cellular responses to stress;Transport of small molecules;Infectious disease;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Infection with Mycobacterium tuberculosis;Blockage of phagosome acidification;Suppression of phagosomal maturation;Response of Mtb to phagocytosis;Amino acids regulate mTORC1;Ion channel transport
Q9UI17	Metabolism;Choline catabolism;Metabolism of amino acids and derivatives
Q9UI30	Metabolism;Phase II - Conjugation of compounds;Methylation;Biological oxidations;Metabolism of proteins;tRNA modification in the nucleus and cytosol;rRNA modification in the nucleus and cytosol;tRNA processing;rRNA processing;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9UI32	Neurotransmitter release cycle;Transmission across Chemical Synapses;Neuronal System;Metabolism;Glutamate Neurotransmitter Release Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Glutamate and glutamine metabolism
Q9UI33	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q9UI40	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers
Q9UI43	rRNA modification in the mitochondrion;rRNA processing;rRNA processing in the mitochondrion;Metabolism of RNA
Q9UI95	Translesion synthesis by REV1;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA Damage Bypass;DNA Repair
Q9UIA0	Membrane Trafficking;Vesicle-mediated transport;Intra-Golgi traffic;Intra-Golgi and retrograde Golgi-to-ER traffic
Q9UIB8	Hemostasis;Cell surface interactions at the vascular wall
Q9UIC8	Cell Cycle;Mitotic G2-G2/M phases;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic
Q9UID3	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q9UIE0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UIF7-3	Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Displacement of DNA glycosylase by APEX1;Disease;Base Excision Repair;DNA Repair;Depurination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Diseases of Base Excision Repair;Defective Base Excision Repair Associated with MUTYH;Defective MUTYH substrate binding;Defective MUTYH substrate processing;Diseases of DNA repair
Q9UIF7-6	Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Displacement of DNA glycosylase by APEX1;Disease;Base Excision Repair;DNA Repair;Depurination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);Diseases of Base Excision Repair;Defective Base Excision Repair Associated with MUTYH;Defective MUTYH substrate processing;Diseases of DNA repair
Q9UIF9	Epigenetic regulation of gene expression;NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Gene expression (Transcription)
Q9UIG0	Epigenetic regulation of gene expression;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;DNA Repair;Gene expression (Transcription)
Q9UIG8-1	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of organic anions
Q9UIH9	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
Q9UII4	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Adaptive Immune System;Innate Immune System;Immune System;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Interferon Signaling;Negative regulators of DDX58/IFIH1 signaling;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UIJ5	Metabolism of proteins;Surfactant metabolism
Q9UIJ7	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9UIK4	Apoptosis;Caspase activation via Dependence Receptors in the absence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death
Q9UIL1	Membrane Trafficking;Vesicle-mediated transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic
Q9UIL4	Hemostasis;Membrane Trafficking;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9UIM3	Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint
Q9UIQ6	Antigen processing-Cross presentation;Endosomal/Vacuolar pathway;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Immune System;Membrane Trafficking;Vesicle-mediated transport;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UIR0	Adaptive Immune System;Immune System;Butyrophilin (BTN) family interactions
Q9UIS9	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification
Q9UIU0	Presynaptic depolarization and calcium channel opening;Transmission across Chemical Synapses;Neuronal System;Muscle contraction;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase
Q9UIV1	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9UIV8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
Q9UIW2	Developmental Biology;Semaphorin interactions;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;CRMPs in Sema3A signaling;Other semaphorin interactions;Axon guidance;Nervous system development
Q9UIX4	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9UJ14	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations;Aflatoxin activation and detoxification
Q9UJ37	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q9UJ41	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9UJ68	Metabolism of proteins;Protein repair
Q9UJ70	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9UJ71	Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);Adaptive Immune System;Immune System;Class I MHC mediated antigen processing & presentation
Q9UJ83	Metabolism;Alpha-oxidation of phytanate;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q9UJ90	Muscle contraction;Phase 3 - rapid repolarisation;Cardiac conduction;Phase 2 - plateau phase
Q9UJ96	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Metabolism;Integration of energy metabolism;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Regulation of insulin secretion
Q9UJ98	Meiotic synapsis;Reproduction;Meiosis;Cell Cycle
Q9UJA2	Metabolism;Acyl chain remodelling of PG;Synthesis of CL;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9UJA3	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Cell Cycle;Activation of ATR in response to replication stress;Unwinding of DNA;Mitotic G1 phase and G1/S transition;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;DNA strand elongation;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q9UJA5	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9UJF2	Cytokine Signaling in Immune system;Signal Transduction;Immune System;Regulation of RAS by GAPs;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q9UJK0	rRNA modification in the nucleus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9UJL9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UJM8	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives;Peroxisomal protein import;Protein localization
Q9UJP4	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UJQ4	PIP3 activates AKT signaling;Developmental Biology;Signal Transduction;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Transcriptional regulation of pluripotent stem cells;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q9UJS0	Mitochondrial protein import;Metabolism;Gluconeogenesis;Glucose metabolism;Metabolism of amino acids and derivatives;Metabolism of carbohydrates;Aspartate and asparagine metabolism;Protein localization
Q9UJT9	Adaptive Immune System;Cell Cycle;Immune System;Metabolism of proteins;Mitotic G2-G2/M phases;Post-translational protein modification;G2/M Transition;Cell Cycle, Mitotic;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UJU2	Developmental Biology;Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Generic Transcription Pathway;Deactivation of the beta-catenin transactivating complex;Beta-catenin independent WNT signaling;Ca2+ pathway;Binding of TCF/LEF:CTNNB1 to target gene promoters;Repression of WNT target genes;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX3;RUNX3 regulates WNT signaling;Transcriptional regulation of granulopoiesis
Q9UJU3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UJU5	Developmental Biology;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation;Transcriptional regulation of pluripotent stem cells
Q9UJU6	Apoptosis;Apoptotic cleavage of cellular proteins;Neuronal System;Innate Immune System;Immune System;Caspase-mediated cleavage of cytoskeletal proteins;Programmed Cell Death;Neurexins and neuroligins;Protein-protein interactions at synapses;Neutrophil degranulation;Apoptotic execution phase
Q9UJV9	Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Regulation of innate immune responses to cytosolic DNA;IRF3-mediated induction of type I IFN
Q9UJW0	Adaptive Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification
Q9UJW3	Epigenetic regulation of gene expression;DNA methylation;Gene expression (Transcription)
Q9UJW8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UJX2	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UJX3	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UJX4	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UJX5	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UJX6	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UJY1	Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Cellular responses to external stimuli
Q9UJY4	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking;Amyloid fiber formation
Q9UJY5	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking;Amyloid fiber formation
Q9UJZ1	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q9UK05	Signal Transduction;Signaling by BMP;Signaling by TGF-beta family members
Q9UK08	Hemostasis;Opioid Signalling;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Activation of G protein gated Potassium channels;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels;Metabolism;Signal Transduction;Glucagon signaling in metabolic regulation;Integration of energy metabolism;Disease;Signaling by WNT;G-protein activation;Signaling by GPCR;Class B/2 (Secretin family receptors);Glucagon-like Peptide-1 (GLP1) regulates insulin secretion;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Chaperonin-mediated protein folding;Protein folding;ADP signalling through P2Y purinoceptor 12;G beta:gamma signalling through PI3Kgamma;Metabolism of proteins;Signal amplification;Prostacyclin signalling through prostacyclin receptor;G-protein beta:gamma signalling;Adrenaline,noradrenaline inhibits insulin secretion;Ca2+ pathway;G alpha (q) signalling events;G alpha (12/13) signalling events;G beta:gamma signalling through PLC beta;Platelet homeostasis;G alpha (s) signalling events;ADP signalling through P2Y purinoceptor 1;G alpha (i) signalling events;G alpha (z) signalling events;Glucagon-type ligand receptors;Regulation of insulin secretion;Thromboxane signalling through TP receptor;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport;Activation of kainate receptors upon glutamate binding;Thrombin signalling through proteinase activated receptors (PARs);Presynaptic function of Kainate receptors;GPCR ligand binding;Infectious disease;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Platelet activation, signaling and aggregation;ESR-mediated signaling;G beta:gamma signalling through BTK;G beta:gamma signalling through CDC42;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;GABA receptor activation;GABA B receptor activation;Activation of GABAB receptors;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
Q9UK10	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UK11	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UK12	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UK13	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UK17	Neuronal System;Potassium Channels;Voltage gated Potassium channels;Muscle contraction;Cardiac conduction;Phase 1 - inactivation of fast Na+ channels
Q9UK22	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UK32	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Post NMDA receptor activation events;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;RSK activation;Nervous system development
Q9UK39	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
Q9UK41	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Disease;Membrane binding and targetting of GAG proteins;Synthesis And Processing Of GAG, GAGPOL Polyproteins;Assembly Of The HIV Virion;Membrane Trafficking;Vesicle-mediated transport;Infectious disease;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy
Q9UK45	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9UK55	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Post-translational protein modification;Post-translational protein phosphorylation
Q9UK73	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9UK80	Signal Transduction;Metabolism of proteins;TNFR1-induced proapoptotic signaling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling
Q9UK96	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UK97	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UKA1	Adaptive Immune System;Immune System;Transport of small molecules;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Iron uptake and transport;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UKA2	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UKB1	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cytokine Signaling in Immune system;Adaptive Immune System;Cell Cycle;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;Regulation of PLK1 Activity at G2/M Transition;FCERI mediated NF-kB activation;Metabolism of proteins;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;Mitotic G2-G2/M phases;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Post-translational protein modification;G2/M Transition;Cell Cycle, Mitotic;Neddylation;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q9UKE5	Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Cellular responses to external stimuli
Q9UKF2	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
Q9UKF6	Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Metabolism of RNA
Q9UKG1	Apoptosis;Caspase activation via Dependence Receptors in the absence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death
Q9UKG4	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Sodium-coupled sulphate, di- and tri-carboxylate transporters
Q9UKG9	Metabolism;Beta-oxidation of pristanoyl-CoA;Peroxisomal lipid metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal protein import;Protein localization
Q9UKI2	Signal Transduction;MAPK family signaling cascades;MAPK6/MAPK4 signaling
Q9UKI3	Hemostasis;Cell surface interactions at the vascular wall
Q9UKJ0	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9UKJ1	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9UKJ8	Fertilization;Reproduction;Interaction With Cumulus Cells And The Zona Pellucida
Q9UKK3	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q9UKK6	Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9UKK9	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NUDT proteins;Purine catabolism;Nucleobase catabolism
Q9UKL0	Hemostasis;PIP3 activates AKT signaling;Signal Transduction;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;PTEN Regulation;Regulation of PTEN gene transcription;Intracellular signaling by second messengers;Factors involved in megakaryocyte development and platelet production
Q9UKL2	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9UKL3	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription cofactors;Metabolism of proteins;Post-translational protein modification
Q9UKL4	Electric Transmission Across Gap Junctions;Transmission across Electrical Synapses ;Neuronal System;Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q9UKL6	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q9UKM7	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Asparagine N-linked glycosylation;Defective MAN1B1 causes MRT15;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Diseases of metabolism;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9UKN1	Disease;Innate Immune System;Immune System;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC);Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS);Defective GALNT12 causes colorectal cancer 1 (CRCS1);O-linked glycosylation;Dectin-2 family;C-type lectin receptors (CLRs);Diseases of metabolism;Post-translational protein modification;O-linked glycosylation of mucins;Termination of O-glycan biosynthesis
Q9UKN5	Signal Transduction;p75NTR negatively regulates cell cycle via SC1;p75 NTR receptor-mediated signalling;Death Receptor Signalling
Q9UKN8	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
Q9UKP4	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9UKP5	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9UKP6	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q9UKR0	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9UKR3	Developmental Biology;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Keratinization;Formation of the cornified envelope
Q9UKS6	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q9UKT4	Cell Cycle;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;Phosphorylation of Emi1;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Mitotic Metaphase/Anaphase Transition;M Phase;G1/S-Specific Transcription;G1/S Transition;Cell Cycle, Mitotic
Q9UKT5	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UKT6	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UKT7	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Circadian Clock;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UKT8	Adaptive Immune System;Immune System;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UKU0	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9UKU7	Metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives
Q9UKV0	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UKV3	Apoptosis;Apoptotic cleavage of cellular proteins;Programmed Cell Death;Apoptotic execution phase
Q9UKV5	Metabolism of proteins;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;Post-translational protein modification;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle
Q9UKV8	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;Small interfering RNA (siRNA) biogenesis;Post-transcriptional silencing by small RNAs;Transcriptional regulation by small RNAs;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9UKW4	Hemostasis;GPVI-mediated activation cascade;Developmental Biology;Signal Transduction;Disease;Innate Immune System;Immune System;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Signaling by VEGF;Signaling by Rho GTPases;Rho GTPase cycle;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Cell death signalling via NRAGE, NRIF and NADE;DAP12 interactions;DAP12 signaling;Fc epsilon receptor (FCERI) signaling;EPH-Ephrin signaling;FCERI mediated MAPK activation;FCERI mediated Ca+2 mobilization;Signaling by GPCR;GPCR downstream signalling;EPH-ephrin mediated repulsion of cells;G alpha (12/13) signalling events;Axon guidance;VEGFA-VEGFR2 Pathway;VEGFR2 mediated vascular permeability;Infectious disease;Death Receptor Signalling;Platelet activation, signaling and aggregation;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis;Nervous system development
Q9UKX2	Disease;Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Infectious disease;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9UKX5	Extracellular matrix organization;Integrin cell surface interactions
Q9UKX7	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Metabolism;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Rev-mediated nuclear export of HIV RNA;Influenza Infection;Immune System;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Cellular responses to stress;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Metabolism of proteins;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);Disorders of transmembrane transporters;Infectious disease;Post-translational protein modification;tRNA processing in the nucleus;Mitotic Prophase;M Phase;Cell Cycle, Mitotic;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;tRNA processing;Gene expression (Transcription);Metabolism of RNA;Cellular responses to external stimuli;Interferon Signaling;HCMV Infection;HCMV Early Events;HCMV Late Events
Q9UKY0	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9UKY4	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2;Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1;O-linked glycosylation;Diseases of metabolism;Post-translational protein modification
Q9UKZ1	Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9UKZ9	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
Q9UL01	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Dermatan sulfate biosynthesis;Metabolism of carbohydrates
Q9UL03	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UL12	Metabolism;Choline catabolism;Metabolism of amino acids and derivatives
Q9UL15	Cellular responses to stress;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Cellular responses to external stimuli
Q9UL18	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;Small interfering RNA (siRNA) biogenesis;Post-transcriptional silencing by small RNAs;Transcriptional regulation by small RNAs;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9UL19	Metabolism;Acyl chain remodelling of PE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9UL25	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;Post-translational protein modification;RAB geranylgeranylation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9UL26	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q9UL33	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q9UL45	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q9UL46	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Interleukin-12 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-12 signaling;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q9UL51	Neuronal System;HCN channels;Potassium Channels
Q9UL58	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UL59	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UL62	Developmental Biology;Stimuli-sensing channels;TRP channels;Netrin-1 signaling;Transport of small molecules;Role of second messengers in netrin-1 signaling;Axon guidance;Nervous system development;Ion channel transport
Q9ULB1	Neuronal System;Extracellular matrix organization;Non-integrin membrane-ECM interactions;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9ULB4	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
Q9ULB5	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
Q9ULC3	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q9ULC5	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
Q9ULC6	Chromatin modifying enzymes;Chromatin organization
Q9ULC8	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;HDL assembly;Plasma lipoprotein assembly
Q9ULD4	Hemostasis;Platelet degranulation ;Generic Transcription Pathway;HATs acetylate histones;Chromatin modifying enzymes;Transcriptional Regulation by TP53;Chromatin organization;Regulation of TP53 Activity;Regulation of TP53 Activity through Acetylation;RNA Polymerase II Transcription;Gene expression (Transcription);Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9ULD5	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9ULD6	Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
Q9ULD8	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9ULE3	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9ULF5	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc influx into cells by the SLC39 gene family
Q9ULG1	Metabolism of proteins;Deubiquitination;UCH proteinases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q9ULH0	Signal Transduction;Signaling by NTRKs;Prolonged ERK activation events;ARMS-mediated activation;Signaling by NTRK1 (TRKA);Signalling to ERKs;Signaling by Receptor Tyrosine Kinases
Q9ULH1	Organelle biogenesis and maintenance;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane
Q9ULH4	Neuronal System;Protein-protein interactions at synapses;Synaptic adhesion-like molecules
Q9ULI2	Metabolism;Metabolism of amino acids and derivatives;Glutamate and glutamine metabolism
Q9ULI4	Hemostasis;Adaptive Immune System;Immune System;Membrane Trafficking;MHC class II antigen presentation;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9ULK4	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9ULK5	Signal Transduction;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins
Q9ULL4	Developmental Biology;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Nervous system development
Q9ULM2	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9ULM3	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9ULM6	Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9ULP9	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9ULQ1	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9ULR0	Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;DNA Repair;Metabolism of RNA
Q9ULS6	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9ULT6	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of FZD by ubiquitination
Q9ULT8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9ULV0	Transport of small molecules;Vasopressin regulates renal water homeostasis via Aquaporins;Aquaporin-mediated transport
Q9ULV1	Signal Transduction;Disease;Signaling by WNT;Membrane Trafficking;TCF dependent signaling in response to WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;Ca2+ pathway;PCP/CE pathway;Asymmetric localization of PCP proteins;Regulation of FZD by ubiquitination;Signaling by WNT in cancer;GPCR ligand binding;WNT5A-dependent internalization of FZD4;RNF mutants show enhanced WNT signaling and proliferation;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9ULW0	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Mitotic G2-G2/M phases;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;G2/M Transition;Cell Cycle, Mitotic;RNA Polymerase II Transcription;Gene expression (Transcription);AURKA Activation by TPX2
Q9ULW2	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q9ULW5	Metabolism of proteins;Post-translational protein modification;RAB geranylgeranylation
Q9ULW8	Chromatin modifying enzymes;Chromatin organization
Q9ULX3	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9ULX7	Metabolism;Reversible hydration of carbon dioxide
Q9ULX9	Hemostasis;Factors involved in megakaryocyte development and platelet production
Q9ULY5	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
Q9ULZ1	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q9ULZ3	Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CLEC7A/inflammasome pathway;Infectious disease;Inflammasomes;Neutrophil degranulation;The NLRP3 inflammasome;The AIM2 inflammasome;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
Q9ULZ9	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
Q9UM01	Hemostasis;Disease;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;SLC transporter disorders;Disorders of transmembrane transporters;Defective SLC7A7 causes lysinuric protein intolerance (LPI)
Q9UM07	Chromatin modifying enzymes;Chromatin organization
Q9UM11	Adaptive Immune System;Cell Cycle;Immune System;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;Phosphorylation of Emi1;Generic Transcription Pathway;Cellular responses to stress;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UM13	Adaptive Immune System;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;Cell Cycle;Immune System;APC/C:Cdc20 mediated degradation of Cyclin B;Autodegradation of Cdh1 by Cdh1:APC/C;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Phosphorylation of the APC/C;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC-Cdc20 mediated degradation of Nek2A;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Generic Transcription Pathway;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Senescence-Associated Secretory Phenotype (SASP);Cellular Senescence;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Cellular responses to external stimuli;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UM21	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Post-translational protein phosphorylation;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
Q9UM47	Signaling by NOTCH;Signal Transduction;Disease;Pre-NOTCH Processing in the Endoplasmic Reticulum;Pre-NOTCH Transcription and Translation;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Generic Transcription Pathway;Notch-HLH transcription pathway;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Defective LFNG causes SCDO3;Diseases of metabolism;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;NOTCH3 Intracellular Domain Regulates Transcription;Noncanonical activation of NOTCH3
Q9UM54	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Gap junction trafficking and regulation;Gap junction trafficking;Gap junction degradation;Membrane Trafficking;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Vesicle-mediated transport
Q9UM63	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9UMD9	Adaptive Immune System;Collagen degradation;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Cell-Cell communication;Collagen biosynthesis and modifying enzymes;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Assembly of collagen fibrils and other multimeric structures;Type I hemidesmosome assembly;Cell junction organization;Collagen chain trimerization
Q9UMF0	Adaptive Immune System;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Integrin cell surface interactions
Q9UMN6	Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q9UMQ6	Degradation of the extracellular matrix;Extracellular matrix organization
Q9UMR5	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
Q9UMR7	Innate Immune System;Immune System;Dectin-2 family;C-type lectin receptors (CLRs)
Q9UMS4	Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;DNA Repair;Metabolism of RNA
Q9UMW8	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Interferon alpha/beta signaling;Regulation of IFNA signaling;Interferon Signaling
Q9UMX0	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9UMX1	Signal Transduction;Signaling by Hedgehog;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state
Q9UMX2	Metabolism;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Metabolism of amino acids and derivatives
Q9UMX6	Signal Transduction;Visual phototransduction;The phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q9UMX9	Metabolism;Melanin biosynthesis;Metabolism of amino acids and derivatives
Q9UN19	Adaptive Immune System;Immune System;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers;Signaling by the B Cell Receptor (BCR)
Q9UN37	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Sealing of the nuclear envelope (NE) by ESCRT-III
Q9UN42	Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
Q9UN76	Disease;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Variant SLC6A14 may confer susceptibility towards obesity;SLC transporter disorders;Disorders of transmembrane transporters
Q9UN79	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q9UN88	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Signaling by ERBB4;Signal Transduction;Signaling by Receptor Tyrosine Kinases;GABA receptor activation
Q9UNA0	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9UNA1	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9UNA3	Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;O-linked glycosylation of mucins
Q9UNA4	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion synthesis by POLI;Termination of translesion DNA synthesis;DNA Damage Bypass;DNA Repair
Q9UNE0	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q9UNE7	Signaling by ERBB2;PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Immune System;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Downregulation of ERBB2 signaling;Transcriptional regulation by RUNX2;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Signaling by TGF-beta family members;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9UNF0	Membrane Trafficking;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q9UNF1	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9UNG2	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors
Q9UNH5	Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Regulation of mitotic cell cycle;MAPK family signaling cascades;MAPK6/MAPK4 signaling;Cell Cycle, Mitotic
Q9UNK4	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PS;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Acyl chain remodelling of PG;Synthesis of PA;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9UNL2	SRP-dependent cotranslational protein targeting to membrane;Metabolism of proteins;Translation
Q9UNL4	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9UNM6	Apoptosis;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Developmental Biology;Cytokine Signaling in Immune system;Adaptive Immune System;Metabolism;Signaling by NOTCH;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Innate Immune System;Immune System;Regulation of Apoptosis;Autodegradation of Cdh1 by Cdh1:APC/C;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;SCF(Skp2)-mediated degradation of p27/p21;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Regulation of activated PAK-2p34 by proteasome mediated degradation;Generic Transcription Pathway;Cellular responses to stress;Fc epsilon receptor (FCERI) signaling;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;FCERI mediated NF-kB activation;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;Transport of small molecules;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;Metabolism of proteins;PCP/CE pathway;Axon guidance;Interleukin-1 family signaling;Signaling by Interleukins;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Mitotic G1 phase and G1/S transition;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Programmed Cell Death;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Neutrophil degranulation;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Cyclin E associated events during G1/S transition ;G1/S Transition;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cyclin A:Cdk2-associated events at S phase entry;Metabolism of amino acids and derivatives;RNA Polymerase II Transcription;Gene expression (Transcription);Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX3;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of RUNX3 expression and activity;Regulation of PTEN stability and activity;Neddylation;Metabolism of RNA;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Signaling by NOTCH4;Interleukin-1 signaling;Negative regulation of NOTCH4 signaling;FLT3 Signaling;Nervous system development;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q9UNN8	Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Cell surface interactions at the vascular wall
Q9UNP4	Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9UNP9	Innate Immune System;Immune System;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Neutrophil degranulation;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;DNA Repair;Metabolism of RNA
Q9UNQ0	Metabolism;Metabolism of porphyrins;Heme biosynthesis;Heme degradation;Abacavir transmembrane transport;Abacavir transport and metabolism;Transport of small molecules;Iron uptake and transport
Q9UNQ2	rRNA modification in the nucleus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9UNS1	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Processing of DNA double-strand break ends;DNA Repair
Q9UNS2	Membrane Trafficking;Metabolism of proteins;Vesicle-mediated transport;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);DNA Repair;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Neddylation
Q9UNU6	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Bile acid and bile salt metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Eicosanoids;Sterols are 12-hydroxylated by CYP8B1;Arachidonic acid metabolism;Synthesis of Prostaglandins (PG) and Thromboxanes (TX);Metabolism of lipids;Metabolism of steroids;Fatty acid metabolism
Q9UNW1	Metabolism;Inositol phosphate metabolism;Synthesis of IPs in the ER lumen
Q9UNW8	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding
Q9UNX3	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9UNX4	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9UNX9	Neuronal System;Classical Kir channels;Inwardly rectifying K+ channels;Potassium Channels;Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9UP38	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Signaling by GPCR;Class B/2 (Secretin family receptors);Beta-catenin independent WNT signaling;PCP/CE pathway;Asymmetric localization of PCP proteins;Disassembly of the destruction complex and recruitment of AXIN to the membrane;GPCR ligand binding
Q9UP52	Transport of small molecules;Iron uptake and transport;Transferrin endocytosis and recycling
Q9UP65	Metabolism;Acyl chain remodelling of PC;Acyl chain remodelling of PE;Acyl chain remodelling of PI;Hydrolysis of LPC;Hydrolysis of LPE;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9UP79	Degradation of the extracellular matrix;Extracellular matrix organization;Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9UP83	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q9UP95	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Cation-coupled Chloride cotransporters
Q9UPM8	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q9UPM9	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q9UPN4	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9UPN7	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q9UPN9	Signal Transduction;Signaling by TGF-beta Receptor Complex;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;RNA Polymerase II Transcription;Gene expression (Transcription);Signaling by TGF-beta family members
Q9UPP1-1	Cell Cycle;Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q9UPP1-2	Cell Cycle;Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q9UPP1-3	Cell Cycle;Condensation of Prophase Chromosomes;Mitotic Prophase;M Phase;Cell Cycle, Mitotic
Q9UPP1	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q9UPQ4	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9UPQ8	Disease;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Synthesis of Dolichyl-phosphate;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Defective DOLK causes DOLK-CDG (CDG-1m);Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
Q9UPQ9	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Pre-NOTCH Transcription and Translation;Pre-NOTCH Expression and Processing;Signaling by WNT;Gene Silencing by RNA;Generic Transcription Pathway;Cellular responses to stress;Oxidative Stress Induced Senescence;Cellular Senescence;Oncogene Induced Senescence;Transcriptional Regulation by TP53;Beta-catenin independent WNT signaling;Ca2+ pathway;Post-transcriptional silencing by small RNAs;TP53 Regulates Metabolic Genes;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by VENTX;Transcriptional regulation by RUNX1;Regulation of RUNX1 Expression and Activity;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;ESR-mediated signaling;Regulation of PTEN mRNA translation;Competing endogenous RNAs (ceRNAs) regulate PTEN translation;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9UPR3	Metabolism of RNA;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9UPR5	Hemostasis;Transport of small molecules;Muscle contraction;Platelet homeostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Calcium exchangers;Cardiac conduction;Ion homeostasis
Q9UPS6	Generic Transcription Pathway;PKMTs methylate histone lysines;Chromatin modifying enzymes;Chromatin organization;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
Q9UPT5	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Organelle biogenesis and maintenance;Membrane Trafficking;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Cilium Assembly;VxPx cargo-targeting to cilium;Cargo trafficking to the periciliary membrane;Vesicle-mediated transport
Q9UPT9	HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9UPU5	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9UPV0	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9UPV9	Disease;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling
Q9UPW5	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q9UPW6	Generic Transcription Pathway;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of chromatin organization proteins;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development
Q9UPX8	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9UPY3	MicroRNA (miRNA) biogenesis;Gene Silencing by RNA;Small interfering RNA (siRNA) biogenesis;Gene expression (Transcription)
Q9UPY5	Hemostasis;Cell surface interactions at the vascular wall;Basigin interactions;Amino acid transport across the plasma membrane;Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q9UPY6	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9UPZ6	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective B3GALTL causes Peters-plus syndrome (PpS);O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Diseases of metabolism;Post-translational protein modification
Q9UQ05	Neuronal System;Potassium Channels;Voltage gated Potassium channels
Q9UQ16	Developmental Biology;Adaptive Immune System;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;Signaling by NTRKs;Innate Immune System;Immune System;Toll-like Receptor Cascades;Retrograde neurotrophin signalling;Signaling by NTRK1 (TRKA);Membrane Trafficking;MHC class II antigen presentation;L1CAM interactions;Axon guidance;Recycling pathway of L1;Vesicle-mediated transport;Clathrin-mediated endocytosis;Signaling by Receptor Tyrosine Kinases;Nervous system development
Q9UQ35	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9UQ49	Metabolism;Glycosphingolipid metabolism;Metabolism of proteins;Sialic acid metabolism;Sphingolipid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Metabolism of lipids;Post-translational protein modification
Q9UQ52	Developmental Biology;L1CAM interactions;Axon guidance;CHL1 interactions;Nervous system development
Q9UQ53	Metabolism of proteins;Asparagine N-linked glycosylation;Post-translational protein modification;Transport to the Golgi and subsequent modification;N-glycan antennae elongation in the medial/trans-Golgi;N-Glycan antennae elongation
Q9UQ72	Hemostasis;Cell surface interactions at the vascular wall
Q9UQ74	Hemostasis;Cell surface interactions at the vascular wall
Q9UQ80	Innate Immune System;Immune System;Neutrophil degranulation
Q9UQ84	Cell Cycle;Generic Transcription Pathway;Transcriptional Regulation by TP53;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Regulation of TP53 Activity;HDR through Single Strand Annealing (SSA);HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;Regulation of TP53 Activity through Phosphorylation;G2/M DNA damage checkpoint;G2/M Checkpoints;Cell Cycle Checkpoints;RNA Polymerase II Transcription;DNA Repair;Gene expression (Transcription)
Q9UQ88	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic
Q9UQ90	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q9UQB8	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9UQC2	PI3K Cascade;IRS-mediated signalling;Signaling by FGFR in disease;Developmental Biology;Cytokine Signaling in Immune system;Signaling by SCF-KIT;Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Fc epsilon receptor (FCERI) signaling;Role of LAT2/NTAL/LAB on calcium mobilization;Axon guidance;Signaling by Interleukins;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Signaling by FGFR1 in disease;Diseases of signal transduction by growth factor receptors and second messengers;Insulin receptor signalling cascade;Signaling by Insulin receptor;RET signaling;Interleukin-15 signaling;Signaling by Receptor Tyrosine Kinases;Interleukin receptor SHC signaling;FLT3 Signaling;STAT5 Activation;Nervous system development
Q9UQC9	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9UQD0	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q9UQE7	Meiotic synapsis;Reproduction;Meiosis;Signal Transduction;Cell Cycle;Separation of Sister Chromatids;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;Post-translational protein modification;Mitotic Prometaphase;Mitotic Anaphase;Mitotic Telophase/Cytokinesis;M Phase;S Phase;Cell Cycle, Mitotic;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q9UQK1	Metabolism;Disease;Glycogen storage diseases;Glycogen synthesis;Myoclonic epilepsy of Lafora;Diseases of carbohydrate metabolism;Diseases of metabolism;Metabolism of carbohydrates;Glycogen metabolism
Q9UQL6	PIP3 activates AKT signaling;Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Notch-HLH transcription pathway;Diseases of signal transduction by growth factor receptors and second messengers;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q9UQM7	Opioid Signalling;CaMK IV-mediated phosphorylation of CREB;Calmodulin induced events;Ca-dependent events;CaM pathway;G-protein mediated events;PLC beta mediated events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Cytokine Signaling in Immune system;DAG and IP3 signaling;Signal Transduction;Disease;Immune System;Signaling by WNT;Generic Transcription Pathway;Cellular responses to stress;Cellular response to heat stress;HSF1-dependent transactivation;Signaling by GPCR;Transport of small molecules;Beta-catenin independent WNT signaling;GPCR downstream signalling;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Ca2+ pathway;G alpha (i) signalling events;Post NMDA receptor activation events;Unblocking of NMDA receptors, glutamate binding and activation;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Activation of NMDA receptors and postsynaptic events;Ras activation upon Ca2+ influx through NMDA receptor;Cardiac conduction;Phase 0 - rapid depolarisation;Ion homeostasis;Diseases of signal transduction by growth factor receptors and second messengers;RAF activation;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;RNA Polymerase II Transcription;Gene expression (Transcription);Interferon gamma signaling;Cellular responses to external stimuli;Transcriptional Regulation by MECP2;Intracellular signaling by second messengers;Regulation of MECP2 expression and activity;Interferon Signaling;Ion transport by P-type ATPases;FLT3 Signaling;Assembly and cell surface presentation of NMDA receptors;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Signaling downstream of RAS mutants;Ion channel transport
Q9UQN3	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
Q9UQP3	Extracellular matrix organization;ECM proteoglycans
Q9UQQ2	Hemostasis;Signaling by SCF-KIT;Regulation of KIT signaling;Signal Transduction;Signaling by Receptor Tyrosine Kinases;Factors involved in megakaryocyte development and platelet production
Q9Y210	Hemostasis;Effects of PIP2 hydrolysis;Developmental Biology;Elevation of cytosolic Ca2+ levels;Signal Transduction;Stimuli-sensing channels;TRP channels;Signaling by GPCR;Netrin-1 signaling;Transport of small molecules;GPCR downstream signalling;G alpha (q) signalling events;Platelet homeostasis;Platelet calcium homeostasis;Role of second messengers in netrin-1 signaling;Axon guidance;Platelet activation, signaling and aggregation;Nervous system development;Ion channel transport
Q9Y216	Metabolism;Inositol phosphate metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the late endosome membrane;Synthesis of IP2, IP, and Ins in the cytosol;Metabolism of lipids
Q9Y217	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9Y219	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus
Q9Y221	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y223	Disease;Diseases of glycosylation;Metabolism of proteins;Sialic acid metabolism;Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Diseases associated with glycosylation precursor biosynthesis;Diseases of metabolism;Post-translational protein modification
Q9Y224	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q9Y226	Metabolism;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Nicotinamide salvaging
Q9Y227	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism
Q9Y230	Telomere Maintenance;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization;Chromosome Maintenance
Q9Y231	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q9Y233	Hemostasis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects;G alpha (s) signalling events
Q9Y234	Metabolism;Glyoxylate metabolism and glycine degradation;Metabolism of amino acids and derivatives
Q9Y235	mRNA Editing: C to U Conversion;mRNA Editing;Formation of the Editosome;Metabolism of RNA
Q9Y239	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;Deubiquitination;Ovarian tumor domain proteases;Post-translational protein modification;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane
Q9Y241	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Cellular responses to stress;Cellular responses to external stimuli
Q9Y243	Apoptosis;Intrinsic Pathway for Apoptosis;Activation of BAD and translocation to mitochondria ;Activation of BH3-only proteins;Signaling by ERBB2;PIP3 activates AKT signaling;Developmental Biology;Adaptive Immune System;Downregulation of ERBB2:ERBB3 signaling;Signal Transduction;Cell Cycle;Disease;Immune System;Regulation of beta-cell development;Signaling by VEGF;AKT phosphorylates targets in the cytosol;AKT phosphorylates targets in the nucleus;Negative regulation of the PI3K/AKT network;Membrane Trafficking;Regulation of gene expression in beta cells;AKT-mediated inactivation of FOXO1A;Generic Transcription Pathway;PI3K/AKT Signaling in Cancer;Transcriptional Regulation by TP53;Signaling by GPCR;GPCR downstream signalling;Costimulation by the CD28 family;CD28 co-stimulation;CD28 dependent PI3K/Akt signaling;CTLA4 inhibitory signaling;G beta:gamma signalling through PI3Kgamma;G-protein beta:gamma signalling;VEGFA-VEGFR2 Pathway;Mitotic G1 phase and G1/S transition;VEGFR2 mediated vascular permeability;Programmed Cell Death;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Diseases of signal transduction by growth factor receptors and second messengers;Constitutive Signaling by AKT1 E17K in Cancer;Regulation of TP53 Degradation;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Expression and Degradation;PTEN Regulation;Cyclin E associated events during G1/S transition ;G1/S Transition;S Phase;Cell Cycle, Mitotic;Cyclin A:Cdk2-associated events at S phase entry;RNA Polymerase II Transcription;Gene expression (Transcription);Downregulation of ERBB2 signaling;RAB GEFs exchange GTP for GDP on RABs;Transcriptional regulation by RUNX2;ESR-mediated signaling;RUNX2 regulates genes involved in cell migration;Regulation of PTEN stability and activity;Intracellular signaling by second messengers;Signaling by Nuclear Receptors;Signaling by Receptor Tyrosine Kinases;Rab regulation of trafficking;Extra-nuclear estrogen signaling;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;Estrogen-dependent nuclear events downstream of ESR-membrane signaling
Q9Y248	Cell Cycle;Unwinding of DNA;DNA strand elongation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication
Q9Y251	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Innate Immune System;Immune System;HS-GAG degradation;Neutrophil degranulation;Metabolism of carbohydrates
Q9Y252	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y253	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Translesion Synthesis by POLH;Termination of translesion DNA synthesis;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Damage Bypass;DNA Repair
Q9Y255	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Death Genes;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y256	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9Y257	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9Y259	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q9Y261	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in beta cells
Q9Y262	L13a-mediated translational silencing of Ceruloplasmin expression;Metabolism of proteins;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
Q9Y264	Hemostasis;Cell surface interactions at the vascular wall;Tie2 Signaling
Q9Y265	Telomere Maintenance;Signal Transduction;Cell Cycle;Telomere Extension By Telomerase;Extension of Telomeres;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;UCH proteinases;Ub-specific processing proteases;DNA Damage Recognition in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;DNA Repair;Nucleosome assembly
Q9Y266	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9Y271	Signal Transduction;Disease;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Leukotriene receptors;G alpha (q) signalling events;GPCR ligand binding;Infectious disease;Leishmania infection;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival;LTC4-CYSLTR mediated IL4 production
Q9Y274	Metabolism;Signaling by NOTCH;Signal Transduction;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing;Keratan sulfate biosynthesis;Metabolism of proteins;Sialic acid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q9Y275	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
Q9Y276	Mitochondrial protein import;Protein localization
Q9Y277	Transport of small molecules;Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification;Mitochondrial calcium ion transport
Q9Y278	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q9Y285	Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Metabolism of proteins;Translation
Q9Y286	Adaptive Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Q9Y287	Metabolism of proteins;Amyloid fiber formation
Q9Y289	Metabolism;Biotin transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B5 (pantothenate) metabolism;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport
Q9Y291	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y294	Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular responses to external stimuli
Q9Y296	Extracellular matrix organization;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Syndecan interactions;Non-integrin membrane-ECM interactions;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q9Y297	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Prolactin receptor signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;HIV Infection;Host Interactions of HIV factors;Cell Cycle;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;Vpu mediated degradation of CD4;Toll Like Receptor 2 (TLR2) Cascade;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;Regulation of PLK1 Activity at G2/M Transition;FCERI mediated NF-kB activation;Deactivation of the beta-catenin transactivating complex;Metabolism of proteins;Circadian Clock;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Signaling by Hedgehog;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;C-type lectin receptors (CLRs);Infectious disease;TNFR2 non-canonical NF-kB pathway;NIK-->noncanonical NF-kB signaling;MAP3K8 (TPL2)-dependent MAPK1/3 activation;Post-translational protein modification;G2/M Transition;Cell Cycle, Mitotic;Neddylation;Interleukin-1 signaling;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q9Y2A4	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2A7	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9Y2A9	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of proteins;O-linked glycosylation;Post-translational protein modification;Metabolism of carbohydrates;O-linked glycosylation of mucins
Q9Y2B2	Synthesis of glycosylphosphatidylinositol (GPI);Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9Y2C2	Metabolism;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Dermatan sulfate biosynthesis;Metabolism of carbohydrates
Q9Y2C3	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q9Y2C9	ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Diseases of Immune System;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Regulation of TLR by endogenous ligand;Class I MHC mediated antigen processing & presentation
Q9Y2D0	Metabolism;Reversible hydration of carbon dioxide
Q9Y2D1	Cellular responses to stress;Cellular responses to external stimuli;Response of EIF2AK1 (HRI) to heme deficiency
Q9Y2D2	Disease;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS);SLC transporter disorders;Disorders of transmembrane transporters;Transport of nucleotide sugars
Q9Y2E5	Metabolism;Metabolism of carbohydrates;Lysosomal oligosaccharide catabolism
Q9Y2E6	Signaling by NOTCH;ZBP1(DAI) mediated induction of type I IFNs;IRF3 mediated activation of type 1 IFN;Signal Transduction;Innate Immune System;Immune System;STING mediated induction of host immune responses;Cytosolic sensors of pathogen-associated DNA ;Signaling by NOTCH1;Activated NOTCH1 Transmits Signal to the Nucleus;Regulation of innate immune responses to cytosolic DNA;IRF3-mediated induction of type I IFN
Q9Y2E8	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Sodium/Proton exchangers
Q9Y2F5	RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2G2	Apoptosis;Intrinsic Pathway for Apoptosis;Formation of apoptosome;Cytochrome c-mediated apoptotic response;Apoptotic factor-mediated response;Programmed Cell Death;Regulation of the apoptosome activity
Q9Y2G3	Innate Immune System;Immune System;Transport of small molecules;Neutrophil degranulation;Ion transport by P-type ATPases;Ion channel transport
Q9Y2G5	Metabolism of proteins;O-linked glycosylation;O-glycosylation of TSR domain-containing proteins;Post-translational protein modification
Q9Y2G7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2H0	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9Y2H2	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the early endosome membrane;Metabolism of lipids
Q9Y2H5	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Metabolism of lipids
Q9Y2H8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2I2	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9Y2I6	Cell Cycle;Organelle biogenesis and maintenance;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Cilium Assembly;Anchoring of the basal body to the plasma membrane;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2
Q9Y2I7	Metabolism;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the late endosome membrane;Metabolism of lipids
Q9Y2J2	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9Y2J4	Signal Transduction;Signaling by Hippo
Q9Y2J8	Innate Immune System;Immune System;Chromatin modifying enzymes;Chromatin organization;Neutrophil degranulation
Q9Y2K6	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9Y2K7	HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
Q9Y2L1	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y2L5	Membrane Trafficking;Vesicle-mediated transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking
Q9Y2L8	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2M0	Fanconi Anemia Pathway;DNA Repair
Q9Y2M5	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y2N7	Regulation of gene expression by Hypoxia-inducible Factor;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Developmental Biology;Cellular responses to stress;Metabolism of proteins;Transcriptional regulation of pluripotent stem cells;Post-translational protein modification;Neddylation;Cellular responses to external stimuli
Q9Y2P4	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of fatty acids
Q9Y2P5	Metabolism;Recycling of bile acids and salts;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Bile acid and bile salt metabolism;Metabolism of lipids;Metabolism of steroids
Q9Y2P7	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2P8	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y2Q0	Innate Immune System;Immune System;Transport of small molecules;Neutrophil degranulation;Ion transport by P-type ATPases;Ion channel transport
Q9Y2Q1	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2Q3	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Biological oxidations;Peroxisomal protein import;Protein localization
Q9Y2Q5	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Signal Transduction;Macroautophagy;mTOR signalling;mTORC1-mediated signalling;Innate Immune System;Immune System;Generic Transcription Pathway;Cellular responses to stress;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;TP53 Regulates Metabolic Genes;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Neutrophil degranulation;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Cellular responses to external stimuli;Intracellular signaling by second messengers;FLT3 Signaling;Autophagy;Amino acids regulate mTORC1
Q9Y2Q9	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y2R2	Adaptive Immune System;Immune System;TCR signaling;Phosphorylation of CD3 and TCR zeta chains;Translocation of ZAP-70 to Immunological synapse
Q9Y2R4	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y2R5	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y2R9	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y2S2	Metabolism;Formation of xylulose-5-phosphate;Metabolism of carbohydrates
Q9Y2T1	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Metabolism of proteins;Binding of TCF/LEF:CTNNB1 to target gene promoters;Degradation of AXIN;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9Y2T2	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins
Q9Y2T3	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism
Q9Y2T6	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q9Y2U2	Neuronal System;Potassium Channels;Tandem pore domain potassium channels;Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK);Muscle contraction;Phase 4 - resting membrane potential;Cardiac conduction
Q9Y2U8	Cell Cycle;Mitotic Metaphase and Anaphase;Nuclear Envelope Breakdown;Initiation of Nuclear Envelope (NE) Reformation;Nuclear Envelope (NE) Reassembly;Depolymerisation of the Nuclear Lamina;Mitotic Prophase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
Q9Y2V7	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;Intra-Golgi traffic;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic;Transport to the Golgi and subsequent modification
Q9Y2W1	Developmental Biology;Metabolism;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids
Q9Y2W2	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9Y2W6	Gene Silencing by RNA;PIWI-interacting RNA (piRNA) biogenesis;Gene expression (Transcription)
Q9Y2W7	Muscle contraction;Cardiac conduction;Phase 1 - inactivation of fast Na+ channels
Q9Y2X0	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y2X3	SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;SUMOylation of RNA binding proteins;Post-translational protein modification;rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y2X7	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;EPH-Ephrin signaling;Ephrin signaling;Axon guidance;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Activation of RAC1 downstream of NMDARs;Nervous system development
Q9Y2X8	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y2Y0	Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
Q9Y2Y1	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9Y2Y8	Innate Immune System;Immune System;Neutrophil degranulation
Q9Y2Z0	Disease;Innate Immune System;Immune System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Infectious disease;Inflammasomes;The NLRP3 inflammasome;Leishmania infection;Purinergic signaling in leishmaniasis infection;Cell recruitment (pro-inflammatory response)
Q9Y2Z2	tRNA modification in the mitochondrion;tRNA processing;Metabolism of RNA
Q9Y2Z4	tRNA Aminoacylation;Mitochondrial tRNA aminoacylation;Metabolism of proteins;Translation
Q9Y2Z9	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
Q9Y303	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9Y305	Metabolism;Metabolism of lipids;Mitochondrial Fatty Acid Beta-Oxidation;Fatty acid metabolism
Q9Y314	Metabolism;Metabolism of nitric oxide: eNOS activation and regulation;NOSIP mediated eNOS trafficking
Q9Y315	Metabolism;Innate Immune System;Immune System;Neutrophil degranulation;Pentose phosphate pathway;Metabolism of carbohydrates
Q9Y316	Signaling by ERBB2;Signal Transduction;ERBB2 Regulates Cell Motility;Signaling by Receptor Tyrosine Kinases
Q9Y324	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y333	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9Y336	Adaptive Immune System;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Neutrophil degranulation
Q9Y337	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9Y345	Disease;Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Na+/Cl- dependent neurotransmitter transporters;Defective SLC6A5 causes hyperekplexia 3 (HKPX3);SLC transporter disorders;Disorders of transmembrane transporters
Q9Y365	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9Y366	Signal Transduction;Organelle biogenesis and maintenance;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport
Q9Y375	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9Y376	Signal Transduction;mTOR signalling;Innate Immune System;Immune System;Energy dependent regulation of mTOR by LKB1-AMPK;Neutrophil degranulation
Q9Y385	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y399	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y3A2	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y3A4	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y3A6	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking
Q9Y3B2	ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;Unfolded Protein Response (UPR);Metabolism of proteins;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;KSRP (KHSRP) binds and destabilizes mRNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y3B3	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9Y3B4	mRNA Splicing - Major Pathway;mRNA Splicing - Minor Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9Y3B7	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y3C4	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9Y3C6	mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9Y3C7	Developmental Biology;Metabolism;PPARA activates gene expression;Generic Transcription Pathway;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y3D0	Metabolism;Cytosolic iron-sulfur cluster assembly
Q9Y3D2	Metabolism of proteins;Protein repair
Q9Y3D3	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y3D5	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y3D6	Class I peroxisomal membrane protein import;Protein localization
Q9Y3D7	Mitochondrial protein import;Protein localization
Q9Y3D8	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q9Y3D9	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y3E5	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9Y3E7	HIV Life Cycle;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Infection;Macroautophagy;Cell Cycle;Disease;Membrane Trafficking;Mitotic Metaphase and Anaphase;Nuclear Envelope (NE) Reassembly;Vesicle-mediated transport;Infectious disease;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Endosomal Sorting Complex Required For Transport (ESCRT);HCMV Infection;HCMV Late Events;Autophagy;Late endosomal microautophagy;Sealing of the nuclear envelope (NE) by ESCRT-III
Q9Y3F4	Signal Transduction;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Signaling by TGF-beta family members
Q9Y3I0	tRNA processing in the nucleus;tRNA processing;Metabolism of RNA
Q9Y3I1	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y3L5	Innate Immune System;Immune System;Neutrophil degranulation
Q9Y3M2	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Deactivation of the beta-catenin transactivating complex
Q9Y3M8	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle
Q9Y3M9	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y3N9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9Y3P9	Membrane Trafficking;Vesicle-mediated transport;TBC/RABGAPs;Rab regulation of trafficking
Q9Y3Q0	Metabolism;Metabolism of amino acids and derivatives;Aspartate and asparagine metabolism
Q9Y3Q3	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9Y3Q4	Neuronal System;HCN channels;Potassium Channels
Q9Y3R0	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Trafficking of GluR2-containing AMPA receptors
Q9Y3R4	Metabolism;Glycosphingolipid metabolism;Metabolism of proteins;Sialic acid metabolism;Sphingolipid metabolism;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Metabolism of lipids;Post-translational protein modification
Q9Y3S1	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9Y3T9	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y3U8	Developmental Biology;Metabolism;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Elongation;Peptide chain elongation;Disease;Influenza Infection;Influenza Viral RNA Transcription and Replication;SRP-dependent cotranslational protein targeting to membrane;Viral mRNA Translation;Cellular responses to stress;Selenoamino acid metabolism;Selenocysteine synthesis;Signaling by ROBO receptors;Metabolism of proteins;Axon guidance;Infectious disease;Major pathway of rRNA processing in the nucleolus and cytosol;Metabolism of amino acids and derivatives;rRNA processing;Eukaryotic Translation Initiation;Formation of a pool of free 40S subunits;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Eukaryotic Translation Termination;Translation;rRNA processing in the nucleus and cytosol;Metabolism of RNA;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Response of EIF2AK4 (GCN2) to amino acid deficiency;Nervous system development;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9Y3V2	SUMOylation;SUMO is transferred from E1 to E2 (UBE2I, UBC9);Processing and activation of SUMO;Metabolism of proteins;Post-translational protein modification
Q9Y3Y2	Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA
Q9Y3Y4	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;Deactivation of the beta-catenin transactivating complex
Q9Y3Z3	Cytokine Signaling in Immune system;Metabolism;Metabolism of nucleotides;Immune System;Nucleobase catabolism;Interferon alpha/beta signaling;Interferon Signaling
Q9Y446	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9Y450	Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease;Metabolism of RNA
Q9Y462	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y466	PIP3 activates AKT signaling;Signal Transduction;Generic Transcription Pathway;Nuclear Receptor transcription pathway;PTEN Regulation;RNA Polymerase II Transcription;Gene expression (Transcription);Regulation of PTEN gene transcription;Intracellular signaling by second messengers
Q9Y468	Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Regulation of TP53 Activity through Methylation;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y473	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y478	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Mitochondrial biogenesis;Signal Transduction;Macroautophagy;mTOR signalling;Organelle biogenesis and maintenance;Membrane Trafficking;Generic Transcription Pathway;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Transcriptional Regulation by TP53;Energy dependent regulation of mTOR by LKB1-AMPK;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;TP53 Regulates Metabolic Genes;Regulation of TP53 Activity;Vesicle-mediated transport;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);Autophagy;Lipophagy;Activation of AMPK downstream of NMDARs;Selective autophagy
Q9Y483	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;Gene expression (Transcription)
Q9Y484	Macroautophagy;Autophagy
Q9Y487	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Transport of small molecules;Signaling by Insulin receptor;Insulin receptor recycling;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Ion channel transport
Q9Y490	Hemostasis;Platelet degranulation ;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Immune System;Integrin signaling;GRB2:SOS provides linkage to MAPK signaling for Integrins ;p130Cas linkage to MAPK signaling for integrins;Semaphorin interactions;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Muscle contraction;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Axon guidance;Smooth Muscle Contraction;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAP2K and MAPK activation;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Signaling by moderate kinase activity BRAF mutants;Signaling by high-kinase activity BRAF mutants;Signaling by RAS mutants;Signaling by BRAF and RAF fusions;Paradoxical activation of RAF signaling by kinase inactive BRAF;Oncogenic MAPK signaling;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+;Platelet Aggregation (Plug Formation);FLT3 Signaling;Signaling downstream of RAS mutants;Nervous system development
Q9Y496	Hemostasis;Adaptive Immune System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Signal Transduction;Immune System;Organelle biogenesis and maintenance;Membrane Trafficking;MHC class II antigen presentation;Signaling by Hedgehog;Hedgehog 'off' state;Cilium Assembly;Intraflagellar transport;Hedgehog 'on' state;Activation of SMO;Vesicle-mediated transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
Q9Y4A5	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Formation of the beta-catenin:TCF transactivating complex;HATs acetylate histones;Chromatin modifying enzymes;Metabolism of proteins;Chromatin organization;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9Y4A9	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9Y4B6	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y4C0	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9Y4C1	Signal Transduction;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
Q9Y4C5	Metabolism;Glycosaminoglycan metabolism;Keratan sulfate/keratin metabolism;Keratan sulfate biosynthesis;Metabolism of carbohydrates
Q9Y4D1	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;Signaling by WNT;Beta-catenin independent WNT signaling;PCP/CE pathway;RHO GTPases Activate Formins
Q9Y4D2	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Arachidonate production from DAG;Platelet activation, signaling and aggregation
Q9Y4D7	Developmental Biology;Signaling by NOTCH;Signal Transduction;Semaphorin interactions;Other semaphorin interactions;Axon guidance;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Nervous system development
Q9Y4E8	Signal Transduction;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Metabolism of proteins;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Post-translational protein modification;Signaling by TGF-beta family members
Q9Y4G8	Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q9Y4H2	PI3K Cascade;IRS-mediated signalling;SOS-mediated signalling;PIP3 activates AKT signaling;Interleukin-7 signaling;Developmental Biology;Cytokine Signaling in Immune system;Signal Transduction;Disease;Signaling by NTRKs;Immune System;Signaling by NTRK1 (TRKA);PI3K/AKT activation;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);IGF1R signaling cascade;IRS-related events triggered by IGF1R;Signaling by Leptin;Axon guidance;Signaling by Interleukins;Diseases of signal transduction by growth factor receptors and second messengers;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;IRS activation;Signal attenuation;Insulin receptor signalling cascade;Signaling by Insulin receptor;RET signaling;Signaling by Erythropoietin;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Erythropoietin activates Phosphoinositide-3-kinase (PI3K);Erythropoietin activates Phospholipase C gamma (PLCG);Erythropoietin activates STAT5;Erythropoietin activates RAS;FLT3 Signaling;Nervous system development;Growth hormone receptor signaling
Q9Y4H4	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events
Q9Y4I1	Translocation of SLC2A4 (GLUT4) to the plasma membrane;Disease;Innate Immune System;Immune System;Membrane Trafficking;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Insulin processing;Peptide hormone metabolism;Metabolism of proteins;Vesicle-mediated transport;Infectious disease;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9Y4K0	Extracellular matrix organization;Collagen formation;Elastic fibre formation;Assembly of collagen fibrils and other multimeric structures;Crosslinking of collagen fibrils
Q9Y4K3	PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Adaptive Immune System;Signal Transduction;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Toll Like Receptor 2 (TLR2) Cascade;p75NTR signals via NF-kB;Regulated proteolysis of p75NTR;p75 NTR receptor-mediated signalling;Negative regulation of the PI3K/AKT network;TCR signaling;Downstream TCR signaling;Cell death signalling via NRAGE, NRIF and NADE;NRIF signals cell death from the nucleus;p75NTR recruits signalling complexes;NF-kB is activated and signals survival;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Death Receptor Signalling;Intracellular signaling by second messengers;TICAM1,TRAF6-dependent induction of TAK1 complex;Interleukin-1 signaling;TRAF6 mediated IRF7 activation;TRAF6 mediated NF-kB activation;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;IRAK2 mediated activation of TAK1 complex;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;Alpha-protein kinase 1 signaling pathway;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;MyD88 cascade initiated on plasma membrane
Q9Y4L1	Binding and Uptake of Ligands by Scavenger Receptors;Scavenging by Class F Receptors;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Vesicle-mediated transport
Q9Y4L5	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y4P1	Macroautophagy;Autophagy
Q9Y4P8	Macroautophagy;Autophagy
Q9Y4R7	Metabolism of proteins;Post-translational protein modification;Carboxyterminal post-translational modifications of tubulin
Q9Y4U1	Metabolism;Disease;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD;Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC;Diseases of metabolism
Q9Y4W2	Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y4W6	Transport of small molecules;Mitochondrial calcium ion transport;Processing of SMDT1
Q9Y4X1	Metabolism;Phase II - Conjugation of compounds;Glucuronidation;Biological oxidations
Q9Y4X3	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;Chemokine receptors bind chemokines;GPCR downstream signalling;G alpha (i) signalling events;GPCR ligand binding
Q9Y4X5	ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon Signaling
Q9Y4Y9	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9Y4Z0	Deadenylation-dependent mRNA decay;mRNA decay by 5' to 3' exoribonuclease;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA;Metabolism of RNA
Q9Y4Z2	Developmental Biology;Regulation of beta-cell development;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
Q9Y508	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y512	Mitochondrial protein import;Mitochondrial biogenesis;Organelle biogenesis and maintenance;Cristae formation;Protein localization
Q9Y535	Innate Immune System;Immune System;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation;RNA Polymerase III Transcription Termination;RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter
Q9Y547	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport
Q9Y561	Metabolism;Signal Transduction;Metabolism of vitamins and cofactors;Visual phototransduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
Q9Y566	Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
Q9Y570	Cell Cycle;Mitotic G2-G2/M phases;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic
Q9Y572	ZBP1(DAI) mediated induction of type I IFNs;Toll Like Receptor 4 (TLR4) Cascade;MyD88-independent TLR4 cascade ;Toll Like Receptor 3 (TLR3) Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;RIP-mediated NFkB activation via ZBP1;Cytosolic sensors of pathogen-associated DNA ;TRIF-mediated programmed cell death;Stimuli-sensing channels;TRP channels;Transport of small molecules;RIPK1-mediated regulated necrosis;Regulated Necrosis;Programmed Cell Death;TLR3-mediated TICAM1-dependent programmed cell death;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;Ion channel transport
Q9Y574	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y575	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y576	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y577	Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
Q9Y584	Mitochondrial protein import;Protein localization
Q9Y585	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9Y587	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Vesicle-mediated transport
Q9Y592	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
Q9Y5A7-1	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9Y5A7-2	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9Y5B0	Formation of RNA Pol II elongation complex ;Formation of the Early Elongation Complex;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;Formation of the HIV-1 Early Elongation Complex;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Abortive elongation of HIV-1 transcript in the absence of Tat;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q9Y5B8	Cell Cycle;Recruitment of mitotic centrosome proteins and complexes;Centrosome maturation;Recruitment of NuMA to mitotic centrosomes;Mitotic G2-G2/M phases;Mitotic Prometaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic
Q9Y5B9	Formation of RNA Pol II elongation complex ;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Disease;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;Generic Transcription Pathway;Transcriptional Regulation by TP53;Regulation of TP53 Activity;Infectious disease;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Transcription;Gene expression (Transcription);RNA Polymerase II Transcription Elongation
Q9Y5C1	Signal Transduction;Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Assembly of active LPL and LIPC lipase complexes;Plasma lipoprotein remodeling;Signaling by Nuclear Receptors;NR1H2 and NR1H3-mediated signaling;NR1H2 & NR1H3 regulate gene expression linked to lipogenesis
Q9Y5I7	Cell-Cell communication;Tight junction interactions;Cell-cell junction organization;Cell junction organization
Q9Y5J1	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y5J3	Signaling by NOTCH;Signal Transduction;Disease;Signaling by NOTCH1;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Diseases of signal transduction by growth factor receptors and second messengers;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates osteoblast differentiation;RUNX2 regulates bone development;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH4;NOTCH4 Intracellular Domain Regulates Transcription
Q9Y5J6	Mitochondrial protein import;Protein localization
Q9Y5J7	Mitochondrial protein import;Protein localization
Q9Y5J9	Mitochondrial protein import;Protein localization
Q9Y5K1	Reproduction;Meiosis;Cell Cycle;Meiotic recombination
Q9Y5K3	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Phospholipid metabolism;Metabolism of lipids
Q9Y5K5	Signal Transduction;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs;Metabolism of proteins;Deubiquitination;UCH proteinases;Post-translational protein modification;Signaling by TGF-beta family members
Q9Y5K6	Cell-Cell communication;Nephrin family interactions
Q9Y5K8	ROS and RNS production in phagocytes;Signal Transduction;Innate Immune System;Immune System;Cellular responses to stress;Transport of small molecules;Neutrophil degranulation;Signaling by Insulin receptor;Insulin receptor recycling;Cellular responses to external stimuli;Signaling by Receptor Tyrosine Kinases;Iron uptake and transport;Transferrin endocytosis and recycling;Amino acids regulate mTORC1;Ion channel transport
Q9Y5L2	Metabolism;Metabolism of lipids;Lipid particle organization
Q9Y5L3	Metabolism;Metabolism of nucleotides;Phosphate bond hydrolysis by NTPDase proteins;Nucleobase catabolism
Q9Y5L4	Mitochondrial protein import;Protein localization
Q9Y5M8	SRP-dependent cotranslational protein targeting to membrane;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Translation
Q9Y5N1	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;GPCR downstream signalling;Histamine receptors;G alpha (i) signalling events;GPCR ligand binding
Q9Y5N5	Metabolism;Phase II - Conjugation of compounds;Methylation;Biological oxidations;Metabolism of proteins;Eukaryotic Translation Termination;Translation
Q9Y5N6	E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Cell Cycle;Activation of ATR in response to replication stress;Mitotic G1 phase and G1/S transition;Assembly of the ORC complex at the origin of replication;CDC6 association with the ORC:origin complex;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;Activation of the pre-replicative complex;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;G1/S Transition;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints
Q9Y5P0	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9Y5P1	Signal Transduction;Signaling by GPCR;Olfactory Signaling Pathway;GPCR downstream signalling;G alpha (s) signalling events
Q9Y5P4-2	Metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Metabolism of lipids
Q9Y5P6	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of GDP-mannose;Synthesis of substrates in N-glycan biosythesis;Post-translational protein modification
Q9Y5P8	Inhibition of replication initiation of damaged DNA by RB1/E2F1;E2F mediated regulation of DNA replication;Cell Cycle;Mitotic G2-G2/M phases;Mitotic G1 phase and G1/S transition;G1/S Transition;Cyclin D associated events in G1;G1 Phase;Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Cell Cycle, Mitotic
Q9Y5Q3	Developmental Biology;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
Q9Y5Q5	Muscle contraction;Cardiac conduction;Physiological factors
Q9Y5Q6	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;G alpha (i) signalling events;Relaxin receptors;GPCR ligand binding
Q9Y5Q8	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
Q9Y5Q9	RNA Polymerase III Transcription;Gene expression (Transcription);RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter
Q9Y5R2	Degradation of the extracellular matrix;Extracellular matrix organization;Activation of Matrix Metalloproteinases
Q9Y5R8	Innate Immune System;Immune System;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Neutrophil degranulation;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Transport to the Golgi and subsequent modification
Q9Y5S1	Stimuli-sensing channels;TRP channels;Transport of small molecules;Ion channel transport
Q9Y5S8	Signal Transduction;Disease;Signaling by Rho GTPases;RHO GTPase Effectors;Infectious disease;RHO GTPases Activate NADPH Oxidases;Leishmania infection;Killing mechanisms;WNT5:FZD7-mediated leishmania damping
Q9Y5S9	Developmental Biology;Transport of Mature mRNA derived from an Intron-Containing Transcript;Signaling by ROBO receptors;Axon guidance;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA 3'-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Regulation of expression of SLITs and ROBOs;Nonsense-Mediated Decay (NMD);Nervous system development;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
Q9Y5T5	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9Y5U4	Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Metabolism of lipids;Metabolism of steroids
Q9Y5U5	Cytokine Signaling in Immune system;Immune System;Generic Transcription Pathway;TNFR2 non-canonical NF-kB pathway;TNFs bind their physiological receptors;RNA Polymerase II Transcription;Gene expression (Transcription);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1
Q9Y5U8	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
Q9Y5V0	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y5V3	Apoptosis;Signal Transduction;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Caspase activation via Dependence Receptors in the absence of ligand;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Death Receptor Signalling
Q9Y5W5	Signal Transduction;Signaling by WNT;TCF dependent signaling in response to WNT;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
Q9Y5X1	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Clathrin-mediated endocytosis
Q9Y5X3	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q9Y5X4-1	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y5X4-2	Generic Transcription Pathway;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y5X5	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);Peptide ligand-binding receptors;GPCR downstream signalling;Orexin and neuropeptides FF and QRFP bind to their respective receptors;G alpha (q) signalling events;GPCR ligand binding
Q9Y5X9	Plasma lipoprotein assembly, remodeling, and clearance;Transport of small molecules;Plasma lipoprotein remodeling;HDL remodeling
Q9Y5Y0-1	Metabolism;Metabolism of porphyrins;Heme biosynthesis;Transport of small molecules;Iron uptake and transport
Q9Y5Y0-2	Metabolism;Metabolism of porphyrins;Heme biosynthesis
Q9Y5Y2	Metabolism;Cytosolic iron-sulfur cluster assembly
Q9Y5Y3	Signal Transduction;Disease;Signaling by GPCR;GPCR downstream signalling;G alpha (s) signalling events;Infectious disease;Leishmania infection;ADORA2B mediated anti-inflammatory cytokines production;Anti-inflammatory response favouring Leishmania parasite infection;Leishmania parasite growth and survival
Q9Y5Y4	Signal Transduction;Signaling by GPCR;Class A/1 (Rhodopsin-like receptors);GPCR downstream signalling;Eicosanoid ligand-binding receptors;Prostanoid ligand receptors;G alpha (i) signalling events;GPCR ligand binding
Q9Y5Y5	Class I peroxisomal membrane protein import;Protein localization
Q9Y5Y6	Developmental Biology;Keratinization;Formation of the cornified envelope
Q9Y5Y7	Metabolism;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan uptake and degradation;Metabolism of carbohydrates
Q9Y5Y9	Developmental Biology;L1CAM interactions;Muscle contraction;Axon guidance;Interaction between L1 and Ankyrins;Cardiac conduction;Phase 0 - rapid depolarisation;Nervous system development
Q9Y5Z4	Innate Immune System;Immune System;Neutrophil degranulation
Q9Y5Z6	Metabolism;Metabolism of carbohydrates;Blood group systems biosynthesis;Lewis blood group biosynthesis
Q9Y5Z9	Metabolism;Metabolism of vitamins and cofactors;Metabolism of vitamin K;Metabolism of fat-soluble vitamins
Q9Y600	Metabolism;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q9Y606-1	tRNA modification in the mitochondrion;tRNA processing;Metabolism of RNA
Q9Y606-2	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
Q9Y616	Cytokine Signaling in Immune system;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling;Signaling by Interleukins;Interleukin-1 signaling
Q9Y617	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
Q9Y618	Developmental Biology;Metabolism;Signaling by NOTCH;Signal Transduction;Disease;Signaling by TGF-beta Receptor Complex;Signaling by NOTCH1;PPARA activates gene expression;NOTCH1 Intracellular Domain Regulates Transcription;Generic Transcription Pathway;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;SUMOylation;SUMO E3 ligases SUMOylate target proteins;HDACs deacetylate histones;Chromatin modifying enzymes;Notch-HLH transcription pathway;Transcriptional regulation of white adipocyte differentiation;Nuclear Receptor transcription pathway;SUMOylation of transcription cofactors;Metabolism of proteins;Regulation of lipid metabolism by PPARalpha;Chromatin organization;Metabolism of lipids;Diseases of signal transduction by growth factor receptors and second messengers;Infectious disease;Post-translational protein modification;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional Regulation by MECP2;Loss of function of MECP2 in Rett syndrome;Pervasive developmental disorders;Signaling by Nuclear Receptors;Signaling by TGF-beta family members;Loss of MECP2 binding ability to the NCoR/SMRT complex;Regulation of MECP2 expression and activity;NR1H2 and NR1H3-mediated signaling;NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux;HCMV Infection;HCMV Early Events;NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis;Disorders of developmental biology
Q9Y619	Metabolism;Urea cycle;Metabolism of amino acids and derivatives
Q9Y624	Hemostasis;Extracellular matrix organization;Cell-Cell communication;Signal Transduction;Signaling by TGF-beta Receptor Complex;Cell surface interactions at the vascular wall;Integrin cell surface interactions;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition);Tight junction interactions;Cell-cell junction organization;Cell junction organization;Signaling by TGF-beta family members
Q9Y625	Metabolism;Signal Transduction;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Disease;Chondroitin sulfate/dermatan sulfate metabolism;Metabolism of vitamins and cofactors;A tetrasaccharide linker sequence is required for GAG synthesis;HS-GAG biosynthesis;HS-GAG degradation;Visual phototransduction;Diseases associated with glycosaminoglycan metabolism;Defective B4GALT7 causes EDS, progeroid type;Defective B3GAT3 causes JDSSDHD;Defective EXT2 causes exostoses 2;Defective EXT1 causes exostoses 1, TRPS2 and CHDS;Signaling by GPCR;Diseases of glycosylation;GPCR downstream signalling;G alpha (i) signalling events;Defective B3GALT6 causes EDSP2 and SEMDJL1;Diseases of metabolism;Metabolism of fat-soluble vitamins;Metabolism of carbohydrates;Retinoid metabolism and transport
Q9Y639	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;GABA receptor activation
Q9Y644	Signaling by NOTCH;Signal Transduction;Pre-NOTCH Processing in Golgi;Pre-NOTCH Expression and Processing
Q9Y661	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q9Y662	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q9Y663	Metabolism;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG biosynthesis;Metabolism of carbohydrates
Q9Y664	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q9Y666	Transport of small molecules;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Cation-coupled Chloride cotransporters
Q9Y672	Disease;Diseases associated with N-glycosylation of proteins;Diseases of glycosylation;Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Defective ALG6 causes ALG6-CDG (CDG-1c);Diseases of metabolism;Post-translational protein modification
Q9Y673	Metabolism of proteins;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Synthesis of substrates in N-glycan biosythesis;Synthesis of dolichyl-phosphate-glucose;Post-translational protein modification
Q9Y676	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y678	ER to Golgi Anterograde Transport;Membrane Trafficking;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;COPI-mediated anterograde transport;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Transport to the Golgi and subsequent modification
Q9Y691	Hemostasis;Neuronal System;Ca2+ activated K+ channels;Potassium Channels;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
Q9Y694	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Organic cation/anion/zwitterion transport;Organic anion transport
Q9Y697-1	Mitochondrial iron-sulfur cluster biogenesis;Metabolism
Q9Y697-2	Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Molybdenum cofactor biosynthesis
Q9Y698	Presynaptic depolarization and calcium channel opening;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Developmental Biology;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Cardiac conduction;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;LGI-ADAM interactions
Q9Y6A1	Disease;Diseases of glycosylation;Diseases associated with O-glycosylation of proteins;Metabolism of proteins;Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2;Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1;O-linked glycosylation;Diseases of metabolism;Post-translational protein modification
Q9Y6A2	Metabolism;Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Bile acid and bile salt metabolism;Biological oxidations;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of lipids;Metabolism of steroids
Q9Y6A5	Signaling by NOTCH;Signal Transduction;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
Q9Y6A9	SRP-dependent cotranslational protein targeting to membrane;Peptide hormone metabolism;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1);Metabolism of proteins;Incretin synthesis, secretion, and inactivation;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP);Synthesis, secretion, and deacylation of Ghrelin;Translation
Q9Y6B6	Adaptive Immune System;Metabolism;Regulation of cholesterol biosynthesis by SREBP (SREBF);Immune System;Plasma lipoprotein assembly, remodeling, and clearance;ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;MHC class II antigen presentation;Transport of small molecules;Metabolism of proteins;Asparagine N-linked glycosylation;Metabolism of lipids;Vesicle-mediated transport;Cargo concentration in the ER;Post-translational protein modification;Metabolism of steroids;Chylomicron assembly;Plasma lipoprotein assembly;Transport to the Golgi and subsequent modification;Class I MHC mediated antigen processing & presentation;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
Q9Y6B7	Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport
Q9Y6C2	Extracellular matrix organization;Elastic fibre formation;Molecules associated with elastic fibres
Q9Y6C5	Signal Transduction;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q9Y6D5	Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;Metabolism of proteins
Q9Y6D9	Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Cell Cycle;Signaling by Rho GTPases;RHO GTPase Effectors;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;RHO GTPases Activate Formins;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;EML4 and NUDC in mitotic spindle formation
Q9Y6E0	Apoptosis;Apoptotic cleavage of cellular proteins;Programmed Cell Death;Apoptotic execution phase
Q9Y6E7	Mitochondrial biogenesis;Organelle biogenesis and maintenance;Transcriptional activation of mitochondrial biogenesis
Q9Y6F6	Hemostasis;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;cGMP effects
Q9Y6F9	Signal Transduction;Signaling by WNT;WNT ligand biogenesis and trafficking;Signaling by GPCR;Class B/2 (Secretin family receptors);GPCR ligand binding
Q9Y6G3	Metabolism of proteins;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination;Translation
Q9Y6G5	Metabolism of proteins;Post-translational protein modification;Neddylation
Q9Y6G9	Adaptive Immune System;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Signal Transduction;Macroautophagy;Cell Cycle;Disease;Innate Immune System;Immune System;Signaling by Rho GTPases;RHO GTPase Effectors;ER to Golgi Anterograde Transport;Membrane Trafficking;MHC class II antigen presentation;Cellular responses to stress;Separation of Sister Chromatids;Resolution of Sister Chromatid Cohesion;Mitotic Metaphase and Anaphase;HSP90 chaperone cycle for steroid hormone receptors (SHR);Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Infectious disease;RHO GTPases Activate Formins;Post-translational protein modification;Neutrophil degranulation;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Mitotic Prometaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Mitotic Spindle Checkpoint;Cell Cycle Checkpoints;Golgi-to-ER retrograde transport;Cellular responses to external stimuli;Transport to the Golgi and subsequent modification;HCMV Infection;HCMV Early Events;Autophagy;Aggrephagy;EML4 and NUDC in mitotic spindle formation;Selective autophagy
Q9Y6H1	Mitochondrial protein import;Protein localization
Q9Y6H5-2	Metabolism of proteins;Amyloid fiber formation
Q9Y6H5	Metabolism of proteins;Amyloid fiber formation
Q9Y6H6	Muscle contraction;Phase 3 - rapid repolarisation;Cardiac conduction;Phase 2 - plateau phase
Q9Y6H8	Gap junction trafficking and regulation;Gap junction trafficking;Gap junction assembly;Membrane Trafficking;Vesicle-mediated transport
Q9Y6I3	Signal Transduction;Signaling by EGFR;EGFR downregulation;Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis;Signaling by Receptor Tyrosine Kinases
Q9Y6I4	Metabolism of proteins;Deubiquitination;Ub-specific processing proteases;Post-translational protein modification
Q9Y6I7	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neddylation;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
Q9Y6I8	Class I peroxisomal membrane protein import;Protein localization
Q9Y6I9	Hemostasis;Platelet degranulation ;Platelet activation, signaling and aggregation;Response to elevated platelet cytosolic Ca2+
Q9Y6J0	Cellular responses to stress;Cellular Senescence;Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular responses to external stimuli
Q9Y6J6	Muscle contraction;Phase 3 - rapid repolarisation;Cardiac conduction;Phase 2 - plateau phase
Q9Y6J9	HATs acetylate histones;Chromatin modifying enzymes;Chromatin organization
Q9Y6K0	Metabolism;Synthesis of PC;Glycerophospholipid biosynthesis;Synthesis of PE;Phospholipid metabolism;Metabolism of lipids
Q9Y6K1	Epigenetic regulation of gene expression;PRC2 methylates histones and DNA;SUMOylation;SUMO E3 ligases SUMOylate target proteins;RMTs methylate histone arginines;Chromatin modifying enzymes;Metabolism of proteins;SUMOylation of DNA methylation proteins;Chromatin organization;DNA methylation;Post-translational protein modification;Gene expression (Transcription)
Q9Y6K5	Antiviral mechanism by IFN-stimulated genes;Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;OAS antiviral response;Interferon alpha/beta signaling;Interferon Signaling
Q9Y6K8	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
Q9Y6K9	Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;ER-Phagosome pathway;Antigen processing-Cross presentation;Cytokine Signaling in Immune system;Adaptive Immune System;ZBP1(DAI) mediated induction of type I IFNs;Signal Transduction;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;NOD1/2 Signaling Pathway;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Toll-like Receptor Cascades;TICAM1, RIP1-mediated IKK complex recruitment;DDX58/IFIH1-mediated induction of interferon-alpha/beta;RIP-mediated NFkB activation via ZBP1;Toll Like Receptor 2 (TLR2) Cascade;Cytosolic sensors of pathogen-associated DNA ;TCR signaling;Downstream TCR signaling;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;Interleukin-1 family signaling;Interleukin-17 signaling;Signaling by Interleukins;MAP kinase activation;activated TAK1 mediates p38 MAPK activation;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1;SUMOylation of immune response proteins;Diseases of Immune System;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;Diseases associated with the TLR signaling cascade;IKBKB deficiency causes SCID;IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR);IkBA variant leads to EDA-ID;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);MAP3K8 (TPL2)-dependent MAPK1/3 activation;Deubiquitination;Ub-specific processing proteases;Ovarian tumor domain proteases;Post-translational protein modification;Death Receptor Signalling;TNF signaling;Interleukin-1 signaling;TRAF6 mediated NF-kB activation;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10;IRAK1 recruits IKK complex;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation;MyD88 dependent cascade initiated on endosome;MyD88 cascade initiated on plasma membrane;Class I MHC mediated antigen processing & presentation;Signaling by the B Cell Receptor (BCR)
Q9Y6L6	Metabolism;Recycling of bile acids and salts;Disease;Metabolism of porphyrins;Heme degradation;Bile acid and bile salt metabolism;Transport of small molecules;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Metabolism of lipids;SLC transporter disorders;Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR);Disorders of transmembrane transporters;Transport of organic anions;Metabolism of steroids
Q9Y6L7	Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes;Assembly of collagen fibrils and other multimeric structures;Anchoring fibril formation;Crosslinking of collagen fibrils
Q9Y6M0	Post-translational modification: synthesis of GPI-anchored proteins;Metabolism of proteins;Post-translational protein modification
Q9Y6M1	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA;Metabolism of RNA
Q9Y6M5	Transport of small molecules;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Metal ion SLC transporters;Zinc transporters;Zinc efflux and compartmentalization by the SLC30 family
Q9Y6M7	Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport
Q9Y6M9	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Complex I biogenesis
Q9Y6N1	The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;Respiratory electron transport;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y6N3	Stimuli-sensing channels;Transport of small molecules;Ion channel transport
Q9Y6N5	Metabolism;Sulfide oxidation to sulfate;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism;Metabolism of amino acids and derivatives
Q9Y6N6	Extracellular matrix organization;Signal Transduction;Laminin interactions;Non-integrin membrane-ECM interactions;Signaling by MET;MET activates PTK2 signaling;MET promotes cell motility;Signaling by Receptor Tyrosine Kinases
Q9Y6N7	Developmental Biology;Netrin-1 signaling;Signaling by ROBO receptors;Axon guidance;Activation of RAC1;Regulation of commissural axon pathfinding by SLIT and ROBO;Inactivation of CDC42 and RAC1;Role of ABL in ROBO-SLIT signaling;SLIT2:ROBO1 increases RHOA activity;Regulation of cortical dendrite branching;Regulation of expression of SLITs and ROBOs;Nervous system development
Q9Y6N8	Cell-Cell communication;Adherens junctions interactions;Cell-cell junction organization;Cell junction organization
Q9Y6P5-1	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y6P5-3	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Metabolic Genes;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y6P5	Cellular responses to stress;Cellular responses to external stimuli;Amino acids regulate mTORC1
Q9Y6Q1	Degradation of the extracellular matrix;Extracellular matrix organization
Q9Y6Q2	Membrane Trafficking;Vesicle-mediated transport;Cargo recognition for clathrin-mediated endocytosis;Clathrin-mediated endocytosis
Q9Y6Q3	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
Q9Y6Q5	Adaptive Immune System;HIV Infection;Host Interactions of HIV factors;Disease;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters;Nef mediated downregulation of MHC class I complex cell surface expression;The role of Nef in HIV-1 replication and disease pathogenesis;Immune System;Membrane Trafficking;trans-Golgi Network Vesicle Budding;MHC class II antigen presentation;Lysosome Vesicle Biogenesis;Golgi Associated Vesicle Biogenesis;Vesicle-mediated transport;Infectious disease
Q9Y6Q6	Cytokine Signaling in Immune system;Immune System;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
Q9Y6Q9	Developmental Biology;Metabolism;Signal Transduction;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Metabolism of lipids;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;MAPK family signaling cascades;MAPK6/MAPK4 signaling;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression
Q9Y6R1	Disease;Transport of small molecules;Bicarbonate transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA);SLC transporter disorders;Disorders of transmembrane transporters
Q9Y6T7	Hemostasis;Effects of PIP2 hydrolysis;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;Platelet activation, signaling and aggregation
Q9Y6V7	rRNA modification in the nucleus and cytosol;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Metabolism of RNA
Q9Y6W3	Degradation of the extracellular matrix;Extracellular matrix organization
Q9Y6W5	Signal Transduction;Disease;Innate Immune System;Immune System;Signaling by VEGF;Signaling by Rho GTPases;RHO GTPase Effectors;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;VEGFA-VEGFR2 Pathway;Infectious disease;RHO GTPases Activate WASPs and WAVEs;Signaling by Receptor Tyrosine Kinases;Leishmania infection;Parasite infection;Leishmania phagocytosis;FCGR3A-mediated phagocytosis
Q9Y6W6	RAF-independent MAPK1/3 activation;Cytokine Signaling in Immune system;Signal Transduction;Immune System;RAF/MAP kinase cascade;Negative regulation of MAPK pathway;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling
Q9Y6W8-1	PIP3 activates AKT signaling;Adaptive Immune System;Signal Transduction;Disease;Immune System;Negative regulation of the PI3K/AKT network;PI3K/AKT Signaling in Cancer;Constitutive Signaling by Aberrant PI3K in Cancer;Costimulation by the CD28 family;Diseases of signal transduction by growth factor receptors and second messengers;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Intracellular signaling by second messengers
Q9Y6X1	XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR);Metabolism of proteins;Protein localization;Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
Q9Y6X2	SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of transcription factors;SUMOylation of transcription cofactors;Metabolism of proteins;SUMOylation of intracellular receptors;SUMOylation of DNA replication proteins;SUMOylation of immune response proteins;Formation of Incision Complex in GG-NER;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);Post-translational protein modification;DNA Repair
Q9Y6X3	Cell Cycle;Cohesin Loading onto Chromatin;Mitotic Telophase/Cytokinesis;M Phase;Cell Cycle, Mitotic
Q9Y6X5	Innate Immune System;Immune System;Neutrophil degranulation
Q9Y6X9	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism
Q9Y6Y8	ER to Golgi Anterograde Transport;Membrane Trafficking;COPII-mediated vesicle transport;Metabolism of proteins;Asparagine N-linked glycosylation;Vesicle-mediated transport;Post-translational protein modification;Transport to the Golgi and subsequent modification
Q9Y6Y9	Apoptosis;ER-Phagosome pathway;Antigen processing-Cross presentation;Adaptive Immune System;Caspase activation via Death Receptors in the presence of ligand;Disease;Toll Like Receptor 4 (TLR4) Cascade;MyD88:MAL(TIRAP) cascade initiated on plasma membrane;MyD88-independent TLR4 cascade ;Toll Like Receptor 9 (TLR9) Cascade;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor 7/8 (TLR7/8) Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Innate Immune System;Immune System;Toll-like Receptor Cascades;Toll Like Receptor 2 (TLR2) Cascade;TRIF-mediated programmed cell death;Diseases of Immune System;Caspase activation via extrinsic apoptotic signalling pathway;Programmed Cell Death;Diseases associated with the TLR signaling cascade;MyD88 deficiency (TLR2/4);IRAK4 deficiency (TLR2/4);Regulation of TLR by endogenous ligand;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;IKK complex recruitment mediated by RIP1;TRIF(TICAM1)-mediated TLR4 signaling ;TRAF6-mediated induction of TAK1 complex within TLR4 complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation;Class I MHC mediated antigen processing & presentation
Q9Y6Z7	Complement cascade;Lectin pathway of complement activation;Initial triggering of complement;Creation of C4 and C2 activators;Innate Immune System;Immune System
